<SEC-DOCUMENT>0001193125-22-016151.txt : 20220124
<SEC-HEADER>0001193125-22-016151.hdr.sgml : 20220124
<ACCEPTANCE-DATETIME>20220124172401
ACCESSION NUMBER:		0001193125-22-016151
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		41
CONFORMED PERIOD OF REPORT:	20220123
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220124
DATE AS OF CHANGE:		20220124

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FLUIDIGM CORP
		CENTRAL INDEX KEY:			0001162194
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				770513190
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34180
		FILM NUMBER:		22550427

	BUSINESS ADDRESS:	
		STREET 1:		2 TOWER PLACE
		STREET 2:		SUITE 2000
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		6502666000

	MAIL ADDRESS:	
		STREET 1:		2 TOWER PLACE
		STREET 2:		SUITE 2000
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d243622d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:fldm="http://fluidigm.com/20220123" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2022-01-23_to_2022-01-23">FLUIDIGM CORP</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2022-01-23_to_2022-01-23">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2022-01-23_to_2022-01-23">0001162194</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_CurrentFiscalYearEndDate_duration_2022-01-23_to_2022-01-23" name="dei:CurrentFiscalYearEndDate" contextRef="duration_2022-01-23_to_2022-01-23">--12-31</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="fldm-20220123.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2022-01-23_to_2022-01-23"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-23</xbrli:startDate> <xbrli:endDate>2022-01-23</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2022-01-23_to_2022-01-23">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2022-01-23_to_2022-01-23" format="ixt:datemonthdayyearen">January&#160;23, 2022</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">Fluidigm Corporation</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2022-01-23_to_2022-01-23" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2022-01-23_to_2022-01-23">001-34180</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2022-01-23_to_2022-01-23">77-0513190</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2022-01-23_to_2022-01-23">2 Tower Place</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2022-01-23_to_2022-01-23">Suite 2000</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2022-01-23_to_2022-01-23">South San Francisco</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2022-01-23_to_2022-01-23" format="ixt-sec:stateprovnameen">California</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2022-01-23_to_2022-01-23">94080</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices) (Zip Code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2022-01-23_to_2022-01-23">(650)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2022-01-23_to_2022-01-23">266-6000</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code</p> <p style="margin-top:20pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="font-style:italic">see</span> General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2022-01-23_to_2022-01-23" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2022-01-23_to_2022-01-23" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2022-01-23_to_2022-01-23" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2022-01-23_to_2022-01-23" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-01-23_to_2022-01-23">Common stock, par value $0.001 per share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-01-23_to_2022-01-23">FLDM</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-01-23_to_2022-01-23" format="ixt-sec:exchnameen">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2022-01-23_to_2022-01-23" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;1.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Casdin and Viking Loan Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&#160;23, 2022, Fluidigm Corporation (the &#8220;Company&#8221;) entered into (i)&#160;a Loan Agreement, dated and effective as of January&#160;23, 2022, among the lenders party thereto affiliated with Casdin Private Growth Equity Fund II, L.P. and the Company (the &#8220;Casdin Loan Agreement&#8221;) and (ii)&#160;a Loan Agreement, dated and effective as of January&#160;23, 2022, among the lenders party thereto affiliated with Viking Global Investors LP and the Company (the &#8220;Viking Loan Agreement,&#8221; and together with the Casdin Loan Agreement, the &#8220;Loan Agreements&#8221;).&#160;Each Loan Agreement provides for a $12.5&#160;million term loan to the Company (each, a &#8220;Term Loan&#8221; and collectively, the &#8220;Term Loans&#8221;). The Term Loans were fully drawn on January&#160;24, 2022. The Term Loans mature on the 91st calendar day after the latest maturity date of the loans borrowed under the Company&#8217;s Loan and Security Agreement, dated as of August&#160;2, 2018 (as amended, the &#8220;SVB Loan Agreement&#8221;), with Silicon Valley Bank (the &#8220;Maturity Date&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The proceeds of the Term Loans may be used for working capital and general corporate purposes. The Company may not prepay the Term Loans under the Loan Agreements without the consent of their respective lenders. The Term Loans are subordinated to the obligations arising under the SVB Loan Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Term Loans bear interest (i)&#160;from and including the effective date of the Loan Agreements to but excluding March&#160;1, 2022, at 10%, (ii) from and including March&#160;1, 2022 to but excluding June&#160;1, 2022, at 12%, (iii) from and including June&#160;1, 2022 to but excluding September&#160;1, 2022, at 14%, and (iv)&#160;from and including September&#160;1, 2022 and thereafter, at 16%. Interest accrues daily and is payable in kind by adding the accrued interest to the outstanding principal amount on the last date of each month.&#160;Principal, together with accrued and unpaid interest, is due on the Maturity Date.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the issuance of the Series B Preferred Stock (as defined below) pursuant to the Purchase Agreements (as defined below), the Term Loans will be automatically converted into a number of shares of Series <span style="white-space:nowrap">B-1</span> Preferred Stock (as defined below) or Series <span style="white-space:nowrap">B-2</span> Preferred Stock (as defined below), in accordance with the terms of the Casdin Loan Agreement or the Viking Loan Agreement, as applicable, equal to (i)&#160;the outstanding principal amount of the applicable Term Loan (including any interest added to the original principal amount thereof) plus accrued and unpaid interest on the Term Loans divided by $1,000 multiplied by (ii)&#160;the Conversion Price (as defined in the Certificates of Designations (as defined below) for the Series B Preferred Stock) divided by $2.84. If the Series B Preferred Stock is not approved for issuance at a stockholder meeting or the Purchase Agreements are terminated, then the Term Loans will become convertible, at each lender&#8217;s option, into common stock, par value $0.001 per share, of the Company (the &#8220;Common Stock&#8221;) at an initial conversion rate of 352.1126 shares of Common Stock per $1,000 of conversion amount, subject to the cap set forth in the Loan Agreements. The conversion rate is subject to customary adjustments as set forth in the Loan Agreements. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Loan Agreements contain customary affirmative covenants, including covenants regarding the payment of taxes and other obligations, maintenance of insurance, reporting requirements and compliance with applicable laws and regulations.&#160;Further, the Loan Agreements contain customary negative covenants limiting the ability of the Company and its subsidiaries, among other things, to incur debt, grant liens, make investments, make certain restricted payments and sell assets, in each case subject to certain exceptions.&#160;Upon the occurrence and during the continuance of an event of default, the lenders under each Loan Agreement may declare all outstanding principal and accrued and unpaid interest under such Loan Agreement immediately due and payable and may exercise the other rights and remedies provided for under such Loan Agreement. The events of default under the Loan Agreements include, subject to grace periods in certain instances, payment defaults, cross defaults with certain other indebtedness, breaches of covenants or representations and warranties, change in control of the Company, the occurrence of a Material Adverse Change (as defined in the Loan Agreements) and certain bankruptcy and insolvency events with respect to the Company and its subsidiaries. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The description of the Loan Agreements contained herein is qualified in its entirety by reference to the text of each of the Loan Agreements, which are attached as Exhibits 10.1 and 10.2, respectively, hereto, and incorporated herein by reference. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Series <span style="white-space:nowrap">B-1</span> and <span style="white-space:nowrap">B-2</span> Convertible Preferred Stock Purchase Agreements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Also on January&#160;23, 2022, the Company entered into separate Series B Convertible Preferred Stock Purchase Agreements (together, the &#8220;Purchase Agreements&#8221; and the transactions contemplated by the Purchase Agreements, together, the &#8220;Preferred Equity Transactions&#8221;) with each of Casdin Private Growth Equity Fund II, L.P. and Casdin Partners Master Fund, L.P. (collectively, &#8220;Casdin&#8221;) and Viking Global Opportunities Illiquid Investments <span style="white-space:nowrap">Sub-Master</span> LP and Viking Global Opportunities Drawdown (Aggregator) LP (collectively, &#8220;Viking&#8221; and, together with Casdin, the &#8220;Purchasers&#8221;), pursuant to which, among other things, at the closing of the Preferred Equity Transactions (the &#8220;Closing&#8221;), and on the terms and subject to the conditions set forth therein, the Company will issue and sell in a private placement (a)&#160;to Casdin 112,500 shares of the Company&#8217;s newly designated Series <span style="white-space:nowrap">B-1</span> Convertible Preferred Stock, par value $0.001 per share (&#8220;Series <span style="white-space:nowrap">B-1</span> Preferred Stock&#8221;) in exchange for $112.5&#160;million, and (b)&#160;to Viking, 112,500 shares of the Company&#8217;s newly designated Series <span style="white-space:nowrap">B-2</span> Convertible Preferred Stock, par value $0.001 per share (&#8220;Series <span style="white-space:nowrap">B-2</span> Preferred Stock&#8221; and, together with the Series <span style="white-space:nowrap">B-1</span> Preferred Stock, the &#8220;Series B Preferred Stock&#8221;) in exchange for $112.5&#160;million (collectively, the &#8220;Aggregate Purchase Price&#8221;). The Series B Preferred Stock to be purchased by Casdin and Viking pursuant to the Purchase Agreements is in addition to any Series B Preferred Stock to be issued upon conversion of outstanding amounts under the Loan Agreements. The proceeds of the Preferred Equity Transactions will be used by the Company for expenses related to the Preferred Equity Transactions, as well as working capital, general corporate purposes and potential future merger and acquisition opportunities that the Company may identify from time to time. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The board of directors of the Company (the &#8220;Board&#8221;) has (a)&#160;determined that it is in the best interests of the Company and its stockholders that the Company enter into the Purchase Agreements and consummate the Preferred Equity Transactions and the other transactions contemplated thereby on the terms and subject to the conditions set forth therein, (b)&#160;approved and declared advisable the Purchase Agreements, the Preferred Equity Transactions and the other transactions contemplated thereby on the terms and subject to the conditions set forth therein, (c)&#160;resolved to recommend that the Company&#8217;s stockholders approve the issuance of the Series B Preferred Stock in connection with the Preferred Equity Transactions and adopt the Certificates of Designations and (d)&#160;directed that the Preferred Equity Transactions be submitted to the Company&#8217;s stockholders for approval. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to them in the Purchase Agreements. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Closing is subject to customary mutual closing conditions, including approval by the Company&#8217;s stockholders of the issuance of the Series B Preferred Stock in connection with the Preferred Equity Transactions. Each Preferred Equity Transaction is conditioned on the substantially contemporaneous consummation of the other Preferred Equity Transaction. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While the Purchase Agreements are in effect, there are various restrictions on the Company&#8217;s ability to solicit or entertain alternative transactions, whether in lieu of the Preferred Equity Transactions or otherwise. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Purchase Agreements contain customary termination rights for the Company and each of the Purchasers, including by: (a)&#160;mutual written agreement of the applicable Purchaser and the Company; (b)&#160;the applicable Purchaser or the Company in the event of a permanent legal restraint prohibiting the Preferred Equity Transactions; (c)&#160;the applicable Purchaser or the Company if the Closing has not occurred by June&#160;30, 2022; (d)&#160;the applicable Purchaser or the Company if the Company fails to obtain the approval of the Preferred Equity Transactions by its stockholders; (e)&#160;the applicable Purchaser if the Company has breached or failed to perform in any material respect any of its representations, warranties, covenants or other agreements contained in the applicable Purchase Agreement, which breach or failure to perform would result in a failure of a closing condition, subject to cure rights; (f)&#160;the applicable Purchaser if at any time the Board has effected a Company Board Recommendation Change (as defined in, and subject to, the Purchase Agreements); (g) the Company if the applicable Purchaser has breached or failed to perform in any material respect any of its respective representations, warranties, covenants or other agreements contained in the applicable Purchase Agreement, which breach or failure to perform would result in a failure of a closing condition, subject to cure rights; and (h)&#160;by the applicable Purchaser if the other Purchase Agreement has been terminated. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally speaking, the Company will be required to reimburse each Purchaser for an amount not to exceed $1,250,000 for each Purchaser&#8217;s documented expenses if the Purchase Agreements are terminated for any reason other than the applicable Purchaser&#8217;s breach of its Purchase Agreement. The Company will be required to pay each Purchaser a termination fee equal to $1,250,000 (for an aggregate payment to both Purchasers of $2,500,000) if the Purchase Agreements are terminated in certain circumstances; that amount may be offset against amounts paid by the Company for expense reimbursement. If a Purchase Agreement is terminated in certain circumstances and the Company subsequently effects an Acquisition Transaction (as defined in the Purchase Agreement), then the Company will owe the applicable Purchaser a termination fee of $2,500,000 (for an aggregate payment to both Purchasers of $5,000,000). If the Purchase Agreements are terminated due to the Board effecting a Company Board Recommendation Change, then the Company will owe the applicable Purchaser a termination fee of $5,000,000 (for an aggregate payment to both Purchasers of $10,000,000). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Purchase Agreements contain customary representations and warranties from the Purchasers and the Company, and each party has agreed to certain covenants, including, among others, covenants relating to (a)&#160;the conduct of the Company&#8217;s business during the interim period between the execution of the Purchase Agreements and the Closing; (b)&#160;the use of reasonable best efforts to complete the Preferred Equity Transactions; (c)&#160;the preparation of the proxy statement and related stockholder meeting; (d)&#160;information access rights; (e)&#160;certain standstill provisions and preemptive rights and (f)&#160;the composition of the Board immediately after the Closing. The Purchase Agreements prohibit the Purchasers from transferring the Series B Preferred Stock, or Common Stock issued upon conversion of such Series B Preferred Stock, in either case without the Company&#8217;s consent for six months from the Closing, except for certain permitted transfers. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing summary of the Purchase Agreements and the transactions contemplated by the Purchase Agreements does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Purchase Agreements, which are attached as Exhibits 10.3 and 10.4, respectively, hereto&#160;and incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Loan Agreements and the Purchase Agreements each contain customary representations and warranties by the parties thereto. These representations and warranties were made solely for the benefit of the parties to such agreements and: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">may not be treated as categorical statements of fact, but rather as a way of allocating risk to one of the parties if those statements prove inaccurate; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">may have been qualified in the applicable agreement by disclosures that were made to the other party in the confidential disclosure documents; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">may apply contractual standards of &#8220;materiality&#8221; that are different from &#8220;materiality&#8221; under applicable securities laws; and </p></td></tr></table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">were made only as of the date of the applicable agreement or such other date as may be specified in the applicable agreement. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Loan Agreements and the Purchase Agreements each also contain customary covenants and agreements of the parties thereto. These covenants and agreements may have been qualified in the appliable agreement by disclosures that were made in confidential disclosure document to such agreement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Registration Rights Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Also on January&#160;23, 2022, the Company entered into a Registration Rights Agreement with the Purchasers, pursuant to which the Purchasers will have certain customary registration rights with respect to shares issuable under the Loan Agreements and the Purchase Agreements, including (i)&#160;any shares of Common Stock acquired by any Holder (as defined in the Registration Rights Agreement) pursuant to the conversion of the Series B Preferred Stock in accordance with the Certificates of Designations, (ii)&#160;Common Stock issued upon conversion of the Term Loans if no Series B Preferred Stock is issued in accordance with the Loan Agreements and (iii) any shares of Common Stock acquired by any Holder pursuant to preemptive rights under the Purchase Agreements. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing summary of the Registration Rights Agreement and the transactions contemplated by the Registration Rights Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Registration Rights Agreement, which is filed as Exhibit 10.5, to this <span style="white-space:nowrap">Form&#160;8-K&#160;and</span> incorporated herein by reference. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Certificates of Designations for the Series B Preferred Stock </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the Closing, the Company will file with the Secretary of State of the State of Delaware two separate Certificates of Designations for the Series <span style="white-space:nowrap">B-1</span> Preferred Stock and the Series <span style="white-space:nowrap">B-2</span> Preferred Stock, respectively, establishing the powers, designations, preferences and privileges and the qualifications, limitations or restrictions of the shares of Series <span style="white-space:nowrap">B-1</span> Preferred Stock and Series <span style="white-space:nowrap">B-2</span> Preferred Stock (collectively, the &#8220;Certificates of Designations&#8221;). The Certificates of Designations will become effective upon filing. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series B Preferred Stock will rank senior to the Common Stock, with respect to dividend rights, redemption rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, the Series B Preferred Stock has a liquidation preference equal to the greater of (i)&#160;the Liquidation Preference (as defined in the Certificates of Designations) and (ii)&#160;the amount per share of Series B Preferred Stock that such holder would have received had all holders of Series B Preferred Stock, immediately prior to such voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, converted all shares of Series B Preferred Stock into Common Stock pursuant to the terms of the applicable Certificate of Designations (without regard to any limitations on conversion contained therein). The holders of Series B Preferred Stock will be entitled to participate in all dividends declared on the Common Stock on an <span style="white-space:nowrap">as-converted</span> basis, on the terms and subject to the conditions set forth in the Certificates of Designations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to certain anti-dilution adjustments and limitations on conversion with respect to certain Purchasers, the Series B Preferred Stock will be convertible at the option of the holders thereof at any time into a number of shares of Common Stock equal to the Conversion Rate (as defined in the Certificates of Designations), which shall initially be 294.1176; <span style="font-style:italic">provided</span> that in lieu of fractional shares otherwise issuable in connection with the conversion of shares of Series B Preferred Stock, each holder will receive either (i)&#160;cash in lieu of fractional shares (if any) or (ii)&#160;one additional whole share of fully paid and nonassessable Common Stock. At any time after the fifth anniversary of the Closing, if the last reported sale price of the </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Common Stock is greater than 250% of the Conversion Price as of such time for at least 20 consecutive trading days immediately preceding the date of the notice of mandatory conversion, the Company may elect to convert all of the outstanding shares of Series B Preferred Stock into shares of Common Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Company undergoes certain change of control transactions, each holder of outstanding Series B Preferred Stock will have the option, subject to the holder&#8217;s right to convert all or a portion of the shares of Series B Preferred Stock held by such holder into Common Stock prior to such redemption, to require the Company to purchase all or a portion of such holder&#8217;s outstanding shares of Series B Preferred Stock that have not been converted into Common Stock at a purchase price per share of Series B Preferred Stock, payable in cash, equal to the greater of (A)&#160;the Liquidation Preference of such share of Series B Preferred Stock, and (B)&#160;the amount of cash and/or other property that such holder would have been entitled to receive if such holder had converted such share of Series B Preferred Stock into Common Stock (&#8220;Change of Control Put&#8221;). In the event of a change of control in which the Company is anticipated to merge with another person and will not be the surviving corporation or if the Common Stock will no longer be listed on a U.S. national securities exchange, the Company will have a right to redeem, subject to the holder&#8217;s right to convert into Common Stock prior to such redemption, all of such holder&#8217;s shares of Series B Preferred Stock, or if a holder exercises the Change of Control Put in part, the remainder of such holder&#8217;s shares of Series B Preferred Stock, at a redemption price per share payable in cash, equal to the greater of (A)&#160;the Liquidation Preference of such share of Series B Preferred Stock, and (B)&#160;the amount of cash and/or other property that the holder would have received if such holder had converted such share of Series B Preferred Stock into Common Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After the seventh anniversary of the Closing, subject to certain conditions, the Company may, at its option, redeem all of the outstanding shares of Series B Preferred Stock at a redemption price per share of Series B Preferred Stock, payable in cash, equal to the Liquidation Preference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of shares of Series B Preferred Stock will have voting power measured in a manner related to the conversion ratio of the shares of Series B Preferred Stock and be entitled to vote as a single class with the holders of the Common Stock and the holders of any other class or series of equity interest of the Company then entitled to vote with the Common Stock on all matters submitted to a vote of the holders of Common Stock; <span style="font-style:italic">provided</span>, among other things, that to the extent the Series <span style="white-space:nowrap">B-1</span> Preferred Stock or Series <span style="white-space:nowrap">B-2</span> Preferred Stock held by the Casdin Parties or Viking Parties (as each term is defined the Purchase Agreements) would each, in the aggregate, represent voting rights with respect to more than 19.9% of the Common Stock (including the Series B Preferred Stock on an <span style="white-space:nowrap">as-converted</span> basis) (the &#8220;Voting Threshold&#8221;), the Casdin Parties or Viking Parties will not be permitted to exercise the voting rights with respect to any shares of Series <span style="white-space:nowrap">B-1</span> Preferred Stock or Series <span style="white-space:nowrap">B-2</span> Preferred Stock, as applicable, held by them in excess of the Voting Threshold and an officer of the Company shall exercise the voting rights with respect to such shares of Series <span style="white-space:nowrap">B-1</span> Preferred Stock and Series <span style="white-space:nowrap">B-2</span> Preferred Stock in excess of the Voting Threshold in a neutral manner. The Certificates of Designations also provide that the holders of the Series B preferred will have separate class approval rights over certain specified actions that would affect the rights of holder of the Preferred Stock and other specified matters. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, from and after the Closing of the Preferred Equity Transactions, for so long as, in each case, (a)&#160;Casdin and its Permitted Transferees (as defined in the Series <span style="white-space:nowrap">B-1</span> Certificate of Designations) continue to beneficially own shares of Series <span style="white-space:nowrap">B-1</span> Preferred Stock that represent at least 7.5% of the outstanding shares of Common Stock, on an as converted basis (the &#8220;Casdin Ownership Percentage&#8221;), and (b)&#160;Viking and its Permitted Transferees (as defined in the Series <span style="white-space:nowrap">B-2</span> Certificate of Designations) continue to beneficially own shares of Series <span style="white-space:nowrap">B-2</span> Preferred Stock that represent at least 7.5% of the outstanding shares of Common Stock, on an as converted basis (the &#8220;Viking Ownership Percentage&#8221;), on the terms and subject to the conditions set forth in the respective Certificates of Designations, the holders of a majority of the outstanding shares of Series <span style="white-space:nowrap">B-1</span> Preferred Stock and Series <span style="white-space:nowrap">B-2</span> Preferred Stock will each have the right to nominate for election and to </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
elect one member to the Board (the &#8220;Series <span style="white-space:nowrap">B-1</span> Preferred Director&#8221; and the &#8220;Series <span style="white-space:nowrap">B-2</span> Preferred Director&#8221; and collectively, the &#8220;Series B Directors&#8221;), provided that each of Casdin&#8217;s and Viking&#8217;s nominees will be appointed at the Closing as the Series <span style="white-space:nowrap">B-1</span> Preferred Director and Series <span style="white-space:nowrap">B-2</span> Preferred Director, respectively. The Certificates of Designations also provide that for so long as the Casdin Ownership Percentage and the Viking Ownership Percentage continue to be met or exceeded for such series of Series B Preferred Stock, each of the Series B Directors will have certain consent rights over, among other things: (i)&#160;any increase in the number of directors on the Board beyond seven; (ii)&#160;the hiring, promotion, demotion, or termination of the Company&#8217;s Chief Executive Officer; (iii)&#160;entering into or modifying (including by waiver) any transaction, agreement or arrangement with any Related Person (as such term is defined in the Certificates of Designations), subject to certain exceptions; (iv)&#160;any voluntary petition under any applicable federal or state bankruptcy or insolvency law effected by the Company; (v)&#160;any change in the principal business of the Company or entry by the Company into any material new line of business; and (vi)&#160;for a period of three years after the Closing, (A)&#160;any acquisition (including by merger, consolidation or acquisition of stock or assets) of any assets, securities or property of any other person or (B)&#160;any sale, lease, license, transfer or other disposition of any assets of the Company or any of its subsidiaries, in each case, other than acquisitions or disposition of inventory or equipment in the ordinary course of business consistent with past practice, for consideration in excess of $50,000,000 in the aggregate in any six month period. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Certificates of Designations does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the substantially final forms of the Certificates of Designations, which are attached to the Purchase Agreements and incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;2.03.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Creation of a Direct Financial Obligation or an Obligation under an <span style="white-space:nowrap">Off-Balance</span> Sheet Arrangement of the Registrant. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information set forth in Item 1.01 of this Current Report on <span style="white-space:nowrap">Form&#160;8-K&#160;is</span> incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;3.02.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Unregistered Sales of Equity Securities. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The disclosure set forth above in Item 1.01 of this Current Report on Form <span style="white-space:nowrap">8-K</span> is incorporated by reference herein. The securities of the Company that will be issued as part of the Preferred Equity Transactions and Loan Agreements will not initially be registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), in reliance on the exemption from registration provided by Section&#160;4(a)(2) of the Securities Act. The investors represented to the Company in the Purchase Agreements and the Loan Agreements that they are &#8220;accredited investors&#8221; within the meaning of Regulation D of the Securities Act. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;3.03.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Material Modification to Rights of Security Holders. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The disclosure set forth above in Item 1.01 of this Current Report on Form <span style="white-space:nowrap">8-K</span> is incorporated by reference herein. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The disclosure set forth above in Item 1.01 of this Current Report on Form <span style="white-space:nowrap">8-K</span> is incorporated by reference herein. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Resignation of Chief Executive Officer and Director </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Preferred Equity Transactions contemplated under the Purchase Agreements, Stephen Christopher Linthwaite, the Company&#8217;s President and Chief Executive Officer and a member of the Board, will resign on the terms described below. Mr.&#160;Linthwaite&#8217;s resignation did not involve any disagreement with the Company relating to the Company&#8217;s operations, policies or practices. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Transition Agreement with Stephen Christopher Linthwaite </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the execution of the Purchase Agreements, the Company entered into a transition agreement and release (the &#8220;Transition Agreement&#8221;) with Mr.&#160;Linthwaite. Pursuant to the Transition Agreement, Mr.&#160;Linthwaite will continue to be employed as the Company&#8217;s President and Chief Executive Officer and serve on the Board until the earliest to occur of (i)&#160;immediately prior to the date of Closing, (ii)&#160;May&#160;15, 2022 and (iii)&#160;such earlier date as Mr.&#160;Linthwaite and the Company mutually agree to terminate the employment relationship (the earliest date under clause (i), (ii), or (iii)&#160;is referred to as the &#8220;Linthwaite Separation Date&#8221;), or, if earlier, the date Mr.&#160;Linthwaite&#8217;s employment with the Company terminates (the period from the effective date of the Transition Agreement through the Linthwaite Separation Date, the &#8220;Transition Period&#8221;). During the Transition Period, Mr.&#160;Linthwaite will continue to be eligible for the same compensation and benefits he was eligible for prior to the Transition Period, provided that he will not participate in the Company&#8217;s 2022 bonus plan. The Company will reimburse Mr.&#160;Linthwaite&#8217;s reasonable attorneys&#8217; fees incurred in connection with the review and negotiation of the Transition Agreement and its enclosed exhibits, up to a maximum of $8,000. The Transition Agreement includes a limited release in favor of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Transition Agreement contemplates that, within 10 days following the Linthwaite Separation Date, subject to Mr. Linthwaite&#8217;s timely execution and <span style="white-space:nowrap">non-revocation</span> of a separation agreement and release (the &#8220;Separation Agreement&#8221;), Mr. Linthwaite will be entitled to receive the severance benefits under the Company&#8217;s 2020 Change of Control and Severance Plan (the &#8220;Severance Plan&#8221;), which are: (i) $1,190,000, less applicable withholdings, paid in equal installments over 24 months; (ii) eligibility for COBRA reimbursement for up to 12 months following the Linthwaite Separation Date; (iii) reasonable outplacement services in accordance with any applicable Company policy in effect as of the Linthwaite Separation Date, and (iv) a $200,000 lump sum payment, provided Mr. Linthwaite remains employed by the Company through the earlier of (i) the Closing and (ii) May&#160;15, 2022, in all cases subject to the Closing. In addition, Mr. Linthwaite holds an award of restricted stock unit awards (the &#8220;2022 PSUs&#8221;) that is eligible to vest based on (i) a relative TSR performance component in the performance period ending December&#160;31, 2022, and (ii) a time-based vesting component, and, subject to the Separation Agreement become effective, the Company will amend the 2022 PSUs to remove the time-based vesting component, such that, notwithstanding the termination of his service on the Linthwaite Separation Date, the 2022 PSUs will remain outstanding and eligible to vest to the extent of achievement of the performance component alone. The Separation Agreement also provides that the Company will assign to Mr. Linthwaite and reimburse him for payment of premiums paid by him to maintain the life insurance policy insuring his life for 30 months following the Linthwaite Separation Date. The Separation Agreement includes a general release of claims in favor of the Company and a customary mutual nondisparagement provision. If any of the severance and other benefits provided for under the Separation Agreement or otherwise payable to Mr. Linthwaite constitute &#8220;parachute payments&#8221; within the meaning of Section 280G of the Internal Revenue Code and could be subject to excise tax under Section 4999 of the Internal Revenue Code, then the payments will be delivered in full or delivered as to such lesser extent which would result in no portion of such benefits being subject to excise tax, whichever results in the greater amount of <span style="white-space:nowrap">after-tax</span> benefits to Mr. Linthwaite. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Separation Agreement also contemplates that, commencing on the Linthwaite Separation Date and continuing through November&#160;30, 2022, Mr.&#160;Linthwaite will provide consulting services to the Company pursuant to the terms of a consulting agreement (the &#8220;Consulting Agreement&#8221;). Pursuant to the Consulting Agreement, Mr.&#160;Linthwaite will receive a monthly fee of $25,000 during the term of the Consulting Agreement. Additionally, if Mr.&#160;Linthwaite provides services in excess of 60 hours in a month, then his monthly fee will be increased by $350 per each hour in excess of 60 hours. During the term of the Consulting Agreement, the Company will reimburse Mr.&#160;Linthwaite for reasonable expenses, and Mr.&#160;Linthwaite will vest in his outstanding Company equity awards in accordance with the terms and conditions of the awards and the Separation Agreement and Consulting Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the Separation Agreement and the Consulting Agreement, if the Company terminates Mr. Linthwaite&#8217;s consulting relationship prior to November 30, 2022, (i) any unpaid consulting fees that would otherwise have been paid through the first 6 months following the Linthwaite Separation Date will be due and payable, and (ii) Mr. Linthwaite&#8217;s equity awards that would otherwise vest through November 30, 2022 will vest on an accelerated basis as if he had provided services through November 30, 2022. Following the termination of his consulting relationship, Mr.&#160;Linthwaite must sign a supplemental release of claims in favor of the Company in order to continue receiving the severance and benefits provided under the Separation Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing summary of Mr.&#160;Linthwaite&#8217;s Transition Agreement and Release, Separation Agreement, and Consulting Agreement is qualified in its entirety by reference to the full text of those agreements, which is attached as Exhibit 10.6 hereto, and the terms of which are incorporated herein by reference. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Appointment of Chief Executive Officer </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Preferred Equity Transactions under the Purchase Agreements, Dr.&#160;Michael Egholm entered into an offer letter pursuant to which he will be appointed Chief Executive Officer of the Company, effective as of, and conditioned upon, the Closing of the Preferred Equity Transactions. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Michael Egholm, Ph.D., age 58, has served as the Chief Executive Officer of Standard Biotools, LLC since October 2021. He previously served as the Chief Technology Officer of Danaher Life Sciences, the life sciences arm of Danaher Corporation, a global science and technology company, from 2017 to September 2021. Prior to that, he served as President, Biopharmaceuticals at Pall Corporation, a global supplier of filtration, separations and purification products, from 2014 to 2017 and as their Chief Technology Officer from 2010 to 2014. Dr.&#160;Egholm has also served as a member of the board of directors of IsoPlexis Corporation, a publicly traded biopharmaceutical company, since 2018. Dr.&#160;Egholm is an elected member of the Royal Danish Academy of Sciences and Letters. Dr.&#160;Egholm completed his Ph.D. and Master&#8217;s degree in Chemistry at the University of Copenhagen. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&#160;Egholm has no family relationship with any member of the Board or any executive officer of the Company, and, other than the Preferred Equity Transactions described above, has not been involved in any related person transaction within the meaning of Item 404(a) of Regulation <span style="white-space:nowrap">S-K</span> promulgated under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) and required to be disclosed herein. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to Dr.&#160;Egholm&#8217;s offer letter, he will be an <span style="white-space:nowrap">at-will</span> employee of the Company. He will receive an annual base salary of $500,000, and will be eligible to receive an annual bonus with a target level of 100% of his base salary. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a material inducement for Dr.&#160;Egholm commencing employment with the Company, promptly following the Closing of the Preferred Equity Transactions, he will receive nonqualified stock options (the &#8220;Egholm Option Award&#8221;) to purchase up to 2.8% of the outstanding shares of Common Stock at the Closing of the Preferred Equity Transactions, calculated on a fully diluted basis (such number of shares, the &#8220;Egholm Option Shares&#8221;), provided that the number of shares subject to the Egholm Option Award may be reduced as described in the paragraph below, with a per share exercise price (the &#8220;Exercise Price&#8221;) of the greater of (i)&#160;the Conversion Price or (ii)&#160;the fair market value of a share of Common Stock on the Egholm Option Award </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
grant date (the &#8220;Grant Price&#8221;). Subject to his continued employment with the Company through the applicable vesting date, 25% of the shares subject to the Egholm Option Award will vest on the first anniversary of the vesting commencement date, and the remaining 75% of the shares subject to the Egholm Option Award will vest in equal monthly installments thereafter. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, if the Exercise Price exceeds the Conversion Price, then, as a material inducement for Dr.&#160;Egholm commencing employment with the Company, promptly following the Closing of the Preferred Equity Transactions, he will receive restricted stock units (&#8220;Egholm RSU Award&#8221;), covering a number of shares of Common Stock at the Closing of the Preferred Equity Transactions equal to (i)&#160;the amount by which the Exercise Price exceeds the Conversion Price, multiplied by the number of Egholm Option Shares underlying the Egholm Option Award, divided by (ii)&#160;the Exercise Price, with such amount rounded to the nearest whole share. The shares of Common Stock underlying the Egholm RSU Award will then reduce on a <span style="white-space:nowrap"><span style="white-space:nowrap">share-by-share</span></span> basis the number of Egholm Option Shares subject to the Egholm Option Award. Subject to his continued employment with the Company, 25% of the Egholm RSU Award (if any) will vest in equal annual installments over a four-year period, beginning on the first anniversary of the vesting commencement date. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If Dr.&#160;Egholm&#8217;s employment is terminated due to his death or &#8220;disability&#8221; (as defined in the Severance Plan), a number of unvested shares underlying the Egholm Option Award and the Egholm RSU Award (if any) that otherwise would vest during the period between the termination date and the <span style="white-space:nowrap">one-year</span> anniversary of the termination date immediately will vest. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Egholm Option Award and Egholm RSU Award (if any) will be subject to the terms of the Company&#8217;s 2022 Inducement Equity Incentive Plan (the &#8220;Inducement Plan&#8221;) that the Company expects to adopt in connection with the Closing of the Preferred Equity Transactions and the applicable award agreement thereunder, which terms are expected to be substantially similar to the terms of the Company&#8217;s 2011 Equity Incentive Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of Dr.&#160;Egholm&#8217;s offer letter, he will be a participant in the Severance Plan, and eligible to receive benefits at the same level and subject to the same terms and conditions as described with respect to Mr.&#160;Linthwaite in our 2021 Proxy Statement and previously filed with the Securities and Exchange Commission, except that, in addition, in a <span style="white-space:nowrap">&#8220;Non-COC</span> Involuntary Termination&#8221; Dr.&#160;Egholm will be entitled to receive an additional 12 months of vesting acceleration of his Company equity awards. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&#160;23, 2022, Dr.&#160;Egholm and the Company entered into an indemnification agreement for executive officers and directors. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of Dr.&#160;Egholm&#8217;s offer letter and indemnification agreement are qualified in their entirety by reference to the full text of his offer letter and indemnification agreement, which are attached as Exhibits 10.7 and 10.8 hereto, and the terms of which are incorporated by reference herein. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Appointment of Chief Operating Officer </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Preferred Equity Transactions under the Purchase Agreements, Mr.&#160;Hanjoon Alex Kim entered into an offer letter agreement pursuant to which he will be appointed Chief Operating Officer of the Company, effective as of, and conditioned upon, the Closing of the Preferred Equity Transactions. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hanjoon Alex Kim, age 50, has served as the EVP and President of the Healthcare Division of Milliken&#160;&amp; Company. He previously served as the EVP of the Growth Ventures Group of Milliken&#160;&amp; Company the two years prior. Prior to his position, he served as the EVP of Corporate Strategy and Corporate Development of Milliken&#160;&amp; Company. Mr.&#160;Kim had also served as the SVP of Corporate Strategy and Business Development of the Pall Corporation for three years. Prior to that, Mr.&#160;Kim had worked at the Danaher Corporation for twelve years in roles including VP of Business Development of the Water Quality Group, Corporate Director of Strategic Development and Business Unit Manager of the Motion Group. Mr.&#160;Kim received his M.B.A. from the Stanford Graduate School of Business and also has his M.S. in Mechanical Engineering from the University of Pittsburg and B.S. in Mechanical Engineering from Carnegie Mellon University. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to Mr.&#160;Kim&#8217;s offer letter, he will be an <span style="white-space:nowrap">at-will</span> employee of the Company. He will receive an annual base salary of $400,000, and will be eligible to receive an annual bonus with a target level of 55% of his base salary. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a material inducement for Mr.&#160;Kim commencing employment with the Company, promptly following the Closing of the Preferred Equity Transactions, he will receive nonqualified stock options (the &#8220;Kim Option Award&#8221;) to purchase up to 1% of the outstanding shares of Common Stock at the Closing of the Preferred Equity Transactions, calculated on a fully diluted basis (such number of shares, the &#8220;Kim Option Shares&#8221;), provided that the number of shares subject to the Kim Option Award may be reduced as described in the paragraph below, with an Exercise Price of the greater of (i)&#160;the Conversion Price or (ii)&#160;the Grant Price. Subject to his continued employment with the Company through the applicable vesting date, 25% of the shares subject to the Kim Option Award will vest on the first anniversary of the vesting commencement date, and the remaining 75% of the shares subject to the Kim Option Award will vest in equal monthly installments thereafter. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, if the Exercise Price exceeds the Conversion Price, then, as a material inducement for Mr.&#160;Kim commencing employment with the Company, promptly following the Closing of the Preferred Equity Transactions, and subject to approval by the Committee, he will receive restricted stock units (&#8220;Kim RSU Award&#8221;), covering a number of shares of Common Stock at Closing of the Preferred Equity Transactions equal to (i)&#160;the amount by which the Exercise Price exceeds the Conversion Price, multiplied by the number of Kim Option Shares underlying the Kim Option Award divided by (ii)&#160;the Exercise Price, with such amount rounded to the nearest whole share. The shares of Common Stock underlying the Kim RSU Award will reduce on a <span style="white-space:nowrap"><span style="white-space:nowrap">share-by-share</span></span> basis the number of Kim Option Shares subject to the Kim Option Award. Subject to his continued employment with the Company, 25% of the Kim RSU Award (if any) will vest in equal annual installments over a four-year period, beginning on the first anniversary of the vesting commencement date. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If Mr.&#160;Kim&#8217;s employment is terminated due to his death or &#8220;disability&#8221; (as defined in the Severance Plan), a number of unvested shares underlying the Kim Option Award and Kim RSU Award (if any) that otherwise would vest during the period between the termination date and the <span style="white-space:nowrap">one-year</span> anniversary of the termination date immediately will vest. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Kim Option Award and Kim RSU Award (if any) will be subject to the terms of the Company&#8217;s Inducement Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of Mr.&#160;Kim&#8217;s offer letter, he will be a participant in the Severance Plan, and eligible to receive benefits at the same level and subject to the same terms and conditions as described with respect to our executive officers other than Mr.&#160;Linthwaite in our 2021 Proxy Statement and previously filed with the Securities and Exchange Commission, except in a <span style="white-space:nowrap">&#8220;Non-COC</span> Involuntary Termination,&#8221; Mr.&#160;Kim will be entitled to receive 12 months of vesting acceleration of his Company equity awards. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company expects to enter into its form of indemnification agreement for directors and executive officers with Mr.&#160;Kim, which requires the Company to indemnify its directors and executive officers for certain expenses, including attorneys&#8217; fees, judgments, penalties, fines and settlement amounts incurred by a director or executive officer in any action or proceeding arising out of their services as one of the Company&#8217;s directors or executive officers or as a director or executive officer of any other company or enterprise to which the person provides services at the Company&#8217;s request. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of Mr.&#160;Kim&#8217;s offer letter is qualified in its entirety by reference to the full text of his offer letter, which is attached as Exhibit&#160;10.9 attached hereto, and the terms of which are incorporated by reference herein. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Election of New Directors </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the Certificates of Designations, and to the extent the Casdin Ownership Percentage (with respect to the Series&#160;B-1 Director) and Viking Ownership Percentage (with respect to the Series&#160;B-2 Director) continue to be met, the holders of a majority of the outstanding shares of Series <span style="white-space:nowrap">B-1</span> Preferred Stock, voting separately as a single class, have the right to nominate and elect one member of the Board (the &#8220;Series <span style="white-space:nowrap">B-1</span> Director&#8221;) and the holders of a majority of the outstanding shares of Series <span style="white-space:nowrap">B-2</span> Preferred Stock, voting separately as a single class have the right to nominate and elect one member of the Board (the &#8220;Series <span style="white-space:nowrap">B-2</span> Director&#8221;). The Series <span style="white-space:nowrap">B-1</span> Director and the Series <span style="white-space:nowrap">B-2</span> Director shall not be subject to the classified board of directors provisions of the Company&#8217;s certificate of incorporation. The Board has approved the appointment of Eli Casdin as the Series <span style="white-space:nowrap">B-1</span> Director and Dr.&#160;Martin Madaus as the Series <span style="white-space:nowrap">B-2</span> Director to serve as members of the Board effective as of, and conditioned upon, the Closing of the Preferred Equity Transactions. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Casdin (other than pursuant to the Casdin Loan Agreement and the Series <span style="white-space:nowrap">B-1</span> Purchase Agreement described above) and Dr.&#160;Madaus each have not been involved in any related person transaction within the meaning of Item 404(a) of Regulation <span style="white-space:nowrap">S-K</span> promulgated under the Exchange Act and required to be disclosed herein. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company expects to enter into its form of indemnification agreement for directors and executive officers with Mr.&#160;Casdin and Dr.&#160;Madaus, which requires the Company to indemnify its directors and executive officers for certain expenses, including attorneys&#8217; fees, judgments, penalties, fines and settlement amounts incurred by a director or executive officer in any action or proceeding arising out of their services as one of the Company&#8217;s directors or executive officers or as a director or executive officer of any other company or enterprise to which the person provides services at the Company&#8217;s request. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Departure of Directors </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&#160;23, 2022, Stephen Christopher Linthwaite, Ana K. Stankovic and Nicolas M. Barthelemy each notified the Company of their decision to step down from the Board, effective as of, and condition upon, the Closing, or with respect to Mr.&#160;Linthwaite, as of such time as described above. Each of Mr.&#160;Linthwaite&#8217;s, Dr.&#160;Stankovic&#8217;s and Mr.&#160;Barthelemy&#8217;s decision to step down did not involve any disagreement with the Company relating to the Company&#8217;s operations, policies or practices. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Retention Program </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&#160;23, 2022, the Board approved a retention compensation program for certain of our named executive officers, and certain other members of our executive leadership team. The retention program provides for a lump sum cash payment if the named executive officer remains employed with us through December&#160;31, 2022. The cash payment is $293,877 in the case of Vikram Jog, $279,685 in the case of Colin McCracken, $263,640 in the case of Brad Kreger, and $268,421 in the case of Nicholas Khadder. If the employment with the Company of a participant in the retention program terminates for any reason prior to December&#160;31, 2022, then he or she will forfeit any rights to the cash payment. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, the retention compensation program provides that, in the event that the employment with the Company of a participant in the retention compensation program is terminated by the Company without &#8220;cause&#8221; (excluding by reason of death or &#8220;disability&#8221;) (as defined in the Severance Plan) (such a termination, a &#8220;Qualifying Termination&#8221;) on or prior to January&#160;15, 2023, the Company will amend such participant&#8217;s award of restricted stock unit awards that are eligible to vest </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
based on (i)&#160;a relative TSR performance component in the performance period ending December&#160;31, 2022, and (ii)&#160;a time-based vesting component to remove the time-based vesting component, such that, notwithstanding the termination of his service on or prior to January&#160;15, 2023, such award will remain outstanding and eligible to vest to the extent of achievement of the performance component alone. Each of Messrs. Jog, McCracken, and Kreger hold this type of award. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, the Company granted each of Messrs. Jog, Khadder, Kreger, and McCracken an award of restricted stock units covering 50,000 shares of the Company&#8217;s common stock (the &#8220;Retention RSUs&#8221;). The Retention RSUs will be subject to the terms of our 2011 Equity Incentive Plan, as amended, and restricted stock unit award agreement thereunder. The Retention RSUs will be scheduled to vest on February&#160;20, 2023 (the &#8220;Vesting Date&#8221;), subject to the individual&#8217;s continued employment with the Company through that date. If the employment with the Company of a participant in the retention program is terminated in a Qualifying Termination prior to the Vesting Date, the Retention RSUs will become fully vested as of the termination date. If the participant&#8217;s employment with the Company terminates for any reason other than a Qualifying Termination prior to the Vesting Date, then he or she forfeit any rights to the Retention RSUs. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The receipt of any termination benefits described in the retention program is conditioned upon the participant timely signing and not revoking a separation and release of claims agreement in substantially the form attached to the Severance Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the retention program is qualified in its entirety by reference to the full text of the substantially final form of the retention letter, which is attached as Exhibit 10.10 hereto, and the terms of which are incorporated by reference herein. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.03.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Amendment to Articles of Incorporation or Bylaws, Change in Fiscal Year. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To create each of the Series <span style="white-space:nowrap">B-1</span> Preferred Stock and the Series <span style="white-space:nowrap">B-2</span> Preferred Stock that will be issued as part of the Preferred Equity Transactions and Loan Agreements, the Company will execute and file a Certificate of Designations with respect to each such series. The disclosure set forth above in Item 1.01 of this Current Report on Form <span style="white-space:nowrap">8-K</span> is incorporated by reference herein. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;8.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&#160;24, 2022, the Company issued a press release announcing the execution of the Purchase Agreements and the funding of the Term Loans. The press release is attached hereto as Exhibit 99.1 and is incorporated by reference into this Item 8.01. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">(d) Exhibits.&#160;&#160;&#160;&#160; </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br />No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d243622dex101.htm">Series <span style="white-space:nowrap">B-1</span> Loan Agreement, dated as of January&#160;23, 2022, by and among Fluidigm Corporation, Casdin Partners Master Fund, L.P., and Casdin Private Growth Equity Fund II, L.P. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d243622dex102.htm">Series <span style="white-space:nowrap">B-2</span> Loan Agreement, dated as of January&#160;23, 2022, by and among Fluidigm Corporation, Viking Global Opportunities Illiquid Investments <span style="white-space:nowrap">Sub-Master</span> LP, and Viking Global Opportunities Drawdown (Aggregator) LP. </a></td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td style="width:93%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d243622dex103.htm">Series <span style="white-space:nowrap">B-1</span> Convertible Preferred Stock Purchase Agreement, dated as of January&#160;23, 2022, by and among Fluidigm Corporation, Casdin Private Growth Equity Fund II, L.P., and Casdin Partners Master Fund, L.P. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d243622dex104.htm">Series <span style="white-space:nowrap">B-2</span> Convertible Preferred Stock Purchase Agreement, dated as of January&#160;23, 2022, by and among Fluidigm Corporation, Viking Global Opportunities Illiquid Investments <span style="white-space:nowrap">Sub-Master</span> LP, and Viking Global Opportunities Drawdown (Aggregator) LP. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.5</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d243622dex105.htm">Registration Rights Agreement, dated as of January&#160;23, 2022, by and between Fluidigm Corporation, Casdin Private Growth Equity Fund II, L.P., Casdin Partners Master Fund, L.P., Viking Global Opportunities Illiquid Investments <span style="white-space:nowrap">Sub-Master</span> LP, and Viking Global Opportunities Drawdown (Aggregator) LP. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.6</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d243622dex106.htm">Stephen Christopher Linthwaite Transition Agreement and Release. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.7</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d243622dex107.htm">Michael Egholm Offer Letter. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.8</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d243622dex108.htm">Indemnification Agreement, dated January&#160;23, 2022, by and between Fluidigm Corporation and Michael Egholm. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.9</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d243622dex109.htm">Hanjoon Alex Kim Offer Letter. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.10</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d243622dex1010.htm">Form of Retention Letter. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d243622dex991.htm">Fluidigm Corporation Press Release dated January&#160;24, 2022. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Date File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">FLUIDIGM CORPORATION</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: January&#160;24, 2022</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Nicholas Khadder</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Nicholas Khadder</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Senior Vice President, General Counsel, and Secretary</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d243622dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Exhibit 10.1 </I></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LOAN AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS
LOAN AGREEMENT</B> (this &#147;<B>Agreement</B>&#148;) dated and effective as of January&nbsp;23, 2022 (the &#147;<B>Effective Date</B>&#148;) between <B>CASDIN PARTNERS MASTER FUND, L.P.</B>, a Cayman Islands exempted limited partnership
(&#147;<B>Master Fund</B>&#148;), <B>CASDIN PRIVATE GROWTH EQUITY FUND II, L.P.</B>, a Delaware limited partnership (&#147;<B>PGE Fund</B>&#148; and together with Master Fund, each a &#147;<B>Lender</B>&#148; and collectively, the
&#147;<B>Lenders</B>&#148;) and <B>FLUIDIGM CORPORATION</B>, a Delaware corporation (&#147;<B>Borrower</B>&#148;), provides the terms on which Lenders shall lend to Borrower and Borrower shall repay Lenders. The parties agree as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1 <U>ACCOUNTING AND OTHER TERMS</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accounting terms not defined in this Agreement shall be construed following GAAP. Calculations and determinations must be made following GAAP,
provided, however, that if at any time any change in GAAP would affect the computation of any covenant or requirement set forth in any Loan Document, and either Borrower or any Lender shall so request, Borrower and Lenders shall negotiate in good
faith to amend such covenant or requirement to preserve the original intent thereof in light of such change in GAAP; provided, further, that, until so amended, (i)&nbsp;such covenant or requirement shall continue to be computed in accordance with
GAAP prior to such change therein and (ii)&nbsp;Borrower shall provide Lenders financial statements and other documents required under this Agreement or as reasonably requested hereunder setting forth a reconciliation between calculations of such
ratio or requirement made before and after giving effect to such change in GAAP; provided, further, that (x)&nbsp;all obligations of any Person that are or would have been treated as operating leases for purposes of GAAP prior to the issuance by the
Financial Accounting Standards Board on February&nbsp;25, 2016 of an Accounting Standards Update (the &#147;<B>ASU</B>&#148;) shall continue to be accounted for as operating leases for purposes of all financial definitions, calculations and
covenants for purpose of this Agreement (whether or not such operating lease obligations were in effect on such date) notwithstanding the fact that such obligations are required in accordance with the ASU (on a prospective or retroactive basis or
otherwise) to be treated as capitalized lease obligations in accordance with GAAP. Notwithstanding the foregoing, all financial covenant (if any) and other financial calculations shall be computed with respect to Borrower only, and not on a
consolidated basis. Capitalized terms not otherwise defined in this Agreement shall have the meanings set forth in Section&nbsp;14. All other terms contained in this Agreement, unless otherwise indicated, shall have the meaning provided by the Code
to the extent such terms are defined therein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2 <U>LOAN AND TERMS OF PAYMENT</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.1</B> <B>Promise to Pay</B>. Borrower hereby unconditionally promises to pay Lenders the Outstanding Principal Amount of the Loan and
accrued and unpaid interest thereon as and when due in accordance with this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.2</B> <B>Loan</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.2.1 [Reserved] </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.2.2
<U>Loan</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Availability</U>. Subject to the terms and conditions of this Agreement, Master Fund shall make one term loan to
Borrower in an aggregate original principal amount equal to Eight Million and Seven Hundred Fifty Thousand Dollars ($8,750,000) (the &#147;<B>Master Fund Loan</B>&#148;) and PGE Fund shall make one term loan to Borrower in an aggregate original
principal amount equal to Three Million and Seven Hundred Fifty Thousand Dollars ($3,750,000) (the &#147;<B>PGE Fund Loan</B>&#148; and collectively with the Master Fund Loan, the &#147;<B>Loan</B>&#148;). The Loan shall equal an aggregate original
principal amount of Twelve Million and Five Hundred Thousand Dollars ($12,500,000). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Repayment</U>. Unless earlier converted, the
Outstanding Principal Amount of the Loan (inclusive of principal and accrued and unpaid interest) shall be due and payable in cash on the Loan Maturity Date. Interest shall be due and payable in accordance with Section&nbsp;2.4(b) hereof. Each
Lender shall maintain in accordance with its usual practice an account or accounts evidencing the Obligations of the Borrower to such Lender resulting from the Loan made by such Lender from time to time, including the amounts of principal and
interest payable and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
paid to such Lender from time to time under this Agreement. The entries made in the accounts maintained pursuant to this Section&nbsp;2.2 shall be prima facie evidence of the existence and
amounts of the obligations therein recorded; <U>provided</U> that the failure of any Lender to maintain such accounts or any error therein shall not in any manner affect the obligations of the Borrower to repay the Obligations in accordance with
their terms. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>No Permitted Prepayment</U>. Borrower shall not have the option to pay any of the balance under the Loan before the
Loan becomes due without the consent of the Lenders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Evidence of Debt</U>. Each Lender may request that the Loan made by it
hereunder be evidenced by a Promissory Note. In such event, the Borrower shall execute and deliver to such Lender a Promissory Note dated the Effective Date, payable to the order of such Lender in an amount equal to the Master Fund Loan or the PGE
Fund Loan, as applicable.<U> </U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.3 [Reserved] </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.4</B> <B>Payment of Interest on the Loan</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Interest Rates</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)
<U>[Reserved]</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) <U>Loan; Interest; Computation.</U> The Borrower agrees to pay to Lenders interest on the Outstanding Principal
Amount of the Loan at the Applicable Interest Rate for the period from the Funding Date (as defined herein) until the date the Loan shall be paid in full. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All interest shall (a)&nbsp;accrue daily, (b)&nbsp;be payable &#147;in kind&#148; by adding such interest to the Outstanding Principal
Amount on the last Business Day of each month after the Funding Date and (c)&nbsp;constitute principal thereafter. On each such last Business Day of each month after the Funding Date, accrued interest shall be capitalized. For the avoidance of
doubt, under the terms of this Agreement accrued interest under the Loan shall first be due by Borrower to Lenders on January&nbsp;31, 2022. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.5</B> <B>Fees. </B>Borrower shall pay to Lenders all Lender Expenses (including reasonable attorneys&#146; fees and expenses for
documentation and negotiation of this Agreement) incurred through and after the Effective Date when due (or, if no stated due date, upon demand by Lenders). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.6 Payments; Application of Payments. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) All payments to be made by Borrower under any Loan Document shall be made in immediately available funds in Dollars, without setoff or
counterclaim, before 12:00 p.m. New York time on the date when due. Payments of principal and/or interest received after 12:00 p.m. New York time are considered received at the opening of business on the next Business Day. When a payment is due on a
day that is not a Business Day, the payment shall be due the next Business Day, and additional fees or interest, as applicable, shall continue to accrue until paid in accordance with the Master Fund Loan or the PGE Fund Loan, as applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Lenders have the exclusive right to determine the order and manner in which all payments with respect to the Obligations may be applied.
Borrower shall have no right to specify the order or the accounts to which Lenders shall allocate or apply any payments required to be made by Borrower to Lenders or otherwise received by Lenders under this Agreement when any such allocation or
application is not specified elsewhere in this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.7</B> <B>Withholding</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Payments received by Lenders from Borrower under this Agreement will be made free and clear of and without deduction for any and all
present or future taxes, levies, imposts, duties, deductions, withholdings, assessments, fees or other charges imposed by any Governmental Authority (including any interest, additions to tax or penalties applicable thereto), except as required by
applicable law. Specifically, however, if at any time any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
applicable law requires Borrower to make any withholding or deduction from any such payment or other sum payable hereunder to any Lender, Borrower shall be entitled to make such deduction or
withholding and shall timely pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with applicable law and, if such Tax is an Indemnified Tax, then the sum payable by the Borrower shall be increased as
necessary so that after such deduction or withholding has been made (including such deductions and withholdings applicable to additional sums payable under this Section) the Lender receives an amount equal to the sum it would have received had no
such deduction or withholding been made. Borrower will, upon request, furnish such Lender with proof reasonably satisfactory to such Lender indicating that Borrower has made such withholding payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Each Lender shall
deliver to Borrower, on the Effective Date and at the time or times reasonably requested by the Borrower, properly completed documentation certifying that it is not subject to backup withholding, together with any other documentation such Lender is
legally entitled to deliver establishing an exemption from or reduction in the applicable rate of any withholding tax. Notwithstanding anything to the contrary in this Section&nbsp;2.7, the completion, execution and submission of such documentation
(other than such documentation set forth in paragraphs&nbsp;(b)(ii)(A), (ii)(B)&nbsp;and (ii)(D)&nbsp;of this Section) shall not be required if in such Lender&#146;s reasonable judgment such completion, execution or submission would subject such
Lender to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position of such Lender. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)
Without limiting the generality of the foregoing, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(A) any Lender that is a U.S. Person shall deliver to the Borrower on or
about the date on which such Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower), executed copies of IRS Form <FONT STYLE="white-space:nowrap">W-9</FONT> certifying that such
Lender is exempt from U.S. federal backup withholding tax; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(B) any Lender that is not a U.S. Person shall, to the extent
it is legally entitled to do so, deliver to the Borrower (in such number of copies as shall be requested by the recipient) on or about the date on which such Lender becomes a Lender under this Agreement (and from time to time thereafter upon the
reasonable request of the Borrower), whichever of the following is applicable: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) in the case of a Lender that is not a
U.S. Person claiming the benefits of an income tax treaty to which the United States is a party (x)&nbsp;with respect to payments of interest under any Loan Document, executed copies of IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN</FONT> or
IRS <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN-E</FONT></FONT> establishing an exemption from, or reduction of, U.S.&nbsp;federal withholding Tax pursuant to the &#147;interest&#148; article of such tax treaty
and (y)&nbsp;with respect to any other applicable payments under any Loan Document, IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN</FONT> or IRS
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN-E</FONT></FONT> establishing an exemption from, or reduction of, U.S.&nbsp;federal withholding Tax pursuant to the &#147;business profits&#148; or &#147;other
income&#148; article of such tax treaty; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) executed copies of IRS Form <FONT STYLE="white-space:nowrap">W-8ECI;</FONT>
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(3) in the case of a Lender that is not a U.S. Person claiming the benefits of the exemption for portfolio interest under
Section&nbsp;881(c) of the Code, (x)&nbsp;a certificate executed under penalty of perjury to the effect that such Lender is not a &#147;bank&#148; within the meaning of Section&nbsp;881(c)(3)(A) of the Code, a &#147;10&nbsp;percent shareholder&#148;
of the Borrower within the meaning of Section&nbsp;871(h)(3)(B) of the Code, or a &#147;controlled foreign corporation&#148; related to the Borrower as described in Section&nbsp;881(c)(3)(C) of the Code (a &#147;<B>U.S. Tax Compliance
Certificate</B>&#148;) and (y)&nbsp;executed copies of IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN</FONT> or IRS <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN-E;</FONT></FONT> or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(4) to the extent a Foreign Lender is not the beneficial owner, executed
copies of IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8IMY,</FONT> accompanied by IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8ECI,</FONT> IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN,</FONT> IRS <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Form&nbsp;W-8BEN-E,</FONT></FONT> a U.S. Tax Compliance Certificate, IRS Form <FONT STYLE="white-space:nowrap">W-9,</FONT> and/or other certification documents from each beneficial owner, as applicable; provided that if
the Lender is a partnership and one or more direct or indirect partners of such Foreign Lender are claiming the portfolio interest exemption, such Lender may provide a U.S.&nbsp;Tax Compliance Certificate on behalf of each such direct and indirect
partner; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(C) any Lender that is not a U.S. Person shall, to the extent it is legally entitled to do so, deliver to the
Borrower (in such number of copies as shall be requested by the recipient) on or about the date on which such Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower), executed
copies of any other form prescribed by Applicable Law as a basis for claiming exemption from or a reduction in U.S. federal withholding Tax, duly completed, together with such supplementary documentation as may be prescribed by applicable law to
permit the Borrower to determine the withholding or deduction required to be made; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(D) if a payment made to a Lender
under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section&nbsp;1471(b) or 1472(b) of the
Code, as applicable), such Lender shall deliver to the Borrower at the time or times prescribed by law and at such time or times reasonably requested by the Borrower such documentation prescribed by applicable law (including as prescribed by
Section&nbsp;1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrower as may be necessary for the Borrower to comply with their obligations under FATCA and to determine that such Lender has complied with
such Lender&#146;s obligations under FATCA or to determine the amount, if any, to deduct and withhold from such payment. Solely for purposes of this clause&nbsp;(D), &#147;FATCA&#148; shall include any amendments made to FATCA after the date of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Each Lender agrees that if any form or certification it previously delivered expires or becomes obsolete or inaccurate in any
respect, it shall at Borrower&#146;s request update such form or certification or promptly notify the Borrower in writing of its legal inability to do so. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The agreements and obligations of Borrower and Lenders contained in this Section&nbsp;2.7 shall survive the termination of this Agreement.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.8</B> <B>Original Issue Discount. </B>The parties acknowledge and agree that the Loan pursuant to this Agreement will be issued with
original issue discount (as that term is used in Section&nbsp;1273(a) of the Internal Revenue Code of 1986, as amended) solely for U.S. federal, state and local income tax purposes. Additional information regarding original issue discount, including
the issue date and the yield to maturity with respect to Term Loans can be obtained by contacting Borrower at the address listed in Article 10. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3 <U>CONDITIONS OF LOANS</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.1</B> <B>Conditions Precedent to Loan</B><B>.</B> Lenders&#146; obligation to make the Loan is subject to the condition precedent that
Lenders shall have received, in form and substance satisfactory to Lenders, such documents, and completion of such other matters, as Lenders may reasonably deem necessary or appropriate, including, without limitation: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) duly executed signatures to the Loan Documents; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the Operating Documents and good standing certificates of Borrower certified by the Secretary of State (or equivalent agency) of
Borrower&#146;s jurisdiction of organization or formation and each jurisdiction in which Borrower is qualified to conduct business, each as of a date no earlier than thirty (30)&nbsp;days prior to the Effective Date; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) a secretary&#146;s certificate of Borrower with respect to such Borrower&#146;s
Operating Documents, incumbency, specimen signatures and resolutions authorizing the execution and delivery of this Agreement and the other Loan Documents to which it is a party; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) [Reserved]; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) certified
copies, dated as of a recent date, of financing statement searches, as Lenders may request, accompanied by written evidence (including any UCC termination statements) that the Liens indicated in any such financing statements either constitute
Permitted Liens or have been or, in connection with the Loan, will be terminated or released; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) payment of the fees and Lender Expenses
then due as specified in Section&nbsp;2.5 hereof; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) duly executed subordination agreements by Subsidiaries that would subordinate
any outstanding Indebtedness owing from Borrower to such Subsidiaries, which subordination agreement shall (i)&nbsp;be in form and substance similar to the subordination agreements in existence among such Subsidiaries and Silicon Valley Bank and
(ii)&nbsp;subordinate such Indebtedness to the Obligations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.2 [Reserved] </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.3</B> <B>[Reserved</B>] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.4</B> <B>Procedures for Borrowing</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>[Reserved]</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
<U>Loan.</U> Subject to the prior satisfaction of all other applicable conditions to the making of the Loan set forth in this Agreement, to obtain the Loan, Borrower shall notify Lenders (which notice shall be irrevocable) by electronic mail by
12:00 noon New York time on the date on which the Loan is made to or for the account of Borrower. Such notice shall be in a written format acceptable to Lenders that is executed by an Authorized Signer. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4 <U>[RESERVED]</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5
<U>REPRESENTATIONS AND WARRANTIES</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Borrower represents and warrants as of the Effective Date as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.1</B> <B>Due Organization, Authorization; Power and Authority</B><B>.</B> Borrower is duly existing and in good standing as a Registered
Organization in its jurisdiction of formation and is qualified and licensed to do business and is in good standing in any jurisdiction in which the conduct of its business or its ownership of property requires that it be qualified except where the
failure to do so could not reasonably be expected to have a material adverse effect on Borrower&#146;s business. Borrower represents and warrants to Lenders that, except as may have been updated by a notification to Lenders pursuant to
Section&nbsp;7.2, (a)&nbsp;Borrower&#146;s exact legal name is that indicated on the signature page hereof; and (b)&nbsp;Borrower (and each of its predecessors) has not, in the past five (5)&nbsp;years, changed its jurisdiction of formation,
organizational structure or type, or any organizational number assigned by its jurisdiction. If Borrower is not now a Registered Organization but later becomes one, Borrower shall promptly notify Lenders of such occurrence and provide Lenders with
Borrower&#146;s organizational identification number. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The execution, delivery and performance by Borrower of the Loan Documents to which
it is a party have been duly authorized, and do not (i)&nbsp;conflict with any of Borrower&#146;s organizational documents, (ii)&nbsp;contravene, conflict with, constitute a default under or violate any material Requirement of Law,
(iii)&nbsp;contravene, conflict or violate any applicable order, writ, judgment, injunction, decree, determination or award of any Governmental Authority by which Borrower or any of its Subsidiaries or any of their property or assets may be bound or
affected, (iv)&nbsp;require any action by, filing, registration, or qualification with, or Governmental Approval from, any Governmental Authority </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(except such Governmental Approvals which have already been obtained and are in full force and effect), or (v)&nbsp;conflict with, contravene, constitute a default or breach under, or result in
or permit the termination or acceleration of, any material agreement by which Borrower is bound. Borrower is not in default under any agreement to which it is a party or by which it is bound in which the default could reasonably be expected to have
a material adverse effect on Borrower&#146;s business. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.2 [Reserved] </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.3</B> <B>[Reserved</B>] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.4</B> <B>Litigation</B><B>. </B>Except as disclosed, there are no actions or proceedings pending or, to the knowledge of any Responsible
Officer, threatened in writing by or against Borrower or any of its Subsidiaries that could, individually or in the aggregate, reasonably be expected to result in expenses to Borrower of more than One Million Dollars ($1,000,000). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.5</B> <B>Financial Statements; Financial Condition</B><B>. </B>All consolidated financial statements for Borrower and any of its
Subsidiaries delivered to Lenders fairly present in all material respects Borrower&#146;s consolidated financial condition and Borrower&#146;s consolidated results of operations. There has not been any material deterioration in Borrower&#146;s
consolidated financial condition since the date of the most recent financial statements submitted to Lenders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.6</B>
<B>Solvency</B><B>.</B> The fair salable value of Borrower&#146;s consolidated assets (including goodwill minus disposition costs) exceeds the fair value of Borrower&#146;s liabilities; Borrower is not left with unreasonably small capital after the
transactions in this Agreement; and Borrower is able to pay its debts (including trade debts) as they mature. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.7</B> <B>Regulatory
Compliance</B><B>.</B> Borrower is not an &#147;investment company&#148; or a company &#147;controlled&#148; by an &#147;investment company&#148; under the Investment Company Act of 1940, as amended. Borrower is not engaged as one of its important
activities in extending credit for margin stock (under Regulations X, T and U of the Federal Reserve Board of Governors). Borrower (a)&nbsp;has complied in all material respects with all Requirements of Law, and (b)&nbsp;has not violated any
Requirements of Law the violation of which could reasonably be expected to have a material adverse effect on its business. None of Borrower&#146;s or any of its Subsidiaries&#146; properties or assets has been used by Borrower or any Subsidiary or,
to the best of Borrower&#146;s knowledge, by previous Persons, in disposing, producing, storing, treating, or transporting any hazardous substance other than in compliance with all applicable laws. Borrower and each of its Subsidiaries have obtained
all consents, approvals and authorizations of, made all declarations or filings with, and given all notices to, all Governmental Authorities that are necessary to continue their respective businesses as currently conducted. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.8</B> <B>Subsidiaries; Investments</B><B>.</B> Borrower does not own any stock, partnership, or other ownership interest or other equity
securities except for Permitted Investments. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.9</B> <B>Tax Returns and Payments; Pension Contributions</B><B>.</B> Borrower has timely
filed all required tax returns and reports, and Borrower has timely paid all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower except (a)&nbsp;to the extent such taxes are being contested in good faith
by appropriate proceedings promptly instituted and diligently conducted, so long as such reserve or other appropriate provision, if any, as shall be required in conformity with GAAP shall have been made therefor or (b)&nbsp;if such taxes,
assessments, deposits and contributions do not, individually or in the aggregate, exceed Fifty Thousand Dollars ($50,000). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent
Borrower defers payment of any contested taxes, Borrower shall (i)&nbsp;notify Lenders in writing of the commencement of, and any material development in, the proceedings, and (ii)&nbsp;post bonds or take any other steps required to prevent the
Governmental Authority levying such contested taxes from obtaining a Lien that is other than a &#147;Permitted Lien.&#148; Borrower is unaware of any claims or adjustments proposed for any of Borrower&#146;s prior tax years which could result in
additional taxes becoming due and payable by Borrower. Borrower has paid all amounts necessary to fund all present pension, profit sharing and deferred compensation plans in accordance with their terms, and Borrower has not withdrawn from
participation in, and has not permitted partial or complete termination of, or permitted the occurrence of any other event with respect to, any such plan which could reasonably be expected to result in any liability of Borrower, including any
liability to the Pension Benefit Guaranty Corporation or its successors or any other governmental agency. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.10</B> <B>Use of Proceeds</B><B>.</B> Borrower shall use the proceeds of the Loan
solely as working capital and for general corporate purposes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.11</B> <B>Full Disclosure</B><B>. </B>No written representation,
warranty or other statement of Borrower in any report, certificate, or written statement submitted to Lenders, as of the date such representation, warranty, or other statement was made, taken together with all such written reports, written
certificates and written statements submitted to Lenders, contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements contained in the reports, certificates, or written statements not
misleading (it being recognized by Lenders that the projections and forecasts provided by Borrower in good faith and based upon reasonable assumptions are not viewed as facts and that actual results during the period or periods covered by such
projections and forecasts may differ from the projected or forecasted results). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.12</B> <B>Definition of
</B><B>&#147;</B><B>Knowledge</B><B>&#148;</B><B>.</B> For purposes of the Loan Documents, whenever a representation or warranty is made to Borrower&#146;s knowledge or awareness, to the &#147;best of&#148; Borrower&#146;s knowledge, or with a
similar qualification, knowledge or awareness means the actual knowledge, after reasonable investigation, of any Responsible Officer. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6
<U>AFFIRMATIVE COVENANTS</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Borrower shall do all of the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.1</B> <B>Government Compliance</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as permitted by Section&nbsp;7.3, maintain its and all its Subsidiaries&#146; legal existence and good standing (or its foreign
equivalent, if any) in their respective jurisdictions of formation and maintain qualification in each jurisdiction in which the failure to so qualify would reasonably be expected to have a material adverse effect on Borrower&#146;s business or
operations. Borrower shall comply, and have each Subsidiary comply, in all material respects, with all laws, ordinances and regulations to which it is subject, noncompliance with which could reasonably be expected to have a material adverse effect
on Borrower&#146;s business. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Obtain all of the Governmental Approvals necessary for the performance by Borrower of its obligations
under the Loan Documents to which it is a party. Borrower shall promptly provide copies of any such obtained Governmental Approvals to Lenders. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.2</B> <B>Financial Statements, Reports, Certificates</B>. Provide Lenders with the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) [Reserved]; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) [Reserved];
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) as soon as available, but no later than within forty-five (45)&nbsp;days after the end of each fiscal quarter, a company prepared
consolidated balance sheet and income statement covering Borrower&#146;s and each of its Subsidiary&#146;s operations for such period in a form acceptable to Lenders (the &#147;<B>Quarterly</B><B></B><B>&nbsp;Financial Statements</B>&#148;);
provided, however, notwithstanding the foregoing, the Quarterly Financial Statements for Borrower&#146;s fourth (4th) quarter of each fiscal year, shall be due within ninety (90)&nbsp;days of such fiscal quarter; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) [Reserved]; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) [Reserved];
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) within five (5)&nbsp;days of filing, copies of all periodic and other reports, proxy
statements and other materials filed by Borrower and/or any Guarantor with the SEC, any Governmental Authority succeeding to any or all of the functions of the SEC or with any national securities exchange, or distributed to its shareholders, as the
case may be. Documents required to be delivered pursuant to the terms hereof (to the extent any such documents are included in materials otherwise filed with the SEC) may be delivered electronically and if so delivered, shall be deemed to have been
delivered on the date on which Borrower posts such documents, or provides a link thereto, on Borrower&#146;s website on the internet at Borrower&#146;s website address; provided, however, Borrower shall promptly notify Lenders in writing (which may
be by electronic mail) of the posting of any such documents; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) prompt report of any legal actions pending or threatened in writing
against Borrower or any of its Subsidiaries that could reasonably be expected to result in damages or costs to Borrower or any of its Subsidiaries of, individually or in the aggregate, One Million Dollars ($1,000,000) or more as reasonably requested
by Lenders; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) within thirty (30)&nbsp;days of the end of each calendar quarter, an update on the status of any litigation along with
such other information relating thereto as reasonably requested by Lenders; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) promptly, from time to time, such other information
regarding Borrower or compliance with the terms of any Loan Documents as reasonably requested by Lenders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.3</B> Except as otherwise
disclosed to Lenders, any submission by Borrower of any financial statement submitted to Lender shall be deemed to be a representation by Borrower that (i)&nbsp;as of the date of such financial statement, the information and calculations set forth
therein are true, accurate and correct, (ii)&nbsp;as of the end of the compliance period set forth in such submission, Borrower is in complete compliance with all required covenants except as noted in such financial statement, (iii)&nbsp;as of the
date of such submission, no Events of Default have occurred or are continuing, (iv)&nbsp;as of the date of such submission, Borrower and each of its Subsidiaries has timely filed all required tax returns and reports, and Borrower has timely paid all
foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower except as otherwise permitted pursuant to the terms of Section&nbsp;5.9, and (v)&nbsp;as of the date of such submission, no Liens have been levied or
claims made against Borrower or any of its Subsidiaries relating to unpaid employee payroll or benefits of which Borrower has not previously provided written notification to Lender. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.4 [Reserved] </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.5</B>
<B>Taxes; Pensions</B><B>.</B> Timely file, and require each of its Subsidiaries to timely file, all required tax returns and reports and timely pay, and require each of its Subsidiaries to timely pay, all foreign, federal, state and local taxes,
assessments, deposits and contributions owed by Borrower and each of its Subsidiaries, except for deferred payment of any taxes contested pursuant to the terms of Section&nbsp;5.9 hereof, and shall deliver to Lenders, on demand, appropriate
certificates attesting to such payments, and pay all amounts necessary to fund all present pension, profit sharing and deferred compensation plans in accordance with their terms. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.6</B> <B>Access to Books and Records</B><B>. </B>At reasonable times, on five (5)&nbsp;Business Days&#146; notice (provided no notice is
required if an Event of Default has occurred and is continuing), Lenders shall have the right to audit and copy Borrower&#146;s Books. The foregoing inspections and audits shall be conducted no more often than once every twelve (12)&nbsp;months (or
more frequently as Lenders in their reasonable discretion determines that conditions warrant) unless an Event of Default has occurred and is continuing in which case such inspections and audits shall occur as often as Lenders shall determine is
necessary. The foregoing inspections and audits shall be conducted at Borrower&#146;s expense and the charge therefor shall be One Thousand Dollars ($1,000) per person per day (or such higher amount as shall represent Lenders&#146; then-current
standard charge for the same), plus reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses. In the event Borrower and Lenders schedule an audit more than eight (8)&nbsp;days in advance, and
Borrower cancels or seeks to or reschedules the audit with less than eight (8)&nbsp;days written notice to Lenders, then (without limiting any of Lenders&#146; rights or remedies) Borrower shall pay Lenders a fee of Two Thousand Dollars ($2,000)
plus any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by Lenders to compensate Lenders for the anticipated costs and expenses of the cancellation or rescheduling. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.7</B> <B>Insurance</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Keep its business insured for risks and in amounts standard for companies in Borrower&#146;s industry and location and as Lenders may
reasonably request. Insurance policies shall be in a form, with financially sound and reputable insurance companies that are not Affiliates of Borrower, and in amounts that are satisfactory to Lenders. All property policies shall have a
lender&#146;s loss payable endorsement showing Lenders as lender loss payee. All liability policies shall show, or have endorsements showing, Lenders as additional insured. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Ensure that proceeds payable under any property policy are, at Lenders&#146; option, payable to Lenders on account of the Obligations.
Notwithstanding the foregoing, so long as no Event of Default has occurred and is continuing, Borrower shall have the option of applying the proceeds of any casualty policy up to Five Hundred Thousand Dollars ($500,000) toward the replacement or
repair of destroyed or damaged property or the purchase of other property useful to Borrower&#146;s business. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) [Reserved] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.8</B> <B>[Reserved</B>] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.9 [Reserved] </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.10</B> <B>Protection of Intellectual Property Rights</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) (i) Protect, defend and maintain the validity and enforceability of its Intellectual Property material to Borrower&#146;s business;
(ii)&nbsp;promptly advise Lenders in writing of material infringements or any other event that could reasonably be expected to materially and adversely affect the value of its Intellectual Property material to Borrower&#146;s business; and
(iii)&nbsp;not allow any Intellectual Property material to Borrower&#146;s business to be abandoned, forfeited or dedicated to the public without Lender&#146;s written consent. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.11 [Reserved] </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.12</B> <B>[Reserved</B>] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.13</B> <B>Formation or Acquisition of Subsidiaries</B><B>.</B> Notwithstanding and without limiting the negative covenants contained in
Sections 7.3 and 7.7 hereof, at the time that Borrower or any Guarantor forms any direct or indirect Subsidiary or acquires any direct or indirect Subsidiary after the Effective Date (including, without limitation, pursuant to a Division), Borrower
and such Guarantor shall (a)&nbsp;with respect to Domestic Subsidiaries only, cause such new Domestic Subsidiary to provide to Lenders a joinder to this Agreement to become a <FONT STYLE="white-space:nowrap">co-borrower</FONT> hereunder or a
Guaranty to become a Guarantor hereunder, all in form and substance satisfactory to Lenders, (b) [reserved]; and (c)&nbsp;provide to Lenders all other documentation in form and substance satisfactory to Lenders, including one or more opinions of
counsel satisfactory to Lenders, which in its opinion is appropriate with respect to the execution and delivery of the applicable documentation referred to above. Any document, agreement, or instrument executed or issued pursuant to this
Section&nbsp;6.13 shall be a Loan Document. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.14 [Reserved] </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.15</B> <B>Permitted Convertible Indebtedness. </B>Promptly after Borrower&#146;s receipt of notice of any election or request by the
holders of Permitted Convertible Indebtedness to redeem, provide Lender<B> </B>with written notice of such election or request. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7
<U>NEGATIVE COVENANTS</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Borrower shall not do any of the following without the Required Lenders&#146; prior written consent: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.1</B> <B>Dispositions</B><B>.</B> Convey, sell, lease, transfer, assign, or otherwise
dispose of (including, without limitation, pursuant to a Division) (collectively, &#147;<B>Transfer</B>&#148;), or permit any of its Subsidiaries to Transfer, all or any part of its business or property, except for Transfers (a)&nbsp;of Inventory in
the ordinary course of business; (b)&nbsp;of <FONT STYLE="white-space:nowrap">worn-out</FONT> or obsolete Equipment that is, in the reasonable judgment of Borrower, no longer economically practicable to maintain or useful in the ordinary course of
business of Borrower; (c)&nbsp;consisting of Permitted Liens and Permitted Investments; (d)&nbsp;consisting of the sale or issuance of any stock of Borrower permitted under Section&nbsp;7.2 of this Agreement; (e)&nbsp;dispositions of Intellectual
Property that are permitted pursuant to Section&nbsp;6.10(a); (f) consisting of Borrower&#146;s use or transfer of money or Cash Equivalents in a manner that is not prohibited by the terms of this Agreement or the other Loan Documents; (g)&nbsp;of <FONT
STYLE="white-space:nowrap">non-exclusive</FONT> licenses for the use of the property of Borrower or its Subsidiaries in the ordinary course of business and licenses that could not result in a legal transfer of title of the licensed property but that
may be exclusive in respects other than territory and that may be exclusive as to territory only as to discrete geographical areas outside of the United States; and (h)&nbsp;of other property with a book value not to exceed Five Hundred Thousand
Dollars ($500,000) in the aggregate in any fiscal year. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.2</B> <B>Changes in Business, Management, Control, or Business
Locations</B><B>.</B> (a)&nbsp;Engage in or permit any of its Subsidiaries to engage in any business other than the businesses currently engaged in by Borrower and such Subsidiary, as applicable, or reasonably related thereto; (b)&nbsp;liquidate or
dissolve; or (c)&nbsp;except with respect to Key Person departures currently contemplated in connection with Lenders&#146; purchase of certain Preferred Shares of Borrower, fail to provide notice to Lenders of any Key Person departing from or
ceasing to be employed by Borrower within five (5)&nbsp;days after his or her departure from Borrower. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Borrower shall not, without at
least thirty (30)&nbsp;days prior written notice to Lenders: (1)&nbsp;add any new offices or business locations, including warehouses (unless such new offices or business locations contain less than Five Hundred Thousand Dollars ($500,000) in
Borrower&#146;s assets or property), (2) change its jurisdiction of organization, (3)&nbsp;change its organizational structure or type, (4)&nbsp;change its legal name, or (5)&nbsp;change any organizational number (if any) assigned by its
jurisdiction of organization. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.3</B> <B>Mergers or Acquisitions</B><B>.</B> Merge or consolidate, or permit any of its Subsidiaries to
merge or consolidate, with any other Person, or acquire, or permit any of its Subsidiaries to acquire, all or substantially all of the capital stock or property of another Person (including, without limitation, by the formation of any Subsidiary or
pursuant to a Division). Notwithstanding the foregoing, (a)&nbsp;a Subsidiary may merge or consolidate into another Subsidiary or into Borrower and (b)&nbsp;Borrower may consummate Permitted Acquisitions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.4</B> <B>Indebtedness</B><B>.</B> Create, incur, assume, or be liable for any Indebtedness, or permit any Subsidiary to do so, other than
Permitted Indebtedness. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.5</B> <B>Encumbrance</B><B>.</B> Create, incur, allow, or suffer any Lien on any of its property, except for
Permitted Liens. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.6 [Reserved] </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.7</B> <B>Distributions; Investments</B>. (a)&nbsp;Pay any dividends or make any distribution or payment or redeem, retire or purchase any
capital stock of Borrower provided that Borrower may (i)&nbsp;convert any of its convertible securities into other securities pursuant to the terms of such convertible securities or otherwise in exchange thereof, (ii)&nbsp;pay dividends solely in
common stock; (iii)&nbsp;pay cash in lieu of fractional shares in connection with any distribution, payment or redemption permitted pursuant to this Section&nbsp;7.7; (iv) make <FONT STYLE="white-space:nowrap">non-cash</FONT> purchases or
withholding of capital stock in connection with the exercise of stock options or stock appreciation rights by way of cashless exercise or the vesting of restricted stock units or in connection with the satisfaction of withholding tax obligations;
and (v)&nbsp;make other payments, distributions, redemptions, retirements or purchases in an aggregate amount not to exceed Five Hundred Thousand Dollars ($500,000) in any fiscal year so long as an Event of Default does not exist at the time of any
such payment, distribution, redemption, retirement or purchase and would not exist after giving effect thereto; or (b)&nbsp;directly or indirectly make any Investment (including, without limitation, by the formation of any Subsidiary) other than
Permitted Investments, or permit any of its Subsidiaries to do so other than Permitted Investments. For the avoidance of doubt, the term &#147;capital stock&#148; shall not include any convertible debt security and clause (a)&nbsp;shall not apply to
the redemption, repurchase or conversion of any convertible debt security. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.8</B> <B>Transactions with Affiliates</B><B>.</B> Directly or indirectly enter into or
permit to exist any material transaction with any Affiliate of Borrower, except (i)&nbsp;for transactions that are in the ordinary course of Borrower&#146;s business, upon fair and reasonable terms that are no less favorable to Borrower than would
be obtained in an arm&#146;s length transaction with a <FONT STYLE="white-space:nowrap">non-affiliated</FONT> Person, (ii)&nbsp;employee agreements or arrangements, indemnification agreements and compensation arrangements approved by the Board (or a
committee thereof), (iii) transactions of the type described in and permitted in Section&nbsp;7.7 and Permitted Investments and (iv)&nbsp;equity or Subordinated Debt financing transactions with existing investors that are not otherwise prohibited by
this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.9 Subordinated Debt; Permitted Convertible Indebtedness. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <B>Subordinated Debt.</B> (i)&nbsp;Make or permit any payment on any Subordinated Debt, except under the terms of the subordination,
intercreditor, or other similar agreement to which such Subordinated Debt is subject, or (ii)&nbsp;amend any provision in any document relating to the Subordinated Debt which would increase the amount thereof, provide for earlier or greater
principal, interest, or other payments thereon, or adversely affect the subordination thereof to Obligations owed to Lenders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
<B>Permitted Convertible Indebtedness.</B> Except for redemptions or repurchases of the Permitted Convertible Indebtedness mandatorily required to be made pursuant to the terms of the Indentures as in effect on the date hereof, make any payment or
prepayment of principal of, premium, if any, or interest on, or redemption, purchase, retirement, defeasance (including <FONT STYLE="white-space:nowrap">in-substance</FONT> or legal defeasance), sinking fund, settlement, conversion, or similar
payment with respect to, any Permitted Convertible Indebtedness, except that (i)&nbsp;Borrower may make any required payments of cash or deliveries in shares of common stock of Borrower or any combination thereof (or other securities or property
following a merger event, reclassification or other change of the common stock) (and cash in lieu of fractional shares) pursuant to the terms of, and otherwise perform its obligations under, any Permitted Convertible Indebtedness (including, without
limitation, making payments of interest and principal thereon, making payments due upon required repurchase or redemption thereof and/or making payments and deliveries upon conversion thereof) (provided that, for the sake of clarity, &#147;required
payments or deliveries&#148; shall not include a redemption of the Permitted Convertible Indebtedness by Borrower at Borrower&#146;s option) and (ii)&nbsp;notwithstanding anything to the contrary herein, Borrower may issue a conversion notice under
Section&nbsp;14.13 of the Indenture for the 2019 Notes and may make all required payments and deliveries upon conversion of the 2019 Notes in connection with such conversion notice. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.10</B> <B>Compliance</B><B>.</B> Become an &#147;investment company&#148; or a company controlled by an &#147;investment company&#148;,
under the Investment Company Act of 1940, as amended, or undertake as one of its important activities extending credit to purchase or carry margin stock (as defined in Regulation U of the Board of Governors of the Federal Reserve System), or use the
proceeds of the Loan for that purpose; fail to meet the minimum funding requirements of ERISA, permit a Reportable Event or Prohibited Transaction, as defined in ERISA, to occur; fail to comply with the Federal Fair Labor Standards Act or violate
any other law or regulation, if the violation could reasonably be expected to have a material adverse effect on Borrower&#146;s business, or permit any of its Subsidiaries to do so; withdraw or permit any Subsidiary to withdraw from participation
in, permit partial or complete termination of, or permit the occurrence of any other event with respect to, any present pension, profit sharing and deferred compensation plan which could reasonably be expected to result in any liability of Borrower,
including any liability to the Pension Benefit Guaranty Corporation or its successors or any other governmental agency. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.11</B>
<B>Guaranty. </B>To permit any of its Subsidiaries to guarantee the payment of any Indebtedness of Borrower or any of its Subsidiaries unless such Subsidiary within 10 days executes and delivers a Guaranty in form and substance reasonably
satisfactory to Lenders providing for a Guaranty by such Subsidiary of the Obligations, provided that the Guaranty arising under this provision in favor of Lenders as a result of a Subsidiary guaranteeing obligations under the SVB Loan and Security
Agreement shall be subordinated in right of payment to the same extent the Obligations are subordinated to the obligations under the SVB Loan and Security Agreement. <B></B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8 <U>EVENTS OF DEFAULT</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any one of the following shall constitute an event of default (an &#147;<B>Event of Default</B>&#148;) under this Agreement: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.1</B> <B>Payment Default</B><B>.</B> Borrower fails to (a)&nbsp;make any payment of
principal or interest on the Loan when due, or (b)&nbsp;pay any other Obligations within three (3)&nbsp;Business Days after such Obligations are due and payable (which three (3)&nbsp;Business Day cure period shall not apply to payments due on the
Loan Maturity Date). During the cure period, the failure to make or pay any payment specified under clause (b)&nbsp;hereunder is not an Event of Default; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.2</B> <B>Covenant Default</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Borrower fails or neglects to perform any obligation in Sections 6.2, 6.5, 6.6, 6.7, 6.10 or 6.13 or violates any covenant in
Section&nbsp;7; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Borrower fails or neglects to perform, keep, or observe any other term, provision, condition, covenant or agreement
contained in this Agreement or any Loan Documents, and as to any default (other than those specified in this Section&nbsp;8) under such other term, provision, condition, covenant or agreement that can be cured, has failed to cure the default within
fifteen (15)&nbsp;days after the occurrence thereof; provided, however, that if the default cannot by its nature be cured within the fifteen (15)&nbsp;day period or cannot after diligent attempts by Borrower be cured within such fifteen
(15)&nbsp;day period, and such default is likely to be cured within a reasonable time, then Borrower shall have an additional period (which shall not in any case exceed thirty (30)&nbsp;days) to attempt to cure such default, and within such
reasonable time period the failure to cure the default shall not be deemed an Event of Default. Cure periods provided under this section shall not apply, among other things, to financial covenants or any other covenants set forth in clause
(a)&nbsp;above; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.3</B> <B>Material Adverse Change</B>. A Material Adverse Change occurs; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.4</B> <B>Attachment; Levy; Restraint on Business</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) (i) The service of process seeking to attach, by trustee or similar process, any funds of Borrower or of any entity under the control of
Borrower (including a Subsidiary), or (ii)&nbsp;a notice of lien or levy is filed against any of Borrower&#146;s assets by any Governmental Authority, and the same under subclauses (i)&nbsp;and (ii) hereof are not, within ten (10)&nbsp;days after
the occurrence thereof, discharged or stayed (whether through the posting of a bond or otherwise); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) (i) any material portion of
Borrower&#146;s assets is attached, seized, levied on, or comes into possession of a trustee or receiver, or (ii)&nbsp;any court order enjoins, restrains, or prevents Borrower from conducting all or any material part of its business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.5</B> <B>Insolvency</B><B>.</B> (a)&nbsp;Borrower or any of its Subsidiaries is unable to pay its debts (including trade debts) as they
become due or otherwise becomes insolvent; (b)&nbsp;Borrower or any of its Subsidiaries begins an Insolvency Proceeding; or (c)&nbsp;an Insolvency Proceeding is begun against Borrower or any of its Subsidiaries and is not dismissed or stayed within
forty-five (45)&nbsp;days; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.6</B> <B>Other Agreements</B><B>.</B> There is, under any agreement to which Borrower or any Guarantor is
a party with a third party or parties, (a)&nbsp;any default resulting in a right by such third party or parties, whether or not exercised, to accelerate the maturity of any Indebtedness in an amount individually or in the aggregate in excess of Five
Hundred Thousand Dollars ($500,000); or (b)&nbsp;any breach or default by Borrower or Guarantor, the result of which could have a material adverse effect on Borrower&#146;s or any Guarantor&#146;s business; provided, however, that the Event of
Default under this Section&nbsp;8.6 caused by the occurrence of a breach or default under such other agreement shall be cured or waived for purposes of this Agreement upon Lenders receiving written notice from the party asserting such breach or
default of such cure or waiver of the breach or default under such other agreement, if at the time of such cure or waiver under such other agreement (x)&nbsp;Lenders have not declared an Event of Default under this Agreement and/or exercised any
rights with respect thereto; (y)&nbsp;any such cure or waiver does not result in an Event of Default under any other provision of this Agreement or any Loan Document; and (z)&nbsp;in connection with any such cure or waiver under such other
agreement, the terms of any agreement with such third party are not modified or amended in any manner which could in the good faith business judgment of Lenders be materially less advantageous to Borrower; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.7</B> <B>Judgments; Penalties</B><B>.</B> One or more fines, penalties or final
judgments, orders or decrees for the payment of money in an amount, individually or in the aggregate, of at least Five Hundred Thousand Dollars ($500,000) (not covered by independent third-party insurance as to which liability has been accepted by
such insurance carrier) shall be rendered against Borrower by any Governmental Authority, and the same are not, within ten (10)&nbsp;days after the entry, assessment or issuance thereof, discharged, satisfied, or paid, or after execution thereof,
stayed or bonded pending appeal, or such judgments are not discharged prior to the expiration of any such stay; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.8</B>
<B>Misrepresentations</B><B>.</B> Borrower or any Person acting for Borrower makes any representation, warranty, or other statement now or later in this Agreement, any Loan Document or in any writing delivered to Lenders or to induce Lenders to
enter this Agreement or any Loan Document, and such representation, warranty, or other statement is incorrect in any material respect when made; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.9</B> <B>Subordinated Debt</B><B>.</B> Any document, instrument, or agreement evidencing any Subordinated Debt shall for any reason be
revoked or invalidated or otherwise cease to be in full force and effect, any Person shall be in breach thereof or contest in any manner the validity or enforceability thereof or deny that it has any further liability or obligation thereunder, or
the Obligations shall for any reason be subordinated or shall not have the priority contemplated by this Agreement or any applicable subordination or intercreditor agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.10</B> <B>Guaranty</B><B>.</B> (a)&nbsp;Any guaranty of any Obligations terminates or ceases for any reason to be in full force and
effect; (b)&nbsp;any Guarantor does not perform any obligation or covenant under any guaranty of the Obligations; (c)&nbsp;any circumstance described in Sections 8.3, 8.4, 8.5, 8.6, 8.7, or 8.8 of this Agreement occurs with respect to any Guarantor,
(d)&nbsp;the death, liquidation, winding up, or termination of existence of any Guarantor; or (e)&nbsp;a material adverse change in the general affairs, management, results of operation, condition (financial or otherwise) or the prospect of
repayment of the Obligations occurs with respect to any Guarantor; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.11</B> <B>Governmental Approvals</B><B>.</B> Any Governmental
Approval shall have been revoked, rescinded, suspended, modified in an adverse manner or not renewed in the ordinary course for a full term and such decision or such revocation, rescission, suspension, modification or
<FONT STYLE="white-space:nowrap">non-renewal</FONT> could reasonably be expected to cause, a Material Adverse Change. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9
<U>LENDERS&#146; RIGHTS AND REMEDIES</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.1</B> <B>Rights and Remedies</B><B>.</B> Upon the occurrence and during the continuance
of an Event of Default, Required Lenders may, without notice or demand, do any or all of the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) declare all Obligations
immediately due and payable (but if an Event of Default described in Section&nbsp;8.5 occurs all Obligations are immediately due and payable without any action by Required Lenders); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) exercise all rights and remedies available to Lenders under the Loan Documents or at law or equity. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.2</B> <B>No Waiver; Remedies Cumulative</B><B>.</B> Lenders&#146; failure, at any time or times, to require strict performance by Borrower
of any provision of this Agreement or any other Loan Document shall not waive, affect, or diminish any right of Lenders thereafter to demand strict performance and compliance herewith or therewith. No waiver hereunder shall be effective unless
signed by the party granting the waiver and then is only effective for the specific instance and purpose for which it is given. Lenders&#146; rights and remedies under this Agreement and the other Loan Documents are cumulative. Lenders have all
rights and remedies provided under the Code, by law, or in equity. Lender&#146;s exercise of one right or remedy is not an election and shall not preclude Lenders from exercising any other remedy under this Agreement or other remedy available at law
or in equity, and Lenders&#146; waiver of any Event of Default is not a continuing waiver. Lenders&#146; delay in exercising any remedy is not a waiver, election, or acquiescence. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.3</B> <B>Demand Waiver</B><B>.</B> Borrower waives demand, notice of default or dishonor, notice of payment and nonpayment, notice of any
default, nonpayment at maturity, release, compromise, settlement, extension, or renewal of accounts, documents, instruments, chattel paper, and guarantees held by Lenders on which Borrower is liable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10 <U>NOTICES</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All notices, consents, requests, approvals, demands, or other communication by any party to this Agreement or any other Loan Document must be
in writing and shall be deemed to have been validly served, given, or delivered: (a)&nbsp;upon the earlier of actual receipt and three (3)&nbsp;Business Days after deposit in the U.S. mail, first class, registered or certified mail return receipt
requested, with proper postage prepaid; (b)&nbsp;upon transmission, when sent by electronic mail or facsimile transmission; (c)&nbsp;one (1) Business Day after deposit with a reputable overnight courier with all charges prepaid; or (d)&nbsp;when
delivered, if hand-delivered by messenger, all of which shall be addressed to the party to be notified and sent to the address, facsimile number, or email address indicated below. Lender or Borrower may change their respective mailing or electronic
mail address or facsimile number by giving the other party written notice thereof in accordance with the terms of this Section&nbsp;10. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">If to Borrower:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">FLUIDIGM CORPORATION</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2 Tower Place, Suite 2000</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">South San Francisco, CA 94080</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Attn: Vikram Jog, Chief Financial Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Email: vikram.jog@fluidigm.com</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">If to Lenders:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">CASDIN CAPITAL, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">1350 Avenue of the Americas, Suite 2600</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">New York, NY 10019</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Attn: Fund Accounting</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Email: fundacct@casdincapital.com</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11 <U>CHOICE OF LAW, VENUE, JURY TRIAL WAIVER AND JUDICIAL REFERENCE</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New York law governs the Loan Documents. Borrower and Lender each submit to the exclusive jurisdiction of the State and Federal courts of New
York, in each case sitting in the Borough of Manhattan. Borrower expressly submits and consents in advance to such jurisdiction in any action or suit commenced in any such court, and Borrower hereby waives any objection that it may have based upon
lack of personal jurisdiction, improper venue, or forum non conveniens and hereby consents to the granting of such legal or equitable relief as is deemed appropriate by such court. Borrower hereby waives personal service of the summons, complaints,
and other process issued in such action or suit and agrees that service of such summons, complaints, and other process may be made by registered or certified mail addressed to Borrower at the address set forth in, or subsequently provided by
Borrower in accordance with, Section&nbsp;10 of this Agreement and that service so made shall be deemed completed upon the earlier to occur of Borrower&#146;s actual receipt thereof or three (3)&nbsp;days after deposit in the U.S. mails, proper
postage prepaid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE
TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OF THE LOAN DOCUMENTS (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO CERTIFIES THAT NO REPRESENTATIVE,
AGENT OR ATTORNEY OF ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B)&nbsp;ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE
BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND ANY NOTE BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 11. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Section&nbsp;11 shall survive the termination of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12 <U>GENERAL PROVISIONS</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.1</B> <B>Termination; Survival</B><B>. </B>All covenants, representations and warranties made in this Agreement shall continue in full
force until all Obligations (other than inchoate indemnity obligations, and any other obligations which, by their terms, are to survive the termination of this Agreement) have been satisfied. Upon the earlier of the payment in full of the Loan or
the conversion of the Conversion Amount pursuant to this Agreement, this Agreement shall </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
automatically terminate (other than inchoate indemnity obligations, and any other obligations which, by their terms, are to survive the termination of this Agreement). Those obligations that are
expressly specified in this Agreement as surviving this Agreement&#146;s termination shall continue to survive notwithstanding this Agreement&#146;s termination. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.2</B> <B>Successors and Assigns</B><B>.</B> This Agreement binds and is for the benefit of the successors and permitted assigns of each
party. Borrower may not assign this Agreement or any rights or obligations under it without Lender&#146;s prior written consent (which may be granted or withheld in Lenders&#146; discretion). Each Lender has the right, without the consent of or
notice to Borrower, to sell, transfer, assign, negotiate, or grant participation in all or any part of, or any interest in, such Lender&#146;s obligations, rights, and benefits under this Agreement and the other Loan Documents to any Person.
Borrower shall maintain at one of its offices a copy of each assignment and assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, principal amounts (and stated interest) of the Loans owing to, each
Lender pursuant to the terms hereof from time to time (the &#147;<B>Register</B>&#148;). The entries in the Register shall be conclusive absent manifest error, and the Borrower and the Lenders shall treat each Person whose name is recorded in the
Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement. The Register shall be available for inspection by the Lender, at any reasonable time and from time to time upon reasonable prior notice. If any Lender
sells at any time participations to any person (each, a &#147;<B>Participant</B>&#148;) in all or a portion of such Lender&#146;s right or obligations under this Agreement, (i)&nbsp;such Lender&#146;s obligations under this Agreement shall remain
unchanged, (ii)&nbsp;such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations, and (iii)&nbsp;the Borrower shall continue to deal solely and directly with such Lender in connection with such
Lender&#146;s rights and obligations under this Agreement. Each Lender that sells a participation shall, acting solely for this purpose as a <FONT STYLE="white-space:nowrap">non-fiduciary</FONT> agent of the Borrower, maintain a register on which it
enters the name and address of each Participant and the principal amounts (and stated interest) of each Participant&#146;s interest in the Loans (the &#147;<B>Participant Register</B>&#148;); provided that no Lender shall have any obligation to
disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a Participant&#146;s interest in obligations under any Loan Document) to any Person except to the extent that such
disclosure is necessary to establish that obligation is in registered form under <FONT STYLE="white-space:nowrap">Section&nbsp;5f.103-1(c)</FONT> of the United States Treasury Regulations. The entries in the Participant Register shall be conclusive
absent manifest error, and such Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.3</B> <B>Indemnification</B>. Borrower agrees to indemnify, defend and hold Lenders and their directors, officers, employees, agents,
attorneys, or any other Person affiliated with or representing Lenders (each, an &#147;<B>Indemnified Person</B>&#148;) harmless against: (i)&nbsp;all obligations, demands, claims, and liabilities (collectively, &#147;<B>Claims</B>&#148;) claimed or
asserted by any other party in connection with the transactions contemplated by the Loan Documents; and (ii)&nbsp;all losses or expenses (including Lender Expenses) in any way suffered, incurred, or paid by such Indemnified Person as a result of,
following from, consequential to, or arising from transactions between Lenders and Borrower (including reasonable attorneys&#146; fees and expenses), except for Claims and/or losses directly caused by such Indemnified Person&#146;s gross negligence
or willful misconduct. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Section&nbsp;12.3 shall survive until all statutes of limitation with respect to the Claims, losses, and
expenses for which indemnity is given shall have run. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.4</B> <B>Time of Essence</B><B>.</B> Time is of the essence for the
performance of all Obligations in this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.5</B> <B>Severability of Provisions</B><B>.</B> Each provision of this Agreement
is severable from every other provision in determining the enforceability of any provision. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.6</B> <B>Correction of Loan
Documents</B><B>.</B> Required Lenders may correct patent errors and fill in any blanks in the Loan Documents consistent with the agreement of the parties so long as Lenders provide Borrower with written notice of such correction and allows Borrower
at least ten (10)&nbsp;days to object to such correction. In the event of such objection, such correction shall not be made except by an amendment signed by the Required Lenders and Borrower. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.7</B> <B>Amendments in Writing; Waiver; Integration</B><B>.</B> Without the consent of Required Lenders, no purported amendment or
modification of any Loan Document, or waiver, discharge or termination of any obligation under any Loan Document, shall be enforceable or admissible unless, and only to the extent, expressly set forth in a writing signed by the party against which
enforcement or admission is sought; and provided, further, that no such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
waiver and no such amendment, supplement or modification shall, without the consent of each Lender directly and adversely affected thereby: (i)&nbsp;forgive or reduce any portion of any Loan
owing to such Lender or extend the final scheduled maturity date of any such Loan or reduce the stated rate, or forgive any portion thereof, or extend the date for the payment, of any principal, interest or fee payable hereunder, or make any Loan,
interest, Fee or other amount payable in any currency, or (ii)&nbsp;release all or substantially all of the Guarantors under the Guaranty, if any (except as expressly permitted by the Guaranty), or (iii)&nbsp;reduce the percentages specified in the
definitions of the terms Required Lenders, or amend, restate, supplement, modify or waive any provision of this Section&nbsp;12.7 that has the effect of decreasing the number of Lenders that must approve any amendment, restatement, supplementation,
modification or waiver, (iv)&nbsp;amend, modify or supplement Article 13 hereof, or (v)&nbsp;consent to the assignment or transfer by Borrower of its rights and obligations under this Agreement party (except as explicitly permitted hereunder). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.8</B> <B>Counterparts</B><B>.</B> This Agreement may be executed in any number of counterparts and by different parties on separate
counterparts, each of which, when executed and delivered, is an original, and all taken together, constitute one Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.9</B>
<B>Confidentiality</B><B>.</B> In handling any confidential information, Lenders shall exercise the same degree of care that they exercise for their own proprietary information and Lenders will not disclose, divulge, or use for any purpose (other
than to monitor its Loan to Borrower) any confidential information obtained from Borrower (including any confidential information obtained pursuant to the terms of this Agreement), but disclosure of information may be made: (a)&nbsp;to Lenders
Subsidiaries or Affiliates in the ordinary course of business (such Subsidiaries and Affiliates, together with Lenders, collectively, &#147;<B>Lender Entities</B>&#148;), provided that Lenders inform such Subsidiary or Affiliate that such
information is confidential and direct such Subsidiary and Affiliate to maintain the confidentiality of such information; (b)&nbsp;to investors or prospective investors of the Lenders or the funds or accounts for whom the Lenders&#146; investment
managers act as managers or investment managers, provided, however Lenders, their investment managers or their Affiliates shall enter into (or have already entered into) confidentiality agreements with such recipients on terms substantively similar
to the provisions contained in this paragraph); (c) to prospective transferees or purchasers of any interest in the Loan (provided, however, Lenders shall enter into confidentiality agreement with prospective transferees or purchasers on terms
substantially similar to the provisions contained in this paragraph); (d) as required by law, regulation, subpoena, or other order, provided that Lenders promptly notify Borrower of such disclosure and takes reasonable steps to minimize the extent
of any such required disclosure; (e)&nbsp;to the extent required by securities Laws or Governmental Authority or rules or regulations of securities exchanges or similar entities in connection with any required securities filings; (f)&nbsp;as Lenders
consider appropriate in exercising remedies under the Loan Documents; and (g)&nbsp;to their attorneys, accountants, consultants, and other professionals to the extent necessary to obtain their services in connection with monitoring the Loan to
Borrower and so long as such service providers have executed a confidentiality agreement with Lenders with terms no less restrictive than those contained herein. Confidential information does not include information that is either: (i)&nbsp;in the
public domain or in Lenders&#146; possession when disclosed to Lenders, or becomes part of the public domain (other than as a result of its disclosure by Lenders in violation of this Agreement) after disclosure to Lenders; or (ii)&nbsp;disclosed to
Lenders by a third party, if Lenders do not know that the third party is prohibited from disclosing the information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The provisions of
the immediately preceding sentence shall survive the termination of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.10</B> <B>Attorneys&#146; Fees, Costs and
Expenses</B><B>.</B> In any action or proceeding between Borrower and Lenders arising out of or relating to the Loan Documents, the prevailing party shall be entitled to recover its reasonable attorneys&#146; fees and other costs and expenses
incurred, in addition to any other relief to which it may be entitled. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.11</B> <B>Electronic Execution of Documents</B><B>.</B> The
words &#147;execution,&#148; &#147;signed,&#148; &#147;signature&#148; and words of like import in any Loan Document shall be deemed to include electronic signatures or the keeping of records in electronic form, each of which shall be of the same
legal effect, validity and enforceability as a manually executed signature or the use of a paper-based recordkeeping systems, as the case may be, to the extent and as provided for in any applicable law, including, without limitation, any state law
based on the Uniform Electronic Transactions Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.12 Calculations in Respect of the Loans.</B> Other than as specified herein,
Borrower and its agents shall be responsible for making the calculations called for under the Loans. These calculations include, but are not limited to, any adjustments to the Conversion Rate, the determination of any Last Reported Sale Price and
the consideration deliverable in respect of any conversion. Borrower will make all these calculations in good faith and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shall provide written notice of any such calculation to Lenders, which written notice shall set forth in reasonable detail the basis for the calculation thereof, and, absent manifest error,
Borrower&#146;s calculations as specified in such written notice shall become final and binding on Lenders on the earlier of (i) 30 days after the receipt thereof and (ii)&nbsp;agreement on the part of Lenders. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.13</B> <B>Captions</B><B>.</B> The headings used in this Agreement are for convenience only and shall not affect the interpretation of
this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.14</B> <B>Construction of Agreement</B><B>.</B> The parties mutually acknowledge that they and their attorneys have
participated in the preparation and negotiation of this Agreement. In cases of uncertainty this Agreement shall be construed without regard to which of the parties caused the uncertainty to exist. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.15</B> <B>Relationship</B><B>.</B> The relationship of the parties to this Agreement is determined solely by the provisions of this
Agreement. The parties do not intend to create any agency, partnership, joint venture, trust, fiduciary or other relationship with duties or incidents different from those of parties to an <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT>
contract. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.16</B> <B>Third Parties</B><B>.</B> Nothing in this Agreement, whether express or implied, is intended to: (a)&nbsp;confer
any benefits, rights or remedies under or by reason of this Agreement on any persons other than the express parties to it and their respective permitted successors and assigns; (b)&nbsp;relieve or discharge the obligation or liability of any person
not an express party to this Agreement; or (c)&nbsp;give any person not an express party to this Agreement any right of subrogation or action against any party to this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12</B>.17 <B>Restricted Securities;</B> <B>Legends</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Lenders understand that the Common Shares or Preferred Shares, as applicable, issued in accordance with this Agreement will be
characterized as &#147;restricted securities&#148; under Rule 144(a)(3) of the Securities Act unless registered under the Securities Act or resold pursuant to an exemption from the registration requirements of the Securities Act in a transaction
that results in such Common Shares or Preferred Shares, as the case may be, no longer being a &#147;restricted security.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) It is
understood that the Common Shares or Preferred Shares, as applicable, issued in accordance with this Agreement shall bear the following or a similar legend for so long as such securities constitute &#147;restricted securities&#148; within the
meaning of Rule 144(a)(3) of the Securities Act: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS SECURITY AND THE COMMON STOCK, IF ANY, ISSUABLE UPON CONVERSION OF THIS SECURITY
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#147;SECURITIES ACT&#148;), AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF OR OF
A BENEFICIAL INTEREST HEREIN, THE ACQUIRER: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) REPRESENTS THAT IT AND ANY ACCOUNT FOR WHICH IT IS ACTING IS A
&#147;QUALIFIED INSTITUTIONAL BUYER&#148; (WITHIN THE MEANING OF RULE 144A UNDER THE SECURITIES ACT) OR AN &#147;ACCREDITED INVESTOR&#148; WITHIN THE MEANING OF RULE 501(A) OF THE SECURITIES ACT, AND </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) AGREES FOR THE BENEFIT OF FLUIDIGM CORPORATION (THE &#147;COMPANY&#148;) THAT IT WILL NOT OFFER, SELL, PLEDGE OR OTHERWISE
TRANSFER THIS SECURITY OR ANY BENEFICIAL INTEREST HEREIN PRIOR TO THE DATE THAT IS THE LATER OF (X)&nbsp;ONE YEAR AFTER THE LAST ORIGINAL ISSUE DATE HEREOF OR SUCH SHORTER PERIOD OF TIME AS PERMITTED BY RULE 144 UNDER THE SECURITIES ACT OR ANY
SUCCESSOR PROVISION THERETO AND (Y)&nbsp;SUCH LATER DATE, IF ANY, AS MAY BE REQUIRED BY APPLICABLE LAW, EXCEPT: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) TO THE
COMPANY OR ANY SUBSIDIARY THEREOF, OR </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) PURSUANT TO A REGISTRATION STATEMENT THAT HAS BECOME EFFECTIVE UNDER THE
SECURITIES ACT AND IS EFFECTIVE AT THE TIME OF SUCH TRANSFER, OR </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) TO A PERSON THAT YOU REASONABLY BELIEVE TO BE A
QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT, OR </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) PURSUANT TO AN EXEMPTION FROM
REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT OR ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PRIOR TO THE REGISTRATION OF ANY TRANSFER IN ACCORDANCE WITH CLAUSE (2)(D) ABOVE, THE COMPANY RESERVES THE RIGHT TO REQUIRE THE DELIVERY OF
SUCH LEGAL OPINIONS, CERTIFICATIONS OR OTHER EVIDENCE AS MAY REASONABLY BE REQUIRED IN ORDER TO DETERMINE THAT THE PROPOSED TRANSFER IS BEING MADE IN COMPLIANCE WITH THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. NO REPRESENTATION IS MADE
AS TO THE AVAILABILITY OF ANY EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13 <U>CONVERSION </U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.1</B> <B>Preferred Share Automatic Conversion. </B>Upon issuance of the Preferred Shares by the Borrower (if approved at the Company
Stockholder Meeting), without any further action taken or notice given by the Lenders, the Conversion Amount shall convert automatically into a number of Preferred Shares equal to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(1) the Conversion Amount divided by $1,000 multiplied by </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(2) the Conversion Price (as defined under the applicable definitive documentation governing the Preferred Shares) divided by $2.84 (the
&#147;<B>Initial Company Share Price</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, no Preferred Shares will be issued prior to obtaining the approval of the
stockholders of the Company authorizing the issuance of such Preferred Shares at a duly called meeting of such stockholders (the &#147;<B>Company Stockholder Meeting</B>&#148;) and shall be issued in connection with the Closing (as defined in the
Purchase Agreement). In lieu of fractional shares otherwise issuable, each Lender shall be entitled to receive, at the Company&#146;s sole discretion, either (i)&nbsp;cash in lieu of delivering any fractional Preferred Shares issuable on conversion
in an amount equal to the product obtained by <I>multiplying</I> (A)&nbsp;the applicable &#147;Conversion Rate&#148; (not as defined herein, but in the applicable certificate of designations for the Preferred Shares) <I>by</I> (B)&nbsp;the fraction
of a Preferred Share not issued <I>by</I> (C)&nbsp;the VWAP of the Common Shares for the relevant Conversion Date (or, if such Conversion Date is not a Trading Day, the next following Trading Day) or (ii)&nbsp;one additional whole share of fully
paid and nonassessable Preferred Share. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.2 Common Share Conversion Privilege. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Upon the earlier to occur of (i)&nbsp;a negative vote at the Company Stockholder Meeting with respect to the authorization of the Preferred
Shares, and therefore the automatic conversion pursuant to Section&nbsp;13.1 does not occur, or (ii)&nbsp;the termination of the Purchase Agreement and therefore the automatic conversion pursuant to Section&nbsp;13.1 does not occur (the earlier to
occur of immediately preceding clauses (i)&nbsp;and (ii), the &#147;<B>Conversion Privilege Trigger</B>&#148;), Lenders shall have the right, at Lenders&#146; option, at any time following the conclusion of the Company Stockholder Meeting or
termination of the Purchase Agreement, but prior to the close of business on the Business Day immediately preceding the Loan Maturity Date, subject to the conversion procedures set forth in Section&nbsp;13.3, to convert all or a portion of such
Lender&#146;s Conversion Amount at any time into a number of Common Shares equal to (1)&nbsp;the Conversion Amount so converted <I>multiplied by</I> (2)&nbsp;the Conversion Rate <I>divided by</I> (3)&nbsp;$1,000; <U>provided</U>, that Lenders shall
receive cash in lieu of any fractional shares as set out in Section&nbsp;13.3(f). For the avoidance of doubt, Lenders may not convert any portion of such Lender&#146;s Conversion Amount pursuant to this Section&nbsp;13.2(a) prior to the occurrence
of the Conversion Privilege Trigger. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Borrower shall at all times reserve and keep available out of its authorized and
unissued Common Shares, solely for issuance on the conversion of the Conversion Amount, such number of Common Shares as shall from time to time be issuable on the conversion of all the Conversion Amount then outstanding. The Borrower shall use its
reasonable best efforts to maintain the listing on the NASDAQ of such number of Common Shares as shall from time to time be issuable on the conversion of the Conversion Amount then outstanding. Any Common Shares issued on conversion of the
Conversion Amount shall be duly authorized, validly issued, fully paid and nonassessable and shall not be subject to preemptive rights or subscription rights of any other stockholder of the Borrower. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the contrary in this Agreement, nothing in this Agreement shall require Borrower to issue any Common Shares to
Lenders to the extent such issuance would result in the number of Aggregate Shares issued by Borrower to the Lenders under this Agreement, to exceed the Conversion Cap. For purposes of this Section&nbsp;13.2(c), &#147;<B>Aggregate Shares</B>&#148;
shall be equal to the number of shares of Common Stock of the Company issued at any time in the aggregate to the Lenders under this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.3 Conversion Procedure. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Conversion Procedure</U>. A Lender must do each of the following in order to convert all or a portion of the Conversion Amount held by
such Lender pursuant to Section&nbsp;13.2(a) (the first date on which a Lender has complied with all such procedures (including the satisfaction of any conditions to conversion set forth in the Conversion Notice), the &#147;<B>Conversion
Date</B>&#148;): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) complete and manually sign the conversion notice provided by the Borrower, a form of which is attached hereto as
<U>Exhibit A</U> (the &#147;<B>Conversion Notice</B>&#148;), and deliver such notice to the Borrower; provided, that a Conversion Notice may be conditional on the completion of a Change in Control or other condition, transaction or event as Lenders
may specify; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) deliver to the Borrower the Promissory Note (if any) representing the Conversion Amount to be converted; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) if required, furnish appropriate endorsements and transfer documents; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) if required, pay the amount of any tax that may be payable in respect of any transfer involved in the issuance or delivery of Common
Shares to a Person other than Lenders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Effect of Conversion</U>. Effective immediately prior to the close of business on the
Conversion Date applicable to any Conversion Amount converted, such Conversion Amount shall cease to be outstanding, interest with respect to such Conversion Amount shall cease to accrue and the corresponding Common Shares pursuant to the conversion
shall be issued and outstanding. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Record Holder of Underlying Securities as of Conversion Date</U>. The Lender or Lenders entitled
to receive the Common Stock and, to the extent applicable, cash, securities or other property issuable on conversion of the Conversion Amount on a Conversion Date shall be treated for all purposes as the record holder(s) of such shares of Common
Shares and/or cash, securities or other property as of the close of business on such Conversion Date. As promptly as practicable on or after the Conversion Date and, if applicable, compliance by the applicable Lender with the relevant procedures
contained in Section&nbsp;13.3(a) (and in any event no later than three Trading Days thereafter; provided, that if a written notice from such Lender in accordance with Section&nbsp;13.3(a)(i) specifies a date of delivery for any shares of Common
Shares, such shares shall be delivered on the date so specified, which shall be no earlier than the second Business Day and no later than the seventh Business Day following the date of such notice), Borrower shall issue the number of whole shares of
Common Shares issuable on conversion (and deliver payment of cash in lieu of fractional shares or as otherwise set out in Section&nbsp;13.3(f)) and, to the extent applicable, any cash, securities or other property issuable thereon. Such delivery of
shares of Common Shares, securities or other property, shall be made by book-entry or, at the request of the applicable Lender, by delivering a notice to the Borrower, through the facilities of The Depository Trust Company, or in certificated form.
Any such certificate or certificates shall be delivered by the Borrower to the appropriate Lender on a book-entry basis, through </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the facilities of The Depository Trust Company, or by mailing certificates evidencing the shares to the applicable Lender, in each case at their respective addresses set forth in the Conversion
Notice. In the event that a Lender shall not by written notice designate the name in which shares of Common Shares (and payments of cash in lieu of fractional shares) and, to the extent applicable, cash, securities or other property to be delivered
on conversion of the Conversion Amount should be registered or paid, or the manner in which such shares, cash, securities or other property should be delivered, the Borrower shall be entitled to register and deliver such shares, securities or other
property, and make such payment, in the name of the Lender and in the manner shown on the records of the Borrower. The Lender shall promptly deliver or cause to be delivered to Borrower&#146;s transfer agent or any other Person all such customary
additional documentation as may be reasonably necessary to effectuate the delivery of any Common Shares, securities, or other property in accordance with this Section&nbsp;13.3(c). Any securities issued to the Lender pursuant to this Agreement shall
bear the legends set forth in Section&nbsp;12.17 to the extent such securities constitute &#147;restricted securities&#148; within the meaning of Rule 144(a)(3). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Status of Reacquired Conversion Amount</U>. The Conversion Amount converted in accordance with this Agreement, or otherwise acquired by
the Borrower or any of its Subsidiaries in any manner whatsoever, shall cease to be outstanding after the acquisition thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)
<U>Partial Conversion</U>. In case any Promissory Note for the Conversion Amount shall be surrendered for partial conversion, the Borrower shall, at its expense, execute and deliver to or on the written order of Lender of the Promissory Note so
surrendered a new Promissory Note for the Conversion Amount not converted. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>No Fractional Shares</U>. Notwithstanding the foregoing,
the Borrower shall not deliver any fractional Common Shares on conversion of the Conversion Amount but the Borrower shall instead pay cash in lieu of delivering any fractional Common Shares issuable on conversion based on the VWAP of the Common
Shares for the relevant Conversion Date (or, if such Conversion Date is not a Trading Day, the next following Trading Day). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.4</B>
<B>Adjustments of Conversion Rate.</B> The Conversion Rate shall be adjusted from time to time by the Borrower if any of the following events occurs, except that the Borrower shall not make any adjustments to the Conversion Rate if Lenders
participate (other than in the case of a share split or share combination or a tender or exchange offer), at the same time and upon the same terms as holders of the Common Shares and solely as a result of their capacities as Lenders hereunder, in
any of the transactions described in this Section&nbsp;13.4, without having to convert the Conversion Amount, as if it held a number of Common Shares equal to the Conversion Rate <I>multiplied by</I> the Conversion Amount <I>divided by</I> $1,000.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If the Borrower exclusively issues Common Shares as a dividend or distribution on shares of the Common Shares, or if the Borrower<B>
</B>effects a share split or share combination, the Conversion Rate shall be adjusted based on the following formula: </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g243622g0124171246184.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">where,</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately prior to the open of business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date of such dividend or distribution, or immediately prior to the open of business on the Effective
Date of such share split or share combination, as applicable;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the open of business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date or Effective Date;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OS<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of Common Shares outstanding immediately prior to the open of business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date or Effective Date (before giving effect to any such dividend, distribution, split or
combination); and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OS<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of Common Shares outstanding immediately after giving effect to such dividend, distribution, share split or share combination.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any adjustment made under this <U>Section</U><U></U><U>&nbsp;13.4(a)</U> shall become effective immediately
after the open of business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such dividend or distribution, or immediately after the open of business on the Effective Date for such share split or share combination, as applicable.
If any dividend or distribution of the type described in this <U>Section</U><U></U><U>&nbsp;13.4</U> is declared but not so paid or made, the Conversion Rate shall be immediately readjusted, effective as of the date the Board determines not to pay
such dividend or distribution, to the Conversion Rate that would then be in effect if such dividend or distribution had not been declared. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If the Borrower issues to all or substantially all holders of the Common Shares any rights, options or warrants (other than in connection
with a stockholder rights plan) entitling them, for a period of not more than 45 calendar days after the announcement date of such issuance, to subscribe for or purchase shares of the Common Shares at a price per share that is less than the average
of the Last Reported Sale Prices of the Common Shares for the ten consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement of such issuance, the Conversion Rate shall be increased based
on the following formula: </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g243622g0124171247950.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">where,</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately prior to the open of business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such issuance;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the open of business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OS<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of Common Shares outstanding immediately prior to the open of business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">X</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the total number of Common Shares issuable pursuant to such rights, options or warrants; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Y</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of Common Shares equal to the aggregate price payable to exercise such rights, options or warrants, divided by the average of the Last Reported Sale Prices of the Common Shares over the ten consecutive Trading Day period
ending on, and including, the Trading Day immediately preceding the date of announcement of the issuance of such rights, options or warrants.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any increase made under this <U>Section</U><U></U><U>&nbsp;13.4(b)</U> shall be made successively whenever any such rights,
options or warrants are issued and shall become effective immediately after the open of business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such issuance. To the extent that shares of the Common Shares are not delivered
after the expiration of such rights, options or warrants, the Conversion Rate shall be decreased to the Conversion Rate that would then be in effect had the increase with respect to the issuance of such rights, options or warrants been made on the
basis of delivery of only the number of Common Shares actually delivered. If such rights, options or warrants are not so issued, the Conversion Rate shall be decreased to the Conversion Rate that would then be in effect if such <FONT
STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such issuance had not occurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this <U>Section</U><U></U><U>&nbsp;13.4(b)</U>, in
determining whether any rights, options or warrants entitle the holders to subscribe for or purchase shares of the Common Shares at less than such average of the Last Reported Sale Prices of the Common Shares for the ten consecutive Trading Day
period ending on, and including, the Trading Day immediately preceding the date of announcement for such issuance, and in determining the aggregate offering price of such Common Shares, there shall be taken into account any consideration received by
the Borrower for such rights, options or warrants and any amount payable on exercise or conversion thereof, the value of such consideration, if other than cash, to be determined by the Borrower in good faith and in a commercially reasonable manner.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If the Borrower distributes shares of its Capital Stock, evidences of its indebtedness,
other assets or property of the Borrower or rights, options or warrants to acquire its Capital Stock or other securities, to all or substantially all holders of the Common Shares, excluding (i)&nbsp;dividends, distributions or issuances (including
share splits) as to which an adjustment was effected (or would be required to be effected, notwithstanding the 1%&nbsp;Exception in <U>Section</U><U></U><U>&nbsp;13.4(k)</U>) pursuant to <U>Section</U><U></U><U>&nbsp;13.4(a)</U> or
<U>Section</U><U></U><U>&nbsp;13.4(b)</U>, (ii)&nbsp;dividends or distributions paid exclusively in cash, as to which the provisions set forth in <U>Section</U><U></U><U>&nbsp;13.4(d)</U> shall apply, (iii)&nbsp;except as otherwise described below,
rights issued pursuant to a stockholder rights plan of the Borrower, (iv)&nbsp;distributions of Exchange Property in a Reorganization Event and (v)&nbsp;Spin-Offs, as to which the provisions set forth below in this
<U>Section</U><U></U><U>&nbsp;13.4(c)</U> shall apply (any of such shares of Capital Stock, evidences of indebtedness, other assets or property or rights, options or warrants to acquire Capital Stock or other securities, the &#147;<B>Distributed
Property</B>&#148;), then the Conversion Rate shall be increased based on the following formula: </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g243622g0124171246872.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">where:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">the Conversion Rate in effect immediately prior to the open of business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such distribution;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the open of business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SP<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Last Reported Sale Prices of the Common Shares over the ten consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT>
Date for such distribution; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FMV</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the fair market value (as determined by the Borrower in good faith and in a commercially reasonable manner) of the Distributed Property with respect to each outstanding share of the Common Shares on the <FONT
STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such distribution.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any increase made under the portion of this <U>Section</U><U></U><U>&nbsp;13.4(c</U><U>)</U> above shall become effective
immediately after the open of business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such distribution. If such distribution is not so paid or made, the Conversion Rate shall be decreased to the Conversion Rate that would then
be in effect if such distribution had not been declared. If the Borrower issues rights, options or warrants that are only exercisable on the occurrence of certain triggering events, then the Borrower shall not adjust the Conversion Rate pursuant to
the clauses above until the earliest of these triggering events occurs, and the Borrower shall readjust the Conversion Rate to the extent that any of these rights, options or warrants are not exercised before they expire. In the case of any
distribution of rights, options or warrants, to the extent any such rights, options or warrants expire unexercised, the Conversion Rate shall be immediately readjusted to the Conversion Rate that would then be in effect had the increase made for the
distribution of such rights, options or warrants been made on the basis of delivery of only the number of shares of the Common Shares actually delivered on exercise of such rights, options or warrants. Notwithstanding the foregoing, if
&#147;FMV&#148; (as defined above) is equal to or greater than &#147;SP<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB>&#148; (as defined above), in lieu of the foregoing increase, Lenders shall receive, in respect of each $1,000 of the
Conversion Amount then held, at the same time and on the same terms as holders of the Common Shares, the amount and kind of Distributed Property Lenders would have received if Lenders owned a number of Common Shares equal to the Conversion Rate in
effect on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for the distribution. If the Borrower determines the &#147;FMV&#148; (as defined above) of any distribution for purposes of this <U>Section</U><U></U><U>&nbsp;13.4(c)</U> by
reference to the actual or when-issued trading market for any securities, it shall in doing so consider the prices in such market over the same period used in computing the Last Reported Sale Prices of the Common Shares over the ten consecutive
Trading Day period ending on, and including, the Trading Day immediately preceding the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With respect to an adjustment pursuant to this <U>Section</U><U></U><U>&nbsp;13.4(c)</U> where there has been a payment of a dividend or other distribution on
the Common Shares of shares of Capital Stock of any class or series, or similar equity interest, of or relating to a Subsidiary or other business unit of the Borrower, that are, or, when issued, will be, listed or admitted for trading on a U.S.
national securities exchange (a &#147;<B><FONT STYLE="white-space:nowrap">Spin-Off</FONT></B>&#148;), the Conversion Rate shall be increased based on the following formula: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g243622g0124171248513.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">where,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">the Conversion Rate in effect immediately prior to the end of the Valuation Period;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the end of the Valuation Period;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FMV<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Last Reported Sale Prices of the Capital Stock or similar equity interest distributed to holders of the Common Shares applicable to one share of the Common Shares (determined by reference to the definition of Last
Reported Sale Price as set forth in Section&nbsp;14.1 as if references therein to Common Shares were to such Capital Stock or similar equity interest) over the first ten consecutive Trading Day period after, and including, the <FONT
STYLE="white-space:nowrap">Ex-Dividend</FONT> Date of the <FONT STYLE="white-space:nowrap">Spin-Off</FONT> (the &#147;<B>Valuation Period</B>&#148;); provided, that if there is no Last Reported Sale Price of the Capital Stock or similar equity
interest distributed to the holders of the Common Shares on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date, the &#147;Valuation Period&#148; shall be the first ten consecutive Trading Day period after, and including, the first Trading
Day such Last Reported Sale Price is available; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">MP<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Last Reported Sale Prices of the Common Shares over the Valuation Period.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The adjustment to the Conversion Rate under the preceding paragraph shall occur at the close of business on the last Trading
Day of the Valuation Period; <U>provided</U>, that if the relevant Conversion Date occurs during the Valuation Period, references to &#147;ten&#148; in the preceding paragraph shall be deemed to be replaced with such lesser number of Trading Days as
have elapsed from, and including, the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date of such <FONT STYLE="white-space:nowrap">Spin-Off</FONT> to, and including, the Conversion Date in determining the Conversion Rate. If any dividend or
distribution that constitutes a <FONT STYLE="white-space:nowrap">Spin-Off</FONT> is declared but not so paid or made, the Conversion Rate shall be immediately decreased, effective as of the date the Board determines not to pay or make such dividend
or distribution, to the Conversion Rate that would then be in effect if such dividend or distribution had not been declared or announced. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of
this <U>Section</U><U></U><U>&nbsp;13.4(c)</U> (and subject in all respect to Section&nbsp;14.11), rights, options or warrants distributed by the Borrower to all holders of the Common Shares entitling them to subscribe for or purchase shares of the
Borrower&#146;s Capital Stock, including Common Shares (either initially or under certain circumstances), which rights, options or warrants, until the occurrence of a specified event or events (a &#147;<B>Trigger Event</B>&#148;) (i)&nbsp;are deemed
to be transferred with such shares of the Common Shares, (ii)&nbsp;are not exercisable and (iii)&nbsp;are also issued in respect of future issuances of the Common Shares, shall be deemed not to have been distributed for purposes of this
<U>Section</U><U></U><U>&nbsp;13.4(c)</U> (and no adjustment to the Conversion Rate under this <U>Section</U><U></U><U>&nbsp;13.4(c)</U> shall be required) until the occurrence of the earliest Trigger Event, whereupon such rights, options or
warrants shall be deemed to have been distributed and an appropriate adjustment (if any is required) to the Conversion Rate shall be made under this <U>Section</U><U></U><U>&nbsp;13.4(c)</U>. If any such right, option or warrant, including any such
existing rights, options or warrants distributed prior to the Effective Date, are subject to events, on the occurrence of which such rights, options or warrants become exercisable to purchase different securities, evidences of indebtedness or other
assets, then the date of the occurrence of any and each such event shall be deemed to be the date of distribution and <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date with respect to new rights, options or warrants with such rights (in which
case the existing rights, options or warrants shall be deemed to terminate and expire on such date without exercise by any of the holders thereof). In addition, in the event of any distribution (or deemed distribution) of rights, options or
warrants, or any Trigger Event or other event (of the type described in the immediately preceding sentence) with respect thereto that was counted for purposes of calculating a distribution amount for which an adjustment to the Conversion Rate under
this <U>Section</U><U></U><U>&nbsp;13.4(c)</U> was made, (A)&nbsp;in the case of any such rights, options or warrants that shall all have been purchased without exercise by any holders thereof, on such final redemption or purchase (1)&nbsp;the
Conversion Rate shall be readjusted as if such rights, options or warrants had not been issued and (2)&nbsp;the Conversion Rate shall then again be readjusted to give effect to such distribution, deemed distribution or Trigger Event, as the case may
be, as though it were a cash distribution, equal to the per share </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
redemption or purchase price received by a holder or holders of Common Shares with respect to such rights, options or warrants (assuming such holder had retained such rights, options or
warrants), made to all holders of Common Shares as of the date of such redemption or purchase and (B)&nbsp;in the case of such rights, options or warrants that shall have expired or been terminated without exercise by any holders thereof, the
Conversion Rate shall be readjusted as if such rights, options and warrants had not been issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of
<U>Section</U><U></U><U>&nbsp;13.4(a)</U>, <U>Section</U><U></U><U>&nbsp;13.4(b)</U> and <U>Section</U><U></U><U>&nbsp;13.4(c)</U>, if any dividend or distribution to which this <U>Section</U><U></U><U>&nbsp;13.4(c)</U> is applicable also includes
one or both of: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) a dividend or distribution of Common Shares to which <U>Section</U><U></U><U>&nbsp;13.4(a)</U> is
applicable (a &#147;<B>Clause A Distribution</B>&#148;); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) a dividend or distribution of rights, options or warrants
to which <U>Section</U><U></U><U>&nbsp;13.4(b)</U> is applicable (a &#147;<B>Clause B Distribution</B>&#148;), </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">then, in either case, (1)&nbsp;such
dividend or distribution, other than the Clause A Distribution and/or Clause B Distribution, shall be deemed to be a dividend or distribution to which this <U>Section</U><U></U><U>&nbsp;13.4(c)</U> is applicable (a &#147;<B>Clause C
Distribution</B>&#148;) and any Conversion Rate adjustment required by this <U>Section</U><U></U><U>&nbsp;13.4(c)</U> with respect to such Clause C Distribution shall then be made and (2)&nbsp;the Clause A Distribution and/or Clause B Distribution
shall be deemed to immediately follow such Clause C Distribution and any Conversion Rate adjustment required by <U>Section</U><U></U><U>&nbsp;13.4(a)</U> and/or <U>Section</U><U></U><U>&nbsp;13.4(b)</U> with respect thereto shall then be made,
except that, if determined by the Borrower (I)&nbsp;the <FONT STYLE="white-space:nowrap">&#147;Ex-Dividend</FONT> Date&#148; of the Clause A Distribution and/or Clause B Distribution shall be deemed to be the
<FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date of the Clause C Distribution and (II)&nbsp;any Common Shares included in the Clause A Distribution and/or Clause B Distribution shall be deemed not to be &#147;outstanding immediately prior to
the open of business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date or Effective Date&#148; within the meaning of <U>Section</U><U></U><U>&nbsp;13.4(a)</U> or &#147;outstanding immediately prior to the open of business on such <FONT
STYLE="white-space:nowrap">Ex-Dividend</FONT> Date&#148; within the meaning of <U>Section</U><U></U><U>&nbsp;13.4(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(d) If any
cash dividend or distribution is made to all or substantially all holders of the Common Shares, the Conversion Rate shall be adjusted based on the following formula: </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g243622g0124171247341.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">where,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately prior to the open of business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such dividend or distribution;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the open of business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such dividend or distribution;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SP<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Last Reported Sale Price of the Common Shares on the Trading Day immediately preceding the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such dividend or distribution; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">C</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the amount in cash per share the Borrower distributes to all or substantially all holders of the Common Shares.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any increase pursuant to this <U>Section</U><U></U><U>&nbsp;13.4(d)</U> shall become effective immediately after the open of
business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such dividend or distribution. If such dividend or distribution is not so paid, the Conversion Rate shall be decreased, effective as of the date the Board determines not to
make or pay such dividend or distribution, to be the Conversion Rate that would then be in effect if such dividend or distribution had not been declared. Notwithstanding the foregoing, if &#147;C&#148; (as defined above) is equal to or greater than
&#147;SP<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB>&#148; (as defined above), in lieu of the foregoing increase, Lenders shall receive, for each $1,000 of the Conversion Amount, at the same time and on the same terms as holders of
shares of the Common Shares, the amount of cash that Lenders would have received if Lender owned a number of Common Shares equal to the Conversion Rate in effect on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such cash dividend
or distribution. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) If the Borrower or any of its Subsidiaries make a payment in respect of a tender or
exchange offer for the Common Shares that is subject to the then-applicable tender offer rules under the Exchange Act, other than an <FONT STYLE="white-space:nowrap">odd-lot</FONT> tender offer, to the extent that the cash and value of any other
consideration included in the payment per share of the Common Shares exceeds the average of the Last Reported Sale Prices of the Common Shares over the ten consecutive Trading Day period commencing on, and including, the Trading Day next succeeding
the last date on which tenders or exchanges may be made pursuant to such tender or exchange offer, the Conversion Rate shall be increased based on the following formula: </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g243622g0124171249075.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">where,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately prior to the close of business on the tenth Trading Day immediately following, and including, the Trading Day next succeeding the date such tender or exchange offer expires;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the close of business on the tenth Trading Day immediately following, and including, the Trading Day next succeeding the date such tender or exchange offer expires;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the aggregate value of all cash and any other consideration (as determined by the Borrower in good faith and in a commercially reasonable manner) paid or payable for Common Shares purchased in such tender or exchange
offer;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OS<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of Common Shares outstanding immediately prior to the date such tender or exchange offer expires (prior to giving effect to the purchase of all Common Shares accepted for purchase or exchange in such tender or exchange
offer);</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OS<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of Common Shares outstanding immediately after the date such tender or exchange offer expires (after giving effect to the purchase of all Common Shares accepted for purchase or exchange in such tender or exchange offer);
and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SP<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Last Reported Sale Prices of the Common Shares over the ten consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the date such tender or exchange offer expires.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The adjustment to the Conversion Rate under this <U>Section</U><U></U><U>&nbsp;13.4(e)</U> shall occur at the close of
business on the tenth Trading Day immediately following, and including, the Trading Day immediately following the expiration date of such tender or exchange offer expires; provided that if the relevant Conversion Date occurs during the ten Trading
Days immediately following, and including, the Trading Day next succeeding the expiration date of any tender or exchange offer, references to &#147;ten&#148; or &#147;tenth&#148; in the preceding paragraph shall be deemed replaced with such lesser
number of Trading Days as have elapsed from, and including, the Trading Day next succeeding the date that such tender or exchange offer expires to, and including, the Conversion Date in determining the Conversion Rate. For the avoidance of doubt, no
adjustment under this <U>Section</U><U></U><U>&nbsp;13.4(e)</U> shall be made if such adjustment would result in a decrease in the Conversion Rate (other than, for the avoidance of doubt, any readjustment described in the immediately succeeding
paragraph). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Borrower or one of its Subsidiaries is obligated to purchase the Common Shares pursuant to any such tender or exchange offer described
in this <U>Section</U><U></U><U>&nbsp;13.4(e)</U> but the Borrower or such Subsidiary is permanently prevented by applicable law from effecting any such purchase or all such purchases are rescinded, the Conversion Rate shall be decreased to be the
Conversion Rate that would then be in effect if such tender or exchange offer had not been made or had been made only in respect of the purchases that have been effected. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Notwithstanding this <U>Section</U><U></U><U>&nbsp;13.4</U> or any other provision of
this Agreement, if (i)&nbsp;a Conversion Rate adjustment becomes effective on any <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date, (ii)&nbsp;Lenders have converted their Conversion Amount and the Conversion Date for such conversion occurs
on or after such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date and on or prior to the related Record Date, (iii)&nbsp;the consideration due on such conversion includes any whole Common Shares based on a Conversion Rate that is adjusted
for such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date and (iv)&nbsp;such Common Shares would be entitled to participate in such dividend, distribution, or other event giving rise to such adjustment, then the Conversion Rate adjustment
relating to such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date shall not be made for such conversion, and, instead, the Common Shares issuable on conversion on an unadjusted basis shall be entitled to participate in the related dividend,
distribution or other event giving rise to such adjustment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Except as stated herein, the Borrower shall not adjust the Conversion Rate
for the issuance of shares of the Common Shares or any securities convertible into or exchangeable for shares of the Common Shares or the right to purchase shares of the Common Shares or such convertible or exchangeable securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) In addition to those adjustments required by <U>Sections 13.4(a)</U>, <U>(b)</U>, <U>(c)</U>, <U>(d)</U> and <U>(e)</U>, and to the extent
permitted by applicable law and subject to the applicable rules of any exchange on which any of the Borrower&#146;s securities are then listed, the Borrower from time to time may increase the Conversion Rate by any amount for a period of at least 20
Business Days if the Board determines that such increase would be in the Borrower&#146;s best interest. In addition, to the extent permitted by applicable law and subject to the applicable rules of any exchange on which any of the Borrower&#146;s
securities are then listed, the Borrower may (but is not required to) increase the Conversion Rate to avoid or diminish income tax to holders of Common Shares or rights to purchase Common Shares in connection with a dividend or distribution of
Common Shares (or rights to acquire Common Shares) or similar event. Whenever the Conversion Rate is increased pursuant to either of the preceding two sentences, the Borrower shall deliver to Lender a notice of the increase at least 15 days prior to
the date the increased Conversion Rate takes effect, and such notice shall state the increased Conversion Rate and the period during which it will be in effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) If the Borrower has a stockholder rights plan in effect on conversion of any portion of the Conversion Amount, each share of Common Shares,
if any, issued on such conversion shall be entitled to receive the appropriate number of rights, if any, and the certificates representing the Common Shares issued on such conversion shall bear such legends, if any, in each case as may be provided
by the terms of any such stockholder rights plan, as the same may be amended from time to time. However, if, prior to any conversion of any portion of the Conversion Amount, the rights have separated from the Common Shares in accordance with the
provisions of the applicable stockholder rights plan, the Conversion Rate shall be adjusted at the time of separation as if the Borrower distributed to all or substantially all holders of the Common Shares Distributed Property as provided in
<U>Section</U><U></U><U>&nbsp;13.4(</U><U>i</U><U>)</U>, subject to readjustment in the event of the expiration, termination or redemption of such rights. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Notwithstanding anything to the contrary in this <U>Section</U><U></U><U>&nbsp;13.4(j)</U>, the Conversion Rate shall not be adjusted: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) on the issuance of Common Shares at a price below the Initial Company Share Price or otherwise, other than any such issuance described in
<U>Section</U><U></U><U>&nbsp;13.4(a)</U>, <U>(b)</U> or <U>(c)</U>; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) on the issuance of any Common Shares pursuant to any present or
future plan providing for the reinvestment of dividends or interest payable on the Borrower&#146;s securities and the investment of additional optional amounts in Common Shares under any plan; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) on the issuance of any Common Shares or options or rights to purchase those shares pursuant to any present or future employee, director
or consultant benefit or incentive plan (including pursuant to any evergreen plan) or program of or assumed by the Borrower or any of the Borrower&#146;s Subsidiaries or in connection with any such shares withheld by the Borrower for tax withholding
purposes; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) on the issuance of any Common Shares pursuant to any option, warrant, right or
exercisable, exchangeable or convertible security not described in clause&nbsp;(ii) of this subsection and outstanding as of the Effective Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) for a tender offer by any party other than a tender offer by the Borrower or one or more of the Borrower&#146;s Subsidiaries as described
in <U>Section</U><U></U><U>&nbsp;13.4(e)</U>; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) on the repurchase of any shares of the Common Shares pursuant to an open-market share
repurchase program or other <FONT STYLE="white-space:nowrap">buy-back</FONT> transaction (including, without limitation, through any structured or derivative transactions such as accelerated share repurchase transactions or similar forward
derivatives), or other <FONT STYLE="white-space:nowrap">buy-back</FONT> transaction, that is not a tender offer or exchange offer of the nature described under <U>Section</U><U></U><U>&nbsp;13.4(e)</U>; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) solely for a change in the par value (or lack of par value) of the Common Shares; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) for accrued and unpaid interest, if any. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) The Borrower shall not adjust the Conversion Rate pursuant to the clauses above unless the adjustment would result in a change of at least
1% in the then effective Conversion Rate; <U>provided</U>, that the Borrower shall carry forward any adjustment to the Conversion Rate that the Borrower would otherwise have to make and take that adjustment into account in any subsequent adjustment.
Notwithstanding the foregoing, all such carried-forward adjustments shall be made with respect to the Conversion Amount (i)&nbsp;in connection with any subsequent adjustment to the Conversion Rate of at least 1% of the Conversion Rate and
(ii)&nbsp;regardless of whether the aggregate adjustment is less than 1% of the Conversion Rate, on the Conversion Date, in each case, unless the adjustment has already been made. The provisions described above in this
<U>Section</U><U></U><U>&nbsp;13.4(k)</U> are referred to as the &#147;<B>1% </B><B>Exception</B>&#148;. All calculations and other determinations under this <U>Section</U><U></U><U>&nbsp;13</U> shall be made by the Borrower and shall be made to the
nearest 1/10,000th of a share. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Whenever the Conversion Rate is adjusted as herein provided, the Borrower shall promptly deliver to
Lenders an Officers&#146; Certificate setting forth the Conversion Rate after such adjustment and setting forth a brief statement of the facts requiring such adjustment. Failure to deliver such notice shall not affect the legality or validity of any
such adjustment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) For purposes of this <U>Section</U><U></U><U>&nbsp;13</U> the number of Common Shares at any time outstanding shall
not include Common Shares held in the treasury of the Borrower so long as the Borrower does not pay any dividend or make any distribution on Common Shares held in the treasury of the Borrower, but shall include Common Shares issuable in respect of
scrip certificates issued in lieu of fractions of Common Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.5 Reorganization Events. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Reorganization Events</U>. In the event of: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) any reclassification, statutory exchange, merger, consolidation or other similar business combination of the Borrower with or into another
Person, in each case, pursuant to which at least a majority of the Common Shares is changed or converted into, or exchanged for, cash, securities or other property of the Borrower or another Person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) any sale, transfer, lease or conveyance to another Person of all or substantially all of the consolidated assets of the Borrower and its
Subsidiaries, taken as a whole, in each case pursuant to which the Common Shares are converted into cash, securities or other property; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) any statutory exchange of securities of the Borrower with another Person (other than in connection with a merger or acquisition) or
reclassification, recapitalization or reorganization of the Common Shares into other securities; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(each, a &#147;<B>Reorganization Event</B>&#148;), the Conversion Amount outstanding immediately prior to
such Reorganization Event (to the extent Lenders have not elected a Lender Repurchase Right in accordance with Section&nbsp;13.5(c)(ii)) shall, without the consent of Lenders and subject to Section&nbsp;13.5(d), shall automatically become
convertible into, in accordance with Section&nbsp;13.2, the number, kind and amount of securities, cash and other property (the &#147;<B>Exchange Property</B>&#148;) (without any interest on such Exchange Property) that Lenders would have received
in such Reorganization Event had Lenders converted their Conversion Amount into the applicable number of Common Shares immediately prior to the effective date of the Reorganization Event using the Conversion Rate applicable immediately prior to the
effective date of the Reorganization Event; provided, that the foregoing shall not apply if Lender is a Person with which the Borrower consolidated or into which the Borrower merged or which merged into the Borrower or to which such sale or transfer
was made, as the case may be (any such Person, a &#147;<B>Constituent Person</B>&#148;), or an Affiliate of a Constituent Person, to the extent such Reorganization Event provides for different treatment of Common Shares held by such Constituent
Persons or such Affiliate thereof. If the kind or amount of securities, cash and other property receivable on such Reorganization Event is not the same for each share of Common Shares held immediately prior to such Reorganization Event by a Person
(other than a Constituent Person or an Affiliate thereof), then for the purpose of this Section&nbsp;13.5(a), the kind and amount of securities, cash and other property receivable on conversion following such Reorganization Event shall be deemed to
be the weighted average of the types and amounts of consideration received by the holders of Common Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Successive
Reorganization Events</U>. The above provisions of this Section&nbsp;13.5 shall similarly apply to successive Reorganization Events and the provisions of Section&nbsp;13.4 shall apply to any shares of Capital Stock (as though such Capital Stock were
Common Shares) received by the holders of the Common Shares in any such Reorganization Event. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Reorganization Event Notice; Lender
Repurchase Right</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Borrower (or any successor) shall, no less than 20 days prior to the anticipated effective date of any
Reorganization Event, provide written notice to Lenders of such anticipated occurrence of such event and of the kind and amount of the cash, securities or other property that constitutes the Exchange Property (the &#147;<B>Reorganization Event
Notice</B>&#148;); <I>provided</I>, nothing in this Section&nbsp;13.5(c) shall require the Borrower to deliver such notice to Lenders prior to the public announcement of such anticipated Reorganization Event. Failure to deliver such notice shall not
affect the operation of this Section&nbsp;13.5. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Upon receipt of the Reorganization Event Notice, Lenders will have the right to
require the Borrower to repurchase the Loan (the &#147;<B>Lender Repurchase Right</B>&#148;) at a repurchase price equal to (i) 100% of the Outstanding Principal Amount, <I>plus</I> (ii)&nbsp;accrued and unpaid interest to, but excluding, the
effective date of the Reorganization Event (the &#147;<B>Repurchase Price</B>&#148;). To elect the Lender Repurchase Right, the Lenders shall notify Borrower of such election in writing at least three Business Days prior to the later of (i)&nbsp;the
anticipated effective date of the Reorganization Event specified in the Reorganization Event Notice, or (ii)&nbsp;the actual effective date of such Reorganization Event. To the extent Lenders exercises their Lender Repurchase Right, payment of the
Repurchase Price shall be made to Lenders on the effective date of the Reorganization Event. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Reorganization Event Agreements</U>.
The Borrower shall not enter into any agreement for a transaction constituting a Reorganization Event unless (i)&nbsp;such agreement provides for or does not interfere with or prevent (as applicable) conversion of the Conversion Amount into the
Exchange Property in a manner that is consistent with and gives effect to this Section&nbsp;13.5 and (ii)&nbsp;to the extent that the Borrower is not the surviving corporation in such Reorganization Event or shall be dissolved in connection with
such Reorganization Event, proper provision shall be made in the agreements governing such Reorganization Event for the conversion of the Conversion Amount into stock of the Person surviving such Reorganization Event or such other continuing entity
in such Reorganization Event. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.6 Certain Covenants. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Borrower covenants that all Common Shares issued upon conversion of the Conversion Amount will be fully paid and <FONT
STYLE="white-space:nowrap">non-assessable</FONT> by the Borrower and free from all taxes, liens and charges with respect to the issue thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Borrower covenants that, if any Common Shares to be provided for the purpose of
conversion of the Conversion Amount hereunder require registration with or approval of any governmental authority under any federal or state law before such Common Shares may be validly issued upon conversion, the Borrower will, to the extent then
permitted by the rules and interpretations of the SEC, secure such registration or approval, as the case may be. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Borrower further
covenants that if at any time the Common Shares shall be listed on any national securities exchange or automated quotation system the Borrower will list and keep listed, so long as the Common Shares shall be so listed on such exchange or automated
quotation system, any Common Shares issuable upon conversion of the Conversion Amount. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.7</B> <B>Investor Representations.</B> Each
Lender represents and warrants as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Such Lender is an &#147;accredited investor&#148; within the meaning of Regulation D of the
Securities Act and is able to bear the risk of its investment in the Preferred Shares and Common Shares.&nbsp;Such Lender has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of
the conversion of the Conversion Amount into Preferred Shares and Common Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Such Lender and its Representatives has been
furnished with (i)&nbsp;materials relating to the business, finances and operations of Borrower, (ii)&nbsp;materials relating to the Preferred Shares and Common Shares and (iii)&nbsp;materials relating to the Loan Agreement, in each case, that have
been requested by such Lender.&nbsp;Such Lender and its Representatives have been afforded the opportunity to ask questions of Borrower.&nbsp;Neither such inquiries nor any other due diligence investigations conducted at any time by such Lender and
its Representatives shall modify, amend or affect such Lender&#146;s right (i)&nbsp;to rely on Borrower&#146;s representations and warranties contained in Section&nbsp;5 above or (ii)&nbsp;to indemnification or any other remedy based on, or with
respect to the accuracy or inaccuracy of, or compliance with, the representations, warranties, covenants and agreements in this Agreement.&nbsp;Each Lender understands that its conversion of the Conversion Amount into Preferred Shares and Common
Shares involves a high degree of risk.&nbsp;Such Lender has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to making the Loan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Such Lender understands that any certificate or book-entry position evidencing Preferred Shares and Common Shares will bear the restrictive
legend set forth in the Section&nbsp;12.17 or the certificate of designations for the Preferred Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Such Lender is acquiring the
Loan for its own account, the account of its Affiliates, or the accounts of clients for whom such Lender exercises discretionary investment authority (all of whom such Lender hereby represents and warrants are &#147;accredited investors&#148; within
the meaning of Regulation D of the Securities Act), not as a nominee or agent, and not with a view to distribution in violation of any securities Laws.&nbsp;Such Lender has been advised and understands that the conversion of the Conversion Amount
into Preferred Shares or Common Shares, as applicable, will not be registered under the Securities Act or under the &#147;blue sky&#148; laws of any jurisdiction and may be resold only if registered pursuant to the requirements of the Securities Act
(or if eligible, pursuant to Rule 144 promulgated under the Securities Act or pursuant to another available exemption from the registration requirements of the Securities Act).</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Such Lender understands that there is no public trading market for the Preferred Shares, that none is expected to develop and that the
Preferred Shares shall be held indefinitely unless and until the Preferred Shares are registered under the Securities Act or an exemption from registration is available.&nbsp;Such Lender has been advised of and is knowledgeable with respect to the
provisions of Rule 144 promulgated under the Securities Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The obligations of Lender under this Agreement are several and not joint
with the obligations of (i)&nbsp;the other Lender under this Agreement and (ii)&nbsp;any lender under that certain Loan Agreement between <B>VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS <FONT STYLE="white-space:nowrap">SUB-MASTER</FONT> LP</B>,
a Cayman Islands exempted limited partnership, <B>VIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LP</B>, a Cayman Islands exempted limited partnership and Borrower dated and effective as of January&nbsp;23, 2022 (the &#147;<B>Viking Loan
Agreement</B>&#148;), and Lender shall not be responsible in any way for the performance of the obligations of any lender under the Viking Loan Agreement. Nothing contained herein, and no action taken by any Lender
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
pursuant hereto or any lender pursuant to the Viking Loan Agreement, shall be deemed to constitute a partnership, an association, a joint venture or any other kind of entity among Lender and any
lender under the Viking Loan Agreement, or create a presumption that Lender and any lender under the Viking Loan Agreement are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by this
Agreement or the Viking Loan Agreement. Lender shall be entitled to independently protect and enforce its rights, including the rights arising out of this Agreement, and it shall not be necessary for any lender under the Viking Loan Agreement to be
joined as an additional party in any proceeding for such purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Other than with its Affiliates, Lenders are not a member of a
&#147;group&#148; (as such term is used in Section&nbsp;13(d) of the Exchange Act) of Persons with respect to any securities of the Company (it being understood that in no event will the lenders under the Viking Loan Agreement or any of their
Affiliates be deemed to be Affiliates of Lenders for purposes of this Agreement). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14 <U>DEFINITIONS</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14.1</B> <B>Definitions</B><B>.</B> As used in the Loan Documents, the word &#147;shall&#148; is mandatory, the word &#147;may&#148; is
permissive, the word &#147;or&#148; is not exclusive, the words &#147;includes&#148; and &#147;including&#148; are not limiting, the singular includes the plural, and numbers denoting amounts that are set off in brackets are negative. As used in
this Agreement, the following capitalized terms have the following meanings: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>2014 Notes</B>&#148; are (i)&nbsp;the existing
unsecured Indebtedness issued under that certain Indenture between Borrower as issuer and U.S. Bank National Association as Trustee dated as of February&nbsp;4, 2014, and (ii)&nbsp;that certain First Supplemental Indenture between Borrower as issuer
and U.S. Bank National Association as Trustee dated as of February&nbsp;4, 2014. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>2019 Notes</B>&#148; are the existing unsecured
Indebtedness issued under that certain Indenture between Borrower as issuer and U.S. Bank National Association as Trustee dated as of November&nbsp;22, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Affiliate</B>&#148; is, with respect to any Person, each other Person that owns or controls directly or indirectly the Person, any
Person that controls or is controlled by or is under common control with the Person, and each of that Person&#146;s senior executive officers, directors, partners and, for any Person that is a limited liability company, that Person&#146;s managers
and members. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Agreement</B>&#148; is defined in the preamble hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Interest Rate</B>&#148; means: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="24%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Applicable&nbsp;Interest&nbsp;Rate</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">From and including the Effective Date to but excluding March&nbsp;1, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">From and including March&nbsp;1, 2022 to but excluding June&nbsp;1, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">From and including June&nbsp;1, 2022 to but excluding September&nbsp;1, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">From and including September&nbsp;1, 2022 and thereafter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Authorized Signer</B>&#148; is any individual listed in Borrower&#146;s Borrowing Resolution who is
authorized to execute the Loan Documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Board</B>&#148; is Borrower&#146;s board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Borrower</B>&#148; is defined in the preamble hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Borrower&#146;s Books</B>&#148; are all Borrower&#146;s books and records including ledgers, federal and state tax returns, records
regarding Borrower&#146;s assets or liabilities, business operations or financial condition, and all computer programs or storage or any equipment containing such information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Borrowing Resolutions</B>&#148; are, with respect to any Person, those resolutions adopted by such Person&#146;s board of directors
(and, if required under the terms of such Person&#146;s Operating Documents, stockholders) and delivered by such Person to Lender approving the Loan Documents to which such Person is a party and the transactions contemplated thereby, together with a
certificate executed by its secretary on behalf of such Person certifying (a)&nbsp;such Person has the authority to execute, deliver, and perform its obligations under each of the Loan Documents to which it is a party, (b)&nbsp;that set forth as a
part of or attached as an exhibit to such certificate is a true, correct, and complete copy of the resolutions then in full force and effect authorizing and ratifying the execution, delivery, and performance by such Person of the Loan Documents to
which it is a party, (c)&nbsp;the name(s) of the Person(s) authorized to execute the Loan Documents, on behalf of such Person, together with a sample of the true signature(s) of such Person(s), and (d)&nbsp;that Lender may conclusively rely on such
certificate unless and until such Person shall have delivered to Lender a further certificate canceling or amending such prior certificate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Business Day</B>&#148; is any day that is not a Saturday, Sunday or a day on which commercial banks are required to close in New
York, New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Capital Stock</B>&#148; means, for any entity, any and all shares, interests, rights to purchase, warrants,
options, participations or other equivalents of or interests in (however designated) stock issued by that entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Cash
Equivalents</B>&#148; means (a)&nbsp;marketable direct obligations issued or unconditionally guaranteed by the United States or any agency or any State thereof having maturities of not more than one (1)&nbsp;year from the date of acquisition;
(b)&nbsp;commercial paper maturing no more than one (1)&nbsp;year after its creation and having the highest rating from either Standard&nbsp;&amp; Poor&#146;s Ratings Group or Moody&#146;s Investors Service, Inc.; and (c)&nbsp;money market funds at
least ninety-five percent (95%) of the assets of which constitute Cash Equivalents of the kinds described in clauses (a)&nbsp;through (b) of this definition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>CFC</B>&#148; means a &#147;controlled foreign corporation&#148; within the meaning of Section&nbsp;957 of the Internal Revenue Code.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change in Control</B>&#148; means (a)&nbsp;at any time, any &#147;person&#148; or &#147;group&#148; (as such terms are used in
Sections 13(d) and 14(d) of the Exchange Act), shall become, or obtain rights (whether by means of warrants, options or otherwise) to become, the &#147;beneficial owner&#148; (as defined in Rules <FONT STYLE="white-space:nowrap">13(d)-3</FONT> and
13(d) 5 under the Exchange Act), directly or indirectly, of forty percent (40%) or more of the ordinary voting power for the election of directors of Borrower (determined on a fully diluted basis); (b) during any period of twelve
(12)&nbsp;consecutive months, a majority of the members of the board of directors or other equivalent governing body of Borrower cease to be composed of individuals (i)&nbsp;who were members of that board or equivalent governing body on the first
day of such period, (ii)&nbsp;whose election or nomination to that board or equivalent governing body was approved by individuals referred to in clause (i)&nbsp;above constituting at the time of such election or nomination at least a majority of
that board or equivalent governing body or (iii)&nbsp;whose election or nomination to that board or other equivalent governing body was approved by individuals referred to in clauses (i)&nbsp;and (ii) above constituting at the time of such election
or nomination at least a majority of that board or equivalent governing body; (c)&nbsp;at any time, Borrower shall cease to own and control, of record and beneficially, directly or indirectly, one hundred percent (100%) of each class of outstanding
capital stock of each Subsidiary of Borrower (other than director&#146;s qualifying shares) free and clear of all Liens (other than Permitted Liens); or (d)&nbsp;the occurrence of any &#147;Fundamental Change&#148; under the applicable Indenture
governing Permitted Convertible Indebtedness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Claims</B>&#148; is defined in Section&nbsp;12.3. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Clause A Distribution</B>&#148; is defined in Section&nbsp;13.4(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Clause B Distribution</B>&#148; is defined in Section&nbsp;13.4(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Clause C Distribution</B>&#148; is defined in Section&nbsp;13.4(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Code</B>&#148; is the Uniform Commercial Code, as the same may, from time to time, be enacted and in effect in the State of New York;
provided, that, to the extent that the Code is used to define any term herein or in any Loan Document and such term is defined differently in different Articles or Divisions of the Code, the definition of such term contained in Article or Division 9
shall govern. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Common Shares</B>&#148; mean shares of common stock, $0.001 per value per share of the Borrower. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Constituent Person</B>&#148; is defined in Section&nbsp;13.5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Contingent Obligation</B>&#148; is, for any Person, any direct or indirect liability, contingent or not, of that Person for
(a)&nbsp;any indebtedness, lease, dividend, letter of credit or other obligation of another such as an obligation, in each case, directly or indirectly guaranteed, endorsed, co made, discounted or sold with recourse by that Person, or for which that
Person is directly or indirectly liable; (b)&nbsp;any obligations for undrawn letters of credit for the account of that Person; and (c)&nbsp;all obligations from any interest rate, currency or commodity swap agreement, interest rate cap or collar
agreement, or other agreement or arrangement designated to protect a Person against fluctuation in interest rates, currency exchange rates or commodity prices; but &#147;Contingent Obligation&#148; does not include endorsements in the ordinary
course of business. The amount of a Contingent Obligation is the stated or determined amount of the primary obligation for which the Contingent Obligation is made or, if not determinable, the maximum reasonably anticipated liability for it
determined by the Person in good faith; but the amount may not exceed the maximum of the obligations under any guarantee or other support arrangement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Conversion Amount</B>&#148; means the Outstanding Principal Amount plus all accrued and unpaid interest as of the Conversion Date.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Conversion Cap</B>&#148; means at all times prior to 60 days prior to the Maturity Date, a number of shares of Common Shares not
to exceed 9.5% of the number of Common Shares outstanding as of the date hereof (as determined pursuant to Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Securities Exchange Act of 1934, as amended), and at all times, at the
Lender&#146;s election, a number of Common Shares not to exceed (collectively for such Lender, together with Lenders that are Affiliates) 19.99% of the number of Common Shares outstanding (calculated in accordance with the listing standards of the
Nasdaq Stock Market Rule 5635(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Conversion Date</B>&#148; is defined in Section&nbsp;13.3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Conversion Notice</B>&#148; is defined in Section&nbsp;13.3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Conversion Rate</B>&#148; means, in respect of conversion into Common Shares, an initial conversion rate of 352.1126 Common Shares
(subject to adjustment as provided herein) per $1,000 Conversion Amount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Copyrights</B>&#148; are any and all copyright rights,
copyright applications, copyright registrations and like protections in each work of authorship and derivative work thereof, whether published or unpublished and whether or not the same also constitutes a trade secret. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Distributed Property</B>&#148; is defined in Section&nbsp;13.4(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Division</B>&#148; means, in reference to any Person which is an entity, the division of such Person into two (2)&nbsp;or more
separate Persons, with the dividing Person either continuing or terminating its existence as part of such division, including, without limitation, as contemplated under <FONT STYLE="white-space:nowrap">Section&nbsp;18-217</FONT> of the Delaware
Limited Liability Company Act for limited liability companies formed under Delaware law, or any analogous action taken pursuant to any other applicable law with respect to any corporation, limited liability company, partnership or other entity. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Dollars</B>,&#148; &#147;<B>dollars</B>&#148; or use of the sign &#147;$&#148;
means only lawful money of the United States and not any other currency, regardless of whether that currency uses the &#147;$&#148; sign to denote its currency or may be readily converted into lawful money of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Domestic Subsidiary</B>&#148; means a Subsidiary organized under the laws of the United States or any state or territory thereof or
the District of Columbia (excluding any FSHCO). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Effective Date</B>&#148; is defined in the preamble hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Equipment</B>&#148; is all &#147;<B>equipment</B>&#148; as defined in the Code with such additions to such term as may hereafter be
made, and includes without limitation all machinery, fixtures, goods, vehicles (including motor vehicles and trailers), and any interest in any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>ERISA</B>&#148; is the Employee Retirement Income Security Act of 1974, and its regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Event of Default</B>&#148; is defined in Section&nbsp;8. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Exchange Act</B>&#148; is the Securities Exchange Act of 1934, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Exchange Property</B>&#148; is defined in Section&nbsp;13.5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Excluded Taxes</B>&#148; means any of the following Taxes imposed on or with respect to the Lender or required to be withheld or
deducted from a payment to the Lender, (a)&nbsp;Taxes imposed on or measured by net income (however denominated), franchise Taxes, and branch profits Taxes, in each case, (i)&nbsp;imposed as a result of the Lender being organized under the laws of,
or having its principal office or, in the case of any Lender, its applicable lending office located in, the jurisdiction imposing such Tax (or any political subdivision thereof) or (ii)&nbsp;that are Other Connection Taxes, (b)&nbsp;in the case of a
Lender, withholding Taxes imposed on amounts payable to or for the account of such Lender with respect to an applicable interest in a Loan pursuant to a law in effect on the date on which (i)&nbsp;such Lender acquires such interest in the Loan or
(ii)&nbsp;such Lender changes its lending office, except in each case to the extent that, pursuant to Section&nbsp;2.7, amounts with respect to such Taxes were payable either to such Lender&#146;s assignor immediately before such Lender became a
party hereto or to such Lender immediately before it changed its lending office, (c)&nbsp;Taxes attributable to a Lender&#146;s failure to provide tax forms pursuant to Section&nbsp;2.7, and (d)&nbsp;any withholding Taxes imposed under FATCA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date</B>&#148; means the first date on which Common Shares trade on the
applicable exchange or in the applicable market, regular way, without the right to receive the issuance, dividend or distribution in question, from the Borrower or, if applicable, from the seller of Common Shares on such exchange or market (in the
form of due bills or otherwise) as determined by such exchange or market. For the avoidance of doubt, any alternative trading convention on the applicable exchange or market in respect of Common Shares under a separate ticker symbol or CUSIP number
shall not be considered &#147;regular way&#148; for the purposes of this definition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>FATCA</B>&#148; means Sections 1471 through
1474 of the Internal Revenue Code of 1986, as amended, as of the date of this Agreement (or any amended or successor version), any current or future regulations or official interpretations thereof, any agreements entered into pursuant to
Section&nbsp;1471(b)(1) of the Code and any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement, treaty or convention among Governmental Authorities and implementing such Sections of the Internal
Revenue Code of 1986, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Funding Date</B>&#148; means the date on which the Loan has been made pursuant to
Section&nbsp;3.4(b) of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>FSHCO</B>&#148; means any Subsidiary organized under the laws of any political
subdivision of the United States (including any disregarded entity for U.S. federal income tax purposes), substantially all of the assets of which consist of, directly or indirectly, equity securities of one or more CFCs or Indebtedness of such
CFCs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>GAAP</B>&#148; is generally accepted accounting principles set forth in the
opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other Person
as may be approved by a significant segment of the accounting profession, which are applicable to the circumstances as of the date of determination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Governmental Approval</B>&#148; is any consent, authorization, approval, order, license, franchise, permit, certificate,
accreditation, registration, filing or notice, of, issued by, from or to, or other act by or in respect of, any Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Governmental Authority</B>&#148; is any nation or government, any state or other political subdivision thereof, any agency,
authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative functions of or pertaining to government, any securities exchange and any
self-regulatory organization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Guarantor</B>&#148; is any Person providing a Guaranty in favor of Lender. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Guaranty</B>&#148; is any guarantee of all or any part of the Obligations, as the same may from time to time be amended, restated,
modified or otherwise supplemented. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Indebtedness</B>&#148; is (a)&nbsp;indebtedness for borrowed money or the deferred price of
property or services, such as reimbursement and other obligations for surety bonds and letters of credit, (b)&nbsp;obligations evidenced by notes, bonds, debentures or similar instruments, (c)&nbsp;capital lease obligations, and (d)&nbsp;Contingent
Obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Indemnified Person</B>&#148; is defined in Section&nbsp;12.3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Indemnified Taxes</B>&#148; means (a)&nbsp;Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on
account of any obligation of the Borrower under any Loan Document and (b)&nbsp;to the extent not otherwise described in (a), Other Taxes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Indenture</B>&#148; means each of (i)&nbsp;that certain Indenture between Borrower as issuer and U.S. Bank National Association as
Indenture Trustee dated as of November&nbsp;22, 2019 and (ii)&nbsp;the Indenture between Borrower as issuer and U.S. Bank National Association as Indenture Trustee dated as of February&nbsp;4, 2014, as supplemented by that certain First Supplemental
Indenture between Borrower as issuer and U.S. Bank National Association as Indenture Trustee dated as of February&nbsp;4, 2014. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Insolvency Proceeding</B>&#148; is any proceeding by or against any Person under the United States Bankruptcy Code, or any other
bankruptcy or insolvency law, including assignments for the benefit of creditors, compositions, extensions generally with its creditors, or proceedings seeking reorganization, arrangement, or other relief. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Intellectual Property</B>&#148; means, with respect to any Person, all of such Person&#146;s right, title, and interest in and to the
following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) its Copyrights, Trademarks and Patents; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) any and all trade secrets and trade secret rights, including, without limitation, any rights to unpatented inventions, <FONT
STYLE="white-space:nowrap">know-how</FONT> and operating manuals; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) any and all source code; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) any and all design rights which may be available to such Person; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) any and all claims for damages by way of past, present and future infringement of any of the foregoing, with the right, but not the
obligation, to sue for and collect such damages for said use or infringement of the Intellectual Property rights identified above; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) all amendments, renewals and extensions of any of the Copyrights, Trademarks or Patents.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Inventory</B>&#148; is all &#147;<B>inventory</B>&#148; as defined in the Code in effect on the date hereof with such additions
to such term as may hereafter be made, and includes without limitation all merchandise, raw materials, parts, supplies, packing and shipping materials, work in process and finished products, including without limitation such inventory as is
temporarily out of Borrower&#146;s custody or possession or in transit and including any returned goods and any documents of title representing any of the above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment</B>&#148; is any beneficial ownership interest in any Person (including stock, partnership interest or other securities),
and any loan, advance or capital contribution to any Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Key Person</B>&#148; is each of Borrower&#146;s (a)&nbsp;Chief
Executive Officer, who is Stephen Christopher Linthwaite as of the Effective Date, and (b)&nbsp;Chief Financial Officer, who is Vikram Jog as of the Effective Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Last Reported Sale Price</B>&#148; of the Common Shares (or other security for which a closing sale price must be determined) on any
date means the closing sale price per share (or if no closing sale price is reported, the average of the bid and ask prices or, if more than one in either case, the average of the average bid and the average ask prices) on that date as reported in
composite transactions for the principal U.S. national or regional securities exchange on which the Common Shares (or such other security) is traded. If the Common Shares (or such other security) is not listed for trading on a U.S. national or
regional securities exchange on the relevant date, the &#147;Last Reported Sale Price&#148; shall be the last quoted bid price for the Common Shares (or such other security) in the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market on the relevant date as reported by OTC Markets Group Inc. or a similar organization. If the Common Shares (or such other security) is not so
quoted, the &#147;Last Reported Sale Price&#148; shall be the average of the <FONT STYLE="white-space:nowrap">mid-point</FONT> of the last bid and ask prices per share of the Common Shares (or such other security) on the relevant date from each of
at least three nationally recognized independent investment banking firms selected by the Borrower for this purpose. The &#147;Last Reported Sale Price&#148; shall be determined without regard to after-hours trading or any other trading outside of
the regular trading session hours. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Lender Entities</B>&#148; is defined in Section&nbsp;12.9. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Lender Expenses</B>&#148; are all audit fees and expenses, costs, and expenses (including reasonable attorneys&#146; fees and
expenses) for preparing, amending, negotiating, administering, defending and enforcing the Loan Documents (including, without limitation, those incurred in connection with appeals or Insolvency Proceedings) or otherwise incurred with respect to
Borrower or any Guarantor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Lien</B>&#148; is a claim, mortgage, deed of trust, levy, charge, pledge, security interest or other
encumbrance of any kind, whether voluntarily incurred or arising by operation of law or otherwise against any property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Loan
Documents</B>&#148; are, collectively, this Agreement and any schedules, exhibits, certificates, notices, and any other documents related to this Agreement, any subordination agreement, any note, or notes or guaranties executed by Borrower or any
Guarantor, and any other present or future agreement by Borrower and/or any Guarantor with or for the benefit of Lender pursuant to this Agreement, all as amended, restated, or otherwise modified. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Loan Maturity Date</B>&#148; is the 91st calendar day after the latest maturity date of the loans (the &#147;<B>Reference Loan
Maturity Date</B>&#148;) borrowed pursuant to the SVB Loan and Security Agreement as in effect as of the Effective Date (without giving effect to any amendments, supplements or other modifications to the SVB Loan and Security Agreement after the
Effective Date that would extend the Reference Loan Maturity Date to a later date). For the avoidance of doubt, to the extent that the Reference Loan Maturity Date is pulled forward to an earlier maturity date pursuant to the terms of the SVB Loan
and Security Agreement as in effect as of the Effective Date, the Loan Maturity Date shall be automatically adjusted to be the 91st day after the then-current maturity date of the Reference Loan Maturity Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Market Disruption Event</B>&#148; means any of the following events: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) any suspension of, or limitation imposed on, trading of the Common Shares or options
contracts relating to the Common Shares by any U.S. exchange or quotation system on which the Last Reported Sale Price is determined pursuant to the definition of &#147;Last Reported Sale Price&#148; (the &#147;<B><I>Relevant Exchange</I></B>&#148;)
during the <FONT STYLE="white-space:nowrap">one-hour</FONT> period prior to the close of trading for the regular trading session on the Relevant Exchange (or for purposes of determining the VWAP per Common Share, any period or periods aggregating
one half-hour or longer during the regular trading session on the relevant day) whether by reason of movements in price exceeding limits permitted by the Relevant Exchange or otherwise; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) any event that disrupts or impairs (as determined by the Borrower in its reasonable discretion) the ability of market participants during
the <FONT STYLE="white-space:nowrap">one-hour</FONT> period prior to the close of trading for the regular trading session on the Relevant Exchange (or for purposes of determining the VWAP per Common Share, any period or periods aggregating one
half-hour or longer during the regular trading session on the relevant day) to effect transactions in, or obtain market values for, Common Shares on the Relevant Exchange or to effect transactions in, or obtain market values for, options contracts
relating to Common Shares on the Relevant Exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Material Adverse Change</B>&#148; is (a) [reserved]; (b) a material adverse
change in the business, operations, or condition (financial or otherwise) of Borrower; or (c)&nbsp;a material impairment of the prospect of repayment of any portion of the Obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Obligations</B>&#148; are Borrower&#146;s obligations to pay when due any debts, principal, interest, fees, Lender Expenses and other
amounts Borrower owes Lender now or later, whether under this Agreement, the other Loan Documents, or otherwise, including, without limitation, interest accruing after Insolvency Proceedings begin and debts, liabilities, or obligations of Borrower
assigned to Lender, and to perform Borrower&#146;s duties under the Loan Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Officer</B>&#148; means, with respect to the
Borrower, the President, the Chief Executive Officer, the Chief Financial Officer, the Treasurer, the Secretary, any Executive or Senior Vice President or any Vice President (whether or not designated by a number or numbers or word or words added
before or after the title &#147;Vice President&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Officers&#146; Certificate</B>&#148; means a certificate that is
delivered to Lender and that is signed by (a)&nbsp;two Officers of the Borrower or (b)&nbsp;one Officer of the Borrower and one of the Treasurer, any Assistant Treasurer, the Secretary, any Assistant Secretary or the Controller of the Borrower. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Operating Documents</B>&#148; are, for any Person, such Person&#146;s formation documents, as certified by the Secretary of State (or
equivalent agency) of such Person&#146;s jurisdiction of organization on a date that is no earlier than thirty (30)&nbsp;days prior to the Effective Date, and, (a)&nbsp;if such Person is a corporation, its bylaws in current form, (b)&nbsp;if such
Person is a limited liability company, its limited liability company agreement (or similar agreement), and (c)&nbsp;if such Person is a partnership, its partnership agreement (or similar agreement), each of the foregoing with all current amendments
or modifications thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Other Connection Taxes</B>&#148; means, with respect to the Lender, Taxes imposed as a result of a
present or former connection between the Lender and the jurisdiction imposing such Tax (other than connections arising from the Lender having executed, delivered, become a party to, performed its obligations under, received payments under, received
or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Loan or Loan Document). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Other Taxes</B>&#148; means all present or future stamp, court or documentary, intangible, recording, filing or similar Taxes that
arise from any payment made under, from the execution, delivery, performance, enforcement or registration of, from the receipt or perfection of a security interest under, or otherwise with respect to, any Loan Document, except any such Taxes that
are Other Connection Taxes imposed with respect to an assignment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Outstanding Principal Amount</B>&#148; means the original
principal amount of the Loan of $12,500,000 and all accrued interest thereon that has been capitalized pursuant to Section&nbsp;2.4(a)(ii) hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Patents</B>&#148; means all patents, patent applications and like protections
including without limitation improvements, divisions, continuations, renewals, reissues, extensions and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part</FONT></FONT> of the same. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Permitted Acquisition</B>&#148; is an acquisition of all or substantially all of the equity interests or assets (or all or
substantially all of the assets constituting a business unit, division, product line or line of business) of a Person, provided: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the
Person acquired or assets acquired is a type of business (or the assets are used in a type of business) permitted to be engaged by Borrower under this Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the acquisition is <FONT STYLE="white-space:nowrap">non-hostile</FONT> in nature; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) the Person or Persons to be acquired shall be solely organized in the United States and shall conduct their principal operations in the
United States; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) no Event of Default exists at the time of such acquisition or would exist after giving effect to such acquisition; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) the acquisition of the Person does not materially and adversely affect Borrower&#146;s earnings; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) the consideration paid in connection with all such acquisitions consists solely of (i)&nbsp;Borrower&#146;s equity securities,
(ii)&nbsp;the net proceeds received by Borrower or its Subsidiaries in connection with a contemporaneous issuance of equity securities solely for the purpose of consummating such acquisition or (iii)&nbsp;a combination of the foregoing <FONT
STYLE="white-space:nowrap">sub-clauses</FONT> (i)&nbsp;and (ii); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Lender shall have received at least thirty (30)&nbsp;days prior
written notice of the closing date for such acquisition; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Borrower shall remain a surviving legal entity; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any Person that is acquired and remains a separate legal entity shall be organized in the United States and shall become a <FONT
STYLE="white-space:nowrap">co-borrower</FONT> under this Agreement in accordance with Section&nbsp;6.13 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Permitted
Convertible Indebtedness</B>&#148; means the 2014 Notes and the 2019 Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Permitted Indebtedness</B>&#148; is: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) (i) Borrower&#146;s or any Subsidiary&#146;s Indebtedness to Lender under this Agreement and the other Loan Documents and
(ii)&nbsp;Borrower&#146;s or any Subsidiary&#146;s Indebtedness under the Viking Loan Agreement and the related loan documents; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
Indebtedness existing on the Effective Date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Subordinated Debt; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) unsecured Indebtedness to trade creditors incurred in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Indebtedness incurred as a result of endorsing negotiable instruments received in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Indebtedness secured by Liens permitted under clauses (a)&nbsp;and (c) of the definition of &#147;Permitted Liens&#148; hereunder; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Indebtedness in respect of performance bonds, bid bonds, appeal bonds, surety bonds and similar obligations, in each case provided in the
ordinary course of business; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Permitted Convertible Indebtedness; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Indebtedness that otherwise constitutes a Permitted Investment; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Indebtedness consisting of reimbursement obligations in respect of letters of credit, bank guarantees or
bankers<B>&#146;</B><B></B>&nbsp;acceptances issued for the benefit of customers, suppliers or distributors located in foreign jurisdictions in a face amount not to exceed Seven Hundred Thousand Dollars ($700,000); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) other unsecured Indebtedness not exceeding Five Hundred Thousand Dollars ($500,000) in the aggregate outstanding at any time; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Indebtedness under the SVB Loan and Security Agreement or any guaranty provided in respect thereof and (ii)&nbsp;Indebtedness to Silicon
Valley Bank in connection with bank services; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) Indebtedness of Borrower or a Guarantor owing to a Subsidiary (other than a Guarantor)
if and only if such Indebtedness is Subordinated Debt; provided, further, that any subsequent issuance or transfer of any Capital Stock or any other event which results in any such Subsidiary ceasing to be a Subsidiary or any other subsequent
transfer of any such Indebtedness (except to Borrower) shall be deemed, in each case, to be an incurrence of such Indebtedness not permitted by this clause; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) extensions, refinancings, modifications, amendments and restatements of any items of Permitted Indebtedness (a)&nbsp;through (m) above,
provided that the principal amount thereof is not increased or the terms thereof are not modified to impose more burdensome terms upon Borrower or its Subsidiary, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Permitted Investments</B>&#148; are: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Investments (including, without limitation, Subsidiaries) existing on the Effective Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Investments consisting of Cash Equivalents; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Investments consisting of the endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary
course of Borrower; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Investments consisting of deposit accounts; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Investments accepted in connection with Transfers permitted by Section&nbsp;7.1; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Investments consisting of the creation of a Subsidiary for the purpose of consummating a merger transaction permitted by Section&nbsp;7.3
of this Agreement, which is otherwise a Permitted Investment; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Investments (i)&nbsp;by Borrower in Subsidiaries not to exceed Five
Hundred Thousand Dollars ($500,000) in the aggregate in any fiscal year and (ii)&nbsp;by Subsidiaries in other Subsidiaries in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Investments consisting of (i)&nbsp;travel advances and employee relocation loans and other employee loans and advances in the ordinary
course of business, and (ii)&nbsp;loans to employees, officers or directors relating to the purchase of equity securities of Borrower or its Subsidiaries pursuant to employee stock purchase plans or agreements approved by the Board; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Investments (including debt obligations) received in connection with the bankruptcy or reorganization of customers or suppliers and in
settlement of delinquent obligations of, and other disputes with, customers or suppliers arising in the ordinary course of business; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Investments consisting of notes receivable of, or prepaid royalties and other credit
extensions, to customers and suppliers who are not Affiliates, in the ordinary course of business; provided that this paragraph (j)&nbsp;shall not apply to Investments of Borrower in any Subsidiary; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Indebtedness permitted under clause (m)&nbsp;of Permitted Indebtedness; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) other Investments not otherwise permitted by Section&nbsp;7.7 not exceeding Five Hundred Thousand Dollars ($500,000) in the aggregate
outstanding at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Permitted Liens</B>&#148; are: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Liens existing on the Effective Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Liens for taxes, fees, assessments or other government charges or levies, either (i)&nbsp;not due and payable or (ii)&nbsp;being contested
in good faith and for which Borrower maintains adequate reserves on Borrower&#146;s Books, provided that no notice of any such Lien has been filed or recorded under the Internal Revenue Code of 1986, as amended, and the Treasury Regulations adopted
thereunder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Liens securing capital leases and purchase money Liens (i)&nbsp;on Equipment acquired or held by Borrower incurred for
financing the acquisition of the Equipment securing no more than Five Hundred Thousand Dollars ($500,000) in the aggregate amount outstanding, or (ii)&nbsp;existing on Equipment when acquired, if the Lien is confined to the property and improvements
and the proceeds of the Equipment; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Liens of carriers, warehousemen, suppliers, or other Persons that are possessory in nature arising
in the ordinary course of business so long as such Liens attach only to Inventory, securing liabilities in the aggregate amount not to exceed Five Hundred Thousand Dollars ($500,000) and which are not delinquent or remain payable without penalty or
which are being contested in good faith and by appropriate proceedings which proceedings have the effect of preventing the forfeiture or sale of the property subject thereto; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Liens to secure payment of workers&#146; compensation, employment insurance, <FONT STYLE="white-space:nowrap">old-age</FONT> pensions,
social security and other like obligations incurred in the ordinary course of business (other than Liens imposed by ERISA); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Liens
incurred in the extension, renewal or refinancing of the Indebtedness secured by Liens described in (a)&nbsp;through (c), but any extension, renewal or replacement Lien must be limited to the property encumbered by the existing Lien and the
principal amount of the indebtedness may not increase; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) leases or subleases of real property granted in the ordinary course of
Borrower&#146;s business (or, if referring to another Person, in the ordinary course of such Person&#146;s business), and leases, subleases, <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses or sublicenses of personal property (other
than Intellectual Property) granted in the ordinary course of Borrower&#146;s business (or, if referring to another Person, in the ordinary course of such Person&#146;s business); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses of Intellectual Property in the ordinary course of business, and licenses of
Intellectual Property that could not result in a legal transfer of title of the licensed property that may be exclusive in respects other than territory and that may be exclusive as to territory only as to discrete geographical areas outside of the
United States; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) deposits to secure the performance of bids, trade contracts, leases, statutory obligations, surety and appeal bonds,
performance bonds and other obligations of a like nature, in each case in the ordinary course of business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Liens in favor of customs
and revenue authorities arising as a matter of law to secure payment of customs duties in connection with the importation of goods; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Liens consisting of cash collateral securing obligations described in clause (j)&nbsp;of
the definition of &#147;Permitted Indebtedness&#148; hereunder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Liens arising from attachments or judgments, orders, or decrees in
circumstances not constituting an Event of Default under Sections 8.4 and 8.7; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) Liens in favor of other financial institutions arising
in connection with Borrower&#146;s deposit and/or securities accounts held at such institutions; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) customary Liens on funds in a
trustee&#146;s possession and granted in favor of such trustee to secure fees and other amounts owing to such trustee under the Indentures or other similar instruments pursuant to which any Permitted Convertible Indebtedness is issued; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) Liens on Intellectual Property; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) Liens granted in connection with the SVB Loan and Security Agreement and any Loan Documents (as defined in the SVB Loan and Security
Agreement) entered into in connection therewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Person</B>&#148; is any individual, sole proprietorship, partnership, limited
liability company, joint venture, company, trust, unincorporated organization, association, corporation, institution, public benefit corporation, firm, joint stock company, estate, entity or government agency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Preferred Shares</B>&#148; mean the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock of the Borrower or its
Affiliate to be issued to the Lenders or their Affiliates, which is the same series as may be issued in connection with that certain Purchase Agreement, by and between the Company and the Lenders (the &#147;<B>Purchase Agreement</B>&#148;), dated as
of the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Quarterly Financial Statements</B>&#148; is defined in Section&nbsp;6.2(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Record Date</B>&#148; means, with respect to any dividend, distribution or other transaction or event in which holders of Common
Shares have the right to receive any cash, securities or other property or in which Common Shares is exchanged for or converted into any combination of cash, securities or other property, the date fixed for determination of holders of Common Shares
entitled to receive such cash, securities or other property (whether such date is fixed by the Board or by statute, contract or otherwise). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Registered Organization</B>&#148; is any &#147;registered organization&#148; as defined in the Code with such additions to such term
as may hereafter be made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Reorganization Event</B>&#148; is defined in Section&nbsp;13.5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Reorganization Event Notice</B>&#148; is defined in Section&nbsp;13.5(c)(i). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Representatives</B>&#148; means, in respect of any Person, such Person&#146;s directors, officers, employees, investment bankers,
attorneys, accountants and other advisors or representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Repurchase Price</B>&#148; is defined in Section&nbsp;13.5(c)(ii).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Required Lenders</B>&#148; shall mean, at any date, Lenders having or holding a majority of the outstanding principal amount of
the Term Loans at such date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Requirement of Law</B>&#148; is as to any Person, the organizational or governing documents of such
Person, and any law (statutory or common), treaty, rule or regulation or determination of an arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon such Person or any of its property or to which such Person
or any of its property is subject. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Responsible Officer</B>&#148; is any of the Chief Executive Officer, President,
Chief Financial Officer and Controller of Borrower. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>SEC</B>&#148; shall mean the Securities and Exchange Commission, any
successor thereto, and any analogous Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Securities Act</B>&#148; means the Securities Act of 1933, as
amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">Spin-Off</FONT></B>&#148; is defined in Section&nbsp;13.4(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Subordinated Debt</B>&#148; is indebtedness incurred by Borrower subordinated to all of Borrower&#146;s now or hereafter indebtedness
to Lender (pursuant to a subordination, intercreditor, or other similar agreement in form and substance satisfactory to Lender entered into between Lender and the other creditor), on terms acceptable to Lender. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Subsidiary</B>&#148; is, as to any Person, a corporation, partnership, limited liability company or other entity of which shares of
stock or other ownership interests having ordinary voting power (other than stock or such other ownership interests having such power only by reason of the happening of a contingency) to elect a majority of the board of directors or other managers
of such corporation, partnership or other entity are at the time owned, or the management of which is otherwise controlled, directly or indirectly through one or more intermediaries, or both, by such Person. Unless the context otherwise requires,
each reference to a Subsidiary herein shall be a reference to a Subsidiary of Borrower. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>SVB Loan and Security
Agreement</B>&#148; means that Loan and Security Agreement, dated as of August&nbsp;2, 2018 by and between the Borrower and Silicon Valley Bank, as amended, restated, modified or otherwise supplemented from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Trademarks</B>&#148; means any trademark and servicemark rights, whether registered or not, applications to register and
registrations of the same and like protections, and the entire goodwill of the business of Borrower connected with and symbolized by such trademarks. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transfer</B>&#148; is defined in Section&nbsp;7.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Trading Day</B>&#148; means a Business Day on which the Relevant Exchange is scheduled to be open for business and on which there has
not occurred a Market Disruption Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Trigger Event</B>&#148; is defined in Section&nbsp;13.4(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>U.S.</B><B></B><B>&nbsp;Person</B>&#148; means any Person that is a &#147;United States Person&#148; as defined in
Section&nbsp;7701(a)(30) of the Internal Revenue Code of 1986, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Valuation Period</B>&#148; is defined in
Section&nbsp;13.4(c). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>VWAP</B>&#148; means, for any Trading Days, the per share volume-weighted average price of the Common
Shares as displayed under the heading &#147;Bloomberg VWAP&#148; on Bloomberg page &#147;FLDM &lt;equity&gt; AQR&#148; (or its equivalent successor if such page is not available) in respect of the period from the scheduled open of trading until the
scheduled close of trading of the primary trading session on such Trading Day (or if such volume-weighted average price is unavailable, the market value of one Common Share on such Trading Day reasonably determined, using a volume-weighted average
method, by a nationally recognized independent investment banking firm retained for this purpose by the Borrower). The &#147;VWAP&#148; shall be determined without regard to after-hours trading or any other trading outside of the regular trading
session trading hours. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature page follows.] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties hereto have caused this Agreement to be executed as
of the Effective Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B></B>BORROWER:<B></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>FLUIDIGM CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Vikram Jog</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Vikram Jog</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">LENDERS:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CASDIN PARTNERS MASTER FUND, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Casdin Partners GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kevin O&#146;Brien</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Kevin O&#146;Brien</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: General Counsel</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CASDIN PRIVATE GROWTH EQUITY FUND II, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Casdin Private Growth Equity Fund II GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kevin O&#146;Brien</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Kevin O&#146;Brien</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: General Counsel</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>signature page to Loan Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONVERSION NOTICE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Reference is made to
the Loan Agreement, dated and effective as of January&nbsp;23, 2022 (the &#147;<B>Agreement</B>&#148;), between <B>CASDIN PARTNERS MASTER FUND, L.P.</B>, a Cayman Islands exempted limited partnership (&#147;<B>Master Fund</B>&#148;), <B>CASDIN
PRIVATE GROWTH EQUITY FUND II, L.P.</B>, a Delaware limited partnership (&#147;<B>PGE Fund</B>&#148;) and Fluidigm Corporation. In accordance with and pursuant to the Agreement, the undersigned hereby elects to convert the Conversion Amount with
respect to the Loan under the Agreement, indicated below into shares of common stock, par value $0.001 per share (the &#147;<B>Common </B><B>Shares</B>&#148;), of the Borrower, [as of the date specified below // on // immediately prior to[, and
subject to the occurrence of,] [&#149;]]. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date&nbsp;of&nbsp;Conversion&nbsp;(if&nbsp;applicable):</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="72%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Conversion&nbsp;Amount&nbsp;to&nbsp;be&nbsp;converted:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="63%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Promissory&nbsp;Note&nbsp;(if&nbsp;applicable)&nbsp;to&nbsp;be&nbsp;converted:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="75%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Tax&nbsp;ID&nbsp;Number&nbsp;(if&nbsp;applicable):</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="68%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Please&nbsp;confirm&nbsp;the&nbsp;following&nbsp;information:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Conversion&nbsp;Rate:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="68%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Number&nbsp;of&nbsp;Common&nbsp;Shares&nbsp;to&nbsp;be&nbsp;issued:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Please issue the Common Shares into which the Conversion Amount is being converted in the following name and to the following address:</TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Issue&nbsp;to:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Telephone&nbsp;Number:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Email:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Authorization:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="60%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Account&nbsp;Number&nbsp;(if&nbsp;electronic&nbsp;book&nbsp;entry&nbsp;transfer):</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="54%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Transaction&nbsp;Code&nbsp;Number&nbsp;(if&nbsp;electronic&nbsp;book&nbsp;entry&nbsp;transfer):</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="50%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Payment&nbsp;Instructions&nbsp;for&nbsp;cash&nbsp;payment&nbsp;in&nbsp;lieu&nbsp;of&nbsp;fractional&nbsp;shares:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>d243622dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Exhibit 10.2 </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LOAN AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS
LOAN AGREEMENT</B> (this &#147;<B>Agreement</B>&#148;) dated and effective as of January&nbsp;23, 2022 (the &#147;<B>Effective Date</B>&#148;) between <B>VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS
<FONT STYLE="white-space:nowrap">SUB-MASTER</FONT> LP</B>, a Cayman Islands exempted limited partnership (&#147;<B>Illiquid <FONT STYLE="white-space:nowrap">Sub-Master</FONT></B>&#148;), <B>VIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LP</B>, a
Cayman Islands exempted limited partnership (&#147;<B>Drawdown (Aggregator)</B> and together with Illiquid <FONT STYLE="white-space:nowrap">Sub-Master,</FONT> each a &#147;<B>Lender</B>&#148; and collectively, the &#147;<B>Lenders</B>&#148;) and
<B>FLUIDIGM CORPORATION</B>, a Delaware corporation (&#147;<B>Borrower</B>&#148;), provides the terms on which Lenders shall lend to Borrower and Borrower shall repay Lenders. The parties agree as follows: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>1 <U>ACCOUNTING AND OTHER TERMS</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accounting terms not defined in this Agreement shall be construed following GAAP. Calculations and determinations must be made following GAAP,
provided, however, that if at any time any change in GAAP would affect the computation of any covenant or requirement set forth in any Loan Document, and either Borrower or any Lender shall so request, Borrower and Lenders shall negotiate in good
faith to amend such covenant or requirement to preserve the original intent thereof in light of such change in GAAP; provided, further, that, until so amended, (i)&nbsp;such covenant or requirement shall continue to be computed in accordance with
GAAP prior to such change therein and (ii)&nbsp;Borrower shall provide Lenders financial statements and other documents required under this Agreement or as reasonably requested hereunder setting forth a reconciliation between calculations of such
ratio or requirement made before and after giving effect to such change in GAAP; provided, further, that (x)&nbsp;all obligations of any Person that are or would have been treated as operating leases for purposes of GAAP prior to the issuance by the
Financial Accounting Standards Board on February&nbsp;25, 2016 of an Accounting Standards Update (the &#147;<B>ASU</B>&#148;) shall continue to be accounted for as operating leases for purposes of all financial definitions, calculations and
covenants for purpose of this Agreement (whether or not such operating lease obligations were in effect on such date) notwithstanding the fact that such obligations are required in accordance with the ASU (on a prospective or retroactive basis or
otherwise) to be treated as capitalized lease obligations in accordance with GAAP. Notwithstanding the foregoing, all financial covenant (if any) and other financial calculations shall be computed with respect to Borrower only, and not on a
consolidated basis. Capitalized terms not otherwise defined in this Agreement shall have the meanings set forth in Section&nbsp;14. All other terms contained in this Agreement, unless otherwise indicated, shall have the meaning provided by the Code
to the extent such terms are defined therein. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>2 <U>LOAN AND TERMS OF PAYMENT</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.1 Promise to Pay</B>. Borrower hereby unconditionally promises to pay Lenders the Outstanding Principal Amount of the Loan and accrued and
unpaid interest thereon as and when due in accordance with this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.2 Loan</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.2.1 [Reserved] </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.2.2
<U>Loan</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Availability</U>. Subject to the terms and conditions of this Agreement, Illiquid
<FONT STYLE="white-space:nowrap">Sub-Master</FONT> shall make one term loan to Borrower in an aggregate original principal amount equal to Eight Million and Three Hundred Seventy Five Thousand Dollars ($8,375,000) (the &#147;<B>Illiquid <FONT
STYLE="white-space:nowrap">Sub-Master</FONT> Loan</B>&#148;) and Drawdown (Aggregator) shall make one term loan to Borrower in an aggregate original principal amount equal to Four Million and One Hundred Twenty Five Thousand Dollars ($4,125,000)
(the &#147;<B>Drawdown (Aggregator) Loan</B>&#148; and collectively with the Illiquid <FONT STYLE="white-space:nowrap">Sub-Master</FONT> Loan, the &#147;<B>Loan</B>&#148;). The Loan shall equal an aggregate original principal amount of Twelve
Million and Five Hundred Thousand Dollars ($12,500,000). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Repayment</U>. Unless earlier converted, the Outstanding Principal Amount of the Loan
(inclusive of principal and accrued and unpaid interest) shall be due and payable in cash on the Loan Maturity Date. Interest shall be due and payable in accordance with Section&nbsp;2.4(b) hereof. Each Lender shall maintain in accordance with its
usual practice an account or accounts evidencing the Obligations of the Borrower to such Lender resulting from the Loan made by such Lender from time to time, including the amounts of principal and interest payable and paid to such Lender from time
to time under this Agreement. The entries made in the accounts maintained pursuant to this Section&nbsp;2.2 shall be prima facie evidence of the existence and amounts of the obligations therein recorded; <U>provided</U> that the failure of any
Lender to maintain such accounts or any error therein shall not in any manner affect the obligations of the Borrower to repay the Obligations in accordance with their terms. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>No Permitted Prepayment</U>. Borrower shall not have the option to pay any of the balance under the Loan before the Loan becomes due
without the consent of the Lenders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Evidence of Debt</U>. Each Lender may request that the Loan made by it hereunder be evidenced
by a Promissory Note. In such event, the Borrower shall execute and deliver to such Lender a Promissory Note dated the Effective Date, payable to the order of such Lender in an amount equal to the Illiquid
<FONT STYLE="white-space:nowrap">Sub-Master</FONT> Loan or the Drawdown (Aggregator) Loan, as applicable.<U> </U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.3 [Reserved]
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.4 Payment of Interest on the Loan</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Interest Rates</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)
<U>[Reserved]</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) <U>Loan; Interest; Computation.</U> The Borrower agrees to pay to Lenders interest on the Outstanding Principal
Amount of the Loan at the Applicable Interest Rate for the period from the Funding Date (as defined herein) until the date the Loan shall be paid in full. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All interest shall (a)&nbsp;accrue daily, (b)&nbsp;be payable &#147;in kind&#148; by adding such interest to the Outstanding Principal
Amount on the last Business Day of each month after the Funding Date and (c)&nbsp;constitute principal thereafter. On each such last Business Day of each month after the Funding Date, accrued interest shall be capitalized. For the avoidance of
doubt, under the terms of this Agreement accrued interest under the Loan shall first be due by Borrower to Lenders on January&nbsp;31, 2022. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.5 Fees. </B>Borrower shall pay to Lenders all Lender Expenses (including reasonable attorneys&#146; fees and expenses for documentation
and negotiation of this Agreement) incurred through and after the Effective Date when due (or, if no stated due date, upon demand by Lenders). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.6 Payments; Application of Payments. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) All payments to be made by Borrower under any Loan Document shall be made in immediately available funds in Dollars, without setoff or
counterclaim, before 12:00 p.m. New York time on the date when due. Payments of principal and/or interest received after 12:00 p.m. New York time are considered received at the opening of business on the next Business Day. When a payment is due on a
day that is not a Business Day, the payment shall be due the next Business Day, and additional fees or interest, as applicable, shall continue to accrue until paid in accordance with the Illiquid <FONT STYLE="white-space:nowrap">Sub-Master</FONT>
Loan or the Drawdown (Aggregator) Loan, as applicable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Lenders have the exclusive right to determine the order and manner in which all
payments with respect to the Obligations may be applied. Borrower shall have no right to specify the order or the accounts to which Lenders shall allocate or apply any payments required to be made by Borrower to Lenders or otherwise received by
Lenders under this Agreement when any such allocation or application is not specified elsewhere in this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.7 Withholding</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Payments received by Lenders from Borrower under this Agreement will be made free and clear of and without deduction for any and all
present or future taxes, levies, imposts, duties, deductions, withholdings, assessments, fees or other charges imposed by any Governmental Authority (including any interest, additions to tax or penalties applicable thereto), except as required by
applicable law. Specifically, however, if at any time any applicable law requires Borrower to make any withholding or deduction from any such payment or other sum payable hereunder to any Lender, Borrower shall be entitled to make such deduction or
withholding and shall timely pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with applicable law and, if such Tax is an Indemnified Tax, then the sum payable by the Borrower shall be increased as
necessary so that after such deduction or withholding has been made (including such deductions and withholdings applicable to additional sums payable under this Section) the Lender receives an amount equal to the sum it would have received had no
such deduction or withholding been made. Borrower will, upon request, furnish such Lender with proof reasonably satisfactory to such Lender indicating that Borrower has made such withholding payment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Each Lender shall
deliver to Borrower, on the Effective Date and at the time or times reasonably requested by the Borrower, properly completed documentation certifying that it is not subject to backup withholding, together with any other documentation such Lender is
legally entitled to deliver establishing an exemption from or reduction in the applicable rate of any withholding tax. Notwithstanding anything to the contrary in this Section&nbsp;2.7, the completion, execution and submission of such documentation
(other than such documentation set forth in paragraphs&nbsp;(b)(ii)(A), (ii)(B)&nbsp;and (ii)(D)&nbsp;of this Section) shall not be required if in such Lender&#146;s reasonable judgment such completion, execution or submission would subject such
Lender to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position of such Lender. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)
Without limiting the generality of the foregoing, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(A) any Lender that is a U.S. Person shall deliver to the Borrower on or
about the date on which such Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower), executed copies of IRS Form <FONT STYLE="white-space:nowrap">W-9</FONT> certifying that such
Lender is exempt from U.S. federal backup withholding tax; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(B) any Lender that is not a U.S. Person shall, to the extent
it is legally entitled to do so, deliver to the Borrower (in such number of copies as shall be requested by the recipient) on or about the date on which such Lender becomes a Lender under this Agreement (and from time to time thereafter upon the
reasonable request of the Borrower), whichever of the following is applicable: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) in the case of a Lender that is not a
U.S. Person claiming the benefits of an income tax treaty to which the United States is a party (x)&nbsp;with respect to payments of interest under any Loan Document, executed copies of IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN</FONT> or
IRS <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN-E</FONT></FONT> establishing an exemption from, or reduction of, U.S.&nbsp;federal withholding Tax pursuant to the &#147;interest&#148; article of such tax treaty
and (y)&nbsp;with respect to any other applicable payments under any Loan Document, IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN</FONT> or IRS
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN-E</FONT></FONT> establishing an exemption from, or reduction of, U.S.&nbsp;federal withholding Tax pursuant to the &#147;business profits&#148; or &#147;other
income&#148; article of such tax treaty; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) executed copies of IRS Form <FONT STYLE="white-space:nowrap">W-8ECI;</FONT>
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(3) in the case of a Lender that is not a U.S. Person claiming the benefits of the exemption for portfolio interest under
Section&nbsp;881(c) of the Code, (x)&nbsp;a certificate executed under penalty of perjury to the effect that such Lender is not a &#147;bank&#148; within the meaning of Section&nbsp;881(c)(3)(A) of the Code, a &#147;10&nbsp;percent shareholder&#148;
of the Borrower within the meaning of Section&nbsp;871(h)(3)(B) of the Code, or a &#147;controlled foreign corporation&#148; related to the Borrower as described in Section&nbsp;881(c)(3)(C) of the Code (a &#147;<B>U.S. Tax Compliance
Certificate</B>&#148;) and (y)&nbsp;executed copies of IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN</FONT> or IRS <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN-E;</FONT></FONT> or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(4) to the extent a Foreign Lender is not the beneficial owner, executed
copies of IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8IMY,</FONT> accompanied by IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8ECI,</FONT> IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN,</FONT> IRS <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Form&nbsp;W-8BEN-E,</FONT></FONT> a U.S. Tax Compliance Certificate, IRS Form <FONT STYLE="white-space:nowrap">W-9,</FONT> and/or other certification documents from each beneficial owner, as applicable; provided that if
the Lender is a partnership and one or more direct or indirect partners of such Foreign Lender are claiming the portfolio interest exemption, such Lender may provide a U.S.&nbsp;Tax Compliance Certificate on behalf of each such direct and indirect
partner; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(C) any Lender that is not a U.S. Person shall, to the extent it is legally entitled to do so, deliver to the
Borrower (in such number of copies as shall be requested by the recipient) on or about the date on which such Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower), executed
copies of any other form prescribed by Applicable Law as a basis for claiming exemption from or a reduction in U.S. federal withholding Tax, duly completed, together with such supplementary documentation as may be prescribed by applicable law to
permit the Borrower to determine the withholding or deduction required to be made; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(D) if a payment made to a Lender
under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section&nbsp;1471(b) or 1472(b) of the
Code, as applicable), such Lender shall deliver to the Borrower at the time or times prescribed by law and at such time or times reasonably requested by the Borrower such documentation prescribed by applicable law (including as prescribed by
Section&nbsp;1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrower as may be necessary for the Borrower to comply with their obligations under FATCA and to determine that such Lender has complied with
such Lender&#146;s obligations under FATCA or to determine the amount, if any, to deduct and withhold from such payment. Solely for purposes of this clause&nbsp;(D), &#147;FATCA&#148; shall include any amendments made to FATCA after the date of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Each Lender agrees that if any form or certification it previously delivered expires or becomes obsolete or inaccurate in any
respect, it shall at Borrower&#146;s request update such form or certification or promptly notify the Borrower in writing of its legal inability to do so. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The agreements and obligations of Borrower and Lenders contained in this Section&nbsp;2.7 shall survive the termination of this Agreement.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.8 Original Issue Discount. </B>The parties acknowledge and agree that the Loan pursuant to this Agreement will be issued with
original issue discount (as that term is used in Section&nbsp;1273(a) of the Internal Revenue Code of 1986, as amended) solely for U.S. federal, state and local income tax purposes. Additional information regarding original issue discount, including
the issue date and the yield to maturity with respect to Term Loans can be obtained by contacting Borrower at the address listed in Article 10. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>3 <U>CONDITIONS OF LOANS</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.1 Conditions Precedent to Loan</B><B>.</B> Lenders&#146; obligation to make the Loan is subject to the condition precedent that Lenders
shall have received, in form and substance satisfactory to Lenders, such documents, and completion of such other matters, as Lenders may reasonably deem necessary or appropriate, including, without limitation: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) duly executed signatures to the Loan Documents; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the Operating Documents and good standing certificates of Borrower certified by the Secretary of State (or equivalent agency) of
Borrower&#146;s jurisdiction of organization or formation and each jurisdiction in which Borrower is qualified to conduct business, each as of a date no earlier than thirty (30)&nbsp;days prior to the Effective Date; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) a secretary&#146;s certificate of Borrower with respect to such Borrower&#146;s
Operating Documents, incumbency, specimen signatures and resolutions authorizing the execution and delivery of this Agreement and the other Loan Documents to which it is a party; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) [Reserved]; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) certified
copies, dated as of a recent date, of financing statement searches, as Lenders may request, accompanied by written evidence (including any UCC termination statements) that the Liens indicated in any such financing statements either constitute
Permitted Liens or have been or, in connection with the Loan, will be terminated or released; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) payment of the fees and Lender Expenses
then due as specified in Section&nbsp;2.5 hereof; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) duly executed subordination agreements by Subsidiaries that would subordinate
any outstanding Indebtedness owing from Borrower to such Subsidiaries, which subordination agreement shall (i)&nbsp;be in form and substance similar to the subordination agreements in existence among such Subsidiaries and Silicon Valley Bank and
(ii)&nbsp;subordinate such Indebtedness to the Obligations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.2 [Reserved] </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.3 [Reserved</B>] </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.4
Procedures for Borrowing</B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>[Reserved]</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Loan.</U> Subject to the prior satisfaction of all other applicable conditions to the making of the Loan set forth in this Agreement, to
obtain the Loan, Borrower shall notify Lenders (which notice shall be irrevocable) by electronic mail by 12:00 noon New York time on the date on which the Loan is made to or for the account of Borrower. Such notice shall be in a written format
acceptable to Lenders that is executed by an Authorized Signer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>4 <U>[RESERVED]</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>5 <U>REPRESENTATIONS AND WARRANTIES</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Borrower represents and warrants as of the Effective Date as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.1 Due Organization, Authorization; Power and Authority</B><B>.</B> Borrower is duly existing and in good standing as a Registered
Organization in its jurisdiction of formation and is qualified and licensed to do business and is in good standing in any jurisdiction in which the conduct of its business or its ownership of property requires that it be qualified except where the
failure to do so could not reasonably be expected to have a material adverse effect on Borrower&#146;s business. Borrower represents and warrants to Lenders that, except as may have been updated by a notification to Lenders pursuant to
Section&nbsp;7.2, (a)&nbsp;Borrower&#146;s exact legal name is that indicated on the signature page hereof; and (b)&nbsp;Borrower (and each of its predecessors) has not, in the past five (5)&nbsp;years, changed its jurisdiction of formation,
organizational structure or type, or any organizational number assigned by its jurisdiction. If Borrower is not now a Registered Organization but later becomes one, Borrower shall promptly notify Lenders of such occurrence and provide Lenders with
Borrower&#146;s organizational identification number. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The execution, delivery and performance by Borrower of the Loan Documents to which
it is a party have been duly authorized, and do not (i)&nbsp;conflict with any of Borrower&#146;s organizational documents, (ii)&nbsp;contravene, conflict with, constitute a default under or violate any material Requirement of Law,
(iii)&nbsp;contravene, conflict or violate any applicable order, writ, judgment, injunction, decree, determination or award of any Governmental Authority by which Borrower or any of its Subsidiaries or any of their property or assets may be bound or
affected, (iv)&nbsp;require any action by, filing, registration, or qualification with, or Governmental Approval from, any Governmental Authority </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(except such Governmental Approvals which have already been obtained and are in full force and effect), or (v)&nbsp;conflict with, contravene, constitute a default or breach under, or result in
or permit the termination or acceleration of, any material agreement by which Borrower is bound. Borrower is not in default under any agreement to which it is a party or by which it is bound in which the default could reasonably be expected to have
a material adverse effect on Borrower&#146;s business. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.2 [Reserved] </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.3 [Reserved</B>] </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.4
Litigation</B><B>. </B>Except as disclosed<B>, </B>there are no actions or proceedings pending or, to the knowledge of any Responsible Officer, threatened in writing by or against Borrower or any of its Subsidiaries that could, individually or in
the aggregate, reasonably be expected to result in expenses to Borrower of more than One Million Dollars ($1,000,000). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.5 Financial
Statements; Financial Condition</B><B>. </B>All consolidated financial statements for Borrower and any of its Subsidiaries delivered to Lenders fairly present in all material respects Borrower&#146;s consolidated financial condition and
Borrower&#146;s consolidated results of operations. There has not been any material deterioration in Borrower&#146;s consolidated financial condition since the date of the most recent financial statements submitted to Lenders. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.6 Solvency</B><B>.</B> The fair salable value of Borrower&#146;s consolidated assets (including goodwill minus disposition costs) exceeds
the fair value of Borrower&#146;s liabilities; Borrower is not left with unreasonably small capital after the transactions in this Agreement; and Borrower is able to pay its debts (including trade debts) as they mature. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.7 Regulatory Compliance</B><B>.</B> Borrower is not an &#147;investment company&#148; or a company &#147;controlled&#148; by an
&#147;investment company&#148; under the Investment Company Act of 1940, as amended. Borrower is not engaged as one of its important activities in extending credit for margin stock (under Regulations X, T and U of the Federal Reserve Board of
Governors). Borrower (a)&nbsp;has complied in all material respects with all Requirements of Law, and (b)&nbsp;has not violated any Requirements of Law the violation of which could reasonably be expected to have a material adverse effect on its
business. None of Borrower&#146;s or any of its Subsidiaries&#146; properties or assets has been used by Borrower or any Subsidiary or, to the best of Borrower&#146;s knowledge, by previous Persons, in disposing, producing, storing, treating, or
transporting any hazardous substance other than in compliance with all applicable laws. Borrower and each of its Subsidiaries have obtained all consents, approvals and authorizations of, made all declarations or filings with, and given all notices
to, all Governmental Authorities that are necessary to continue their respective businesses as currently conducted. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.8 Subsidiaries;
Investments</B><B>.</B> Borrower does not own any stock, partnership, or other ownership interest or other equity securities except for Permitted Investments. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.9 Tax Returns and Payments; Pension Contributions</B><B>.</B> Borrower has timely filed all required tax returns and reports, and Borrower
has timely paid all foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower except (a)&nbsp;to the extent such taxes are being contested in good faith by appropriate proceedings promptly instituted and
diligently conducted, so long as such reserve or other appropriate provision, if any, as shall be required in conformity with GAAP shall have been made therefor or (b)&nbsp;if such taxes, assessments, deposits and contributions do not, individually
or in the aggregate, exceed Fifty Thousand Dollars ($50,000). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent Borrower defers payment of any contested taxes, Borrower
shall (i)&nbsp;notify Lenders in writing of the commencement of, and any material development in, the proceedings, and (ii)&nbsp;post bonds or take any other steps required to prevent the Governmental Authority levying such contested taxes from
obtaining a Lien that is other than a &#147;Permitted Lien.&#148; Borrower is unaware of any claims or adjustments proposed for any of Borrower&#146;s prior tax years which could result in additional taxes becoming due and payable by Borrower.
Borrower has paid all amounts necessary to fund all present pension, profit sharing and deferred compensation plans in accordance with their terms, and Borrower has not withdrawn from participation in, and has not permitted partial or complete
termination of, or permitted the occurrence of any other event with respect to, any such plan which could reasonably be expected to result in any liability of Borrower, including any liability to the Pension Benefit Guaranty Corporation or its
successors or any other governmental agency. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.10 Use of Proceeds</B><B>.</B> Borrower shall use the proceeds of the Loan solely as
working capital and for general corporate purposes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.11 Full Disclosure</B><B>. </B>No written representation, warranty or other
statement of Borrower in any report, certificate, or written statement submitted to Lenders, as of the date such representation, warranty, or other statement was made, taken together with all such written reports, written certificates and written
statements submitted to Lenders, contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements contained in the reports, certificates, or written statements not misleading (it being recognized by
Lenders that the projections and forecasts provided by Borrower in good faith and based upon reasonable assumptions are not viewed as facts and that actual results during the period or periods covered by such projections and forecasts may differ
from the projected or forecasted results). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.12 </B><B>Definition of </B><B>&#147;</B><B>Knowledge</B><B>&#148;</B><B>.</B> For
purposes of the Loan Documents, whenever a representation or warranty is made to Borrower&#146;s knowledge or awareness, to the &#147;best of&#148; Borrower&#146;s knowledge, or with a similar qualification, knowledge or awareness means the actual
knowledge, after reasonable investigation, of any Responsible Officer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>6 <U>AFFIRMATIVE COVENANTS</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Borrower shall do all of the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.1 Government Compliance</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as permitted by Section&nbsp;7.3, maintain its and all its Subsidiaries&#146; legal existence and good standing (or its foreign
equivalent, if any) in their respective jurisdictions of formation and maintain qualification in each jurisdiction in which the failure to so qualify would reasonably be expected to have a material adverse effect on Borrower&#146;s business or
operations. Borrower shall comply, and have each Subsidiary comply, in all material respects, with all laws, ordinances and regulations to which it is subject, noncompliance with which could reasonably be expected to have a material adverse effect
on Borrower&#146;s business. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Obtain all of the Governmental Approvals necessary for the performance by Borrower of its obligations
under the Loan Documents to which it is a party. Borrower shall promptly provide copies of any such obtained Governmental Approvals to Lenders. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.2 Financial Statements, Reports, Certificates</B>. Provide Lenders with the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) [Reserved]; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) [Reserved];
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) as soon as available, but no later than within forty-five (45)&nbsp;days after the end of each fiscal quarter, a company prepared
consolidated balance sheet and income statement covering Borrower&#146;s and each of its Subsidiary&#146;s operations for such period in a form acceptable to Lenders (the &#147;<B>Quarterly</B><B></B><B>&nbsp;Financial Statements</B>&#148;);
provided, however, notwithstanding the foregoing, the Quarterly Financial Statements for Borrower&#146;s fourth (4th) quarter of each fiscal year, shall be due within ninety (90)&nbsp;days of such fiscal quarter; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) [Reserved]; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) [Reserved];
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) within five (5)&nbsp;days of filing, copies of all periodic and other reports, proxy
statements and other materials filed by Borrower and/or any Guarantor with the SEC, any Governmental Authority succeeding to any or all of the functions of the SEC or with any national securities exchange, or distributed to its shareholders, as the
case may be. Documents required to be delivered pursuant to the terms hereof (to the extent any such documents are included in materials otherwise filed with the SEC) may be delivered electronically and if so delivered, shall be deemed to have been
delivered on the date on which Borrower posts such documents, or provides a link thereto, on Borrower&#146;s website on the internet at Borrower&#146;s website address; provided, however, Borrower shall promptly notify Lenders in writing (which may
be by electronic mail) of the posting of any such documents; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) prompt report of any legal actions pending or threatened in writing
against Borrower or any of its Subsidiaries that could reasonably be expected to result in damages or costs to Borrower or any of its Subsidiaries of, individually or in the aggregate, One Million Dollars ($1,000,000) or more as reasonably requested
by Lenders; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) within thirty (30)&nbsp;days of the end of each calendar quarter, an update on the status of any litigation along with
such other information relating thereto as reasonably requested by Lenders; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) promptly, from time to time, such other information
regarding Borrower or compliance with the terms of any Loan Documents as reasonably requested by Lenders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.3 </B>Except as otherwise
disclosed to Lenders, any submission by Borrower of any financial statement submitted to Lender shall be deemed to be a representation by Borrower that (i)&nbsp;as of the date of such financial statement, the information and calculations set forth
therein are true, accurate and correct, (ii)&nbsp;as of the end of the compliance period set forth in such submission, Borrower is in complete compliance with all required covenants except as noted in such financial statement, (iii)&nbsp;as of the
date of such submission, no Events of Default have occurred or are continuing, (iv)&nbsp;as of the date of such submission, Borrower and each of its Subsidiaries has timely filed all required tax returns and reports, and Borrower has timely paid all
foreign, federal, state and local taxes, assessments, deposits and contributions owed by Borrower except as otherwise permitted pursuant to the terms of Section&nbsp;5.9, and (v)&nbsp;as of the date of such submission, no Liens have been levied or
claims made against Borrower or any of its Subsidiaries relating to unpaid employee payroll or benefits of which Borrower has not previously provided written notification to Lender. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.4 [Reserved] </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.5
Taxes; Pensions</B><B>.</B> Timely file, and require each of its Subsidiaries to timely file, all required tax returns and reports and timely pay, and require each of its Subsidiaries to timely pay, all foreign, federal, state and local taxes,
assessments, deposits and contributions owed by Borrower and each of its Subsidiaries, except for deferred payment of any taxes contested pursuant to the terms of Section&nbsp;5.9 hereof, and shall deliver to Lenders, on demand, appropriate
certificates attesting to such payments, and pay all amounts necessary to fund all present pension, profit sharing and deferred compensation plans in accordance with their terms. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.6 Access to Books and Records</B><B>. </B>At reasonable times, on five (5)&nbsp;Business Days&#146; notice (provided no notice is required
if an Event of Default has occurred and is continuing), Lenders shall have the right to audit and copy Borrower&#146;s Books. The foregoing inspections and audits shall be conducted no more often than once every twelve (12)&nbsp;months (or more
frequently as Lenders in their reasonable discretion determines that conditions warrant) unless an Event of Default has occurred and is continuing in which case such inspections and audits shall occur as often as Lenders shall determine is
necessary. The foregoing inspections and audits shall be conducted at Borrower&#146;s expense and the charge therefor shall be One Thousand Dollars ($1,000) per person per day (or such higher amount as shall represent Lenders&#146; then-current
standard charge for the same), plus reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses. In the event Borrower and Lenders schedule an audit more than eight (8)&nbsp;days in advance, and
Borrower cancels or seeks to or reschedules the audit with less than eight (8)&nbsp;days written notice to Lenders, then (without limiting any of Lenders&#146; rights or remedies) Borrower shall pay Lenders a fee of Two Thousand Dollars ($2,000)
plus any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by Lenders to compensate Lenders for the anticipated costs and expenses of the cancellation or rescheduling. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.7 Insurance</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Keep its business insured for risks and in amounts standard for companies in Borrower&#146;s industry and location and as Lenders may
reasonably request. Insurance policies shall be in a form, with financially sound and reputable insurance companies that are not Affiliates of Borrower, and in amounts that are satisfactory to Lenders. All property policies shall have a
lender&#146;s loss payable endorsement showing Lenders as lender loss payee. All liability policies shall show, or have endorsements showing, Lenders as additional insured. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Ensure that proceeds payable under any property policy are, at Lenders&#146; option, payable to Lenders on account of the Obligations.
Notwithstanding the foregoing, so long as no Event of Default has occurred and is continuing, Borrower shall have the option of applying the proceeds of any casualty policy up to Five Hundred Thousand Dollars ($500,000) toward the replacement or
repair of destroyed or damaged property or the purchase of other property useful to Borrower&#146;s business. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) [Reserved] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.8 [Reserved</B>] </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.9
[Reserved] </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.10 Protection of Intellectual Property Rights</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;(i) Protect, defend and maintain the validity and enforceability of its Intellectual Property material to Borrower&#146;s business;
(ii)&nbsp;promptly advise Lenders in writing of material infringements or any other event that could reasonably be expected to materially and adversely affect the value of its Intellectual Property material to Borrower&#146;s business; and
(iii)&nbsp;not allow any Intellectual Property material to Borrower&#146;s business to be abandoned, forfeited or dedicated to the public without Lender&#146;s written consent. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.11 [Reserved] </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.12
[Reserved</B>] </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.13 Formation or Acquisition of Subsidiaries</B><B>.</B> Notwithstanding and without limiting the negative covenants
contained in Sections 7.3 and 7.7 hereof, at the time that Borrower or any Guarantor forms any direct or indirect Subsidiary or acquires any direct or indirect Subsidiary after the Effective Date (including, without limitation, pursuant to a
Division), Borrower and such Guarantor shall (a)&nbsp;with respect to Domestic Subsidiaries only, cause such new Domestic Subsidiary to provide to Lenders a joinder to this Agreement to become a <FONT STYLE="white-space:nowrap">co-borrower</FONT>
hereunder or a Guaranty to become a Guarantor hereunder, all in form and substance satisfactory to Lenders, (b) [reserved]; and (c)&nbsp;provide to Lenders all other documentation in form and substance satisfactory to Lenders, including one or more
opinions of counsel satisfactory to Lenders, which in its opinion is appropriate with respect to the execution and delivery of the applicable documentation referred to above. Any document, agreement, or instrument executed or issued pursuant to this
Section&nbsp;6.13 shall be a Loan Document. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.14 [Reserved] </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.15 Permitted Convertible Indebtedness. </B>Promptly after Borrower&#146;s receipt of notice of any election or request by the holders of
Permitted Convertible Indebtedness to redeem, provide Lender<B> </B>with written notice of such election or request. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>7 <U>NEGATIVE COVENANTS</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Borrower shall not do any of the following without the Required Lenders&#146; prior written consent: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.1 Dispositions</B><B>.</B> Convey, sell, lease, transfer, assign, or otherwise dispose of (including, without limitation, pursuant to a
Division) (collectively, &#147;<B>Transfer</B>&#148;), or permit any of its Subsidiaries to Transfer, all or any part of its business or property, except for Transfers (a)&nbsp;of Inventory in the ordinary course of business; (b)&nbsp;of <FONT
STYLE="white-space:nowrap">worn-out</FONT> or obsolete Equipment that is, in the reasonable judgment of Borrower, no longer economically practicable to maintain or useful in the ordinary course of business of Borrower; (c)&nbsp;consisting of
Permitted Liens and Permitted Investments; (d)&nbsp;consisting of the sale or issuance of any stock of Borrower permitted under Section&nbsp;7.2 of this Agreement; (e)&nbsp;dispositions of Intellectual Property that are permitted pursuant to
Section&nbsp;6.10(a); (f) consisting of Borrower&#146;s use or transfer of money or Cash Equivalents in a manner that is not prohibited by the terms of this Agreement or the other Loan Documents; (g)&nbsp;of
<FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses for the use of the property of Borrower or its Subsidiaries in the ordinary course of business and licenses that could not result in a legal transfer of title of the licensed property
but that may be exclusive in respects other than territory and that may be exclusive as to territory only as to discrete geographical areas outside of the United States; and (h)&nbsp;of other property with a book value not to exceed Five Hundred
Thousand Dollars ($500,000) in the aggregate in any fiscal year. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.2 Changes in Business, Management, Control, or Business
Locations</B><B>.</B> (a)&nbsp;Engage in or permit any of its Subsidiaries to engage in any business other than the businesses currently engaged in by Borrower and such Subsidiary, as applicable, or reasonably related thereto; (b)&nbsp;liquidate or
dissolve; or (c)&nbsp;except with respect to Key Person departures currently contemplated in connection with Lenders&#146; purchase of certain Preferred Shares of Borrower, fail to provide notice to Lenders of any Key Person departing from or
ceasing to be employed by Borrower within five (5)&nbsp;days after his or her departure from Borrower. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Borrower shall not, without at
least thirty (30)&nbsp;days prior written notice to Lenders: (1)&nbsp;add any new offices or business locations, including warehouses (unless such new offices or business locations contain less than Five Hundred Thousand Dollars ($500,000) in
Borrower&#146;s assets or property), (2) change its jurisdiction of organization, (3)&nbsp;change its organizational structure or type, (4)&nbsp;change its legal name, or (5)&nbsp;change any organizational number (if any) assigned by its
jurisdiction of organization. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.3 Mergers or Acquisitions</B><B>.</B> Merge or consolidate, or permit any of its Subsidiaries to merge
or consolidate, with any other Person, or acquire, or permit any of its Subsidiaries to acquire, all or substantially all of the capital stock or property of another Person (including, without limitation, by the formation of any Subsidiary or
pursuant to a Division). Notwithstanding the foregoing, (a)&nbsp;a Subsidiary may merge or consolidate into another Subsidiary or into Borrower and (b)&nbsp;Borrower may consummate Permitted Acquisitions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.4 Indebtedness</B><B>.</B> Create, incur, assume, or be liable for any Indebtedness, or permit any Subsidiary to do so, other than
Permitted Indebtedness. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.5 Encumbrance</B><B>.</B> Create, incur, allow, or suffer any Lien on any of its property, except for
Permitted Liens. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.6 [Reserved] </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.7 Distributions; Investments</B>. (a)&nbsp;Pay any dividends or make any distribution or payment or redeem, retire or purchase any capital
stock of Borrower provided that Borrower may (i)&nbsp;convert any of its convertible securities into other securities pursuant to the terms of such convertible securities or otherwise in exchange thereof, (ii)&nbsp;pay dividends solely in common
stock; (iii)&nbsp;pay cash in lieu of fractional shares in connection with any distribution, payment or redemption permitted pursuant to this Section&nbsp;7.7; (iv) make <FONT STYLE="white-space:nowrap">non-cash</FONT> purchases or withholding of
capital stock in connection with the exercise of stock options or stock appreciation rights by way of cashless exercise or the vesting of restricted stock units or in connection with the satisfaction of withholding tax obligations; and (v)&nbsp;make
other payments, distributions, redemptions, retirements or purchases in an aggregate amount not to exceed Five Hundred Thousand Dollars ($500,000) in any fiscal year so long as an Event of Default does not exist at the time of any such payment,
distribution, redemption, retirement or purchase and would not exist after giving effect thereto; or (b)&nbsp;directly or indirectly make any Investment (including, without limitation, by the formation of any Subsidiary) other than Permitted
Investments, or permit any of its Subsidiaries to do so other than Permitted Investments. For the avoidance of doubt, the term &#147;capital stock&#148; shall not include any convertible debt security and clause (a)&nbsp;shall not apply to the
redemption, repurchase or conversion of any convertible debt security. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.8 Transactions with Affiliates</B><B>.</B> Directly or indirectly enter into or permit
to exist any material transaction with any Affiliate of Borrower, except (i)&nbsp;for transactions that are in the ordinary course of Borrower&#146;s business, upon fair and reasonable terms that are no less favorable to Borrower than would be
obtained in an arm&#146;s length transaction with a <FONT STYLE="white-space:nowrap">non-affiliated</FONT> Person, (ii)&nbsp;employee agreements or arrangements, indemnification agreements and compensation arrangements approved by the Board (or a
committee thereof), (iii) transactions of the type described in and permitted in Section&nbsp;7.7 and Permitted Investments and (iv)&nbsp;equity or Subordinated Debt financing transactions with existing investors that are not otherwise prohibited by
this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.9 Subordinated Debt; Permitted Convertible Indebtedness. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <B>Subordinated Debt.</B> (i)&nbsp;Make or permit any payment on any Subordinated Debt, except under the terms of the subordination,
intercreditor, or other similar agreement to which such Subordinated Debt is subject, or (ii)&nbsp;amend any provision in any document relating to the Subordinated Debt which would increase the amount thereof, provide for earlier or greater
principal, interest, or other payments thereon, or adversely affect the subordination thereof to Obligations owed to Lenders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
<B>Permitted Convertible Indebtedness.</B> Except for redemptions or repurchases of the Permitted Convertible Indebtedness mandatorily required to be made pursuant to the terms of the Indentures as in effect on the date hereof, make any payment or
prepayment of principal of, premium, if any, or interest on, or redemption, purchase, retirement, defeasance (including <FONT STYLE="white-space:nowrap">in-substance</FONT> or legal defeasance), sinking fund, settlement, conversion, or similar
payment with respect to, any Permitted Convertible Indebtedness, except that (i)&nbsp;Borrower may make any required payments of cash or deliveries in shares of common stock of Borrower or any combination thereof (or other securities or property
following a merger event, reclassification or other change of the common stock) (and cash in lieu of fractional shares) pursuant to the terms of, and otherwise perform its obligations under, any Permitted Convertible Indebtedness (including, without
limitation, making payments of interest and principal thereon, making payments due upon required repurchase or redemption thereof and/or making payments and deliveries upon conversion thereof) (provided that, for the sake of clarity, &#147;required
payments or deliveries&#148; shall not include a redemption of the Permitted Convertible Indebtedness by Borrower at Borrower&#146;s option) and (ii)&nbsp;notwithstanding anything to the contrary herein, Borrower may issue a conversion notice under
Section&nbsp;14.13 of the Indenture for the 2019 Notes and may make all required payments and deliveries upon conversion of the 2019 Notes in connection with such conversion notice. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.10 Compliance</B><B>.</B> Become an &#147;investment company&#148; or a company controlled by an &#147;investment company&#148;, under the
Investment Company Act of 1940, as amended, or undertake as one of its important activities extending credit to purchase or carry margin stock (as defined in Regulation U of the Board of Governors of the Federal Reserve System), or use the proceeds
of the Loan for that purpose; fail to meet the minimum funding requirements of ERISA, permit a Reportable Event or Prohibited Transaction, as defined in ERISA, to occur; fail to comply with the Federal Fair Labor Standards Act or violate any other
law or regulation, if the violation could reasonably be expected to have a material adverse effect on Borrower&#146;s business, or permit any of its Subsidiaries to do so; withdraw or permit any Subsidiary to withdraw from participation in, permit
partial or complete termination of, or permit the occurrence of any other event with respect to, any present pension, profit sharing and deferred compensation plan which could reasonably be expected to result in any liability of Borrower, including
any liability to the Pension Benefit Guaranty Corporation or its successors or any other governmental agency. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.11 Guaranty. </B>To
permit any of its Subsidiaries to guarantee the payment of any Indebtedness of Borrower or any of its Subsidiaries unless such Subsidiary within 10 days executes and delivers a Guaranty in form and substance reasonably satisfactory to Lenders
providing for a Guaranty by such Subsidiary of the Obligations, provided that the Guaranty arising under this provision in favor of Lenders as a result of a Subsidiary guaranteeing obligations under the SVB Loan and Security Agreement shall be
subordinated in right of payment to the same extent the Obligations are subordinated to the obligations under the SVB Loan and Security Agreement. <B></B> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>8 <U>EVENTS OF DEFAULT</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any one of the following shall constitute an event of default (an &#147;<B>Event of Default</B>&#148;) under this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.1 Payment Default</B><B>.</B> Borrower fails to (a)&nbsp;make any payment of principal or interest on the Loan when due, or (b)&nbsp;pay
any other Obligations within three (3)&nbsp;Business Days after such Obligations are due and payable (which three (3)&nbsp;Business Day cure period shall not apply to payments due on the Loan Maturity Date). During the cure period, the failure to
make or pay any payment specified under clause (b)&nbsp;hereunder is not an Event of Default; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.2 Covenant Default</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Borrower fails or neglects to perform any obligation in Sections 6.2, 6.5, 6.6, 6.7, 6.10 or 6.13 or violates any covenant in
Section&nbsp;7; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Borrower fails or neglects to perform, keep, or observe any other term, provision, condition, covenant or agreement
contained in this Agreement or any Loan Documents, and as to any default (other than those specified in this Section&nbsp;8) under such other term, provision, condition, covenant or agreement that can be cured, has failed to cure the default within
fifteen (15)&nbsp;days after the occurrence thereof; provided, however, that if the default cannot by its nature be cured within the fifteen (15)&nbsp;day period or cannot after diligent attempts by Borrower be cured within such fifteen
(15)&nbsp;day period, and such default is likely to be cured within a reasonable time, then Borrower shall have an additional period (which shall not in any case exceed thirty (30)&nbsp;days) to attempt to cure such default, and within such
reasonable time period the failure to cure the default shall not be deemed an Event of Default. Cure periods provided under this section shall not apply, among other things, to financial covenants or any other covenants set forth in clause
(a)&nbsp;above; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.3 Material Adverse Change</B>. A Material Adverse Change occurs; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.4 Attachment; Levy; Restraint on Business</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;(i) The service of process seeking to attach, by trustee or similar process, any funds of Borrower or of any entity under the control
of Borrower (including a Subsidiary), or (ii)&nbsp;a notice of lien or levy is filed against any of Borrower&#146;s assets by any Governmental Authority, and the same under subclauses (i)&nbsp;and (ii) hereof are not, within ten (10)&nbsp;days after
the occurrence thereof, discharged or stayed (whether through the posting of a bond or otherwise); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;(i) any material portion of
Borrower&#146;s assets is attached, seized, levied on, or comes into possession of a trustee or receiver, or (ii)&nbsp;any court order enjoins, restrains, or prevents Borrower from conducting all or any material part of its business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.5 Insolvency</B><B>.</B> (a)&nbsp;Borrower or any of its Subsidiaries is unable to pay its debts (including trade debts) as they become
due or otherwise becomes insolvent; (b)&nbsp;Borrower or any of its Subsidiaries begins an Insolvency Proceeding; or (c)&nbsp;an Insolvency Proceeding is begun against Borrower or any of its Subsidiaries and is not dismissed or stayed within
forty-five (45)&nbsp;days; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.6 Other Agreements</B><B>.</B> There is, under any agreement to which Borrower or any Guarantor is a party
with a third party or parties, (a)&nbsp;any default resulting in a right by such third party or parties, whether or not exercised, to accelerate the maturity of any Indebtedness in an amount individually or in the aggregate in excess of Five Hundred
Thousand Dollars ($500,000); or (b)&nbsp;any breach or default by Borrower or Guarantor, the result of which could have a material adverse effect on Borrower&#146;s or any Guarantor&#146;s business; provided, however, that the Event of Default under
this Section&nbsp;8.6 caused by the occurrence of a breach or default under such other agreement shall be cured or waived for purposes of this Agreement upon Lenders receiving written notice from the party asserting such breach or default of such
cure or waiver of the breach or default under such other agreement, if at the time of such cure or waiver under such other agreement (x)&nbsp;Lenders have not declared an Event of Default under this Agreement and/or exercised any rights with respect
thereto; (y)&nbsp;any such cure or waiver does not result in an Event of Default under any other provision of this Agreement or any Loan Document; and (z)&nbsp;in connection with any such cure or waiver under such other agreement, the terms of any
agreement with such third party are not modified or amended in any manner which could in the good faith business judgment of Lenders be materially less advantageous to Borrower; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.7 Judgments; Penalties</B><B>.</B> One or more fines, penalties or final judgments, orders or decrees for the payment of money in an
amount, individually or in the aggregate, of at least Five Hundred Thousand Dollars ($500,000) (not covered by independent third-party insurance as to which liability has been accepted by such insurance carrier) shall be rendered against Borrower by
any Governmental Authority, and the same are not, within ten (10)&nbsp;days after the entry, assessment or issuance thereof, discharged, satisfied, or paid, or after execution thereof, stayed or bonded pending appeal, or such judgments are not
discharged prior to the expiration of any such stay; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.8 Misrepresentations</B><B>.</B> Borrower or any Person acting for Borrower makes any
representation, warranty, or other statement now or later in this Agreement, any Loan Document or in any writing delivered to Lenders or to induce Lenders to enter this Agreement or any Loan Document, and such representation, warranty, or other
statement is incorrect in any material respect when made; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.9 Subordinated Debt</B><B>.</B> Any document, instrument, or agreement
evidencing any Subordinated Debt shall for any reason be revoked or invalidated or otherwise cease to be in full force and effect, any Person shall be in breach thereof or contest in any manner the validity or enforceability thereof or deny that it
has any further liability or obligation thereunder, or the Obligations shall for any reason be subordinated or shall not have the priority contemplated by this Agreement or any applicable subordination or intercreditor agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.10 Guaranty</B><B>.</B> (a)&nbsp;Any guaranty of any Obligations terminates or ceases for any reason to be in full force and effect;
(b)&nbsp;any Guarantor does not perform any obligation or covenant under any guaranty of the Obligations; (c)&nbsp;any circumstance described in Sections 8.3, 8.4, 8.5, 8.6, 8.7, or 8.8 of this Agreement occurs with respect to any Guarantor,
(d)&nbsp;the death, liquidation, winding up, or termination of existence of any Guarantor; or (e)&nbsp;a material adverse change in the general affairs, management, results of operation, condition (financial or otherwise) or the prospect of
repayment of the Obligations occurs with respect to any Guarantor; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.11 Governmental Approvals</B><B>.</B> Any Governmental Approval
shall have been revoked, rescinded, suspended, modified in an adverse manner or not renewed in the ordinary course for a full term and such decision or such revocation, rescission, suspension, modification or
<FONT STYLE="white-space:nowrap">non-renewal</FONT> could reasonably be expected to cause, a Material Adverse Change. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>9
<U>LENDERS&#146; RIGHTS AND REMEDIES</U> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.1 Rights and Remedies</B><B>.</B> Upon the occurrence and during the continuance of an
Event of Default, Required Lenders may, without notice or demand, do any or all of the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) declare all Obligations immediately
due and payable (but if an Event of Default described in Section&nbsp;8.5 occurs all Obligations are immediately due and payable without any action by Required Lenders); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) exercise all rights and remedies available to Lenders under the Loan Documents or at law or equity. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.2 No Waiver; Remedies Cumulative</B><B>.</B> Lenders&#146; failure, at any time or times, to require strict performance by Borrower of any
provision of this Agreement or any other Loan Document shall not waive, affect, or diminish any right of Lenders thereafter to demand strict performance and compliance herewith or therewith. No waiver hereunder shall be effective unless signed by
the party granting the waiver and then is only effective for the specific instance and purpose for which it is given. Lenders&#146; rights and remedies under this Agreement and the other Loan Documents are cumulative. Lenders have all rights and
remedies provided under the Code, by law, or in equity. Lender&#146;s exercise of one right or remedy is not an election and shall not preclude Lenders from exercising any other remedy under this Agreement or other remedy available at law or in
equity, and Lenders&#146; waiver of any Event of Default is not a continuing waiver. Lenders&#146; delay in exercising any remedy is not a waiver, election, or acquiescence. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.3 Demand Waiver</B><B>.</B> Borrower waives demand, notice of default or dishonor, notice of payment and nonpayment, notice of any
default, nonpayment at maturity, release, compromise, settlement, extension, or renewal of accounts, documents, instruments, chattel paper, and guarantees held by Lenders on which Borrower is liable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>10 <U>NOTICES</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All notices, consents, requests, approvals, demands, or other communication by any party to this Agreement or any other Loan Document must be
in writing and shall be deemed to have been validly served, given, or delivered: (a)&nbsp;upon the earlier of actual receipt and three (3)&nbsp;Business Days after deposit in the U.S. mail, first class, registered or certified mail return receipt
requested, with proper postage prepaid; (b)&nbsp;upon transmission, when sent by electronic mail or facsimile transmission; (c)&nbsp;one (1) Business Day after deposit with a reputable overnight courier with all charges prepaid; or (d)&nbsp;when
delivered, if hand-delivered by messenger, all of which shall be addressed to the party to be notified and sent to the address, facsimile number, or email address indicated below. Lender or Borrower may change their respective mailing or electronic
mail address or facsimile number by giving the other party written notice thereof in accordance with the terms of this Section&nbsp;10. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="67%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; font-size:10pt; font-family:Times New Roman">If to Borrower:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">FLUIDIGM CORPORATION</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2 Tower Place, Suite 2000</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">South San Francisco, CA 94080</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Attn: Vikram Jog, Chief Financial Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Email: <U>vikram.jog@fluidigm.com</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; font-size:10pt; font-family:Times New Roman">If to Lenders:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">VIKING GLOBAL INVESTORS LP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">55 Railroad Ave</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Greenwich, Connecticut 06830</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Attn: Legal and Compliance Department</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Email: legalnotices@vikingglobal.com</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>11 <U>CHOICE OF LAW, VENUE, JURY TRIAL WAIVER AND JUDICIAL REFERENCE</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New York law governs the Loan Documents. Borrower and Lender each submit to the exclusive jurisdiction of the State and Federal courts of New
York, in each case sitting in the Borough of Manhattan. Borrower expressly submits and consents in advance to such jurisdiction in any action or suit commenced in any such court, and Borrower hereby waives any objection that it may have based upon
lack of personal jurisdiction, improper venue, or forum non conveniens and hereby consents to the granting of such legal or equitable relief as is deemed appropriate by such court. Borrower hereby waives personal service of the summons, complaints,
and other process issued in such action or suit and agrees that service of such summons, complaints, and other process may be made by registered or certified mail addressed to Borrower at the address set forth in, or subsequently provided by
Borrower in accordance with, Section&nbsp;10 of this Agreement and that service so made shall be deemed completed upon the earlier to occur of Borrower&#146;s actual receipt thereof or three (3)&nbsp;days after deposit in the U.S. mails, proper
postage prepaid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE
TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OF THE LOAN DOCUMENTS (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO CERTIFIES THAT NO REPRESENTATIVE,
AGENT OR ATTORNEY OF ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B)&nbsp;ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE
BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND ANY NOTE BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 11. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Section&nbsp;11 shall survive the termination of this Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>12 <U>GENERAL PROVISIONS</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.1 Termination; Survival</B><B>. </B>All covenants, representations and warranties made in this Agreement shall continue in full force
until all Obligations (other than inchoate indemnity obligations, and any other obligations which, by their terms, are to survive the termination of this Agreement) have been satisfied. Upon the earlier of the payment in full of the Loan or the
conversion of the Conversion Amount pursuant to this Agreement, this Agreement shall automatically terminate (other than inchoate indemnity obligations, and any other obligations which, by their terms, are to survive the termination of this
Agreement). Those obligations that are expressly specified in this Agreement as surviving this Agreement&#146;s termination shall continue to survive notwithstanding this Agreement&#146;s termination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.2 Successors and Assigns</B><B>.</B> This Agreement binds and is for the benefit of
the successors and permitted assigns of each party. Borrower may not assign this Agreement or any rights or obligations under it without Lender&#146;s prior written consent (which may be granted or withheld in Lenders&#146; discretion). Each Lender
has the right, without the consent of or notice to Borrower, to sell, transfer, assign, negotiate, or grant participation in all or any part of, or any interest in, such Lender&#146;s obligations, rights, and benefits under this Agreement and the
other Loan Documents to any Person. Borrower shall maintain at one of its offices a copy of each assignment and assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, principal amounts (and stated
interest) of the Loans owing to, each Lender pursuant to the terms hereof from time to time (the &#147;<B>Register</B>&#148;). The entries in the Register shall be conclusive absent manifest error, and the Borrower and the Lenders shall treat each
Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement. The Register shall be available for inspection by the Lender, at any reasonable time and from time to time upon
reasonable prior notice. If any Lender sells at any time participations to any person (each, a &#147;<B>Participant</B>&#148;) in all or a portion of such Lender&#146;s right or obligations under this Agreement, (i)&nbsp;such Lender&#146;s
obligations under this Agreement shall remain unchanged, (ii)&nbsp;such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations, and (iii)&nbsp;the Borrower shall continue to deal solely and
directly with such Lender in connection with such Lender&#146;s rights and obligations under this Agreement. Each Lender that sells a participation shall, acting solely for this purpose as a <FONT STYLE="white-space:nowrap">non-fiduciary</FONT>
agent of the Borrower, maintain a register on which it enters the name and address of each Participant and the principal amounts (and stated interest) of each Participant&#146;s interest in the Loans (the &#147;<B>Participant Register</B>&#148;);
provided that no Lender shall have any obligation to disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a Participant&#146;s interest in obligations under any Loan
Document) to any Person except to the extent that such disclosure is necessary to establish that obligation is in registered form under <FONT STYLE="white-space:nowrap">Section&nbsp;5f.103-1(c)</FONT> of the United States Treasury Regulations. The
entries in the Participant Register shall be conclusive absent manifest error, and such Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement
notwithstanding any notice to the contrary. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.3 Indemnification</B>. Borrower agrees to indemnify, defend and hold Lenders and their
directors, officers, employees, agents, attorneys, or any other Person affiliated with or representing Lenders (each, an &#147;<B>Indemnified Person</B>&#148;) harmless against: (i)&nbsp;all obligations, demands, claims, and liabilities
(collectively, &#147;<B>Claims</B>&#148;) claimed or asserted by any other party in connection with the transactions contemplated by the Loan Documents; and (ii)&nbsp;all losses or expenses (including Lender Expenses) in any way suffered, incurred,
or paid by such Indemnified Person as a result of, following from, consequential to, or arising from transactions between Lenders and Borrower (including reasonable attorneys&#146; fees and expenses), except for Claims and/or losses directly caused
by such Indemnified Person&#146;s gross negligence or willful misconduct. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Section&nbsp;12.3 shall survive until all statutes of
limitation with respect to the Claims, losses, and expenses for which indemnity is given shall have run. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.4 Time of
Essence</B><B>.</B> Time is of the essence for the performance of all Obligations in this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.5 Severability of
Provisions</B><B>.</B> Each provision of this Agreement is severable from every other provision in determining the enforceability of any provision. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.6 Correction of Loan Documents</B><B>.</B> Required Lenders may correct patent errors and fill in any blanks in the Loan Documents
consistent with the agreement of the parties so long as Lenders provide Borrower with written notice of such correction and allows Borrower at least ten (10)&nbsp;days to object to such correction. In the event of such objection, such correction
shall not be made except by an amendment signed by the Required Lenders and Borrower. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.7 Amendments in Writing; Waiver;
Integration</B><B>.</B> Without the consent of Required Lenders, no purported amendment or modification of any Loan Document, or waiver, discharge or termination of any obligation under any Loan Document, shall be enforceable or admissible unless,
and only to the extent, expressly set forth in a writing signed by the party against which enforcement or admission is sought; and provided, further, that no such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
waiver and no such amendment, supplement or modification shall, without the consent of each Lender directly and adversely affected thereby: (i)&nbsp;forgive or reduce any portion of any Loan
owing to such Lender or extend the final scheduled maturity date of any such Loan or reduce the stated rate, or forgive any portion thereof, or extend the date for the payment, of any principal, interest or fee payable hereunder, or make any Loan,
interest, Fee or other amount payable in any currency, or (ii)&nbsp;release all or substantially all of the Guarantors under the Guaranty, if any (except as expressly permitted by the Guaranty), or (iii)&nbsp;reduce the percentages specified in the
definitions of the terms Required Lenders, or amend, restate, supplement, modify or waive any provision of this Section&nbsp;12.7 that has the effect of decreasing the number of Lenders that must approve any amendment, restatement, supplementation,
modification or waiver, (iv)&nbsp;amend, modify or supplement Article 13 hereof, or (v)&nbsp;consent to the assignment or transfer by Borrower of its rights and obligations under this Agreement party (except as explicitly permitted hereunder). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.8 Counterparts</B><B>.</B> This Agreement may be executed in any number of counterparts and by different parties on separate
counterparts, each of which, when executed and delivered, is an original, and all taken together, constitute one Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.9
Confidentiality</B><B>.</B> In handling any confidential information, Lenders shall exercise the same degree of care that they exercise for their own proprietary information and Lenders will not disclose, divulge, or use for any purpose (other than
to monitor its Loan to Borrower) any confidential information obtained from Borrower (including any confidential information obtained pursuant to the terms of this Agreement), but disclosure of information may be made: (a)&nbsp;to Lenders
Subsidiaries or Affiliates in the ordinary course of business (such Subsidiaries and Affiliates, together with Lenders, collectively, &#147;<B>Lender Entities</B>&#148;), provided that Lenders inform such Subsidiary or Affiliate that such
information is confidential and direct such Subsidiary and Affiliate to maintain the confidentiality of such information; (b)&nbsp;to investors or prospective investors of the Lenders or the funds or accounts for whom the Lenders&#146; investment
managers act as managers or investment managers, provided, however Lenders, their investment managers or their Affiliates shall enter into (or have already entered into) confidentiality agreements with such recipients on terms substantively similar
to the provisions contained in this paragraph); (c) to prospective transferees or purchasers of any interest in the Loan (provided, however, Lenders shall enter into confidentiality agreement with prospective transferees or purchasers on terms
substantially similar to the provisions contained in this paragraph); (d) as required by law, regulation, subpoena, or other order, provided that Lenders promptly notify Borrower of such disclosure and takes reasonable steps to minimize the extent
of any such required disclosure; (e)&nbsp;to the extent required by securities Laws or Governmental Authority or rules or regulations of securities exchanges or similar entities in connection with any required securities filings; (f)&nbsp;as Lenders
consider appropriate in exercising remedies under the Loan Documents; and (g)&nbsp;to their attorneys, accountants, consultants, and other professionals to the extent necessary to obtain their services in connection with monitoring the Loan to
Borrower and so long as such service providers have executed a confidentiality agreement with Lenders with terms no less restrictive than those contained herein. Confidential information does not include information that is either: (i)&nbsp;in the
public domain or in Lenders&#146; possession when disclosed to Lenders, or becomes part of the public domain (other than as a result of its disclosure by Lenders in violation of this Agreement) after disclosure to Lenders; or (ii)&nbsp;disclosed to
Lenders by a third party, if Lenders do not know that the third party is prohibited from disclosing the information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The provisions of
the immediately preceding sentence shall survive the termination of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.10 Attorneys&#146; Fees, Costs and
Expenses</B><B>.</B> In any action or proceeding between Borrower and Lenders arising out of or relating to the Loan Documents, the prevailing party shall be entitled to recover its reasonable attorneys&#146; fees and other costs and expenses
incurred, in addition to any other relief to which it may be entitled. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.11 Electronic Execution of Documents</B><B>.</B> The words
&#147;execution,&#148; &#147;signed,&#148; &#147;signature&#148; and words of like import in any Loan Document shall be deemed to include electronic signatures or the keeping of records in electronic form, each of which shall be of the same legal
effect, validity and enforceability as a manually executed signature or the use of a paper-based recordkeeping systems, as the case may be, to the extent and as provided for in any applicable law, including, without limitation, any state law based
on the Uniform Electronic Transactions Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.12 Calculations in Respect of the Loans. </B>Other than as specified herein, Borrower
and its agents shall be responsible for making the calculations called for under the Loans. These calculations include, but are not limited to, any adjustments to the Conversion Rate, the determination of any Last Reported Sale Price and the
consideration deliverable in respect of any conversion. Borrower will make all these calculations in good faith and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shall provide written notice of any such calculation to Lenders, which written notice shall set forth in reasonable detail the basis for the calculation thereof, and, absent manifest error,
Borrower&#146;s calculations as specified in such written notice shall become final and binding on Lenders on the earlier of (i) 30 days after the receipt thereof and (ii)&nbsp;agreement on the part of Lenders. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.13 Captions</B><B>.</B> The headings used in this Agreement are for convenience only and shall not affect the interpretation of this
Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.14 Construction of Agreement</B><B>.</B> The parties mutually acknowledge that they and their attorneys have participated
in the preparation and negotiation of this Agreement. In cases of uncertainty this Agreement shall be construed without regard to which of the parties caused the uncertainty to exist. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.15 Relationship</B><B>.</B> The relationship of the parties to this Agreement is determined solely by the provisions of this Agreement.
The parties do not intend to create any agency, partnership, joint venture, trust, fiduciary or other relationship with duties or incidents different from those of parties to an <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> contract.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.16 Third Parties</B><B>.</B> Nothing in this Agreement, whether express or implied, is intended to: (a)&nbsp;confer any benefits,
rights or remedies under or by reason of this Agreement on any persons other than the express parties to it and their respective permitted successors and assigns; (b)&nbsp;relieve or discharge the obligation or liability of any person not an express
party to this Agreement; or (c)&nbsp;give any person not an express party to this Agreement any right of subrogation or action against any party to this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12</B>.17 <B>Restricted Securities;</B> <B>Legends</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Lenders understand that the Common Shares or Preferred Shares, as applicable, issued in accordance with this Agreement will be
characterized as &#147;restricted securities&#148; under Rule 144(a)(3) of the Securities Act unless registered under the Securities Act or resold pursuant to an exemption from the registration requirements of the Securities Act in a transaction
that results in such Common Shares or Preferred Shares, as the case may be, no longer being a &#147;restricted security.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) It is
understood that the Common Shares or Preferred Shares, as applicable, issued in accordance with this Agreement shall bear the following or a similar legend for so long as such securities constitute &#147;restricted securities&#148; within the
meaning of Rule 144(a)(3) of the Securities Act: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS SECURITY AND THE COMMON STOCK, IF ANY, ISSUABLE UPON CONVERSION OF THIS SECURITY
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#147;SECURITIES ACT&#148;), AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF OR OF
A BENEFICIAL INTEREST HEREIN, THE ACQUIRER: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) REPRESENTS THAT IT AND ANY ACCOUNT FOR WHICH IT IS ACTING IS A
&#147;QUALIFIED INSTITUTIONAL BUYER&#148; (WITHIN THE MEANING OF RULE 144A UNDER THE SECURITIES ACT) OR AN &#147;ACCREDITED INVESTOR&#148; WITHIN THE MEANING OF RULE 501(A) OF THE SECURITIES ACT, AND </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) AGREES FOR THE BENEFIT OF FLUIDIGM CORPORATION (THE &#147;COMPANY&#148;) THAT IT WILL NOT OFFER, SELL, PLEDGE OR OTHERWISE
TRANSFER THIS SECURITY OR ANY BENEFICIAL INTEREST HEREIN PRIOR TO THE DATE THAT IS THE LATER OF (X)&nbsp;ONE YEAR AFTER THE LAST ORIGINAL ISSUE DATE HEREOF OR SUCH SHORTER PERIOD OF TIME AS PERMITTED BY RULE 144 UNDER THE SECURITIES ACT OR ANY
SUCCESSOR PROVISION THERETO AND (Y)&nbsp;SUCH LATER DATE, IF ANY, AS MAY BE REQUIRED BY APPLICABLE LAW, EXCEPT: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) TO THE
COMPANY OR ANY SUBSIDIARY THEREOF, OR </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) PURSUANT TO A REGISTRATION STATEMENT THAT HAS BECOME EFFECTIVE UNDER THE
SECURITIES ACT AND IS EFFECTIVE AT THE TIME OF SUCH TRANSFER, OR </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) TO A PERSON THAT YOU REASONABLY BELIEVE TO BE A
QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT, OR </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) PURSUANT TO AN EXEMPTION FROM
REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT OR ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PRIOR TO THE REGISTRATION OF ANY TRANSFER IN ACCORDANCE WITH CLAUSE (2)(D) ABOVE, THE COMPANY RESERVES THE RIGHT TO REQUIRE THE DELIVERY OF
SUCH LEGAL OPINIONS, CERTIFICATIONS OR OTHER EVIDENCE AS MAY REASONABLY BE REQUIRED IN ORDER TO DETERMINE THAT THE PROPOSED TRANSFER IS BEING MADE IN COMPLIANCE WITH THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. NO REPRESENTATION IS MADE
AS TO THE AVAILABILITY OF ANY EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>13 <U>CONVERSION </U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.1 Preferred Share Automatic Conversion. </B>Upon issuance of the Preferred Shares by the Borrower (if approved at the Company Stockholder
Meeting), without any further action taken or notice given by the Lenders, the Conversion Amount shall convert automatically into a number of Preferred Shares equal to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(1) the Conversion Amount divided by $1,000 multiplied by </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(2) the Conversion Price (as defined under the applicable definitive documentation governing the Preferred Shares) divided by $2.84 (the
&#147;<B>Initial Company Share Price</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, no Preferred Shares will be issued prior to obtaining the approval of the
stockholders of the Company authorizing the issuance of such Preferred Shares at a duly called meeting of such stockholders (the &#147;<B>Company Stockholder Meeting</B>&#148;) and shall be issued in connection with the Closing (as defined in the
Purchase Agreement). In lieu of fractional shares otherwise issuable, each Lender shall be entitled to receive, at the Company&#146;s sole discretion, either (i)&nbsp;cash in lieu of delivering any fractional Preferred Shares issuable on conversion
in an amount equal to the product obtained by <I>multiplying</I> (A)&nbsp;the applicable &#147;Conversion Rate&#148; (not as defined herein, but in the applicable certificate of designations for the Preferred Shares) <I>by</I> (B)&nbsp;the fraction
of a Preferred Share not issued <I>by</I> (C)&nbsp;the VWAP of the Common Shares for the relevant Conversion Date (or, if such Conversion Date is not a Trading Day, the next following Trading Day) or (ii)&nbsp;one additional whole share of fully
paid and nonassessable Preferred Share. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.2 Common Share Conversion Privilege. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Upon the earlier to occur of (i)&nbsp;a negative vote at the Company Stockholder Meeting with respect to the authorization of the Preferred
Shares, and therefore the automatic conversion pursuant to Section&nbsp;13.1 does not occur, or (ii)&nbsp;the termination of the Purchase Agreement and therefore the automatic conversion pursuant to Section&nbsp;13.1 does not occur (the earlier to
occur of immediately preceding clauses (i)&nbsp;and (ii), the &#147;<B>Conversion Privilege Trigger</B>&#148;), Lenders shall have the right, at Lenders&#146; option, at any time following the conclusion of the Company Stockholder Meeting or
termination of the Purchase Agreement, but prior to the close of business on the Business Day immediately preceding the Loan Maturity Date, subject to the conversion procedures set forth in Section&nbsp;13.3, to convert all or a portion of such
Lender&#146;s Conversion Amount at any time into a number of Common Shares equal to (1)&nbsp;the Conversion Amount so converted <I>multiplied by</I> (2)&nbsp;the Conversion Rate <I>divided by</I> (3)&nbsp;$1,000; <U>provided</U>, that Lenders shall
receive cash in lieu of any fractional shares as set out in Section&nbsp;13.3(f). For the avoidance of doubt, Lenders may not convert any portion of such Lender&#146;s Conversion Amount pursuant to this Section&nbsp;13.2(a) prior to the occurrence
of the Conversion Privilege Trigger. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Borrower shall at all times reserve and keep available out of its authorized and
unissued Common Shares, solely for issuance on the conversion of the Conversion Amount, such number of Common Shares as shall from time to time be issuable on the conversion of all the Conversion Amount then outstanding. The Borrower shall use its
reasonable best efforts to maintain the listing on the NASDAQ of such number of Common Shares as shall from time to time be issuable on the conversion of the Conversion Amount then outstanding. Any Common Shares issued on conversion of the
Conversion Amount shall be duly authorized, validly issued, fully paid and nonassessable and shall not be subject to preemptive rights or subscription rights of any other stockholder of the Borrower. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the contrary in this Agreement, nothing in this Agreement shall require Borrower to issue any Common Shares to
Lenders to the extent such issuance would result in the number of Aggregate Shares issued by Borrower to the Lenders under this Agreement, to exceed the Conversion Cap. For purposes of this Section&nbsp;13.2(c), &#147;<B>Aggregate Shares</B>&#148;
shall be equal to the number of shares of Common Stock of the Company issued at any time in the aggregate to the Lenders under this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.3 Conversion Procedure. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Conversion Procedure</U>. A Lender must do each of the following in order to convert all or a portion of the Conversion Amount held by
such Lender pursuant to Section&nbsp;13.2(a) (the first date on which a Lender has complied with all such procedures (including the satisfaction of any conditions to conversion set forth in the Conversion Notice), the &#147;<B>Conversion
Date</B>&#148;): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) complete and manually sign the conversion notice provided by the Borrower, a form of which is attached hereto as
<U>Exhibit A</U> (the &#147;<B>Conversion Notice</B>&#148;), and deliver such notice to the Borrower; provided, that a Conversion Notice may be conditional on the completion of a Change in Control or other condition, transaction or event as Lenders
may specify; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) deliver to the Borrower the Promissory Note (if any) representing the Conversion Amount to be converted; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) if required, furnish appropriate endorsements and transfer documents; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) if required, pay the amount of any tax that may be payable in respect of any transfer involved in the issuance or delivery of Common
Shares to a Person other than Lenders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Effect of Conversion</U>. Effective immediately prior to the close of business on the
Conversion Date applicable to any Conversion Amount converted, such Conversion Amount shall cease to be outstanding, interest with respect to such Conversion Amount shall cease to accrue and the corresponding Common Shares pursuant to the conversion
shall be issued and outstanding. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Record Holder of Underlying Securities as of Conversion Date</U>. The Lender or Lenders entitled
to receive the Common Stock and, to the extent applicable, cash, securities or other property issuable on conversion of the Conversion Amount on a Conversion Date shall be treated for all purposes as the record holder(s) of such shares of Common
Shares and/or cash, securities or other property as of the close of business on such Conversion Date. As promptly as practicable on or after the Conversion Date and, if applicable, compliance by the applicable Lender with the relevant procedures
contained in Section&nbsp;13.3(a) (and in any event no later than three Trading Days thereafter; provided, that if a written notice from such Lender in accordance with Section&nbsp;13.3(a)(i) specifies a date of delivery for any shares of Common
Shares, such shares shall be delivered on the date so specified, which shall be no earlier than the second Business Day and no later than the seventh Business Day following the date of such notice), Borrower shall issue the number of whole shares of
Common Shares issuable on conversion (and deliver payment of cash in lieu of fractional shares or as otherwise set out in Section&nbsp;13.3(f)) and, to the extent applicable, any cash, securities or other property issuable thereon. Such delivery of
shares of Common Shares, securities or other property, shall be made by book-entry or, at the request of the applicable Lender, by delivering a notice to the Borrower, through the facilities of The Depository Trust Company, or in certificated form.
Any such certificate or certificates shall be delivered by the Borrower to the appropriate Lender on a book-entry basis, through </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the facilities of The Depository Trust Company, or by mailing certificates evidencing the shares to the applicable Lender, in each case at their respective addresses set forth in the Conversion
Notice. In the event that a Lender shall not by written notice designate the name in which shares of Common Shares (and payments of cash in lieu of fractional shares) and, to the extent applicable, cash, securities or other property to be delivered
on conversion of the Conversion Amount should be registered or paid, or the manner in which such shares, cash, securities or other property should be delivered, the Borrower shall be entitled to register and deliver such shares, securities or other
property, and make such payment, in the name of the Lender and in the manner shown on the records of the Borrower. The Lender shall promptly deliver or cause to be delivered to Borrower&#146;s transfer agent or any other Person all such customary
additional documentation as may be reasonably necessary to effectuate the delivery of any Common Shares, securities, or other property in accordance with this Section&nbsp;13.3(c). Any securities issued to the Lender pursuant to this Agreement shall
bear the legends set forth in Section&nbsp;12.17 to the extent such securities constitute &#147;restricted securities&#148; within the meaning of Rule 144(a)(3). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Status of Reacquired Conversion Amount</U>. The Conversion Amount converted in accordance with this Agreement, or otherwise acquired by
the Borrower or any of its Subsidiaries in any manner whatsoever, shall cease to be outstanding after the acquisition thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)
<U>Partial Conversion</U>. In case any Promissory Note for the Conversion Amount shall be surrendered for partial conversion, the Borrower shall, at its expense, execute and deliver to or on the written order of Lender of the Promissory Note so
surrendered a new Promissory Note for the Conversion Amount not converted. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>No Fractional Shares</U>. Notwithstanding the foregoing,
the Borrower shall not deliver any fractional Common Shares on conversion of the Conversion Amount but the Borrower shall instead pay cash in lieu of delivering any fractional Common Shares issuable on conversion based on the VWAP of the Common
Shares for the relevant Conversion Date (or, if such Conversion Date is not a Trading Day, the next following Trading Day). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.4
Adjustments of Conversion Rate.</B> The Conversion Rate shall be adjusted from time to time by the Borrower if any of the following events occurs, except that the Borrower shall not make any adjustments to the Conversion Rate if Lenders participate
(other than in the case of a share split or share combination or a tender or exchange offer), at the same time and upon the same terms as holders of the Common Shares and solely as a result of their capacities as Lenders hereunder, in any of the
transactions described in this Section&nbsp;13.4, without having to convert the Conversion Amount, as if it held a number of Common Shares equal to the Conversion Rate <I>multiplied by</I> the Conversion Amount <I>divided by</I> $1,000. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If the Borrower exclusively issues Common Shares as a dividend or distribution on shares of the Common Shares, or if the Borrower<B>
</B>effects a share split or share combination, the Conversion Rate shall be adjusted based on the following formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g243622dsp309.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately prior to the open of business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date of such dividend or distribution, or immediately prior to the open of business on the Effective
Date of such share split or share combination, as applicable;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the open of business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date or Effective Date;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OS<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of Common Shares outstanding immediately prior to the open of business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date or Effective Date (before giving effect to any such dividend, distribution, split or
combination); and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OS<SUP STYLE="font-size:85%; vertical-align:top">1</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of Common Shares outstanding immediately after giving effect to such dividend, distribution, share split or share combination.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any adjustment made under this <U>Section</U><U></U><U>&nbsp;13.4(a)</U> shall become effective immediately
after the open of business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such dividend or distribution, or immediately after the open of business on the Effective Date for such share split or share combination, as applicable.
If any dividend or distribution of the type described in this <U>Section</U><U></U><U>&nbsp;13.4</U> is declared but not so paid or made, the Conversion Rate shall be immediately readjusted, effective as of the date the Board determines not to pay
such dividend or distribution, to the Conversion Rate that would then be in effect if such dividend or distribution had not been declared. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If the Borrower issues to all or substantially all holders of the Common Shares any rights, options or warrants (other than in connection
with a stockholder rights plan) entitling them, for a period of not more than 45 calendar days after the announcement date of such issuance, to subscribe for or purchase shares of the Common Shares at a price per share that is less than the average
of the Last Reported Sale Prices of the Common Shares for the ten consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement of such issuance, the Conversion Rate shall be increased based
on the following formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g243622dsp310.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately prior to the open of business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such issuance;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the open of business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OS<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of Common Shares outstanding immediately prior to the open of business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">X</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the total number of Common Shares issuable pursuant to such rights, options or warrants; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Y</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of Common Shares equal to the aggregate price payable to exercise such rights, options or warrants, divided by the average of the Last Reported Sale Prices of the Common Shares over the ten consecutive Trading Day period
ending on, and including, the Trading Day immediately preceding the date of announcement of the issuance of such rights, options or warrants.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any increase made under this <U>Section</U><U></U><U>&nbsp;13.4(b)</U> shall be made successively whenever any such rights,
options or warrants are issued and shall become effective immediately after the open of business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such issuance. To the extent that shares of the Common Shares are not delivered
after the expiration of such rights, options or warrants, the Conversion Rate shall be decreased to the Conversion Rate that would then be in effect had the increase with respect to the issuance of such rights, options or warrants been made on the
basis of delivery of only the number of Common Shares actually delivered. If such rights, options or warrants are not so issued, the Conversion Rate shall be decreased to the Conversion Rate that would then be in effect if such <FONT
STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such issuance had not occurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this <U>Section</U><U></U><U>&nbsp;13.4(b)</U>, in
determining whether any rights, options or warrants entitle the holders to subscribe for or purchase shares of the Common Shares at less than such average of the Last Reported Sale Prices of the Common Shares for the ten consecutive Trading Day
period ending on, and including, the Trading Day immediately preceding the date of announcement for such issuance, and in determining the aggregate offering price of such Common Shares, there shall be taken into account any consideration received by
the Borrower for such rights, options or warrants and any amount payable on exercise or conversion thereof, the value of such consideration, if other than cash, to be determined by the Borrower in good faith and in a commercially reasonable manner.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If the Borrower distributes shares of its Capital Stock, evidences of its indebtedness,
other assets or property of the Borrower or rights, options or warrants to acquire its Capital Stock or other securities, to all or substantially all holders of the Common Shares, excluding (i)&nbsp;dividends, distributions or issuances (including
share splits) as to which an adjustment was effected (or would be required to be effected, notwithstanding the 1%&nbsp;Exception in <U>Section</U><U></U><U>&nbsp;13.4(k)</U>) pursuant to <U>Section</U><U></U><U>&nbsp;13.4(a)</U> or
<U>Section</U><U></U><U>&nbsp;13.4(b)</U>, (ii)&nbsp;dividends or distributions paid exclusively in cash, as to which the provisions set forth in <U>Section</U><U></U><U>&nbsp;13.4(d)</U> shall apply, (iii)&nbsp;except as otherwise described below,
rights issued pursuant to a stockholder rights plan of the Borrower, (iv)&nbsp;distributions of Exchange Property in a Reorganization Event and (v)&nbsp;Spin-Offs, as to which the provisions set forth below in this
<U>Section</U><U></U><U>&nbsp;13.4(c)</U> shall apply (any of such shares of Capital Stock, evidences of indebtedness, other assets or property or rights, options or warrants to acquire Capital Stock or other securities, the &#147;<B>Distributed
Property</B>&#148;), then the Conversion Rate shall be increased based on the following formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g243622dsp311.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">where: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately prior to the open of business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such distribution;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the open of business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SP<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Last Reported Sale Prices of the Common Shares over the ten consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT>
Date for such distribution; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FMV</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the fair market value (as determined by the Borrower in good faith and in a commercially reasonable manner) of the Distributed Property with respect to each outstanding share of the Common Shares on the <FONT
STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such distribution.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any increase made under the portion of this <U>Section</U><U></U><U>&nbsp;13.4(c)</U> above shall become effective immediately
after the open of business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such distribution. If such distribution is not so paid or made, the Conversion Rate shall be decreased to the Conversion Rate that would then be in effect
if such distribution had not been declared. If the Borrower issues rights, options or warrants that are only exercisable on the occurrence of certain triggering events, then the Borrower shall not adjust the Conversion Rate pursuant to the clauses
above until the earliest of these triggering events occurs, and the Borrower shall readjust the Conversion Rate to the extent that any of these rights, options or warrants are not exercised before they expire. In the case of any distribution of
rights, options or warrants, to the extent any such rights, options or warrants expire unexercised, the Conversion Rate shall be immediately readjusted to the Conversion Rate that would then be in effect had the increase made for the distribution of
such rights, options or warrants been made on the basis of delivery of only the number of shares of the Common Shares actually delivered on exercise of such rights, options or warrants. Notwithstanding the foregoing, if &#147;FMV&#148; (as defined
above) is equal to or greater than &#147;SP<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB>&#148; (as defined above), in lieu of the foregoing increase, Lenders shall receive, in respect of each $1,000 of the Conversion Amount then held, at
the same time and on the same terms as holders of the Common Shares, the amount and kind of Distributed Property Lenders would have received if Lenders owned a number of Common Shares equal to the Conversion Rate in effect on the <FONT
STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for the distribution. If the Borrower determines the &#147;FMV&#148; (as defined above) of any distribution for purposes of this <U>Section</U><U></U><U>&nbsp;13.4(c)</U> by reference to the actual
or when-issued trading market for any securities, it shall in doing so consider the prices in such market over the same period used in computing the Last Reported Sale Prices of the Common Shares over the ten consecutive Trading Day period ending
on, and including, the Trading Day immediately preceding the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With respect
to an adjustment pursuant to this <U>Section</U><U></U><U>&nbsp;13.4(c)</U> where there has been a payment of a dividend or other distribution on the Common Shares of shares of Capital Stock of any class or series, or similar equity interest, of or
relating to a Subsidiary or other business unit of the Borrower, that are, or, when issued, will be, listed or admitted for trading on a U.S. national securities exchange (a &#147;<B><FONT STYLE="white-space:nowrap">Spin-Off</FONT></B>&#148;), the
Conversion Rate shall be increased based on the following formula: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g243622dsp312.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately prior to the end of the Valuation Period;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the end of the Valuation Period;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FMV<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Last Reported Sale Prices of the Capital Stock or similar equity interest distributed to holders of the Common Shares applicable to one share of the Common Shares (determined by reference to the definition of Last
Reported Sale Price as set forth in Section&nbsp;14.1 as if references therein to Common Shares were to such Capital Stock or similar equity interest) over the first ten consecutive Trading Day period after, and including, the <FONT
STYLE="white-space:nowrap">Ex-Dividend</FONT> Date of the <FONT STYLE="white-space:nowrap">Spin-Off</FONT> (the &#147;<B>Valuation Period</B>&#148;); provided, that if there is no Last Reported Sale Price of the Capital Stock or similar equity
interest distributed to the holders of the Common Shares on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date, the &#147;Valuation Period&#148; shall be the first ten consecutive Trading Day period after, and including, the first Trading
Day such Last Reported Sale Price is available; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">MP<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Last Reported Sale Prices of the Common Shares over the Valuation Period.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The adjustment to the Conversion Rate under the preceding paragraph shall occur at the close of business on the last Trading
Day of the Valuation Period; <U>provided</U>, that if the relevant Conversion Date occurs during the Valuation Period, references to &#147;ten&#148; in the preceding paragraph shall be deemed to be replaced with such lesser number of Trading Days as
have elapsed from, and including, the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date of such <FONT STYLE="white-space:nowrap">Spin-Off</FONT> to, and including, the Conversion Date in determining the Conversion Rate. If any dividend or
distribution that constitutes a <FONT STYLE="white-space:nowrap">Spin-Off</FONT> is declared but not so paid or made, the Conversion Rate shall be immediately decreased, effective as of the date the Board determines not to pay or make such dividend
or distribution, to the Conversion Rate that would then be in effect if such dividend or distribution had not been declared or announced. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of
this <U>Section</U><U></U><U>&nbsp;13.4(c)</U> (and subject in all respect to Section&nbsp;14.11), rights, options or warrants distributed by the Borrower to all holders of the Common Shares entitling them to subscribe for or purchase shares of the
Borrower&#146;s Capital Stock, including Common Shares (either initially or under certain circumstances), which rights, options or warrants, until the occurrence of a specified event or events (a &#147;<B>Trigger Event</B>&#148;) (i)&nbsp;are deemed
to be transferred with such shares of the Common Shares, (ii)&nbsp;are not exercisable and (iii)&nbsp;are also issued in respect of future issuances of the Common Shares, shall be deemed not to have been distributed for purposes of this
<U>Section</U><U></U><U>&nbsp;13.4(c)</U> (and no adjustment to the Conversion Rate under this <U>Section</U><U></U><U>&nbsp;13.4(c)</U> shall be required) until the occurrence of the earliest Trigger Event, whereupon such rights, options or
warrants shall be deemed to have been distributed and an appropriate adjustment (if any is required) to the Conversion Rate shall be made under this <U>Section</U><U></U><U>&nbsp;13.4(c)</U>. If any such right, option or warrant, including any such
existing rights, options or warrants distributed prior to the Effective Date, are subject to events, on the occurrence of which such rights, options or warrants become exercisable to purchase different securities, evidences of indebtedness or other
assets, then the date of the occurrence of any and each such event shall be deemed to be the date of distribution and <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date with respect to new rights, options or warrants with such rights (in which
case the existing rights, options or warrants shall be deemed to terminate and expire on such date without exercise by any of the holders thereof). In addition, in the event of any distribution (or deemed distribution) of rights, options or
warrants, or any Trigger Event or other event (of the type described in the immediately preceding sentence) with respect thereto that was counted for purposes of calculating a distribution amount for which an adjustment to the Conversion Rate under
this <U>Section</U><U></U><U>&nbsp;13.4(c)</U> was made, (A)&nbsp;in the case of any such rights, options or warrants that shall all have been purchased without exercise by any holders thereof, on such final redemption or purchase (1)&nbsp;the
Conversion Rate shall be readjusted as if such rights, options or warrants had not been issued and (2)&nbsp;the Conversion Rate shall then again be readjusted to give effect to such distribution, deemed distribution or Trigger Event, as the case may
be, as though it were a cash distribution, equal to the per share </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
redemption or purchase price received by a holder or holders of Common Shares with respect to such rights, options or warrants (assuming such holder had retained such rights, options or
warrants), made to all holders of Common Shares as of the date of such redemption or purchase and (B)&nbsp;in the case of such rights, options or warrants that shall have expired or been terminated without exercise by any holders thereof, the
Conversion Rate shall be readjusted as if such rights, options and warrants had not been issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of
<U>Section</U><U></U><U>&nbsp;13.4(a)</U>, <U>Section</U><U></U><U>&nbsp;13.4(b)</U> and <U>Section</U><U></U><U>&nbsp;13.4(c)</U>, if any dividend or distribution to which this <U>Section</U><U></U><U>&nbsp;13.4(c)</U> is applicable also includes
one or both of: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) a dividend or distribution of Common Shares to which <U>Section</U><U></U><U>&nbsp;13.4(a)</U> is
applicable (a &#147;<B>Clause A Distribution</B>&#148;); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) a dividend or distribution of rights, options or warrants
to which <U>Section</U><U></U><U>&nbsp;13.4(b)</U> is applicable (a &#147;<B>Clause B Distribution</B>&#148;), </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">then, in either case, (1)&nbsp;such
dividend or distribution, other than the Clause A Distribution and/or Clause B Distribution, shall be deemed to be a dividend or distribution to which this <U>Section</U><U></U><U>&nbsp;13.4(c)</U> is applicable (a &#147;<B>Clause C
Distribution</B>&#148;) and any Conversion Rate adjustment required by this <U>Section</U><U></U><U>&nbsp;13.4(c)</U> with respect to such Clause C Distribution shall then be made and (2)&nbsp;the Clause A Distribution and/or Clause B Distribution
shall be deemed to immediately follow such Clause C Distribution and any Conversion Rate adjustment required by <U>Section</U><U></U><U>&nbsp;13.4(a)</U> and/or <U>Section</U><U></U><U>&nbsp;13.4(b)</U> with respect thereto shall then be made,
except that, if determined by the Borrower (I)&nbsp;the <FONT STYLE="white-space:nowrap">&#147;Ex-Dividend</FONT> Date&#148; of the Clause A Distribution and/or Clause B Distribution shall be deemed to be the
<FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date of the Clause C Distribution and (II)&nbsp;any Common Shares included in the Clause A Distribution and/or Clause B Distribution shall be deemed not to be &#147;outstanding immediately prior to
the open of business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date or Effective Date&#148; within the meaning of <U>Section</U><U></U><U>&nbsp;13.4(a)</U> or &#147;outstanding immediately prior to the open of business on such <FONT
STYLE="white-space:nowrap">Ex-Dividend</FONT> Date&#148; within the meaning of <U>Section</U><U></U><U>&nbsp;13.4(b)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If any cash
dividend or distribution is made to all or substantially all holders of the Common Shares, the Conversion Rate shall be adjusted based on the following formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g243622dsp313.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately prior to the open of business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such dividend or distribution;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the open of business on the Ex-Dividend Date for such dividend or distribution;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SP<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Last Reported Sale Price of the Common Shares on the Trading Day immediately preceding the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such dividend or distribution; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">C</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the amount in cash per share the Borrower distributes to all or substantially all holders of the Common Shares.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any increase pursuant to this <U>Section</U><U></U><U>&nbsp;13.4(d)</U> shall become effective immediately after the open of
business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such dividend or distribution. If such dividend or distribution is not so paid, the Conversion Rate shall be decreased, effective as of the date the Board determines not to
make or pay such dividend or distribution, to be the Conversion Rate that would then be in effect if such dividend or distribution had not been declared. Notwithstanding the foregoing, if &#147;C&#148; (as defined above) is equal to or greater than
&#147;SP<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB>&#148; (as defined above), in lieu of the foregoing increase, Lenders shall receive, for each $1,000 of the Conversion Amount, at the same time and on the same terms as holders of
shares of the Common Shares, the amount of cash that Lenders would have received if Lender owned a number of Common Shares equal to the Conversion Rate in effect on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such cash dividend
or distribution.&nbsp;&nbsp;&nbsp;&nbsp; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) If the Borrower or any of its Subsidiaries make a payment in respect of a tender or
exchange offer for the Common Shares that is subject to the then-applicable tender offer rules under the Exchange Act, other than an <FONT STYLE="white-space:nowrap">odd-lot</FONT> tender offer, to the extent that the cash and value of any other
consideration included in the payment per share of the Common Shares exceeds the average of the Last Reported Sale Prices of the Common Shares over the ten consecutive Trading Day period commencing on, and including, the Trading Day next succeeding
the last date on which tenders or exchanges may be made pursuant to such tender or exchange offer, the Conversion Rate shall be increased based on the following formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g243622dsp314.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately prior to the close of business on the tenth Trading Day immediately following, and including, the Trading Day next succeeding the date such tender or exchange offer expires;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the close of business on the tenth Trading Day immediately following, and including, the Trading Day next succeeding the date such tender or exchange offer expires;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the aggregate value of all cash and any other consideration (as determined by the Borrower in good faith and in a commercially reasonable manner) paid or payable for Common Shares purchased in such tender or exchange
offer;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OS<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of Common Shares outstanding immediately prior to the date such tender or exchange offer expires (prior to giving effect to the purchase of all Common Shares accepted for purchase or exchange in such tender or exchange
offer);</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OS<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of Common Shares outstanding immediately after the date such tender or exchange offer expires (after giving effect to the purchase of all Common Shares accepted for purchase or exchange in such tender or exchange offer);
and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SP<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Last Reported Sale Prices of the Common Shares over the ten consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the date such tender or exchange offer expires.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The adjustment to the Conversion Rate under this <U>Section</U><U></U><U>&nbsp;13.4(e)</U> shall occur at the close of
business on the tenth Trading Day immediately following, and including, the Trading Day immediately following the expiration date of such tender or exchange offer expires; provided that if the relevant Conversion Date occurs during the ten Trading
Days immediately following, and including, the Trading Day next succeeding the expiration date of any tender or exchange offer, references to &#147;ten&#148; or &#147;tenth&#148; in the preceding paragraph shall be deemed replaced with such lesser
number of Trading Days as have elapsed from, and including, the Trading Day next succeeding the date that such tender or exchange offer expires to, and including, the Conversion Date in determining the Conversion Rate. For the avoidance of doubt, no
adjustment under this <U>Section</U><U></U><U>&nbsp;13.4(e)</U> shall be made if such adjustment would result in a decrease in the Conversion Rate (other than, for the avoidance of doubt, any readjustment described in the immediately succeeding
paragraph). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Borrower or one of its Subsidiaries is obligated to purchase the Common Shares pursuant to any such tender or exchange offer described
in this <U>Section</U><U></U><U>&nbsp;13.4(e)</U> but the Borrower or such Subsidiary is permanently prevented by applicable law from effecting any such purchase or all such purchases are rescinded, the Conversion Rate shall be decreased to be the
Conversion Rate that would then be in effect if such tender or exchange offer had not been made or had been made only in respect of the purchases that have been effected. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Notwithstanding this <U>Section</U><U></U><U>&nbsp;13.4</U> or any other provision of
this Agreement, if (i)&nbsp;a Conversion Rate adjustment becomes effective on any <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date, (ii)&nbsp;Lenders have converted their Conversion Amount and the Conversion Date for such conversion occurs
on or after such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date and on or prior to the related Record Date, (iii)&nbsp;the consideration due on such conversion includes any whole Common Shares based on a Conversion Rate that is adjusted
for such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date and (iv)&nbsp;such Common Shares would be entitled to participate in such dividend, distribution, or other event giving rise to such adjustment, then the Conversion Rate adjustment
relating to such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date shall not be made for such conversion, and, instead, the Common Shares issuable on conversion on an unadjusted basis shall be entitled to participate in the related dividend,
distribution or other event giving rise to such adjustment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Except as stated herein, the Borrower shall not adjust the Conversion Rate
for the issuance of shares of the Common Shares or any securities convertible into or exchangeable for shares of the Common Shares or the right to purchase shares of the Common Shares or such convertible or exchangeable securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) In addition to those adjustments required by <U>Sections 13.4(a)</U>, <U>(b)</U>, <U>(c)</U>, <U>(d)</U> and <U>(e)</U>, and to the extent
permitted by applicable law and subject to the applicable rules of any exchange on which any of the Borrower&#146;s securities are then listed, the Borrower from time to time may increase the Conversion Rate by any amount for a period of at least 20
Business Days if the Board determines that such increase would be in the Borrower&#146;s best interest. In addition, to the extent permitted by applicable law and subject to the applicable rules of any exchange on which any of the Borrower&#146;s
securities are then listed, the Borrower may (but is not required to) increase the Conversion Rate to avoid or diminish income tax to holders of Common Shares or rights to purchase Common Shares in connection with a dividend or distribution of
Common Shares (or rights to acquire Common Shares) or similar event. Whenever the Conversion Rate is increased pursuant to either of the preceding two sentences, the Borrower shall deliver to Lender a notice of the increase at least 15 days prior to
the date the increased Conversion Rate takes effect, and such notice shall state the increased Conversion Rate and the period during which it will be in effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) If the Borrower has a stockholder rights plan in effect on conversion of any portion of the Conversion Amount, each share of Common Shares,
if any, issued on such conversion shall be entitled to receive the appropriate number of rights, if any, and the certificates representing the Common Shares issued on such conversion shall bear such legends, if any, in each case as may be provided
by the terms of any such stockholder rights plan, as the same may be amended from time to time. However, if, prior to any conversion of any portion of the Conversion Amount, the rights have separated from the Common Shares in accordance with the
provisions of the applicable stockholder rights plan, the Conversion Rate shall be adjusted at the time of separation as if the Borrower distributed to all or substantially all holders of the Common Shares Distributed Property as provided in
<U>Section</U><U></U><U>&nbsp;13.4(i)</U>, subject to readjustment in the event of the expiration, termination or redemption of such rights. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Notwithstanding anything to the contrary in this <U>Section</U><U></U><U>&nbsp;13.4(j)</U>, the Conversion Rate shall not be adjusted: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) on the issuance of Common Shares at a price below the Initial Company Share Price or otherwise, other than any such issuance described in
<U>Section</U><U></U><U>&nbsp;13.4(a)</U>, <U>(b)</U> or <U>(c)</U>; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) on the issuance of any Common Shares pursuant to any present or
future plan providing for the reinvestment of dividends or interest payable on the Borrower&#146;s securities and the investment of additional optional amounts in Common Shares under any plan; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) on the issuance of any Common Shares or options or rights to purchase those shares pursuant to any present or future employee, director
or consultant benefit or incentive plan (including pursuant to any evergreen plan) or program of or assumed by the Borrower or any of the Borrower&#146;s Subsidiaries or in connection with any such shares withheld by the Borrower for tax withholding
purposes; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) on the issuance of any Common Shares pursuant to any option, warrant, right or
exercisable, exchangeable or convertible security not described in clause&nbsp;(ii) of this subsection and outstanding as of the Effective Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) for a tender offer by any party other than a tender offer by the Borrower or one or more of the Borrower&#146;s Subsidiaries as described
in <U>Section</U><U></U><U>&nbsp;13.4(e)</U>; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) on the repurchase of any shares of the Common Shares pursuant to an open-market share
repurchase program or other <FONT STYLE="white-space:nowrap">buy-back</FONT> transaction (including, without limitation, through any structured or derivative transactions such as accelerated share repurchase transactions or similar forward
derivatives), or other <FONT STYLE="white-space:nowrap">buy-back</FONT> transaction, that is not a tender offer or exchange offer of the nature described under <U>Section</U><U></U><U>&nbsp;13.4(e)</U>; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) solely for a change in the par value (or lack of par value) of the Common Shares; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) for accrued and unpaid interest, if any. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) The Borrower shall not adjust the Conversion Rate pursuant to the clauses above unless the adjustment would result in a change of at least
1% in the then effective Conversion Rate; <U>provided</U>, that the Borrower shall carry forward any adjustment to the Conversion Rate that the Borrower would otherwise have to make and take that adjustment into account in any subsequent adjustment.
Notwithstanding the foregoing, all such carried-forward adjustments shall be made with respect to the Conversion Amount (i)&nbsp;in connection with any subsequent adjustment to the Conversion Rate of at least 1% of the Conversion Rate and
(ii)&nbsp;regardless of whether the aggregate adjustment is less than 1% of the Conversion Rate, on the Conversion Date, in each case, unless the adjustment has already been made. The provisions described above in this
<U>Section</U><U></U><U>&nbsp;13.4(k)</U> are referred to as the &#147;<B>1% </B><B>Exception</B>&#148;. All calculations and other determinations under this <U>Section</U><U></U><U>&nbsp;13</U> shall be made by the Borrower and shall be made to the
nearest 1/10,000th of a share. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Whenever the Conversion Rate is adjusted as herein provided, the Borrower shall promptly deliver to
Lenders an Officers&#146; Certificate setting forth the Conversion Rate after such adjustment and setting forth a brief statement of the facts requiring such adjustment. Failure to deliver such notice shall not affect the legality or validity of any
such adjustment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) For purposes of this <U>Section</U><U></U><U>&nbsp;13</U> the number of Common Shares at any time outstanding shall
not include Common Shares held in the treasury of the Borrower so long as the Borrower does not pay any dividend or make any distribution on Common Shares held in the treasury of the Borrower, but shall include Common Shares issuable in respect of
scrip certificates issued in lieu of fractions of Common Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.5 Reorganization Events. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Reorganization Events</U>. In the event of: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) any reclassification, statutory exchange, merger, consolidation or other similar business combination of the Borrower with or into another
Person, in each case, pursuant to which at least a majority of the Common Shares is changed or converted into, or exchanged for, cash, securities or other property of the Borrower or another Person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) any sale, transfer, lease or conveyance to another Person of all or substantially all of the consolidated assets of the Borrower and its
Subsidiaries, taken as a whole, in each case pursuant to which the Common Shares are converted into cash, securities or other property; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) any statutory exchange of securities of the Borrower with another Person (other than in connection with a merger or acquisition) or
reclassification, recapitalization or reorganization of the Common Shares into other securities; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(each, a &#147;<B>Reorganization Event</B>&#148;), the Conversion Amount outstanding immediately prior to
such Reorganization Event (to the extent Lenders have not elected a Lender Repurchase Right in accordance with Section&nbsp;13.5(c)(ii)) shall, without the consent of Lenders and subject to Section&nbsp;13.5(d), shall automatically become
convertible into, in accordance with Section&nbsp;13.2, the number, kind and amount of securities, cash and other property (the &#147;<B>Exchange Property</B>&#148;) (without any interest on such Exchange Property) that Lenders would have received
in such Reorganization Event had Lenders converted their Conversion Amount into the applicable number of Common Shares immediately prior to the effective date of the Reorganization Event using the Conversion Rate applicable immediately prior to the
effective date of the Reorganization Event; provided, that the foregoing shall not apply if Lender is a Person with which the Borrower consolidated or into which the Borrower merged or which merged into the Borrower or to which such sale or transfer
was made, as the case may be (any such Person, a &#147;<B>Constituent Person</B>&#148;), or an Affiliate of a Constituent Person, to the extent such Reorganization Event provides for different treatment of Common Shares held by such Constituent
Persons or such Affiliate thereof. If the kind or amount of securities, cash and other property receivable on such Reorganization Event is not the same for each share of Common Shares held immediately prior to such Reorganization Event by a Person
(other than a Constituent Person or an Affiliate thereof), then for the purpose of this Section&nbsp;13.5(a), the kind and amount of securities, cash and other property receivable on conversion following such Reorganization Event shall be deemed to
be the weighted average of the types and amounts of consideration received by the holders of Common Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Successive
Reorganization Events</U>. The above provisions of this Section&nbsp;13.5 shall similarly apply to successive Reorganization Events and the provisions of Section&nbsp;13.4 shall apply to any shares of Capital Stock (as though such Capital Stock were
Common Shares) received by the holders of the Common Shares in any such Reorganization Event. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Reorganization Event Notice; Lender
Repurchase Right</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Borrower (or any successor) shall, no less than 20 days prior to the anticipated effective date of any
Reorganization Event, provide written notice to Lenders of such anticipated occurrence of such event and of the kind and amount of the cash, securities or other property that constitutes the Exchange Property (the &#147;<B>Reorganization Event
Notice</B>&#148;); <I>provided</I>, nothing in this Section&nbsp;13.5(c) shall require the Borrower to deliver such notice to Lenders prior to the public announcement of such anticipated Reorganization Event. Failure to deliver such notice shall not
affect the operation of this Section&nbsp;13.5. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Upon receipt of the Reorganization Event Notice, Lenders will have the right to
require the Borrower to repurchase the Loan (the &#147;<B>Lender Repurchase Right</B>&#148;) at a repurchase price equal to (i) 100% of the Outstanding Principal Amount, <I>plus</I> (ii)&nbsp;accrued and unpaid interest to, but excluding, the
effective date of the Reorganization Event (the &#147;<B>Repurchase Price</B>&#148;). To elect the Lender Repurchase Right, the Lenders shall notify Borrower of such election in writing at least three Business Days prior to the later of (i)&nbsp;the
anticipated effective date of the Reorganization Event specified in the Reorganization Event Notice, or (ii)&nbsp;the actual effective date of such Reorganization Event. To the extent Lenders exercises their Lender Repurchase Right, payment of the
Repurchase Price shall be made to Lenders on the effective date of the Reorganization Event. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Reorganization Event Agreements</U>.
The Borrower shall not enter into any agreement for a transaction constituting a Reorganization Event unless (i)&nbsp;such agreement provides for or does not interfere with or prevent (as applicable) conversion of the Conversion Amount into the
Exchange Property in a manner that is consistent with and gives effect to this Section&nbsp;13.5 and (ii)&nbsp;to the extent that the Borrower is not the surviving corporation in such Reorganization Event or shall be dissolved in connection with
such Reorganization Event, proper provision shall be made in the agreements governing such Reorganization Event for the conversion of the Conversion Amount into stock of the Person surviving such Reorganization Event or such other continuing entity
in such Reorganization Event. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.6 Certain Covenants. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Borrower covenants that all Common Shares issued upon conversion of the Conversion Amount will be fully paid and <FONT
STYLE="white-space:nowrap">non-assessable</FONT> by the Borrower and free from all taxes, liens and charges with respect to the issue thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Borrower covenants that, if any Common Shares to be provided for the purpose of
conversion of the Conversion Amount hereunder require registration with or approval of any governmental authority under any federal or state law before such Common Shares may be validly issued upon conversion, the Borrower will, to the extent then
permitted by the rules and interpretations of the SEC, secure such registration or approval, as the case may be. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Borrower further
covenants that if at any time the Common Shares shall be listed on any national securities exchange or automated quotation system the Borrower will list and keep listed, so long as the Common Shares shall be so listed on such exchange or automated
quotation system, any Common Shares issuable upon conversion of the Conversion Amount. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.7 Investor Representations.</B> Each Lender
represents and warrants as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Such Lender is an &#147;accredited investor&#148; within the meaning of Regulation D of the
Securities Act and is able to bear the risk of its investment in the Preferred Shares and Common Shares.&nbsp;Such Lender has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of
the conversion of the Conversion Amount into Preferred Shares and Common Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Such Lender and its Representatives has been
furnished with (i)&nbsp;materials relating to the business, finances and operations of Borrower, (ii)&nbsp;materials relating to the Preferred Shares and Common Shares and (iii)&nbsp;materials relating to the Loan Agreement, in each case, that have
been requested by such Lender.&nbsp;Such Lender and its Representatives have been afforded the opportunity to ask questions of Borrower.&nbsp;Neither such inquiries nor any other due diligence investigations conducted at any time by such Lender and
its Representatives shall modify, amend or affect such Lender&#146;s right (i)&nbsp;to rely on Borrower&#146;s representations and warranties contained in Section&nbsp;5 above or (ii)&nbsp;to indemnification or any other remedy based on, or with
respect to the accuracy or inaccuracy of, or compliance with, the representations, warranties, covenants and agreements in this Agreement.&nbsp;Each Lender understands that its conversion of the Conversion Amount into Preferred Shares and Common
Shares involves a high degree of risk.&nbsp;Such Lender has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to making the Loan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Such Lender understands that any certificate or book-entry position evidencing Preferred Shares and Common Shares will bear the restrictive
legend set forth in the Section&nbsp;12.17 or the certificate of designations for the Preferred Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Such Lender is acquiring the
Loan for its own account, the account of its Affiliates, or the accounts of clients for whom such Lender exercises discretionary investment authority (all of whom such Lender hereby represents and warrants are &#147;accredited investors&#148; within
the meaning of Regulation D of the Securities Act), not as a nominee or agent, and not with a view to distribution in violation of any securities Laws.&nbsp;Such Lender has been advised and understands that the conversion of the Conversion Amount
into Preferred Shares or Common Shares, as applicable, will not be registered under the Securities Act or under the &#147;blue sky&#148; laws of any jurisdiction and may be resold only if registered pursuant to the requirements of the Securities Act
(or if eligible, pursuant to Rule 144 promulgated under the Securities Act or pursuant to another available exemption from the registration requirements of the Securities Act).</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Such Lender understands that there is no public trading market for the Preferred Shares, that none is expected to develop and that the
Preferred Shares shall be held indefinitely unless and until the Preferred Shares are registered under the Securities Act or an exemption from registration is available.&nbsp;Such Lender has been advised of and is knowledgeable with respect to the
provisions of Rule 144 promulgated under the Securities Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The obligations of Lender under this Agreement are several and not joint
with the obligations of (i)&nbsp;the other Lender under this Agreement and (ii)&nbsp;any lender under that certain Loan Agreement between <B>CASDIN PARTNERS MASTER FUND, L.P.</B>, a Cayman Islands exempted limited partnership, <B>CASDIN PRIVATE
GROWTH EQUITY FUND II, L.P.</B>, a Delaware limited partnership and Borrower dated and effective as of January&nbsp;23, 2022 (the &#147;<B>Casdin Loan Agreement</B>&#148;), and Lender shall not be responsible in any way for the performance of the
obligations of any lender under the Casdin Loan Agreement. Nothing contained herein, and no action taken by any Lender pursuant hereto or any lender pursuant to the Casdin Loan Agreement, shall be deemed to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
constitute a partnership, an association, a joint venture or any other kind of entity among Lender and any lender under the Casdin Loan Agreement, or create a presumption that Lender and any
lender under the Casdin Loan Agreement are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by this Agreement or the Casdin Loan Agreement. Lender shall be entitled to independently protect
and enforce its rights, including the rights arising out of this Agreement, and it shall not be necessary for any lender under the Casdin Loan Agreement to be joined as an additional party in any proceeding for such purpose. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Other than with its Affiliates, Lenders are not a member of a &#147;group&#148; (as such term is used in Section&nbsp;13(d) of the Exchange
Act) of Persons with respect to any securities of the Company (it being understood that in no event will the lenders under the Casdin Loan Agreement or any of their Affiliates be deemed to be Affiliates of Lenders for purposes of this Agreement).
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>14 <U>DEFINITIONS</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14.1 Definitions</B><B>.</B> As used in the Loan Documents, the word &#147;shall&#148; is mandatory, the word &#147;may&#148; is permissive,
the word &#147;or&#148; is not exclusive, the words &#147;includes&#148; and &#147;including&#148; are not limiting, the singular includes the plural, and numbers denoting amounts that are set off in brackets are negative. As used in this Agreement,
the following capitalized terms have the following meanings: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>2014 Notes</B>&#148; are (i)&nbsp;the existing unsecured
Indebtedness issued under that certain Indenture between Borrower as issuer and U.S. Bank National Association as Trustee dated as of February&nbsp;4, 2014, and (ii)&nbsp;that certain First Supplemental Indenture between Borrower as issuer and U.S.
Bank National Association as Trustee dated as of February&nbsp;4, 2014. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>2019 Notes</B>&#148; are the existing unsecured
Indebtedness issued under that certain Indenture between Borrower as issuer and U.S. Bank National Association as Trustee dated as of November&nbsp;22, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Affiliate</B>&#148; is, with respect to any Person, each other Person that owns or controls directly or indirectly the Person, any
Person that controls or is controlled by or is under common control with the Person, and each of that Person&#146;s senior executive officers, directors, partners and, for any Person that is a limited liability company, that Person&#146;s managers
and members. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Agreement</B>&#148; is defined in the preamble hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Interest Rate</B>&#148; means: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="24%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Applicable&nbsp;Interest&nbsp;Rate</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">From and including the Effective Date to but excluding March&nbsp;1, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">From and including March&nbsp;1, 2022 to but excluding June&nbsp;1, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">From and including June&nbsp;1, 2022 to but excluding September&nbsp;1, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">From and including September&nbsp;1, 2022 and thereafter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Authorized Signer</B>&#148; is any individual listed in Borrower&#146;s Borrowing Resolution who is
authorized to execute the Loan Documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Board</B>&#148; is Borrower&#146;s board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Borrower</B>&#148; is defined in the preamble hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Borrower&#146;s Books</B>&#148; are all Borrower&#146;s books and records including ledgers, federal and state tax returns, records
regarding Borrower&#146;s assets or liabilities, business operations or financial condition, and all computer programs or storage or any equipment containing such information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Borrowing Resolutions</B>&#148; are, with respect to any Person, those resolutions adopted by such Person&#146;s board of directors
(and, if required under the terms of such Person&#146;s Operating Documents, stockholders) and delivered by such Person to Lender approving the Loan Documents to which such Person is a party and the transactions contemplated thereby, together with a
certificate executed by its secretary on behalf of such Person certifying (a)&nbsp;such Person has the authority to execute, deliver, and perform its obligations under each of the Loan Documents to which it is a party, (b)&nbsp;that set forth as a
part of or attached as an exhibit to such certificate is a true, correct, and complete copy of the resolutions then in full force and effect authorizing and ratifying the execution, delivery, and performance by such Person of the Loan Documents to
which it is a party, (c)&nbsp;the name(s) of the Person(s) authorized to execute the Loan Documents, on behalf of such Person, together with a sample of the true signature(s) of such Person(s), and (d)&nbsp;that Lender may conclusively rely on such
certificate unless and until such Person shall have delivered to Lender a further certificate canceling or amending such prior certificate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Business Day</B>&#148; is any day that is not a Saturday, Sunday or a day on which commercial banks are required to close in New
York, New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Capital Stock</B>&#148; means, for any entity, any and all shares, interests, rights to purchase, warrants,
options, participations or other equivalents of or interests in (however designated) stock issued by that entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Cash
Equivalents</B>&#148; means (a)&nbsp;marketable direct obligations issued or unconditionally guaranteed by the United States or any agency or any State thereof having maturities of not more than one (1)&nbsp;year from the date of acquisition;
(b)&nbsp;commercial paper maturing no more than one (1)&nbsp;year after its creation and having the highest rating from either Standard&nbsp;&amp; Poor&#146;s Ratings Group or Moody&#146;s Investors Service, Inc.; and (c)&nbsp;money market funds at
least ninety-five percent (95%) of the assets of which constitute Cash Equivalents of the kinds described in clauses (a)&nbsp;through (b) of this definition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>CFC</B>&#148; means a &#147;controlled foreign corporation&#148; within the meaning of Section&nbsp;957 of the Internal Revenue Code.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change in Control</B>&#148; means (a)&nbsp;at any time, any &#147;person&#148; or &#147;group&#148; (as such terms are used in
Sections 13(d) and 14(d) of the Exchange Act), shall become, or obtain rights (whether by means of warrants, options or otherwise) to become, the &#147;beneficial owner&#148; (as defined in Rules <FONT STYLE="white-space:nowrap">13(d)-3</FONT> and
13(d) 5 under the Exchange Act), directly or indirectly, of forty percent (40%) or more of the ordinary voting power for the election of directors of Borrower (determined on a fully diluted basis); (b) during any period of twelve
(12)&nbsp;consecutive months, a majority of the members of the board of directors or other equivalent governing body of Borrower cease to be composed of individuals (i)&nbsp;who were members of that board or equivalent governing body on the first
day of such period, (ii)&nbsp;whose election or nomination to that board or equivalent governing body was approved by individuals referred to in clause (i)&nbsp;above constituting at the time of such election or nomination at least a majority of
that board or equivalent governing body or (iii)&nbsp;whose election or nomination to that board or other equivalent governing body was approved by individuals referred to in clauses (i)&nbsp;and (ii) above constituting at the time of such election
or nomination at least a majority of that board or equivalent governing body; (c)&nbsp;at any time, Borrower shall cease to own and control, of record and beneficially, directly or indirectly, one hundred percent (100%) of each class of outstanding
capital stock of each Subsidiary of Borrower (other than director&#146;s qualifying shares) free and clear of all Liens (other than Permitted Liens); or (d)&nbsp;the occurrence of any &#147;Fundamental Change&#148; under the applicable Indenture
governing Permitted Convertible Indebtedness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Claims</B>&#148; is defined in Section&nbsp;12.3. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Clause A Distribution</B>&#148; is defined in Section&nbsp;13.4(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Clause B Distribution</B>&#148; is defined in Section&nbsp;13.4(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Clause C Distribution</B>&#148; is defined in Section&nbsp;13.4(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Code</B>&#148; is the Uniform Commercial Code, as the same may, from time to time, be enacted and in effect in the State of New York;
provided, that, to the extent that the Code is used to define any term herein or in any Loan Document and such term is defined differently in different Articles or Divisions of the Code, the definition of such term contained in Article or Division 9
shall govern. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Common Shares</B>&#148; mean shares of common stock, $0.001 per value per share of the Borrower. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Constituent Person</B>&#148; is defined in Section&nbsp;13.5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Contingent Obligation</B>&#148; is, for any Person, any direct or indirect liability, contingent or not, of that Person for
(a)&nbsp;any indebtedness, lease, dividend, letter of credit or other obligation of another such as an obligation, in each case, directly or indirectly guaranteed, endorsed, co made, discounted or sold with recourse by that Person, or for which that
Person is directly or indirectly liable; (b)&nbsp;any obligations for undrawn letters of credit for the account of that Person; and (c)&nbsp;all obligations from any interest rate, currency or commodity swap agreement, interest rate cap or collar
agreement, or other agreement or arrangement designated to protect a Person against fluctuation in interest rates, currency exchange rates or commodity prices; but &#147;Contingent Obligation&#148; does not include endorsements in the ordinary
course of business. The amount of a Contingent Obligation is the stated or determined amount of the primary obligation for which the Contingent Obligation is made or, if not determinable, the maximum reasonably anticipated liability for it
determined by the Person in good faith; but the amount may not exceed the maximum of the obligations under any guarantee or other support arrangement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Conversion Amount</B>&#148; means the Outstanding Principal Amount plus all accrued and unpaid interest as of the Conversion Date.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Conversion Cap</B>&#148; means at all times prior to 60 days prior to the Maturity Date, a number of shares of Common Shares not
to exceed 9.5% of the number of Common Shares outstanding as of the date hereof (as determined pursuant to Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Securities Exchange Act of 1934, as amended), and at all times, at the
Lender&#146;s election, a number of Common Shares not to exceed (collectively for such Lender, together with Lenders that are Affiliates) 19.99% of the number of Common Shares outstanding (calculated in accordance with the listing standards of the
Nasdaq Stock Market Rule 5635(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Conversion Date</B>&#148; is defined in Section&nbsp;13.3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Conversion Notice</B>&#148; is defined in Section&nbsp;13.3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Conversion Rate</B>&#148; means, in respect of conversion into Common Shares, an initial conversion rate of 352.1126 Common Shares
(subject to adjustment as provided herein) per $1,000 Conversion Amount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Copyrights</B>&#148; are any and all copyright rights,
copyright applications, copyright registrations and like protections in each work of authorship and derivative work thereof, whether published or unpublished and whether or not the same also constitutes a trade secret. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Distributed Property</B>&#148; is defined in Section&nbsp;13.4(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Division</B>&#148; means, in reference to any Person which is an entity, the division of such Person into two (2)&nbsp;or more
separate Persons, with the dividing Person either continuing or terminating its existence as part of such division, including, without limitation, as contemplated under <FONT STYLE="white-space:nowrap">Section&nbsp;18-217</FONT> of the Delaware
Limited Liability Company Act for limited liability companies formed under Delaware law, or any analogous action taken pursuant to any other applicable law with respect to any corporation, limited liability company, partnership or other entity. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Dollars</B>,&#148; &#147;<B>dollars</B>&#148; or use of the sign &#147;$&#148;
means only lawful money of the United States and not any other currency, regardless of whether that currency uses the &#147;$&#148; sign to denote its currency or may be readily converted into lawful money of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Domestic Subsidiary</B>&#148; means a Subsidiary organized under the laws of the United States or any state or territory thereof or
the District of Columbia (excluding any FSHCO). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Effective Date</B>&#148; is defined in the preamble hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Equipment</B>&#148; is all &#147;<B>equipment</B>&#148; as defined in the Code with such additions to such term as may hereafter be
made, and includes without limitation all machinery, fixtures, goods, vehicles (including motor vehicles and trailers), and any interest in any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>ERISA</B>&#148; is the Employee Retirement Income Security Act of 1974, and its regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Event of Default</B>&#148; is defined in Section&nbsp;8. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Exchange Act</B>&#148; is the Securities Exchange Act of 1934, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Exchange Property</B>&#148; is defined in Section&nbsp;13.5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Excluded Taxes</B>&#148; means any of the following Taxes imposed on or with respect to the Lender or required to be withheld or
deducted from a payment to the Lender, (a)&nbsp;Taxes imposed on or measured by net income (however denominated), franchise Taxes, and branch profits Taxes, in each case, (i)&nbsp;imposed as a result of the Lender being organized under the laws of,
or having its principal office or, in the case of any Lender, its applicable lending office located in, the jurisdiction imposing such Tax (or any political subdivision thereof) or (ii)&nbsp;that are Other Connection Taxes, (b)&nbsp;in the case of a
Lender, withholding Taxes imposed on amounts payable to or for the account of such Lender with respect to an applicable interest in a Loan pursuant to a law in effect on the date on which (i)&nbsp;such Lender acquires such interest in the Loan or
(ii)&nbsp;such Lender changes its lending office, except in each case to the extent that, pursuant to Section&nbsp;2.7, amounts with respect to such Taxes were payable either to such Lender&#146;s assignor immediately before such Lender became a
party hereto or to such Lender immediately before it changed its lending office, (c)&nbsp;Taxes attributable to a Lender&#146;s failure to provide tax forms pursuant to Section&nbsp;2.7, and (d)&nbsp;any withholding Taxes imposed under FATCA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date</B>&#148; means the first date on which Common Shares trade on the
applicable exchange or in the applicable market, regular way, without the right to receive the issuance, dividend or distribution in question, from the Borrower or, if applicable, from the seller of Common Shares on such exchange or market (in the
form of due bills or otherwise) as determined by such exchange or market. For the avoidance of doubt, any alternative trading convention on the applicable exchange or market in respect of Common Shares under a separate ticker symbol or CUSIP number
shall not be considered &#147;regular way&#148; for the purposes of this definition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>FATCA</B>&#148; means Sections 1471 through
1474 of the Internal Revenue Code of 1986, as amended, as of the date of this Agreement (or any amended or successor version), any current or future regulations or official interpretations thereof, any agreements entered into pursuant to
Section&nbsp;1471(b)(1) of the Code and any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement, treaty or convention among Governmental Authorities and implementing such Sections of the Internal
Revenue Code of 1986, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Funding Date</B>&#148; means the date on which the Loan has been made pursuant to
Section&nbsp;3.4(b) of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>FSHCO</B>&#148; means any Subsidiary organized under the laws of any political
subdivision of the United States (including any disregarded entity for U.S. federal income tax purposes), substantially all of the assets of which consist of, directly or indirectly, equity securities of one or more CFCs or Indebtedness of such
CFCs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>GAAP</B>&#148; is generally accepted accounting principles set forth in the
opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other Person
as may be approved by a significant segment of the accounting profession, which are applicable to the circumstances as of the date of determination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Governmental Approval</B>&#148; is any consent, authorization, approval, order, license, franchise, permit, certificate,
accreditation, registration, filing or notice, of, issued by, from or to, or other act by or in respect of, any Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Governmental Authority</B>&#148; is any nation or government, any state or other political subdivision thereof, any agency,
authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative functions of or pertaining to government, any securities exchange and any
self-regulatory organization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Guarantor</B>&#148; is any Person providing a Guaranty in favor of Lender. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Guaranty</B>&#148; is any guarantee of all or any part of the Obligations, as the same may from time to time be amended, restated,
modified or otherwise supplemented. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Indebtedness</B>&#148; is (a)&nbsp;indebtedness for borrowed money or the deferred price of
property or services, such as reimbursement and other obligations for surety bonds and letters of credit, (b)&nbsp;obligations evidenced by notes, bonds, debentures or similar instruments, (c)&nbsp;capital lease obligations, and (d)&nbsp;Contingent
Obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Indemnified Person</B>&#148; is defined in Section&nbsp;12.3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Indemnified Taxes</B>&#148; means (a)&nbsp;Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on
account of any obligation of the Borrower under any Loan Document and (b)&nbsp;to the extent not otherwise described in (a), Other Taxes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Indenture</B>&#148; means each of (i)&nbsp;that certain Indenture between Borrower as issuer and U.S. Bank National Association as
Indenture Trustee dated as of November&nbsp;22, 2019 and (ii)&nbsp;the Indenture between Borrower as issuer and U.S. Bank National Association as Indenture Trustee dated as of February&nbsp;4, 2014, as supplemented by that certain First Supplemental
Indenture between Borrower as issuer and U.S. Bank National Association as Indenture Trustee dated as of February&nbsp;4, 2014. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Insolvency Proceeding</B>&#148; is any proceeding by or against any Person under the United States Bankruptcy Code, or any other
bankruptcy or insolvency law, including assignments for the benefit of creditors, compositions, extensions generally with its creditors, or proceedings seeking reorganization, arrangement, or other relief. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Intellectual Property</B>&#148; means, with respect to any Person, all of such Person&#146;s right, title, and interest in and to the
following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) its Copyrights, Trademarks and Patents; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) any and all trade secrets and trade secret rights, including, without limitation, any rights to unpatented inventions, <FONT
STYLE="white-space:nowrap">know-how</FONT> and operating manuals; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) any and all source code; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) any and all design rights which may be available to such Person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) any and all claims for damages by way of past, present and future infringement of any of the foregoing, with the right, but not the
obligation, to sue for and collect such damages for said use or infringement of the Intellectual Property rights identified above; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) all amendments, renewals and extensions of any of the Copyrights, Trademarks or Patents.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Inventory</B>&#148; is all &#147;<B>inventory</B>&#148; as defined in the Code in effect on the date hereof with such additions
to such term as may hereafter be made, and includes without limitation all merchandise, raw materials, parts, supplies, packing and shipping materials, work in process and finished products, including without limitation such inventory as is
temporarily out of Borrower&#146;s custody or possession or in transit and including any returned goods and any documents of title representing any of the above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Investment</B>&#148; is any beneficial ownership interest in any Person (including stock, partnership interest or other securities),
and any loan, advance or capital contribution to any Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Key Person</B>&#148; is each of Borrower&#146;s (a)&nbsp;Chief
Executive Officer, who is Stephen Christopher Linthwaite as of the Effective Date, and (b)&nbsp;Chief Financial Officer, who is Vikram Jog as of the Effective Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Last Reported Sale Price</B>&#148; of the Common Shares (or other security for which a closing sale price must be determined) on any
date means the closing sale price per share (or if no closing sale price is reported, the average of the bid and ask prices or, if more than one in either case, the average of the average bid and the average ask prices) on that date as reported in
composite transactions for the principal U.S. national or regional securities exchange on which the Common Shares (or such other security) is traded. If the Common Shares (or such other security) is not listed for trading on a U.S. national or
regional securities exchange on the relevant date, the &#147;Last Reported Sale Price&#148; shall be the last quoted bid price for the Common Shares (or such other security) in the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market on the relevant date as reported by OTC Markets Group Inc. or a similar organization. If the Common Shares (or such other security) is not so
quoted, the &#147;Last Reported Sale Price&#148; shall be the average of the <FONT STYLE="white-space:nowrap">mid-point</FONT> of the last bid and ask prices per share of the Common Shares (or such other security) on the relevant date from each of
at least three nationally recognized independent investment banking firms selected by the Borrower for this purpose. The &#147;Last Reported Sale Price&#148; shall be determined without regard to after-hours trading or any other trading outside of
the regular trading session hours. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Lender Entities</B>&#148; is defined in Section&nbsp;12.9. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Lender Expenses</B>&#148; are all audit fees and expenses, costs, and expenses (including reasonable attorneys&#146; fees and
expenses) for preparing, amending, negotiating, administering, defending and enforcing the Loan Documents (including, without limitation, those incurred in connection with appeals or Insolvency Proceedings) or otherwise incurred with respect to
Borrower or any Guarantor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Lien</B>&#148; is a claim, mortgage, deed of trust, levy, charge, pledge, security interest or other
encumbrance of any kind, whether voluntarily incurred or arising by operation of law or otherwise against any property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Loan
Documents</B>&#148; are, collectively, this Agreement and any schedules, exhibits, certificates, notices, and any other documents related to this Agreement, any subordination agreement, any note, or notes or guaranties executed by Borrower or any
Guarantor, and any other present or future agreement by Borrower and/or any Guarantor with or for the benefit of Lender pursuant to this Agreement, all as amended, restated, or otherwise modified. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Loan Maturity Date</B>&#148; is the 91st calendar day after the latest maturity date of the loans (the &#147;<B>Reference Loan
Maturity Date</B>&#148;) borrowed pursuant to the SVB Loan and Security Agreement as in effect as of the Effective Date (without giving effect to any amendments, supplements or other modifications to the SVB Loan and Security Agreement after the
Effective Date that would extend the Reference Loan Maturity Date to a later date). For the avoidance of doubt, to the extent that the Reference Loan Maturity Date is pulled forward to an earlier maturity date pursuant to the terms of the SVB Loan
and Security Agreement as in effect as of the Effective Date, the Loan Maturity Date shall be automatically adjusted to be the 91st day after the then-current maturity date of the Reference Loan Maturity Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Market Disruption Event</B>&#148; means any of the following events: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) any suspension of, or limitation imposed on, trading of the Common Shares or options contracts relating to the Common Shares by any U.S.
exchange or quotation system on which the Last Reported Sale Price is determined pursuant to the definition of &#147;Last Reported Sale Price&#148; (the &#147;<B><I>Relevant Exchange</I></B>&#148;) during the
<FONT STYLE="white-space:nowrap">one-hour</FONT> period prior to the close of trading for the regular trading session on the Relevant Exchange (or for purposes of determining the VWAP per Common Share, any period or periods aggregating one half-hour
or longer during the regular trading session on the relevant day) whether by reason of movements in price exceeding limits permitted by the Relevant Exchange or otherwise; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) any event that disrupts or impairs (as determined by the Borrower in its reasonable discretion) the ability of market participants during
the <FONT STYLE="white-space:nowrap">one-hour</FONT> period prior to the close of trading for the regular trading session on the Relevant Exchange (or for purposes of determining the VWAP per Common Share, any period or periods aggregating one
half-hour or longer during the regular trading session on the relevant day) to effect transactions in, or obtain market values for, Common Shares on the Relevant Exchange or to effect transactions in, or obtain market values for, options contracts
relating to Common Shares on the Relevant Exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Material Adverse Change</B>&#148; is (a) [reserved]; (b) a material adverse
change in the business, operations, or condition (financial or otherwise) of Borrower; or (c)&nbsp;a material impairment of the prospect of repayment of any portion of the Obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Obligations</B>&#148; are Borrower&#146;s obligations to pay when due any debts, principal, interest, fees, Lender Expenses and other
amounts Borrower owes Lender now or later, whether under this Agreement, the other Loan Documents, or otherwise, including, without limitation, interest accruing after Insolvency Proceedings begin and debts, liabilities, or obligations of Borrower
assigned to Lender, and to perform Borrower&#146;s duties under the Loan Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Officer</B>&#148; means, with respect to the
Borrower, the President, the Chief Executive Officer, the Chief Financial Officer, the Treasurer, the Secretary, any Executive or Senior Vice President or any Vice President (whether or not designated by a number or numbers or word or words added
before or after the title &#147;Vice President&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Officers&#146; Certificate</B>&#148; means a certificate that is
delivered to Lender and that is signed by (a)&nbsp;two Officers of the Borrower or (b)&nbsp;one Officer of the Borrower and one of the Treasurer, any Assistant Treasurer, the Secretary, any Assistant Secretary or the Controller of the Borrower. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Operating Documents</B>&#148; are, for any Person, such Person&#146;s formation documents, as certified by the Secretary of State (or
equivalent agency) of such Person&#146;s jurisdiction of organization on a date that is no earlier than thirty (30)&nbsp;days prior to the Effective Date, and, (a)&nbsp;if such Person is a corporation, its bylaws in current form, (b)&nbsp;if such
Person is a limited liability company, its limited liability company agreement (or similar agreement), and (c)&nbsp;if such Person is a partnership, its partnership agreement (or similar agreement), each of the foregoing with all current amendments
or modifications thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Other Connection Taxes</B>&#148; means, with respect to the Lender, Taxes imposed as a result of a
present or former connection between the Lender and the jurisdiction imposing such Tax (other than connections arising from the Lender having executed, delivered, become a party to, performed its obligations under, received payments under, received
or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Loan or Loan Document). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Other Taxes</B>&#148; means all present or future stamp, court or documentary, intangible, recording, filing or similar Taxes that
arise from any payment made under, from the execution, delivery, performance, enforcement or registration of, from the receipt or perfection of a security interest under, or otherwise with respect to, any Loan Document, except any such Taxes that
are Other Connection Taxes imposed with respect to an assignment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Outstanding Principal Amount</B>&#148; means the original
principal amount of the Loan of $12,500,000 and all accrued interest thereon that has been capitalized pursuant to Section&nbsp;2.4(a)(ii) hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Patents</B>&#148; means all patents, patent applications and like protections
including without limitation improvements, divisions, continuations, renewals, reissues, extensions and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part</FONT></FONT> of the same. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Permitted Acquisition</B>&#148; is an acquisition of all or substantially all of the equity interests or assets (or all or
substantially all of the assets constituting a business unit, division, product line or line of business) of a Person, provided: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the
Person acquired or assets acquired is a type of business (or the assets are used in a type of business) permitted to be engaged by Borrower under this Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the acquisition is <FONT STYLE="white-space:nowrap">non-hostile</FONT> in nature; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) the Person or Persons to be acquired shall be solely organized in the United States and shall conduct their principal operations in the
United States; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) no Event of Default exists at the time of such acquisition or would exist after giving effect to such acquisition; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) the acquisition of the Person does not materially and adversely affect Borrower&#146;s earnings; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) the consideration paid in connection with all such acquisitions consists solely of (i)&nbsp;Borrower&#146;s equity securities,
(ii)&nbsp;the net proceeds received by Borrower or its Subsidiaries in connection with a contemporaneous issuance of equity securities solely for the purpose of consummating such acquisition or (iii)&nbsp;a combination of the foregoing <FONT
STYLE="white-space:nowrap">sub-clauses</FONT> (i)&nbsp;and (ii); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Lender shall have received at least thirty (30)&nbsp;days prior
written notice of the closing date for such acquisition; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Borrower shall remain a surviving legal entity; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any Person that is acquired and remains a separate legal entity shall be organized in the United States and shall become a <FONT
STYLE="white-space:nowrap">co-borrower</FONT> under this Agreement in accordance with Section&nbsp;6.13 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Permitted
Convertible Indebtedness</B>&#148; means the 2014 Notes and the 2019 Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Permitted Indebtedness</B>&#148; is: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;(i) Borrower&#146;s or any Subsidiary&#146;s Indebtedness to Lender under this Agreement and the other Loan Documents and
(ii)&nbsp;Borrower&#146;s or any Subsidiary&#146;s Indebtedness under the Casdin Loan Agreement and the related loan documents; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
Indebtedness existing on the Effective Date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Subordinated Debt; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) unsecured Indebtedness to trade creditors incurred in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Indebtedness incurred as a result of endorsing negotiable instruments received in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Indebtedness secured by Liens permitted under clauses (a)&nbsp;and (c) of the definition of &#147;Permitted Liens&#148; hereunder; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Indebtedness in respect of performance bonds, bid bonds, appeal bonds, surety bonds and similar obligations, in each case provided in the
ordinary course of business; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Permitted Convertible Indebtedness; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Indebtedness that otherwise constitutes a Permitted Investment; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Indebtedness consisting of reimbursement obligations in respect of letters of credit, bank guarantees or
bankers<B>&#146;</B><B></B>&nbsp;acceptances issued for the benefit of customers, suppliers or distributors located in foreign jurisdictions in a face amount not to exceed Seven Hundred Thousand Dollars ($700,000); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) other unsecured Indebtedness not exceeding Five Hundred Thousand Dollars ($500,000) in the aggregate outstanding at any time; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Indebtedness under the SVB Loan and Security Agreement or any guaranty provided in respect thereof and (ii)&nbsp;Indebtedness to Silicon
Valley Bank in connection with bank services; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) Indebtedness of Borrower or a Guarantor owing to a Subsidiary (other than a Guarantor)
if and only if such Indebtedness is Subordinated Debt; provided, further, that any subsequent issuance or transfer of any Capital Stock or any other event which results in any such Subsidiary ceasing to be a Subsidiary or any other subsequent
transfer of any such Indebtedness (except to Borrower) shall be deemed, in each case, to be an incurrence of such Indebtedness not permitted by this clause; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) extensions, refinancings, modifications, amendments and restatements of any items of Permitted Indebtedness (a)&nbsp;through (m) above,
provided that the principal amount thereof is not increased or the terms thereof are not modified to impose more burdensome terms upon Borrower or its Subsidiary, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Permitted Investments</B>&#148; are: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Investments (including, without limitation, Subsidiaries) existing on the Effective Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Investments consisting of Cash Equivalents; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Investments consisting of the endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary
course of Borrower; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Investments consisting of deposit accounts; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Investments accepted in connection with Transfers permitted by Section&nbsp;7.1; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Investments consisting of the creation of a Subsidiary for the purpose of consummating a merger transaction permitted by Section&nbsp;7.3
of this Agreement, which is otherwise a Permitted Investment; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Investments (i)&nbsp;by Borrower in Subsidiaries not to exceed Five
Hundred Thousand Dollars ($500,000) in the aggregate in any fiscal year and (ii)&nbsp;by Subsidiaries in other Subsidiaries in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Investments consisting of (i)&nbsp;travel advances and employee relocation loans and other employee loans and advances in the ordinary
course of business, and (ii)&nbsp;loans to employees, officers or directors relating to the purchase of equity securities of Borrower or its Subsidiaries pursuant to employee stock purchase plans or agreements approved by the Board; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Investments (including debt obligations) received in connection with the bankruptcy or reorganization of customers or suppliers and in
settlement of delinquent obligations of, and other disputes with, customers or suppliers arising in the ordinary course of business; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Investments consisting of notes receivable of, or prepaid royalties and other credit
extensions, to customers and suppliers who are not Affiliates, in the ordinary course of business; provided that this paragraph (j)&nbsp;shall not apply to Investments of Borrower in any Subsidiary; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Indebtedness permitted under clause (m)&nbsp;of Permitted Indebtedness; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) other Investments not otherwise permitted by Section&nbsp;7.7 not exceeding Five Hundred Thousand Dollars ($500,000) in the aggregate
outstanding at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Permitted Liens</B>&#148; are: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Liens existing on the Effective Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Liens for taxes, fees, assessments or other government charges or levies, either (i)&nbsp;not due and payable or (ii)&nbsp;being contested
in good faith and for which Borrower maintains adequate reserves on Borrower&#146;s Books, provided that no notice of any such Lien has been filed or recorded under the Internal Revenue Code of 1986, as amended, and the Treasury Regulations adopted
thereunder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Liens securing capital leases and purchase money Liens (i)&nbsp;on Equipment acquired or held by Borrower incurred for
financing the acquisition of the Equipment securing no more than Five Hundred Thousand Dollars ($500,000) in the aggregate amount outstanding, or (ii)&nbsp;existing on Equipment when acquired, if the Lien is confined to the property and improvements
and the proceeds of the Equipment; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Liens of carriers, warehousemen, suppliers, or other Persons that are possessory in nature arising
in the ordinary course of business so long as such Liens attach only to Inventory, securing liabilities in the aggregate amount not to exceed Five Hundred Thousand Dollars ($500,000) and which are not delinquent or remain payable without penalty or
which are being contested in good faith and by appropriate proceedings which proceedings have the effect of preventing the forfeiture or sale of the property subject thereto; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Liens to secure payment of workers&#146; compensation, employment insurance, <FONT STYLE="white-space:nowrap">old-age</FONT> pensions,
social security and other like obligations incurred in the ordinary course of business (other than Liens imposed by ERISA); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Liens
incurred in the extension, renewal or refinancing of the Indebtedness secured by Liens described in (a)&nbsp;through (c), but any extension, renewal or replacement Lien must be limited to the property encumbered by the existing Lien and the
principal amount of the indebtedness may not increase; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) leases or subleases of real property granted in the ordinary course of
Borrower&#146;s business (or, if referring to another Person, in the ordinary course of such Person&#146;s business), and leases, subleases, <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses or sublicenses of personal property (other
than Intellectual Property) granted in the ordinary course of Borrower&#146;s business (or, if referring to another Person, in the ordinary course of such Person&#146;s business); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses of Intellectual Property in the ordinary course of business, and licenses of
Intellectual Property that could not result in a legal transfer of title of the licensed property that may be exclusive in respects other than territory and that may be exclusive as to territory only as to discrete geographical areas outside of the
United States; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) deposits to secure the performance of bids, trade contracts, leases, statutory obligations, surety and appeal bonds,
performance bonds and other obligations of a like nature, in each case in the ordinary course of business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Liens in favor of customs
and revenue authorities arising as a matter of law to secure payment of customs duties in connection with the importation of goods; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Liens consisting of cash collateral securing obligations described in clause (j)&nbsp;of
the definition of &#147;Permitted Indebtedness&#148; hereunder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Liens arising from attachments or judgments, orders, or decrees in
circumstances not constituting an Event of Default under Sections 8.4 and 8.7; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) Liens in favor of other financial institutions arising
in connection with Borrower&#146;s deposit and/or securities accounts held at such institutions; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) customary Liens on funds in a
trustee&#146;s possession and granted in favor of such trustee to secure fees and other amounts owing to such trustee under the Indentures or other similar instruments pursuant to which any Permitted Convertible Indebtedness is issued; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) Liens on Intellectual Property; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) Liens granted in connection with the SVB Loan and Security Agreement and any Loan Documents (as defined in the SVB Loan and Security
Agreement) entered into in connection therewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Person</B>&#148; is any individual, sole proprietorship, partnership, limited
liability company, joint venture, company, trust, unincorporated organization, association, corporation, institution, public benefit corporation, firm, joint stock company, estate, entity or government agency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Preferred Shares</B>&#148; mean the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock of the Borrower or its
Affiliate to be issued to the Lenders or their Affiliates, which is the same series as may be issued in connection with that certain Purchase Agreement, by and between the Company and the Lenders (the &#147;<B>Purchase Agreement</B>&#148;), dated as
of the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Quarterly Financial Statements</B>&#148; is defined in Section&nbsp;6.2(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Record Date</B>&#148; means, with respect to any dividend, distribution or other transaction or event in which holders of Common
Shares have the right to receive any cash, securities or other property or in which Common Shares is exchanged for or converted into any combination of cash, securities or other property, the date fixed for determination of holders of Common Shares
entitled to receive such cash, securities or other property (whether such date is fixed by the Board or by statute, contract or otherwise). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Registered Organization</B>&#148; is any &#147;registered organization&#148; as defined in the Code with such additions to such term
as may hereafter be made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Reorganization Event</B>&#148; is defined in Section&nbsp;13.5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Reorganization Event Notice</B>&#148; is defined in Section&nbsp;13.5(c)(i). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Representatives</B>&#148; means, in respect of any Person, such Person&#146;s directors, officers, employees, investment bankers,
attorneys, accountants and other advisors or representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Repurchase Price</B>&#148; is defined in Section&nbsp;13.5(c)(ii).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Required Lenders</B>&#148; shall mean, at any date, Lenders having or holding a majority of the outstanding principal amount of
the Term Loans at such date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Requirement of Law</B>&#148; is as to any Person, the organizational or governing documents of such
Person, and any law (statutory or common), treaty, rule or regulation or determination of an arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon such Person or any of its property or to which such Person
or any of its property is subject. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Responsible Officer</B>&#148; is any of the Chief Executive Officer, President,
Chief Financial Officer and Controller of Borrower. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>SEC</B>&#148; shall mean the Securities and Exchange Commission, any
successor thereto, and any analogous Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Securities Act</B>&#148; means the Securities Act of 1933, as
amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">Spin-Off</FONT></B>&#148; is defined in Section&nbsp;13.4(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Subordinated Debt</B>&#148; is indebtedness incurred by Borrower subordinated to all of Borrower&#146;s now or hereafter indebtedness
to Lender (pursuant to a subordination, intercreditor, or other similar agreement in form and substance satisfactory to Lender entered into between Lender and the other creditor), on terms acceptable to Lender. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Subsidiary</B>&#148; is, as to any Person, a corporation, partnership, limited liability company or other entity of which shares of
stock or other ownership interests having ordinary voting power (other than stock or such other ownership interests having such power only by reason of the happening of a contingency) to elect a majority of the board of directors or other managers
of such corporation, partnership or other entity are at the time owned, or the management of which is otherwise controlled, directly or indirectly through one or more intermediaries, or both, by such Person. Unless the context otherwise requires,
each reference to a Subsidiary herein shall be a reference to a Subsidiary of Borrower. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>SVB Loan and Security
Agreement</B>&#148; means that Loan and Security Agreement, dated as of August&nbsp;2, 2018 by and between the Borrower and Silicon Valley Bank, as amended, restated, modified or otherwise supplemented from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Trademarks</B>&#148; means any trademark and servicemark rights, whether registered or not, applications to register and
registrations of the same and like protections, and the entire goodwill of the business of Borrower connected with and symbolized by such trademarks. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transfer</B>&#148; is defined in Section&nbsp;7.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Trading Day</B>&#148; means a Business Day on which the Relevant Exchange is scheduled to be open for business and on which there has
not occurred a Market Disruption Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Trigger Event</B>&#148; is defined in Section&nbsp;13.4(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>U.S.</B><B></B><B>&nbsp;Person</B>&#148; means any Person that is a &#147;United States Person&#148; as defined in
Section&nbsp;7701(a)(30) of the Internal Revenue Code of 1986, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Valuation Period</B>&#148; is defined in
Section&nbsp;13.4(c). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>VWAP</B>&#148; means, for any Trading Days, the per share volume-weighted average price of the Common
Shares as displayed under the heading &#147;Bloomberg VWAP&#148; on Bloomberg page &#147;FLDM &lt;equity&gt; AQR&#148; (or its equivalent successor if such page is not available) in respect of the period from the scheduled open of trading until the
scheduled close of trading of the primary trading session on such Trading Day (or if such volume-weighted average price is unavailable, the market value of one Common Share on such Trading Day reasonably determined, using a volume-weighted average
method, by a nationally recognized independent investment banking firm retained for this purpose by the Borrower). The &#147;VWAP&#148; shall be determined without regard to after-hours trading or any other trading outside of the regular trading
session trading hours. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature page follows.] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties hereto have caused this Agreement to be executed as
of the Effective Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BORROWER:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>FLUIDIGM CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Vikram Jog</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Vikram Jog</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">LENDERS:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>VIKING GLOBAL OPPORTUNITIES ILLIQUID</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INVESTMENTS SUB-MASTER LP</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Viking Global Opportunities Portfolio GP LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Katerina Novak</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Katerina Novak</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Authorized Signatory</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>VIKING GLOBAL OPPORTUNITIES</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>DRAWDOWN (AGGREGATOR) LP</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Viking Global Opportunities Drawdown Portfolio</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">GP LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Katerina Novak</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Katerina Novak</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Authorized Signatory</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>signature page to Loan Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONVERSION NOTICE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Reference is made to
the Loan Agreement, dated and effective as of January&nbsp;23, 2022 (the &#147;<B>Agreement</B>&#148;), between <B>VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS <FONT STYLE="white-space:nowrap">SUB-MASTER</FONT> LP</B>, a Cayman Islands exempted
limited partnership (&#147;<B>Illiquid <FONT STYLE="white-space:nowrap">Sub-Master</FONT></B>&#148;), <B>VIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LP</B>, a Cayman Islands exempted limited partnership (&#147;<B>Drawdown (Aggregator)</B> and
Fluidigm Corporation. In accordance with and pursuant to the Agreement, the undersigned hereby elects to convert the Conversion Amount with respect to the Loan under the Agreement, indicated below into shares of common stock, par value $0.001 per
share (the &#147;<B>Common </B><B>Shares</B>&#148;), of the Borrower, [as of the date specified below // on // immediately prior to[, and subject to the occurrence of,] [&#149;]]. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date&nbsp;of&nbsp;Conversion&nbsp;(if&nbsp;applicable):</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="72%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Conversion&nbsp;Amount&nbsp;to&nbsp;be&nbsp;converted:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="63%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Promissory&nbsp;Note&nbsp;(if&nbsp;applicable)&nbsp;to&nbsp;be&nbsp;converted:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="76%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Tax&nbsp;ID&nbsp;Number&nbsp;(if&nbsp;applicable):</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"></P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="68%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Please&nbsp;confirm&nbsp;the&nbsp;following&nbsp;information:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Conversion&nbsp;Rate:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="68%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Number&nbsp;of&nbsp;Common&nbsp;Shares&nbsp;to&nbsp;be&nbsp;issued:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Please issue the Common Shares into which the Conversion Amount is being converted in the following name and to the following address:</TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Issue&nbsp;to:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Telephone&nbsp;Number:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Email:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Authorization:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="60%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Account&nbsp;Number&nbsp;(if&nbsp;electronic&nbsp;book&nbsp;entry&nbsp;transfer):</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="54%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Transaction&nbsp;Code&nbsp;Number&nbsp;(if&nbsp;electronic&nbsp;book&nbsp;entry&nbsp;transfer):</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="50%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Payment&nbsp;Instructions&nbsp;for&nbsp;cash&nbsp;payment&nbsp;in&nbsp;lieu&nbsp;of&nbsp;fractional&nbsp;shares:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>d243622dex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Exhibit 10.3 </I></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SERIES <FONT STYLE="white-space:nowrap">B-1</FONT> CONVERTIBLE PREFERRED STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURCHASE AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>by
and between </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FLUIDIGM CORPORATION, </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CASDIN PRIVATE GROWTH EQUITY FUND II, L.P. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CASDIN PARTNERS
MASTER FUND, L.P. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dated as of January&nbsp;23, 2022 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Page</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;I DEFINITIONS&nbsp;&amp; INTERPRETATIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Certain Definitions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Index of Defined Terms</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Certain Interpretations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;II AGREEMENT TO SELL AND PURCHASE; CONVERSION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Sale and Purchase; Conversion of Conversion Amount</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">The Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Adjustments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Independent Nature of Purchaser&#146;s Obligations and Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;III REPRESENTATIONS AND WARRANTIES OF THE COMPANY</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Organization; Good Standing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Corporate Power; Enforceability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Company Board Approval; Anti-Takeover Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Requisite Stockholder Approval</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-Contravention</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Requisite Governmental Approvals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Company Capitalization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Subsidiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Company SEC Reports</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Company Financial Statements; Internal Controls</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Undisclosed Liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Absence of Certain Changes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Material Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Real Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Environmental Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Intellectual Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.17</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.18</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Employee Benefits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.19</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Labor Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.20</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Compliance with Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.21</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Anti-Corruption; International Trade</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.22</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Compliance with Healthcare Laws and Regulations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.23</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Legal Proceedings; Orders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.24</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.25</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Related Party Transactions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.26</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Brokers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.27</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Other Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.28</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Investment Company Status</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.29</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Sale of Securities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.30</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Rights Agreement; Anti-Takeover Provisions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.31</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Registration Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.32</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Exclusivity of Representations and Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;IV REPRESENTATIONS AND WARRANTIES OF PURCHASER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Organization; Good Standing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Corporate Power; Enforceability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-Contravention</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Requisite Governmental Approvals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Legal Proceedings; Orders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Ownership of Company Common Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Brokers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Sufficient Funds</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Unregistered Securities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Stockholder and Management Arrangements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Exclusivity of Representations and Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;V INTERIM OPERATIONS OF THE COMPANY</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Affirmative Obligations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Forbearance Covenants</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Solicitation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Control of the Other Party&#146;s Business</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;VI ADDITIONAL COVENANTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Required Action and Forbearance; Efforts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Antitrust Filings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Proxy Statement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Company Stockholder Meeting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Anti-Takeover Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Use of Proceeds</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Access</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Information Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Notification of Certain Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Public Statements and Disclosure</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Transaction Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Listing of Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Certain Governance and Other Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Inconsistent Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Transfer Restrictions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Pre-Emptive</FONT> Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.17</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Standstill</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.18</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Voting Threshold</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;VII CONDITIONS TO THE CASDIN TRANSACTION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Conditions to Each Party&#146;s Obligations to Effect the Casdin Transaction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Conditions to the Obligations of Purchaser to Effect the Casdin Transaction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Conditions to the Company&#146;s Obligations to Effect the Casdin Transaction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;VIII TERMINATION, AMENDMENT AND WAIVER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Manner and Notice of Termination; Effect of Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Fees and Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Amendment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Extension; Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;IX GENERAL PROVISIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Assignment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Entire Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Survival</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Third Party Beneficiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Remedies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Governing Law</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Consent to Jurisdiction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">WAIVER OF JURY TRIAL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Recourse</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Company Disclosure Letter References</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Counterparts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EXHIBITS </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Exhibit&nbsp;A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Form of Certificate of Designations</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SERIES <FONT STYLE="white-space:nowrap">B-1</FONT> CONVERTIBLE PREFERRED STOCK </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURCHASE AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
<B>SERIES</B><B> </B><B><FONT STYLE="white-space:nowrap">B-1</FONT></B><B> </B><B>CONVERTIBLE</B><B> </B><B>PREFERRED</B><B> STOCK PURCHASE AGREEMENT</B> (this &#147;<B>Agreement</B>&#148;) is made and entered into as of January&nbsp;23, 2022 by and
between Fluidigm Corporation, a Delaware corporation (the &#147;<B>Company</B>&#148;), Casdin Private Growth Equity Fund II, L.P., a Delaware limited partnership (&#147;<B>Casdin</B><B> PGEF II</B>&#148;) and Casdin Partners Master Fund, L.P., a
Cayman Islands exempted limited partnership (&#147;<B>Casdin</B><B> PMF</B>&#148; and, together with Casdin PGEF II, &#147;<B>Purchaser</B>&#148;). Purchaser and the Company are sometimes referred to herein individually, as a
&#147;<B>Party</B>&#148; and collectively, as the &#147;<B>Parties</B>.&#148; All capitalized terms that are used in this Agreement have the respective meanings given to them in <U>Article I</U>. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. (i)&nbsp;The
Company desires to issue and sell to Casdin PGEF II, and Casdin PGEF II desires to purchase from the Company, 33,750 shares of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock and (ii)&nbsp;the Company desires to issue and sell
to Casdin PMF, and Casdin PMF desires to purchase from the Company, 78,750 shares of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock, in each case on the terms and subject to the conditions set forth in this Agreement (the
&#147;<B>Casdin</B><B> </B><B>Transaction</B>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. The Company Board has unanimously (i)&nbsp;determined that it is in the best
interests of the Company and the Company Stockholders that the Company enter into this Agreement and the other Transaction Documents and consummate the Transactions and the other transactions contemplated hereby and thereby on the terms and subject
to the conditions set forth herein and therein, (ii)&nbsp;approved and declared advisable this Agreement, the other Transaction Documents, the Transactions and the other transactions contemplated hereby and thereby on the terms and subject to the
conditions set forth herein and therein, (iii)&nbsp;resolved to recommend that the Company Stockholders approve the Transactions and adopt the Certificate of Amendment and (iv)&nbsp;directed that the Transactions and the Certificate of Amendment be
submitted to the Company Stockholders for approval. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. Purchaser has obtained all entity approvals necessary for its entry into this
Agreement and the other Transaction Documents and the consummation of the transactions contemplated hereby and thereby, including the Transactions, on the terms and subject to the conditions set forth herein and therein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">D. On the date of this Agreement, the Company and Purchaser have entered into a loan agreement (the &#147;<B>Loan Agreement</B>&#148;) pursuant
to which Purchaser has loaned to the Company an aggregate original principal amount of $12,500,000. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">E. On the date of this Agreement, the
Company and Purchaser have entered into a registration rights agreement (the &#147;<B>Registration Rights Agreement</B>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">F. The
Parties desire to (i)&nbsp;make certain representations, warranties, covenants and agreements in connection with this Agreement and the Casdin Transaction and (ii)&nbsp;prescribe certain conditions with respect to the consummation of the Casdin
Transaction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing premises and the representations, warranties, covenants and agreements set forth herein, as
well as other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged and accepted, and intending to be legally bound hereby, the Parties agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS&nbsp;&amp; INTERPRETATIONS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1 <I>Certain Definitions</I>. For all purposes of this Agreement, the following terms have the following respective meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Acquired Shares</B>&#148; means, collectively, the Purchased Shares and the Converted Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Acquisition Proposal</B>&#148; means any inquiry, indication of interest, offer or proposal (other than an inquiry, indication of
interest, offer or proposal by Purchaser pursuant to this Agreement or the Viking Purchaser pursuant to the Viking Purchase Agreement) to engage in an Acquisition Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Acquisition Transaction</B>&#148; means any transaction or series of related transactions (other than the Casdin Transaction or the
Viking Transaction) involving: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) any direct or indirect purchase or other acquisition by any Person or &#147;group&#148; (as such term
is used in Section&nbsp;13(d) of the Exchange Act) of Persons of shares of capital stock of the Company, including pursuant to a tender offer or exchange offer, that if consummated in accordance with its terms would result in such Person or
&#147;group&#148; of Persons beneficially owning shares of Company Common Stock and/or securities convertible into or exchangeable for shares of Company Common Stock representing, collectively, 10% or more of the outstanding Company Common Stock (on
an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, if applicable), after giving effect to the consummation of such purchase or other acquisition, including such tender or exchange offer; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) any direct or indirect purchase, lease, exchange, transfer, license or other acquisition by any Person or &#147;group&#148; (as such term
is used in Section&nbsp;13(d) of the Exchange Act) of Persons, or stockholders of any such Person or group of Persons, of 10% or more of the consolidated assets of the Company and its Subsidiaries taken as a whole (measured by the fair market value
thereof as of the date of such transaction); or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) any merger, consolidation, business combination, joint venture, repurchase,
redemption, share exchange, extraordinary dividend or distribution, recapitalization, reorganization, liquidation, dissolution or other similar transaction involving the Company or any of its Subsidiaries pursuant to which any Person or
&#147;group&#148; (as such term is used in Section&nbsp;13(d) of the Exchange Act) of Persons, or stockholders of any such Person or group of Persons, would beneficially own shares of Company Common Stock and/or securities convertible into or
exchangeable for shares of Company Common Stock representing, collectively, 10% or more of the outstanding Company Common Stock (on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, if applicable), after giving effect to the
consummation of such transaction; <U>provided</U>, that none of the matters set forth on Section&nbsp;5.2(e) of the Company Disclosure Letter shall constitute an Acquisition Transaction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Activist Investor</B>&#148; means, as of the date of determination, a Person (other
than the Purchaser or its Affiliates)&nbsp;(a) that has, directly or indirectly through its Affiliates, been identified on any &#147;SharkWatch 50&#148; list (or any successor list) published within the three years prior to such date of
determination or (b)&nbsp;is listed on Section&nbsp;1.1(a) of the Company Disclosure Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Affiliate</B>&#148; means, with
respect to any Person, any other Person that, directly or indirectly, controls, is controlled by or is under common control with such Person;<I> </I><U>provided</U>, that none of the Company, Purchaser or the Viking Purchaser shall be deemed to be
Affiliates of one another. For purposes of this definition, the term &#147;control&#148; (including, with correlative meanings, the terms &#147;controlling,&#148; &#147;controlled by&#148; and &#147;under common control with&#148;), as used with
respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of that Person, whether through the ownership of voting securities or partnership or other ownership
interests, by Contract or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Anti-Corruption Laws</B>&#148; means all applicable Laws and all other statutory or
regulatory requirements relating to anti-corruption, anti-bribery and anti-money laundering, including the U.S. Foreign Corrupt Practices Act of 1977, the U.K. Bribery Act 2010 and any other Law implementing the OECD Convention on Combating Bribery
of Foreign Public Officials in International Business Transactions applicable to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Antitrust Law</B>&#148; means the
Sherman Antitrust Act, the Clayton Antitrust Act, the HSR Act, the Federal Trade Commission Act and all other Laws that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of
trade or significant impediments or lessening of competition or the creation or strengthening of a dominant position through merger or acquisition, in any case that are applicable to the Casdin Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Audited Company Balance Sheet</B>&#148; means the consolidated balance sheet (and the notes thereto) of the Company and its
consolidated Subsidiaries as of December&nbsp;31, 2020 set forth in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> filed by the Company with the SEC for the fiscal year ended December&nbsp;31, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>beneficially own</B>&#148; means, with respect to any securities, having &#147;beneficial ownership&#148; of such securities (as
determined pursuant to <FONT STYLE="white-space:nowrap">Rule&nbsp;13d-3</FONT> under the Exchange Act), and the terms &#147;beneficial ownership&#148; and &#147;beneficial owner&#148; shall have correlative meanings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Business Day</B>&#148; means any day other than Saturday or Sunday or a day on which commercial banks are authorized or required by
Law to be closed in New York, New York or San Francisco, California. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Certificate of Amendment</B>&#148; means an amendment to
the Eighth Amended and Restated Certificate of Incorporation of the Company to (a)&nbsp;increase the number of authorized shares and (b)&nbsp;change the name of the Company to &#147;Standard BioTools Inc.&#148; (in each case, effective as of the
Closing), in a form reasonably satisfactory to the Company and Purchaser. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Certificate of Designations</B>&#148; means the Certificate of Designations of the <FONT
STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock, substantially in the form attached to this Agreement as <U>Exhibit</U><U></U><U>&nbsp;A</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Code</B>&#148; means the Internal Revenue Code of 1986. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Board</B>&#148; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Common Stock</B>&#148; means the common stock, par value $0.001 per share, of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company ESPP</B>&#148; means the Fluidigm 2017 Employee Stock Purchase Plan, as amended and restated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Fundamental Representations</B>&#148; means the representations and warranties set forth in
<U>Section</U><U></U><U>&nbsp;3.1</U>, <U>Section</U><U></U><U>&nbsp;3.2</U>, <U>Section</U><U></U><U>&nbsp;3.3</U>, <U>Section</U><U></U><U>&nbsp;3.4</U>, <U>Section</U><U></U><U>&nbsp;3.5(a)</U>, <U>Section</U><U></U><U>&nbsp;3.7</U> and
<U>Section</U><U></U><U>&nbsp;3.26</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Material Adverse Effect</B>&#148; means any change, event, effect, occurrence or
circumstance that, individually or in the aggregate, has had, or would reasonably be expected to have, a material adverse effect on the business, financial condition or results of operations of the Company and its Subsidiaries, taken as a whole;
<U>provided</U>, that, none of the following shall be deemed to be or constitute a Company Material Adverse Effect or shall be taken into account when determining whether a Company Material Adverse Effect has occurred or is reasonably likely to
occur (subject to the limitations set forth below): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) changes in general economic conditions, or changes in conditions in the global or
national economy generally; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) changes in conditions in the financial markets, credit markets or capital markets, including
(i)&nbsp;changes in interest rates or credit ratings; (ii)&nbsp;changes in exchange rates for the currencies of any country; or (iii)&nbsp;any suspension of trading in securities (whether equity, debt, derivative or hybrid securities) generally on
any securities exchange or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
changes in conditions in the industry in which the Company and its Subsidiaries operate; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) changes in regulatory, legislative or
political conditions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) any geopolitical conditions, outbreak of hostilities, acts of war, sabotage, cyberterrorism, terrorism,
military actions, earthquakes, volcanic activity, hurricanes, tsunamis, tornadoes, floods, mudslides, wildfires or other natural disasters, weather conditions, epidemics, pandemics, disease outbreaks (including
<FONT STYLE="white-space:nowrap">COVID-19</FONT> and responses to <FONT STYLE="white-space:nowrap">COVID-19),</FONT> civil unrest or other force majeure events (including any escalation or general worsening thereof); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) any change, event, effect, occurrence or circumstance resulting from the announcement of this Agreement or the pendency of the Casdin
Transaction or the Viking Transaction, including the impact thereof on the relationships, contractual or otherwise, of the Company and its Subsidiaries with customers, suppliers, licensees, licensors, lenders, business
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
partners, employees, prospective employees, regulators, vendors or any other third Person (<U>provided</U>, that this clause (f)&nbsp;shall not apply to any representation or warranty contained
in this Agreement or the Viking Purchase Agreement to the extent that such representation or warranty expressly addresses consequences resulting from the announcement or execution of this Agreement or the consummation or pendency of the Casdin
Transaction or the Viking Transaction); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) changes in GAAP or other accounting standards or in any applicable Laws (or the authoritative
interpretation of any of the foregoing); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) any action taken or refrained from being taken by the Company (i)&nbsp;as expressly required
by this Agreement or (ii)&nbsp;that Purchaser has expressly approved, consented to or requested, in each case in writing following the date of this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) changes in the price or trading volume of the Company Common Stock, in and of itself (it being understood that the underlying cause of
such change may be taken into consideration when determining whether a Company Material Adverse Effect has occurred); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) any failure, in
and of itself, by the Company and its Subsidiaries to meet (i)&nbsp;any public estimates or expectations for the Company&#146;s revenue, earnings or other financial performance or results of operations for any period; or (ii)&nbsp;any internal
budgets, plans, projections or forecasts of its revenues, earnings or other financial performance or results of operations (it being understood that the underlying cause of any such failure may be taken into consideration when determining whether a
Company Material Adverse Effect has occurred); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) any breach by Purchaser of this Agreement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) any Transaction Litigation brought by any Company Stockholder against the Company, any of its executive officers or other employees or any
member of the Company Board, arising from or relating to the Transactions or allegations of any breach of fiduciary duty related to the Transactions; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">except, in each case of clauses (a), (b), (c), (d), (e), and (g), to the extent that such change, event, effect, occurrence or circumstance has had a
disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to other companies in the industry in which the Company and its Subsidiaries operate, in which case the incremental disproportionate adverse impact may
be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Notes</B>&#148; means the Company&#146;s 2.75% Exchange Convertible Senior Notes due 2034 and the Company&#146;s 5.25%
Convertible Senior Notes due 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Options</B>&#148; means any options to purchase shares of Company Common Stock,
whether granted pursuant to any of the Company Stock Plans or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company PSUs</B>&#148; means any performance-based
restricted stock units of the Company, whether granted pursuant to any of the Company Stock Plans or otherwise. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Related
Parties</B>&#148; means (a)&nbsp;the Company, its Subsidiaries and each of its and their respective Affiliates and (b)&nbsp;the former, current and future holders of any equity, controlling persons, directors, officers, employees, agents, attorneys,
Affiliates, members, managers, general or limited partners, stockholders and assignees of each of the Company, its Subsidiaries and each of its and their respective Affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company RSUs</B>&#148; means any service-based restricted stock units or deferred stock units of the Company, whether granted
pursuant to any of the Company Stock Plans or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Software</B>&#148; means all proprietary Software owned or
purported to be owned by the Company or any of its Subsidiaries as of the date of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Source Code</B>&#148;
means Source Code to Company Software. </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Stock Plans</B>&#148; means the 2009 Equity Incentive Plan of Fluidigm, as
amended, the Fluidigm 2011 Equity Incentive Plan, as amended effective May&nbsp;25, 2021, the DVS Sciences Inc. 2010 Equity Incentive Plan, as amended, the Fluidigm 2017 Inducement Award Plan, as amended, the Company ESPP and each other Employee
Plan that provides for the award of rights of any kind to receive shares of Company Common Stock or benefits measured in whole or in part by reference to shares of Company Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Stockholders</B>&#148; means the holders of shares of Company Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Systems</B>&#148; means all Software, computer hardware (whether general or special purpose), information technology,
electronic data processing, information, record keeping, communications, telecommunications, networks, interfaces, platforms, servers, peripherals, and computer systems (including any outsourced systems and processes) that are owned, leased,
licensed or used by or for, or otherwise relied on by, the Company or its Subsidiaries in the conduct of their businesses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Competitor</B>&#148; means the Persons set forth on Section&nbsp;1.1(b) of the Company Disclosure Letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Confidentiality Agreement</B>&#148; means the Confidentiality Agreement, between the Company and Casdin Capital, LLC, dated as of
August&nbsp;2, 2021 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Contract</B>&#148; means any contract, subcontract, note, bond, mortgage, indenture, lease, license,
sublicense or other instrument, commitment, understanding, undertaking or agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Converted Shares</B>&#148; means a number
of shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock equal to (a) (i)&nbsp;the Conversion Amount (as defined in the Loan Agreement), in each case as of the Closing, <I>divided by</I> (ii)&nbsp;$1,000 <I>multiplied by</I>
(b) (i)&nbsp;$3.40 <I>divided by</I> (ii)&nbsp;$2.84, rounded up to the nearest integer, into which the Conversion Amount shall be converted pursuant to the terms of this Agreement and thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">COVID-19</FONT></B>&#148; means <FONT
STYLE="white-space:nowrap">SARS-CoV-2</FONT> and its disease commonly known as <FONT STYLE="white-space:nowrap">COVID-19,</FONT> and any evolutions or additional strains, variations or mutations thereof or any related or associated epidemics,
pandemic or disease outbreaks. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures</B>&#148; means any quarantine,
&#147;shelter in place,&#148; &#147;stay at home,&#148; workforce reduction, social distancing, shut down, closure, sequester or other mandatory directive imposed by applicable Law, order, writ, injunction, judgment or decree in connection with or
in response to <FONT STYLE="white-space:nowrap">COVID-19.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Data</B>&#148; means, collectively, data, databases, data
repositories, data lakes and collections of data. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Data Security Requirements</B>&#148; means, collectively, all of the following
to the extent relating to the Processing of Data or otherwise relating to privacy, security, or security breach notification requirements and applicable to the Company or its Subsidiaries: (a)&nbsp;the Company&#146;s and its Subsidiaries&#146; own
written rules, policies and procedures; (b)&nbsp;applicable Laws (including, as applicable, the California Consumer Privacy Act, the General Data Protection Regulation (EU) 2016/679, and the ePrivacy Directive 2002/58/EC); (c)&nbsp;applicable
industry standards with which the Company or any of its Subsidiaries operates (including, as applicable, the Payment Card Industry Data Security Standard); and (d)&nbsp;Contracts into which the Company or any of its Subsidiaries has entered or by
which it is otherwise bound. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>DOJ</B>&#148; means the United States Department of Justice or any successor thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Employee Plan</B>&#148; means each &#147;employee benefit plan&#148; (within the meaning of Section&nbsp;3(3) of ERISA, whether or
not subject to ERISA) and each other plan, program, arrangement, policy or contract relating to severance, termination, garden leave, pay in lieu, <FONT STYLE="white-space:nowrap">gross-up,</FONT> pension, profit-sharing, savings, retirement, death
benefit, group insurance, hospitalization, medical, dental, life, employee loan, restrictive covenant, relocation, clawback, fringe benefit, cafeteria, disability, consulting, change in control, employment, compensation, incentive, bonus, retention,
stock option, restricted stock, restricted or deferred stock unit, stock purchase, phantom stock or other equity or equity-based compensation (including the Company Stock Plans and all outstanding awards granted thereunder), deferred compensation or
other benefit or compensation plan, program, arrangement, or policy, whether written or oral, formal or informal, that is sponsored, maintained or contributed to by the Company or any Subsidiary of the Company for the benefit of any current or
former director, officer, independent contractor, or employee of the Company or any Subsidiary or any spouse, dependent, or beneficiary thereof, or with respect to which the Company or any Subsidiary of the Company has or reasonably expects to have
any liability or obligation, including on account of an ERISA Affiliate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Environmental Law</B>&#148; means any Law enacted or in
effect on or prior to the Closing Date relating to public or worker health and safety (to the extent relating to exposure to Hazardous Materials), the protection of the environment or natural resources (including ambient or indoor air, surface
water, groundwater or land) or pollution, including any such Law relating to the production, distribution, marketing, labeling, registration, notification, packaging, import, use, storage, treatment, transportation, recycling, disposal, discharge,
release or other handling of, or exposure to, any Hazardous Materials, or the investigation, <FONT STYLE="white-space:nowrap">clean-up</FONT> or remediation thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Environmental Permits</B>&#148; means any Governmental Authorizations required
under Environmental Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Equity Securities</B>&#148; means any equity securities of the Company or any of its Subsidiaries, or
securities convertible into or exercisable or exchangeable for equity securities of the Company or any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>ERISA</B>&#148; means the Employee Retirement Income Security Act of 1974. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>ERISA Affiliate</B>&#148; means, with respect to any entity, trade or business, any other entity, trade or business that is (or was
at any relevant time) a member of a group described in Section&nbsp;414(b), (c), (m) or (o)&nbsp;of the Code or Section&nbsp;4001(b)(1) of ERISA that includes the first entity, trade or business, or that is (or was at any relevant time) a member of
the same &#147;controlled group&#148; as the first entity, trade or business pursuant to Section&nbsp;4001(a)(14) of ERISA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Exchange Act</B>&#148; means the Securities Exchange Act of 1934. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Excluded Securities</B>&#148; means any securities of the Company issued or issuable (a)&nbsp;on the exercise, exchange or conversion
of any (i)&nbsp;New Securities issued to Purchaser in accordance with this Agreement, (ii)&nbsp;New Securities issued to the Viking Purchaser in accordance with the Viking Purchase Agreement, (iii)&nbsp;New Securities issued to Purchaser upon
conversion of the Loan Agreement; or (iv)&nbsp;New Securities issued to the Viking Purchaser upon conversion of the Loan Agreement (as defined in the Viking Purchase Agreement), (b)&nbsp;to directors, officers, employees or consultants of the
Company pursuant to any present or future employee, director or consultant benefit plan or program of, or assumed by, the Company or any of its Subsidiaries and approved by the Company Board, or a committee thereof, or any employee agreements or
arrangements or programs approved by the Company Board, or a committee thereof, including the Company Stock Plans or other compensatory arrangements, (c)&nbsp;on conversion of the Series B Preferred Stock or the Company Notes in accordance with the
terms thereof, (d)&nbsp;as consideration for the acquisition of another entity by the Company by merger, purchase of substantially all of the assets or other reorganization or a <I>bona fide</I> joint venture agreement, if approved by the Company
Board, including the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Director and Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Director if such directors are then in office, (e)&nbsp;in connection with any stockholder
rights plan approved by the Company Board, (f)&nbsp;pursuant to any dividend, split, combination or other reclassification, (g)&nbsp;upon the exercise, exchange or conversion of options, convertible notes, warrants, or other derivative securities of
the Company or any Subsidiary, (h)&nbsp;as part of an exchange, refinancing or similar transaction with respect to any debt or convertible-debt securities of the Company or any Subsidiary of the Company outstanding on the date of this Agreement,
including any securities issued upon conversion of such securities, if approved by the Company Board, including the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Director and Series <FONT STYLE="white-space:nowrap">B-2</FONT>
Preferred Director if such directors are then in office, (i)&nbsp;of a Subsidiary of the Company issued to the Company or a Subsidiary of the Company or (j)&nbsp;under (i)&nbsp;this Agreement (for the avoidance of doubt, other than pursuant to
<U>Section</U><U></U><U>&nbsp;6.16</U> hereof), (ii)&nbsp;the Viking Purchase Agreement (for the avoidance of doubt, other than pursuant to <U>Section</U><U></U><U>&nbsp;6.16</U> thereof), (iii)&nbsp;the Loan Agreement or (iv)&nbsp;the Loan
Agreement, dated as of the date of this Agreement, between the Company and Viking Purchaser. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>FTC</B>&#148; means the United States Federal Trade Commission or any successor
thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>GAAP</B>&#148; means generally accepted accounting principles, consistently applied, in the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Government Official</B>&#148; means any (a)&nbsp;official, officer, employee, or representative of, or any Person acting in an
official capacity for or on behalf of, any Governmental Authority, (b)&nbsp;political party or party official or candidate for political office or (c)&nbsp;company, business, enterprise or other entity owned, in whole or in part, or controlled by
any person described in the foregoing clause (a)&nbsp;or (b) of this definition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Governmental Authority</B>&#148; means any
government, political subdivision, governmental, administrative or regulatory entity or body, department, commission, board, agency or instrumentality, or other legislative, executive or judicial governmental entity, and any court, tribunal,
judicial or arbitral body, in each case whether federal, national, state, county, municipal, provincial, local, foreign or multinational. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Governmental Authorization</B>&#148; means any authorizations, approvals, licenses,
<FONT STYLE="white-space:nowrap">sub-licenses,</FONT> franchises, clearances, permits, certificates, waivers, consents, exemptions, variances, expirations and terminations of any waiting period requirements (including, pursuant to Antitrust Laws)
issued by or obtained from, and notices, filings, registrations, qualifications, declarations and designations with, a Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Hazardous Materials</B>&#148; means any substance, waste, or material that is regulated by or for which standards of conduct or
liability may be imposed pursuant to Environmental Laws, including petroleum and petroleum byproducts, <FONT STYLE="white-space:nowrap">per-</FONT> and poly-fluoroalkyl substances, polychlorinated biphenyls, lead, asbestos, noise, radiation, toxic
mold, odor and pesticides. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Hedge</B>&#148; means to make any short sale of, grant any option for the purchase of, or enter into
any hedging or similar transaction with the same economic effect as a short sale of or the purpose of which is to offset the loss that results from a decline in the market price of, any <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares, or
otherwise establish or increase, directly or indirectly, a put equivalent position, as defined in Rule <FONT STYLE="white-space:nowrap">16a-1(h)</FONT> under the Exchange Act, or enter into any derivative transactions with linked financing, with
respect to any <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>HSR Act</B>&#148; means the Hart-Scott-Rodino Antitrust
Improvements Act of 1976. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Intellectual Property</B>&#148; means all intellectual property and proprietary rights throughout the
world, including: (a)&nbsp;all patents, patent applications, patent disclosures, and inventions and all improvements thereto (whether or not patentable or reduced to practice), and all reissues, continuations, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> revisions, divisional, extensions, applications therefor, and reexaminations in connection therewith (&#147;<B>Patents</B>&#148;); (b) all copyrights, works of authorship (whether or
not copyrightable), moral rights, and all registrations, applications and renewals therefor and any other rights corresponding thereto throughout the world (&#147;<B>Copyrights</B>&#148;); (c)&nbsp;trademarks, service marks, internet domain names,
corporate names, trade dress rights and similar designation of origin and rights therein, other indicia of origin, and all registrations, renewals and applications in connection therewith, together with all of the goodwill associated with any of the
foregoing (&#147;<B>Marks</B>&#148;); (d) rights in Trade Secrets; (e)&nbsp;rights in Software; and (f)&nbsp;intellectual property and proprietary rights in Data. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Intervening Event</B>&#148; means any change, event, effect, occurrence or
circumstance (other than any change, event, effect, occurrence or circumstance resulting from a breach of this Agreement by the Company), in each case that (a)&nbsp;is not known or reasonably foreseeable by the Company Board as of the date hereof
and (b)&nbsp;does not relate to any Acquisition Proposal, Purchaser or the Viking Purchaser; <U>provided</U>, that in no event shall the following constitute, or be taken into account in determining the existence of, an Intervening Event:
(i)&nbsp;the fact that the Company and its Subsidiaries meet or exceed (A)&nbsp;any public estimates or expectations for the Company&#146;s revenue, earnings or other financial performance or results of operations for any period or (B)&nbsp;any
internal budgets, plans, projections or forecasts of its revenues, earnings or other financial performance or results of operations (it being understood that the underlying cause of any such events may be taken into consideration when determining
whether an Intervening Event has occurred); (ii)&nbsp;changes in the price or trading volume of the Company Common Stock, in and of itself (it being understood that the underlying cause of such change may be taken into consideration when determining
whether an Intervening Event has occurred); (iii)&nbsp;changes in the Company&#146;s credit ratings; (iv)&nbsp;the taking of any action required or expressly contemplated by this Agreement; (v)&nbsp;any change, event, effect, occurrence or
circumstance relating to Purchaser, the Viking Purchaser or any of their respective Affiliates; or (vi)&nbsp;changes in conditions generally affecting the industry in which the Company and its Subsidiaries operate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>IRS</B>&#148; means the United States Internal Revenue Service or any successor thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Knowledge</B>&#148; of the Company, with respect to any matter in question, means the actual knowledge of the individuals set forth
on Section&nbsp;1.1(c)(i) of the Company Disclosure Letter, in each case after reasonable inquiry of their direct reports who would reasonably be expected to have actual knowledge of the matter in question. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Labor Laws</B>&#148; means all Laws relating to labor and employment, including but not limited to, all Law relating to employment
and independent contractor practices, wages, equal employment opportunity, affirmative action and other hiring practices, immigration (including the completion of <FONT STYLE="white-space:nowrap">I-9s</FONT> for all employees and the proper
confirmation of employee visas), workers&#146; compensation, unemployment, the payment of social security and other employment-related taxes, employment standards, employment of minors, occupational health and safety, labor relations, unions,
withholdings, payment of wages and overtime, meal and rest periods, workplace safety, employee benefits, pay equity, employee and worker classification (including the classification of independent contractors and exempt and <FONT
STYLE="white-space:nowrap">non-exempt</FONT> employees), leaves of absence, family and medical leave, civil rights, retaliation, discrimination, sexual or other workplace harassment, the WARN Act, the National Labor Relations Act, the Labor
Management Relations Act, the Occupational Safety and Health Act, Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Age Discrimination in Employment Act, the Family Medical Leave Act, the Fair Labor Standards Act,
the Equal Pay Act, the Rehabilitation Act, the Employee Retirement Income Security Act, the Uniform Services Employment and Reemployment Rights Act, the Genetic Information Nondiscrimination Act, 42 U.S.C. &#167;&#167;&nbsp;1981, 1983, 1985 and
1986, the Sarbanes-Oxley Act and the Immigration Reform and Control Act, or any similar state, local or foreign Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Law</B>&#148; means any federal, national, state, county, municipal, provincial,
local, foreign or multinational law, act, statute, constitution, common law, ordinance, code, decree, writ, order, determination, judgment, injunction, rule, regulation, ruling, award or requirement issued, enacted, adopted, promulgated, implemented
or otherwise put into effect by or under the authority of any Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Legal Proceeding</B>&#148; means any
claim, action, charge, complaint, lawsuit, litigation, audit, investigation, inquiry, proceeding, arbitration or other similar legal proceeding brought by or pending before any Governmental Authority, arbitrator or other tribunal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Lien</B>&#148; means any lien, security interest, deed of trust, mortgage, pledge, encumbrance, restriction on transfer, proxies,
voting trusts or agreements, hypothecation, assignment, claim, right of way, defect in title, encroachment, easement, restrictive covenant, charge, deposit arrangement or preference, priority or other security agreement or preferential arrangement
of any kind or nature whatsoever (including any restriction on the voting interest of any security, any restriction on the transfer of any security (except for those imposed by applicable securities Laws) or other asset or any restriction on the
possession, exercise or transfer of any other attribute of ownership of any asset). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Material Contract</B>&#148; means any of the
following Contracts of the Company or any of its Subsidiaries (other than an Employee Plan) that are currently in effect: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) any
&#147;material contract&#148; (as defined in Item 601(b)(10) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated by the SEC, other than those agreements and arrangements described in Item 601(b)(10)(iii) of Regulation <FONT
STYLE="white-space:nowrap">S-K)</FONT> with respect to the Company and its Subsidiaries, taken as whole; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) any Contract under which the
Company or any of its Subsidiaries has been granted a license under any third Person&#146;s Intellectual Property, other than <FONT STYLE="white-space:nowrap">(i)&nbsp;non-disclosure</FONT> agreements;
<FONT STYLE="white-space:nowrap">(ii)&nbsp;non-exclusive</FONT> licenses or related services Contracts for commercially available software, technology or Intellectual Property; (iii)&nbsp;Open Source Licenses; (iv)&nbsp;Contracts with employees or
independent contractors for the assignment of, or license to, any Intellectual Property; and (v)&nbsp;licenses authorizing limited use of brand materials, feedback, or other Intellectual Property that are incidental to the primary purpose of the
Contract; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) any Contract under which the Company or any of its Subsidiaries has licensed any material Company Owned IP to a third
Person, other than (i)&nbsp;any <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreements; (ii)&nbsp;Contracts with end users and other customers (including resellers, distributors, <FONT STYLE="white-space:nowrap">co-marketers</FONT> and <FONT
STYLE="white-space:nowrap">co-promoters),</FONT> or with potential end users and other customers (including potential resellers and distributors), to the extent granting licenses in connection with the evaluation, provision, sale, resale, license,
distribution, support or maintenance of a Company Product; (iii)&nbsp;Contracts with consultants, contractors and vendors (including manufacturers, suppliers and contract research organizations) to the extent granting licenses in connection with the
counterparty&#146;s provision of products or services to or for the Company or any of its Subsidiaries; (iv)&nbsp;original equipment manufacturer agreements and/or collaboration agreements involving the development or commercialization of Company
and/or third-party products or services, including licenses that are incidental to the conduct of development activities for such products or services, the supply of such products and services (whether for testing or commercialization), or the <FONT
STYLE="white-space:nowrap">co-marketing</FONT> or <FONT STYLE="white-space:nowrap">co-promotion</FONT> of such products or services; and (v)&nbsp;other licenses entered in the ordinary course of business; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) any Contract (i)&nbsp;containing any covenant limiting in any material respect the right
of the Company or any of its Subsidiaries to engage in or compete with any Person in any line of business that is material to the Company and its Subsidiaries, taken as a whole or (ii)&nbsp;containing any &#147;minimum requirement,&#148; &#147;most
favored nation&#148; or &#147;exclusivity&#148; provisions that limit in any material respect the freedom or right of the Company or any of its Subsidiaries to sell, distribute or manufacture any products or services or any technology or other
assets to or for any other Person; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) any Contract with respect to the future issuance of Company Securities (other than this Agreement,
the Viking Purchase Agreement, the Company Stock Plans or the awards made or that the Company agreed to make thereunder); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) any
Contract entered into within the five year period prior to the date of this Agreement (i)&nbsp;relating to a disposition or acquisition of assets by the Company or any of its Subsidiaries other than dispositions or acquisitions of products or
services in the ordinary course of business or solely among the Company and its Subsidiaries or (ii)&nbsp;pursuant to which the Company or any of its Subsidiaries will acquire after the date of this Agreement any material ownership interest in any
other Person or other business enterprise other than any existing Subsidiary of the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) any letter of credit in excess of
$1,000,000, or any mortgages, indentures, guarantees, loans or credit agreements, security agreements or other Contracts (other than letters of credit) relating to indebtedness, including the borrowing of money or extension of credit, in each case
in excess of $1,000,000 other than (i)&nbsp;accounts receivables and payables incurred in the ordinary course of business; (ii)&nbsp;loans to Subsidiaries of the Company in the ordinary course of business; (iii)&nbsp;intercompany loans, receivables
and payables among the Company and its Subsidiaries; and (iv)&nbsp;extensions of credit to customers in the ordinary course of business and (v)&nbsp;pursuant to the SVB Loan Agreement or the Company Notes; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) any Contract providing for indemnification of any officer, director or employee by the Company or any of its Subsidiaries; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any material joint venture, partnership or similar arrangement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) any Contract (other than purchase orders in the ordinary course of business that are terminable or cancelable without penalty on 90
days&#146; notice or less) under which the Company or any of its Subsidiaries is a purchaser of goods and services which, pursuant to the terms thereof, requires payments by the Company or any of its Subsidiaries in excess of $1,000,000 within any <FONT
STYLE="white-space:nowrap">12-month</FONT> period; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) any Collective Bargaining Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) any Contract that is a settlement, conciliation or similar agreement with any
Governmental Authority or Person pursuant to which the Company or a Subsidiary will have any material outstanding obligation after the date of this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) any agreement to purchase Real Property or any interest therein; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) any Lease; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) any master
services agreement and other Contracts (other than purchase orders, service orders, statements of work, invoices, sales orders, bills, shipping orders, credit memos, sales receipts, proposals or other similar items) with the top ten customers and
top ten suppliers of the Company and its Subsidiaries, taken as a whole, by revenue or cost (as applicable) for the 12 months ended September&nbsp;30, 2021; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) any agreement under which a broker, finder or similar fee commission, or other like payment is payable; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) any Contract between the Company or any of its Subsidiaries, on the one hand, and any Person that, to the Knowledge of the Company,
beneficially owns five percent or more of the outstanding shares of Company Common Stock or outstanding shares of common stock of any of any of the Company&#146;s Subsidiaries, on the other hand; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) any Contracts with any current director or executive officer of the Company, with the exception of any confidentiality or invention
assignment agreement on the Company&#146;s standard for, which standard form has been made available to Purchaser; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) any employment
or consulting Contract with any individual service provider of the Company or any of its Subsidiaries that (i)&nbsp;provides for annual base compensation in excess of $250,000, and (ii)&nbsp;(A)&nbsp;provides for the payment or accelerated vesting
of any compensation or benefits in connection with the consummation of the transactions contemplated by this Agreement or (B)&nbsp;otherwise restricts the Company&#146;s or its Subsidiaries ability to terminate the employment or engagement of such
service provider at any time for any reason or no reason without more than 30 days&#146; prior notice and without penalty or liability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>NASDAQ</B>&#148; means the Nasdaq Stock Market and any successor stock exchange or inter-dealer quotation system operated by the
Nasdaq Stock Market or any successor thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Open Source Software</B>&#148; means any Software licensed under terms meeting the
definition of &#147;Open Source&#148; promulgated by the Open Source Initiative, available online at http://www.opensource.org/osd.html (any such license, an &#147;<B>Open Source License</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Organizational Documents</B>&#148; means the certificate of incorporation, bylaws, certificate of formation, partnership agreement,
limited liability company agreement and all other similar documents, instruments or certificates executed, adopted or filed in connection with the creation, formation or organization of a Person, including any amendments thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Permitted Liens</B>&#148; means any of the following: (a)&nbsp;Liens for Taxes,
assessments and governmental charges or levies either not yet delinquent or that are being contested in good faith by appropriate proceedings and for which appropriate reserves have been established to the extent required by GAAP;
(b)&nbsp;mechanics, carriers&#146;, workmen&#146;s, warehouseman&#146;s, repairmen&#146;s, materialmen&#146;s or other Liens or security interests that are not yet due or that are being contested in good faith and by appropriate proceedings;
(c)&nbsp;pledges or deposits to secure obligations pursuant to workers&#146; compensation Law or similar legislation or to secure public or statutory obligations; (d)&nbsp;pledges or deposits to secure the performance of appeal bonds, fidelity bonds
and other obligations of a similar nature, in each case in the ordinary course of business; (e)&nbsp;easements, covenants and rights of way (unrecorded and of record) and other similar Liens (or other encumbrances), and zoning, building and other
similar codes or restrictions, in each case imposed by any governmental authority having jurisdiction over the Real Property and that do not adversely affect in any material respect, and are not violated by, the current use, operation or occupancy
of such Real Property or the operation of the business of the Company and its Subsidiaries thereon; (f)&nbsp;Liens the existence of which are disclosed in the notes to the most recent consolidated financial statements of the Company included in the
Company SEC Reports; (g)&nbsp;Liens granted pursuant to the SVB Loan Agreement and the Loan Documents (as defined in the SVB Loan Agreement); and (h)&nbsp;any <FONT STYLE="white-space:nowrap">non-exclusive</FONT> license of any Intellectual Property
granted by the Company or any of its Subsidiaries in the ordinary course of business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Person</B>&#148; means any individual,
corporation (including any <FONT STYLE="white-space:nowrap">non-profit</FONT> corporation), limited liability company, joint stock company, general partnership, limited partnership, limited liability partnership, joint venture, estate, trust, firm,
Governmental Authority or other enterprise, association, organization or entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Personal Information</B>&#148; means any Data
that is defined as &#147;personal data,&#148; &#147;personal information,&#148; &#147;personally identifiable information,&#148; or any comparable term under applicable Laws, and any Data that, alone or when combined with other Data, identifies,
allows the identification of, relates to, describes, is reasonably capable of being associated with, or could reasonably be linked, directly or indirectly, with an individual, household, or device, or is about or from an individual, household, or
device, or constitutes name, address, phone number, email address, financial account number, payment card data, government issued identifier, and health or medical information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>PGEF II Purchase Price</B>&#148; means $33,750,000, which amount is calculated by multiplying the number of PGEF II Purchased Shares
by the Share Price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>PGEF II Purchased Shares</B>&#148; means 33,750 shares of
<FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock to be purchased by Casdin PGEF II pursuant to the terms of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>PMF Purchase Price</B>&#148; means $78,750,000, which amount is calculated by multiplying the number of PMF Purchased Shares by the
Share Price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>PMF Purchased Shares</B>&#148; means 78,750 shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT>
Preferred Stock to be purchased by Casdin PMF pursuant to the terms of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Process</B>&#148; (or
&#147;<B>Processing</B>&#148; or &#147;<B>Processed</B>&#148;) means any operation or set of operations which is performed on Data or other information or sets or collections thereof, such as the development, access, collection, use, adaption,
recording, retrieval, organization, structuring, erasure, exploitation, processing, storage, sharing, copying, display, distribution, transfer, transmission, disclosure, aggregation, destruction, or disposal thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Purchased Shares</B>&#148; means, collectively, the PGEF II Purchased Share and the
PMF Purchased Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Purchaser Fundamental Representations</B>&#148; means the representations and warranties set forth in
<U>Section</U><U></U><U>&nbsp;4.1</U>, <U>Section</U><U></U><U>&nbsp;4.2</U>, <U>Section</U><U></U><U>&nbsp;4.3(a)</U> and <U>Section</U><U></U><U>&nbsp;4.7</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Purchaser Parties</B>&#148; means, collectively, Purchaser and each Permitted Transferee of Purchaser to whom shares of Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Preferred Stock or Company Common Stock are Transferred pursuant to <U>Section</U><U></U><U>&nbsp;6.15(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Purchaser Preferred Percentage</B>&#148; means, as of any time, (a)&nbsp;the number of shares of Company Common Stock beneficially
owned by the Purchaser Parties <I>divided by</I> (b)&nbsp;the total number of shares of Company Common Stock issued and outstanding, in each case as of such time and determined on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Purchaser Related Parties</B>&#148; means (a)&nbsp;Purchaser, its Subsidiaries and each of its and their respective Affiliates and
(b)&nbsp;the former, current and future holders of any equity, controlling persons, directors, officers, employees, agents, attorneys, Affiliates, members, managers, general or limited partners, stockholders and assignees of Purchaser, its
Subsidiaries and its and their respective Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Real Property</B>&#148; means real property, including all land, together
with all buildings, structures, improvements and fixtures located thereon, and all easements and other rights and interests appurtenant thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Registered Intellectual Property</B>&#148; means Intellectual Property that has been registered, filed or issued under the authority
of, with or by any Governmental Authority, or other public or quasi-public legal authority, including (a)&nbsp;Patents and Patent applications (including provisional applications); (b) registered Marks and applications to register Marks (including <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">intent-to-use</FONT></FONT> applications, or other registrations or applications related to Marks, including, for clarity, internet domain names); and (c)&nbsp;registered Copyrights and
applications for Copyright registration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Sarbanes-Oxley Act</B>&#148; means the Sarbanes-Oxley Act of 2002. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>SEC</B>&#148; means the United States Securities and Exchange Commission or any successor thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Securities Act</B>&#148; means the Securities Act of 1933. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Security Incident</B>&#148; means any actual or reasonably suspected successful (a)&nbsp;security breach, denial of service, phishing
attack, or ransomware and malware attack on the Company Systems or (b)&nbsp;unauthorized access to, or collection, use, Processing, storage, sharing, distribution, transfer, disclosure, or destruction of, any Company Systems or Sensitive
Information, or any loss, distribution, compromise or unauthorized disclosure of any of the foregoing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Sensitive Information</B>&#148; means, in any form or medium, any (a)&nbsp;Trade
Secrets or other material confidential information, (b)&nbsp;privileged or proprietary information that, if compromised through any theft, interruption, modification, corruption, loss, misuse or unauthorized access or disclosure, could cause serious
harm to the organization owning it, (c)&nbsp;information protected by Law and (d)&nbsp;Personal Information, in each case of (a) &#150; (d), in the Company&#146;s or any of its Subsidiaries&#146; possession or control or Processed on their behalf.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Director</B>&#148; has the meaning set forth in the Certificate of
Designations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock</B>&#148; means the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock, par value $0.001 per share, of the Company, the terms of which will be set forth in the Certificate of Designations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Director</B>&#148; has the meaning set forth in the Certificate of
Designations of Rights, Preferences and Privileges of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock, par value $0.001 per share, of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series B Preferred Stock</B>&#148; means, collectively, the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock and
the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock (as defined in the Viking Purchase Agreement). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Share
Price</B>&#148; means $1,000 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Software</B>&#148; means, in any form or medium, any and all software and computer
programs, source code, object code, software implementations of algorithms, models and methodologies, firmware, application programming interfaces, descriptions, schematics, specifications, flow charts and other work product used to design, plan,
organize and develop any of the foregoing, and all documentation, and manuals related to any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Source
Code</B>&#148; means uncompiled human readable source code underlying any computer software program written in a language designed to be compiled prior to execution, and excluding human readable source code written in languages traditionally
distributed in source code form and designed to run on an interpreted basis (e.g. HTML, Javascript, Perl, PHP, and the like). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Subsidiary</B>&#148; means, with respect to any Person, any other Person (other than a natural Person) of which securities or other
ownership interests (a)&nbsp;having ordinary voting power to elect a majority of the board of directors or other persons performing similar functions or (b)&nbsp;representing more than 50% of such securities or ownership interests, in each case, are
at the time directly or indirectly owned by such first Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Subsidiary Securities</B>&#148; has the same meaning ascribed to
&#147;Company Securities&#148;, except that all references to &#147;the Company&#148; therein shall be deemed to be replaced with &#147;any Subsidiary of the Company&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>SVB Loan Agreement</B>&#148; means that Loan and Security Agreement, dated as of August&nbsp;2, 2018 by and between the Borrower and
Silicon Valley Bank, as amended, restated, modified or otherwise supplemented from time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Tax</B>&#148; or &#147;<B>Taxes</B>&#148; means any taxes and similar assessments,
fees, and other governmental charges imposed by any Governmental Authority, including income, profits, gross receipts, net proceeds, ad valorem, value added, turnover, sales, use, property, personal property (tangible and intangible), stamp, excise,
duty, franchise, capital stock, transfer, payroll, employment, severance, and estimated tax, together with any interest and any penalties, additions to tax or additional amounts imposed by any Governmental Authority, whether disputed or not. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Tax Return</B>&#148; means any return, estimates, report, statement, information return or other document (including any related or
supporting information such as a schedule or attachment thereto) filed or required to be filed with any Governmental Authority in connection with the determination, assessment, collection or administration of any Taxes, including any amendment
thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Trade Secrets</B>&#148; means, collectively, trade secrets and confidential and proprietary information, including
trade secrets, <FONT STYLE="white-space:nowrap">know-how,</FONT> business rules, data analytic techniques and methodologies, formulae, source code, ideas, concepts, discoveries, innovations, improvements, results, reports, information, research,
laboratory and programmer notebooks, methods, procedures, proprietary technology, operating and maintenance manuals, engineering and other drawings and sketches, customer lists, supplier lists, pricing information, cost information, business
manufacturing and production processes and techniques, designs, specifications, and blueprints. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transactions</B>&#148; means,
collectively, the Casdin Transaction and the Viking Transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transaction Documents</B>&#148; means this Agreement, the
Viking Purchase Agreement, the Company Disclosure Letter, the Loan Agreement, the Certificate of Designations and the Registration Rights Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transaction Litigation</B>&#148; means any Legal Proceeding commenced against a Party, any of its Subsidiaries or Affiliates, any of
their respective directors or officers, or otherwise relating to, involving or affecting such Persons, in each case in connection with, arising from or otherwise relating to the Casdin Transaction, the Viking Transaction or any other transaction
contemplated by this Agreement or the Transaction Documents, other than any Legal Proceedings among the Parties related to this Agreement or the other Transaction Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transfer Taxes</B>&#148; means any transfer, sales, use, stamp, documentary, registration, value added or other similar Taxes;
provided, for the avoidance of doubt, that Transfer Taxes shall not include any income, franchise or similar Taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Underlying
Shares</B>&#148; means the shares of Company Common Stock issuable on conversion of the Acquired Shares in accordance with the Certificate of Designations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Viking Parties</B>&#148; has the meaning given to the term &#147;Purchaser Parties&#148; by the Viking Purchase Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Viking Purchaser</B>&#148; means, collectively, Viking Global Opportunities
Illiquid Investments <FONT STYLE="white-space:nowrap">Sub-Master</FONT> LP, a Cayman Islands exempted limited partnership and Viking Global Opportunities Drawdown (Aggregator) LP, a Cayman Islands exempted limited partnership. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Viking Purchase Agreement</B>&#148; means that certain Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock
Purchase Agreement, dated as of even date herewith, by and between the Company and the Viking Purchaser. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Viking
Transaction</B>&#148; means the issuance of and sale of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock to Viking Purchaser on the terms and subject to the conditions set forth in the Viking Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Voting Stock</B>&#148; means (a)&nbsp;with respect to the Company, the Company Common Stock, the Series&nbsp;B Preferred Stock and
any other capital stock of the Company having the right to vote generally in any election of directors of the Company Board and (b)&nbsp;with respect to any other Person, all equity of such Person having the right to vote generally in any election
of directors of the board of directors of such Person or other similar governing body. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>WARN Act</B>&#148; means the Worker
Adjustment and Retraining Notification Act of 1988, and the regulations promulgated thereunder and any similar state, local or foreign Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Willful Breach</B>&#148; means a material breach of this Agreement that is the result of a willful or intentional act or failure to
act where the breaching party knows, or should reasonably be expected to have known, that the taking of such act or failure to act would result, or would reasonably be expected to result, in a material breach of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 <I>Index of Defined Terms</I>. The following capitalized terms have the respective meanings given to them in the respective Sections of
this Agreement set forth opposite each of the capitalized terms below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="7%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Term</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>Section</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Acquisition Termination Fee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">8.3(b)(iv)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Alternative Acquisition Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">5.3(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">BIS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.21(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Bylaws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Capitalization Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.7(a)(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Casdin PGEF II</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Casdin PMF</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Casdin Transaction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Change of Recommendation Termination Fee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">8.3(b)(iii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Charter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chosen Courts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">9.10</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Closing Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Collective Bargaining Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.19(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Board Recommendation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.3(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Board Recommendation Change</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.3(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Breach Notice Period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">8.1(e)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Disclosure Letter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Article&nbsp;III</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Intellectual Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.16(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Owned IP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.16(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Preferred Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.7(a)(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Product</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.22(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company SEC Reports</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.9</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Securities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.7(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Stockholder Meeting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">6.4(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Contracting Parties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">9.12</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DGCL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Electronic Delivery</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">9.14</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Expense Reimbursement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">8.3(b)(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FDA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.22(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Foreign Benefit Plan</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.18(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Fully Participating Parties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">6.16(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Healthcare Authorities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.22(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Lease</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.14(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Leased Real Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.14(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Loan Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">6.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">New Securities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">6.16(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Nonparty Affiliates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">9.12</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OFAC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.21(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Offer Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">6.16(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Offeree</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">6.16(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Participating Parties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">6.16(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Parties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Party</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Permitted Transferees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">6.15(b)(ii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Preemptive Percentage</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">6.16(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Proxy Statement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">6.3(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Purchaser</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Purchaser Breach Notice Period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">8.1(g)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Recall</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.22(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Registration Rights Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Representatives</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.3(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Requisite Stockholder Approval</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.4(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Series <FONT STYLE="white-space:nowrap">B-1</FONT> Conversion</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">6.2(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Termination Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">8.1(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Trade Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.21(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Transfer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">6.15(a)</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.3 <I>Certain Interpretations</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) When a reference is made in this Agreement to an Article or a Section, such reference is to an Article or a Section of this Agreement
unless otherwise indicated. When a reference is made in this Agreement to a Schedule or Exhibit, such reference is to a Schedule or Exhibit to this Agreement, as applicable, unless otherwise indicated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) When used herein, (i)&nbsp;the words &#147;hereof,&#148; &#147;herein&#148; and &#147;herewith&#148; and words of similar import shall,
unless otherwise stated, be construed to refer to this Agreement as a whole and not to any particular provision of this Agreement; and (ii)&nbsp;the words &#147;include,&#148; &#147;includes&#148; and &#147;including&#148; shall be deemed in each
case to be followed by the words &#147;without limitation.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Unless the context otherwise requires, &#147;neither,&#148;
&#147;nor,&#148; &#147;any,&#148; &#147;either&#148; and &#147;or&#148; are not exclusive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The word &#147;extent&#148; in the phrase
&#147;to the extent&#148; means the degree to which a subject or other thing extends, and does not simply mean &#147;if.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) When
used in this Agreement, references to &#147;$&#148; or &#147;Dollars&#148; are references to U.S. dollars. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The meaning assigned to
each capitalized term defined and used in this Agreement is equally applicable to both the singular and the plural forms of such term, and words denoting any gender include all genders. Where a word or phrase is defined in this Agreement, each of
its other grammatical forms has a corresponding meaning. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) When reference is made to any Party to this Agreement or any other agreement
or document, such reference includes such Party&#146;s successors and permitted assigns. References to any Person include the successors and permitted assigns of that Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Unless the context otherwise requires, all references in this Agreement to the Subsidiaries of a Person shall be deemed to include all
direct and indirect Subsidiaries of such Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) A reference to any specific Law or to any provision of any Law includes any
amendment to, and any modification, <FONT STYLE="white-space:nowrap">re-enactment</FONT> or successor thereof, any legislative provision substituted therefor and all rules, regulations and statutory instruments issued thereunder or pursuant thereto,
except that, for purposes of any representations and warranties in this Agreement that are made as of a specific date, references to any specific Law shall be deemed to refer to such legislation or provision (and all rules, regulations and statutory
instruments issued thereunder or pursuant thereto) as of such date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) References to any agreement or Contract are to that agreement or
Contract as amended, modified or supplemented (including by waiver or consent) from time to time in accordance with the terms hereof and thereof, except that for purposes of any representations and warranties in this Agreement that are made as of a
specific date, references to any specific Contract shall be deemed to refer to such Contract as of such date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) All accounting terms used herein shall be interpreted, and all accounting determinations
hereunder shall be made, in accordance with GAAP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) The table of contents and headings set forth in this Agreement are for convenience
of reference purposes only and shall not affect or be deemed to affect in any way the meaning or interpretation of this Agreement or any term or provision hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) The measure of a period of one month or year for purposes of this Agreement shall be the date of the following month or year corresponding
to the starting date. If no corresponding date exists, then the end date of such period being measured shall be the next actual date of the following month or year (for example, one month following February&nbsp;18 is March&nbsp;18 and one month
following March&nbsp;31 is May 1). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) The Parties agree that they have been represented by legal counsel during the negotiation,
execution and delivery of this Agreement and therefore waive the application of any Law, regulation, holding or rule of construction providing that ambiguities in an agreement or other document shall be construed against the Party drafting such
agreement or document. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) No summary of this Agreement or any Exhibit or Schedule delivered herewith prepared by or on behalf of any
Party shall affect the meaning or interpretation of this Agreement or such Exhibit or Schedule. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) The information contained in this
Agreement and in the Company Disclosure Letter is disclosed solely for purposes of this Agreement, and no information contained herein or therein shall be deemed to be an admission by any Party to any third Person of any matter whatsoever, including
(i)&nbsp;any violation of Law or breach of Contract; or (ii)&nbsp;that such information is material or that such information is required to be referred to or disclosed under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) The representations and warranties in this Agreement are the product of negotiations among the Parties and are for the sole benefit of the
Parties. Any inaccuracies in such representations and warranties are subject to waiver by the Parties in accordance with <U>Section</U><U></U><U>&nbsp;8.5</U> without notice or liability to any other Person. In some instances, the representations
and warranties in this Agreement may represent an allocation among the Parties of risks associated with particular matters regardless of the knowledge of any of the Parties. Consequently, Persons other than the Parties may not rely on the
representations and warranties in this Agreement as characterizations of actual facts or circumstances as of the date of this Agreement or as of any other date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) Documents or other information or materials shall be deemed to have been &#147;made available&#148; by the Company if such documents,
information or materials have been (i)&nbsp;posted and made available to Purchaser in the virtual data room maintained by the Company and hosted by Datasite, (ii)&nbsp;delivered or provided to Purchaser or its Affiliates or Representatives in
connection with the Casdin Transaction or (iii)&nbsp;filed or furnished by the Company with, and available through, the SEC&#146;s Electronic Data Gathering and Retrieval System, in each of clauses (ii)&nbsp;and (iii), at least two Business Days
prior to the date hereof, and with respect to clause (i), at least 3 hours before the execution of this Agreement by the Parties. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) All references to &#147;ordinary course of business&#148; shall be deemed to be followed
by the words &#147;consistent with past practice,&#148; subject, however, to such commercially reasonable actions as are reasonably necessary given changing economics and other conditions, circumstances or events relating to or arising from the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) All references to time shall refer to New York City time unless otherwise
specified. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;II </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT TO SELL AND PURCHASE; CONVERSION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <I>Sale and Purchase; Conversion of Conversion Amount</I>. Subject to the terms and conditions hereof, at the Closing,
(a)&nbsp;(i)&nbsp;the Company shall issue and sell to Casdin PGEF II, and Casdin PGEF II shall purchase from the Company, the PGEF II Purchased Shares in exchange for payment by Casdin PGEF II to the Company of the PGEF II Purchase Price and
(ii)&nbsp;the Company shall issue and sell to Casdin PMF, and Casdin PMF shall purchase from the Company, the PMF Purchased Shares in exchange for payment by Casdin PMF to the Company of the PMF Purchase Price and (b)&nbsp;the Conversion Amount (as
defined in the Loan Agreement) shall be converted into the Converted Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <I>The Closing</I>. The consummation of the Casdin
Transaction shall take place at a closing (the &#147;<B>Closing</B>&#148;) to occur at (a)&nbsp;9:00 a.m., New York City time, at the offices of Paul, Weiss, Rifkind, Wharton&nbsp;&amp; Garrison LLP, 1285 Avenue of the Americas, New York, NY 10019,
on the fifth Business Day after the satisfaction or waiver (to the extent permitted hereunder) of the last to be satisfied or waived of the conditions set forth in <U>Article</U><U></U><U>&nbsp;VII</U> (other than those conditions that by their
terms are to be satisfied at the Closing, but subject to the satisfaction or waiver (to the extent permitted hereunder) of such conditions); or (b)&nbsp;such other time, location and date as the Parties mutually agree in writing. The date on which
the Closing actually occurs is referred to as the &#147;<B>Closing Date</B>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 <I>Adjustments</I>. Without limiting or affecting
any of the provisions of <U>Section</U><U></U><U>&nbsp;5.2</U>, if between the date of this Agreement and the Closing Date the outstanding shares of Company Common Stock shall have been changed into a different number of shares or a different class
by reason of the occurrence of any stock split, reverse stock split, stock dividend (including any dividend or other distribution of securities convertible into Company Common Stock), reorganization, recapitalization, reclassification, combination,
exchange of shares or other like change, the Share Price, PGEF II Purchase Price, PMF Purchase Price and Acquired Shares to be delivered pursuant to this <U>Article</U><U></U><U>&nbsp;II</U> shall be appropriately adjusted to reflect such stock
split, reverse stock split, stock dividend (including any dividend or other distribution of securities convertible into Company Common Stock), reorganization, recapitalization, reclassification, combination, exchange of shares or other like change.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4 <I>Independent Nature of Purchaser</I><I>&#146;</I><I>s Obligations and Rights</I>. The obligations of Purchaser under this Agreement
are several and not joint with the obligations of the Viking Purchaser, and Purchaser shall not be responsible in any way for the performance of the obligations of the Viking Purchaser under the Viking Purchase Agreement. Nothing contained herein,
and no action taken by Purchaser pursuant hereto or the Viking Purchaser pursuant to the Viking Purchase </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agreement, shall be deemed to constitute a partnership, an association, a joint venture or any other kind of entity among Purchaser and the Viking Purchaser, or create a presumption that
Purchaser and the Viking Purchaser are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by this Agreement or the Viking Purchase Agreement. Purchaser shall be entitled to independently
protect and enforce its rights, including the rights arising out of this Agreement, and it shall not be necessary for the Viking Purchaser to be joined as an additional party in any proceeding for such purpose. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;III </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES OF THE COMPANY </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except (a)&nbsp;as disclosed in the Company SEC Reports filed by the Company or furnished by the Company to the SEC, in each case pursuant to
the Exchange Act on or after January&nbsp;1, 2019 and at least two Business Days prior to the date of this Agreement (other than any disclosures contained or referenced therein under the captions &#147;Risk Factors&#148; and &#147;Quantitative and
Qualitative Disclosures About Market Risk&#148; or set forth in any &#147;forward-looking statements&#148; disclaimer, and any other <FONT STYLE="white-space:nowrap">non-specific</FONT> or <FONT STYLE="white-space:nowrap">non-precise</FONT>
cautionary, predictive or forward-looking language contained or referenced therein) or (b)&nbsp;subject to the terms of <U>Section</U><U></U><U>&nbsp;9.13</U>, as set forth in the disclosure letter delivered by the Company to Purchaser on the date
of this Agreement (the &#147;<B>Company Disclosure Letter</B>&#148;), the Company hereby represents and warrants to Purchaser as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 <I>Organization; Good Standing</I>. The Company is a corporation duly organized, validly existing and in good standing pursuant to the
General Corporation Law of the State of Delaware (the &#147;<B>DGCL</B>&#148;). The Company has the requisite corporate power and authority to conduct its business as it is presently being conducted and to own, lease or operate its properties,
rights and assets, except where the failure to have such power or authority, individually or in the aggregate, has not had and would not reasonably be expected to have a Company Material Adverse Effect. The Company is duly qualified to do business
and is in good standing in each jurisdiction where the character of its properties owned or leased or the nature of its activities make such qualification necessary (with respect to jurisdictions that recognize the concept of good standing), except
where the failure to be so qualified or in good standing has not had and would not reasonably be expected to have a Company Material Adverse Effect. The Company has made available to Purchaser true, correct and complete copies of the Amended and
Restated Certificate of Incorporation (the &#147;<B>Charter</B>&#148;) and the Amended and Restated Bylaws of the Company (the &#147;<B>Bylaws</B>&#148;), each as amended to date. The Company is not in violation of the Charter or the Bylaws in any
material respect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <I>Corporate Power; Enforceability</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the filing of the Certificate of Amendment with the Secretary of State for the State of Delaware, the Company has the requisite
corporate power and authority to: (i)&nbsp;execute and deliver this Agreement and the other Transaction Documents; (ii)&nbsp;perform its covenants and obligations hereunder and thereunder; and (iii)&nbsp;subject to receiving the Requisite
Stockholder Approval and assuming that the representations set forth in <U>Section</U><U></U><U>&nbsp;4.6</U> are true and correct, consummate the Casdin Transaction and the other transactions contemplated by this Agreement and the other Transaction
Documents. The execution and delivery of this Agreement </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and the other Transaction Documents by the Company, the performance by the Company of its covenants and obligations hereunder, and the consummation of the transactions contemplated by this
Agreement and the other Transaction Documents, have been duly authorized and approved by the Company Board, and except for obtaining the Requisite Stockholder Approval and assuming that the representations set forth in
<U>Section</U><U></U><U>&nbsp;4.6</U> are true and correct, no other corporate action on the part of the Company or the Company Stockholders is necessary to authorize the execution and delivery of this Agreement or the other Transaction Documents,
the performance by the Company of its covenants and obligations and the consummation by the Company of the transactions contemplated by this Agreement or the other Transaction Documents. This Agreement and each other Transaction Document has been
duly executed and delivered by the Company and, assuming the due authorization, execution and delivery by Purchaser, constitutes a legal, valid and binding agreement of the Company, enforceable against the Company in accordance with its terms,
except as such enforceability (A)&nbsp;may be limited by applicable bankruptcy, insolvency, reorganization, moratorium and other similar Laws affecting or relating to creditors&#146; rights generally or (B)&nbsp;is subject to general principles of
equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Subject to the receipt of the Requisite Stockholder Approval and assuming that the representations set forth in
<U>Section</U><U></U><U>&nbsp;4.6</U> are true and correct, the Company has all requisite power and authority to issue, sell and deliver the Acquired Shares in accordance with and on the terms and conditions set forth in this Agreement, the Loan
Agreement and the Certificate of Designations. The Certificate of Designations will set forth the rights, preferences and priorities of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock, and the holders of the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Preferred Stock shall have the rights set forth in the Certificate of Designations on filing with the Secretary of State for the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <I>Company Board Approval; Anti-Takeover Laws</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Company Board Approval</I>. The Company Board, at a meeting duly called and held, has adopted resolutions, prior to the execution of
this Agreement unanimously (i)&nbsp;determining that it is in the best interests of the Company and the Company Stockholders that the Company enter into this Agreement and the other Transaction Documents and consummate the Casdin Transaction and the
other transactions contemplated hereby and thereby on the terms and subject to the conditions set forth herein and therein, (ii)&nbsp;approving and declaring advisable this Agreement, the other Transaction Documents, the Casdin Transaction and the
other transactions contemplated hereby and thereby on the terms and subject to the conditions set forth herein and therein, (iii)&nbsp;resolving to recommend that the Company Stockholders approve the Transactions and the Certificate of Amendment and
(iv)&nbsp;directing that the Transactions and the Certificate of Amendment be submitted to the Company Stockholders for approval and adoption (clauses (ii), (iii) and (iv), collectively, the &#147;<B>Company Board Recommendation</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Anti-Takeover Laws</I>. Assuming that the representations of Purchaser set forth in <U>Section</U><U></U><U>&nbsp;4.6</U> are true and
correct, the Company Board has taken all necessary actions so that the restrictions contained in Section&nbsp;203 of the DGCL applicable to a &#147;business combination&#148; (as defined in Section&nbsp;203 of the DGCL) shall not apply to the
execution, delivery or performance of this Agreement or the other Transaction Documents or the consummation of the Casdin Transaction or other transactions contemplated hereby and thereby (including with respect to the issuance of the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Preferred Stock or the shares of Company Common Stock issuable on conversion of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock) and any other similar applicable &#147;anti-takeover&#148;
Law will not be applicable to this Agreement or the other Transaction Documents or the consummation of the Casdin Transaction or any other transaction contemplated hereby or thereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4 <I>Requisite Stockholder Approval</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The approval of the Transactions by the affirmative vote of a majority of the voting power of the shares of Company Common Stock present
in person or represented by proxy at the Company Stockholder Meeting and entitled to vote on the subject matter (the &#147;<B>Casdin</B><B> Approval</B>&#148;) and the adoption of the Certificate of Amendment by a majority of the outstanding shares
of Company Common Stock entitled to vote (together with the Casdin Approval, the &#147;<B>Requisite Stockholder Approval</B>&#148;) are the only votes or approvals of the holders of any class or series of capital stock of the Company necessary under
applicable Law, the NASDAQ rules, the Charter or the Bylaws to consummate the Casdin Transaction and the other transactions contemplated in this Agreement and the other Transaction Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) No appraisal or dissenters&#146; rights (pursuant to Section&nbsp;262 of the DGCL or otherwise) will be available to holders of shares of
Company Common Stock in connection with the Casdin Transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.5 <I><FONT STYLE="white-space:nowrap">Non-Contravention</FONT></I>. The
execution and delivery of this Agreement by the Company, the performance by the Company of its covenants and obligations hereunder, and the consummation of the Casdin Transaction and the other transactions contemplated by this Agreement and the
other Transaction Documents do not: (a)&nbsp;violate or conflict with any provision of the Charter or the Bylaws; (b)&nbsp;violate, conflict with, result in the breach of, constitute a default (or an event that, with notice or lapse of time or both,
would become a default) pursuant to, result in the termination of, accelerate the performance required by, or result in a right of termination or acceleration or the vesting or receipt of any benefit or value to a third party, pursuant to any
Contract; (c)&nbsp;assuming compliance with the matters referred to in <U>Section</U><U></U><U>&nbsp;3.6</U> and, in the case of the consummation of the Casdin Transaction, subject to obtaining the Requisite Stockholder Approval and assuming that
the representations set forth in <U>Section</U><U></U><U>&nbsp;4.6</U> are true and correct, violate or conflict with any Law or order applicable to the Company or any of its Subsidiaries or by which any of their respective properties or assets are
bound; or (d)&nbsp;result in the creation of any Lien (other than Permitted Liens) on any of the properties or assets of the Company or any of its Subsidiaries, except in the case of each of clauses (b), (c) and (d)&nbsp;for such consents as have
been obtained and violations, conflicts, breaches, defaults, terminations, accelerations or Liens that have not had, and would not reasonably be expected to have, a Company Material Adverse Effect or prevent or materially impair or materially delay,
or be reasonably expected to prevent or materially impair or materially delay, the consummation of the Casdin Transaction and/or Viking Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.6 <I>Requisite Governmental Approvals</I>. No Governmental Authorization is required on the part of the Company in connection with:
(a)&nbsp;the execution and delivery of this Agreement by the Company; (b)&nbsp;the performance by the Company of its covenants and obligations pursuant to this Agreement; or (c)&nbsp;the consummation of the Casdin Transaction and the other
transactions contemplated by this Agreement, except (i)&nbsp;the filing of the Certificate of Designations and the Certificate of Amendment with the Secretary of State of the State of Delaware, (ii)&nbsp;such filings and approvals as may be required
by any applicable federal or state securities Laws, including </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
compliance with any applicable requirements of the Exchange Act, (iii)&nbsp;compliance with any applicable requirements of NASDAQ; (iv)&nbsp;compliance with any applicable requirements of the HSR
Act and any applicable foreign Antitrust Laws, and (v)&nbsp;such other Governmental Authorizations the failure of which to obtain would not reasonably be expected to have a Company Material Adverse Effect or prevent or materially impair or
materially delay, or be reasonably expected to prevent or materially impair or materially delay, the consummation of the Casdin Transaction and/or Viking Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.7 <I>Company Capitalization</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Capital Stock</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The authorized capital stock of the Company consists of (i)&nbsp;200,000,000 shares of Company Common Stock and
(ii)&nbsp;10,000,000 shares of preferred stock, par value $0.001 per share, of the Company (the &#147;<B>Company Preferred Stock</B>&#148;). As of 5:00&nbsp;p.m., New York City time, on January&nbsp;13, 2022 (such time and date, the
&#147;<B>Capitalization Date</B>&#148;): (A)&nbsp;76,919,287 shares of Company Common Stock were issued and outstanding; (B)&nbsp;no shares of Company Preferred Stock were issued and outstanding; and (C)&nbsp;no shares of Company Common Stock were
held by the Company as treasury shares. From the Capitalization Date to the date of this Agreement, the Company has not issued or granted any Company Securities other than pursuant to the exercise, vesting or settlement of Company Options, Company
RSUs and Company PSUs granted prior to the date of this Agreement in accordance with their respective terms or pursuant to the terms of the Company Notes in accordance with their terms. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) All issued and outstanding shares of Company Common Stock are duly authorized and validly issued, fully paid,
nonassessable and free of any preemptive or similar rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Stock Reservation and Awards</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) As of the Capitalization Date, the Company has reserved 3,539,935 shares of Company Common Stock for issuance pursuant to
the Company Stock Plans, which number excludes shares subject to outstanding awards and 20,312,725 shares of Company Common Stock for issuance pursuant to the Company Notes. As of the Capitalization Date, there were outstanding: (i)&nbsp;Company
Options to acquire 1,596,806 shares of Company Common Stock with a weighted average exercise price of $7.0841; (ii)&nbsp;5,118,456 shares of Company Common Stock subject to outstanding Company RSUs; (iii)&nbsp;2,448,042 shares of Company Common
Stock subject to outstanding Company PSUs (based on maximum achievement, if applicable) (iv)&nbsp;2,633,013 shares of Company Common Stock reserved for issuance under the Company ESPP; and (v)&nbsp;43,750 shares of Company Common Stock estimated to
be subject to outstanding purchase rights under the Company ESPP. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Section&nbsp;3.7(b)(ii) of the Company Disclosure Letter sets forth a
correct and complete list of all equity awards outstanding as of the Capitalization Date, including with respect to each such equity award: (A)&nbsp;the name of the holder thereof; (B) the number of shares subject to such equity award; (C)&nbsp;the
grant or issuance date; (D)&nbsp;any applicable vesting schedule, including the amounts vested and unvested; and (E)&nbsp;with respect to each Company Option, (1)&nbsp;the exercise price and (2)&nbsp;the expiration date. All Company Options have an
exercise price per share of Company Common Stock that may be purchased thereunder that was not less than the &#147;fair market value&#148; of such share on the date of grant, as determined in accordance with the terms of the applicable granting
instrument, the applicable Company Stock Plan and, to the extent applicable, Sections 409A and 422 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Company
Securities</I>. Except as set forth in <U>Section</U><U></U><U>&nbsp;3.7(a)</U> or <U>3.7(b)</U>, there are (i)&nbsp;no issued and outstanding shares of capital stock of, or other equity or voting interest in, the Company, (ii)&nbsp;no outstanding
securities of the Company convertible into or exchangeable or exercisable for shares of capital stock of, or other equity or voting interest in, the Company, (iii)&nbsp;no outstanding options, warrants or other rights or binding arrangements to
acquire from the Company, or that obligate the Company to issue, any capital stock of, or other equity or voting interest in, or any securities convertible into or exchangeable or exercisable for shares of capital stock of, or other equity or voting
interest in, the Company, (iv)&nbsp;no obligations of the Company to grant, extend or enter into any subscription, warrant, right, convertible or exchangeable security, or other similar Contract relating to any capital stock of, or other equity or
voting interest (including any voting debt) in, the Company, (v)&nbsp;no outstanding restricted shares, restricted share units, stock appreciation rights, performance shares, contingent value rights, &#147;phantom&#148; stock or similar securities
or rights that are derivative of, or provide economic benefits based, directly or indirectly, on the value or price of, any capital stock of, or other securities or ownership interests in, the Company and (vi)&nbsp;no other obligations of the
Company to make any payment based on the price or value of any of the items in the foregoing clauses&nbsp;(i) through (v) (the items in clauses (i), (ii), (iii), (iv), (v) and (vi), collectively, the &#147;<B>Company Securities</B>&#148;);
(vii)&nbsp;no voting trusts, proxies or similar arrangements or understandings to which the Company is a party or by which the Company is bound with respect to the voting of any shares of capital stock of, or other equity or voting interest in, the
Company; and (viii)&nbsp;no obligations or binding commitments of any character restricting the transfer of any shares of capital stock of, or other equity or voting interest in, the Company to which the Company is a party or by which it is bound.
Other than the Company Notes, the Company is not a party to any Contract that obligates it to repurchase, redeem or otherwise acquire any Company Securities. There are no accrued and unpaid dividends with respect to any outstanding Company
Securities. The Company does not have a stockholder rights plan in effect or outstanding bonds, debentures, notes or other similar obligations which provide such holder the right to vote with the holders of shares of Company Common Stock on any
matter. The announcement or consummation of the Casdin Transaction and the other transactions contemplated by this Agreement will not, in and of themselves, result in any vesting, acceleration or the receipt of any rights, benefits or value under
any issued and outstanding Company Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Other Rights</I>. The Company is not a party to any Contract relating to the voting
of, requiring registration of, or granting any preemptive or similar rights, anti-dilutive rights or rights of first refusal or other similar rights with respect to any Company Securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <I>Valid Issuance of Shares</I>. The Acquired Shares and the Underlying Shares to be
issued on conversion of the Acquired Shares will be duly authorized by the Company and, when issued and delivered by the Company in accordance with this Agreement, the Loan Agreement and the Certificate of Designations against payment of the
consideration set forth herein, will be validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and will be free and clear of any and all Liens and restrictions on transfer, except for generally applicable transfer
restrictions under applicable securities Law, the Stockholders Agreement or the Charter or such Liens as are created by Purchaser. There are no Persons entitled to statutory, preemptive or other similar contractual rights to subscribe for the
Acquired Shares or the Underlying Shares nor are there any other restrictions on transfer under any contract to which the Company is a party. On issuance in accordance with the Certificate of Designations, the Underlying Shares will be duly
authorized, validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and will be free and clear of any and all Liens and restrictions on transfer, other than (i)&nbsp;restrictions on transfer under the Certificate of
Designations, under this Agreement and under applicable state and federal securities laws and (ii)&nbsp;such Liens as are created by Purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.8 <I>Subsidiaries</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
Each of the Subsidiaries of the Company (i)&nbsp;is duly organized, validly existing and in good standing (with respect to jurisdictions that recognize the concept of good standing) under the laws of the jurisdiction of its organization and
(ii)&nbsp;has the requisite corporate power and authority to conduct its business as it is presently being conducted and to own, lease or operate its properties and assets, except in each case as has not had, and would not reasonably be expected to
have, a Company Material Adverse Effect. Each of the Subsidiaries of the Company is duly qualified to do business and is in good standing in each jurisdiction where the character of its properties owned or leased or the nature of its activities make
such qualification necessary (with respect to jurisdictions that recognize the concept of good standing), except where the failure to be so qualified or in good standing has not had, and would not reasonably be expected to have, a Company Material
Adverse Effect. The Company has made available to Purchaser true, correct and complete copies of the Organizational Documents of each of the Subsidiaries of the Company. No Subsidiary is in violation of any of its Organizational Documents in any
material respect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of the Subsidiaries of the Company is wholly owned by the Company, directly or indirectly, free and clear of
any Liens. Other than for routine cash management purposes and for securities held by employee benefit plans, the Company does not own, directly or indirectly, any capital stock or other equity interest of, or any other securities convertible or
exchangeable into or exercisable for capital stock or other equity interest of, any Person other than the Subsidiaries of the Company, and the Company directly or indirectly owns all outstanding Subsidiary Securities. No Subsidiary of the Company
owns any shares of capital stock or other securities of the Company. <U>Section</U><U></U><U>&nbsp;3.8(b)</U> of the Company Disclosure Letter sets forth each of the Subsidiaries of the Company existing as of the date of this Agreement. Neither the
Company nor any of its Subsidiaries has any Contract pursuant to which it is obligated to make any investment (in the form of a loan, capital contribution or otherwise) in any Person (other than the Company with respect to its Subsidiaries and the
Subsidiaries with respect to each other). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.9 <I>Company SEC Reports</I>. Since January&nbsp;1, 2019 through the date of this Agreement,
the Company has filed or furnished all forms, reports and documents with the SEC that have been required to be filed or furnished by it pursuant to applicable Laws prior to the date of this Agreement (the &#147;<B>Company SEC Reports</B>&#148;).
Each Company SEC Report complied, as of its filing date (or, if amended or superseded by a filing prior to the date of this Agreement, on the date of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such amended or superseding filing), in all material respects with the applicable requirements of the Sarbanes-Oxley Act of 2002, the Securities Act or the Exchange Act, as the case may be, each
as in effect on the date that such Company SEC Report was filed. True, correct and complete copies of all Company SEC Reports are publicly available in the Electronic Data Gathering, Analysis and Retrieval database of the SEC. As of its filing date
(or, if amended or superseded by a filing prior to the date of this Agreement, on the date of such amended or superseded filing), no Company SEC Report contained any untrue statement of a material fact or omitted to state any material fact necessary
in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.10
<I>Company Financial Statements; Internal Controls</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Company Financial Statements</I>. The consolidated financial statements
(including any related notes and schedules) of the Company filed with the Company SEC Reports: (i)&nbsp;were prepared in accordance Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Exchange Act and with GAAP (except as may be
indicated in the notes thereto or as otherwise permitted by Form <FONT STYLE="white-space:nowrap">10-Q</FONT> with respect to any financial statements filed on <FONT STYLE="white-space:nowrap">Form&nbsp;10-Q);</FONT> (ii) complied, as of their
respective date of filing with the SEC, in all material respects with the published rules and regulations of the SEC with respect thereto and (iii)&nbsp;fairly present, in all material respects, the consolidated financial position of the Company as
of the dates thereof and the consolidated results of operations and cash flows for the periods then ended (subject, in the case of the unaudited financial statements, to normal and recurring <FONT STYLE="white-space:nowrap">year-end</FONT> and audit
adjustments). Neither the Company nor any of its Subsidiaries is a party to or bound by, or has any commitment to become a party to, any joint venture, <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet partnership or any similar Contract
(including any Contract or arrangement relating to any transaction or relationship between or among the Company or any of its Subsidiaries, on the one hand, and any unconsolidated Affiliate, on the other hand), including any structured finance,
special purpose or limited purpose entity or Person, or any <FONT STYLE="white-space:nowrap">&#147;off-balance</FONT> sheet arrangements&#148; (as defined in Item&nbsp;303(a) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated
under the Securities Act), where the result, purpose or effect of such Contract is to avoid disclosure of any material transaction involving, or material liabilities of, the Company or any of its Subsidiaries in the Company SEC Reports (including
any audited financial statements and unaudited interim financial statements of the Company included therein). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Disclosure Controls
and Procedures</I>. The Company has established and maintains, and at all times since January&nbsp;1, 2019 has maintained, &#147;disclosure controls and procedures&#148; and &#147;internal control over financial reporting&#148; (in each case as
defined pursuant to Rule <FONT STYLE="white-space:nowrap">13a-15</FONT> and Rule <FONT STYLE="white-space:nowrap">15d-15</FONT> promulgated under the Exchange Act) that are (i)&nbsp;with respect to disclosure controls and procedures, reasonably
designed to ensure that all material information (both financial and <FONT STYLE="white-space:nowrap">non-financial)</FONT> required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded,
processed, summarized and reported within the time periods specified in the rules and forms of the SEC and that all such material information required to be disclosed is accumulated and communicated to the management of the Company, as appropriate,
to allow timely decisions regarding required disclosure and to enable the chief executive officer and chief financial officer of the Company to make the certifications required under the Exchange Act with respect to such reports, and (ii)&nbsp;with
respect to internal control over financial reporting, sufficient in all material respects to provide reasonable assurance (A)&nbsp;that transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP,
(B)&nbsp;that transactions are executed only in accordance with the authorization of management and (C)&nbsp;regarding prevention or timely detection of the unauthorized acquisition, use or disposition of the Company&#146;s properties or assets, in
each case that could have a material effect on the Company&#146;s financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Internal Controls</I>. The Company has established and maintains a system of internal
accounting controls that are effective in providing reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with GAAP. Neither the Company nor, to the Knowledge of the Company,
the Company&#146;s independent registered public accounting firm, has identified or been made aware of: (i)&nbsp;any significant deficiency or material weakness in the system of internal control over financial reporting used by the Company and its
Subsidiaries that has not been subsequently remediated; or (ii)&nbsp;any fraud that involves the Company&#146;s management or other employees who have a role in the preparation of financial statements or the internal control over financial reporting
utilized by the Company and its Subsidiaries. Since January&nbsp;1, 2019, neither the Company nor any of its Subsidiaries nor, to the Company&#146;s Knowledge, any director, officer, employee, auditor, accountant or representative of the Company or
any of its Subsidiaries has received any written complaint, allegation, assertion, or claim (or otherwise has been informed) that the Company or any of its Subsidiaries has engaged in improper or illegal accounting or auditing practices or maintains
improper or inadequate internal accounting controls. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) As of the date of this Agreement, there are no outstanding or unresolved
comments in any comment letters from the staff of the SEC relating to the Company&#146;s SEC Reports and received by the Company prior to the date of this Agreement. None of the Company&#146;s SEC Reports filed on or prior to the date of this
Agreement, is, to the Company&#146;s Knowledge, subject to ongoing SEC review or investigation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.11 <I>No Undisclosed Liabilities</I>.
Neither the Company nor any of its Subsidiaries has any liabilities (accrued, absolute, contingent or otherwise) of a nature required to be reflected or reserved against on a balance sheet prepared in accordance with GAAP, as in effect on the date
of this Agreement, or notes thereto, other than liabilities: (a)&nbsp;reflected or otherwise reserved against in the Audited Company Balance Sheet or in the consolidated financial statements of the Company and its Subsidiaries (including the notes
thereto) included in the Company SEC Reports filed prior to the date of this Agreement; (b)&nbsp;arising pursuant to this Agreement or the Viking Purchase Agreement or incurred in connection with the Casdin Transaction or the Viking Transaction;
(c)&nbsp;incurred in the ordinary course of business (none of which is a liability resulting from noncompliance with any applicable Laws or licenses, breach of Contract, breach of warranty, tort, infringement, misappropriation, dilution, claim or
lawsuit); or (d)&nbsp;that, individually or in the aggregate, have not had, and would not reasonably be expected to have, a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.12 <I>Absence of Certain Changes</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Since September&nbsp;30, 2021 through the date of this Agreement (i)&nbsp;the business of the Company and its Subsidiaries has been
conducted, in all material respects, in the ordinary course of business and (ii)&nbsp;there has not been any action taken by the Company or any of its Subsidiaries that, if taken during the period from the date of this Agreement through the Closing
without Purchaser&#146;s consent, would constitute a breach of, or require consent of Purchaser under <U>Section</U><U></U><U>&nbsp;5.2(b)</U>, <U>Section</U><U></U><U>&nbsp;5.2(c)</U>, <U>Section</U><U></U><U>&nbsp;5.2(d)</U>,
<U>Section</U><U></U><U>&nbsp;5.2(i)</U>, <U>Section</U><U></U><U>&nbsp;5.2(k)</U> or <U>Section</U><U></U><U>&nbsp;5.2(l)</U> (as it relates to the foregoing sections). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Since December&nbsp;31, 2020 through the date of this Agreement, there has not been any
effect, change, development or occurrence that, individually or in the aggregate, has had, or would reasonably be expected to have, a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.13 <I>Material Contracts</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>List of Material Contracts</I>. Section&nbsp;3.13(a) of the Company Disclosure Letter contains a true, correct and complete list of all
Material Contracts, as of the date of this Agreement, to which the Company or any of its Subsidiaries is a party. Prior to the date of this Agreement, the Company has made available to Purchaser complete and correct copies of all of the Material
Contracts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Validity</I>. Each Material Contract (other than any Material Contract that has expired in accordance with its terms)
is valid and binding on the Company or each Subsidiary of the Company that is a party thereto (as the case may be) and, to the Knowledge of the Company, any other party thereto and is enforceable in accordance with its terms, and is in full force
and effect, except where the failure to be valid and binding and in full force and effect has not had, and would not reasonably be expected to have, a Company Material Adverse Effect. The Company and each of its Subsidiaries, and, to the Knowledge
of the Company, any other party thereto, has performed all obligations required to be performed by it under each Material Contract, except where the failure to fully perform has not had, and would not reasonably be expected to have, a Company
Material Adverse Effect. No event has occurred that, whether or not with notice or lapse of time or both, would constitute such a breach, default, acceleration of rights or an event of termination pursuant to any Material Contract by the Company or
any of its Subsidiaries, or, to the Knowledge of the Company, any other party thereto, except for such breaches, defaults, acceleration or termination that have not had, and would not reasonably be expected to have, a Company Material Adverse
Effect. As of the date of this Agreement, neither the Company nor any of its Subsidiaries has received written notice that it has breached, violated or defaulted under any Material Contract. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.14 <I>Real Property</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
<I>Owned Real Property</I>. Neither the Company nor any of its Subsidiaries owns any real property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Leased Real Property</I>.
Section&nbsp;3.14(b) of the Company Disclosure Letter contains a true, correct and complete list, as of the date of this Agreement, of all of the existing material leases, subleases, licenses or other agreements pursuant to which the Company or any
of its Subsidiaries, leases, subleases, uses or occupies, or has the right to use or occupy, now or in the future, any real property for which the annual rent is in excess of $100,000 (such property, the &#147;<B>Leased Real Property</B>,&#148; and
each such lease, sublease, license or other agreement, a &#147;<B>Lease</B>&#148;). The Company has made available to Purchaser true, correct and complete copies of the Leases (including all material modifications, amendments and supplements
thereto). Except as has not </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
had, and would not reasonably be expected to have, a Company Material Adverse Effect, the Company or one of its Subsidiaries has valid leasehold estates in the Leased Real Property, free and
clear of all Liens (other than Permitted Liens). Each Lease is legal, valid, binding, enforceable and in full force and effect. Neither the Company&#146;s nor any of its Subsidiaries&#146; possession and quiet enjoyment of the Leased Real Property
under any Lease has been disturbed, and there are no disputes with respect to any such Lease in any material respect. Neither the Company nor any of its Subsidiaries is in material breach of or default pursuant to any Lease. There are no material
subleases, licenses or similar agreements granting to any Person, other than the Company or any of its Subsidiaries, any right to use or occupy the Leased Real Property or any portion thereof, now or in the future. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.15 <I>Environmental Matters</I>. Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect:
(a)&nbsp;the Company and its Subsidiaries are, and since January&nbsp;1, 2019, have been, in compliance with all Environmental Laws and Environmental Permits (including obtaining and maintaining all such Environmental Permits); (b) since
January&nbsp;1, 2019 (or earlier if unresolved), no notice, report, order, directive or other information has been received by the Company or any of its Subsidiaries alleging any violation of, or liability arising out of, any Environmental Law;
(c)&nbsp;no Legal Proceeding is pending or, to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries relating to a violation of, or liability under, any Environmental Law; (d)&nbsp;neither the Company nor any of its
Subsidiaries has transported, manufactured, distributed, sold, handled, stored, treated, released, disposed or arranged for disposal of, or exposed any Person to, any Hazardous Materials, or owned or operated any real property or facility
contaminated by any Hazardous Materials, in each case, that has resulted, or would reasonably be expected to result, in an investigation or required cleanup by, or other liability (contingent or otherwise) for, the Company or any of its
Subsidiaries; and (e)&nbsp;the Company and its Subsidiaries have not assumed, provided an indemnity with respect to or otherwise become subject to the liability of any other Person relating to Environmental Laws. The Company has made available to
Purchaser copies of all environmental reports, audits and assessments and all other material documents bearing on environmental, health or safety matters relating to the Company, any of its Subsidiaries, or any of their current or former facilities,
properties or operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.16 <I>Intellectual Property</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Within 10 days after the date of this Agreement, the Company shall provide Purchaser with a true, correct and complete (i)&nbsp;list of
all Registered Intellectual Property owned by, or registered in the name of, the Company or any of its Subsidiaries (for each, indicating, as applicable, the owner(s), filing or registration number, title, jurisdiction, filing date and status and,
for Internet domain names, the registrant, registrar, and expiration date) and (ii)&nbsp;description of all material Company Software. All material Registered Intellectual Property is subsisting, and to the Knowledge of the Company, excluding any
pending patent applications, valid and enforceable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company and its Subsidiaries solely and exclusively own all right, title, and
interest in and to all Registered Intellectual Property and all other material Intellectual Property that is owned or purported to be owned by the Company or any of its Subsidiaries, including all Company Software (the &#147;<B>Company Owned
IP</B>&#148;), and is licensed or otherwise possesses adequate rights to use pursuant to a valid license or subscription agreement, all material Intellectual Property </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
used or held for use in, or necessary for, their respective businesses as currently conducted (collectively, and together with the Company Owned IP, the &#147;<B>Company Intellectual
Property</B>&#148;), in each case free and clear of all Liens (other than Permitted Liens). The Company has not (i)&nbsp;sold, transferred, or otherwise divested any Intellectual Property that would be Company Owned IP, but for such sale, transfer,
or divestiture, or (ii)&nbsp;granted any Person any exclusive right to any Company Owned IP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company and its Subsidiaries have
taken commercially reasonable actions to maintain and protect all of the Company Owned IP, including the secrecy, confidentiality and value of the material Trade Secrets of the Company and its Subsidiaries. All past and present employees,
consultants and contractors of the Company and its Subsidiaries who have had access to material Trade Secrets of the Company and its Subsidiaries or have authored, developed or otherwise created any material Company Intellectual Property for the
Company, have executed written agreements pursuant to which such Person (i)&nbsp;is bound to maintain and protect the confidential information of the Company and its Subsidiaries, and (ii)&nbsp;in accordance with applicable Laws and without further
consideration or any restrictions or obligations on the Company or any of its Subsidiaries, assigns to the Company or its applicable Subsidiaries all of their respective ownership rights in the Intellectual Property authored, developed or otherwise
created by such Person in the course of such Person&#146;s employment or other engagement with the Company and its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) No
Company Owned IP is subject to any consent, settlement, decree, order, injunction, judgment or ruling prohibiting or restricting the Company&#146;s or any of its Subsidiaries&#146; use, ownership, enforcement or other exploitation or disposition
thereof, except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect. No Company Owned IP is subject to any proceeding or outstanding decree, order, judgment or settlement agreement to which the Company or
one of its Subsidiaries is a party, or, to the Knowledge of the Company, to which any third Person is a party, that restricts in any manner the use, provision, transfer, assignment or licensing thereof by the Company or its Subsidiaries or affects
the validity, use or enforceability of such Company Owned IP, except for any such prohibitions or restrictions that would not have a Company Material Adverse Effect. The transactions contemplated by this Agreement and the consummation thereof will
not impair any right, title or interest of the Company or any of its Subsidiaries in or to any Company Intellectual Property or material Company Systems, and all of the Company Intellectual Property and material Company Systems will be owned or
available for use by the Company and its Subsidiaries immediately after the Closing on terms and conditions identical to those under which the Company and its Subsidiaries owned or used the Company Intellectual Property and material Company Systems
immediately prior to the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) No Company Owned IP was developed by the Company or any of its Subsidiaries using (in whole or in
part) government, public or private foundation, or university funding or facilities nor was it obtained from any Governmental Authority, public or private foundation, or university, and neither the Company nor any of its Subsidiaries has granted to
any Governmental Authority, public or private foundation, or university, either expressly, or by any act or omission, any unlimited, unrestricted or government purpose rights, or any similar rights in Company Owned IP. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) There are no claims by any Person that are either pending or made or, to the Knowledge
of the Company, threatened in writing since January&nbsp;1, 2019, (i)&nbsp;alleging infringement, misappropriation, or other violation by the Company or any of its Subsidiaries of any Intellectual Property of such Person, or (ii)&nbsp;contesting the
validity, use, ownership, enforceability, patentability or registrability of any material Company Owned IP, excluding any ordinary course &#147;office actions&#148; received by the Company or a Subsidiary in connection with the prosecution of
Patents. Neither the Company nor any of its Subsidiaries has received any written notices or written requests for indemnification from any third party related to any of the foregoing matters in clauses (i)&nbsp;and (ii). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) (i) Neither the Company nor any of its Subsidiaries, nor the conduct of the business of the Company and its Subsidiaries, including the
sale or licensing of the Company&#146;s products, infringes, misappropriates, or otherwise violates or, since January&nbsp;1, 2019, has infringed, misappropriated, or otherwise violated, any Intellectual Property of any Person in any material
respect; (ii)&nbsp;neither the Company nor any of its Subsidiaries has received any written notices regarding any of the foregoing matters in clause (i) (including any cease and desist letters, demands or unsolicited offers to license any
Intellectual Property from any Person); and (iii)&nbsp;to the Knowledge of the Company as of the date of this Agreement, no Person is infringing, misappropriating, or otherwise violating any Intellectual Property owned by the Company or any of its
Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Company and its Subsidiaries have not incorporated in or distributed with any Company Software or Company Product
any Open Source Software in a manner that has subjected any Company Source Code to any requirement under any applicable Open Source License to distribute or otherwise disclose such Company Source Code. Neither the Company nor any of its Subsidiaries
have received a written notice or request from any Person to disclose, distribute or license any Company Source Code pursuant to an Open Source License, or alleging noncompliance with any such Open Source License. The Company and its Subsidiaries
possess all Company Source Code and other documentation and materials reasonably necessary for a developer competent in the programming language for such Software to compile, operate and maintain the Company Software. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Company and its Subsidiaries own, lease, license, or otherwise have the valid right to use all material Company Systems, and such
Company Systems are sufficient in all material respects for the needs of the Company&#146;s and its Subsidiaries&#146; businesses, and the Company and its Subsidiaries have purchased sufficient license rights for all material third party Software
used in their operations. All Company Software operates in all material respects in accordance with its requirements, technical, <FONT STYLE="white-space:nowrap">end-user</FONT> and other documentation. To the Knowledge of the Company, there are no
viruses, &#147;worms&#148;, &#147;time bombs&#148;, <FONT STYLE="white-space:nowrap">&#147;key-locks&#148;,</FONT> Trojan horses or similar disabling codes, programs or devices in any of the Company Software, or any other codes, programs or devices
designed to disrupt or interfere with the operation of the Company Software or equipment on which the Company Software operates, or the integrity of the Data, information or signals the Company Software produces in a manner adverse to the Company,
any of its Subsidiaries, any customer, licensee or other Person. The Company and its Subsidiaries have not delivered, licensed, or made available, and is not obligated to deliver, license, or make available any Company Source Code to any escrow
agent or other Person who is not an employee, contractor or other service provider of the Company or any of its Subsidiaries, and any Person providing backup, source code repository, hosting and similar services to Company or its Subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Since January&nbsp;1, 2019: (i) the Company and its Subsidiaries (including the conduct
of their respective businesses and their Processing of Data) have complied with all Data Security Requirements in all material respects; (ii)&nbsp;there has not been any Security Incident; and (iii)&nbsp;the Company and its Subsidiaries have taken
commercially reasonable actions, including instituting commercially reasonable physical, technical, and administrative security measures and policies, to protect the security and integrity of the Company Systems, all Data stored or contained therein
or transmitted thereby, and all Sensitive Information from and against unauthorized access, use, or disclosure. Since January&nbsp;1, 2019, neither the Company nor any of its Subsidiaries has (i)&nbsp;provided or been required under any applicable
Data Security Requirement to provide any notices to data owners in connection with any unauthorized access, use or disclosure of Sensitive Information, (ii)&nbsp;received any written complaint from any Person regarding any Data Security Requirement,
Security Incident, or Sensitive Information, nor (iii)&nbsp;to the Knowledge of the Company, been subject to any investigations or audits by a Governmental Authority concerning any violation of Data Security Requirements, Security Incident, or
Sensitive Information. The execution and delivery of this Agreement by the Company and the consummation of the Casdin Transaction will not result in any violation by the Company or its Subsidiaries of any applicable Data Security Requirement, except
as would not reasonably be expected to have a Company Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.17 <I>Tax Matters</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, each of the Company and its
Subsidiaries has: (i)&nbsp;timely filed (taking into account valid extensions) all Tax Returns required to be filed by it, and all Tax Returns are true, correct and complete in all respects; (ii)&nbsp;timely paid all Taxes that are due and payable
by it, except for those being contested in good faith by appropriate proceedings and for which adequate reserves have been established in accordance with GAAP; and (iii)&nbsp;reflected or otherwise reserved against in its books in accordance with
GAAP an amount reasonably adequate for the payment of all material amounts of Taxes for the taxable period subsequent to the latest period to which such Tax Returns apply. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect: (i)&nbsp;no audits or other
examinations with respect to Taxes of the Company or any of its Subsidiaries are presently in progress or have been asserted or proposed in writing, except for any audit or other examination for which adequate reserves have been made (in accordance
with GAAP); (ii) neither the Company nor any of its Subsidiaries has outstanding any waiver or extension of any statute of limitations on, or extended the period for the assessment or collection of any Tax; and (iii)&nbsp;no written claim has been
made by a Governmental Authority in a jurisdiction where the Company or any of its Subsidiaries does not file Tax Returns of a particular type that the Company or such Subsidiary, as the case may be, is or may be subject to Tax of such type in that
jurisdiction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as has not had, and would not reasonably be expected to have, a Company Material
Adverse Effect, each of the Company and each of its Subsidiaries (or its agent) has withheld or collected from each payment made to each of its employees or any other Person the amount of all Taxes required to be withheld or collected therefrom, and
has paid the same to the proper Tax receiving officers or authorized depositories. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company is not and has not been, during the
five-year period ending on the date hereof, a &#147;United States real property holding corporation&#148; within the meaning of Section&nbsp;897 of the Code and any applicable regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, there are no Liens for Taxes on
the assets of the Company or any of its Subsidiaries other than those described in clause (i)&nbsp;of the definition of Permitted Liens. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.18 <I>Employee Benefits</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Employee Plans</I>. Section&nbsp;3.18(a) of the Company Disclosure Letter sets forth a true, correct, current and complete list of each
material Employee Plan as of the date of this Agreement. With respect to each Employee Plan, copies of the following materials have been provided to Purchaser: (i)&nbsp;all current plan documents for each Employee Plan and all amendments thereto
(and for any unwritten Employee Plan, a summary of the material terms); (ii) the most recent determination letter from the IRS with respect to any of the Employee Plans; (iii)&nbsp;all current summary plan descriptions, summaries of material
modifications, annual reports and summary annual reports with respect to any of the Employee Plans; and (iv)&nbsp;all material <FONT STYLE="white-space:nowrap">non-routine</FONT> correspondence from a Governmental Authority with respect to any of
the Employee Plans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Absence of Certain Plans</I>. Neither the Company, its Subsidiaries nor any ERISA Affiliate of the Company has
maintained, sponsored or participated in, or contributed to, in the <FONT STYLE="white-space:nowrap">six-year</FONT> period preceding the date hereof or otherwise has any liability or obligation with respect to: (i)&nbsp;a &#147;multiemployer
plan&#148; (as defined in Section&nbsp;3(37) or 4001(a)(3) of ERISA); (ii) a &#147;multiple employer plan&#148; (as defined in Section&nbsp;4063 or Section&nbsp;4064 of ERISA) or as described in Section&nbsp;413(c) of the Code; (iii)&nbsp;a
&#147;defined benefit plan&#148; as defined in the Section&nbsp;3(35) of ERISA or a plan that is or was subject to the funding standards of Section&nbsp;302 of ERISA or covered by Section&nbsp;412 of the Code or Title IV of ERISA; or (iv)&nbsp;a
&#147;multiple employer welfare arrangement&#148; (as defined in Section&nbsp;3(40) of ERISA). No event has occurred and, to the Knowledge of the Company, no condition exists that would, either directly or indirectly or by reason of the
Company&#146;s or any Subsidiary&#146;s affiliation with any ERISA Affiliate, subject the Company or any of its Subsidiaries to any material Tax, fine, lien, penalty or other liability imposed by ERISA, the Code or other applicable Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Compliance</I>. Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, each Employee
Plan has been established, maintained, funded, operated and administered in accordance with its terms and with all applicable Law, including the applicable provisions of ERISA, the Code, the Patient Protection and Affordable Care Act and any
applicable regulatory guidance issued by any Governmental Authority. Each Employee Plan that is intended to be qualified under Section&nbsp;401(a) of the Code (i)&nbsp;has received a favorable determination letter issued by the IRS regarding such
qualified status or is maintained pursuant to a prototype or volume submitter document approved by the IRS and is entitled to rely on a favorable opinion letter issued by the IRS with respect to such prototype or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
volume submitter document, and (ii)&nbsp;to the Knowledge of the Company, no events have occurred that would reasonably be expected to adversely affect the qualified status of any such Employee
Plan. Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, neither the Company nor any of its Subsidiaries has incurred or could reasonably be expected to incur any penalty or Tax (whether or not
assessed) under Sections 4980B, 4980D or 4980H of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Contributions</I>. Except as has not had, and would not reasonably be
expected to have, a Company Material Adverse Effect, (i)&nbsp;all contributions, premiums, reimbursements or other payments that are due and owing to or in respect of any Employee Plan have been paid, and (ii)&nbsp;all such contributions, premiums,
reimbursements or other payments for any period ending on or before the Closing Date that are not yet due have been (or will be prior to the Closing Date) paid or properly accrued (in accordance with GAAP, to the extent applicable). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <I>No Post-Termination Welfare Benefit Plan</I>. No Employee Plan that is a welfare benefit plan (as defined in Section&nbsp;3(1) of
ERISA) provides, and neither the Company nor any of its Subsidiaries has committed to or otherwise has any obligation to provide, post-termination or retiree life insurance or welfare benefits to any Person, except as may be required by
Section&nbsp;4980B of the Code or any similar Law for which the covered Person pays the full premium cost of coverage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <I>Employee
Plan Legal Proceedings</I>. Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, there are no Legal Proceedings or claims pending or, to the Knowledge of the Company, threatened on behalf of,
against or in relation to, any Employee Plan, the assets of any trust pursuant to any Employee Plan, or the plan sponsor, plan administrator or any fiduciary or any Employee Plan, other than routine claims for benefits, and there is no fact or
circumstance that could reasonably be expected to give rise to any such Legal Proceeding or claim. There have been no <FONT STYLE="white-space:nowrap">non-exempt</FONT> &#147;prohibited transactions&#148; (as defined in Section&nbsp;406 of ERISA or
Section&nbsp;4975 of the Code), or breaches of duty by a &#147;fiduciary&#148; (as defined in Section&nbsp;3(21) of ERISA) with respect to any Employee Plan involving the Company or any of its Subsidiaries or, to the Knowledge of the Company, any
other Person, that could reasonably be expected to result in material liability to the Company or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <I>Impact
of the Transaction on Employee Plans</I>. Neither the execution or delivery of this Agreement nor the consummation of the Casdin Transaction (alone or in conjunction with the Viking Transaction or any other actions contemplated by this Agreement or
the Viking Purchase Agreement) will constitute a &#147;change in control,&#148; &#147;change of control,&#148; or term of similar meaning under any Employee Plan including, for the avoidance of doubt, any Company Stock Plan. Neither the execution or
delivery of this Agreement nor the consummation of the Casdin Transaction (either alone or in conjunction with the Viking Transaction or any other actions contemplated by this Agreement or the Viking Purchase Agreement) could (alone or in
conjunction with any other event) result in (i)&nbsp;any of the following with respect to any current or former employee, officer, director, independent contractor or other service provider of the Company or any Subsidiary of the Company:
(A)&nbsp;severance pay upon any termination of employment or service, or any increase thereof, (B)&nbsp;any payment, compensation or benefit becoming due, or increase thereof, (C)&nbsp;the acceleration of the time of payment or vesting of any
payment, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
compensation or benefit, or (D)&nbsp;any funding (through a grantor trust or otherwise) of any compensation benefit; (ii)&nbsp;any other liability or obligation pursuant to any of the Employee
Plans; (iii)&nbsp;result in any limitation on the right of the Company or any Subsidiary of the Company to amend, merge, terminate or receive a reversion of assets from any Employee Plan or related trust; or (iv)&nbsp;the payment an amount that
could, individually or in combination with any other payment or benefit, be characterized as an &#147;excess parachute payment&#148; within the meaning of Section&nbsp;280G(1) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <I>Section 409A</I>. Each Employee Plan that constitutes in any part a &#147;nonqualified deferred compensation plan&#148; within the
meaning of Section&nbsp;409A of the Code has been administered, operated and maintained in all material respects in operational and documentary compliance with Section&nbsp;409A of the Code and all IRS guidance promulgated thereunder, to the extent
such Section and such guidance have been applicable to such Employee Plan. No Employee Plan, agreement or other arrangement to which the Company or any Subsidiary is a party or by which the Company or any Subsidiary is otherwise bound obligates the
Company to compensate, <FONT STYLE="white-space:nowrap">gross-up,</FONT> indemnify or reimburse any Person in respect of Taxes pursuant to Section&nbsp;409A or 4999 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <I>Foreign Benefit Plans</I>. Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, with
respect to each Employee Plan that is subject to the Laws of a jurisdiction other than the United States (whether or not United States Law also applies) (a &#147;<B>Foreign Benefit Plan</B>&#148;): (i) all employer and employee contributions to each
Foreign Benefit Plan required by Law or by the terms of such Foreign Benefit Plan have been made, or if applicable, accrued in accordance with normal accounting practices, (ii)&nbsp;each Foreign Benefit Plan required to be registered has been
registered and each Foreign Benefit Plan has been maintained in good standing with applicable Governmental Authorities and in compliance with all applicable Laws, (iii)&nbsp;each Foreign Benefit Plan intended to receive favorable tax treatment under
applicable tax Laws, to the extent applicable, has been qualified or similarly determined by applicable Governmental Authorities to satisfy the requirements of such Laws, (iv)&nbsp;no Foreign Benefit Plan is a defined benefit or similar type of plan
or arrangement, and (v)&nbsp;no Foreign Benefit Plan has any material unfunded liabilities, nor are any unfunded liabilities reasonably expected to arise in connection with the transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.19 <I>Labor Matters</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
<I>Union Activities</I>. There are no collective bargaining agreements, labor union contracts, trade union agreements, works council agreements or any other agreements or arrangements with an employee representative body (each, a &#147;<B>Collective
Bargaining Agreement</B>&#148;) to which the Company or any of its Subsidiaries is a party to or is bound and no employees of the Company or any of its Subsidiaries are represented by any labor union, works council or other labor organization with
respect to their employment with the Company or any of its Subsidiaries. There are no representation or certification proceedings or petitions seeking a representation proceeding presently pending or, to the Company&#146;s Knowledge, threatened to
be brought or filed with or before the National Labor Relations Board or any other labor relations Governmental Authority with respect to representation of any such employees in respect of their employment with the Company or any of its
Subsidiaries. No Collective Bargaining Agreement is being negotiated by the Company or any of its Subsidiaries and no labor union, works council, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other labor organization, or group of employees of the Company or its Subsidiaries has made a demand for recognition or certification. Since January&nbsp;1, 2017, (i) there have been no union
organizing or union election activities or attempts to bargain collectively and (ii)&nbsp;there have been no strikes, lockouts, slowdowns, work stoppages, picketing, concerted refusal to work overtime, handbilling, demonstrations, leafletting,
arbitrations, grievances or lockouts (in each case involving labor matters) or other material labor disputes against or affecting the Company or any of its Subsidiaries pending or, to the Knowledge of the Company, threatened against the Company or
any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Employment Law</I>. Each of the Company and its Subsidiaries is, and has been since January&nbsp;1, 2019,
in compliance with all Labor Laws, except for such noncompliance that has not had, and would not reasonably be expected to have, a Company Material Adverse Effect. Each employee, independent contractor and service provider who is providing, or in
the past three (3)&nbsp;years has provided, services to the Company or any of its Subsidiaries has all work permits, immigration permits, visas or other authorizations required by applicable Law. Each of the Company and its Subsidiaries has met all
requirements under Laws relating to employment of foreign citizens and residents, including all Form <FONT STYLE="white-space:nowrap">I-9</FONT> requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company has not incurred any liability or obligation under the WARN Act that remains unsatisfied. With respect to the employees of the
Company and its Subsidiaries, during the last 12 months, there has been no mass layoff, plant closing, shutdown or term of similar import that triggered the WARN Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) No current employee of the Company or any of its Subsidiaries with an annualized base salary from the Company at or above $250,000 is in
any material respect in violation of any term of any employment agreement, nondisclosure agreement, common law nondisclosure obligation, fiduciary duty, noncompetition agreement, <FONT STYLE="white-space:nowrap">non-solicitation</FONT> agreement,
restrictive covenant or other obligation: (i)&nbsp;owed to the Company or any of its Subsidiaries; or (ii)&nbsp;to the Knowledge of the Company, owed to any third party with respect to such Person&#146;s right to be employed or engaged by the
Company or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except as has not had, and would not reasonably be expected to have, a Company Material Adverse
Effect, there are no pending, or to the Company&#146;s Knowledge, threatened Legal Proceedings against the Company or any of its Subsidiaries brought by or on behalf of any applicant for employment, any employee, independent contractor or service
provider, any current or former leased employee, intern, volunteer or &#147;temp&#148; of the Company or any of its Subsidiaries, or Person alleging to be a current or former employee, or any group or class of the foregoing, or any Governmental
Authority, alleging: (i)&nbsp;violation of any Labor Laws; (ii)&nbsp;breach of any Collective Bargaining Agreement; (iii)&nbsp;breach of any express or implied contract of Law; (iv)&nbsp;wrongful termination of employment; or (v)&nbsp;any other
discriminatory, wrongful or tortious conduct in connection with any employment relationship, including before the Equal Employment Opportunity Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Since January&nbsp;1, 2019, the Company has not incurred any material liability with respect to the classification of any Person as
(i)&nbsp;an individual independent contractor rather than an employee, or (ii)&nbsp;an &#147;exempt&#148; employee rather than a <FONT STYLE="white-space:nowrap">&#147;non-exempt&#148;</FONT> employee (within the meaning of the Fair Labor Standards
Act and state Law), and no such Person has been improperly included or excluded from any Employee Plan. Neither the Company nor any of its Subsidiaries has notice of any pending or, to the Company&#146;s Knowledge, threatened, inquiry or audit from
any Governmental Authority concerning any such classifications. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Since January&nbsp;1, 2019, there have been no Legal Proceedings or settlements
involving allegations of sexual or other unlawful harassment or discrimination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.20 <I>Compliance with Laws</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company and each of its Subsidiaries is, and since January&nbsp;1, 2019 has been, in compliance in all material respects with all Laws
that are applicable to the Company or any of its Subsidiaries or to the conduct of the business or operations of the Company or any its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect,
as of the date of this Agreement: (i)&nbsp;the Company and its Subsidiaries have all Governmental Authorizations necessary for the ownership and operation of its business as presently conducted, and each such Governmental Authorization is in full
force and effect; (ii)&nbsp;the Company and its Subsidiaries are, and since January&nbsp;1, 2019 have been, in compliance with the terms of all Governmental Authorizations necessary for the ownership and operation of the businesses of the Company or
any of its Subsidiaries; and (iii)&nbsp;since January&nbsp;1, 2019, neither the Company nor any of its Subsidiaries has received written notice from any Governmental Authority alleging any conflict with or breach of any such Governmental
Authorization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.21 <I>Anti-Corruption; International Trade</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Since January&nbsp;1, 2017, none of the Company, any of its Subsidiaries, or any of their respective directors, officers, or employees
has, nor, to the Knowledge of the Company, have any of their agents or other Person acting on their behalf, violated any Anti-Corruption Laws, nor has the Company, any Subsidiary of the Company, any of their respective directors, officers, or
employees nor, to the Knowledge of the Company, any other Representative of the Company or any of its Subsidiaries offered, paid, promised to pay, or authorized the payment of any money, or offered, given, promised to give, or authorized the giving
of anything of value, including cash, checks, wire transfers, tangible and intangible gifts, favors, services, or those entertainment and travel expenses that go beyond what is reasonable and customary, to any Government Official or to any Person
for the purpose of influencing any act or decision of a Government Official in their official capacity, securing any improper advantage, or assisting the Company or any Subsidiary of the Company in obtaining or retaining business, in each case in
violation of any Anti-Corruption Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company, each of its Subsidiaries, and their respective directors, officers and, to the
Knowledge of the Company, employees and other Representatives are in compliance in all material respects with all applicable Laws relating to imports, exports and economic sanctions, including all applicable Laws administered and enforced by the
U.S. Treasury Department&#146;s Office of Foreign Assets Control (&#147;<B>OFAC</B>&#148;), the U.S. State Department (including the Directorate of Defense Trade Controls), the U.S. Commerce Department&#146;s Bureau of Industry
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and Security (&#147;<B>BIS</B>&#148;), or U.S. Customs and Border Protection (&#147;<B>Trade Laws</B>&#148;). Except as has not had, and would not reasonably be expected to have, a Company
Material Adverse Effect, since January&nbsp;1, 2017, neither the Company nor any of its Subsidiaries, nor any of their respective directors, officers or, to the Knowledge of the Company, employees or other Representatives has been a party to any
Contract or engaged in any transaction or other business, directly or indirectly, (i)&nbsp;in breach of any applicable Trade Laws or (ii)&nbsp;to the extent it would be prohibited under applicable Trade Laws, with any Governmental Authority or other
Person that (A)&nbsp;appears on any applicable list of sanctioned parties (including any Person that appears on OFAC&#146;s Specially Designated Nationals and Blocked Persons List or Sectoral Sanctions Identification List or BIS&#146;s Denied
Persons, Entity, or Unverified Lists), (B) is located or organized in any country or territory that is, or at the time of the transaction or business was, subject to comprehensive OFAC sanctions (including Cuba, Iran, North Korea, Syria or the
Crimea region of Ukraine) or (C)&nbsp;is 50% or more owned or otherwise controlled by a Person described in clause (A)&nbsp;or (B). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.22
<I>Compliance with Healthcare Laws and Regulations</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Any preclinical and clinical studies subject to regulatory oversight by a
Governmental Authority and conducted by or on behalf of or sponsored by the Company or its Subsidiaries, or in which the Company or its Subsidiaries have participated, were (and, if still pending, are being) conducted in all material respects in
accordance with all applicable statutes and all applicable rules and regulations of the U.S. Food and Drug Administration (the &#147;<B>FDA</B>&#148;) and comparable regulatory agencies outside of the United States to which they are subject,
including the European Medicines Agency (collectively, the &#147;<B>Healthcare Authorities</B>&#148;) and Good Clinical Practice and Good Laboratory Practice requirements. The Company and its Subsidiaries have operated at all times and are currently
in compliance in all material respects with all statutes, rules and regulations applicable to the ownership, testing, development, marketing, promotion, manufacture, packaging, processing, use, distribution, storage, import, export or disposal of
any product manufactured, distributed or sold by or on behalf of the Company or any of its Subsidiaries (each, a &#147;<B>Company Product</B>&#148;), including all statutes, rules and regulations of the Healthcare Authorities, except where <FONT
STYLE="white-space:nowrap">such&nbsp;non-compliance&nbsp;would</FONT> not, individually or in the aggregate, be material. Neither the Company nor any of its Subsidiaries have received any written notices, correspondence or other communications from
the Healthcare Authorities or any other governmental agency requiring or threatening the termination or suspension of any of the Company&#146;s activities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Since January&nbsp;1, 2019, except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, neither the Company nor any Subsidiary has voluntarily or involuntarily initiated, conducted or issued, caused to be initiated, conducted or issued, any recall, field corrective action, market withdrawal, seizure,
suspension, safety alert, written warning, &#147;dear doctor&#148; letter, investigator notice to healthcare wholesalers, healthcare distributors, healthcare retailers, healthcare professionals or patients (including any action required to be
reported or for which records must be maintained under 21 C.F.R. Part 806) relating to any Company Product (collectively, a &#147;<B>Recall</B>&#148;) or, as of the date hereof, currently intends to initiate, conduct or issue any Recall of any
Company Product. Except as would not reasonably be expected to be, individually or in the aggregate, material to the Company and its Subsidiaries, taken as a whole, neither the Company nor any of its Subsidiaries has received any written notice from
the FDA or any other Healthcare Authority regarding (i)&nbsp;any Recall of any Company Product, (ii)&nbsp;a change in the marketing status or classification, or a material change in the labeling, of any such Company Product or (iii)&nbsp;a notice of
<FONT STYLE="white-space:nowrap">non-coverage</FONT> from a Healthcare Authority in the reimbursement status of a Company Product (not including any routine adjustments made to the amount of reimbursement). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.23 <I>Legal Proceedings; Orders</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>No Legal Proceedings</I>. Except as has not been, and would not reasonably be expected to be, individually or in the aggregate,
material to the Company and its Subsidiaries, taken as a whole, there are no current Legal Proceedings pending or, to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries or their respective assets, operations or
properties or relating to the Transaction Documents or the transactions contemplated hereby or thereby, nor, since January&nbsp;1, 2019, has the Company or any of its Subsidiaries made any voluntary or involuntary disclosures of <FONT
STYLE="white-space:nowrap">non-compliance</FONT> with applicable Law to any Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>No Orders</I>. Except as has
not been, and would not reasonably be expected to be, individually or in the aggregate, material to the Company and its Subsidiaries, taken as a whole, or that would prevent or materially impair or materially delay, or would reasonably be expected
to prevent or materially impair or materially delay, the consummation of the Casdin Transaction and/or Viking Transaction, neither the Company nor any of its Subsidiaries (nor any of its or their respective properties) is subject to any order of any
kind or nature. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.24 <I>Insurance</I>. As of the date of this Agreement, except as has not had, and would not reasonably be expected to
have, individually or in the aggregate, a Company Material Adverse Effect, the Company and its Subsidiaries have all policies of insurance covering the Company and its Subsidiaries and any of their respective employees, properties or assets,
including policies of life, property, fire, workers&#146; compensation, products liability, directors&#146; and officers&#146; liability and other casualty and liability insurance, that is customarily carried by Persons conducting business similar
to that of the Company and its Subsidiaries. As of the date of this Agreement, all such insurance policies are in full force and effect, no notice of cancellation has been received and there is no existing default or event that, with notice or lapse
of time or both, would constitute a default by any insured thereunder, except for such cancellations and defaults that, individually or in the aggregate, have not had, and would not reasonably be expected to have, a Company Material Adverse Effect.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.25 <I>Related Party Transactions</I>. Except for compensation or other employment arrangements in the ordinary course of business,
there are no Contracts, transactions, arrangements or understandings between the Company or any of its Subsidiaries, on the one hand, and any Affiliate of the Company (including any director or executive officer) thereof, but not including any
wholly owned Subsidiary of the Company, on the other hand, that would be required to be disclosed pursuant to Item 404 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated by the SEC in the Company&#146;s Form <FONT
STYLE="white-space:nowrap">10-K</FONT> or proxy statement pertaining to an annual meeting of stockholders that have not been disclosed in the Company SEC Reports. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.26 <I>Brokers</I>. Except for Jefferies LLC, there is no financial advisor, investment
banker, broker, finder or agent that has been retained by or is authorized to act on behalf of the Company or any of its Subsidiaries who is entitled to any financial advisor&#146;s, investment banking, brokerage, finder&#146;s or other similar fee
or commission in connection with the Casdin Transaction or the other transactions contemplated by this Agreement or the other Transaction Documents. The Company has made available to Purchaser the engagement letter of Jefferies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.27 <I>Other Agreements</I>. The Company has provided to Purchaser, prior to the execution and delivery of this Agreement, a true, complete
and correct copy of the Viking Purchase Agreement which, on execution of this Agreement, shall be in full force and effect. The Company has not entered into any other agreement, arrangement or understanding with the Viking Purchaser or any of its
respective Affiliates with respect to any securities of the Company or any of its Subsidiaries, the transactions contemplated by the Viking Purchase Agreement or the payment of any fees or expenses in connection therewith, except for any <FONT
STYLE="white-space:nowrap">non-disclosure</FONT> agreements or term sheets with the Viking Purchaser or its Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.28
<I>Investment Company Status</I>. Neither the Company nor any of its Subsidiaries is, and immediately after the Closing hereunder, none of the Company nor any of its Subsidiaries will be, required to be registered as an &#147;investment
company&#148; under the Investment Company Act of 1940. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.29 <I>Sale of Securities</I>. Without limiting the foregoing, neither the
Company nor, to the Knowledge of the Company, any other Person authorized by the Company to act on its behalf, has engaged in a general solicitation or general advertising (within the meaning of Regulation D of the Securities Act) of investors with
respect to offers or sales of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock, and neither the Company nor, to the Knowledge of the Company, any Person acting on its behalf has made any offers or sales of any security or
solicited any offers to buy any security, under circumstances that would cause the offering or issuance of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock under this Agreement to be integrated with prior offerings by the
Company for purposes of the Securities Act that would result in none of Regulation D or any other applicable exemption from registration under the Securities Act to be available. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.30 <I>No </I><I>Rights Agreement</I><I>; Anti-Takeover</I><I> Provisions</I>. As of the date of this Agreement, neither the Company nor any
of its Subsidiaries is party to a stockholder rights agreement, &#147;poison pill&#148; or similar anti-takeover agreement or plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.31
<I>Registration Rights</I>. Except as contemplated by the Registration Rights Agreement, no Person has the right to require the Company or any of its Subsidiaries to register any securities for sale under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.32 <I>Exclusivity of Representations and Warranties</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>No Other Representations and Warranties</I>. The Company acknowledges and agrees that, except for the representations and warranties
expressly set forth in <U>Article</U><U></U><U>&nbsp;IV</U>, in any other Transaction Document or in any certificate delivered pursuant to this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) neither Purchaser nor any other Person makes, or has made, any representation or warranty relating to Purchaser or any of
its businesses, operations or otherwise in connection with this Agreement or the Transactions; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Purchaser hereby disclaims any other express or implied representations
or warranties, notwithstanding the delivery or disclosure to the Company or any of its Representatives of any documentation or other information (including any financial information, supplemental data, financial projections or other forward-looking
statements). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>No Reliance</I>. The Company acknowledges and agrees that, except for the representations and warranties expressly
set forth in <U>Article</U><U></U><U>&nbsp;IV</U>, in any other Transaction Document or in any certificate delivered by Purchaser pursuant to this Agreement, it is not acting, by entering into this Agreement or consummating the Transactions, in
reliance on: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any other representation or warranty, express or implied; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) any estimate, projection, prediction, data, financial information, memorandum, presentation or other materials or
information provided or addressed to the Company or any of its Representatives, including any materials or information made available in connection with the Transactions, in connection with presentations by Purchaser&#146;s management or in any
other forum or setting; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) the accuracy or completeness of any other representation, warranty, estimate, projection,
prediction, data, financial information, memorandum, presentation or other materials or information. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;IV </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES OF PURCHASER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Purchaser hereby represents and warrants to the Company as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <I>Organization; Good Standing</I>. Purchaser is duly organized, validly existing and in good standing pursuant to the Laws of its
jurisdiction of organization. Purchaser has the requisite power and authority to conduct its business as it is presently being conducted and to own, lease or operate its material properties, rights and assets, except where the failure to have such
power or authority, individually or in the aggregate, would not, individually or in the aggregate, prevent or materially delay the consummation of the Casdin Transaction or the other transactions contemplated by this Agreement. Purchaser is not in
violation of its Organizational Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 <I>Corporate Power; Enforceability</I>. Purchaser has the requisite corporate power and
authority to: (a)&nbsp;execute and deliver this Agreement and the other applicable Transaction Documents; (b)&nbsp;perform its covenants and obligations hereunder and thereunder; and (c)&nbsp;consummate the Casdin Transaction and the other
transactions contemplated by this Agreement and the other applicable Transaction Documents. The execution and delivery of this Agreement and the other applicable Transaction Documents by Purchaser, the performance by Purchaser of its covenants and
obligations hereunder and the consummation of the Casdin Transaction and the transactions contemplated by this Agreement and the other applicable Transaction Documents have been duly authorized by all necessary action on the part of Purchaser and no
additional action on the part of Purchaser is necessary. This Agreement and each other applicable Transaction Documents have been duly executed and delivered by Purchaser and, assuming the due authorization, execution and delivery by the Company,
constitute legal, valid and binding obligations of Purchaser, enforceable against Purchaser in accordance with their terms, except as such enforceability (i)&nbsp;may be limited by applicable bankruptcy, insolvency, reorganization, moratorium and
other similar Laws affecting or relating to creditors&#146; rights generally and (ii)&nbsp;is subject to general principles of equity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3 <I><FONT STYLE="white-space:nowrap">Non-Contravention</FONT></I>. The execution and
delivery of this Agreement by Purchaser, the performance by Purchaser of its covenants and obligations hereunder, and the consummation of the Casdin Transaction and the other transactions contemplated by this Agreement and the other applicable
Transaction Documents do not: (a)&nbsp;violate or conflict with any provision of the Organizational Documents of Purchaser; (b)&nbsp;violate, conflict with, result in the breach of, constitute a default (or an event that, with notice or lapse of
time or both, would become a default) pursuant to, or result in the termination of, or accelerate the performance required by, or result in a right of termination or acceleration pursuant to any of the terms, conditions or provisions of any material
note, bond, mortgage, indenture, lease, license, contract, agreement or other instrument or obligation to which Purchaser is a party or by which Purchaser or any of its properties or assets may be bound; (c)&nbsp;assuming the consents, approvals and
authorizations referred to in <U>Section</U><U></U><U>&nbsp;4.4</U> have been obtained, violate or conflict with any Law or order applicable to Purchaser or by which any of its properties or assets are bound; or (d)&nbsp;result in the creation of
any Lien (other than Permitted Liens) on any of the properties or assets of Purchaser, except in the case of each of clauses (b), (c) and (d)&nbsp;for such violations, conflicts, breaches, defaults, terminations, accelerations or Liens that would
not, individually or in the aggregate, prevent or materially delay the consummation of the Casdin Transaction or the other transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4 <I>Requisite Governmental Approvals</I>. No Governmental Authorization is required on the part of Purchaser in connection with:
(a)&nbsp;the execution and delivery of this Agreement by Purchaser; (b)&nbsp;the performance by Purchaser of its covenants and obligations pursuant to this Agreement; or (c)&nbsp;the consummation of the Casdin Transaction and the other transactions
contemplated by this Agreement, except (i)&nbsp;such filings and approvals as may be required by any federal or state securities Laws, including compliance with any applicable requirements of the Exchange Act; (ii)&nbsp;compliance with any
applicable requirements of the HSR Act and any applicable foreign Antitrust Laws; and (iii)&nbsp;such other Governmental Authorizations the failure of which to obtain would not, individually or in the aggregate, prevent or materially delay the
consummation of the Casdin Transaction or the other transactions contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.5 <I>Legal Proceedings; Orders</I>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>No Legal Proceedings</I>. There are no Legal Proceedings pending or, to the knowledge of Purchaser, threatened against Purchaser
that would, individually or in the aggregate, prevent or materially delay Purchaser&#146;s ability to consummate the Casdin Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>No Orders</I>. Purchaser is not subject to any order of any kind or nature that would prevent or materially delay the consummation of
the Casdin Transaction or the other transactions contemplated by this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.6 <I>Ownership of Company Common Stock</I>. Neither Purchaser nor any of its
&#147;affiliates&#148; or &#147;associates&#148; is or, during the three years prior to the date of this Agreement, has been an &#147;interested stockholder&#148; (in each case, as such quoted terms are defined under Section&nbsp;203 of the DGCL) of
the Company. Neither Purchaser nor any of its &#147;affiliates&#148; or &#147;associates&#148; (as those terms are defined in Section&nbsp;203 of the DGCL) beneficially owns, directly or indirectly, any shares of Company Common Stock or any other
security convertible into, exchangeable for or exercisable for shares of Company Common Stock. Other than with its Affiliates, Purchaser is not a member of a &#147;group&#148; (as such term is used in Section&nbsp;13(d) of the Exchange Act) of
Persons with respect to any securities of the Company (it being understood that in no event will the Viking Purchaser or any of its Affiliates be deemed to be Affiliates of Purchaser for purposes of this <U>Section</U><U></U><U>&nbsp;4.6</U>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.7 <I>Brokers</I>. There is no financial advisor, investment banker, broker, finder, agent or other Person that has been retained by or is
authorized to act on behalf of Purchaser or any of its Affiliates that will be entitled to any financial advisor&#146;s, investment banking, brokerage, finder&#146;s or other fee or commission from the Company or its Subsidiaries in connection with
the Casdin Transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.8 <I>Sufficient Funds</I>. (a)&nbsp;(i)&nbsp;Casdin PGEF II will have at the Closing sufficient funds to enable
Casdin PGEF II to pay in full at the Closing the entire amount of the PGEF II Purchase Price and all other amounts payable by Casdin PGEF II hereunder in immediately available cash funds and (ii)&nbsp;Casdin PGEF II has uncalled capital commitments
or otherwise has available funds in excess of the PGEF II Purchase Price and all other amounts payable by Casdin PGEF II pursuant to this Agreement and (b)&nbsp;(i)&nbsp;Casdin PMF will have at the Closing sufficient funds to enable Casdin PMF to
pay in full at the Closing the entire amount of the PMF Purchase Price and all other amounts payable by Casdin PMF hereunder in immediately available cash funds (ii)&nbsp;Casdin PMF has uncalled capital commitments or otherwise has available funds
in excess of the PMF Purchase Price and all other amounts payable by Casdin PMF pursuant to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.9 <I>Unregistered
Securities</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Investor Status; Sophisticated Purchaser</I>. Purchaser is an &#147;accredited investor&#148; within the meaning
of Regulation D of the Securities Act and is able to bear the risk of its investment in the Purchased Shares. Purchaser has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of the
purchase of the Purchased Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Information</I>. Purchaser and its Representatives have been furnished with (i)&nbsp;materials
relating to the business, finances and operations of the Company, (ii)&nbsp;materials relating to the offer and sale of the Purchased Shares and (iii)&nbsp;materials relating to the Casdin Transaction, in each case, that have been requested by
Purchaser. Purchaser and its Representatives have been afforded the opportunity to ask questions of the Company. Neither such inquiries nor any other due diligence investigations conducted at any time by Purchaser and its Representatives shall
modify, amend or affect Purchaser&#146;s right (i)&nbsp;to rely on the Company&#146;s representations and warranties contained in <U>Article</U><U></U><U>&nbsp;III</U> above or (ii)&nbsp;to indemnification or any other remedy based on, or with
respect to the accuracy or inaccuracy of, or compliance with, the representations, warranties, covenants and agreements in this Agreement. Purchaser understands that its purchase of the Purchased Shares involves a high degree of risk. Purchaser has
sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition of the Purchased Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Legends</I>. Purchaser understands that any certificate or book-entry position
evidencing Acquired Shares will bear the restrictive legend set forth in the Certificate of Designations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Purchase
Representations</I>. Purchaser is purchasing the Purchased Shares for its own account, the account of its Affiliates, or the accounts of clients for whom Purchaser exercises discretionary investment authority (all of whom Purchaser hereby represents
and warrants are &#147;accredited investors&#148; within the meaning of Regulation D of the Securities Act), not as a nominee or agent, and not with a view to distribution in violation of any securities Laws. Purchaser has been advised and
understands that the Purchased Shares have not been registered under the Securities Act or under the &#147;blue sky&#148; laws of any jurisdiction and may be resold only if registered pursuant to the requirements of the Securities Act (or if
eligible, pursuant to Rule 144 promulgated under the Securities Act or pursuant to another available exemption from the registration requirements of the Securities Act). Purchaser has been advised and understands that the Company, in issuing the
Purchased Shares, is relying upon, among other things, the representations and warranties of Purchaser contained in this <U>Section</U><U></U><U>&nbsp;4.9</U> in concluding that such issuance is a &#147;private offering&#148; and is exempt from the
registration provisions of the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <I>Rule 144</I>. Purchaser understands that there is no public trading market for the
Purchased Shares, that none is expected to develop and that the Purchased Shares shall be held indefinitely unless and until the Purchased Shares are registered under the Securities Act or an exemption from registration is available. Purchaser has
been advised of and is knowledgeable with respect to the provisions of Rule 144 promulgated under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <I>Reliance by
the Company</I>. Purchaser understands that the Purchased Shares are being offered and sold in reliance on a transactional exemption from the registration requirements of federal and state securities Laws and that the Company is relying on the truth
and accuracy of the representations, warranties, agreements, acknowledgments and understandings of Purchaser set forth herein in order to determine the applicability of such exemptions and the suitability of Purchaser to acquire the Purchased
Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.10 <I>Stockholder and Management Arrangements</I>. Except for the Transaction Documents or as previously disclosed to the
Company in writing, neither Purchaser nor any of its Affiliates is a party to any Contract, or has authorized, made or entered into, or committed or agreed to enter into, any formal or informal arrangements or other understandings (whether or not
binding) with any stockholder, director, officer, employee or other Affiliate of the Company or any of its Subsidiaries: (a)&nbsp;relating to this Agreement, the Casdin Transaction or the Viking Transaction, (b)&nbsp;pursuant to which any holder of
Company Common Stock has agreed to approve this Agreement or (c)&nbsp;pursuant to which any Person has agreed to provide, directly or indirectly, an equity investment to the Purchaser or the Company to finance any portion of the Transaction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.11 <I>Exclusivity of Representations and Warranties</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>No Other Representations and Warranties</I>. Purchaser acknowledges and agrees that, except for the representations and warranties
expressly set forth in <U>Article</U><U></U><U>&nbsp;III</U> (as qualified by the Company Disclosure Letter), in any other Transaction Document or in any certificate delivered pursuant to this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) neither the Company nor any other Person makes, or has made, any representation or warranty relating to the Company, its
Subsidiaries, or any of its or their businesses, operations or otherwise in connection with this Agreement or the Transactions; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the Company hereby disclaims any other express or implied representations or warranties, notwithstanding the delivery or
disclosure to Purchaser or any of its Representatives of any documentation or other information (including any financial information, supplemental data, financial projections or other forward-looking statements). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>No Reliance</I>. Purchaser acknowledges and agrees that, except for the representations and warranties expressly set forth in
<U>Article</U><U></U><U>&nbsp;III</U> (as qualified by the Company Disclosure Letter), in any other Transaction Document or in any certificate delivered by the Company pursuant to this Agreement, it is not acting, by entering into this Agreement or
consummating the Transactions, in reliance on: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any other representation or warranty, express or implied; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) any estimate, projection, prediction, data, financial information, memorandum, presentation or other materials or
information provided or addressed to Purchaser or any of its Representatives, including any materials or information made available in the electronic data room hosted by or on behalf of the Company in connection with the Transactions, in connection
with presentations by the Company&#146;s management or in any other forum or setting; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) the accuracy or
completeness of any other representation, warranty, estimate, projection, prediction, data, financial information, memorandum, presentation or other materials or information. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;V </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INTERIM
OPERATIONS OF THE COMPANY </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 <I>Affirmative Obligations</I>. Except (a)&nbsp;as expressly contemplated by this Agreement,
(b)&nbsp;as set forth in Section&nbsp;5.1 or Section&nbsp;5.2 of the Company Disclosure Letter, (c)&nbsp;as required by applicable Law or by <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures or (d)&nbsp;as approved in advance in writing by
Purchaser (which approval shall not be unreasonably withheld, conditioned or delayed), during the period from the execution and delivery of this Agreement until the earlier to occur of the termination of this Agreement pursuant to
<U>Article</U><U></U><U>&nbsp;VIII</U> and the Closing, the Company shall, and shall cause each of its Subsidiaries to, (i)&nbsp;conduct its business in all material respects in the ordinary course of business, and (ii)&nbsp;use reasonable best
efforts to preserve intact in all material respects its current business organization, ongoing businesses and significant relationships with third parties. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <I>Forbearance Covenants</I>. Except (a)&nbsp;as expressly contemplated by this
Agreement, (b)&nbsp;as set forth in Section&nbsp;5.1 or Section&nbsp;5.2 of the Company Disclosure Letter, (c)&nbsp;as required by applicable Law or by <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures or (d)&nbsp;as approved in advance in
writing by Purchaser (which approval shall not be unreasonably withheld, conditioned or delayed), during the period from the execution and delivery of this Agreement until the earlier to occur of the termination of this Agreement pursuant to
<U>Article</U><U></U><U>&nbsp;VIII</U> and the Closing, the Company shall not, and shall not permit any of its Subsidiaries to, directly or indirectly: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) take any action set forth in Section&nbsp;13(b) or 13(c) of the Certificate of Designations; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) acquire or agree to acquire, directly or indirectly, by purchase, merger, consolidation or otherwise, any equity or assets constituting
all or a material portion of the business of (or any division of the business of) another Person; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) sell, assign, transfer, license
(other than <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses in the ordinary course of business consistent with past practice), sublicense, abandon, permit to lapse, grant a covenant not to sue, or otherwise dispose of any material
Company Owned IP (other than <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses or sublicenses granted in the ordinary course of business); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) disclose, release or otherwise fail to maintain the confidential nature of any source code to Company Software or other Trade Secrets;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) (i) authorize for issuance, issue, deliver, sell or transfer or agree or commit to issue, deliver, sell or transfer any shares of
capital stock of or other equity interest or convertible security in the Company or any of its Subsidiaries or other rights of any kind to acquire, any shares of capital stock of or any other equity interest in the Company or any of its
Subsidiaries, other than (A)&nbsp;the issuance of capital stock or other equity interests pursuant to any Employee Plan, (B)&nbsp;the issuance of capital stock or other equity interests from any wholly owned Subsidiary to the Company or any other
wholly owned Subsidiary of the Company or (C)&nbsp;the issuance of Company Common Stock pursuant to the Company Notes; (ii)&nbsp;amend or modify any term or provision of any of the Company&#146;s outstanding equity securities; or
(iii)&nbsp;accelerate or waive any restrictions pertaining to the vesting of any Company equity-based awards or warrants or other rights of any kind to acquire any shares of capital stock or other equity interests in the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) reclassify, combine, split or subdivide any capital stock of the Company or any of its Subsidiaries or issue or authorize the issuance of
any other securities in respect of, in lieu of, or in substitution for, shares of capital stock of the Company or any of its Subsidiaries, except for, with respect to any Subsidiary of the Company, any intercompany restructuring, recapitalization or
similar transaction that will not prevent or delay the consummation of the Casdin Transaction or the other transactions contemplated by this Agreement or result in any adverse impact on Purchaser; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) except as required under the terms of any Employee Plan or as set forth in
Section&nbsp;5.2(g) of the Company Disclosure Letter, (i)&nbsp;increase the compensation or benefits payable to any current or former (A)&nbsp;director, (B) executive officer, or (C)&nbsp;employee or independent contractor, other than increases with
respect to employees at the Director level or below in the ordinary course of business consistent with past practice, by no more than ten percent of such individual&#146;s compensation or benefits payable immediately prior to such increase, and as
otherwise not prohibited by <U>Section</U><U></U><U>&nbsp;5.2(h)</U>, (ii)&nbsp;accelerate the vesting or payment of any Employee Plan or other compensation or benefit plan, program, agreement or arrangement for, any director, employee or
independent contractor, (iii)&nbsp;enter into, adopt, amend, terminate or increase the coverage or benefits available under any Employee Plan (or other compensation or benefit plan, program, agreement or arrangement that would be an Employee Plan if
in effect on the date of this Agreement), other than ordinary course changes in relation to annual renewals, or (iv)&nbsp;grant any equity or equity-based awards of the Company or any of its Subsidiaries to any director, employee or independent
contractor of the Company or any of its Subsidiaries; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) (i)&nbsp;hire, offer to hire or promote any new Person with an annual salary or
annualized fee in excess of $250,000, (ii)&nbsp;terminate the employment or service of any employee with an annual salary or annualized fee in excess of $250,000 or any employee with a title of Director or above of the Company or any of its
Subsidiaries other than for &#147;cause&#148; or (iii)&nbsp;institute any general layoff of employees or implement any plant closings, reductions in force, furloughs, temporary layoffs, early retirement plan or announce the planning of any such
action; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) enter into, amend or extend any Collective Bargaining Agreement or other Contract with any union or similar labor
organization; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) waive or release any material noncompetition, nonsolicitation, nondisclosure, noninterference, nondisparagement or
other restrictive covenant obligation of any current or former employee or independent contractor; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) (i)&nbsp;make any loans, advances
or capital contributions to, or investments in, any other Person, other than investments by the Company or a wholly owned Subsidiary of the Company to a wholly owned Subsidiary of the Company or the Company or advances of expenses to any director,
officer, employee or agent of the Company in connection with advancement obligations in effect on the date of this Agreement, (ii)&nbsp;incur, assume or modify any indebtedness or (iii)&nbsp;assume, guarantee, endorse, grant a lien (other than a
Permitted Lien or any lien on Intellectual Property) on any of the Company&#146;s assets as security or otherwise become liable for indebtedness of another Person (excluding the Company or any of its Subsidiaries); or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) agree, resolve, authorize or commit to take any action prohibited by this <U>Section</U><U></U><U>&nbsp;5.2</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 <I>No Solicitation</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>No Solicitation or Negotiation</I>. From the date hereof until the earlier to occur of the termination of this Agreement pursuant to
<U>Article</U><U></U><U>&nbsp;VIII</U> and the Closing, the Company shall (i)&nbsp;cease and cause to be terminated any discussions or negotiations with any Person and its Affiliates and their respective directors, officers, employees, investment
bankers, attorneys, accountants and other advisors or representatives (collectively, &#147;<B>Representatives</B>&#148;) that would be prohibited by this <U>Section</U><U></U><U>&nbsp;5.3(a)</U> and (ii)&nbsp;terminate all physical and electronic
data room access </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
previously granted to any such Person, its Affiliates and their respective Representatives. From the date hereof until the earlier to occur of the termination of this Agreement pursuant to
<U>Article</U><U></U><U>&nbsp;VIII</U> and the Closing, the Company and its Subsidiaries shall not, and shall cause their respective directors, officers and employees, and shall instruct their other Representatives not to, directly or indirectly:
(A)&nbsp;solicit, initiate or propose the making, submission or announcement of, or knowingly encourage, induce, facilitate or assist, an Acquisition Proposal or any inquiries or the making of any proposal that could reasonably be expected to lead
to an Acquisition Proposal; (B)&nbsp;furnish to any Person (other than Purchaser, the Viking Purchaser (solely with respect to the Viking Transaction) or their respective Representatives) any <FONT STYLE="white-space:nowrap">non-public</FONT>
information relating to the Company or any of its Subsidiaries or afford to any Person access to the business, properties, assets, books, records or other <FONT STYLE="white-space:nowrap">non-public</FONT> information, or to any personnel, of the
Company or any of its Subsidiaries, in any such case to knowingly encourage, facilitate or assist an Acquisition Proposal or any inquiries relating to, or the making of, any proposal that could reasonably be expected to lead to an Acquisition
Proposal; (C)&nbsp;participate, continue or engage in discussions or negotiations with any Person with respect to an Acquisition Proposal (other than informing such Persons of the provisions contained in this <U>Section</U><U></U><U>&nbsp;5.3</U> or
contacting such Person making any unsolicited Acquisition Proposal to clarify the terms and conditions thereof); (D)&nbsp;approve, endorse or recommend an Acquisition Proposal; or (E)&nbsp;enter into any letter of intent, memorandum of
understanding, merger agreement, acquisition agreement or other Contract relating to an Acquisition Transaction (any such letter of intent, memorandum of understanding, merger agreement, acquisition agreement or other Contract relating to an
Acquisition Transaction, an &#147;<B>Alternative Acquisition Agreement</B>&#148;). From the date of this Agreement until the earlier to occur of the termination of this Agreement pursuant to <U>Article</U><U></U><U>&nbsp;VIII</U> and the Closing,
the Company shall not be required to enforce, and shall be permitted to waive, any provision of any standstill or confidentiality agreement to permit any proposal to be made to the Company Board (or any committee thereof). In furtherance and not in
limitations of the other provisions of this <U>Section</U><U></U><U>&nbsp;5.3</U>, the Company agrees that if it (i)&nbsp;permits any of its Representatives (other than an employee or consultant of the Company who is not an executive officer of the
Company) to take any action or (ii)&nbsp;is made aware of an action by one of its Representatives (other than an employee or consultant of the Company who is not an executive officer of the Company) and does not use its reasonable best efforts to
prohibit or terminate such action and, in each case, such action would constitute a material breach of this <U>Section</U><U></U><U>&nbsp;5.3</U> if taken by the Company during the period from the earlier to occur of the termination of this
Agreement pursuant to <U>Article VIII</U> and the Closing, then such action shall be deemed to constitute a breach by the Company of this <U>Section</U><U></U><U>&nbsp;5.3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>No Change in Company Board Recommendation or Entry into an Alternative Acquisition Agreement</I>. At no time after the date of this
Agreement until the earlier of the termination of this Agreement or the Closing Date shall the Company Board (or a committee thereof)&nbsp;(i) withhold, withdraw, amend, qualify or modify, or publicly propose to withhold, withdraw, amend, qualify or
modify, the Company Board Recommendation in a manner adverse to Purchaser; (ii)&nbsp;publicly adopt, approve or recommend an Acquisition Proposal; (iii)&nbsp;in connection with a tender or exchange offer by a third party, fail to recommend against
such offer by the close of business on the 10th Business Day after the commencement of a tender or exchange offer in connection with an Acquisition Proposal (it being understood that the Company Board (or a committee thereof) may refrain from taking
a position with respect to an Acquisition Proposal until the close of business on the 10th Business Day after the commencement of a tender or exchange offer in connection with such Acquisition Proposal without such action being considered a
violation of this <U>Section</U><U></U><U>&nbsp;5.3(b)</U>); (iv)&nbsp;fail to include the Company Board Recommendation in the Proxy Statement; or (v)&nbsp;enter into any Contract or letter of intent regarding an Acquisition Proposal (any action
described in clauses (i)&nbsp;through (iv), a &#147;<B>Company Board Recommendation Change</B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Company Board Recommendation Change</I>. Notwithstanding anything to the contrary set
forth in this Agreement, at any time prior to obtaining the Requisite Stockholder Approval, the Company Board (or a committee thereof) may effect a Company Board Recommendation Change in response to an Intervening Event if the Company Board (or a
committee thereof) determines in good faith (after consultation with its financial advisor and outside legal counsel) that the failure to do so would be inconsistent with its fiduciary duties pursuant to applicable Law; provided, that, the Company
Board (or a committee thereof) shall not effect such a Company Board Recommendation Change unless: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the Company has
provided prior written notice to Purchaser and the Viking Purchaser at least five Business Days in advance to the effect that the Company Board (or a committee thereof) has (A)&nbsp;made such determination; and (B)&nbsp;resolved to effect a Company
Board Recommendation Change pursuant to this <U>Section</U><U></U><U>&nbsp;5.3(c)</U>, which notice shall specify the basis for such Company Board Recommendation Change, including a reasonably detailed description of the facts and circumstances
relating to such Intervening Event and copies of all relevant documents relating thereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) prior to effecting such
Company Board Recommendation Change, the Company and its Representatives, during such five Business Day period, shall have negotiated with Purchaser, the Viking Purchaser and their respective Representatives in good faith (to the extent that
Purchaser or the Viking Purchaser desires to so negotiate) to make such adjustments to the terms and conditions of this Agreement so that the Company Board (or a committee thereof) would no longer determine that the failure to make a Company Board
Recommendation Change in response to such Intervening Event would be inconsistent with its fiduciary duties pursuant to applicable Law; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) at the end of such five Business Day period and taking into account any adjustments to the terms and conditions of this
Agreement and the Viking Purchase Agreement, the Company Board (or a committee thereof) has determined in good faith (after consultation with its financial advisor and outside legal counsel) that the failure to make a Company Board Recommendation
Change in response to such Intervening Event would continue to be inconsistent with its fiduciary duties pursuant to applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the avoidance of
doubt, the determination by the Company Board (or a committee thereof) that an Intervening Event has occurred or the delivery by the Company of a notice contemplated by this <U>Section</U><U></U><U>&nbsp;5.3(c)</U> shall not constitute a Company
Board Recommendation Change if otherwise in compliance with this <U>Section</U><U></U><U>&nbsp;5.3</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Notice</I>. From the date hereof until the earlier to occur of the termination of
this Agreement pursuant to <U>Article</U><U></U><U>&nbsp;VIII</U> and the Closing, the Company shall promptly (and, in any event, within 24 hours) notify Purchaser if any offers or proposals that constitute an Acquisition Proposal are received by,
any <FONT STYLE="white-space:nowrap">non-public</FONT> information is requested from, or any discussions or negotiations are sought to be initiated or continued with, the Company or any of its Representatives. Such notice shall include a summary of
the material terms and conditions of such offer, proposal, request, inquiry, discussions or negotiations, including the identity of the Person making any such offer, proposal, request or inquiry or seeking to engage in such discussions or
negotiations, and a copy of any written documents in connection therewith (including any updates or amendments thereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <I>Certain
Disclosures</I>. Nothing in this Agreement shall prohibit the Company or the Company Board (or a committee thereof) from (i)&nbsp;taking and disclosing to the Company Stockholders a &#147;stop, look and listen&#148; communication by the Company
Board (or a committee thereof) to the Company Stockholders pursuant to Rule <FONT STYLE="white-space:nowrap">14d-9(f)</FONT> promulgated under the Exchange Act (or any substantially similar communication); (ii) informing any Person of the existence
of the provisions contained in this <U>Section</U><U></U><U>&nbsp;5.3</U>; or (iii)&nbsp;complying with the Company&#146;s disclosure obligations under U.S. federal or state Law with regard to an Acquisition Proposal, it being understood that any
such statement or disclosure made by the Company Board (or a committee thereof) shall be subject to the terms and conditions of this Agreement and nothing in this <U>Section</U><U></U><U>&nbsp;5.3(e)</U> shall permit the Company to make a Company
Board Recommendation Change. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4 <I>No Control of the Other Party</I><I>&#146;</I><I>s Business</I>. The Parties acknowledge and agree
that the restrictions set forth in this Agreement are not intended to give Purchaser, on the one hand, or the Company, on the other hand, directly or indirectly, the right to control or direct the business or operations of the other at any time
prior to the Closing. Prior to the Closing Date, Purchaser and the Company shall exercise, consistent with the terms, conditions and restrictions of this Agreement, complete control and supervision over their own business and operations. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;VI </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADDITIONAL COVENANTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1
<I>Required Action and Forbearance; Efforts</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Reasonable Best Efforts</I>. On the terms and subject to the conditions set forth
in this Agreement, Purchaser shall (and shall cause its Affiliates to, if applicable), on the one hand, and the Company shall, on the other hand, use their respective reasonable best efforts to (x)&nbsp;take (or cause to be taken) all actions,
(y)&nbsp;do (or cause to be done) all things and (z)&nbsp;assist and cooperate with the other Parties in doing (or causing to be done) all things, in each case as are necessary, proper or advisable pursuant to applicable Law or otherwise to
consummate and make effective, as promptly as practicable, the Casdin Transaction, including by using reasonable best efforts to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) cause the conditions to the Casdin Transaction set forth in <U>Article</U><U></U><U>&nbsp;VII</U> to be satisfied; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) (A)&nbsp;obtain all consents, waivers, approvals, orders and authorizations from Governmental Authorities and
(B)&nbsp;make all registrations, declarations and filings with Governmental Authorities, in each case that are necessary or advisable to consummate the Casdin Transaction; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) obtain all consents, waivers and approvals and delivering all
notifications from or to any third parties in connection with this Agreement and the consummation of the Casdin Transaction that are necessary or advisable to consummate the Casdin Transactions; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) execute and deliver any Contracts and other instruments that are reasonably necessary to consummate the Casdin
Transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Section</U><U></U><U>&nbsp;6.1(a)</U> shall not apply to filings under Antitrust Laws, which shall be governed by the
obligations set forth in <U>Section</U><U></U><U>&nbsp;6.2</U> below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>No Consent Fee</I>. Notwithstanding anything to the contrary
set forth in this <U>Section</U><U></U><U>&nbsp;6.1</U> or elsewhere in this Agreement, neither the Company nor any of its Subsidiaries shall be required to agree to: (i)&nbsp;the payment of a consent fee, &#147;profit sharing&#148; payment or other
consideration (including increased or accelerated payments); (ii) the provision of additional security (including a guaranty); or (iii)&nbsp;material conditions or obligations, including amendments to existing conditions and obligations, in each
case, in connection with the Casdin Transaction, including in connection with obtaining any consent pursuant to any Material Contract. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2 <I>Antitrust Filings</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Filing Under Antitrust Laws</I>. Purchaser and the Company shall (i)&nbsp;cooperate and coordinate with the other in determining
whether any filings are required by applicable Antitrust Laws in connection with the Casdin Transaction and, solely after the Closing and upon written notice by Purchaser to the Company, the conversion of Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock into Company Common Stock (the &#147;<B>Series <FONT STYLE="white-space:nowrap">B-1</FONT> Conversion</B>&#148;), (ii) cooperate and coordinate (and cause its respective Affiliates to
cooperate and coordinate) with the other in the making of any required filings with any Governmental Authority as are required by applicable Antitrust Laws in connection with the Casdin Transaction and the Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Conversion; (iii)&nbsp;supply the other (or cause the other to be supplied) with any information that may be required in order to make such filings; (iv)&nbsp;supply (or cause to be supplied) any
additional information that reasonably may be required or requested by the FTC, the DOJ or the Governmental Authorities of any other applicable jurisdiction in which any such filing is made; and (v)&nbsp;use reasonable best efforts to take all
action necessary, proper or advisable to (A)&nbsp;cause the expiration or termination of the applicable waiting periods pursuant to the HSR Act and any other Antitrust Laws (to the extent applicable to this Agreement, the Casdin Transaction or the
Series <FONT STYLE="white-space:nowrap">B-1</FONT> Conversion (as applicable)) and (B)&nbsp;obtain any required consents pursuant to any HSR Act or Antitrust Laws (to the extent applicable to this Agreement, the Casdin Transaction or the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Conversion (as applicable)), in each case as promptly as reasonably practicable. Purchaser (and its Affiliates, if applicable), on the one hand, and the Company (and its Affiliates), on the other hand, shall
promptly inform the other of any communication from any Governmental Authority regarding the Casdin Transaction and the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Conversion (as applicable) in connection with such filings. If either Party or
Affiliate thereof receives any comments or a request for additional information or documentary material from any Governmental Authority with respect to the Casdin Transaction or the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Conversion
pursuant to any Antitrust Law applicable to the Casdin Transaction or the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Conversion (respectively), then such Party shall make (or cause to be made), as promptly as practicable and after
consultation with the other Parties, an appropriate response to such request; <U>provided</U>, that neither Party may extend any waiting period or enter or propose to enter into any agreement, commitment or understanding with any Governmental
Authority without the permission of the other Party, which shall not be unreasonably withheld, conditioned or delayed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Cooperation</I>. In furtherance and not in limitation of the foregoing, the Company
and Purchaser shall (and shall cause their respective controlling Persons, controlled Affiliates and Subsidiaries, respectively, to), subject to any restrictions under applicable Laws: (i)&nbsp;promptly notify the other Party of, and, if in writing,
furnish the other with copies of (or, in the case of oral communications, advise the others of the contents of) any material communication received by such Person from a Governmental Authority in connection with the Casdin Transaction and the Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Conversion and permit the other Party to review and discuss in advance (and to consider in good faith any comments made by the other Party in relation to) any proposed draft notifications, formal
notifications, filing, submission or other written communication (and any analyses, memoranda, white papers, presentations, correspondence or other documents submitted therewith) made in connection with the Casdin Transaction and the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Conversion (as applicable) to a Governmental Authority; (ii)&nbsp;keep the other Party informed with respect to the status of any such submissions and filings to any Governmental Authority in connection with the
Casdin Transaction and the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Conversion (as applicable) and any developments, meetings or discussions with any Governmental Authority in respect thereof, including with respect to (A)&nbsp;the receipt
of any <FONT STYLE="white-space:nowrap">non-action,</FONT> action, clearance, consent, approval or waiver, (B)&nbsp;the expiration of any waiting period, (C)&nbsp;the commencement or proposed or threatened commencement of any investigation,
litigation or administrative or judicial action or proceeding under applicable Laws, including any proceeding initiated by a private party and (D)&nbsp;the nature and status of any objections raised or proposed or threatened to be raised by any
Governmental Authority with respect to the Casdin Transaction and the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Conversion (as applicable); and (iii)&nbsp;not independently participate in any meeting, hearing, proceeding or discussions
(whether in person, by telephone or otherwise) with or before any Governmental Authority in respect of the Casdin Transaction or the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Conversion without giving the other party reasonable prior notice
of such meeting or discussions and, unless prohibited by such Governmental Authority, the opportunity to attend or participate. Subject to restrictions under applicable Law, Purchaser shall not, without the prior written consent of the Company,
extend or offer or agree to extend any waiting period under the HSR Act or any other Antitrust Law, or enter into any agreement with any Governmental Authority related to this Agreement, the transactions contemplated by this Agreement or the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Conversion. However, the Company and Purchaser may each designate any <FONT STYLE="white-space:nowrap">non-public</FONT> information provided to any Governmental Authority as restricted to &#147;outside
counsel&#148; only and any such information shall not be shared with employees, officers or directors or their equivalents of the other Party without approval of the Party providing the <FONT STYLE="white-space:nowrap">non-public</FONT> information;
provided, that each of the Company and Purchaser may redact any valuation and related information before sharing any information provided to any Governmental Authority with the other Party on an &#147;outside counsel&#148; only basis, and that the
Company and Purchaser shall not in any event be required to share information that benefits from legal privilege with the other Party, even on an &#147;outside counsel&#148; only basis, where this would cause such information to cease to benefit
from legal privilege. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Other Action</I>. Purchaser shall not, directly or indirectly (whether by merger, consolidation or
otherwise), acquire (or agree to acquire) any business, corporation partnership, association or other business organization or division or part thereof, or any securities or collection of assets, if doing so would reasonably be expected to prevent
or materially delay the consummation of the Casdin Transaction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Limitations on Action</I>. Notwithstanding anything to the contrary in this
Agreement, nothing in this Agreement, including this <U>Section</U><U></U><U>&nbsp;6.2</U>, shall require or obligate Purchaser or any of its Affiliates to agree, propose, commit to, or effect, or otherwise be required, by consent decree, hold
separate, or otherwise, any sale, divestiture, hold separate, or any other action otherwise limiting the freedom of action in any respect with respect to any businesses, products, rights, services, licenses, assets, or interest therein, of Purchaser
or any Affiliate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.3 <I>Proxy Statement</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Proxy Statement</I>. As promptly as practical following the date of this Agreement, the Company (with the assistance and cooperation of
Purchaser as reasonably requested by the Company) shall prepare and file with the SEC a preliminary proxy statement (as amended or supplemented, the &#147;<B>Proxy Statement</B>&#148;) relating to the Company Stockholder Meeting, and the Company
shall use its reasonable best efforts to make such filing within 15 days of the date of this Agreement. Subject to <U>Section</U><U></U><U>&nbsp;5.3(c)</U>, the Company shall include the Company Board Recommendation in the Proxy Statement. Prior to
the filing of the Proxy Statement (or any amendment or supplement thereto), or any dissemination thereof to the Company Stockholders, or responding to any comments from the SEC with respect thereto, the Company shall provide Purchaser and its
counsel with a reasonable opportunity to review and to comment on such document or response, which comments the Company shall consider in good faith. None of the information supplied or to be supplied by or on behalf of the Company or Purchaser for
inclusion or incorporation by reference in the Proxy Statement, as of the date it or any amendment or supplement is mailed to the Company Stockholders and at the time of the Company Stockholder Meeting, shall contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances in which they are made, not misleading. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Furnishing Information</I>. The Company, on the one hand, and Purchaser, on the other hand, shall furnish all information concerning it
and its Affiliates, if applicable, as the other Party may reasonably request in connection with the preparation and filing with the SEC of the Proxy Statement. If at any time prior to the Company Stockholder Meeting any information relating to the
Company, Purchaser or any of their respective Affiliates should be discovered by the Company, on the one hand, or Purchaser, on the other hand, that should be set forth in an amendment or supplement to the Proxy Statement so that such filing would
not include any misstatement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, then the Party
that discovers such information shall promptly notify the other, and an appropriate amendment or supplement to such filing describing such information shall be promptly prepared and filed with the SEC by the appropriate Party and, to the extent
required by applicable law or the SEC or its staff, disseminated to the Company Stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Consultation Prior to Certain Communications</I>. The Company and its Affiliates, on
the one hand, and Purchaser and its Affiliates, on the other hand, shall not communicate in writing with the SEC or its staff with respect to the Proxy Statement without first providing the other Party a reasonable opportunity to review and comment
on such written communication, and each Party shall give due consideration to all reasonable additions, deletions or changes suggested thereto by the other Parties or their respective counsel. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Notices</I>. The Company, on the one hand, and Purchaser, on the other hand, shall advise the other, promptly after it receives notice
thereof, of (i)&nbsp;any receipt of a request by the SEC or its staff for any amendment or revisions to the Proxy Statement, (ii)&nbsp;any receipt of comments from the SEC or its staff on the Proxy Statement; or (iii)&nbsp;any receipt of a request
by the SEC or its staff for additional information in connection therewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <I>Dissemination of Proxy Statement</I>. Subject to
applicable Law, the Company shall use its reasonable best efforts to cause the definitive Proxy Statement to be disseminated to the Company Stockholders as promptly as reasonably practicable following the filing thereof with the SEC and confirmation
from the SEC that it will not review, or that it has completed its review of, the Proxy Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.4 <I>Company Stockholder
Meeting</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Call of Company Stockholder Meeting</I>. Within 10 calendar days after the date of this Agreement (and thereafter as
reasonably determined by the Company in consultation with Purchaser), the Company shall conduct a &#147;broker search&#148; in accordance with <FONT STYLE="white-space:nowrap">Rule&nbsp;14a-13</FONT> of the Exchange Act for a record date for the
Company Stockholder Meeting that is 20 Business Days after the date of such &#147;broker search.&#148; Following the clearance of the Proxy Statement by the SEC, the Company shall duly call and hold a meeting of its stockholders (the
&#147;<B>Company Stockholder Meeting</B>&#148;) as promptly as reasonably practicable (taking into account the time necessary to solicit proxies for the approval of the Transactions and the Certificate of Amendment) following the mailing of the
Proxy Statement to the Company Stockholders, which mailing shall be initiated in accordance with <U>Section</U><U></U><U>&nbsp;6.3(e)</U>. Unless there has been a Company Board Recommendation Change in accordance with
<U>Section</U><U></U><U>&nbsp;5.3(c)</U>, the Company shall use its reasonable best efforts to solicit proxies to obtain the Requisite Stockholder Approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Adjournment of Company Stockholder Meeting</I>. Notwithstanding anything to the contrary in this Agreement, nothing shall prevent the
Company from postponing or adjourning the Company Stockholder Meeting: (i)&nbsp;to allow additional solicitation of votes in order to obtain the Requisite Stockholder Approval; (ii)&nbsp;if there are holders of an insufficient number of shares of
Company Common Stock present or represented by proxy at the Company Stockholder Meeting to constitute a quorum at the Company Stockholder Meeting; (iii)&nbsp;if the Company is required to postpone or adjourn the Company Stockholder Meeting by
applicable Law or receives a request from the SEC or its staff to do so; or (iv)&nbsp;if the Company Board (or a committee thereof) has determined in good faith (after consultation with outside legal counsel) that it is required under applicable Law
to postpone or adjourn the Company Stockholder Meeting in order to give the Company Stockholders sufficient time to evaluate any information or disclosure that the Company has sent to the Company Stockholders or otherwise made available to the
Company Stockholders. Notwithstanding the foregoing, (A)&nbsp;the Company shall not, without the prior written consent of Purchaser, postpone the Company Stockholder Meeting for more than 20 Business Days in the aggregate and (B)&nbsp;the Company
shall, at the request of Purchaser, to the extent permitted by applicable Law, adjourn the Company Stockholder Meeting to a date specified jointly by Purchaser </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and the Company (acting in good faith and taking into account the time necessary to solicit proxies) if a quorum is absent at the Company Stockholder Meeting or if the Company has not received
proxies representing a sufficient number of shares of Company Common Stock to obtain the Requisite Stockholder Approval (it being understood that Purchaser shall not be able to cause the Company to adjourn the Company Stockholders Meeting to a date
that is less than 10 Business Days before the Termination Date). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Meeting Obligation</I>. For the avoidance of doubt, the
Company&#146;s obligations pursuant to this <U>Section</U><U></U><U>&nbsp;6.4</U> shall not be affected by (i)&nbsp;the commencement, public proposal, public disclosure or communication to the Company of an Acquisition Proposal or (ii)&nbsp;any
Company Board Recommendation Change. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.5 <I>Anti-Takeover Laws</I>. The Company and Purchaser shall (a)&nbsp;take all actions within
their power to ensure that no &#147;control share acquisition,&#148; &#147;fair price,&#148; &#147;moratorium,&#148; &#147;business combination&#148; or other state anti-takeover Law (including Section&nbsp;203 of the DGCL), statute or similar
statute or regulation is or becomes applicable to the Transactions or any other transactions contemplated by this Agreement or the other Transaction Documents and (b)&nbsp;if any &#147;control share acquisition,&#148; &#147;fair price,&#148;
&#147;moratorium,&#148; &#147;business combination&#148; or other state anti-takeover Law (including Section&nbsp;203 of the DGCL), statute or similar statute or regulation becomes applicable to the Transactions or any other transactions
contemplated by this Agreement or the other Transaction Documents, take all actions within their power to ensure that the Transactions may be consummated as promptly as reasonably practicable on the terms contemplated by this Agreement and otherwise
to minimize the effect of such statute or regulation on the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.6 <I>Use of Proceeds</I>. The Company shall use the proceeds
of the PGEF II Purchase Price and the PMF Purchase Price paid by Purchaser, together with the proceeds of the purchase price paid by the Viking Purchaser pursuant to the Viking Purchase Agreement to pay the Company&#146;s expenses related to the
Casdin Transaction, the Viking Transaction, for working capital, for mergers and acquisitions and for general corporate purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.7
<I>Access</I>. At all times during the period commencing with the execution and delivery of this Agreement and continuing until the earlier to occur of the termination of this Agreement pursuant to <U>Article</U><U></U><U>&nbsp;VIII</U> and the
Closing, the Company shall afford Purchaser reasonable access, consistent with applicable Law, during normal business hours, on reasonable advance notice provided in writing to the General Counsel of the Company, or another Person designated in
writing by the Company, to the properties, books and records and personnel of the Company, except that the Company may restrict or otherwise prohibit access to any documents or information to the extent that (a)&nbsp;any applicable Law or Contract
requires the Company to restrict or otherwise prohibit access to such documents or information (in which case, the Company shall use reasonable best efforts to provide such access as can be provided (or otherwise convey such information regarding
the applicable matter as can be conveyed) in compliance with such applicable Law or Contract), (b)&nbsp;access to such documents or information would give rise to a material risk of waiving any attorney-client privilege, work product doctrine or
other privilege applicable to such documents or information (in which case, the Company shall use reasonable best efforts to provide such access as can be provided (or otherwise convey such information regarding the applicable matter as can be
conveyed) without jeopardizing such privilege), (c)&nbsp;such disclosure relates to interactions with other prospective buyers or transaction partners of the Company or the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
negotiation of this Agreement and the transactions contemplated hereby, or information relating to the analysis, valuation or consideration of the Transactions or the other transactions
contemplated hereby, in each case, subject to <U>Section</U><U></U><U>&nbsp;5.3</U>, which shall not be limited by this <U>Section</U><U></U><U>&nbsp;6.7</U> or (d)&nbsp;access would result in the disclosure of any trade secrets of third Persons.
Nothing in this <U>Section</U><U></U><U>&nbsp;6.7</U> shall be construed to require the Company, any of its Subsidiaries or any of their respective Representatives to prepare any reports, analyses, appraisals or opinions. Any investigation conducted
pursuant to the access contemplated by this <U>Section</U><U></U><U>&nbsp;6.7</U> shall be conducted in a manner that is consistent with all applicable <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures and (i)&nbsp;that does not unreasonably
interfere with the conduct of the business of the Company and its Subsidiaries or otherwise result in any significant interference with the prompt and timely discharge by officers, employees and other authorized Representatives of the Company or any
of its Subsidiaries of their normal duties or (ii)&nbsp;create a risk of damage or destruction to any property or assets of the Company or its Subsidiaries. Any access to the properties of the Company and its Subsidiaries shall be subject to the
Company&#146;s reasonable security measures and insurance requirements and will not include the right to perform invasive or subsurface testing or any sampling, monitoring or analysis of soil, groundwater, building materials, indoor air, or other
environmental media of the sort generally referred to as a &#147;Phase II&#148; environmental investigation. The terms and conditions of the Confidentiality Agreement shall apply to any information obtained by Purchaser or any of its Representatives
in connection with any investigation conducted pursuant to the access contemplated by this <U>Section</U><U></U><U>&nbsp;6.7</U>. Notwithstanding anything to the contrary in this Agreement, each Party may satisfy its obligations set forth in this
<U>Section</U><U></U><U>&nbsp;6.7</U> by electronic means if physical access would not be permitted under applicable <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.8 <I>Information Rights</I>. Following the Closing Date, so long as Purchaser Parties, collectively, continue to beneficially own at least
25% of the Acquired Shares (including shares of Company Common Stock issued on conversion of such Acquired Shares), calculated on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, the Company shall publicly file with the SEC or provide
Purchaser with the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) within 90 days after the end of each fiscal year of the Company, the Company&#146;s Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the applicable fiscal year, which shall include: (i)&nbsp;an audited, consolidated balance sheet of the Company and its Subsidiaries as of the end of such fiscal year; (ii)&nbsp;an audited, consolidated
income statement of the Company and its Subsidiaries for such fiscal year; and (iii)&nbsp;an audited, consolidated statement of cash flows of the Company and its Subsidiaries for such fiscal year; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) within 45 days after the end of each of the first three quarters of each fiscal year of the Company, the Company&#146;s Form <FONT
STYLE="white-space:nowrap">10-Q</FONT> for the applicable fiscal quarter, which shall include: (i)&nbsp;an unaudited, consolidated balance sheet of the Company and its Subsidiaries as of the end of such fiscal quarter; (ii)&nbsp;an unaudited,
consolidated income statement of the Company and its Subsidiaries for such fiscal quarter; and (iii)&nbsp;an unaudited, consolidated statement of cash flows of the Company and its Subsidiaries for such fiscal quarter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.9 <I>Notification of Certain Matters</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Notification by the Company</I>. From the date of this Agreement until the earlier to occur of the termination of this Agreement
pursuant to <U>Article</U><U></U><U>&nbsp;VIII</U> and the Closing, the Company shall promptly give written notice to Purchaser on having Knowledge of any matter that may constitute a breach of any representation, warranty, agreement or covenant of
the Company contained in this Agreement that would reasonably be expected to cause any conditions to Closing set forth in <U>Section</U><U></U><U>&nbsp;7.2(a)</U>, <U>Section</U><U></U><U>&nbsp;7.2(b)</U> or <U>Section</U><U></U><U>&nbsp;7.2(c)</U>
to not be satisfied; <U>provided</U>, that the Company&#146;s breach of its obligations pursuant to this <U>Section</U><U></U><U>&nbsp;6.9(a)</U> shall not cause the condition to Closing set forth in <U>Section</U><U></U><U>&nbsp;7.2(b)</U> to not
be satisfied. No such notification shall affect or be deemed to modify any representation or warranty of the Company set forth in this Agreement or the conditions to the obligations of Purchaser to consummate the Casdin Transaction or the remedies
available to the Parties under this Agreement. The terms and conditions of the Confidentiality Agreement apply to any information provided to Purchaser pursuant to this <U>Section</U><U></U><U>&nbsp;6.9(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Notification by Purchaser</I>. From the date of this Agreement until the earlier to occur of the termination of this Agreement pursuant
to <U>Article</U><U></U><U>&nbsp;VIII</U> and the Closing, Purchaser shall promptly give written notice to the Company on having knowledge of any matter that may constitute a breach of any representation, warranty, agreement or covenant of Purchaser
contained in this Agreement that would reasonably be expected to cause any conditions to Closing set forth in <U>Section</U><U></U><U>&nbsp;7.3(a)</U> or <U>Section</U><U></U><U>&nbsp;7.3(b)</U> to not be satisfied; <U>provided</U>, that
Purchaser&#146;s breach of its obligations pursuant to this <U>Section</U><U></U><U>&nbsp;6.9(b)</U> shall not cause the condition to Closing set forth in or <U>Section</U><U></U><U>&nbsp;7.3(b)</U> to not be satisfied. No such notification will
affect or be deemed to modify any representation or warranty of Purchaser set forth in this Agreement or the conditions to the obligations of the Company to consummate the Casdin Transaction or the remedies available to the Parties under this
Agreement. The terms and conditions of the Confidentiality Agreement apply to any information provided to Purchaser pursuant to this <U>Section</U><U></U><U>&nbsp;6.9(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.10 <I>Public Statements and Disclosure</I>. The initial press release with respect to the execution of this Agreement shall be a joint press
release to be reasonably agreed on by the Company and Purchaser. Following such initial press release, the Company and Purchaser shall consult with each other before issuing, and give each other the opportunity to review and comment on, any press
release or other public statements with respect to the Casdin Transaction or the Viking Transaction and shall not issue any such press release or make any such public statement prior to such consultation, except as such party may reasonably conclude
may be required by applicable Law, court process or by obligations pursuant to any listing agreement with any national securities exchange or national securities quotation system (and then only after as much advance notice and consultation as is
feasible); <U>provided</U>, that neither the Company nor Purchaser shall be obligated to engage in such consultation with respect to communications that are not materially inconsistent with public statements previously made in accordance with this
<U>Section</U><U></U><U>&nbsp;6.10</U>; <U>provided</U>, <U>further</U>, that the restrictions set forth in this <U>Section</U><U></U><U>&nbsp;6.10</U> shall not apply to any release or public statement in connection with any dispute between the
Parties or the Viking Purchaser regarding this Agreement or the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.11 <I>Transaction Litigation</I>. Prior to the Closing,
the Company shall provide Purchaser with prompt notice (and in any event within three Business Days) of all Transaction Litigation commenced or threatened in writing to be commenced, after the date of this Agreement, against the Company or any of
its directors or officers by any stockholder relating to this Agreement, the other Transaction Documents and the transactions contemplated hereby and thereby (including by providing copies of all pleadings with respect thereto) and keep Purchaser
reasonably informed </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with respect to the status thereof. The Company shall (a)&nbsp;give Purchaser the opportunity to, subject to the entry into a joint defense agreement with terms mutually agreeably to the parties,
participate in the defense, settlement or prosecution of any Transaction Litigation, and shall consider Purchaser&#146;s views and (b)&nbsp;consult with Purchaser with respect to the defense, settlement and prosecution of any Transaction Litigation.
The Company shall not compromise, settle or come to an arrangement regarding, or agree to compromise, settle or come to an arrangement regarding, any Transaction Litigation unless Purchaser has consented thereto in writing (which consent will not be
unreasonably withheld, conditioned or delayed). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.12 <I>Listing of Shares</I>. Prior to the Closing and subject to the stockholder
approval rules of the NASDAQ, the Company and Purchaser shall each use their respective reasonable best efforts to obtain approval for listing, subject to notice of issuance, of the Underlying Shares on the NASDAQ, subject to and in accordance with
the principles set forth on Section&nbsp;6.12 of the Company Disclosure Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.13 <I>Certain Governance and Other Matters</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall take all necessary action so that, effective as of the Closing: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <I>Directors</I>. The Company Board is comprised of seven members, including (A)&nbsp;one individual designated by
Purchaser prior to the Closing as the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Director, and (B)&nbsp;the Chief Executive Officer of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <I>Company Name</I>. The name of the Company is changed to &#147;Standard BioTools Inc.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company and Purchaser shall take the actions specified on Section&nbsp;6.13(b) of the Company Disclosure Letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company shall adopt and take all actions necessary to implement the 2022 Inducement Plan (as defined in the Company Disclosure
Schedule) and take the other actions set forth in Section&nbsp;6.13(c) of the Company Disclosure Schedule, in each case effective as of the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.14 <I>No Inconsistent Agreements</I>. From the date of this Agreement through the Closing, neither the Company nor any of its Affiliates
shall enter into any additional, or modify any existing, agreements with the Viking Purchaser that have the effect of establishing rights or otherwise benefiting Viking Purchaser in a manner more favorable in any respect to the rights and benefits
established in favor of Purchaser by this Agreement, unless in any such case, Purchaser has been offered such rights and benefits and the Company has agreed to such amendments to this Agreement as may be necessary to provide such rights and benefits
to Purchaser. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.15 <I>Transfer Restrictions</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the exceptions set forth in <U>Section</U><U></U><U>&nbsp;6.15(b),</U> until the
<FONT STYLE="white-space:nowrap">six-month</FONT> anniversary of the Closing Date, Purchaser agrees not to, without the prior written consent of the Company Board (excluding the <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred
Director), directly or indirectly, (i)&nbsp;transfer, sell, hypothecate, pledge, grant any option to purchase or otherwise dispose of any shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock held by Purchaser, including any
Underlying Shares issued or issuable upon conversion of such shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock (&#147;<B><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares</B>&#148;) or (ii)&nbsp;enter into any swap or
other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any of, or Hedge, such <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares (the actions specified in clauses&nbsp;(i) and (ii),
other than any entry into a cash-settled Hedge, a &#147;<B>Transfer</B>&#148;). Thereafter, Purchaser shall not Transfer any shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock held by Purchaser, including any
Underlying Shares issued or issuable upon conversion of such shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock, to an Activist Investor, to a Competitor or to any Person that would beneficially own, after giving
effect to such Transfer, five percent or more of the outstanding Company Common Stock (measured on <FONT STYLE="white-space:nowrap">as-converted</FONT> basis), in each case, to the extent that the identity of the transaction counterparty can be
reasonably ascertained and such Person meets the applicable definition thereof to Purchaser&#146;s knowledge after reasonable inquiry; <U>provided</U>, that the provisions of the foregoing clause shall not apply to (A)&nbsp;any block trade in which
a broker-dealer will attempt to sell the shares to a third-party as agent or other similar transactions with a financial intermediary, (B)&nbsp;any Transfer into the public market pursuant to a <I>bona fide</I>, broadly distributed underwritten
public offering or (C)&nbsp;any Transfers through a <I>bona fide</I> sale to the public that is not directed at a particular transferee, without registration effectuated pursuant to Rule 144 under the Securities Act. Any attempt to Transfer in
violation of the terms of this <U>Section</U><U></U><U>&nbsp;6.15(a)</U> shall be null and void <I>ab initio</I> and no right, title or interest therein or thereto shall be transferred to the purported transferee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything to the contrary herein, the restrictions set forth in <U>Section</U><U></U><U>&nbsp;6.15(a)</U> shall not apply
to the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Transfers to any Affiliate of Purchaser, including an affiliated investment fund, <FONT
STYLE="white-space:nowrap">co-investment</FONT> vehicle or aggregator vehicle (or equivalent) that is controlled, managed or advised by Purchaser or an Affiliate of Purchaser; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Transfers by virtue of laws of the state of the entity&#146;s organization and the entity&#146;s organizational documents
upon dissolution of the entity (any transferees pursuant to clauses (i)&nbsp;and (ii), &#147;<B>Permitted Transferees</B>&#148;); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) Transfers in connection with a change of control of any Purchaser Party; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) Transfers or issuances of any limited partnership interests or other equity interests in any Purchaser Party (or any
direct or indirect parent entity of such Purchaser Party, including any affiliated investment fund, <FONT STYLE="white-space:nowrap">co-investment</FONT> vehicle or aggregator (or equivalent)); <U>provided</U>, that any transferor or transferee
thereof shall be controlled (directly or indirectly) by the Person (directly or indirectly) controlling such Person immediately prior to such transfer; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) Transfers to the Company; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) Transfers in the event of a liquidation, merger, consolidation, stock
exchange, business combination, tender offer or other similar transaction that results in all holders of the Voting Stock of the Company having the right to exchange such Voting Stock for cash, securities or other property (including, for the
avoidance of doubt, any tender offer or exchange offer that is for less than all of the outstanding shares of Company Common Stock); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) Transfers after commencement by the Company or a significant subsidiary (as such term is defined in Rule <FONT
STYLE="white-space:nowrap">12b-2</FONT> under the Exchange Act) of the Company of bankruptcy, insolvency or other similar proceedings; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>,
that in the case of clauses (i)&nbsp;and (ii), the Permitted Transferees (if not already a party hereto) must agree in writing to be bound by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.16 <I><FONT STYLE="white-space:nowrap">Pre-Emptive</FONT> </I><I>Rights</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Following the Closing Date, so long as Purchaser Parties, collectively, continue to beneficially own at least 25% of the Acquired Shares
(including Underlying Shares issued on conversion of such Acquired Shares), calculated on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, if the Company proposes to issue or sell any Equity Securities (other than any Excluded
Securities) (&#147;<B>New Securities</B>&#148;) to any Person or Persons (the &#147;<B>Offeree</B>&#148;), the Company shall first offer to sell to each Purchaser Party a portion of such New Securities equal to the (i)&nbsp;the number of shares of
Company Common Stock beneficially owned by such Purchaser Party <I>divided by</I> (ii)&nbsp;the total number of shares of Company Common Stock issued and outstanding, in each case as of immediately prior to such issuance and determined on an <FONT
STYLE="white-space:nowrap">as-converted</FONT> basis (the &#147;<B>Preemptive Percentage</B>&#148;). The Purchaser Parties shall be entitled to purchase such New Securities at the same price, on the same terms and subject to the same conditions as
are to be offered to the Offeree. The Purchaser Parties electing to purchase their Preemptive Percentage of the New Securities proposed to be issued or sold to the Offeree (&#147;<B>Participating Parties</B>&#148;) shall take all necessary actions
in connection with the consummation of the purchase transactions contemplated by this <U>Section</U><U></U><U>&nbsp;6.16</U> as requested by the Company Board, including the execution of all agreements, documents and instruments in connection
therewith in the form presented by the Company, so long as such agreements, documents and instruments are on customary forms for such a transaction and do not require such Participating Parties to make or agree to any representation, warranty,
covenant or indemnity that is more burdensome than that required of the Offeree in the agreements, documents or instruments in connection with such transaction. If any Purchaser Party or any Viking Party elects not to purchase all of the New
Securities that it is entitled to purchase pursuant to the first sentence of this <U>Section</U><U></U><U>&nbsp;6.16</U> or the first sentence of <U>Section</U><U></U><U>&nbsp;6.16</U> of the Viking Purchase Agreement, as applicable, each
Participating Party that has elected to purchase its Preemptive Percentage of the New Securities proposed to be issued or sold to the Offeree (together with any Viking Party that has elected to purchase its Preemptive Percentage of such New
Securities, the &#147;<B>Fully Participating Parties</B>&#148;) shall be entitled to purchase an additional number of New Securities equal to the aggregate number of New Securities that the Purchaser Parties and/or Viking Parties elected not to
purchase; <U>provided</U>, that if there is an oversubscription in respect of such remaining New Securities due to more than one Fully Participating Party requesting additional New Securities, the oversubscribed amount shall be fully allocated among
the Fully Participating Parties pro rata based on such Fully Participating Parties&#146; relative Preemptive Percentages. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In order to exercise its purchase rights hereunder, a Purchaser Party shall, within 15
days after receipt of written notice (an &#147;<B>Offer Notice</B>&#148;) from the Company describing the New Securities being offered, the purchase price thereof, the payment terms and such Purchaser Party&#146;s percentage allotment, deliver a
written notice to the Company describing its election hereunder (which election shall be absolute and unconditional other than being conditioned upon the consummation of the issuance or sale to the Offeree). If the Company receives no such notice
from the Purchaser within 15 days after the Offer Notice is given, the Company shall be deemed to have notified the Company that it does not elect to participate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) In connection with any exercise by Purchaser of its rights to purchase New Securities pursuant to this Agreement, the Company will
cooperate with the Purchaser as reasonably requested by the Purchaser to complete any such purchase, including, to the extent requested by the Purchaser, entering into &#147;blocker&#148; arrangements with respect to derivative securities and
effecting any required filings or notices required by any governmental agency at the Purchaser&#146;s sole cost and expense. Purchaser shall take all such actions as may be reasonably necessary to complete any such purchase, including, without
limitation, providing such information to the Company as requested in order to determine the Purchaser&#146;s Preemptive Percentage and entering into such additional agreements as may be necessary and appropriate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) During the 90 days following the expiration of the <FONT STYLE="white-space:nowrap">15-day</FONT> offering period described in
<U>Section</U><U></U><U>&nbsp;6.16(b)</U>, the Company shall be entitled to sell any New Securities that the Purchaser Parties have not elected to purchase to the Offeree at a price no less than the purchase price, and on other terms and subject to
other conditions no more favorable than those, stated in the notice provided under <U>Section</U><U></U><U>&nbsp;6.16(b)</U> (in addition to the New Securities that the Company is not required to offer to the Purchaser Parties pursuant to the first
sentence of <U>Section</U><U></U><U>&nbsp;6.16(a)</U>). Any New Securities proposed to be issued or sold by the Company to the Offeree after such <FONT STYLE="white-space:nowrap">90-day</FONT> period, or at a price or on terms or subject to
conditions not complying with the preceding sentence, shall be reoffered to the Purchaser Parties pursuant to the terms of this <U>Section</U><U></U><U>&nbsp;6.16</U> prior to any issuance or sale to the Offeree. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) For purposes of determining the Purchaser&#146;s beneficial ownership of Company Common Stock, the Company shall be permitted to rely on
any information provided to the Company by Purchaser and any public disclosures made by Purchaser. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) In the case of a proposed issuance
or sale of New Securities for consideration in whole or in part other than cash, including securities acquired in exchange therefor, for purposes of this <U>Section</U><U></U><U>&nbsp;6.16</U> the consideration other than cash shall be deemed to be
cash in an amount equal to the fair value of such consideration as reasonably determined by the Company Board; <U>provided</U>, that such fair value as determined by the Company Board shall not exceed the aggregate market price of the securities
being offered as of the date the Company Board authorizes the offering of such securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Notwithstanding anything in this Agreement
to the contrary, a Purchaser Party may designate any of its Permitted Transferees to purchase all or part of the New Securities offered to such Purchaser Party pursuant to <U>Section</U><U></U><U>&nbsp;6.16(a)</U>; <U>provided</U>, that such
Purchaser Party shall remain obligated to consummate the purchase if such designee fails to do so. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.17 <I>Standstill</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Purchaser agrees that, from and after the Closing until the later of (x)&nbsp;the first anniversary of the Closing and (y)&nbsp;such time
as the Purchaser Preferred Percentage is no longer equal to or greater than 7.5%, Purchaser shall not, directly or indirectly, do any of the following unless requested or approved in advance in writing by the Company (acting through the Company
Board): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) (A)&nbsp;make, or in any way participate in, any &#147;solicitation&#148; of &#147;proxies&#148; (within the
meaning of Rule <FONT STYLE="white-space:nowrap">14a-1</FONT> under the Exchange Act) to vote any Voting Stock of the Company or its Subsidiaries, (B)&nbsp;call or seek to call a meeting of the Company&#146;s stockholders or initiate any stockholder
proposal for action by the Company&#146;s stockholders or (C)&nbsp;seek the removal of any director from the Company Board (other than the <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Director); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) make any public announcement with respect to, or submit a proposal or offer for, any merger, consolidation, business
combination, tender or exchange offer, restructuring, recapitalization or other extraordinary transaction involving the Company or any of its Subsidiaries (other than (A)&nbsp;any nonpublic proposal to the Company Board that would not require the
Company, Purchaser or any other Person to make any public announcement or other disclosure with respect thereto or (B)&nbsp;any public disclosure in any filings by Purchaser or its Affiliates with the SEC to the extent required by applicable Law or
stock exchange rules); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) form, join or in any way participate in a &#147;group&#148; (as defined in
Section&nbsp;13(d)(3) of the Exchange Act) in connection with any Voting Stock of the Company or its Subsidiaries, including with the Viking Purchaser; <U>provided</U>, that taking any action contemplated by this Agreement shall not constitute a
violation of this <U>Section</U><U></U><U>&nbsp;6.17(a)(iii)</U>; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) take any action that would reasonably be
expected to require the Company to make a public announcement regarding any actions prohibited by this <U>Section</U><U></U><U>&nbsp;6.17(a);</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>, that nothing contained in this <U>Section</U><U></U><U>&nbsp;6.17(a)</U> shall limit, restrict or prohibit (x)&nbsp;any confidential, <FONT
STYLE="white-space:nowrap">non-public</FONT> discussions with or communications or proposals to management or the Company Board by Purchaser or its Affiliates or Representatives related to any of the foregoing, (y)&nbsp;any Purchaser Party&#146;s
ability to vote, Transfer, convert, exercise its rights under <U>Section</U><U></U><U>&nbsp;6.16</U> or otherwise exercise rights with respect to its <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock or Company Common Stock in
accordance with the terms and conditions of this Agreement and the Certificate of Designations or (z)&nbsp;the ability of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Director to vote or otherwise exercise his or her duties or
otherwise act in his or her capacity as a member of the Company Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the foregoing, the restrictions set forth in
<U>Section</U><U></U><U>&nbsp;6.17(a)</U> shall not apply if any of the following occurs: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the Company enters into a definitive agreement providing for a merger,
consolidation or other business combination transaction as a result of which the stockholders of the Company would own Voting Stock of the resulting corporation having 50% or less of the votes that may be cast generally in an election of directors
if all outstanding Voting Stock were present and voted at a meeting held for such purpose; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) a tender offer or exchange
offer for a majority of the capital stock of the Company is commenced by a third person (other than Purchaser and its Affiliates), which tender offer or exchange offer, if consummated, would result in a Change of Control (as defined in the
Certificate of Designations), and either the Company Board recommends that the stockholders of the Company tender their shares in response to such offer or does not recommend against the tender offer or exchange offer within ten Business Days after
the commencement thereof; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) the Company solicits from one or more Persons, or enters into discussions with one or
more Persons, regarding a proposal with respect to a merger of, or a business combination transaction involving, the Company without similarly soliciting a proposal from Purchaser, or the Company makes a public announcement, with the approval of the
Company Board, that it is seeking to sell itself. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.18 <I>Voting Threshold</I>. Purchaser hereby grants a proxy to the Chief Financial
Officer and the General Counsel of the Company in office from time to time, each of them individually, with full power of substitution and resubstitution, to vote any shares in excess of the Voting Threshold (as such term is defined in the
Certificate of Designations) in the manner contemplated by the Certificate of Designations. The proxy granted herein is irrevocable and coupled with an interest and shall continue to apply following the transfer of any shares purchased herein to any
Casdin Party (as such term is defined in the Certificate of Designations). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;VII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDITIONS TO THE CASDIN TRANSACTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1 <I>Conditions to Each Party</I><I>&#146;</I><I>s Obligations to Effect the </I><I>Casdin</I><I> Transaction</I>. The respective
obligations of the Parties to consummate the Casdin Transaction are subject to the satisfaction or waiver (where permissible pursuant to applicable Law) prior to the Closing of each of the following conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Requisite Stockholder Approval</I>. The Company shall have received the Requisite Stockholder Approval at the Company Stockholder
Meeting (or any adjournment, postponement or other delay thereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Regulatory Approval</I>. The waiting periods (and any
extensions thereof) applicable to the Casdin Transaction pursuant to the HSR Act shall have expired or otherwise been terminated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
<I>No Prohibitive Laws or Injunctions</I>. No temporary restraining order, preliminary or permanent injunction or other judgment or order or other legal or regulatory restraint or prohibition preventing the consummation of the Casdin Transaction
issued by a court or other Governmental Authority of competent jurisdiction in the United States shall be in effect, and no statute, rule, regulation or order shall have been issued, enacted, entered, enforced, promulgated, entered into, enforced,
or deemed applicable to the Casdin Transaction by a Governmental Authority of competent jurisdiction in the United States that, in each case, prohibits, makes illegal or enjoins the consummation of the Casdin Transaction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>NASDAQ Matters</I>. The consummation of the Casdin Transaction shall not be
prohibited by NASDAQ, and the Company shall not have received a written notice from NASDAQ (which notice has not been withdrawn or remedied) that such consummation will result in a delisting by NASDAQ of the Company Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2 <I>Conditions to the Obligations of Purchaser to Effect the </I><I>Casdin</I><I> Transaction</I>. The obligations of Purchaser to
consummate the Casdin Transaction are subject to the satisfaction or waiver (where permissible pursuant to applicable Law) prior to the Closing of each of the following conditions, any of which may be waived exclusively by Purchaser: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Representations and Warranties</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The representations and warranties of the Company set forth in <U>Section</U><U></U><U>&nbsp;3.1</U>,
<U>Section</U><U></U><U>&nbsp;3.2</U>, <U>Section</U><U></U><U>&nbsp;3.3</U>, <U>Section</U><U></U><U>&nbsp;3.4</U>, <U>Section</U><U></U><U>&nbsp;3.5(a)</U>, <U>Section</U><U></U><U>&nbsp;3.7(a)(ii)</U>,
<U>Section</U><U></U><U>&nbsp;3.7(b)(ii)</U>, <U>Section</U><U></U><U>&nbsp;3.7(c)</U> through <U>(e)</U>, <U>Section</U><U></U><U>&nbsp;3.8(b)</U> and <U>Section</U><U></U><U>&nbsp;3.26</U> shall be true and correct in all material respects
(without giving effect to any materiality or Company Material Adverse Effect qualifications set forth therein) as of the date of this Agreement and as of the Closing Date as if made at and as of the Closing Date (except to the extent that any such
representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty will be true and correct as of such earlier date). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) The representations and warranties of the Company set forth in <U>Section</U><U></U><U>&nbsp;3.7(a)(i) </U>and
<U>Section</U><U></U><U>&nbsp;3.7(b)(i)</U> shall be true and correct as of the date of this Agreement and as of the Closing Date as if made at and as of the Closing Date (except to the extent that any such representation and warranty expressly
speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date), in each case except for inaccuracies that are <I>de minimis</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) The representation and warranty of the Company set forth in <U>Section</U><U></U><U>&nbsp;3.12(b)</U> shall be true and
correct in all respects as of the date of this Agreement and as of the Closing Date as if made at and as of the Closing Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) Except as provided elsewhere in this <U>Section</U><U></U><U>&nbsp;7.2(a)</U>, all other representations and warranties of
the Company set forth in this Agreement shall be true and correct (without giving effect to any materiality or Company Material Adverse Effect qualifications set forth therein) as of the date of this Agreement and as of the Closing Date as if made
at and as of the Closing Date (except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty will be true and correct as of such earlier date), except for such
failures to be so true and correct that, individually or in the aggregate, have not had and would not reasonably be expected to have, a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Performance of Obligations of the Company</I>. The Company shall have performed and complied in all material respects with the
covenants, obligations and conditions of this Agreement required to be performed and complied with by it at or prior to the Closing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Company Material Adverse Effect</I>. Since the date of this Agreement, no change,
event, effect, occurrence or circumstance shall have occurred that, individually or in the aggregate, has had, or would reasonably be expected to have a Company Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Officer&#146;s Certificate</I>. Purchaser shall have received a certificate of the Company, validly executed for and on behalf of the
Company and in its name by a duly authorized officer thereof, certifying that the conditions set forth in <U>Section</U><U></U><U>&nbsp;7.2(a)</U>, <U>Section</U><U></U><U>&nbsp;7.2(b)</U> and <U>Section</U><U></U><U>&nbsp;7.2(c)</U> have been
satisfied. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <I>Certificate of Designations</I>. The Company shall have delivered to Purchaser a copy of the Certificate of Designations
that has been filed with and accepted (as of the Closing) by the Secretary of State of the State of Delaware. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <I>Evidence of
Issuance</I>. The Company shall have delivered to Purchaser evidence of the issuance (as of the Closing) of the Acquired Shares credited to book-entry accounts maintained by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <I>Reservation and Approval for Listing of Underlying Shares</I>. The Underlying Shares shall have been reserved by the Company and
approved for listing on the NASDAQ, subject to official notice of issuance. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <I>Viking Purchase Agreement. </I>Each of the conditions
precedent to the obligations of the parties to the Viking Purchase Agreement shall have been satisfied or waived (other than those conditions that by their terms are to be satisfied concurrently with the Closing, but subject to the satisfaction or
waiver (to the extent permitted under the Viking Purchase Agreement) of such conditions) and the Viking Transaction shall be consummated at substantially the same time as the Closing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <I>Opinion. </I>The Company shall have delivered to Purchaser an opinion addressed to Purchaser from Wilson Sonsini Goodrich&nbsp;&amp;
Rosati, Professional Corporation, counsel to the Company, dated as of the Closing Date, substantially in the form included in Section&nbsp;7.2(i) of the Company Disclosure Letter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3 <I>Conditions to the Company</I><I>&#146;</I><I>s Obligations to Effect the </I><I>Casdin</I><I> Transaction</I>. The obligations of the
Company to consummate the Casdin Transaction are subject to the satisfaction or waiver (where permissible pursuant to applicable Law) prior to the Closing of each of the following conditions, any of which may be waived exclusively by the Company:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Representations and Warranties</I>. The representations and warranties of Purchaser set forth in this Agreement shall be true and
correct on and as of the date of this Agreement and as of the Closing Date with the same force and effect as if made on and as of such date, except for (i)&nbsp;any failure to be so true and correct that would not, individually or in the aggregate,
prevent or materially delay the consummation of the Casdin Transaction or the other transactions contemplated by this Agreement and (ii)&nbsp;those representations and warranties that expressly speak as of an earlier date, which representations
shall have been true and correct as of such earlier date, except for any failure to be so true and correct that would not, individually or in the aggregate, prevent or materially delay the consummation of the Casdin Transaction or the other
transactions contemplated by this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Performance of Obligations of Purchaser</I>. Purchaser shall have performed and
complied in all material respects with the covenants, obligations and conditions of this Agreement required to be performed and complied with by Purchaser at or prior to the Closing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Officer&#146;s Certificate</I>. The Company shall have received a certificate of Purchaser, validly executed for and on behalf of
Purchaser and in its name by a duly authorized officer thereof, certifying that the conditions set forth in <U>Section</U><U></U><U>&nbsp;7.3(a)</U> and <U>Section</U><U></U><U>&nbsp;7.3(b)</U> have been satisfied. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Payment of Purchase Price</I>. Casdin PGE II shall have delivered to the Company payment of the PGEF II Purchase Price and Casdin PMF
shall have delivered to the Company payment of the PMF Purchase Price, in each case payable by wire transfer of immediately available funds to accounts designated in advance of the Closing Date by the Company. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;VIII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TERMINATION, AMENDMENT AND WAIVER </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1 <I>Termination</I>. This Agreement may be validly terminated only as follows (it being understood and agreed that this Agreement may not be
terminated for any other reason or on any other basis): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) at any time prior to the Closing (whether prior to or after the receipt of the
Requisite Stockholder Approval) by mutual written agreement of Purchaser and the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) by Purchaser or the Company, at any time
prior to the Closing (whether prior to or after the receipt of the Requisite Stockholder Approval) if (i)&nbsp;any permanent injunction or other judgment or order issued by any court of competent jurisdiction or other legal or regulatory restraint
or prohibition preventing the consummation of the Casdin Transaction is in effect, or any action has been taken by any Governmental Authority of competent jurisdiction, that, in each case, prohibits, makes illegal or enjoins the consummation of the
Casdin Transaction and has become final and <FONT STYLE="white-space:nowrap">non-appealable</FONT> or (ii)&nbsp;any statute, rule, regulation or order has been enacted, entered, enforced or deemed applicable to the Casdin Transaction that
permanently prohibits, makes illegal or enjoins the consummation of the Casdin Transaction; <U>provided</U>, that the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(b)</U> shall not be available to any Party
that has breached its obligations to resist, appeal, obtain consent pursuant to, resolve or lift, as applicable, such injunction, judgment, action, statute, rule, regulation or order; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) by Purchaser or the Company, at any time prior to the Closing (whether prior to or after the receipt of the Requisite Stockholder Approval)
if the Closing has not occurred by 11:59 p.m., New York City time, on June&nbsp;30, 2022 (the &#147;<B>Termination Date</B>&#148;); <U>provided</U>, that the<I> </I>right to terminate this Agreement pursuant to this
<U>Section</U><U></U><U>&nbsp;8.1(c)</U> shall not be available to any Party whose action or failure to act (which action or failure to act constitutes a breach by such Party of this Agreement) has been the primary cause of, or primarily resulted
in, either (i)&nbsp;the failure to satisfy the conditions to the obligations of the terminating Party to consummate the Casdin Transaction set forth in <U>Article</U><U></U><U>&nbsp;VII</U> prior to the Termination Date or (ii)&nbsp;the failure of
the Closing to have occurred prior to the Termination Date; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) by Purchaser or the Company, at any time prior to the Closing if the Company fails to
obtain the Requisite Stockholder Approval at the Company Stockholder Meeting (or any adjournment, postponement or other delay thereof) at which a vote on the Transactions is taken; <U>provided</U>, that the right to terminate this Agreement pursuant
to this <U>Section</U><U></U><U>&nbsp;8.1(d)</U> shall not be available to any Party whose action or failure to act (which action or failure to act constitutes a breach by such Party of this Agreement) has been the primary cause of, or primarily
resulted in, the failure to obtain the Requisite Stockholder Approval at the Company Stockholder Meeting (or any adjournment or postponement thereof); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) by Purchaser, if the Company has breached or failed to perform in any material respect any of its representations, warranties, covenants or
other agreements contained in this Agreement, which breach or failure to perform would result in a failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;7.2(a)</U> or <U>Section</U><U></U><U>&nbsp;7.2(b)</U>; <U>provided</U>, that if
such breach is capable of being cured by the Termination Date, Purchaser shall not be entitled to terminate this Agreement prior to the delivery by Purchaser to the Company of written notice of such breach, delivered at least 30 days prior to such
termination or such shorter period of time as remains prior to the Termination Date (the shorter of such periods, the &#147;<B>Company Breach Notice Period</B>&#148;) stating Purchaser&#146;s intention to terminate this Agreement pursuant to this
<U>Section</U><U></U><U>&nbsp;8.1(e)</U> and the basis for such termination, it being understood that Purchaser shall not be entitled to terminate this Agreement if (i)&nbsp;such breach has been cured within the Company Breach Notice Period (to the
extent capable of being cured) or (ii)&nbsp;Purchaser is then in breach of any representation, warranty, agreement or covenant contained in this Agreement which breach would result in a failure of a condition set forth in
<U>Section</U><U></U><U>&nbsp;7.3(a)</U> or <U>Section</U><U></U><U>&nbsp;7.3(b)</U>; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) by the Purchaser, if at any time the Company
Board (or a committee thereof) has effected a Company Board Recommendation Change; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) by the Company, if Purchaser has breached or failed
to perform in any material respect any of its respective representations, warranties, covenants or other agreements contained in this Agreement, which breach or failure to perform would result in a failure of a condition set forth in
<U>Section</U><U></U><U>&nbsp;7.3(a)</U> or <U>Section</U><U></U><U>&nbsp;7.3(b)</U>; <U>provided</U>, that if such breach is capable of being cured by the Termination Date, the Company shall not be entitled to terminate this Agreement pursuant to
this <U>Section</U><U></U><U>&nbsp;8.1(g)</U> prior to the delivery by the Company to Purchaser of written notice of such breach, delivered at least 30 days prior to such termination or such shorter period of time as remains prior to the Termination
Date (the shorter of such periods, the &#147;<B>Purchaser Breach Notice Period</B>&#148;) stating the Company&#146;s intention to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(g)</U> and the basis for such termination,
it being understood that the Company shall not be entitled to terminate this Agreement if (i)&nbsp;such breach has been cured within the Purchaser Breach Notice Period (to the extent capable of being cured) or (ii)&nbsp;the Company is then in breach
of any representation, warranty, agreement or covenant contained in this Agreement which breach would result in a failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;7.2(a)</U> or <U>Section</U><U></U><U>&nbsp;7.2(b)</U>; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) by Purchaser or the Company, if the Viking Purchase Agreement has been terminated in accordance with its terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2 <I>Manner and Notice of Termination; Effect of Termination</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Manner of Termination</I>. The Party terminating this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.1</U> (other than pursuant
to <U>Section</U><U></U><U>&nbsp;8.1(a)</U>) shall deliver prompt written notice thereof to the other Party specifying the provision of <U>Section</U><U></U><U>&nbsp;8.1</U> pursuant to which this Agreement is being terminated and setting forth in
reasonable detail the facts and circumstances forming the basis for such termination pursuant to such provision. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Effect of
Termination</I>. Any proper and valid termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.1</U> shall be effective immediately on the delivery of written notice by the terminating Party to the other Party. In the event of the
termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.1</U>, this Agreement shall be of no further force or effect without liability of either Party (or any partner, member, stockholder, director, officer, employee, Affiliate or
Representative of such Party) to the other Party, as applicable, except that this <U>Section</U><U></U><U>&nbsp;8.2</U>, <U>Section</U><U></U><U>&nbsp;8.3</U> and <U>Article</U><U></U><U>&nbsp;IX</U> shall each survive the termination of this
Agreement. Notwithstanding the foregoing, nothing in this Agreement or the termination hereof shall relieve either Party from any liability for intentional fraud in respect of the statements made in this Agreement or any Willful Breach prior to its
termination. The rights and obligations under the Confidentiality Agreement shall survive in accordance with the terms of the Confidentiality Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.3 <I>Fees and Expenses</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>General</I>. Except as set forth in this <U>Section</U><U></U><U>&nbsp;8.3</U> and in <U>Section</U><U></U><U>&nbsp;9.2(b)</U>, all fees
and expenses incurred in connection with this Agreement and the Casdin Transaction will be paid by the Party incurring such fees and expenses whether or not the Casdin Transaction is consummated. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Company Payments</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Company shall, at or prior to the earlier to occur of (A)&nbsp;the date that is three Business Days following the
termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.1</U> (other than any termination pursuant to <U>Section</U><U></U><U>&nbsp;8.1(g)</U>) and (B)&nbsp;the Closing, reimburse Purchaser (or cause Purchaser to be reimbursed) for
an amount not to exceed $1,250,000 in cash, by wire transfer of immediately available funds, for Purchaser&#146;s documented expenses incurred in connection with this Agreement and the transactions contemplated hereby (collectively, the
&#147;<B>Expense Reimbursement</B>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) If this Agreement is terminated by Purchaser or the Company pursuant to
<U>Section</U><U></U><U>&nbsp;8.1(d)</U>, then the Company shall promptly (and in any event within two Business Days) after such termination pay, or cause to be paid, to Purchaser an amount equal to $1,250,000 in cash, less any amount previously
paid to Purchaser pursuant to <U>Section</U><U></U><U>&nbsp;8.3(b)(</U><U>i</U><U>)</U> (the &#147;<B>Company Termination Fee</B>&#148;), by wire transfer of immediately available funds (and, following such payment, no additional amounts shall be
payable under <U>Section</U><U></U><U>&nbsp;8.3(b)(</U><U>i</U><U>)</U>). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) If this Agreement is terminated by
Purchaser pursuant to <U>Section</U><U></U><U>&nbsp;8.1(f)</U>, then the Company shall promptly (and in any event within three Business Days) after such termination pay, or cause to be paid, to Purchaser an amount equal to $5,000,000 in cash (the
&#147;<B>Change of Recommendation Termination Fee</B>&#148;), by wire transfer of immediately available funds. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) If, within 12 months following termination of this Agreement by
Purchaser or the Company pursuant to <U>Section</U><U></U><U>&nbsp;8.1(d)</U> or by Purchaser pursuant to <U>Section</U><U></U><U>&nbsp;8.1(e)</U>, either (A)&nbsp;an Acquisition Transaction is consummated (other than in connection with the
conversion of the Company&#146;s Convertible Notes) or (B)&nbsp;the Company enters into a definitive agreement providing for an Acquisition Transaction, then the Company shall promptly (and in any event within three Business Days) after the earlier
to occur of the events described in clauses&nbsp;(A) and (B), pay, or cause to be paid, to Purchaser an amount equal to $2,500,000 in cash (the &#147;<B>Acquisition Termination Fee</B>&#148;), by wire transfer of immediately available funds. For
purposes of this <U>Section</U><U></U><U>&nbsp;8.3(b)(ii)</U>, all references to &#147;10%&#148; in the definition of &#147;Acquisition Transaction&#148; shall be deemed to be references to &#147;20%.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Payments; Default</I>. The Parties acknowledge that the agreements contained in this <U>Section</U><U></U><U>&nbsp;8.3</U> are an
integral part of the Casdin Transaction, and that the damages resulting from the termination of this Agreement under circumstances where the Company Termination Fee, Change of Recommendation Termination Fee, Acquisition Termination Fee or Expense
Reimbursement is payable are uncertain and incapable of accurate calculation and that, without these agreements, the Parties would not enter into this Agreement, and, therefore, the Company Termination Fee, Change of Recommendation Termination Fee,
Acquisition Termination Fee or Expense Reimbursement, if, as and when required to be paid pursuant to this<U> Section</U><U></U><U>&nbsp;8.3</U>, shall not constitute a penalty, but rather liquidated damages, and in a reasonable amount that will
compensate the Party receiving such amount in the circumstances in which it is payable for the efforts and resources expended and opportunities foregone while negotiating this Agreement and in reliance on this Agreement and on the expectation of the
consummation of the Casdin Transaction. Accordingly, if the Company fails to timely pay any amount due pursuant to <U>Section</U><U></U><U>&nbsp;8.3(b)</U> and, in order to obtain such payment, Purchaser commences a Legal Proceeding that results in
a judgment against the Company for the amount set forth in <U>Section</U><U></U><U>&nbsp;8.3(b)</U> or any portion thereof, the Company shall pay to Purchaser its costs and expenses (including reasonable attorneys&#146; fees) in connection with such
Legal Proceeding, together with interest on such amount or portion thereof at the annual rate of 5% plus the prime rate as published in <I>The Wall Street Journal</I> in effect on the date that such payment or portion thereof was required to be made
through the date that such payment or portion thereof was actually received, or a lesser rate that is the maximum permitted by applicable Law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Exclusivity of Remedies</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Notwithstanding anything in this Agreement to the contrary, but subject to the last sentence of
<U>Section</U><U></U><U>&nbsp;8.3(c)</U> and to this <U>Section</U><U></U><U>&nbsp;8.3(d)</U>, in the event of any valid termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.1</U> where the Company Termination Fee, the Change of
Recommendation Termination Fee or the Acquisition Termination Fee is payable pursuant to <U>Section</U><U></U><U>&nbsp;8.3(b)</U> and such fee is actually paid to Purchaser or its designee, such fee (together with any Expense Reimbursement
previously paid to Purchaser and any other fee that may be payable pursuant to <U>Section</U><U></U><U>&nbsp;8.3(b)</U>) shall constitute the sole and exclusive remedy of Purchaser against the Company Related Parties
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
for any loss suffered as a result of the failure of the transactions contemplated by this Agreement and the Transaction Documents to be consummated, and on payment of the Company Termination Fee,
the Change of Recommendation Termination Fee or Acquisition Termination Fee, as applicable (together with any Expense Reimbursement payable hereunder and any other fee that may be payable pursuant to <U>Section</U><U></U><U>&nbsp;8.3(b)</U>), none
of the Company Related Parties shall have any further liability or obligation relating to or arising out of this Agreement and the Transaction Documents (except that Purchaser may be entitled to remedies with respect to the Confidentiality
Agreement, <U>Section</U><U></U><U>&nbsp;8.3(a)</U> and the last sentence of <U>Section</U><U></U><U>&nbsp;8.3(c)</U>, as applicable); <U>provided</U>, that this <U>Section</U><U></U><U>&nbsp;8.3(d)(i)</U> shall not apply in the case of intentional
fraud in respect of the statements made in this Agreement or any Willful Breach prior to its termination. The Parties acknowledge and agree that, subject to the last sentence of <U>Section</U><U></U><U>&nbsp;8.3(c)</U>, in no event shall the Company
be required to pay the Expense Reimbursement on more than one occasion, the Company Termination Fee on more than one occasion, the Change of Recommendation Termination Fee on more than one occasion or the Acquisition Termination Fee on more than one
occasion. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Subject to <U>Section</U><U></U><U>&nbsp;8.1</U> and <U>Section</U><U></U><U>&nbsp;8.3(d)(iii)</U>, if
Purchaser breaches this Agreement, the Company&#146;s right to (A)&nbsp;seek an injunction, specific performance or other equitable relief in accordance with the terms and limitations of <U>Section</U><U></U><U>&nbsp;9.8(b)</U> or (B)&nbsp;terminate
this Agreement and seek money damages from Purchaser in the event of intentional fraud in respect of the statements made in this Agreement or Willful Breach by Purchaser prior to termination shall be the sole and exclusive remedies (whether such
remedies are sought in equity or at law, in contract, in tort or otherwise) of any of the Company Related Parties against any of the Purchaser Related Parties for any losses, damages, costs, expenses, obligations or liabilities arising out of or
related to this Agreement (or any breach of any representation, warranty, covenant, agreement or obligation contained herein), the transactions contemplated by this Agreement (or any failure of such transactions to be consummated) or in respect of
any oral representations made or alleged to be made in connection with this Agreement, the transactions contemplated herein or therein or otherwise (except that the Parties (or their Affiliates) shall remain obligated with respect to, and the
Company and its Subsidiaries may be entitled to remedies with respect to, the Confidentiality Agreement and <U>Section</U><U></U><U>&nbsp;8.3(a)</U>). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) While each of the Company and Purchaser may pursue a grant of specific performance in accordance with
<U>Section</U><U></U><U>&nbsp;9.8(b)</U>, under no circumstances shall the Company or Purchaser be permitted or entitled to receive both (A)&nbsp;a grant of specific performance that results in the Closing occurring and (B)&nbsp;any money damages
(including the Company Termination Fee, the Change of Recommendation Termination Fee and the Acquisition Termination Fee but, for the avoidance of doubt, excluding the Expense Reimbursement). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.4 <I>Amendment</I>. Subject to applicable Law and subject to the other provisions of this Agreement, this Agreement may be amended by the
Parties at any time by execution of an instrument in writing signed on behalf of Purchaser and the Company (pursuant to authorized action by the Company Board (or a committee thereof)); <U>provided</U>, that in the event that the Company has
received the Requisite Stockholder Approval, no amendment may be made to this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agreement that requires the approval of the Company Stockholders pursuant to the NASDAQ rules without such approval. Notwithstanding the foregoing, (a)&nbsp;no Transaction Document shall be
amended or waived in any manner that would impair, impede or materially delay the consummation of the Viking Transaction (or terminated (other than a termination (excluding a termination due to mutual agreement) in accordance with its terms))
without the prior written consent of the Viking Purchaser and (b)&nbsp;any amendment or waiver that expands the rights or limits the obligations or liabilities of Purchaser hereunder shall, at the Viking Purchaser&#146;s option, be deemed to be made
with respect to the Viking Purchase Agreement and apply to the Viking Purchaser. In furtherance of the preceding sentence, the Company shall provide prompt written notice to the Viking Purchaser of any amendment or waiver of this Agreement. The
Viking Purchaser is an express third-party beneficiary of the prior two sentences of this <U>Section</U><U></U><U>&nbsp;8.4</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.5
<I>Extension; Waiver</I>. At any time and from time to time prior to the Closing, either Party may, to the extent legally allowed and except as otherwise set forth herein (a)&nbsp;extend the time for the performance of any of the obligations or
other acts of the other Party, as applicable, (b)&nbsp;waive any inaccuracies in the representations and warranties made to such Party contained herein or in any document delivered pursuant hereto and (c)&nbsp;subject to the requirements of
applicable Law, waive compliance with any of the agreements or conditions for the benefit of such Party contained herein. Any agreement on the part of either Party to any such extension or waiver shall be valid only if set forth in an instrument in
writing signed by such Party. Any delay in exercising any right pursuant to this Agreement shall not constitute a waiver of such right. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;IX </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GENERAL
PROVISIONS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.1 <I>Notices</I>. All notices and other communications hereunder shall be in writing and will be deemed to have been duly
delivered and received hereunder: (a)&nbsp;four Business Days after being sent by registered or certified mail, return receipt requested, postage prepaid; (b)&nbsp;one Business Day after being sent for next Business Day delivery, fees prepaid, via a
reputable nationwide overnight courier service; or (c)&nbsp;immediately on delivery by electronic mail (provided that no bounceback or similar &#147;undeliverable&#148; message is received by such sender) or by hand (with a written or electronic
confirmation of delivery), in each case to the intended recipient as set forth below (<U>provided</U>, that any notice sent pursuant to clauses (a)&nbsp;or (b) shall be accompanied by notice sent by email within one Business Day after dispatch by
such method): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to Purchaser to: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Casdin Private Growth Equity Fund II, L.P. / Casdin Partners Master Fund, L.P. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">c/o Casdin Capital, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">1350
6th Avenue, Suite 2600 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">New York, NY 10019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Kevin O&#146;Brien </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;kevin@casdincapital.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">with a copy (which will not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Paul, Weiss, Rifkind, Wharton&nbsp;&amp; Garrison LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">1285 Avenue of the Americas </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">New York, NY 10019-6064 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Krishna Veeraraghavan </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;kveeraraghavan@paulweiss.com </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to the Company (prior to the Closing) to: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Fluidigm Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">2 Towers
Place, Suite 2000 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">South San Francisco, CA 94080 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Nicholas S. Khadder </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: nick.khadder@fluidigm.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">with a copy (which will not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Wilson Sonsini Goodrich&nbsp;&amp; Rosati </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Professional Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">650
Page Mill Road </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Palo Alto, CA 94304 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Robert F. Kornegay </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Zachary Myers </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Douglas K. Schnell </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-mail:</FONT> &nbsp;&nbsp;&nbsp;&nbsp;rkornegay@wsgr.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;zmyers@wsgr.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dschnell@wsgr.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice received at the addressee&#146;s location on any Business Day after 5:00&nbsp;p.m., addressee&#146;s local time, or on any day that
is not a Business Day will be deemed to have been received at 9:00 a.m., addressee&#146;s local time, on the next Business Day. From time to time, either Party may provide notice to the other Party of a change in its address or <FONT
STYLE="white-space:nowrap">e-mail</FONT> address through a notice given in accordance with this <U>Section</U><U></U><U>&nbsp;9.1</U>, except that that notice of any change to the address or any of the other details specified in or pursuant to this
<U>Section</U><U></U><U>&nbsp;9.1</U>, shall not be deemed to have been received until, and shall be deemed to have been received on, the later of the date (A)&nbsp;specified in such notice or (B)&nbsp;that is five Business Days after such notice
would otherwise be deemed to have been received pursuant to this <U>Section</U><U></U><U>&nbsp;9.1</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.2 <I>Tax Matters</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Withholding</I>. The Company and its paying agent shall be entitled to deduct or withhold on all applicable payments made to Purchaser
whether in the form of cash or otherwise such Tax amounts as the Company reasonably determines are required to be deducted or withheld therefrom under any provision of applicable Law (and, to the extent such amounts are paid to the relevant taxing
authority in accordance with applicable Law, such amounts will be treated for all </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purposes of this Agreement as having been paid to the Person in respect of which such withholding was made); <U>provided</U>, for the avoidance of doubt, that if the Company determines that an
amount is required to be deducted or withheld on any payment with respect to Purchaser, the Company shall provide reasonable prior notice to Purchaser in writing of its intent to deduct or withhold Taxes on such payment and shall reasonably
cooperate with Purchaser in obtaining any available exemption or reduction of such withholding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Transfer Taxes</I>. The Company
shall pay any and all Transfer Taxes due on (i)&nbsp;the issue of the Acquired Shares and (ii)&nbsp;the issue of shares of Company Common Stock on conversion of the Acquired Shares. However, the Company shall not be required to pay any Transfer Tax
that may be payable in respect of the issue or delivery (or any transfer involved in the issue or delivery) of Acquired Shares or shares of Company Common Stock issued on conversion of the Acquired Shares to a beneficial owner other than the initial
beneficial owner of the Acquired Shares, and no such issue or delivery shall be made unless and until the person requesting such issue or delivery has paid to the Company the amount of any such Transfer Tax or has established to the reasonable
satisfaction of the Company that such Transfer Tax has been paid or is not payable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Intended Tax Treatment</I>. Purchaser and the
Company agree not to treat the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock (based on the terms set forth in the Certificate of Designations) as &#147;preferred stock&#148; for purposes of Section&nbsp;305 of the Code and the
Treasury Regulations promulgated thereunder, and, as a consequence, no difference between the purchase price paid for the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock and the Liquidation Preference (as defined in the
Certificate of Designations) thereof shall, by reason of Section&nbsp;305(b)(4) of the Code or Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.305-5,</FONT> be treated as a distribution of property until paid in cash. The
Company and Purchaser (and their respective Affiliates) shall file all Tax Returns in a manner consistent with the foregoing intended Tax treatment and shall not take any Tax position that is inconsistent with such intended Tax treatment except in
connection with, or as required by, any of the following: (i)&nbsp;a change in relevant Law or official guidance from a taxing authority occurring after the Closing Date, (ii)&nbsp;after the Closing Date, the promulgation of relevant final U.S.
Treasury Regulations addressing instruments similar to the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock (from and after the effective date of such regulations), (iii) an amendment to the terms of the Certificate of Designations
or (iv)&nbsp;a &#147;determination&#148; within the meaning of section 1313(a) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.3 <I>Assignment</I>. No Party may assign
either this Agreement or any of its rights, interests, or obligations hereunder, by operation of Law or otherwise, without the prior written approval of the other Party; <U>provided</U>, that Purchaser or any Purchaser Party may assign its rights,
interests and obligations under this Agreement, in whole or in part, to one or more Permitted Transferees that agree in writing to be bound by the provisions of this Agreement, including the rights, interests and obligations so assigned, so long as
such assignment does not impede or delay the consummation of the Closing; provided, further, that no such assignment will relieve any Purchaser Party of its obligations hereunder prior to the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.4 <I>Entire Agreement</I>. This Agreement and the documents and instruments and other agreements between the Parties as contemplated by or
referred to herein, including the Confidentiality Agreement and the Company Disclosure Letter, constitute the entire agreement between the Parties with respect to the subject matter hereof and supersede all prior agreements
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and understandings, both written and oral, between the Parties with respect to the subject matter hereof. Notwithstanding anything to the contrary in this Agreement, the Confidentiality Agreement
shall: (a)&nbsp;not be superseded; (b)&nbsp;survive any termination of this Agreement in accordance with its terms; and (c)&nbsp;continue in full force and effect until the earlier to occur of the Closing and the date on which the Confidentiality
Agreement expires in accordance with its terms or is validly terminated by the parties thereto. Purchaser and its Representatives shall hold and treat all documents and information concerning the Company and its Subsidiaries furnished or made
available to Purchaser or its Representatives pursuant to <U>Section</U><U></U><U>&nbsp;6.7</U> in accordance with the Confidentiality Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.5 <I>Survival</I>. All of the covenants or other agreements of the Parties contained in this Agreement shall survive until fully performed
or fulfilled, unless and to the extent that <FONT STYLE="white-space:nowrap">non-compliance</FONT> with such covenants or agreements is waived in writing by the party entitled to such performance. Except for the Company Fundamental Representations
and the Purchaser Fundamental Representations, which shall survive until the sixth anniversary of the Closing Date, the representations and warranties made herein shall survive for 12 months following the Closing Date and shall then expire;
<U>provided</U>, that nothing herein shall relieve any party of liability for any inaccuracy or breach of such representation or warranty to the extent that any good faith allegation of such inaccuracy or breach is made in writing prior to such
expiration by a Person entitled to make such claim pursuant to the terms and conditions of this Agreement. For the avoidance of doubt, claims may be made with respect to the breach of any representation, warranty or covenant until the applicable
survival period therefor as described above expires. Notwithstanding anything to the contrary in this Agreement, in no event shall Purchaser be entitled to any recourse against the Company in excess of the sum of the PGEF II Purchase Price and the
PMF Purchase Price for any breach of any representation or warranty in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.6 <I>Third Party Beneficiaries</I>. Unless
expressly set forth herein, this Agreement is not intended to and shall not confer any rights or remedies on any person other than the Parties, their respective successors and permitted assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.7 <I>Severability</I>. In the event that any provision of this Agreement, or the application thereof, becomes or is declared by a court of
competent jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect and the application of such provision to other Persons or circumstances will be interpreted so as reasonably to
effect the intent of the Parties. On such a determination, the Parties agree to negotiate in good faith to replace such void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent
possible, the economic, business and other purposes of such void or unenforceable provision. If any provision of this Agreement is so broad as to be unenforceable, such provision will be interpreted to be only so broad as it is enforceable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.8 <I>Remedies</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
<I>Remedies Cumulative</I>. Except as otherwise provided herein, any and all remedies herein expressly conferred on a Party will be deemed cumulative with and not exclusive of any other remedy conferred hereby or by Law or equity on such Party, and
the exercise by a Party of any one remedy will not preclude the exercise of any other remedy. Except as set forth in <U>Section</U><U></U><U>&nbsp;8.3(d)(iii)</U>, the Parties agree that (i)&nbsp;by seeking the remedies provided for in this
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<U>Section</U><U></U><U>&nbsp;9.8</U>, a Party shall not in any respect waive its right to seek any other form of relief that may be available to a Party under this Agreement and
(ii)&nbsp;nothing set forth in this <U>Section</U><U></U><U>&nbsp;9.8</U> shall require any Party to institute any Legal Proceeding for (or limit any Party&#146;s right to institute any Legal Proceeding for) injunctive relief or specific performance
under this <U>Section</U><U></U><U>&nbsp;9.8</U> prior or as a condition to exercising any termination right under <U>Article</U><U></U><U>&nbsp;VIII</U> (and pursuing damages after such termination), nor shall the commencement of any Legal
Proceeding pursuant to this <U>Section</U><U></U><U>&nbsp;9.8</U> or anything set forth in this <U>Section</U><U></U><U>&nbsp;9.8</U> restrict or limit any Party&#146;s right to terminate this Agreement in accordance with the terms of
<U>Article</U><U></U><U>&nbsp;VIII</U> or pursue any other remedies under this Agreement or applicable Law that may be available then or thereafter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Specific Performance</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Parties agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy
would occur in the event that the Parties do not perform the provisions of this Agreement (including any Party failing to take such actions as are required of it hereunder in order to consummate this Agreement) in accordance with its specified terms
or otherwise breach such provisions. The Parties acknowledge and agree that: (A)&nbsp;the Parties shall be entitled, in addition to any other remedy to which they are entitled at Law or in equity, to an injunction, specific performance and other
equitable relief to prevent breaches (or threatened breaches) of this Agreement in accordance with its specified terms and to enforce specifically the terms and provisions hereof; (B)&nbsp;the provisions of <U>Section</U><U></U><U>&nbsp;8.3</U> are
not intended to and do not adequately compensate the Company, on the one hand, or Purchaser, on the other hand, for the harm that would result from a breach of this Agreement, and will not be construed to diminish or otherwise impair in any respect
any Party&#146;s right to an injunction, specific performance and other equitable relief; and (C)&nbsp;the right of specific enforcement (including specific performance of the Parties&#146; obligations to effect the Closing) is an integral part of
the Casdin Transaction and without that right, neither the Company nor Purchaser would have entered into this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) The Parties agree not to raise any objections based on the adequacy of legal remedies or the enforceability of this
<U>Section</U><U></U><U>&nbsp;9.8</U> to: (A)&nbsp;the granting of an injunction, specific performance or other equitable relief to prevent or restrain breaches or threatened breaches of this Agreement by the Company, on the one hand, or Purchaser,
on the other hand; and (B)&nbsp;the specific performance of the terms and provisions of this Agreement to prevent breaches or threatened breaches of, or to enforce compliance with, the covenants, obligations and agreements of Purchaser pursuant to
this Agreement. Any Party seeking an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement will not be required to provide any bond or other security in connection with
such injunction or enforcement, and each Party irrevocably waives any right that it may have to require the obtaining, furnishing or posting of any such bond or other security. Each Party agrees that it shall use reasonable best efforts to cooperate
with the other Party in seeking and agreeing to an expedited schedule in any litigation seeking an injunction or order of specific performance to attempt to fully resolve any dispute between the Parties prior to the Termination Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.9 <I>Governing Law</I>. This Agreement and all actions, proceedings or counterclaims
(whether based on contract, tort or otherwise) arising out of or relating to this Agreement, any transaction contemplated hereby or the actions of Purchaser or the Company in the negotiation, administration, performance and enforcement thereof,
shall be governed by, and construed in accordance with the Laws of the State of Delaware, including its statute of limitations, without giving effect to any choice or conflict of Laws provision or rule (whether of the State of Delaware or any other
jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.10 <I>Consent to
Jurisdiction</I>. Each of the Parties: (a)&nbsp;irrevocably consents to the service of the summons and complaint and any other process (whether inside or outside the territorial jurisdiction of the Chosen Courts) in any Legal Proceeding relating to
the Casdin Transaction, for and on behalf of itself or any of its properties or assets, in accordance with <U>Section</U><U></U><U>&nbsp;9.1</U> or in such other manner as may be permitted by applicable Law, and nothing in this
<U>Section</U><U></U><U>&nbsp;9.10</U> shall affect the right of any Party to serve legal process in any other manner permitted by applicable Law; (b)&nbsp;irrevocably and unconditionally consents and submits itself and its properties and assets in
any Legal Proceeding to the exclusive general jurisdiction of the Court of Chancery of the State of Delaware and any state appellate court therefrom within the State of Delaware (or, solely if the Court of Chancery of the State of Delaware declines
to accept jurisdiction over a particular matter, any other state or federal court within the State of Delaware) (the &#147;<B>Chosen Courts</B>&#148;) in the event of any dispute or controversy relating to or arising out of this Agreement or the
transactions contemplated hereby or thereby; (c)&nbsp;agrees that it will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court; (d)&nbsp;agrees that any Legal Proceeding relating to or
arising out of this Agreement or the transactions contemplated hereby or thereby will be brought, tried and determined only in the Chosen Courts; (e)&nbsp;waives any objection that it may now or hereafter have to the venue of any such Legal
Proceeding in the Chosen Courts or that such Legal Proceeding was brought in an inconvenient court and agrees not to plead or claim the same; and (f)&nbsp;agrees that it will not bring any Legal Proceeding relating to or arising out of this
Agreement or the transactions contemplated hereby or thereby in any court other than the Chosen Courts unless the Chosen Courts issue a final judgment determining that such court lacks jurisdiction. Purchaser and the Company agree that a final
judgment and any interim relief (whether equitable or otherwise) in any Legal Proceeding in the Chosen Courts will be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable Law.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.11 <I>WAIVER OF JURY TRIAL</I>. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE PURSUANT TO THIS AGREEMENT IS
LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT THAT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL PROCEEDING (WHETHER FOR BREACH OF CONTRACT,
TORTIOUS CONDUCT OR OTHERWISE) DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTION. EACH PARTY ACKNOWLEDGES AND AGREES THAT (i)&nbsp;NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED,
EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER; (ii)&nbsp;IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER; (iii)&nbsp;IT MAKES THIS WAIVER VOLUNTARILY; AND
(iv)&nbsp;IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS <U>SECTION</U><U></U><U>&nbsp;9.11</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.12 <I>No Recourse</I>. All claims, obligations, liabilities, or causes of action (whether
in contract or in tort, in law or in equity, or granted by statute) that may be based on, in respect of, arise under, out or by reason of, be connected with, or relate in any manner to this Agreement, or the negotiation, execution, or performance of
this Agreement (including any representation or warranty made in, in connection with, or as an inducement to, this Agreement), may be made only against (and such representations and warranties are those solely of) the Persons that are expressly
identified as parties in the preamble to this Agreement (the &#147;<B>Contracting Parties</B>&#148;). No Person who is not a Contracting Party, including any current, former or future director, officer, employee, incorporator, member, partner,
manager, stockholder, Affiliate, agent, attorney, Representative or assignee of, and any financial advisor or lender to, any Contracting Party, or any current, former or future director, officer, employee, incorporator, member, partner, manager,
stockholder, Affiliate, agent, attorney, Representative or assignee of, and any financial advisor or lender to, any of the foregoing (collectively, the &#147;<B>Nonparty Affiliates</B>&#148;), shall have any liability (whether in contract or in
tort, in law or in equity, or granted by statute) for any claims, causes of action, obligations, or liabilities arising under, out of, in connection with, or related in any manner to this Agreement or based on, in respect of, or by reason of this
Agreement or its negotiation, execution, performance, or breach, and, to the maximum extent permitted by applicable Law, each Contracting Party hereby waives and releases all such liabilities, claims, causes of action, and obligations against any
such Nonparty Affiliates. Without limiting the foregoing, to the maximum extent permitted by applicable Law: (a)&nbsp;each Contracting Party hereby waives and releases any and all rights, claims, demands, or causes of action that may otherwise be
available at law or in equity, or granted by statute, to avoid or disregard the entity form of a Contracting Party or otherwise impose liability of a Contracting Party on any Nonparty Affiliate, whether granted by statute or based on theories of
equity, agency, control, instrumentality, alter ego, domination, sham, single business enterprise, piercing the veil, unfairness, undercapitalization, or otherwise; and (b)&nbsp;each Contracting Party disclaims any reliance on any Nonparty
Affiliates with respect to the performance of this Agreement or any representation or warranty made in, in connection with, or as an inducement to this Agreement. Notwithstanding anything to the contrary in this
<U>Section</U><U></U><U>&nbsp;9.12</U>, nothing in this <U>Section</U><U></U><U>&nbsp;9.12</U> shall be deemed to limit any liabilities or obligations of, or claims against, (x)&nbsp;any party to any other Transaction Document or serve as a waiver
of any right on the part of any party to such other Transaction Document to initiate any Legal Proceedings permitted by, pursuant to, and in accordance with the specific terms of such other Transaction Document or (y)&nbsp;any Person in respect of
intentional fraud in respect of the statements made in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.13 <I>Company Disclosure Letter References</I>. The Parties
agree that the disclosure set forth in any particular Section or subsection of the Company Disclosure Letter shall be deemed to be an exception to (or, as applicable, a disclosure for purposes of): (a) the representations and warranties (or
covenants, as applicable) of the Company that are set forth in the corresponding Section or subsection of this Agreement; and (b)&nbsp;any other representations and warranties (or covenants, as applicable) of the Company that are set forth in this
Agreement, but in the case of this <U>clause (b)</U>&nbsp;only if the relevance of that disclosure as an exception to (or a disclosure for purposes of) such other representations and warranties (or covenants, as applicable) is reasonably apparent on
the face of such disclosure. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.14 <I>Counterparts</I>. This Agreement and any amendments hereto may be executed in one or
more counterparts, all of which will be considered one and the same agreement and will become effective when one or more counterparts have been signed by each of the Parties and delivered to the other Parties, it being understood that all Parties
need not sign the same counterpart. Any such counterpart, to the extent delivered by fax or .pdf, .tif, .gif, .jpg or similar attachment to electronic mail (any such delivery, an &#147;<B>Electronic Delivery</B>&#148;), will be treated in all manner
and respects as an original executed counterpart and will be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. No Party may raise the use of an Electronic Delivery to deliver a
signature, or the fact that any signature or agreement or instrument was transmitted or communicated through the use of an Electronic Delivery, as a defense to the formation of a contract, and each Party forever waives any such defense, except to
the extent such defense relates to lack of authenticity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature pages follow.</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed and delivered by
their respective duly authorized officers as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">FLUIDIGM CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ S. Christopher Linthwaite</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">S. Christopher Linthwaite</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CASDIN PRIVATE GROWTH EQUITY FUND II, L.P.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kevin O&#146;Brien</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Kevin O&#146;Brien</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">General Counsel</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CASDIN PARTNERS MASTER FUND, L.P.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kevin O&#146;Brien</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Kevin O&#146;Brien</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">General Counsel</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock
Purchase Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Exhibit A </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CERTIFICATE OF
DESIGNATIONS OF RIGHTS, PREFERENCES AND PRIVILEGES </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OF SERIES <FONT STYLE="white-space:nowrap">B-1</FONT> CONVERTIBLE PREFERRED STOCK, PAR
VALUE $0.001 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OF </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">STANDARD
BIOTOOLS INC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to Section&nbsp;151(g) of the General Corporation Law of the State of Delaware (as amended, supplemented or
restated from time to time, the &#147;<B><I>DGCL</I></B>&#148;), STANDARD BIOTOOLS INC., a corporation organized and existing under the laws of the State of Delaware (the &#147;<B><I>Company</I></B>&#148;), in accordance with the provisions of
Section&nbsp;103 of the DGCL, DOES HEREBY CERTIFY: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">That, the Eighth Amended and Restated Certificate of Incorporation of the Company, as
filed with the Secretary of State of the State of Delaware on February&nbsp;15, 2011 (as amended from time to time prior to the filing of this Certificate of Designations, the &#147;<B><I>Certificate of Incorporation</I></B>&#148;), authorizes the
issuance of 410,000,000 shares of capital stock, consisting of 400,000,000 shares of Common Stock, par value $0.001 per share (&#147;<B><I>Common Stock</I></B>&#148;), and 10,000,000 shares of Preferred Stock, par value $0.001 per share
(&#147;<B><I>Preferred Stock</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">That, subject to the provisions of the Certificate of Incorporation, the board of directors
of the Company (the &#147;<B><I>Board</I></B>&#148;) is authorized to fix by resolution the designations, powers, preferences and rights, and the qualifications, limitations or restrictions, of any wholly unissued series of Preferred Stock,
including to fix the number of shares constituting any such series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">That, pursuant to the authority conferred on the Board by the
Certificate of Incorporation, the Board, on January&nbsp;23, 2022, adopted the following resolution designating a new series of Preferred Stock as &#147;Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock&#148;: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">RESOLVED, that, pursuant to the authority vested in the Board in accordance with the provisions of Article IV of the Certificate of
Incorporation and the provisions of Section&nbsp;151 of the DGCL, a series of Preferred Stock of the Company is hereby created and authorized, and the number of shares to be included in such series out of the authorized and unissued shares of
Preferred Stock, and the designations, powers, preferences and rights, and the qualifications, limitations or restrictions of the shares of Preferred Stock included in such series, shall be as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. Designation and Number of Shares. The shares of such series of Preferred Stock shall be designated as &#147;Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock&#148; (the &#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock</I></B>&#148;). The number of authorized shares constituting the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Preferred Stock shall be 128,267. That number from time to time may be increased (but not above the total number of authorized shares of the class of Preferred Stock of the Company) or decreased (but not below
the number of shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock then outstanding) by further resolution duly adopted by the Board, or any duly authorized committee thereof, and by the filing of a certificate pursuant to
the provisions of the DGCL stating that such increase or decrease, as applicable, has been so authorized. The Company shall not have the authority to issue fractional shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. Ranking. Except as otherwise provided herein, the Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock shall rank, with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) on a parity basis with the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock and, subject to <U>13(b)</U>, each other
class or series of Capital Stock of the Company hereafter authorized, classified or reclassified, the terms of which expressly provide that such class or series ranks on a parity basis with the Series <FONT STYLE="white-space:nowrap">B-1</FONT>
Preferred Stock as to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company (such Capital Stock, &#147;<B><I>Parity Stock</I></B>&#148;); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) subject to <U>13(b)</U>, junior to each other class or series of Capital Stock of the Company hereafter authorized, classified or
reclassified, the terms of which expressly provide that such class or series ranks senior to the Series B Preferred Stock as to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or
winding up of the affairs of the Company (such Capital Stock, &#147;<B><I>Senior Stock</I></B>&#148;); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">senior to the Common Stock,
each other currently existing class or series of Capital Stock of the Company (other than the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock) and each class or series of Capital Stock of the Company hereafter authorized,
classified or reclassified, the terms of which do not expressly provide that such class or series ranks on a parity basis with or senior to the <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock as to dividend rights and rights
on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company (such Capital Stock, &#147;<B><I>Junior Stock</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. Definitions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As used in
this Agreement, the following terms shall have the meanings ascribed to them below: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Affiliate</I></B>&#148; means, with
respect to any Person, any other Person that, directly or indirectly, controls, is controlled by or is under common control with such Person; <U>provided</U>, that (i)&nbsp;the Company and its Subsidiaries shall not be deemed to be Affiliates of any
Investor Party or any of its Affiliates, (ii)&nbsp;&#147;portfolio companies&#148; (as such term is customarily used among institutional investors) in which any Investor Party or any of its Affiliates has an investment (whether as debt or equity)
shall not be deemed an Affiliate of such Investor Party and (iii)&nbsp;no Investor Party shall be deemed to be an Affiliate of any other Investor Party solely as a result of the Transactions. For purposes of this definition, the term
&#147;control&#148; (including, with correlative meanings, the terms &#147;controlling,&#148; &#147;controlled by&#148; and &#147;under common control with&#148;), as used with respect to any Person, means the possession, directly or indirectly, of
the power to direct or cause the direction of the management or policies of that Person, whether through the ownership of voting securities or partnership or other ownership interests, by contract or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Beneficially Own</I></B>&#148; means, with respect to any securities, having
&#147;beneficial ownership&#148; of such securities (as determined pursuant to Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act), and the terms &#147;Beneficial Ownership&#148; and &#147;Beneficial Owner&#148; shall have
correlative meanings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Business Day</I></B>&#148; means any weekday that is not a day on which banking institutions in New
York, New York are authorized or required by law, regulation or executive order to be closed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Bylaws</I></B>&#148; means the
Amended and Restated Bylaws of the Company, as may be amended from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Capital Stock</I></B>&#148; means, with
respect to any Person, any and all shares of, interests in, rights to purchase, warrants to purchase, options for, participations in or other equivalents of or interests in (however designated) stock issued by such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Casdin</I></B>&#148; means, collectively, Casdin Private Growth Equity Fund II, L.P., a Delaware limited partnership and Casdin
Partners Master Fund, L.P., a Cayman Islands exempted limited partnership. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Casdin</I></B><B><I> Parties</I></B>&#148; means
Casdin and each Permitted Transferee of Casdin to whom shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock or Common Stock are Transferred pursuant to Section&nbsp;6.15(b) of the Casdin Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Casdin Preferred Percentage</I></B>&#148; means, as of any time, (a)&nbsp;the number of shares of Common Stock into which the
shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock beneficially owned by the Casdin Parties are convertible <I>divided by</I> (b)&nbsp;the total number of shares of Common Stock issued and outstanding, in each case as
of such time and assuming that all shares of Series&nbsp;B Preferred Stock outstanding are converted into shares of Common Stock. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Casdin</I></B><B><I> Purchase Agreement</I></B>&#148; means the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible
Preferred Stock Purchase Agreement by and between the Company and Casdin, dated as of January&nbsp;23, 2022, as it may be amended, modified or supplemented from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Certificate of Designations</I></B>&#148; means this Certificate of Designations relating to the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock, as it may be amended from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Change of
Control</I></B>&#148; means the occurrence of one of the following, whether in a single transaction or a series of transactions, directly or indirectly: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) any &#147;person&#148; or &#147;group&#148; (as such terms are used in Sections&nbsp;13(d) and 14(d) of the Exchange Act) is or becomes
the Beneficial Owner, directly or indirectly, of a majority of the total voting power of the Voting Stock of the Company, other than as a result of a transaction, or a series of related transactions, in which (A)&nbsp;the holders of securities that
represented 100% of the Voting Stock of the Company immediately prior to such transaction are the same as the holders of securities that represent at least a majority of the Voting Stock of the surviving Person or its Parent Entity immediately
following such transaction and (B)&nbsp;the holders of securities that represented 100% of the Voting Stock of the Company immediately prior to such transaction own directly or indirectly Voting Stock of the surviving Person or its Parent Entity in
substantially the same proportion to each other as immediately prior to such transaction; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the merger or consolidation of the Company with or into another Person or the merger
of another Person with or into the Company, or the sale, transfer, license or lease of all or substantially all of the assets of the Company (determined on a consolidated basis), whether in a single transaction or a series of related transactions,
to another Person, or any recapitalization, reclassification or other transaction in which all or substantially all of the Common Stock is exchanged for or converted into cash, securities or other property, other than (A)&nbsp;in the case of a
merger or consolidation, a transaction, or a series of related transactions, following which holders of securities that represented 100% of the Voting Stock of the Company immediately prior to such transaction own directly or indirectly (in
substantially the same proportion to each other as immediately prior to such transaction, other than changes in proportionality as a result of any cash/stock election provided under the terms of the definitive agreement regarding such transaction)
at least a majority of the voting power of the Voting Stock of the surviving Person or Parent Entity in such merger or consolidation transaction immediately after such transaction or (B)&nbsp;in the case of a sale, transfer, license or lease of all
or substantially all of the assets of the Company, to a Subsidiary or a Person that becomes a Subsidiary of the Company; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) shares
of Common Stock or shares of any other Capital Stock into which the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock is convertible are not listed for trading on any U.S. national securities exchange or cease to be traded in
contemplation of a delisting. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, the Transactions shall not constitute a Change of Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Change of Control Purchase Date</I></B>&#148; means, with respect to a share of Series <FONT STYLE="white-space:nowrap">B-1</FONT>
Preferred Stock, (i)&nbsp;in the case of a conversion pursuant to <U>9(a)(i)</U>, the date on which the Company issues the shares of Common Stock on conversion of such share and (ii)&nbsp;in the case of a Change of Control Put, the date on which the
Company makes the payment in full of the Change of Control Put Price for such share to the Holder thereof or to the Transfer Agent, irrevocably, for the benefit of such Holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>close of business</I></B>&#148; means 5:00&nbsp;p.m. (New York City time) on any Business Day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Code</I></B>&#148; means the U.S. Internal Revenue Code of 1986, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Conversion Agent</I></B>&#148; means the Transfer Agent, acting in its capacity as conversion agent for the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Preferred Stock, and its successors and assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Conversion Price</I></B>&#148; means,
for each share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock at any time, a dollar amount equal to the Liquidation Preference <I>divided by</I> the Conversion Rate as of such time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Conversion Rate</I></B>&#148; means 294.1176, subject to adjustment in accordance with <U>11</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Effective Date</I></B>&#148; means the first date on which the shares of Common
Stock trade on the applicable exchange or in the applicable market, regular way, reflecting the relevant share split or share combination, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I><FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date</I></B>&#148; means the first date on which shares of Common Stock trade
on the applicable exchange or in the applicable market, regular way, without the right to receive the issuance, dividend or distribution in question, from the Company or, if applicable, from the seller of Common Stock on such exchange or market (in
the form of due bills or otherwise) as determined by such exchange or market. For the avoidance of doubt, any alternative trading convention on the applicable exchange or market in respect of shares of Common Stock under a separate ticker symbol or
CUSIP number shall not be considered &#147;regular way&#148; for the purposes of this definition and the &#147;Effective Date&#148; definition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Exchange Act</I></B>&#148; means the Securities Exchange Act of 1934, as amended, or any similar successor federal statute and the
rules and regulations thereunder, all as the same shall be in effect from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Governmental Authority</I></B>&#148;
means any government, political subdivision, governmental, administrative or regulatory entity or body, department, commission, board, agency or instrumentality, or other legislative, executive or judicial governmental entity, and any court,
tribunal, judicial or arbitral body, in each case whether federal, national, state, county, municipal, provincial, local, foreign or multinational. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Holder</I></B>&#148; means a Person in whose name shares of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock
are registered, which Person shall be treated by the Company, Transfer Agent, Registrar, paying agent and Conversion Agent as the absolute owner of the shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock for the purpose of
making payment and settling conversions and for all other purposes; <U>provided</U>, that, to the fullest extent permitted by law, (a)&nbsp;no Person that has received shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock in
violation of the Casdin Purchase Agreement shall be a Holder, (b)&nbsp;the Transfer Agent, Registrar, paying agent and Conversion Agent, as applicable, shall not, unless directed otherwise by the Company, recognize any such Person as a Holder and
(c)&nbsp;the Person in whose name the shares of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock were registered immediately prior to such transfer shall remain the Holder of such shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Investor Parties</I></B>&#148; means, collectively, the Casdin Parties and the Viking Parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Issuance Date</I></B>&#148; means, with respect to any share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred
Stock, the date of issuance of such share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Last Reported Sale Price</I></B>&#148; of the Common Stock (or other security for
which a closing sale price must be determined) on any date means the closing sale price per share (or if no closing sale price is reported, the average of the bid and ask prices or, if more than one in either case, the average of the average bid and
the average ask prices) on that date as reported in composite transactions for the principal U.S. national or regional securities exchange on which the Common Stock (or such other security) is traded. If the Common Stock (or such other security) is
not listed for trading on a U.S. national or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
regional securities exchange on the relevant date, the &#147;Last Reported Sale Price&#148; shall be the last quoted bid price for the Common Stock (or such other security) in the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market on the relevant date as reported by OTC Markets Group Inc. or a similar organization. If the Common Stock (or such other security) is not so quoted,
the &#147;Last Reported Sale Price&#148; shall be the average of the <FONT STYLE="white-space:nowrap">mid-point</FONT> of the last bid and ask prices per share of the Common Stock (or such other security) on the relevant date from each of at least
three nationally recognized independent investment banking firms selected by the Company for this purpose. The &#147;Last Reported Sale Price&#148; shall be determined without regard to after-hours trading or any other trading outside of the regular
trading session hours. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Law</I></B>&#148; means any federal, national, state, county, municipal, provincial, local, foreign or
multinational law, act, statute, constitution, common law, ordinance, code, decree, writ, order, judgment, injunction, rule, regulation, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or
under the authority of any Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Liquidation Preference</I></B>&#148; means, with respect to any share of
Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock, as of any date, $1,000 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Mandatory Conversion
Price</I></B>&#148; means, at any time, 250% of the Conversion Price as of such time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Market Disruption Event</I></B>&#148;
means any of the following events: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any suspension of, or limitation imposed on, trading of the Common Stock or options
contracts relating to the Common Stock by any exchange or quotation system on which the Last Reported Sale Price is determined pursuant to the definition of &#147;Last Reported Sale Price&#148; (the &#147;<B><I>Relevant Exchange</I></B>&#148;)
during the <FONT STYLE="white-space:nowrap">one-hour</FONT> period prior to the close of trading for the regular trading session on the Relevant Exchange (or for purposes of determining the VWAP per share of Common Stock, any period or periods
aggregating one half-hour or longer during the regular trading session on the relevant day) whether by reason of movements in price exceeding limits permitted by the Relevant Exchange or otherwise; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) any event that disrupts or impairs (as determined by the Company in its reasonable discretion) the ability of market participants during
the <FONT STYLE="white-space:nowrap">one-hour</FONT> period prior to the close of trading for the regular trading session on the Relevant Exchange (or for purposes of determining the VWAP per share of Common Stock, any period or periods aggregating
one half-hour or longer during the regular trading session on the relevant day) to effect transactions in, or obtain market values for, the Common Stock on the Relevant Exchange or to effect transactions in, or obtain market values for, options
contracts relating to the Common Stock on the Relevant Exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>NASDAQ</I></B>&#148; means the Nasdaq Stock Market and any
successor stock exchange or inter-dealer quotation system operated by the Nasdaq Stock Market or any successor thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Neutral Manner</I></B>&#148; means in the same proportion as the outstanding
Common Stock (excluding any and all Common Stock Beneficially Owned, directly or indirectly, by the Investor Parties) voted on the relevant matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Officers&#146; Certificate</I></B>&#148; means a certificate signed by the Chief Executive Officer, the Chief Financial Officer or
the Secretary of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Original Issuance Date</I></B>&#148; means the Closing Date, as defined in the Casdin Purchase
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Parent Entity</I></B>&#148; means, with respect to any Person, any other Person of which such first Person is a
direct or indirect wholly owned Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Permitted Transferee</I></B>&#148; has the meaning set forth in the Casdin
Purchase Agreement or the Viking Purchase Agreement, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Person</I></B>&#148; means any individual, corporation,
estate, partnership, joint venture, association, joint-stock company, limited liability company, trust, series, unincorporated organization or any other entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Record Date</I></B>&#148; means, with respect to any dividend, distribution or other transaction or event in which holders of
Common Stock have the right to receive any cash, securities or other property or in which Common Stock is exchanged for or converted into any combination of cash, securities or other property, the date fixed for determination of holders of Common
Stock entitled to receive such cash, securities or other property (whether such date is fixed by the Board or a duly authorized committee thereof or by statute, contract or otherwise). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Registrar</I></B>&#148; means the Transfer Agent, acting in its capacity as registrar for the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock, and its successors and assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Registration Rights
Agreement</I></B>&#148; means the Registration Rights Agreement by and among the Company and the purchasers party thereto dated as of January&nbsp;23, 2022 as it may be amended, supplemented or otherwise modified from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Related Person</I></B>&#148; means (a)&nbsp;any executive officer of the Company, (b)&nbsp;any director of the Company or any
Affiliate of such director and (c)&nbsp;any Person that, together with its Affiliates, holds 5% of more of the outstanding shares of Common Stock (measured on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Securities Act</I></B>&#148; means the Securities Act of 1933, as amended, or any similar successor federal statute and the rules
and regulations thereunder, all as the same shall be in effect from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series B Preferred Stock</I></B>&#148;
means, collectively, the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock and the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-2</FONT> Certificate of
Designations</I></B>&#148; means the Certificate of Designations relating to the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock, as it may be amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock</I></B>&#148; means the Series
<FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Subsidiary</I></B>&#148; means, with
respect to any Person, any corporation of which a majority of the total voting power of shares of stock entitled to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by such
Person or one or more of the other Subsidiaries of such Person or a combination thereof or any partnership, limited liability company, trust, association or other business entity of which a majority of the partnership, limited liability company,
trust, association or other similar ownership interest is at the time owned or controlled, directly or indirectly, by such Person or one or more Subsidiaries of such Person or a combination thereof. For purposes of this definition, a Person is
deemed to have a majority ownership interest in a partnership, limited liability company, trust, association or other business entity if such Person is allocated a majority of the gains or losses of such partnership, limited liability company,
trust, association or other business entity or is or controls the managing director, managing member or general (or equivalent) partner of such partnership, limited liability company, trust, association or other business entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Tax</I></B>&#148; or &#147;<B><I>Taxes</I></B>&#148; means any taxes and similar assessments, fees, and other governmental charges
imposed by any Governmental Authority, including income, profits, gross receipts, net proceeds, ad valorem, value added, turnover, sales, use, property, personal property (tangible and intangible), stamp, excise, duty, franchise, capital stock,
transfer, payroll, employment, severance, and estimated tax, together with any interest and any penalties, additions to tax or additional amounts imposed by any Governmental Authority, whether disputed or not. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Tax Return</I></B>&#148; means any return, estimates, report, statement, information return or other document (including any
related or supporting information such as a schedule or attachment thereto) filed or required to be filed with any Governmental Authority in connection with the determination, assessment, collection or administration of any Taxes, including any
amendment thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Trading Day</I></B>&#148; means a Business Day on which the Relevant Exchange is scheduled to be open for
business and on which there has not occurred a Market Disruption Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Transactions</I></B>&#148; has the meaning set forth
in the Casdin Purchase Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Transfer</I></B>&#148; has the meaning set forth in the Casdin Purchase Agreement or the
Viking Purchase Agreement, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Transfer Agent</I></B>&#148; means the Person acting as transfer agent, Registrar
and paying agent and Conversion Agent for the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock and its successors and assigns. The initial Transfer Agent shall be Computershare Trust Company, N.A. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Viking</I></B>&#148; means collectively, Viking Global Opportunities Illiquid
Investments <FONT STYLE="white-space:nowrap">Sub-Master</FONT> LP, a Cayman Islands exempted limited partnership and Viking Global Opportunities Drawdown (Aggregator) LP, a Cayman Islands exempted limited partnership. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Viking Parties</I></B>&#148; means Viking and each Permitted Transferee of Viking to whom shares of Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Preferred Stock or Common Stock are Transferred pursuant to Section&nbsp;6.15(b) of the Viking Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Viking Purchase Agreement</I></B>&#148; means the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock
Purchase Agreement by and between the Company and Viking, dated as of January&nbsp;23, 2022, as it may be amended, modified or supplemented from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Voting Stock</I></B>&#148; means (i)&nbsp;with respect to the Company, the Common Stock, the Series&nbsp;B Preferred Stock
(subject to the limitations set forth herein) and any other Capital Stock of the Company having the right to vote generally in any election of directors of the Board and (ii)&nbsp;with respect to any other Person, all Capital Stock of such Person
having the right to vote generally in any election of directors of the board of directors of such Person or other similar governing body. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>VWAP</I></B>&#148; means, for any Trading Days, the per share volume-weighted average price of the Common Stock as displayed under
the heading &#147;Bloomberg VWAP&#148; on Bloomberg page &#147;FLDM &lt;equity&gt; AQR&#148; (or its equivalent successor if such page is not available) in respect of the period from the scheduled open of trading until the scheduled close of trading
of the primary trading session on such Trading Day (or if such volume-weighted average price is unavailable, the market value of one share of the Common Stock on such Trading Day reasonably determined, using a volume-weighted average method, by a
nationally recognized independent investment banking firm retained for this purpose by the Company). The &#147;VWAP&#148; shall be determined without regard to after-hours trading or any other trading outside of the regular trading session trading
hours. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The following terms have the meanings set forth in the Sections referenced below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Term</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>Section</B></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1% Exception</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">11(j)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Board</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Certificate of Incorporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Change of Control Call</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">9(e)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Change of Control Effective Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">9(c)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Change of Control Election Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">9(b)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Change of Control Put</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">9(a)</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Change of Control Put Price</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">9(a)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Clause A Distribution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">11(c)(1)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Clause B Distribution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">11(c)(2)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Clause C Distribution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">11(c)(2)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Common Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Constituent Person</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">12(a)(iii)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Conversion Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">8(a)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Conversion Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">8(a)(i)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DGCL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Distributed Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">11(c)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exchange Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">12(a)(iii)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Final Change of Control Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">9(c)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Junior Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2(b)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Mandatory Conversion</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">7(a)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Mandatory Conversion Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">7(a)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Notice of Mandatory Conversion</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">7(b)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Notice of Redemption</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10(b)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Parity Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2(a)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Preferred Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Redemption</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10(a)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Redemption Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10(b)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Redemption Price</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">10(a)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Reorganization Event</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">12(a)(iii)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Senior Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2(b)</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">14(a)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">Spin-Off</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">11(c)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Third Party Transfer Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">19(b)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Trigger Event</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">11(c)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Valuation Period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">11(c)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Voting Threshold</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">13(a)</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. Dividends. Subject to the provisions of this Certificate of Designations (including <U>13(b)</U>),
dividends may be declared by the Board or any duly authorized committee thereof on any Junior Stock from time to time. The Holders shall fully participate, on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, in any dividends declared
and paid or distributions on the Common Stock as if the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock were, though the <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock shall not be, converted, at the
Conversion Rate in effect on the Record Date for such dividend or distribution, pursuant to <U>6(a)</U> into shares of Common Stock (without regard to any limitations on conversion) immediately prior to such Record Date, as and when paid with
respect to the Common Stock and using the same Record Date as is used for the Common Stock. No dividend shall be declared or paid on the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock unless a dividend in an equal amount per
share is also declared or paid (as applicable) on the <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.
Liquidation Rights. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Liquidation</U>. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the
affairs of the Company, the Holders shall be entitled, out of assets legally available therefor, before any distribution or payment out of the assets of the Company may be made to or set aside for the holders of any Junior Stock, and subject to the
rights of the holders of any Senior Stock or Parity Stock and the rights of the Company&#146;s existing and future creditors, to receive in full a liquidating distribution in cash in the amount per share of
<FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock equal to the greater of (i)&nbsp;the Liquidation Preference with respect to such share of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock as of the date
of such voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company and (ii)&nbsp;the amount per share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock that such Holders would have received had
all holders of Series&nbsp;B Preferred Stock, immediately prior to such voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, converted all shares of Series B Preferred Stock into Common Stock (pursuant to
<U>6(a)</U> or 6(a) of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Certificate of Designations, as applicable (without regard to any of the limitations on convertibility contained therein)). Holders shall not be entitled to any
further payments in the event of any such voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company other than what is expressly provided for in this <U>5</U> and shall have no right or claim to any of the
Company&#146;s remaining assets. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Partial Payment</U>. If in connection with any distribution described in <U>5(a)</U>
the assets of the Company or proceeds therefrom are not sufficient to pay in full the aggregate liquidating distributions required to be paid pursuant to (i) <U>5(a)</U> to all Holders, (ii)&nbsp;Section&nbsp;5(a) of the <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Certificate of Designations to all holders of the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock, and (iii)&nbsp;the liquidating distributions payable to all holders of any other
Parity Stock, the amounts distributed to the Holders, the holders of the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock and to the holders of all other Parity Stock shall be paid <I>pro rata</I> in accordance with the respective
aggregate liquidating distributions to which they would otherwise be entitled if all amounts payable thereon were paid in full. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
<U>Merger, Consolidation and Sale of Assets Not Liquidation</U>. For purposes of this <U>5</U>, the sale, conveyance, lease, exchange or transfer (for cash, shares of stock, securities or other consideration) of all or substantially all of the
property and assets of the Company shall not be deemed a voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, nor shall the merger, consolidation, statutory exchange or any other business combination
transaction of the Company into or with any other Person or the merger, consolidation, statutory exchange or any other business combination transaction of any other Person into or with the Company or a Subsidiary of the Company be deemed to be a
voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, and the holders of Series B Preferred Stock shall not be entitled to any payments pursuant to <U>5(a)</U> herein or Section&nbsp;5(a) of the Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Certificate of Designations on account of such sale, conveyance, lease, exchange or transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.
Right of the Holders to Convert. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each Holder shall have the right, at such Holder&#146;s option, subject to the conversion procedures
set forth in <U>8</U>, to convert each share of such Holder&#146;s <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock at any time into a number of shares of Common Stock equal to the Conversion Rate; <U>provided</U>, that each
Holder shall receive cash in lieu of any fractional shares or as otherwise set out in <U>8(f)</U>. The right of conversion may be exercised as to all or any portion of such Holder&#146;s <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT>
Preferred Stock from time to time; <U>provided</U>, that in each case, no right of conversion may be exercised by a Holder in respect of fewer than 10,000 shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock (unless such
conversion relates to all shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock held by such Holder). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The
Company shall at all times reserve and keep available out of its authorized and unissued Common Stock, solely for issuance on the conversion of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock, such number of shares of
Common Stock as shall from time to time be issuable on the conversion to Common Stock of all the shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock then outstanding. The Company shall use its reasonable best efforts to
maintain the listing on the NASDAQ of such number of shares of Common Stock as shall from time to time be issuable on the conversion of all the shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock then outstanding. Any shares
of Common Stock issued on conversion of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock shall be duly authorized, validly issued, fully paid and nonassessable and shall not be subject to preemptive rights or subscription rights of
any other stockholder of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. Mandatory Conversion by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) At any time after the five year anniversary of the Original Issuance Date, if the Last Reported Sale Price of the Common Stock was greater
than the Mandatory Conversion Price for at least twenty consecutive Trading Days immediately preceding the date of the Notice of Mandatory Conversion, the Company may elect to convert (a &#147;<B><I>Mandatory Conversion</I></B>&#148;) all, but not
less than all, of the outstanding shares of Series B Preferred Stock into shares of Common Stock (the date selected by the Company for any Mandatory Conversion pursuant to this <U>7(a)</U> and in accordance with <U>7(b)</U>, the
&#147;<B><I>Mandatory Conversion Date</I></B>&#148;). In the case of a Mandatory Conversion, each share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock then outstanding shall be converted into (A)&nbsp;a whole number of shares
of Common Stock at the Conversion Rate <I>plus</I> (B)&nbsp;cash in lieu of fractional shares or as otherwise set forth in <U>8(f)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Notice of Mandatory Conversion</U>. If the Company elects to effect a Mandatory Conversion, the Company shall, within five Business Days
following the completion of the applicable period of 20 Trading Days referred to in <U>7(a)</U>, provide notice of such Mandatory Conversion to each Holder (such notice, a &#147;<B><I>Notice of Mandatory Conversion</I></B>&#148;). For the avoidance
of doubt, a Notice of Mandatory Conversion shall not limit a Holder&#146;s right to convert its shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock on any Conversion Date prior to the Mandatory Conversion Date. The Mandatory
Conversion Date selected by the Company shall be no less than ten Business Days and no more than 20 Business Days after the date on which the Company provides the Notice of Mandatory Conversion to the Holders. The Notice of Mandatory Conversion
shall specify: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the Mandatory Conversion Date selected by the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the applicable procedures a Holder must follow for issuance of the shares of Common Stock pursuant to <U>8(a)</U>; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) the Conversion Rate as anticipated to be in effect on the Mandatory Conversion Date and the number of shares of Common Stock to be
issued to the Holder on conversion of each share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock held by such Holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. Conversion Procedures and Effect of Conversion. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Conversion Procedure</U>. A Holder must do each of the following in order to convert shares of Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock pursuant to this <U>8(a)</U> (the first Business Day on which such Holder has complied with all such procedures (including the satisfaction of any conditions to conversion set forth in the
Conversion Notice), the &#147;<B><I>Conversion Date</I></B>&#148;): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) in the case of a conversion pursuant to <U>6(a)</U>, complete and
manually sign the conversion notice provided by the Conversion Agent, a form of which is attached hereto as <U>Exhibit A</U> together with such additional information as the Conversion Agent may reasonably require (the &#147;<B><I>Conversion
Notice</I></B>&#148;), and deliver such notice to the Conversion Agent; <U>provided</U>,<I> </I>that a Conversion Notice may be conditional on the completion of a Change of Control or other condition, transaction or event as such Holder may specify;
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) deliver to the Conversion Agent the certificate or certificates (if any) representing
the shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock to be converted; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) if required, furnish appropriate
endorsements and transfer documents; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) if required, pay the amount of any Third Party Transfer Taxes. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the forgoing, with respect to a Mandatory Conversion pursuant to <U>7</U>, the Conversion Date shall mean the Mandatory Conversion Date,
regardless of whether the foregoing has occurred or been complied with. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Effect of Conversion</U>. Effective immediately prior to
the close of business on the Conversion Date applicable to any shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock, such shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock shall cease to be
outstanding and the corresponding shares of Common Stock pursuant to the conversion shall be issued and outstanding. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Record Holder
of Underlying Securities as of Conversion Date</U>. The Person or Persons entitled to receive the Common Stock and, to the extent applicable, cash, securities or other property issuable on conversion of Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock on a Conversion Date shall be treated for all purposes as the record holder(s) of such shares of Common Stock and/or cash, securities or other property as of the close of business on such
Conversion Date. As promptly as practicable on or after the Conversion Date and, if applicable, compliance by the applicable Holder with the relevant procedures contained in <U>8(a)</U> (and in any event no later than three Trading Days thereafter;
<U>provided</U>, that if a written notice from the Holder in accordance with <U>8(a)(</U><U>i</U><U>)</U> specifies a date of delivery for any shares of Common Stock, such shares shall be delivered on the date so specified, which shall be no earlier
than the second Business Day and no later than the seventh Business Day following the date of such notice), the Company shall issue the number of whole shares of Common Stock issuable on conversion (and deliver payment of cash in lieu of fractional
shares or as otherwise set out in <U>8(f)</U>) and, to the extent applicable, any cash, securities or other property issuable thereon. Such delivery of shares of Common Stock, securities or other property shall be made by book-entry or, at the
request of the Holder, by delivering a notice to the Conversion Agent, through the facilities of The Depositary Trust Company or in certificated form. Any such certificate or certificates shall be delivered by the Company to the appropriate Holder
on a book-entry basis, through the facilities of The Depositary Trust Company, or by mailing certificates evidencing the shares to the Holders, in each case at their respective addresses as set forth in the Conversion Notice (in the case of a
conversion pursuant to <U>6(a)</U>) or as set forth in the records of the Company or in a notice from the Holder to the Conversion Agent, as applicable (in the case of Mandatory Conversion). In the event that a Holder shall not by written notice
designate the name in which shares of Common Stock (and payments of cash in lieu of fractional shares) and, to the extent applicable, cash, securities or other property to be delivered on conversion of shares of
<FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock should be registered or paid, or the manner in which such shares, cash, securities or other property should be delivered, the Company shall be entitled to register and deliver
such shares, securities or other property, and make such payment, in the name of the Holder and in the manner shown on the records of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Status of Converted or Reacquired Shares</U>. Shares of <FONT
STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock converted in accordance with this Certificate of Designations, or otherwise acquired by the Company or any of its Subsidiaries in any manner whatsoever, shall not be reissued as
shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock and shall be retired promptly after the conversion or acquisition thereof. All such shares shall, on their retirement and any filing required by the DGCL, become authorized
but unissued shares of Preferred Stock, without designation as to series until such shares are once more designated as part of a particular series by the Board pursuant to the provisions of the Certificate of Incorporation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Partial Conversion</U>. In case any certificate for shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock
shall be surrendered for partial conversion, the Company shall, at its expense, execute and deliver to or on the written order of the Holder of the certificate so surrendered a new certificate for the shares of Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock not converted. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>No Fractional Shares</U>. No fractional shares of Common
Stock shall be delivered to the Holders on conversion of shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock. In lieu of fractional shares otherwise issuable, each Holder shall be entitled to receive, at the Company&#146;s
sole discretion, either (i)&nbsp;cash in lieu of delivering any fractional share of Common Stock issuable on conversion based on the VWAP of the Common Stock for the relevant Conversion Date (or, if such Conversion Date is not a Trading Day, the
next following Trading Day) or (ii)&nbsp;one additional whole share of fully paid and nonassessable Common Stock. In order to determine whether the number of shares of Common Stock to be delivered to a Holder on the conversion of such Holder&#146;s
shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock would include a fractional share, such determination shall be based on the aggregate number of shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock
of such Holder that are being converted and/or issued on any single Conversion Date or Change of Control Purchase Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. Change of
Control. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Change of Control Put</U>. In the event of a Change of Control, each Holder of outstanding shares of <FONT
STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock may, at such Holder&#146;s election, (i)&nbsp;effective as of immediately prior to the Change of Control Effective Date, convert all or a portion of its shares of <FONT
STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock pursuant to <U>6(a)</U> or (ii)&nbsp;require the Company to purchase all of such Holder&#146;s shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock that
have not been so converted at a purchase price per share of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock (a &#147;<B><I>Change of Control Put</I></B>&#148;) for an amount in cash (in the case of clause&nbsp;(A)) or the
applicable consideration (in the case of clause (B)) for each such share of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock (the &#147;<B><I>Change of Control Put Price</I></B>&#148;) equal to, at the Holder&#146;s election
(or if the Holder does not so elect, the greater of, as determined by the Board acting in good faith) (A)&nbsp;the Liquidation Preference of such share of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock or (B)&nbsp;the amount
of cash and/or other assets such Holder would have received in the transaction constituting a Change of Control had such Holder, immediately prior to such Change of Control, converted such share of
<FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock into Common Stock pursuant to <U>6(a)</U> but without regard to any of the limitations on convertibility contained therein </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(<U>provided</U>, that if the kind or amount of securities, cash and other property receivable in such transaction is not the same for each share of Common Stock held immediately prior to such
transaction by a Person, then the kind and amount of securities, cash and other property receivable on Change of Control Put following such transaction shall be deemed to be the weighted average of the types and amounts of consideration received by
all holders of Common Stock). The Company shall not take any action that would be reasonably expected to impair the Company&#146;s ability to pay the Change of Control Put Price when due, including by investing available funds in illiquid assets.
For clarity, but subject to <U>9(e)</U>, any shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock that a Holder does not convert as set forth in clause&nbsp;(i) above or subject to the Change of Control Put as set forth in
clause&nbsp;(ii) above shall remain outstanding as provided herein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Initial Change of Control Notice</U>. On or before the 20th
Business Day prior to the date on which the Company anticipates consummating a Change of Control (or, if later, promptly after the Company discovers that a Change of Control may occur), a written notice (the &#147;<B><I>Initial Change of Control
Notice</I></B>&#148;) shall be sent by or on behalf of the Company to the Holders as they appear in the records of the Company, which notice shall contain (i)&nbsp;the date on which the Change of Control is anticipated to be effected (or, if
applicable, the date on which a Schedule TO or other schedule, form or report disclosing a Change of Control was filed), (ii)&nbsp;a description of the material terms and conditions of the Change of Control and (iii)&nbsp;the then-applicable
Conversion Rate. No later than the later of (x)&nbsp;ten Business Days prior to the Change of Control Effective Date as set forth in the Initial Change of Control Notice and (y)&nbsp;the 20th Business Day following receipt of the applicable Initial
Change of Control Notice, any Holder that desires to exercise its rights pursuant to <U>9(a)</U> shall notify the Company in writing thereof (a &#147;<B><I>Change of Control Election Notice</I></B>&#148;) and shall specify (A)&nbsp;whether such
Holder is electing to exercise its rights pursuant to <U>9(a)(</U><U>i</U><U>)</U>, <U>(ii)</U> or both, and (B)&nbsp;the number of shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock subject thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Final Change of Control Notice</U>. Within ten days prior to the effective date of the Change of Control (the &#147;<B><I>Change of
Control Effective Date</I></B>&#148;), a final written notice (the &#147;<B><I>Final Change of Control Notice</I></B>&#148;) shall be sent by or on behalf of the Company to the Holders as they appear in the records of the Company on the Business Day
immediately prior to the date such notice is sent, which notice shall contain: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) a statement setting forth in reasonable detail the
calculation of the Change of Control Put Price with respect to such Holder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the Change of Control Purchase Date, which shall be no
later than ten Business Days after such notice is sent; <U>provided</U>, that a reasonable amount of time shall be provided between delivery of such notice and the Change of Control Purchase Date to allow such Holder to comply with the instructions
delivered pursuant to <U>9(c)(iii)</U>; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) the instructions that a Holder must follow to receive the Change of Control Put Price
in connection with such Change of Control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Change of Control Put Procedure</U>. To receive the Change of Control Put Price, a
Holder must surrender to the Transfer Agent in accordance with the instructions delivered pursuant to <U>9(c)(iii)</U>, the certificates representing the shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock to be repurchased
by the Company or lost stock affidavits therefor, to the extent applicable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Change of Control Call</U>. In the event of a Change of
Control following which the Company merges with another person and is not the surviving corporation or the Common Stock is no longer listed on a U.S. national securities exchange, if a Holder has not delivered a Change of Control Election Notice in
accordance with <U>9(a)</U> within the time specified therein or has delivered a Change of Control Election Notice for less than all of its shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock, the Company may elect to redeem
(a &#147;<B><I>Change of Control Call</I></B>&#148;), subject to the right of such Holders to convert the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock pursuant to <U>6(a)</U> at any time prior to any such redemption, all of
such Holders&#146; shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock that are not subject to the Change of Control Election Notice (if any) at a redemption price per share, payable in cash, equal to the Change of Control
Put Price. In order to elect a Change of Control Call, the Company must send an irrevocable notice of such election at the same time as the Initial Change of Control Notice, which notice shall contain the anticipated redemption date (which shall be
contingent upon the closing of the Change of Control transaction or if the Change of Control transaction has already occurred, such date as elected by the Company no less than 30 nor more than 60 calendar days following the date of such notice),
instructions for Holders to receive the Change of Control Put Price, the amount of the Change of Control Put Price, and the last date for a Holder to convert its shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock in advance
of the Change of Control Call (which shall be the Business Day immediately preceding the redemption date). The Company shall not have the right to elect a Change of Control Call unless, as of the date of delivery of notice of a Change of Control
Call, it has set aside sufficient funds legally available for the payment of the full Change of Control Put Price for all outstanding shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Delivery on Change of Control Put/Call</U>. On a Change of Control Put or a Change of Control Call, the Company (or its successor) shall
deliver or cause to be delivered to the Holder by wire transfer of immediately available funds, the Change of Control Put Price for such Holder&#146;s shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Treatment of Shares</U>. Until a share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock is purchased by the payment
in full of the applicable Change of Control Put Price, such share of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock shall remain outstanding and shall be entitled to all of the powers, designations, preferences and other
rights provided herein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Change of Control Agreements</U>. The Company shall not enter into any agreement for, or otherwise
willingly engage in, a transaction constituting a Change of Control unless (i)&nbsp;such agreement provides for or does not interfere with or prevent (as applicable) the exercise by the Holders of their Change of Control Put and payment in full of
the Change of Control Put Price after payments required pursuant to any credit agreement, indenture or similar agreement evidencing indebtedness for borrowed money specified in Section&nbsp;9(l) below pursuant to this <U>9</U> and (ii)&nbsp;the
acquiring or surviving Person in such Change of Control represents or covenants, in form and substance </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reasonably satisfactory to the Board acting in good faith, that at the closing of such Change of Control such Person shall have sufficient funds (which may include, without limitation, cash and
cash equivalents on the Company&#146;s balance sheet, the proceeds of any debt or equity financing, available lines of credit or uncalled capital commitments) to consummate such Change of Control and the payment of the Change of Control Put Price in
respect of shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock that have not been converted into Common Stock prior to the Change of Control Effective Date pursuant to <U>6(a)</U> and <U>7</U> after all payments required to
be made by the Company pursuant to any credit agreement, indenture or similar agreement evidencing indebtedness for borrowed money have been made. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Effect of Change of Control Put/Call</U>. On full payment of the Change of Control Put Price for any shares of Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Preferred Stock subject to a Change of Control Put or Change of Control Call, such shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock shall no longer be deemed to be outstanding for any
purpose and all rights (except the right to receive the Change of Control Put Price) of the Holder of such shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock shall cease and terminate with respect to such shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Withdrawal of Election for Change of Control Put</U>. Notwithstanding anything to the contrary herein, any Holder&#146;s Change of
Control Election Notice may be withdrawn (in whole or in part) by means of a written notice of withdrawal delivered to the Company at any time prior to the close of business on the fourth Business Day immediately succeeding the date of delivery of a
Final Change of Control Notice (or, if earlier, the close of business on the second Business Day immediately preceding the relevant Change of Control Purchase Date), specifying the number of shares of Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock with respect to which such notice of withdrawal is being submitted. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) The
above provisions of this <U>9</U> shall similarly apply to successive Changes of Control (or anticipated Changes of Control). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) For the
avoidance of doubt, and not in limitation of the rights in this section, in the event of a Change of Control Put, the Company shall be permitted to pay the Change of Control Put Price required above in cash following the prior payment in full in
cash all obligations of the Company and its Subsidiaries under any credit agreement, indenture or similar agreement evidencing indebtedness for borrowed money (including the termination of all commitments to lend, to the extent required by such
credit agreement, indenture or similar agreement), which requires prior payment of the obligations thereunder (and termination of commitments thereunder, if applicable) as a condition to the payment of such Change of Control Put Price in cash.
Nothing contained in this Section (9)(l) shall limit a Holder&#146;s right to pursue any remedies available to it hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.
Redemption at the Option of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) At any time after the seventh anniversary of the Original Issuance Date, the Company shall
have the right (but not the obligation) to redeem all (but not less than all) of the then-outstanding shares of Series&nbsp;B Preferred Stock, at a redemption price per share of Series&nbsp;B Preferred Stock (payable by the Company in cash) equal to
the Liquidation Preference (a &#147;<B><I>Redemption</I></B>&#148; and such amount, the &#147;<B><I>Redemption Price</I></B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In connection with any Redemption, a written notice (a &#147;<B><I>Notice of
Redemption</I></B>&#148;) shall be sent by or on behalf of the Company to each Holder as they appear in the records of the Company at least ten days and not more than 60 days before the date fixed for such redemption (the &#147;<B><I>Redemption
Date</I></B>&#148;). The Notice of Redemption shall specify (i)&nbsp;the Redemption Date, (ii)&nbsp;the total number of shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock to be redeemed from the applicable Holder,
(iii)&nbsp;the amount per share payable to such Holder and (iv)&nbsp;the procedures that such Holders of shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock must follow in order to receive the Redemption Price for their
shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock to be redeemed. The Company shall deliver or cause to be delivered to each Holder that has complied with the instructions set forth in such Notice of Redemption, cash by
wire transfer in an amount equal to the Redemption Price for each share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock held by such Holder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Prior to any Redemption, each Holder of outstanding shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock may,
at such Holder&#146;s election, effective prior to such Redemption on a date designated by the Holder, convert all or a portion of its shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock pursuant to <U>6(a)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) On full payment of the Redemption Price for all shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock subject
to a Redemption, such shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock shall no longer be deemed to be outstanding for any purpose and all rights (except the right to receive the Redemption Price) of the Holder of such
shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock shall cease and terminate with respect to such shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.
Adjustment of Conversion Rate. The Conversion Rate shall be adjusted from time to time by the Company if any of the following events occurs, except that the Company shall not make any adjustments to the Conversion Rate if Holders of the <FONT
STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock participate (other than in the case of a share split or share combination or a tender or exchange offer), at the same time and on the same terms as holders of the Common Stock and
solely as a result of holding the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock, in any of the transactions described in this <U>11</U>, without having to convert their shares of Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock, as if they held a number of shares of Common Stock equal to the Conversion Rate <I>multiplied by</I> the number of shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred
Stock held by such Holder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If the Company exclusively issues shares of Common Stock as a dividend or distribution on shares of the
Common Stock, or if the Company effects a share split or share combination, the Conversion Rate shall be adjusted based on the following formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g243622dsp309.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately prior to the open of business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date of such dividend or distribution, or immediately prior to the open of business on the Effective
Date of such share split or share combination, as applicable;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the open of business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date or Effective Date;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OS<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately prior to the open of business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date or Effective Date (before giving effect to any such dividend, distribution,
split or combination); and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OS<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately after giving effect to such dividend, distribution, share split or share combination.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any adjustment made under this <U>11(a)</U> shall become effective immediately after the open of business on the <FONT
STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such dividend or distribution, or immediately after the open of business on the Effective Date for such share split or share combination, as applicable. If any dividend or distribution of the
type described in this <U>11(a)</U> is declared but not so paid or made, the Conversion Rate shall be immediately readjusted, effective as of the date the Board determines not to pay such dividend or distribution, to the Conversion Rate that would
then be in effect if such dividend or distribution had not been declared. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If the Company issues to all or substantially all holders
of the Common Stock and/or the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock any rights, options or warrants (other than in connection with a stockholder rights plan) entitling them, for a period of not more than 45
calendar days after the announcement date of such issuance, to subscribe for or purchase shares of the Common Stock at a price per share that is less than the average of the Last Reported Sale Prices of the Common Stock for the ten consecutive
Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement of such issuance, the Conversion Rate shall be increased based on the following formula: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g243622dsp310.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately prior to the open of business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such issuance;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the open of business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OS<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately prior to the open of business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">X</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the total number of shares of Common Stock issuable pursuant to such rights, options or warrants; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Y</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock equal to the aggregate price payable to exercise such rights, options or warrants, divided by the average of the Last Reported Sale Prices of the Common Stock over the ten consecutive Trading Day
period ending on, and including, the Trading Day immediately preceding the date of announcement of the issuance of such rights, options or warrants.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any increase made under this <U>11(b)</U> shall be made successively whenever any such rights, options or warrants are issued
and shall become effective immediately after the open of business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such issuance. To the extent that shares of the Common Stock are not delivered after the expiration of such rights,
options or warrants, the Conversion Rate shall be decreased to the Conversion Rate that would then be in effect had the increase with respect to the issuance of such rights, options or warrants been made on the basis of delivery of only the number
of shares of Common Stock actually delivered. If such rights, options or warrants are not so issued, the Conversion Rate shall be decreased to the Conversion Rate that would then be in effect if such
<FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such issuance had not occurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this <U>11(b)</U>, in determining whether
any rights, options or warrants entitle the holders to subscribe for or purchase shares of the Common Stock at less than such average of the Last Reported Sale Prices of the Common Stock for the ten consecutive Trading Day period ending on, and
including, the Trading Day immediately preceding the date of announcement for such issuance, and in determining the aggregate offering price of such shares of Common Stock, there shall be taken into account any consideration received by the Company
for such rights, options or warrants and any amount payable on exercise or conversion thereof, the value of such consideration, if other than cash, to be determined by the Company in good faith and in a commercially reasonable manner. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If the Company distributes shares of its Capital Stock, evidences of its indebtedness, other assets or property of the Company or rights,
options or warrants to acquire its Capital Stock or other securities, to all or substantially all holders of the Common Stock, excluding (i)&nbsp;dividends, distributions or issuances (including share splits) as to which an adjustment was effected
(or would be required to be effected, notwithstanding the 1%&nbsp;Exception in <U>11(j)</U>) pursuant to <U>11(a)</U> or <U>11(b)</U>, (ii)&nbsp;dividends or distributions paid exclusively in cash that are also paid to the Holders of the <FONT
STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock pursuant to <U>4</U>, (iii)&nbsp;except as otherwise described below, rights issued pursuant to a stockholder rights plan of the Company, (iv)&nbsp;distributions of Exchange Property
in a Reorganization Event and (v)&nbsp;Spin-Offs, as to which the provisions set forth below in this <U>11(c)</U> shall apply (any of such shares of Capital Stock, evidences of indebtedness, other assets or property or rights, options or warrants to
acquire Capital Stock or other securities, the &#147;<B><I>Distributed Property</I></B>&#148;), then the Conversion Rate shall be increased based on the following formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g243622dsp311.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">where: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately prior to the open of business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such distribution;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the open of business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SP<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Last Reported Sale Prices of the Common Stock over the ten consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT>
Date for such distribution; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FMV</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the fair market value (as determined by the Company in good faith and in a commercially reasonable manner) of the Distributed Property with respect to each outstanding share of the Common Stock on the
<FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such distribution.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any increase made under the portion of this <U>11(c)</U> above shall become effective immediately after the open of business
on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such distribution. If such distribution is not so paid or made, the Conversion Rate shall be decreased to the Conversion Rate that would then be in effect if such distribution had
not been declared. If the Company issues rights, options or warrants that are only exercisable on the occurrence of certain triggering events, then the Company shall not adjust the Conversion Rate pursuant to the clauses above until the earliest of
these triggering events occurs, and the Company shall readjust the Conversion Rate to the extent that any of these rights, options or warrants are not exercised before they expire. In the case of any distribution of rights, options or warrants, to
the extent any such rights, options or warrants expire unexercised, the Conversion Rate shall be immediately readjusted to the Conversion Rate that would then be in effect had the increase made for the distribution of such rights, options or
warrants been made on the basis of delivery of only the number of shares of the Common Stock actually delivered on exercise of such rights, options or warrants. Notwithstanding the foregoing, if &#147;FMV&#148; (as defined above) is equal to or
greater than &#147;SP<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB>&#148; (as defined above), in lieu of the foregoing increase, each Holder of shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock shall
receive, in respect of each such share, at the same time and on the same terms as holders of the Common Stock, the amount and kind of Distributed Property such Holder would have received if such Holder owned a number of shares of Common Stock equal
to the Conversion Rate in effect on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for the distribution. If the Company determines the &#147;FMV&#148; (as defined above) of any distribution for purposes of this <U>11(c)</U> by
reference to the actual or when-issued trading market for any securities, it shall in doing so consider the prices in such market over the same period used in computing the Last Reported Sale Prices of the Common Stock over the ten consecutive
Trading Day period ending on, and including, the Trading Day immediately preceding the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With respect to an adjustment pursuant to this <U>11(c)</U> where there has been a payment of a dividend or other distribution on the Common Stock of shares
of Capital Stock of any class or series, or similar equity interest, of or relating to a Subsidiary or other business unit of the Company, that are, or, when issued, will be, listed or admitted for trading on a U.S. national securities exchange (a
&#147;<B><I><FONT STYLE="white-space:nowrap">Spin-Off</FONT></I></B>&#148;), the Conversion Rate shall be increased based on the following formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g243622g0124171248513.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately prior to the end of the Valuation Period;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the end of the Valuation Period;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FMV<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Last Reported Sale Prices of the Capital Stock or similar equity interest distributed to holders of the Common Stock applicable to one share of the Common Stock (determined by reference to the definition of Last
Reported Sale Price as set forth in <U>3(a)</U> as if references therein to Common Stock were to such Capital Stock or similar equity interest) over the first ten consecutive Trading Day period after, and including, the <FONT
STYLE="white-space:nowrap">Ex-Dividend</FONT> Date of the <FONT STYLE="white-space:nowrap">Spin-Off</FONT> (the &#147;<B><I>Valuation Period</I></B>&#148;); <U>provided</U>, that if there is no Last Reported Sale Price of the Capital Stock or
similar equity interest distributed to the holders of the Common Stock on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date, the &#147;Valuation Period&#148; shall be the first ten consecutive Trading Day period after, and including, the
first Trading Day such Last Reported Sale Price is available; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">MP<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Last Reported Sale Prices of the Common Stock over the Valuation Period.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The adjustment to the Conversion Rate under the preceding paragraph shall occur at the close of business on the last Trading
Day of the Valuation Period; <U>provided</U>, that if the relevant Conversion Date occurs during the Valuation Period, references to &#147;ten&#148; in the preceding paragraph shall be deemed to be replaced with such lesser number of Trading Days as
have elapsed from, and including, the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date of such <FONT STYLE="white-space:nowrap">Spin-Off</FONT> to, and including, the Conversion Date in determining the Conversion Rate. If any dividend or
distribution that constitutes a <FONT STYLE="white-space:nowrap">Spin-Off</FONT> is declared but not so paid or made, the Conversion Rate shall be immediately decreased, effective as of the date the Board of Directors determines not to pay or make
such dividend or distribution, to the Conversion Rate that would then be in effect if such dividend or distribution had not been declared or announced. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this <U>11(c)</U> (and subject in all respect to <U>11(h)</U>), rights, options or warrants distributed by the Company to all holders of the
Common Stock entitling them to subscribe for or purchase shares of the Company&#146;s Capital Stock, including Common Stock (either initially or under certain circumstances), which rights, options or warrants, until the occurrence of a specified
event or events (a &#147;<B><I>Trigger Event</I></B>&#148;) (i)&nbsp;are deemed to be transferred with such shares of the Common Stock, (ii)&nbsp;are not exercisable and (iii)&nbsp;are also issued in respect of future issuances of the Common Stock,
shall be deemed not to have been distributed for purposes of this 11(c) (and no adjustment to the Conversion Rate under this <U>11(c)</U> shall be required) until the occurrence of the earliest Trigger Event, whereupon such rights, options or
warrants shall be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
deemed to have been distributed and an appropriate adjustment (if any is required) to the Conversion Rate shall be made under this <U>11(c)</U>. If any such right, option or warrant, including
any such existing rights, options or warrants distributed prior to the Original Issuance Date, are subject to events, on the occurrence of which such rights, options or warrants become exercisable to purchase different securities, evidences of
indebtedness or other assets, then the date of the occurrence of any and each such event shall be deemed to be the date of distribution and <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date with respect to new rights, options or warrants with
such rights (in which case the existing rights, options or warrants shall be deemed to terminate and expire on such date without exercise by any of the holders thereof). In addition, in the event of any distribution (or deemed distribution) of
rights, options or warrants, or any Trigger Event or other event (of the type described in the immediately preceding sentence) with respect thereto that was counted for purposes of calculating a distribution amount for which an adjustment to the
Conversion Rate under this <U>11(c)</U> was made, (A)&nbsp;in the case of any such rights, options or warrants that shall all have been purchased without exercise by any holders thereof, on such final redemption or purchase (1)&nbsp;the Conversion
Rate shall be readjusted as if such rights, options or warrants had not been issued and (2)&nbsp;the Conversion Rate shall then again be readjusted to give effect to such distribution, deemed distribution or Trigger Event, as the case may be, as
though it were a cash distribution, equal to the per share redemption or purchase price received by a holder or holders of Common Stock with respect to such rights, options or warrants (assuming such holder had retained such rights, options or
warrants), made to all holders of Common Stock as of the date of such redemption or purchase and (B)&nbsp;in the case of such rights, options or warrants that shall have expired or been terminated without exercise by any holders thereof, the
Conversion Rate shall be readjusted as if such rights, options and warrants had not been issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of <U>11(a)</U>, <U>11(b)</U> and
<U>11(c)</U>, if any dividend or distribution to which this <U>11(c)</U> is applicable also includes one or both of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a dividend or distribution of shares of Common Stock to which <U>11(a)</U> is applicable (a &#147;<B><I>Clause
A Distribution</I></B>&#148;); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a dividend or distribution of rights, options or warrants to which <U>11(b)</U> is applicable (a
&#147;<B><I>Clause B Distribution</I></B>&#148;), </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">then, in either case, (1)&nbsp;such dividend or distribution, other than the Clause A
Distribution and/or Clause B Distribution, shall be deemed to be a dividend or distribution to which this <U>11(c)</U> is applicable (a &#147;<B><I>Clause C Distribution</I></B>&#148;) and any Conversion Rate adjustment required by this <U>11(c)</U>
with respect to such Clause C Distribution shall then be made and (2)&nbsp;the Clause A Distribution and/or Clause B Distribution shall be deemed to immediately follow such Clause C Distribution and any Conversion Rate adjustment required by
<U>11(a)</U> and/or <U>11(b)</U> with respect thereto shall then be made, except that, if determined by the Company (I)&nbsp;the <FONT STYLE="white-space:nowrap">&#147;Ex-Dividend</FONT> Date&#148; of the Clause A Distribution and/or Clause B
Distribution shall be deemed to be the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date of the Clause C Distribution and (II)&nbsp;any shares of Common Stock included in the Clause A Distribution and/or Clause B Distribution shall be deemed
not to be &#147;outstanding immediately prior to the open of business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date or Effective Date&#148; within the meaning of <U>11(a)</U> or &#147;outstanding immediately prior to the open of
business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date&#148; within the meaning of <U>11(b)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If the Company or any of its Subsidiaries make a payment in respect of a tender or
exchange offer for the Common Stock that is subject to the then-applicable tender offer rules under the Exchange Act, other than an <FONT STYLE="white-space:nowrap">odd-lot</FONT> tender offer, to the extent that the cash and value of any other
consideration included in the payment per share of the Common Stock exceeds the average of the Last Reported Sale Prices of the Common Stock over the ten consecutive Trading Day period commencing on, and including, the Trading Day next succeeding
the last date on which tenders or exchanges may be made pursuant to such tender or exchange offer, the Conversion Rate shall be increased based on the following formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g243622g0124171249075.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately prior to the close of business on the tenth Trading Day immediately following, and including, the Trading Day next succeeding the date such tender or exchange offer expires;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the close of business on the tenth Trading Day immediately following, and including, the Trading Day next succeeding the date such tender or exchange offer expires;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AC</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the aggregate value of all cash and any other consideration (as determined by the Company in good faith and in a commercially reasonable manner) paid or payable for shares of Common Stock purchased in such tender or exchange
offer;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OS<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately prior to the date such tender or exchange offer expires (prior to giving effect to the purchase of all shares of Common Stock accepted for purchase or exchange in such
tender or exchange offer);</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OS<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately after the date such tender or exchange offer expires (after giving effect to the purchase of all shares of Common Stock accepted for purchase or exchange in such tender or
exchange offer); and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SP<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Last Reported Sale Prices of the Common Stock over the ten consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the date such tender or exchange offer expires.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The adjustment to the Conversion Rate under this <U>11(d)</U> shall occur at the close of business on the tenth Trading Day
immediately following, and including, the Trading Day immediately following the expiration date of such tender or exchange offer expires; provided that if the relevant Conversion Date occurs during the ten Trading Days immediately following, and
including, the Trading Day next succeeding the expiration date of any tender or exchange offer, references to &#147;ten&#148; or &#147;tenth&#148; in the preceding paragraph shall be deemed replaced with such lesser number of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Trading Days as have elapsed from, and including, the Trading Day next succeeding the date that such tender or exchange offer expires to, and including, the Conversion Date in determining the
Conversion Rate. For the avoidance of doubt, no adjustment under this <U>11(d)</U> shall be made if such adjustment would result in a decrease in the Conversion Rate (other than, for the avoidance of doubt, any readjustment described in the
immediately succeeding paragraph). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Company or one of its Subsidiaries is obligated to purchase the Common Stock pursuant to any such tender or
exchange offer described in this <U>11(d)</U> but the Company or such Subsidiary is permanently prevented by applicable law from effecting any such purchase or all such purchases are rescinded, the Conversion Rate shall be decreased to be the
Conversion Rate that would then be in effect if such tender or exchange offer had not been made or had been made only in respect of the purchases that have been effected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding this <U>11</U> or any other provision of this Certificate of Designations, if (i)&nbsp;a Conversion Rate adjustment
becomes effective on any <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date, (ii)&nbsp;a Holder has converted its shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock and the Conversion Date for such conversion
occurs on or after such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date and on or prior to the related Record Date, (iii)&nbsp;the consideration due on such conversion includes any whole shares of Common Stock based on a Conversion Rate
that is adjusted for such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date and (iv)&nbsp;such shares of Common Stock would be entitled to participate in such dividend, distribution, or other event giving rise to such adjustment, then the
Conversion Rate adjustment relating to such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date shall not be made for such conversion, and, instead, the shares of Common Stock issuable on conversion on an unadjusted basis shall be entitled to
participate in the related dividend, distribution or other event giving rise to such adjustment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Except as stated herein, the Company
shall not adjust the Conversion Rate for the issuance of shares of the Common Stock or any securities convertible into or exchangeable for shares of the Common Stock or the right to purchase shares of the Common Stock or such convertible or
exchangeable securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) In addition to those adjustments required by <U>Sections</U><U></U><U>&nbsp;11(a)</U>, <U>(b)</U>,
<U>(c)</U> and <U>(d)</U>, and to the extent permitted by applicable law and subject to the applicable rules of any exchange on which any of the Company&#146;s securities are then listed, the Company from time to time may increase the Conversion
Rate by any amount for a period of at least 20 Business Days if the Board determines that such increase would be in the Company&#146;s best interest. In addition, to the extent permitted by applicable law and subject to the applicable rules of any
exchange on which any of the Company&#146;s securities are then listed, the Company may (but is not required to) increase the Conversion Rate to avoid or diminish income Tax to holders of Common Stock or rights to purchase Common Stock in connection
with a dividend or distribution of shares of Common Stock (or rights to acquire shares of Common Stock) or similar event. Whenever the Conversion Rate is increased pursuant to either of the preceding two sentences, the Company shall deliver to the
Holder of each share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock and the Conversion Agent a notice of the increase at least 15 days prior to the date the increased Conversion Rate takes effect, and such notice shall state
the increased Conversion Rate and the period during which it will be in effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) If the Company has a stockholder rights plan in effect on conversion of any shares of <FONT
STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock, each share of Common Stock, if any, issued on such conversion shall be entitled to receive the appropriate number of rights, if any, and the certificates representing the Common
Stock issued on such conversion shall bear such legends, if any, in each case as may be provided by the terms of any such stockholder rights plan, as the same may be amended from time to time. However, if, prior to any conversion of shares of Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock, the rights have separated from the shares of Common Stock in accordance with the provisions of the applicable stockholder rights plan, the Conversion Rate shall be adjusted at the time of
separation as if the Company distributed to all or substantially all holders of the Common Stock Distributed Property as provided in <U>11(c)</U>, subject to readjustment in the event of the expiration, termination or redemption of such rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Notwithstanding anything to the contrary in this <U>11</U>, the Conversion Rate shall not be adjusted: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) on the issuance of shares of Common Stock at a price below the Conversion Price or otherwise, other than any such issuance described in
<U>11(a)</U>, <U>(b)</U> or <U>(c)</U>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) on the issuance of any shares of Common Stock pursuant to any present or future plan
providing for the reinvestment of dividends or interest payable on the Company&#146;s securities and the investment of additional optional amounts in shares of Common Stock under any plan; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) on the issuance of any shares of Common Stock or options or rights to purchase those shares pursuant to any present or future employee,
director or consultant benefit or incentive plan (including pursuant to any evergreen plan) or program of or assumed by the Company or any of the Company&#146;s Subsidiaries or in connection with any such shares withheld by the Company for Tax
withholding purposes; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) on the issuance of any shares of Common Stock pursuant to any option, warrant, right or exercisable,
exchangeable or convertible security not described in clause&nbsp;(ii) of this subsection and outstanding as of the Original Issuance Date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) for a tender offer by any party other than a tender offer by the Company or one or more of the Company&#146;s Subsidiaries as described
in <U>11(d)</U>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) on the repurchase of any shares of the Common Stock pursuant to an open-market share repurchase program or other <FONT
STYLE="white-space:nowrap">buy-back</FONT> transaction (including, without limitation, through any structured or derivative transactions such as accelerated share repurchase transactions or similar forward derivatives), or other <FONT
STYLE="white-space:nowrap">buy-back</FONT> transaction, that is not a tender offer or exchange offer of the nature described under 11(d); or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) solely for a change in the par value (or lack of par value) of the Common Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) The Company shall not adjust the Conversion Rate pursuant to the clauses above unless
the adjustment would result in a change of at least 1% in the then effective Conversion Rate; <U>provided</U>, that the Company shall carry forward any adjustment to the Conversion Rate that the Company would otherwise have to make and take that
adjustment into account in any subsequent adjustment. Notwithstanding the foregoing, all such carried-forward adjustments shall be made with respect to the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock (i)&nbsp;in connection
with any subsequent adjustment to the Conversion Rate of at least 1% of the Conversion Rate and (ii)&nbsp;regardless of whether the aggregate adjustment is less than 1% of the Conversion Rate, on the Conversion Date, in each case, unless the
adjustment has already been made. The provisions described above in this <U>11(j)</U> are referred to as the &#147;<B><I>1% </I></B><B><I>Exception</I></B>&#148;. All calculations and other determinations under this <U>11</U> shall be made by the
Company and shall be made to the nearest 1/10,000th of a share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Whenever the Conversion Rate is adjusted as herein provided, the
Company shall promptly file with the Conversion Agent an Officers&#146; Certificate setting forth the Conversion Rate after such adjustment and setting forth a brief statement of the facts requiring such adjustment. Unless and until the Conversion
Agent shall have received such Officers&#146; Certificate, the Conversion Agent shall not be deemed to have knowledge of any adjustment of the Conversion Rate and may assume without inquiry that the last Conversion Rate of which it has knowledge is
still in effect. Promptly after delivery of such certificate, the Company shall prepare a notice of such adjustment of the Conversion Rate setting forth the adjusted Conversion Rate and the date on which each adjustment becomes effective and shall
deliver such notice of such adjustment of the Conversion Rate to each Holder. Failure to deliver such notice shall not affect the legality or validity of any such adjustment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) For purposes of this<U> 11</U> the number of shares of Common Stock at any time outstanding shall not include shares of Common Stock held
in the treasury of the Company so long as the Company does not pay any dividend or make any distribution on shares of Common Stock held in the treasury of the Company, but shall include shares of Common Stock issuable in respect of scrip
certificates issued in lieu of fractions of shares of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. Reorganization Events. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Reorganization Events</U>. In the event of: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) any reclassification, statutory exchange, merger, consolidation or other similar business combination of the Company with or into another
Person, in each case, pursuant to which at least a majority of the Common Stock is changed or converted into, or exchanged for, cash, securities or other property of the Company or another Person; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) any sale, transfer, lease or conveyance to another Person of all or a majority of the property and assets of the Company, in each case
pursuant to which the Common Stock is converted into cash, securities or other property; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) any statutory exchange of securities of the Company with another Person (other than
in connection with a merger or acquisition) or reclassification, recapitalization or reorganization of the Common Stock into other securities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(each, a
&#147;<B><I>Reorganization Event</I></B>&#148;), each share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock outstanding immediately prior to such Reorganization Event shall, without the consent of the Holders and subject to
<U>12(d)</U> and <U>13(b)</U>, remain outstanding but shall become convertible into the number, kind and amount of securities, cash and other property (the &#147;<B><I>Exchange Property</I></B>&#148;) (without any interest on such Exchange Property
and without any right to dividends or distributions on such Exchange Property that have a record date that is prior to the applicable Conversion Date) that the Holder of such share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred
Stock would have received in such Reorganization Event had such Holder converted its shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock into the applicable number of shares of Common Stock immediately prior to the effective
date of the Reorganization Event using the Conversion Rate applicable immediately prior to the effective date of the Reorganization Event; <U>provided</U>, that the foregoing shall not apply if such Holder is a Person with which the Company
consolidated or into which the Company merged or which merged into the Company or to which such sale or transfer was made, as the case may be (any such Person, a &#147;<B><I>Constituent Person</I></B>&#148;), or an Affiliate of a Constituent Person,
to the extent such Reorganization Event provides for different treatment of Common Stock held by such Constituent Persons or such Affiliate thereof. If the kind or amount of securities, cash and other property receivable on such Reorganization Event
is not the same for each share of Common Stock held immediately prior to such Reorganization Event by a Person (other than a Constituent Person or an Affiliate thereof), then for the purpose of this <U>12(a)</U>, the kind and amount of securities,
cash and other property receivable on conversion following such Reorganization Event shall be deemed to be the weighted average of the types and amounts of consideration received by the holders of Common Stock. For the avoidance of doubt, if any
Reorganization Event constitutes a Change of Control, the provisions of <U>9</U> shall also apply. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Successive Reorganization
Events</U>. The above provisions of this <U>12</U> shall similarly apply to successive Reorganization Events and the provisions of <U>11</U> shall apply to any shares of Capital Stock (as though such Capital Stock were Common Stock) received by all
the holders of the Common Stock in any such Reorganization Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Reorganization Event Notice</U>. The Company (or any successor)
shall, no less than 30 days prior to the anticipated effective date of any Reorganization Event, provide written notice to the Holders of such occurrence of such event and of the kind and amount of the cash, securities or other property that
constitutes the Exchange Property. Failure to deliver such notice shall not affect the operation of this <U>12</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Reorganization
Event Agreements</U>. The Company shall not enter into any agreement for a transaction constituting a Reorganization Event unless (i)&nbsp;such agreement provides for or does not interfere with or prevent (as applicable) conversion of the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Preferred Stock into the Exchange Property in a manner that is consistent with and gives effect to this <U>12</U> and (ii)&nbsp;to the extent that the Company is not the surviving corporation in such
Reorganization Event or shall be dissolved in connection with such Reorganization Event, proper provision shall be made in the agreements governing such Reorganization Event for the conversion of the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock into Capital Stock of the Person surviving such Reorganization Event or such other continuing entity in such Reorganization Event. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. Voting Rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>General</U>. Holders of shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock shall be entitled to vote as a
single class with the holders of the Common Stock and the holders of any other class or series of Capital Stock of the Company then entitled to vote with the Common Stock on all matters submitted to a vote of the holders of Common Stock (and, if
applicable, holders of any other class or series of Capital Stock of the Company). The Holders shall be entitled to notice of any meeting of holders of Common Stock in accordance with the Certificate of Incorporation and Bylaws. Each Holder shall be
entitled to the number of votes with respect to the shares of Series <FONT STYLE="white-space:nowrap">B-1&nbsp;Preferred</FONT> Stock held by such Holder equal to (i)&nbsp;the largest number of whole shares of Common Stock into which all shares of <FONT
STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock could be converted pursuant to <U>6(a)</U> <I>multiplied by</I> (ii)&nbsp;(A)&nbsp;the number of shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock held
by such Holder <I>divided by</I> (B)&nbsp;the aggregate number of issued and outstanding shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock, in each case at and calculated as of the record date for the determination of
stockholders entitled to vote or consent on such matters; <U>provided</U>, that to the extent the <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock held by the Casdin Parties would, in the aggregate, represent voting rights
with respect to more than 19.9% of the Company&#146;s outstanding Common Stock (including the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis) (the
&#147;<B><I>Voting Threshold</I></B>&#148;), the Casdin Parties shall not be permitted to exercise the voting rights with respect to any shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock held by them in excess of the
Voting Threshold and the Chief Financial Officer or the General Counsel of the Company in office from time to time, each of them individually, with full power of substitution and resubstitution, shall exercise the voting rights with respect to such
shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock in excess of the Voting Threshold in a Neutral Manner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Investor Consent Rights</U>. In addition to, and not in limitation of, <U>13(a)</U>, the vote or written approval or election of the
Holders of at least 60% of the shares of Series&nbsp;B Preferred Stock outstanding at such time, voting or providing such approval or election together as a single class, and for the avoidance of doubt, without giving effect to limitations
associated with the Voting Threshold, given in person or by proxy, either in writing without a meeting or by vote at any meeting called for the purpose, shall be necessary for, directly or indirectly, taking any of the following actions, whether or
not such approval is required pursuant to the DGCL: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) any amendment or alteration (whether by merger, consolidation or otherwise) of,
or any supplement (whether by a certificate of designations or otherwise) to, the Certificate of Incorporation or any provision thereof, or any other action, to authorize or create, or increase the number of authorized or issued shares of, or any
securities convertible into shares of, or reclassify any security into, or issue, any Parity Stock (other than Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock in connection with the Transactions) or Senior Stock or any other class
or series of Capital Stock of the Company ranking senior to, or on a parity basis with, the <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock or <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock as to
dividend rights or rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the declaration or payment of any dividend or distribution on any Capital Stock of the
Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) the purchase, redemption or other acquisition for consideration by the Company, directly or indirectly, of any Common
Stock or other Junior Stock, except for (A)&nbsp;the &#147;net&#148; or &#147;cashless&#148; exercise of stock options or warrants, (B)&nbsp;the withholding or repurchase of Capital Stock to satisfy applicable tax withholding obligations arising in
connection with exercised stock options or the vesting or settlement of restricted stock units or other stock awards or (C)&nbsp;settlement in cash of restricted stock units or other stock-based awards, in each case of (A)&nbsp;through (C), in the
ordinary course of business pursuant to an existing equity plan of the Company or any equity plan approved by the Board; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) any
amendment or alteration (whether by merger, consolidation, operation of law or otherwise) to the rights, preferences, privileges or voting powers of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock or Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Preferred Stock; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) any amendment, alteration or repeal (whether by merger, consolidation,
operation of law or otherwise) of any provision of the Certificate of Incorporation (including this Certificate of Designations) or Bylaws that would have an adverse effect on the rights, preferences, privileges or voting power of the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Director Consent Rights</U>. For so long as the Casdin Preferred Percentage
is equal to or greater than 7.5%, the vote or consent of at least a majority of the whole Board, including the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Director, if such Series <FONT STYLE="white-space:nowrap">B-1</FONT> Director
is then in office, either in writing without a meeting or by vote at any meeting, shall be necessary for, directly or indirectly, taking any of the following actions, whether or not such approval is required pursuant to the DGCL: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) (A)&nbsp;any amendment, alteration, modification or repeal (whether by merger, consolidation, operation of law or otherwise) of any
provision of the Certificate of Incorporation (including this Certificate of Designations) or Bylaws that increases the size of the Board above seven directors after the Original Issuance Date or (B)&nbsp;the authorization or adoption of any
resolution that would have the effect of increasing the number of directors constituting the Board above seven directors; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the
hiring, promotion, demotion or termination of the Chief Executive Officer (whether on an interim basis or otherwise) of the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) entering into or modifying (including by waiver) any transaction, agreement or arrangement with, or for the benefit of, any Related
Person unless such transaction, agreement or arrangement has been approved by a majority of the disinterested directors of the Company; other than (A)&nbsp;employment or indemnification arrangements with directors (except in a
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
manner that treats the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Director materially differently from the other directors), officers or employees of the Company or any of its
Subsidiaries and any benefit plans or employment benefits in the ordinary course of business, (B)&nbsp;routine <FONT STYLE="white-space:nowrap">non-compensatory</FONT> employment matters such as invention assignment agreements in the ordinary course
of business consistent with past practice, (C)&nbsp;transactions, agreements or arrangements involving less than $120,000 per year, (D)&nbsp;transactions, agreements or arrangements contemplated by the Casdin Purchase Agreement or the Viking
Purchase Agreement, (E)&nbsp;transactions, agreements or arrangements approved by the Compensation Committee or the Nominating and Corporate Governance Committee of the Board in accordance with their charters as in effect as of the Original Issuance
Date (or as may be amended from time to time by the Board (including the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Director if such Series <FONT STYLE="white-space:nowrap">B-1</FONT> Director is then in office),
(F)&nbsp;transactions pursuant to agreements already in effect (but excluding any modifications to such agreements) or (G)&nbsp;transactions, agreements or arrangements under the Company&#146;s and its Subsidiaries&#146; benefit plans (including any
assumed plans), including, without limitation, option exercises, vesting of restricted stock units, or otherwise, (1)&nbsp;the &#147;net&#148; or &#147;cashless&#148; exercise of stock options or warrants, (2)&nbsp;the withholding or repurchase of
Capital Stock to satisfy applicable tax withholding obligations arising in connection with exercised stock options or the vesting or settlement of restricted stock units or other stock awards or (3)&nbsp;settlement in cash of restricted stock units
or other stock-based awards, in each case of (1)&nbsp;through (3), in the ordinary course of business pursuant to the Company&#146;s and its Subsidiaries&#146; equity plans (including any assumed plans); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iv) any voluntary petition under any applicable federal or state bankruptcy or insolvency law effected by the Company or any Subsidiary of
the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(v) any change in the principal business of the Company or entry by the Company into any material new line of business; or
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(vi) for a period of three years after the Original Issuance Date (or such shorter period ending immediately when the Casdin Preferred
Percentage is less than 7.5%), (A)&nbsp;any acquisition (including by merger, consolidation or acquisition of stock or assets) of any assets, securities or property of any other Person or (B)&nbsp;any sale, lease, license, transfer or other
disposition of any assets of the Company or any of its Subsidiaries (in each case other than acquisitions or dispositions of inventory or equipment in the ordinary course of business and consistent with past practice) for consideration in excess of
$50,000,000 in the aggregate in any six month period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Each Holder of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred
Stock shall have one vote per share on any matter on which Holders of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock are entitled to vote either (i)&nbsp;separately as a single class or (ii)&nbsp;together with Holders of the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock as a single class, in each case whether at a meeting or by written approval or election, without giving effect to limitations associated with the Voting Threshold. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The vote or written approval of the Holders of 75% of the shares of <FONT
STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock outstanding at such time, voting together as a single class and, for the avoidance of doubt, without giving effect to limitations associated with the Voting Threshold, given in person
or by proxy, either in writing without a meeting or by vote at any meeting called for the purpose, shall be sufficient to waive or amend the provisions of <U>9(h)</U> of this Certificate of Designations, and any amendment or waiver of any of the
provisions of <U>9(h)</U> approved by such percentage of the Holders shall be binding on all of the Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) For the avoidance of
doubt and notwithstanding anything to the contrary in the Certificate of Incorporation or Bylaws, to the fullest extent permitted by applicable law, the holders of Series B Preferred Stock shall have the exclusive approval, election and voting
rights set forth in <U>13(b)</U> and may effectuate such rights by delivering an approval, election or consent in writing or by electronic transmission of the requisite holders of the Series B Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) On the acquisition of shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock, the Holder of such shares shall be
deemed to irrevocably appoint as its proxy and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact,</FONT></FONT> the Chief Financial Officer and the General Counsel of the Company in office from time to time, each of
them individually, with full power of substitution and resubstitution, to consent, approve or vote any shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock held by them in excess of the Voting Threshold as indicated in
<U>13(a)</U> with respect to any matters that must be voted in a Neutral Manner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. Series <FONT STYLE="white-space:nowrap">B-1</FONT>
Preferred Director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) For so long as the Casdin Preferred Percentage is equal to or greater than 7.5%, the Holders of a majority of the
outstanding shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock, voting separately as a single class, and for the avoidance of doubt, without giving effect to limitations associated with the Voting Threshold, shall be
entitled, at each annual meeting of the stockholders of the Company or at any special meeting called for the purpose of electing directors, to nominate and elect one member of the Board (a &#147;<B><I>Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Director</I></B>&#148;). The <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Director shall not be subject to the classified board of directors provisions of Article&nbsp;V,
Section&nbsp;2 of the Certificate of Incorporation nor classified into Class&nbsp;I, Class&nbsp;II or Class&nbsp;III. The initial <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Director, designated by Casdin pursuant to
<U>14(b)</U>, shall take office effective as of the Original Issuance Date. Each <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Director appointed or elected to the Board of Directors shall continue to hold office until the next
annual meeting of the stockholders of the Company and until his or her successor is elected and qualified in accordance with this <U>14(a)</U> and the Bylaws or until such individual&#146;s earlier resignation, death or removal. A majority of the
outstanding shares of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock, voting separately as a single class, at a meeting called for such purpose shall have the sole right to remove the Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Director. Any vacancy created by the removal, resignation or death of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Director may be filled by a majority of the directors in
office from time to time, but shall solely be filled with the approval of the holders of a majority of the outstanding shares of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock, voting as a single class and, for the
avoidance of doubt, without giving effect to limitations associated with the Voting Threshold. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The initial Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Preferred Director shall be Eli Casdin, who shall serve until the 2022 annual meeting of the Company&#146;s stockholders or such individual&#146;s earlier resignation, death or removal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) In accordance with the provisions of this 14, at each meeting of the Company&#146;s
stockholders at which the election of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Director is to be considered, the Board of Directors shall duly nominate the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Director
designated by the holders of a majority of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock for election to the Board of Directors by the holders of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock,
subject to the terms and conditions of the Casdin Purchase Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Without prejudice to the rights of Casdin pursuant to the
Casdin Purchase Agreement, after the Original Issuance Date, and subject to applicable Law and the listing standards of Relevant Exchange, the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Director shall be offered the opportunity,
with respect to each standing committee of the Board, at Casdin&#146;s option, to sit on such committee. If the <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Director fails to satisfy the applicable qualifications under Law or
stock exchange listing standard to sit on any committee of the Board, then the Board shall offer such Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Director the opportunity to attend (but not vote at) the meetings of such committee as
an observer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Director shall be entitled to receive similar
compensation, benefits, reimbursement (including of reasonable travel expenses), indemnification and insurance coverage for his or her service as director as the other <FONT STYLE="white-space:nowrap">non-employee</FONT> directors of the Company.
For so long as the Company maintains directors and officers liability insurance, the Company shall include the <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Director as an &#147;insured&#148; for all purposes under such insurance
policy for so long as the <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Director is a director of the Company and for the same period as for other former directors of the Company when the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Director ceases to be a director of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. Term. Except as
expressly provided in this Certificate of Designations, the shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock shall not be redeemable or otherwise mature and the term of the Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock shall be perpetual. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. No Sinking Fund. Shares of Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Preferred Stock shall not be subject to or entitled to the operation of a retirement or sinking fund. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. Transfer Agent, Conversion Agent, Registrar and Paying Agent. The duly appointed Transfer Agent, Conversion Agent, Registrar and paying
agent for the <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock shall be Computershare Trust Company, N.A. The Company may appoint any other Person reasonably satisfactory to the Holders to serve as Transfer Agent, Conversion
Agent, Registrar or paying agent for the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock and thereafter may remove or replace such other Person at any time, subject to the appointment of a replacement reasonably satisfactory to
the Holders. On any such appointment or removal, the Company shall send notice thereof to the Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. Replacement Certificates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Mutilated, Destroyed, Stolen and Lost Certificates</U>. If physical certificates evidencing the Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock are issued, the Company shall replace any mutilated certificate at the Holder&#146;s expense on surrender of that certificate to the Transfer Agent. The Company shall replace certificates
that become destroyed, stolen or lost at the Holder&#146;s expense on delivery to the Company and the Transfer Agent of reasonably satisfactory evidence that the certificate has been destroyed, stolen or lost, together with any reasonable indemnity
that may be required by the Transfer Agent and the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Certificates Following Conversion</U>. If physical certificates representing the <FONT
STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock are issued, the Company shall not be required to issue replacement certificates representing shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock on or after
the Conversion Date applicable to such shares (except if any certificate for shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock shall be surrendered for partial conversion, the Company shall, at its expense, execute and
deliver to or on the written order of the Holder of the certificate so surrendered a new certificate for the shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock not converted). In place of the delivery of a replacement
certificate following the applicable Conversion Date, the Transfer Agent, on receipt of the satisfactory evidence and indemnity described in <U>clause (a)</U>&nbsp;above, shall deliver certificates representing the shares of Common Stock issuable on
conversion of such shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock formerly evidenced by the physical certificate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. Taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
<U>Withholding</U>. The Company and its paying agent shall be entitled to deduct or withhold on all applicable payments made to the relevant Holder whether in the form of cash or otherwise such Tax amounts as the Company reasonably determines are
required to be deducted or withheld therefrom under any provision of applicable law (and, to the extent such amounts are paid to the relevant taxing authority in accordance with applicable law, such amounts shall be treated for all purposes of this
Certificate of Designations as having been paid to the Person in respect of which such withholding was made); provided, for the avoidance of doubt, that if the Company determines that an amount is required to be deducted or withheld on any payment
with respect to any Holder, the Company shall provide reasonable prior notice to such Holder in writing of its intent to deduct or withhold Taxes on such payment and shall reasonably cooperate with such Holder in obtaining any available exemption or
reduction of such withholding<U>.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Transfer Taxes</U>. The Company shall pay any and all stock transfer, documentary, stamp and
similar Taxes due on the issuance of shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock or the issuance of shares of Common Stock on conversion of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock pursuant
hereto. However, in the case of conversion of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock, the Company shall not be required to pay any such Tax that may be payable in respect of any transfer involved in the issuance or
delivery of shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock or Common Stock to a Beneficial Owner other than the initial Beneficial Owner of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock
(&#147;<B><I>Third Party Transfer Taxes</I></B>&#148;), and shall not be required to make any such issuance, delivery or payment unless and until the Person requesting such issuance, delivery or payment has paid to the Company the amount of any such
Tax or has established, to the reasonable satisfaction of the Company, that such Tax has been paid or is not payable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Tax Treatment</U>. It is intended that (i)&nbsp;the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Preferred Stock shall not be treated as &#147;preferred stock&#148; for purposes of Section&nbsp;305 of the Code and the Treasury Regulations promulgated thereunder, and (ii)&nbsp;as a consequence, no difference
between the purchase price paid for the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock and the Liquidation Preference thereof shall, by reason of Section&nbsp;305(b)(4) of the Code or Treasury Regulations <FONT
STYLE="white-space:nowrap">Section&nbsp;1.305-5,</FONT> be treated as a distribution of property until paid in cash. The Company and Holders (and their respective affiliates) shall file all Tax Returns in a manner consistent with the foregoing
intended Tax treatment and shall not take any Tax position that is inconsistent with such intended Tax treatment except in connection with, or as required by, any of the following: (A)&nbsp;a change in relevant law or official guidance from a Taxing
authority occurring after the Original Issuance Date, (B)&nbsp;after the Original Issuance Date, the promulgation of relevant final U.S. Treasury Regulations addressing instruments similar to the Series <FONT STYLE="white-space:nowrap">B-1</FONT>
Preferred Stock (from and after the effective date of such regulations), (C) an amendment to the terms of this Certificate of Designations or (D)&nbsp;a &#147;determination&#148; within the meaning of section 1313(a) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. Notices. All notices referred to herein shall be in writing and, unless otherwise specified herein, all notices hereunder shall be deemed
to have been given on the earlier of receipt thereof or three Business Days after the mailing thereof if sent by registered or certified mail with postage prepaid, or by private courier service, or the date of such delivery, if delivered by
electronic mail (provided that no bounceback or similar &#147;undeliverable&#148; message is received by such sender), addressed: (a)&nbsp;if to the Company, to its office at Standard BioTools Inc., 2 Tower Place, Suite 2000, South San Francisco,
California 94080 (Attention: General Counsel) (or such <FONT STYLE="white-space:nowrap">e-mail</FONT> address as specified by the Company, in the case of delivery by electronic mail), (b) if to any Holder, to such Holder at the address (or email
address, in the case of delivery by electronic mail) of such Holder as listed in the stock record books of the Company (which may include the records of the Transfer Agent) or (c)&nbsp;to such other address (or email address, in the case of delivery
by electronic mail) as the Company or any such Holder, as the case may be, shall have designated by notice similarly given. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. Facts
Ascertainable. When the terms of this Certificate of Designations refer to a specific agreement or other document to determine the meaning or operation of a provision hereof, the Secretary of the Company shall maintain a copy of such agreement or
document at the principal executive offices of the Company and a copy thereof shall be provided free of charge to any Holder who makes a request therefor. The Secretary of the Company shall also maintain a written record of the Issuance Date and the
number of shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock issued to a Holder and the date of each such issuance, and shall furnish such written record free of charge to any Holder who makes a request therefor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. Waiver. Notwithstanding any provision in this Certificate of Designations to the contrary, any provision contained herein and any right of
the Holders of shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock granted hereunder may be waived as to all shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock (and the Holders thereof) on the
vote or written approval or election of the Holders of a majority of the shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock then outstanding and, for the avoidance of doubt, without giving effect to limitations
associated with the Voting Threshold. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23. Severability. If any term of the Series <FONT STYLE="white-space:nowrap">B-1</FONT>
Preferred Stock set forth herein is invalid, unlawful or incapable of being enforced by reason of any rule of law or public policy, all other terms set forth herein which can be given effect without the invalid, unlawful or unenforceable term shall,
nevertheless, remain in full force and effect, and no term herein set forth shall be deemed dependent on any other such term unless so expressed herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24. Business Opportunities. To the fullest extent permitted by Section&nbsp;122(17) of the DGCL (or any successor provision) and except as may
be otherwise expressly agreed in writing by the Company and the Casdin Parties, the Company, on behalf of itself and its Subsidiaries, renounces any interest or expectancy of the Company and its Subsidiaries in, or in being offered an opportunity to
participate in, business opportunities, that are from time to time presented to the Casdin Parties or any of their respective officers, representatives, directors, agents, stockholders, members, partners, Affiliates, Subsidiaries (other than the
Company and its Subsidiaries), or any of their respective designees on the Company&#146;s Board and/or any of their respective representatives who, from time to time, may act as officers of the Company, even if the opportunity is one that the
Company or its Subsidiaries might reasonably be deemed to have pursued or had the ability or desire to pursue if granted the opportunity to do so, and no such person shall be liable to the Company or any of its Subsidiaries for breach of any
fiduciary or other duty, as a director or officer or otherwise, by reason of the fact that such person pursues or acquires such business opportunity, directs such business opportunity to another person or fails to present such business opportunity,
or information regarding such business opportunity, to the Company or its Subsidiaries unless, in the case of any such person who is a director or officer of the Company, such business opportunity is expressly offered to such director or officer in
his or her capacity as a director or officer of the Company. Any Person purchasing or otherwise acquiring any interest in any shares of Capital Stock of the Company shall be deemed to have notice of and consented to the provisions of this <U>24</U>.
Neither the alteration, amendment or repeal of this <U>24</U>, nor the adoption of any provision of the Certificate of Incorporation or this Certificate of Designations inconsistent with this <U>24</U>, nor, to the fullest extent permitted by
Delaware law, any modification of law, shall eliminate or reduce the effect of this <U>24</U> in respect of any business opportunity first identified or any other matter occurring, or any cause of action, suit or claim that, but for this <U>24</U>,
would accrue or arise, prior to such alteration, amendment, repeal, adoption or modification. If any provision or provisions of this <U>24</U> shall be held to be invalid, illegal or unenforceable as applied to any circumstance for any reason
whatsoever: (a)&nbsp;the validity, legality and enforceability of such provisions in any other circumstance and of the remaining provisions of this <U>24</U> (including, without limitation, each portion of any paragraph of this <U>24</U> containing
any such provision held to be invalid, illegal or unenforceable that is not itself held to be invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and (b)&nbsp;to the fullest extent possible, the provisions of this
<U>24</U> (including, without limitation, each such portion of any paragraph of this <U>24</U> containing any such provision held to be invalid, illegal or unenforceable) shall be construed so as to permit the Company to protect its directors,
officers, employees and agents from personal liability in respect of their good faith service to or for the benefit of the Company to the fullest extent permitted by law. This <U>24</U> shall not limit any protections or defenses available to, or
indemnification or advancement rights of, any director, officer, employee or agent of the Company under the Certificate of Incorporation, the Bylaws, any other agreement between the Company and such director, officer, employee or agent or applicable
law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page Follows</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Certificate of Designations to be executed
this [___] day of [___], 2022. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">STANDARD BIOTOOLS INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Certificate of Designations</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONVERSION NOTICE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Reference is made to the Certificate of Designations of <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Convertible Preferred Stock,
par value $0.001, of Standard BioTools Inc. (the &#147;<B><I>Certificate of Designations</I></B>&#148;). In accordance with and pursuant to the Certificate of Designations, the undersigned hereby elects to convert the number of shares of <FONT
STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Convertible Preferred Stock, par value $0.001 per share (the &#147;<B><I>Series</I></B><B><I></I></B><B><I>&nbsp;B</I></B><B><I><FONT STYLE="white-space:nowrap">-1</FONT> Preferred
Stock</I></B>&#148;), of Standard BioTools Inc., a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), indicated below into shares of Common Stock, par value $0.001 per share (the &#147;<B><I>Common Stock</I></B>&#148;), of the Company,
[as of the date specified below // on // immediately prior to[, and subject to the occurrence of,] [&#149;]]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date of Conversion (if applicable):
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock to be converted:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share certificate no(s). of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock to be converted:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tax ID Number (if applicable):
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please confirm the following information: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Conversion Rate:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of shares of Common
Stock to be issued:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please issue the shares of Common Stock into which the shares of Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Preferred Stock are being converted in the following name and to the following address: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Issue to:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Telephone Number:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Authorization:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Account Number (if electronic book entry transfer):
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Transaction Code Number (if electronic book entry transfer):
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment Instructions for cash payment in lieu of fractional shares:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>d243622dex104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Exhibit 10.4 </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SERIES <FONT STYLE="white-space:nowrap">B-2</FONT> CONVERTIBLE PREFERRED STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURCHASE AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>by
and between </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FLUIDIGM CORPORATION, </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS <FONT STYLE="white-space:nowrap">SUB-MASTER</FONT> LP </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>VIKING GLOBAL
OPPORTUNITIES DRAWDOWN (AGGREGATOR) LP </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dated as of January&nbsp;23, 2022 </B></P>
<P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;I DEFINITIONS&nbsp;&amp; INTERPRETATIONS </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Certain Definitions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Index of Defined Terms</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Certain Interpretations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;II AGREEMENT TO SELL AND PURCHASE; CONVERSION </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Sale and Purchase; Conversion of Conversion Amount</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">The Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Adjustments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Independent Nature of Purchaser&#146;s Obligations and Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;III REPRESENTATIONS AND WARRANTIES OF THE COMPANY </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Organization; Good Standing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Corporate Power; Enforceability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Company Board Approval; Anti-Takeover Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Requisite Stockholder Approval</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-Contravention</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Requisite Governmental Approvals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Company Capitalization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Subsidiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Company SEC Reports</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Company Financial Statements; Internal Controls</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">No Undisclosed Liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Absence of Certain Changes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Material Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Real Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Environmental Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Intellectual Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Employee Benefits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.19</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Labor Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.20</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Compliance with Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.21</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Anti-Corruption; International Trade</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.22</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Compliance with Healthcare Laws and Regulations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.23</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Legal Proceedings; Orders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.24</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.25</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Related Party Transactions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.26</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Brokers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.27</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Other Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.28</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Investment Company Status</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.29</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Sale of Securities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.30</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">No Rights Agreement; Anti-Takeover Provisions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.31</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Registration Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.32</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Exclusivity of Representations and Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;IV REPRESENTATIONS AND WARRANTIES OF PURCHASER </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Organization; Good Standing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Corporate Power; Enforceability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-Contravention</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Requisite Governmental Approvals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Legal Proceedings; Orders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Ownership of Company Common Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Brokers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Sufficient Funds</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Unregistered Securities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Stockholder and Management Arrangements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Exclusivity of Representations and Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;V INTERIM OPERATIONS OF THE COMPANY </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Affirmative Obligations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Forbearance Covenants</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">No Solicitation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">No Control of the Other Party&#146;s Business</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;VI ADDITIONAL COVENANTS </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Required Action and Forbearance; Efforts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Antitrust Filings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Proxy Statement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Company Stockholder Meeting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Anti-Takeover Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Use of Proceeds</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Access</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Information Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Notification of Certain Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Public Statements and Disclosure</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Transaction Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Listing of Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Certain Governance and Other Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">No Inconsistent Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Transfer Restrictions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Pre-Emptive</FONT> Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Standstill</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Voting Threshold</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;VII CONDITIONS TO THE VIKING TRANSACTION </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Conditions to Each Party&#146;s Obligations to Effect the Viking Transaction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Conditions to the Obligations of Purchaser to Effect the Viking Transaction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Conditions to the Company&#146;s Obligations to Effect the Viking Transaction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;VIII TERMINATION, AMENDMENT AND WAIVER </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Manner and Notice of Termination; Effect of Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Fees and Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Amendment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Extension; Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;IX GENERAL PROVISIONS </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Assignment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Entire Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Survival</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Third Party Beneficiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Remedies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Governing Law</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Consent to Jurisdiction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">WAIVER OF JURY TRIAL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">No Recourse</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Company Disclosure Letter References</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Counterparts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EXHIBITS </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit&nbsp;A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Certificate of Designations</TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SERIES <FONT STYLE="white-space:nowrap">B-2</FONT> CONVERTIBLE PREFERRED STOCK </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURCHASE AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
<B>SERIES</B><B> </B><B><FONT STYLE="white-space:nowrap">B-2</FONT></B><B> </B><B>CONVERTIBLE</B><B> </B><B>PREFERRED</B><B> STOCK PURCHASE AGREEMENT</B> (this &#147;<B>Agreement</B>&#148;) is made and entered into as of January&nbsp;23, 2022 by and
between Fluidigm Corporation, a Delaware corporation (the &#147;<B>Company</B>&#148;), Viking Global Opportunities Illiquid Investments <FONT STYLE="white-space:nowrap">Sub-Master</FONT> LP, a Cayman Islands exempted limited partnership
(&#147;<B>VGO Illiquid Investments</B>&#148;)<B> </B>and Viking Global Opportunities Drawdown (Aggregator) LP, a Cayman Islands exempted limited partnership (&#147;<B>VGO Drawdown</B>&#148; and, together with VGO Illiquid Investments,
&#147;<B>Purchaser</B>&#148;). Purchaser and the Company are sometimes referred to herein individually, as a &#147;<B>Party</B>&#148; and collectively, as the &#147;<B>Parties</B>.&#148; All capitalized terms that are used in this Agreement have the
respective meanings given to them in <U>Article I</U>. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. (i)&nbsp;The Company desires to issue and sell to VGO Illiquid Investments, and VGO Illiquid Investments desires to purchase from the
Company, 75,375 shares of the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock and (ii)&nbsp;the Company desires to issue and sell to VGO Drawdown, and VGO Drawdown desires to purchase from the Company, 37,125 shares of the Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Preferred Stock, in each case on the terms and subject to the conditions set forth in this Agreement (the &#147;<B>Viking </B><B>Transaction</B>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. The Company Board has unanimously (i)&nbsp;determined that it is in the best interests of the Company and the Company Stockholders that the
Company enter into this Agreement and the other Transaction Documents and consummate the Transactions and the other transactions contemplated hereby and thereby on the terms and subject to the conditions set forth herein and therein,
(ii)&nbsp;approved and declared advisable this Agreement, the other Transaction Documents, the Transactions and the other transactions contemplated hereby and thereby on the terms and subject to the conditions set forth herein and therein,
(iii)&nbsp;resolved to recommend that the Company Stockholders approve the Transactions and adopt the Certificate of Amendment and (iv)&nbsp;directed that the Transactions and the Certificate of Amendment be submitted to the Company Stockholders for
approval. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. Purchaser has obtained all entity approvals necessary for its entry into this Agreement and the other Transaction Documents
and the consummation of the transactions contemplated hereby and thereby, including the Transactions, on the terms and subject to the conditions set forth herein and therein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">D. On the date of this Agreement, the Company and Purchaser have entered into a loan agreement (the &#147;<B>Loan Agreement</B>&#148;) pursuant
to which Purchaser has loaned to the Company an aggregate original principal amount of $12,500,000. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">E. On the date of this Agreement, the
Company and Purchaser have entered into a registration rights agreement (the &#147;<B>Registration Rights Agreement</B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">F. The Parties desire to (i)&nbsp;make certain representations, warranties, covenants and
agreements in connection with this Agreement and the Viking Transaction and (ii)&nbsp;prescribe certain conditions with respect to the consummation of the Viking Transaction. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW,
THEREFORE, in consideration of the foregoing premises and the representations, warranties, covenants and agreements set forth herein, as well as other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged and
accepted, and intending to be legally bound hereby, the Parties agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS&nbsp;&amp; INTERPRETATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1 <I>Certain Definitions</I>. For all purposes of this Agreement, the following terms have the following respective meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Acquired Shares</B>&#148; means, collectively, the Purchased Shares and the Converted Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Acquisition Proposal</B>&#148; means any inquiry, indication of interest, offer or proposal (other than an inquiry, indication of
interest, offer or proposal by Purchaser pursuant to this Agreement or the Casdin Purchaser pursuant to the Casdin Purchase Agreement) to engage in an Acquisition Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Acquisition Transaction</B>&#148; means any transaction or series of related transactions (other than the Viking Transaction or the
Casdin Transaction) involving: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) any direct or indirect purchase or other acquisition by any Person or &#147;group&#148; (as such term
is used in Section&nbsp;13(d) of the Exchange Act) of Persons of shares of capital stock of the Company, including pursuant to a tender offer or exchange offer, that if consummated in accordance with its terms would result in such Person or
&#147;group&#148; of Persons beneficially owning shares of Company Common Stock and/or securities convertible into or exchangeable for shares of Company Common Stock representing, collectively, 10% or more of the outstanding Company Common Stock (on
an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, if applicable), after giving effect to the consummation of such purchase or other acquisition, including such tender or exchange offer; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) any direct or indirect purchase, lease, exchange, transfer, license or other acquisition by any Person or &#147;group&#148; (as such term
is used in Section&nbsp;13(d) of the Exchange Act) of Persons, or stockholders of any such Person or group of Persons, of 10% or more of the consolidated assets of the Company and its Subsidiaries taken as a whole (measured by the fair market value
thereof as of the date of such transaction); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) any merger, consolidation, business combination, joint venture, repurchase,
redemption, share exchange, extraordinary dividend or distribution, recapitalization, reorganization, liquidation, dissolution or other similar transaction involving the Company or any of its Subsidiaries pursuant to which any Person or
&#147;group&#148; (as such term is used in Section&nbsp;13(d) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the Exchange Act) of Persons, or stockholders of any such Person or group of Persons, would beneficially own shares of Company Common Stock and/or securities convertible into or exchangeable
for shares of Company Common Stock representing, collectively, 10% or more of the outstanding Company Common Stock (on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, if applicable), after giving effect to the consummation of such
transaction; <U>provided</U>, that none of the matters set forth on Section&nbsp;5.2(e) of the Company Disclosure Letter shall constitute an Acquisition Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Activist Investor</B>&#148; means, as of the date of determination, a Person (other than the Purchaser or its Affiliates)&nbsp;(a)
that has, directly or indirectly through its Affiliates, been identified on any &#147;SharkWatch 50&#148; list (or any successor list) published within the three years prior to such date of determination or (b)&nbsp;is listed on Section&nbsp;1.1(a)
of the Company Disclosure Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Affiliate</B>&#148; means, with respect to any Person, any other Person that, directly or
indirectly, controls, is controlled by or is under common control with such Person;<I> </I><U>provided</U>, that none of the Company, Purchaser or the Casdin Purchaser shall be deemed to be Affiliates of one another. For purposes of this definition,
the term &#147;control&#148; (including, with correlative meanings, the terms &#147;controlling,&#148; &#147;controlled by&#148; and &#147;under common control with&#148;), as used with respect to any Person, means the possession, directly or
indirectly, of the power to direct or cause the direction of the management or policies of that Person, whether through the ownership of voting securities or partnership or other ownership interests, by Contract or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Anti-Corruption Laws</B>&#148; means all applicable Laws and all other statutory or regulatory requirements relating to
anti-corruption, anti-bribery and anti-money laundering, including the U.S. Foreign Corrupt Practices Act of 1977, the U.K. Bribery Act 2010 and any other Law implementing the OECD Convention on Combating Bribery of Foreign Public Officials in
International Business Transactions applicable to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Antitrust Law</B>&#148; means the Sherman Antitrust Act, the
Clayton Antitrust Act, the HSR Act, the Federal Trade Commission Act and all other Laws that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or significant
impediments or lessening of competition or the creation or strengthening of a dominant position through merger or acquisition, in any case that are applicable to the Viking Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Audited Company Balance Sheet</B>&#148; means the consolidated balance sheet (and the notes thereto) of the Company and its
consolidated Subsidiaries as of December&nbsp;31, 2020 set forth in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> filed by the Company with the SEC for the fiscal year ended December&nbsp;31, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>beneficially own</B>&#148; means, with respect to any securities, having &#147;beneficial ownership&#148; of such securities (as
determined pursuant to <FONT STYLE="white-space:nowrap">Rule&nbsp;13d-3</FONT> under the Exchange Act), and the terms &#147;beneficial ownership&#148; and &#147;beneficial owner&#148; shall have correlative meanings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Business Day</B>&#148; means any day other than Saturday or Sunday or a day on which commercial banks are authorized or required by
Law to be closed in New York, New York or San Francisco, California. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Casdin Parties</B>&#148; has the meaning given to the term &#147;Purchaser
Parties&#148; by the Casdin Purchase Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Casdin Purchaser</B>&#148; means, collectively, Casdin Private Growth Equity
Fund II, L.P., a Delaware limited partnership and Casdin Partners Master Fund, L.P., a Cayman Islands exempted limited partnership. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Casdin Purchase Agreement</B>&#148; means that certain Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock
Purchase Agreement, dated as of even date herewith, by and between the Company and the Casdin Purchaser. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Casdin
Transaction</B>&#148; means the issuance of and sale of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock to Casdin Purchaser on the terms and subject to the conditions set forth in the Casdin Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Certificate of Amendment</B>&#148; means an amendment to the Eighth Amended and Restated Certificate of Incorporation of the Company
to (a)&nbsp;increase the number of authorized shares and (b)&nbsp;change the name of the Company to &#147;Standard BioTools Inc.&#148; (in each case, effective as of the Closing), in a form reasonably satisfactory to the Company and Purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Certificate of Designations</B>&#148; means the Certificate of Designations of the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock, substantially in the form attached to this Agreement as <U>Exhibit</U><U></U><U>&nbsp;A</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Code</B>&#148; means the Internal Revenue Code of 1986. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Board</B>&#148; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Common Stock</B>&#148; means the common stock, par value $0.001 per share, of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company ESPP</B>&#148; means the Fluidigm 2017 Employee Stock Purchase Plan, as amended and restated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Fundamental Representations</B>&#148; means the representations and warranties set forth in
<U>Section</U><U></U><U>&nbsp;3.1</U>, <U>Section</U><U></U><U>&nbsp;3.2</U>, <U>Section</U><U></U><U>&nbsp;3.3</U>, <U>Section</U><U></U><U>&nbsp;3.4</U>, <U>Section</U><U></U><U>&nbsp;3.5(a)</U>, <U>Section</U><U></U><U>&nbsp;3.7</U> and
<U>Section</U><U></U><U>&nbsp;3.26</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Material Adverse Effect</B>&#148; means any change, event, effect, occurrence or
circumstance that, individually or in the aggregate, has had, or would reasonably be expected to have, a material adverse effect on the business, financial condition or results of operations of the Company and its Subsidiaries, taken as a whole;
<U>provided</U>, that, none of the following shall be deemed to be or constitute a Company Material Adverse Effect or shall be taken into account when determining whether a Company Material Adverse Effect has occurred or is reasonably likely to
occur (subject to the limitations set forth below): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) changes in general economic conditions, or changes in conditions in the global or
national economy generally; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) changes in conditions in the financial markets, credit markets or capital markets,
including (i)&nbsp;changes in interest rates or credit ratings; (ii)&nbsp;changes in exchange rates for the currencies of any country; or (iii)&nbsp;any suspension of trading in securities (whether equity, debt, derivative or hybrid securities)
generally on any securities exchange or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) changes in conditions in the industry in which the Company and its Subsidiaries operate; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) changes in regulatory, legislative or political conditions; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) any geopolitical conditions, outbreak of hostilities, acts of war, sabotage, cyberterrorism, terrorism, military actions, earthquakes,
volcanic activity, hurricanes, tsunamis, tornadoes, floods, mudslides, wildfires or other natural disasters, weather conditions, epidemics, pandemics, disease outbreaks (including <FONT STYLE="white-space:nowrap">COVID-19</FONT> and responses to <FONT
STYLE="white-space:nowrap">COVID-19),</FONT> civil unrest or other force majeure events (including any escalation or general worsening thereof); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) any change, event, effect, occurrence or circumstance resulting from the announcement of this Agreement or the pendency of the Casdin
Transaction or the Viking Transaction, including the impact thereof on the relationships, contractual or otherwise, of the Company and its Subsidiaries with customers, suppliers, licensees, licensors, lenders, business partners, employees,
prospective employees, regulators, vendors or any other third Person (<U>provided</U>, that this clause (f)&nbsp;shall not apply to any representation or warranty contained in this Agreement or the Casdin Purchase Agreement to the extent that such
representation or warranty expressly addresses consequences resulting from the announcement or execution of this Agreement or the consummation or pendency of the Casdin Transaction or the Viking Transaction); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) changes in GAAP or other accounting standards or in any applicable Laws (or the authoritative interpretation of any of the foregoing); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) any action taken or refrained from being taken by the Company (i)&nbsp;as expressly required by this Agreement or (ii)&nbsp;that Purchaser
has expressly approved, consented to or requested, in each case in writing following the date of this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) changes in the price
or trading volume of the Company Common Stock, in and of itself (it being understood that the underlying cause of such change may be taken into consideration when determining whether a Company Material Adverse Effect has occurred); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) any failure, in and of itself, by the Company and its Subsidiaries to meet (i)&nbsp;any public estimates or expectations for the
Company&#146;s revenue, earnings or other financial performance or results of operations for any period; or (ii)&nbsp;any internal budgets, plans, projections or forecasts of its revenues, earnings or other financial performance or results of
operations (it being understood that the underlying cause of any such failure may be taken into consideration when determining whether a Company Material Adverse Effect has occurred); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) any breach by Purchaser of this Agreement; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) any Transaction Litigation brought by any Company Stockholder against the Company, any
of its executive officers or other employees or any member of the Company Board, arising from or relating to the Transactions or allegations of any breach of fiduciary duty related to the Transactions; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">except, in each case of clauses (a), (b), (c), (d), (e), and (g), to the extent that such change, event, effect, occurrence or circumstance has had a
disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to other companies in the industry in which the Company and its Subsidiaries operate, in which case the incremental disproportionate adverse impact may
be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Notes</B>&#148; means the Company&#146;s 2.75% Exchange Convertible Senior Notes due 2034 and the Company&#146;s 5.25%
Convertible Senior Notes due 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Options</B>&#148; means any options to purchase shares of Company Common Stock,
whether granted pursuant to any of the Company Stock Plans or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company PSUs</B>&#148; means any performance-based
restricted stock units of the Company, whether granted pursuant to any of the Company Stock Plans or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Related
Parties</B>&#148; means (a)&nbsp;the Company, its Subsidiaries and each of its and their respective Affiliates and (b)&nbsp;the former, current and future holders of any equity, controlling persons, directors, officers, employees, agents, attorneys,
Affiliates, members, managers, general or limited partners, stockholders and assignees of each of the Company, its Subsidiaries and each of its and their respective Affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company RSUs</B>&#148; means any service-based restricted stock units or deferred stock units of the Company, whether granted
pursuant to any of the Company Stock Plans or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Software</B>&#148; means all proprietary Software owned or
purported to be owned by the Company or any of its Subsidiaries as of the date of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Source Code</B>&#148;
means Source Code to Company Software. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Stock Plans</B>&#148; means the 2009 Equity Incentive Plan of Fluidigm, as
amended, the Fluidigm 2011 Equity Incentive Plan, as amended effective May&nbsp;25, 2021, the DVS Sciences Inc. 2010 Equity Incentive Plan, as amended, the Fluidigm 2017 Inducement Award Plan, as amended, the Company ESPP and each other Employee
Plan that provides for the award of rights of any kind to receive shares of Company Common Stock or benefits measured in whole or in part by reference to shares of Company Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Stockholders</B>&#148; means the holders of shares of Company Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Systems</B>&#148; means all Software, computer hardware (whether general or special purpose), information technology,
electronic data processing, information, record keeping, communications, telecommunications, networks, interfaces, platforms, servers, peripherals, and computer systems (including any outsourced systems and processes) that are owned, leased,
licensed or used by or for, or otherwise relied on by, the Company or its Subsidiaries in the conduct of their businesses. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Competitor</B>&#148; means the Persons set forth on Section&nbsp;1.1(b) of the
Company Disclosure Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Confidentiality Agreement</B>&#148; means the Confidentiality Agreement, between the Company and
Viking Global Investors LP, dated as of January&nbsp;7, 2022 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Contract</B>&#148; means any contract, subcontract, note, bond,
mortgage, indenture, lease, license, sublicense or other instrument, commitment, understanding, undertaking or agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Converted Shares</B>&#148; means a number of shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock equal to
(a) (i)&nbsp;the Conversion Amount (as defined in the Loan Agreement), in each case as of the Closing, <I>divided by</I> (ii)&nbsp;$1,000 <I>multiplied by</I> (b) (i)&nbsp;$3.40 <I>divided by</I> (ii)&nbsp;$2.84, rounded up to the nearest integer,
into which the Conversion Amount shall be converted pursuant to the terms of this Agreement and thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT
STYLE="white-space:nowrap">COVID-19</FONT></B>&#148; means <FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT> and its disease commonly known as <FONT STYLE="white-space:nowrap">COVID-19,</FONT> and any evolutions or additional strains, variations or
mutations thereof or any related or associated epidemics, pandemic or disease outbreaks. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures</B>&#148; means any quarantine, &#147;shelter in place,&#148; &#147;stay at
home,&#148; workforce reduction, social distancing, shut down, closure, sequester or other mandatory directive imposed by applicable Law, order, writ, injunction, judgment or decree in connection with or in response to
<FONT STYLE="white-space:nowrap">COVID-19.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Data</B>&#148; means, collectively, data, databases, data repositories, data
lakes and collections of data. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Data Security Requirements</B>&#148; means, collectively, all of the following to the extent
relating to the Processing of Data or otherwise relating to privacy, security, or security breach notification requirements and applicable to the Company or its Subsidiaries: (a)&nbsp;the Company&#146;s and its Subsidiaries&#146; own written rules,
policies and procedures; (b)&nbsp;applicable Laws (including, as applicable, the California Consumer Privacy Act, the General Data Protection Regulation (EU) 2016/679, and the ePrivacy Directive 2002/58/EC); (c)&nbsp;applicable industry standards
with which the Company or any of its Subsidiaries operates (including, as applicable, the Payment Card Industry Data Security Standard); and (d)&nbsp;Contracts into which the Company or any of its Subsidiaries has entered or by which it is otherwise
bound. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>DOJ</B>&#148; means the United States Department of Justice or any successor thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Employee Plan</B>&#148; means each &#147;employee benefit plan&#148; (within the
meaning of Section&nbsp;3(3) of ERISA, whether or not subject to ERISA) and each other plan, program, arrangement, policy or contract relating to severance, termination, garden leave, pay in lieu, <FONT STYLE="white-space:nowrap">gross-up,</FONT>
pension, profit-sharing, savings, retirement, death benefit, group insurance, hospitalization, medical, dental, life, employee loan, restrictive covenant, relocation, clawback, fringe benefit, cafeteria, disability, consulting, change in control,
employment, compensation, incentive, bonus, retention, stock option, restricted stock, restricted or deferred stock unit, stock purchase, phantom stock or other equity or equity-based compensation (including the Company Stock Plans and all
outstanding awards granted thereunder), deferred compensation or other benefit or compensation plan, program, arrangement, or policy, whether written or oral, formal or informal, that is sponsored, maintained or contributed to by the Company or any
Subsidiary of the Company for the benefit of any current or former director, officer, independent contractor, or employee of the Company or any Subsidiary or any spouse, dependent, or beneficiary thereof, or with respect to which the Company or any
Subsidiary of the Company has or reasonably expects to have any liability or obligation, including on account of an ERISA Affiliate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Environmental Law</B>&#148; means any Law enacted or in effect on or prior to the Closing Date relating to public or worker health
and safety (to the extent relating to exposure to Hazardous Materials), the protection of the environment or natural resources (including ambient or indoor air, surface water, groundwater or land) or pollution, including any such Law relating to the
production, distribution, marketing, labeling, registration, notification, packaging, import, use, storage, treatment, transportation, recycling, disposal, discharge, release or other handling of, or exposure to, any Hazardous Materials, or the
investigation, <FONT STYLE="white-space:nowrap">clean-up</FONT> or remediation thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Environmental Permits</B>&#148; means
any Governmental Authorizations required under Environmental Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Equity Securities</B>&#148; means any equity securities of
the Company or any of its Subsidiaries, or securities convertible into or exercisable or exchangeable for equity securities of the Company or any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>ERISA</B>&#148; means the Employee Retirement Income Security Act of 1974. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>ERISA Affiliate</B>&#148; means, with respect to any entity, trade or business, any other entity, trade or business that is (or was
at any relevant time) a member of a group described in Section&nbsp;414(b), (c), (m) or (o)&nbsp;of the Code or Section&nbsp;4001(b)(1) of ERISA that includes the first entity, trade or business, or that is (or was at any relevant time) a member of
the same &#147;controlled group&#148; as the first entity, trade or business pursuant to Section&nbsp;4001(a)(14) of ERISA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Exchange Act</B>&#148; means the Securities Exchange Act of 1934. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Excluded Securities</B>&#148; means any securities of the Company issued or issuable (a)&nbsp;on the exercise, exchange or conversion
of any (i)&nbsp;New Securities issued to Purchaser in accordance with this Agreement, (ii)&nbsp;New Securities issued to the Casdin Purchaser in accordance with the Casdin Purchase Agreement, (iii)&nbsp;New Securities issued to Purchaser upon
conversion of the Loan Agreement; or (iv)&nbsp;New Securities issued to the Casdin Purchaser upon conversion of the Loan Agreement (as defined in the Casdin Purchase Agreement), (b)&nbsp;to directors, officers, employees or consultants of the
Company pursuant to any present or future employee, director or consultant benefit plan or program of, or assumed by, the Company or any of its Subsidiaries and approved by the Company Board, or a committee thereof, or any employee agreements or
arrangements or programs approved by the Company Board, or a committee thereof, including the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company Stock Plans or other compensatory arrangements, (c)&nbsp;on conversion of the Series B Preferred Stock or the Company Notes in accordance with the terms thereof, (d)&nbsp;as consideration
for the acquisition of another entity by the Company by merger, purchase of substantially all of the assets or other reorganization or a <I>bona fide</I> joint venture agreement, if approved by the Company Board, including the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Preferred Director and Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Director if such directors are then in office, (e)&nbsp;in connection with any stockholder rights plan approved by the Company
Board, (f)&nbsp;pursuant to any dividend, split, combination or other reclassification, (g)&nbsp;upon the exercise, exchange or conversion of options, convertible notes, warrants, or other derivative securities of the Company or any Subsidiary,
(h)&nbsp;as part of an exchange, refinancing or similar transaction with respect to any debt or convertible-debt securities of the Company or any Subsidiary of the Company outstanding on the date of this Agreement, including any securities issued
upon conversion of such securities, if approved by the Company Board, including the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Director and Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Director if such directors are
then in office, (i)&nbsp;of a Subsidiary of the Company issued to the Company or a Subsidiary of the Company or (j)&nbsp;under (i)&nbsp;this Agreement (for the avoidance of doubt, other than pursuant to <U>Section</U><U></U><U>&nbsp;6.16</U>
hereof), (ii)&nbsp;the Casdin Purchase Agreement (for the avoidance of doubt, other than pursuant to <U>Section</U><U></U><U>&nbsp;6.16</U> thereof), (iii)&nbsp;the Loan Agreement or (iv)&nbsp;the Loan Agreement, dated as of the date of this
Agreement, between the Company and Casdin Purchaser. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>FTC</B>&#148; means the United States Federal Trade Commission or any
successor thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>GAAP</B>&#148; means generally accepted accounting principles, consistently applied, in the United States.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Government Official</B>&#148; means any (a)&nbsp;official, officer, employee, or representative of, or any Person acting in an
official capacity for or on behalf of, any Governmental Authority, (b)&nbsp;political party or party official or candidate for political office or (c)&nbsp;company, business, enterprise or other entity owned, in whole or in part, or controlled by
any person described in the foregoing clause (a)&nbsp;or (b) of this definition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Governmental Authority</B>&#148; means any
government, political subdivision, governmental, administrative or regulatory entity or body, department, commission, board, agency or instrumentality, or other legislative, executive or judicial governmental entity, and any court, tribunal,
judicial or arbitral body, in each case whether federal, national, state, county, municipal, provincial, local, foreign or multinational. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Governmental Authorization</B>&#148; means any authorizations, approvals, licenses,
<FONT STYLE="white-space:nowrap">sub-licenses,</FONT> franchises, clearances, permits, certificates, waivers, consents, exemptions, variances, expirations and terminations of any waiting period requirements (including, pursuant to Antitrust Laws)
issued by or obtained from, and notices, filings, registrations, qualifications, declarations and designations with, a Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Hazardous Materials</B>&#148; means any substance, waste, or material that is regulated by or for which standards of conduct or
liability may be imposed pursuant to Environmental Laws, including petroleum and petroleum byproducts, <FONT STYLE="white-space:nowrap">per-</FONT> and poly-fluoroalkyl substances, polychlorinated biphenyls, lead, asbestos, noise, radiation, toxic
mold, odor and pesticides. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Hedge</B>&#148; means to make any short sale of, grant any option for the purchase
of, or enter into any hedging or similar transaction with the same economic effect as a short sale of or the purpose of which is to offset the loss that results from a decline in the market price of, any
<FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares, or otherwise establish or increase, directly or indirectly, a put equivalent position, as defined in Rule <FONT STYLE="white-space:nowrap">16a-1(h)</FONT> under the Exchange Act, or enter into
any derivative transactions with linked financing, with respect to any <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>HSR Act</B>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Intellectual Property</B>&#148; means all intellectual property and proprietary rights throughout the world, including: (a)&nbsp;all
patents, patent applications, patent disclosures, and inventions and all improvements thereto (whether or not patentable or reduced to practice), and all reissues, continuations,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> revisions, divisional, extensions, applications therefor, and reexaminations in connection therewith (&#147;<B>Patents</B>&#148;); (b) all
copyrights, works of authorship (whether or not copyrightable), moral rights, and all registrations, applications and renewals therefor and any other rights corresponding thereto throughout the world (&#147;<B>Copyrights</B>&#148;);
(c)&nbsp;trademarks, service marks, internet domain names, corporate names, trade dress rights and similar designation of origin and rights therein, other indicia of origin, and all registrations, renewals and applications in connection therewith,
together with all of the goodwill associated with any of the foregoing (&#147;<B>Marks</B>&#148;); (d) rights in Trade Secrets; (e)&nbsp;rights in Software; and (f)&nbsp;intellectual property and proprietary rights in Data. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Intervening Event</B>&#148; means any change, event, effect, occurrence or circumstance (other than any change, event, effect,
occurrence or circumstance resulting from a breach of this Agreement by the Company), in each case that (a)&nbsp;is not known or reasonably foreseeable by the Company Board as of the date hereof and (b)&nbsp;does not relate to any Acquisition
Proposal, Purchaser or the Casdin Purchaser; <U>provided</U>, that in no event shall the following constitute, or be taken into account in determining the existence of, an Intervening Event: (i)&nbsp;the fact that the Company and its Subsidiaries
meet or exceed (A)&nbsp;any public estimates or expectations for the Company&#146;s revenue, earnings or other financial performance or results of operations for any period or (B)&nbsp;any internal budgets, plans, projections or forecasts of its
revenues, earnings or other financial performance or results of operations (it being understood that the underlying cause of any such events may be taken into consideration when determining whether an Intervening Event has occurred);
(ii)&nbsp;changes in the price or trading volume of the Company Common Stock, in and of itself (it being understood that the underlying cause of such change may be taken into consideration when determining whether an Intervening Event has occurred);
(iii)&nbsp;changes in the Company&#146;s credit ratings; (iv)&nbsp;the taking of any action required or expressly contemplated by this Agreement; (v)&nbsp;any change, event, effect, occurrence or circumstance relating to Purchaser, the Casdin
Purchaser or any of their respective Affiliates; or (vi)&nbsp;changes in conditions generally affecting the industry in which the Company and its Subsidiaries operate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>IRS</B>&#148; means the United States Internal Revenue Service or any successor thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Knowledge</B>&#148; of the Company, with respect to any matter in question, means the actual knowledge of the individuals set forth
on Section&nbsp;1.1(c)(i) of the Company Disclosure Letter, in each case after reasonable inquiry of their direct reports who would reasonably be expected to have actual knowledge of the matter in question. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Labor Laws</B>&#148; means all Laws relating to labor and employment, including but
not limited to, all Law relating to employment and independent contractor practices, wages, equal employment opportunity, affirmative action and other hiring practices, immigration (including the completion of
<FONT STYLE="white-space:nowrap">I-9s</FONT> for all employees and the proper confirmation of employee visas), workers&#146; compensation, unemployment, the payment of social security and other employment-related taxes, employment standards,
employment of minors, occupational health and safety, labor relations, unions, withholdings, payment of wages and overtime, meal and rest periods, workplace safety, employee benefits, pay equity, employee and worker classification (including the
classification of independent contractors and exempt and <FONT STYLE="white-space:nowrap">non-exempt</FONT> employees), leaves of absence, family and medical leave, civil rights, retaliation, discrimination, sexual or other workplace harassment, the
WARN Act, the National Labor Relations Act, the Labor Management Relations Act, the Occupational Safety and Health Act, Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Age Discrimination in Employment Act, the
Family Medical Leave Act, the Fair Labor Standards Act, the Equal Pay Act, the Rehabilitation Act, the Employee Retirement Income Security Act, the Uniform Services Employment and Reemployment Rights Act, the Genetic Information Nondiscrimination
Act, 42 U.S.C. &#167;&#167;&nbsp;1981, 1983, 1985 and 1986, the Sarbanes-Oxley Act and the Immigration Reform and Control Act, or any similar state, local or foreign Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Law</B>&#148; means any federal, national, state, county, municipal, provincial, local, foreign or multinational law, act, statute,
constitution, common law, ordinance, code, decree, writ, order, determination, judgment, injunction, rule, regulation, ruling, award or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the
authority of any Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Legal Proceeding</B>&#148; means any claim, action, charge, complaint, lawsuit,
litigation, audit, investigation, inquiry, proceeding, arbitration or other similar legal proceeding brought by or pending before any Governmental Authority, arbitrator or other tribunal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Lien</B>&#148; means any lien, security interest, deed of trust, mortgage, pledge, encumbrance, restriction on transfer, proxies,
voting trusts or agreements, hypothecation, assignment, claim, right of way, defect in title, encroachment, easement, restrictive covenant, charge, deposit arrangement or preference, priority or other security agreement or preferential arrangement
of any kind or nature whatsoever (including any restriction on the voting interest of any security, any restriction on the transfer of any security (except for those imposed by applicable securities Laws) or other asset or any restriction on the
possession, exercise or transfer of any other attribute of ownership of any asset). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Material Contract</B>&#148; means any of the
following Contracts of the Company or any of its Subsidiaries (other than an Employee Plan) that are currently in effect: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) any
&#147;material contract&#148; (as defined in Item 601(b)(10) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated by the SEC, other than those agreements and arrangements described in Item 601(b)(10)(iii) of Regulation <FONT
STYLE="white-space:nowrap">S-K)</FONT> with respect to the Company and its Subsidiaries, taken as whole; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) any Contract under which the Company or any of its Subsidiaries has been granted a
license under any third Person&#146;s Intellectual Property, other than <FONT STYLE="white-space:nowrap">(i)&nbsp;non-disclosure</FONT> agreements; <FONT STYLE="white-space:nowrap">(ii)&nbsp;non-exclusive</FONT> licenses or related services
Contracts for commercially available software, technology or Intellectual Property; (iii)&nbsp;Open Source Licenses; (iv)&nbsp;Contracts with employees or independent contractors for the assignment of, or license to, any Intellectual Property; and
(v)&nbsp;licenses authorizing limited use of brand materials, feedback, or other Intellectual Property that are incidental to the primary purpose of the Contract; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) any Contract under which the Company or any of its Subsidiaries has licensed any material Company Owned IP to a third Person, other than
(i)&nbsp;any <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreements; (ii)&nbsp;Contracts with end users and other customers (including resellers, distributors, <FONT STYLE="white-space:nowrap">co-marketers</FONT> and <FONT
STYLE="white-space:nowrap">co-promoters),</FONT> or with potential end users and other customers (including potential resellers and distributors), to the extent granting licenses in connection with the evaluation, provision, sale, resale, license,
distribution, support or maintenance of a Company Product; (iii)&nbsp;Contracts with consultants, contractors and vendors (including manufacturers, suppliers and contract research organizations) to the extent granting licenses in connection with the
counterparty&#146;s provision of products or services to or for the Company or any of its Subsidiaries; (iv)&nbsp;original equipment manufacturer agreements and/or collaboration agreements involving the development or commercialization of Company
and/or third-party products or services, including licenses that are incidental to the conduct of development activities for such products or services, the supply of such products and services (whether for testing or commercialization), or the <FONT
STYLE="white-space:nowrap">co-marketing</FONT> or <FONT STYLE="white-space:nowrap">co-promotion</FONT> of such products or services; and (v)&nbsp;other licenses entered in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) any Contract (i)&nbsp;containing any covenant limiting in any material respect the right of the Company or any of its Subsidiaries to
engage in or compete with any Person in any line of business that is material to the Company and its Subsidiaries, taken as a whole or (ii)&nbsp;containing any &#147;minimum requirement,&#148; &#147;most favored nation&#148; or
&#147;exclusivity&#148; provisions that limit in any material respect the freedom or right of the Company or any of its Subsidiaries to sell, distribute or manufacture any products or services or any technology or other assets to or for any other
Person; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) any Contract with respect to the future issuance of Company Securities (other than this Agreement, the Casdin Purchase
Agreement, the Company Stock Plans or the awards made or that the Company agreed to make thereunder); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) any Contract entered into within
the five year period prior to the date of this Agreement (i)&nbsp;relating to a disposition or acquisition of assets by the Company or any of its Subsidiaries other than dispositions or acquisitions of products or services in the ordinary course of
business or solely among the Company and its Subsidiaries or (ii)&nbsp;pursuant to which the Company or any of its Subsidiaries will acquire after the date of this Agreement any material ownership interest in any other Person or other business
enterprise other than any existing Subsidiary of the Company; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) any letter of credit in excess of $1,000,000, or any mortgages, indentures, guarantees,
loans or credit agreements, security agreements or other Contracts (other than letters of credit) relating to indebtedness, including the borrowing of money or extension of credit, in each case in excess of $1,000,000 other than (i)&nbsp;accounts
receivables and payables incurred in the ordinary course of business; (ii)&nbsp;loans to Subsidiaries of the Company in the ordinary course of business; (iii)&nbsp;intercompany loans, receivables and payables among the Company and its Subsidiaries;
and (iv)&nbsp;extensions of credit to customers in the ordinary course of business and (v)&nbsp;pursuant to the SVB Loan Agreement or the Company Notes; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) any Contract providing for indemnification of any officer, director or employee by the Company or any of its Subsidiaries; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any material joint venture, partnership or similar arrangement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) any Contract (other than purchase orders in the ordinary course of business that are terminable or cancelable without penalty on 90
days&#146; notice or less) under which the Company or any of its Subsidiaries is a purchaser of goods and services which, pursuant to the terms thereof, requires payments by the Company or any of its Subsidiaries in excess of $1,000,000 within any <FONT
STYLE="white-space:nowrap">12-month</FONT> period; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) any Collective Bargaining Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) any Contract that is a settlement, conciliation or similar agreement with any Governmental Authority or Person pursuant to which the
Company or a Subsidiary will have any material outstanding obligation after the date of this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) any agreement to purchase Real
Property or any interest therein; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) any Lease; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) any master services agreement and other Contracts (other than purchase orders, service orders, statements of work, invoices, sales orders,
bills, shipping orders, credit memos, sales receipts, proposals or other similar items) with the top ten customers and top ten suppliers of the Company and its Subsidiaries, taken as a whole, by revenue or cost (as applicable) for the 12 months
ended September&nbsp;30, 2021; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) any agreement under which a broker, finder or similar fee commission, or other like payment is payable;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) any Contract between the Company or any of its Subsidiaries, on the one hand, and any Person that, to the Knowledge of the Company,
beneficially owns five percent or more of the outstanding shares of Company Common Stock or outstanding shares of common stock of any of any of the Company&#146;s Subsidiaries, on the other hand; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) any Contracts with any current director or executive officer of the Company, with the exception of any confidentiality or invention
assignment agreement on the Company&#146;s standard for, which standard form has been made available to Purchaser; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) any employment or consulting Contract with any individual service provider of the
Company or any of its Subsidiaries that (i)&nbsp;provides for annual base compensation in excess of $250,000, and (ii)&nbsp;(A)&nbsp;provides for the payment or accelerated vesting of any compensation or benefits in connection with the consummation
of the transactions contemplated by this Agreement or (B)&nbsp;otherwise restricts the Company&#146;s or its Subsidiaries ability to terminate the employment or engagement of such service provider at any time for any reason or no reason without more
than 30 days&#146; prior notice and without penalty or liability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>NASDAQ</B>&#148; means the Nasdaq Stock Market and any
successor stock exchange or inter-dealer quotation system operated by the Nasdaq Stock Market or any successor thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Open
Source Software</B>&#148; means any Software licensed under terms meeting the definition of &#147;Open Source&#148; promulgated by the Open Source Initiative, available online at http://www.opensource.org/osd.html (any such license, an &#147;<B>Open
Source License</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Organizational Documents</B>&#148; means the certificate of incorporation, bylaws, certificate of
formation, partnership agreement, limited liability company agreement and all other similar documents, instruments or certificates executed, adopted or filed in connection with the creation, formation or organization of a Person, including any
amendments thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Permitted Liens</B>&#148; means any of the following: (a)&nbsp;Liens for Taxes, assessments and governmental
charges or levies either not yet delinquent or that are being contested in good faith by appropriate proceedings and for which appropriate reserves have been established to the extent required by GAAP; (b)&nbsp;mechanics, carriers&#146;,
workmen&#146;s, warehouseman&#146;s, repairmen&#146;s, materialmen&#146;s or other Liens or security interests that are not yet due or that are being contested in good faith and by appropriate proceedings; (c)&nbsp;pledges or deposits to secure
obligations pursuant to workers&#146; compensation Law or similar legislation or to secure public or statutory obligations; (d)&nbsp;pledges or deposits to secure the performance of appeal bonds, fidelity bonds and other obligations of a similar
nature, in each case in the ordinary course of business; (e)&nbsp;easements, covenants and rights of way (unrecorded and of record) and other similar Liens (or other encumbrances), and zoning, building and other similar codes or restrictions, in
each case imposed by any governmental authority having jurisdiction over the Real Property and that do not adversely affect in any material respect, and are not violated by, the current use, operation or occupancy of such Real Property or the
operation of the business of the Company and its Subsidiaries thereon; (f)&nbsp;Liens the existence of which are disclosed in the notes to the most recent consolidated financial statements of the Company included in the Company SEC Reports;
(g)&nbsp;Liens granted pursuant to the SVB Loan Agreement and the Loan Documents (as defined in the SVB Loan Agreement); and (h)&nbsp;any <FONT STYLE="white-space:nowrap">non-exclusive</FONT> license of any Intellectual Property granted by the
Company or any of its Subsidiaries in the ordinary course of business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Person</B>&#148; means any individual, corporation
(including any <FONT STYLE="white-space:nowrap">non-profit</FONT> corporation), limited liability company, joint stock company, general partnership, limited partnership, limited liability partnership, joint venture, estate, trust, firm, Governmental
Authority or other enterprise, association, organization or entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Personal Information</B>&#148; means any Data that is
defined as &#147;personal data,&#148; &#147;personal information,&#148; &#147;personally identifiable information,&#148; or any comparable term under applicable Laws, and any Data that, alone or when combined with other Data, identifies, allows the
identification of, relates to, describes, is reasonably capable of being associated with, or could reasonably be linked, directly or indirectly, with an individual, household, or device, or is about or from an individual, household, or device, or
constitutes name, address, phone number, email address, financial account number, payment card data, government issued identifier, and health or medical information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Process</B>&#148; (or &#147;<B>Processing</B>&#148; or
&#147;<B>Processed</B>&#148;) means any operation or set of operations which is performed on Data or other information or sets or collections thereof, such as the development, access, collection, use, adaption, recording, retrieval, organization,
structuring, erasure, exploitation, processing, storage, sharing, copying, display, distribution, transfer, transmission, disclosure, aggregation, destruction, or disposal thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Purchased Shares</B>&#148; means, collectively, the PGEF II Purchased Share and the PMF Purchased Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Purchaser Fundamental Representations</B>&#148; means the representations and warranties set forth in
<U>Section</U><U></U><U>&nbsp;4.1</U>, <U>Section</U><U></U><U>&nbsp;4.2</U>, <U>Section</U><U></U><U>&nbsp;4.3(a)</U> and <U>Section</U><U></U><U>&nbsp;4.7</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Purchaser Parties</B>&#148; means, collectively, Purchaser and each Permitted Transferee of Purchaser to whom shares of Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Preferred Stock or Company Common Stock are Transferred pursuant to <U>Section</U><U></U><U>&nbsp;6.15(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Purchaser Preferred Percentage</B>&#148; means, as of any time, (a)&nbsp;the number of shares of Company Common Stock beneficially
owned by the Purchaser Parties <I>divided by</I> (b)&nbsp;the total number of shares of Company Common Stock issued and outstanding, in each case as of such time and determined on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis (in
each case, without giving effect to any limitations on conversion in the Certificate of Designations). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Purchaser Related
Parties</B>&#148; means (a)&nbsp;Purchaser, its Subsidiaries and each of its and their respective Affiliates and (b)&nbsp;the former, current and future holders of any equity, controlling persons, directors, officers, employees, agents, attorneys,
Affiliates, members, managers, general or limited partners, stockholders and assignees of Purchaser, its Subsidiaries and its and their respective Affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Real Property</B>&#148; means real property, including all land, together with all buildings, structures, improvements and fixtures
located thereon, and all easements and other rights and interests appurtenant thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Registered Intellectual
Property</B>&#148; means Intellectual Property that has been registered, filed or issued under the authority of, with or by any Governmental Authority, or other public or quasi-public legal authority, including (a)&nbsp;Patents and Patent
applications (including provisional applications); (b) registered Marks and applications to register Marks (including <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">intent-to-use</FONT></FONT> applications, or other registrations
or applications related to Marks, including, for clarity, internet domain names); and (c)&nbsp;registered Copyrights and applications for Copyright registration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Sarbanes-Oxley Act</B>&#148; means the Sarbanes-Oxley Act of 2002. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>SEC</B>&#148; means the United States Securities and Exchange Commission or any successor thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Securities Act</B>&#148; means the Securities Act of 1933. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Security Incident</B>&#148; means any actual or reasonably suspected successful (a)&nbsp;security breach, denial of service, phishing
attack, or ransomware and malware attack on the Company Systems or (b)&nbsp;unauthorized access to, or collection, use, Processing, storage, sharing, distribution, transfer, disclosure, or destruction of, any Company Systems or Sensitive
Information, or any loss, distribution, compromise or unauthorized disclosure of any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Sensitive
Information</B>&#148; means, in any form or medium, any (a)&nbsp;Trade Secrets or other material confidential information, (b)&nbsp;privileged or proprietary information that, if compromised through any theft, interruption, modification, corruption,
loss, misuse or unauthorized access or disclosure, could cause serious harm to the organization owning it, (c)&nbsp;information protected by Law and (d)&nbsp;Personal Information, in each case of (a) &#150; (d), in the Company&#146;s or any of its
Subsidiaries&#146; possession or control or Processed on their behalf. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series <FONT STYLE="white-space:nowrap">B-1</FONT>
Preferred Director</B>&#148; has the meaning set forth in the Certificate of Designations of Rights, Preferences and Privileges of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock, par value $0.001 per share, of the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Director</B>&#148; has the meaning set forth in the
Certificate of Designations </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock</B>&#148; means the Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock, par value $0.001 per share, of the Company, the terms of which will be set forth in the Certificate of Designations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series B Preferred Stock</B>&#148; means, collectively, the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock and
the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock (as defined in the Casdin Purchase Agreement). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Share
Price</B>&#148; means $1,000 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Software</B>&#148; means, in any form or medium, any and all software and computer
programs, source code, object code, software implementations of algorithms, models and methodologies, firmware, application programming interfaces, descriptions, schematics, specifications, flow charts and other work product used to design, plan,
organize and develop any of the foregoing, and all documentation, and manuals related to any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Source
Code</B>&#148; means uncompiled human readable source code underlying any computer software program written in a language designed to be compiled prior to execution, and excluding human readable source code written in languages traditionally
distributed in source code form and designed to run on an interpreted basis (e.g. HTML, Javascript, Perl, PHP, and the like). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Subsidiary</B>&#148; means, with respect to any Person, any other Person (other than a natural Person) of which securities or other
ownership interests (a)&nbsp;having ordinary voting power to elect a majority of the board of directors or other persons performing similar functions or (b)&nbsp;representing more than 50% of such securities or ownership interests, in each case, are
at the time directly or indirectly owned by such first Person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Subsidiary Securities</B>&#148; has the same meaning ascribed to &#147;Company
Securities&#148;, except that all references to &#147;the Company&#148; therein shall be deemed to be replaced with &#147;any Subsidiary of the Company&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>SVB Loan Agreement</B>&#148; means that Loan and Security Agreement, dated as of August&nbsp;2, 2018 by and between the Borrower and
Silicon Valley Bank, as amended, restated, modified or otherwise supplemented from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Tax</B>&#148; or
&#147;<B>Taxes</B>&#148; means any taxes and similar assessments, fees, and other governmental charges imposed by any Governmental Authority, including income, profits, gross receipts, net proceeds, ad valorem, value added, turnover, sales, use,
property, personal property (tangible and intangible), stamp, excise, duty, franchise, capital stock, transfer, payroll, employment, severance, and estimated tax, together with any interest and any penalties, additions to tax or additional amounts
imposed by any Governmental Authority, whether disputed or not. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Tax Return</B>&#148; means any return, estimates, report,
statement, information return or other document (including any related or supporting information such as a schedule or attachment thereto) filed or required to be filed with any Governmental Authority in connection with the determination,
assessment, collection or administration of any Taxes, including any amendment thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Trade Secrets</B>&#148; means,
collectively, trade secrets and confidential and proprietary information, including trade secrets, <FONT STYLE="white-space:nowrap">know-how,</FONT> business rules, data analytic techniques and methodologies, formulae, source code, ideas, concepts,
discoveries, innovations, improvements, results, reports, information, research, laboratory and programmer notebooks, methods, procedures, proprietary technology, operating and maintenance manuals, engineering and other drawings and sketches,
customer lists, supplier lists, pricing information, cost information, business manufacturing and production processes and techniques, designs, specifications, and blueprints. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transactions</B>&#148; means, collectively, the Casdin Transaction and the Viking Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transaction Documents</B>&#148; means this Agreement, the Casdin Purchase Agreement, the Company Disclosure Letter, the Loan
Agreement, the Certificate of Designations and the Registration Rights Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transaction Litigation</B>&#148; means any
Legal Proceeding commenced against a Party, any of its Subsidiaries or Affiliates, any of their respective directors or officers, or otherwise relating to, involving or affecting such Persons, in each case in connection with, arising from or
otherwise relating to the Casdin Transaction, the Viking Transaction or any other transaction contemplated by this Agreement or the Transaction Documents, other than any Legal Proceedings among the Parties related to this Agreement or the other
Transaction Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transfer Taxes</B>&#148; means any transfer, sales, use, stamp, documentary, registration, value added or
other similar Taxes; provided, for the avoidance of doubt, that Transfer Taxes shall not include any income, franchise or similar Taxes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Underlying Shares</B>&#148; means the shares of Company Common Stock issuable on
conversion of the Acquired Shares in accordance with the Certificate of Designations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>VGO Drawdown Purchase Price</B>&#148;
means $37,125,000, which amount is calculated by multiplying the number of VGO Drawdown Purchased Shares by the Share Price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>VGO
Drawdown Purchased Shares</B>&#148; means 37,125 shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock to be purchased by VGO Drawdown pursuant to the terms of this Agreement. VGO Illiquid Investments </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>VGO Illiquid Investments Purchase Price</B>&#148; means $75,375,000, which amount is calculated by multiplying the number of VGO
Illiquid Investments Purchased Shares by the Share Price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>VGO Illiquid Investments Purchased Shares</B>&#148; means 75,375
shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock to be purchased by VGO Illiquid Investments pursuant to the terms of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Voting Stock</B>&#148; means (a)&nbsp;with respect to the Company, the Company Common Stock, the Series&nbsp;B Preferred Stock and
any other capital stock of the Company having the right to vote generally in any election of directors of the Company Board and (b)&nbsp;with respect to any other Person, all equity of such Person having the right to vote generally in any election
of directors of the board of directors of such Person or other similar governing body. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>WARN Act</B>&#148; means the Worker
Adjustment and Retraining Notification Act of 1988, and the regulations promulgated thereunder and any similar state, local or foreign Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Willful Breach</B>&#148; means a material breach of this Agreement that is the result of a willful or intentional act or failure to
act where the breaching party knows, or should reasonably be expected to have known, that the taking of such act or failure to act would result, or would reasonably be expected to result, in a material breach of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 <I>Index of Defined Terms</I>. The following capitalized terms have the respective meanings given to them in the respective Sections of
this Agreement set forth opposite each of the capitalized terms below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="7%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Term</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Section</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Acquisition Termination Fee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">8.3(b)(iv)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Alternative Acquisition Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">5.3(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">BIS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.21(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Bylaws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Capitalization Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.7(a)(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Change of Recommendation Termination Fee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">8.3(b)(iii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Charter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chosen Courts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">9.10</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Closing Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2.2</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Collective Bargaining Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.19(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Board Recommendation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.3(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Board Recommendation Change</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">5.3(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Breach Notice Period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">8.1(e)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Disclosure Letter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Article&nbsp;III</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Intellectual Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.16(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Owned IP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.16(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Preferred Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.7(a)(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Product</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.22(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company SEC Reports</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.9</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Securities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.7(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Stockholder Meeting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">6.4(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Contracting Parties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">9.12</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DGCL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Electronic Delivery</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">9.14</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Expense Reimbursement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">8.3(b)(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FDA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.22(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Foreign Benefit Plan</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.18(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Fully Participating Parties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">6.16(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Healthcare Authorities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.22(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Lease</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.14(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Leased Real Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.14(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Loan Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Lock-Up Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">6.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">New Securities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">6.16(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Nonparty Affiliates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">9.12</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OFAC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.21(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Offer Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">6.16(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Offeree</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">6.16(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Participating Parties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">6.16(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Parties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Party</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Permitted Transferees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">6.15(b)(ii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Preemptive Percentage</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">6.16(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Proxy Statement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">6.3(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Purchaser</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Purchaser Breach Notice Period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">8.1(g)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Recall</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.22(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Registration Rights Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Representatives</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">5.3(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Requisite Stockholder Approval</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.4(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Series B-2 Conversion</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">6.2(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Termination Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">8.1(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Trade Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3.21(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Transfer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">6.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">VGO Drawdown</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">VGO Illiquid Investments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Viking Transaction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.3 <I>Certain Interpretations</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) When a reference is made in this Agreement to an Article or a Section, such reference is to an Article or a Section of this Agreement
unless otherwise indicated. When a reference is made in this Agreement to a Schedule or Exhibit, such reference is to a Schedule or Exhibit to this Agreement, as applicable, unless otherwise indicated. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) When used herein, (i)&nbsp;the words &#147;hereof,&#148; &#147;herein&#148; and &#147;herewith&#148; and words of similar import shall,
unless otherwise stated, be construed to refer to this Agreement as a whole and not to any particular provision of this Agreement; and (ii)&nbsp;the words &#147;include,&#148; &#147;includes&#148; and &#147;including&#148; shall be deemed in each
case to be followed by the words &#147;without limitation.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Unless the context otherwise requires, &#147;neither,&#148;
&#147;nor,&#148; &#147;any,&#148; &#147;either&#148; and &#147;or&#148; are not exclusive. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The word &#147;extent&#148; in the phrase
&#147;to the extent&#148; means the degree to which a subject or other thing extends, and does not simply mean &#147;if.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) When
used in this Agreement, references to &#147;$&#148; or &#147;Dollars&#148; are references to U.S. dollars. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The meaning assigned to
each capitalized term defined and used in this Agreement is equally applicable to both the singular and the plural forms of such term, and words denoting any gender include all genders. Where a word or phrase is defined in this Agreement, each of
its other grammatical forms has a corresponding meaning. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) When reference is made to any Party to this Agreement or any other agreement
or document, such reference includes such Party&#146;s successors and permitted assigns. References to any Person include the successors and permitted assigns of that Person. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Unless the context otherwise requires, all references in this Agreement to the Subsidiaries of a Person shall be deemed to include all
direct and indirect Subsidiaries of such Person. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) A reference to any specific Law or to any provision of any Law includes any amendment
to, and any modification, <FONT STYLE="white-space:nowrap">re-enactment</FONT> or successor thereof, any legislative provision substituted therefor and all rules, regulations and statutory instruments issued thereunder or pursuant thereto, except
that, for purposes of any representations and warranties in this Agreement that are made as of a specific date, references to any specific Law shall be deemed to refer to such legislation or provision (and all rules, regulations and statutory
instruments issued thereunder or pursuant thereto) as of such date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) References to any agreement or Contract are to that agreement or Contract as amended,
modified or supplemented (including by waiver or consent) from time to time in accordance with the terms hereof and thereof, except that for purposes of any representations and warranties in this Agreement that are made as of a specific date,
references to any specific Contract shall be deemed to refer to such Contract as of such date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) All accounting terms used herein shall
be interpreted, and all accounting determinations hereunder shall be made, in accordance with GAAP. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) The table of contents and headings
set forth in this Agreement are for convenience of reference purposes only and shall not affect or be deemed to affect in any way the meaning or interpretation of this Agreement or any term or provision hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) The measure of a period of one month or year for purposes of this Agreement shall be the date of the following month or year corresponding
to the starting date. If no corresponding date exists, then the end date of such period being measured shall be the next actual date of the following month or year (for example, one month following February&nbsp;18 is March&nbsp;18 and one month
following March&nbsp;31 is May 1). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) The Parties agree that they have been represented by legal counsel during the negotiation,
execution and delivery of this Agreement and therefore waive the application of any Law, regulation, holding or rule of construction providing that ambiguities in an agreement or other document shall be construed against the Party drafting such
agreement or document. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) No summary of this Agreement or any Exhibit or Schedule delivered herewith prepared by or on behalf of any
Party shall affect the meaning or interpretation of this Agreement or such Exhibit or Schedule. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) The information contained in this
Agreement and in the Company Disclosure Letter is disclosed solely for purposes of this Agreement, and no information contained herein or therein shall be deemed to be an admission by any Party to any third Person of any matter whatsoever, including
(i)&nbsp;any violation of Law or breach of Contract; or (ii)&nbsp;that such information is material or that such information is required to be referred to or disclosed under this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) The representations and warranties in this Agreement are the product of negotiations among the Parties and are for the sole benefit of the
Parties. Any inaccuracies in such representations and warranties are subject to waiver by the Parties in accordance with <U>Section</U><U></U><U>&nbsp;8.5</U> without notice or liability to any other Person. In some instances, the representations
and warranties in this Agreement may represent an allocation among the Parties of risks associated with particular matters regardless of the knowledge of any of the Parties. Consequently, Persons other than the Parties may not rely on the
representations and warranties in this Agreement as characterizations of actual facts or circumstances as of the date of this Agreement or as of any other date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) Documents or other information or materials shall be deemed to have been &#147;made available&#148; by the Company if such documents,
information or materials have been (i)&nbsp;posted and made available to Purchaser in the virtual data room maintained by the Company and hosted by Datasite, (ii)&nbsp;delivered or provided to Purchaser or its Affiliates or Representatives
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in connection with the Viking Transaction or (iii)&nbsp;filed or furnished by the Company with, and available through, the SEC&#146;s Electronic Data Gathering and Retrieval System, in each of
clauses (ii)&nbsp;and (iii), at least two Business Days prior to the date hereof, and with respect to clause (i), at least 3 hours before the execution of this Agreement by the Parties. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) All references to &#147;ordinary course of business&#148; shall be deemed to be followed by the words &#147;consistent with past
practice,&#148; subject, however, to such commercially reasonable actions as are reasonably necessary given changing economics and other conditions, circumstances or events relating to or arising from the
<FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) All references to time shall refer to New York City time unless otherwise
specified. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;II </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT TO SELL AND PURCHASE; CONVERSION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <I>Sale and Purchase; Conversion of Conversion Amount</I>. Subject to the terms and conditions hereof, at the Closing,
(a)&nbsp;(i)&nbsp;the Company shall issue and sell to VGO Illiquid Investments, and VGO Illiquid Investments shall purchase from the Company, the VGO Illiquid Investments Purchased Shares in exchange for payment by VGO Illiquid Investments to the
Company of the VGO Illiquid Investments Purchase Price and (ii)&nbsp;the Company shall issue and sell to VGO Drawdown, and VGO Drawdown shall purchase from the Company, the VGO Drawdown Purchased Shares in exchange for payment by VGO Drawdown to the
Company of the VGO Drawdown Purchase Price and (b)&nbsp;the Conversion Amount (as defined in the Loan Agreement) shall be converted into the Converted Shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <I>The Closing</I>. The consummation of the Viking Transaction shall take place at a closing (the &#147;<B>Closing</B>&#148;) to occur at
(a)&nbsp;9:00 a.m., New York City time, at the offices of Kirkland&nbsp;&amp; Ellis LLP, 601 Lexington Avenue, New York, NY 10022, on the fifth Business Day after the satisfaction or waiver (to the extent permitted hereunder) of the last to be
satisfied or waived of the conditions set forth in <U>Article</U><U></U><U>&nbsp;VII</U> (other than those conditions that by their terms are to be satisfied at the Closing, but subject to the satisfaction or waiver (to the extent permitted
hereunder) of such conditions); or (b)&nbsp;such other time, location and date as the Parties mutually agree in writing. The date on which the Closing actually occurs is referred to as the &#147;<B>Closing Date</B>.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 <I>Adjustments</I>. Without limiting or affecting any of the provisions of <U>Section</U><U></U><U>&nbsp;5.2</U>, if between the date of
this Agreement and the Closing Date the outstanding shares of Company Common Stock shall have been changed into a different number of shares or a different class by reason of the occurrence of any stock split, reverse stock split, stock dividend
(including any dividend or other distribution of securities convertible into Company Common Stock), reorganization, recapitalization, reclassification, combination, exchange of shares or other like change, the Share Price, VGO Drawdown Purchase
Price, VGO Illiquid Investments Purchase Price and Acquired Shares to be delivered pursuant to this <U>Article</U><U></U><U>&nbsp;II</U> shall be appropriately adjusted to reflect such stock split, reverse stock split, stock dividend (including any
dividend or other distribution of securities convertible into Company Common Stock), reorganization, recapitalization, reclassification, combination, exchange of shares or other like change. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4 <I>Independent Nature of Purchaser</I><I>&#146;</I><I>s Obligations and Rights</I>. The
obligations of Purchaser under this Agreement are several and not joint with the obligations of the Casdin Purchaser, and Purchaser shall not be responsible in any way for the performance of the obligations of the Casdin Purchaser under the Casdin
Purchase Agreement. Nothing contained herein, and no action taken by Purchaser pursuant hereto or the Casdin Purchaser pursuant to the Casdin Purchase Agreement, shall be deemed to constitute a partnership, an association, a joint venture or any
other kind of entity among Purchaser and the Casdin Purchaser, or create a presumption that Purchaser and the Casdin Purchaser are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by this
Agreement or the Casdin Purchase Agreement. Purchaser shall be entitled to independently protect and enforce its rights, including the rights arising out of this Agreement, and it shall not be necessary for the Casdin Purchaser to be joined as an
additional party in any proceeding for such purpose. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;III </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES OF THE COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except (a)&nbsp;as disclosed in the Company SEC Reports filed by the Company or furnished by the Company to the SEC, in each case pursuant to
the Exchange Act on or after January&nbsp;1, 2019 and at least two Business Days prior to the date of this Agreement (other than any disclosures contained or referenced therein under the captions &#147;Risk Factors&#148; and &#147;Quantitative and
Qualitative Disclosures About Market Risk&#148; or set forth in any &#147;forward-looking statements&#148; disclaimer, and any other <FONT STYLE="white-space:nowrap">non-specific</FONT> or <FONT STYLE="white-space:nowrap">non-precise</FONT>
cautionary, predictive or forward-looking language contained or referenced therein) or (b)&nbsp;subject to the terms of <U>Section</U><U></U><U>&nbsp;9.13</U>, as set forth in the disclosure letter delivered by the Company to Purchaser on the date
of this Agreement (the &#147;<B>Company Disclosure Letter</B>&#148;), the Company hereby represents and warrants to Purchaser as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 <I>Organization; Good Standing</I>. The Company is a corporation duly organized, validly existing and in good standing pursuant to the
General Corporation Law of the State of Delaware (the &#147;<B>DGCL</B>&#148;). The Company has the requisite corporate power and authority to conduct its business as it is presently being conducted and to own, lease or operate its properties,
rights and assets, except where the failure to have such power or authority, individually or in the aggregate, has not had and would not reasonably be expected to have a Company Material Adverse Effect. The Company is duly qualified to do business
and is in good standing in each jurisdiction where the character of its properties owned or leased or the nature of its activities make such qualification necessary (with respect to jurisdictions that recognize the concept of good standing), except
where the failure to be so qualified or in good standing has not had and would not reasonably be expected to have a Company Material Adverse Effect. The Company has made available to Purchaser true, correct and complete copies of the Amended and
Restated Certificate of Incorporation (the &#147;<B>Charter</B>&#148;) and the Amended and Restated Bylaws of the Company (the &#147;<B>Bylaws</B>&#148;), each as amended to date. The Company is not in violation of the Charter or the Bylaws in any
material respect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <I>Corporate Power; Enforceability</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the filing of the Certificate of Amendment with the Secretary of State for the State of Delaware, the Company has the requisite
corporate power and authority to: (i)&nbsp;execute and deliver this Agreement and the other Transaction Documents; (ii)&nbsp;perform its covenants and obligations hereunder and thereunder; and (iii)&nbsp;subject to receiving the Requisite
Stockholder Approval and assuming that the representations set forth in <U>Section</U><U></U><U>&nbsp;4.6</U> are true and correct, consummate the Viking Transaction and the other transactions contemplated by this Agreement and the other Transaction
Documents. The execution and delivery of this Agreement and the other Transaction Documents by the Company, the performance by the Company of its covenants and obligations hereunder, and the consummation of the transactions contemplated by this
Agreement and the other Transaction Documents, have been duly authorized and approved by the Company Board, and except for obtaining the Requisite Stockholder Approval and assuming that the representations set forth in
<U>Section</U><U></U><U>&nbsp;4.6</U> are true and correct, no other corporate action on the part of the Company or the Company Stockholders is necessary to authorize the execution and delivery of this Agreement or the other Transaction Documents,
the performance by the Company of its covenants and obligations and the consummation by the Company of the transactions contemplated by this Agreement or the other Transaction Documents. This Agreement and each other Transaction Document has been
duly executed and delivered by the Company and, assuming the due authorization, execution and delivery by Purchaser, constitutes a legal, valid and binding agreement of the Company, enforceable against the Company in accordance with its terms,
except as such enforceability (A)&nbsp;may be limited by applicable bankruptcy, insolvency, reorganization, moratorium and other similar Laws affecting or relating to creditors&#146; rights generally or (B)&nbsp;is subject to general principles of
equity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Subject to the receipt of the Requisite Stockholder Approval and assuming that the representations set forth in
<U>Section</U><U></U><U>&nbsp;4.6</U> are true and correct, the Company has all requisite power and authority to issue, sell and deliver the Acquired Shares in accordance with and on the terms and conditions set forth in this Agreement, the Loan
Agreement and the Certificate of Designations. The Certificate of Designations will set forth the rights, preferences and priorities of the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock, and the holders of the Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Preferred Stock shall have the rights set forth in the Certificate of Designations on filing with the Secretary of State for the State of Delaware. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <I>Company Board Approval; Anti-Takeover Laws</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Company Board Approval</I>. The Company Board, at a meeting duly called and held, has adopted resolutions, prior to the execution of
this Agreement unanimously (i)&nbsp;determining that it is in the best interests of the Company and the Company Stockholders that the Company enter into this Agreement and the other Transaction Documents and consummate the Viking Transaction and the
other transactions contemplated hereby and thereby on the terms and subject to the conditions set forth herein and therein, (ii)&nbsp;approving and declaring advisable this Agreement, the other Transaction Documents, the Viking Transaction and the
other transactions contemplated hereby and thereby on the terms and subject to the conditions set forth herein and therein, (iii)&nbsp;resolving to recommend that the Company Stockholders approve the Transactions and the Certificate of Amendment and
(iv)&nbsp;directing that the Transactions and the Certificate of Amendment be submitted to the Company Stockholders for approval and adoption (clauses (ii), (iii) and (iv), collectively, the &#147;<B>Company Board Recommendation</B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Anti-Takeover Laws</I>. Assuming that the representations of Purchaser set forth in
<U>Section</U><U></U><U>&nbsp;4.6</U> are true and correct, the Company Board has taken all necessary actions so that the restrictions contained in Section&nbsp;203 of the DGCL applicable to a &#147;business combination&#148; (as defined in
Section&nbsp;203 of the DGCL) shall not apply to the execution, delivery or performance of this Agreement or the other Transaction Documents or the consummation of the Viking Transaction or other transactions contemplated hereby and thereby
(including with respect to the issuance of the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock or the shares of Company Common Stock issuable on conversion of the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock)
and any other similar applicable &#147;anti-takeover&#148; Law will not be applicable to this Agreement or the other Transaction Documents or the consummation of the Viking Transaction or any other transaction contemplated hereby or thereby. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4 <I>Requisite Stockholder Approval</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The approval of the Transactions by the affirmative vote of a majority of the voting power of the shares of Company Common Stock present in
person or represented by proxy at the Company Stockholder Meeting and entitled to vote on the subject matter (the &#147;<B>Viking Approval</B>&#148;) and the adoption of the Certificate of Amendment by a majority of the outstanding shares of Company
Common Stock entitled to vote (together with the Viking Approval, the &#147;<B>Requisite Stockholder Approval</B>&#148;) are the only votes or approvals of the holders of any class or series of capital stock of the Company necessary under applicable
Law, the NASDAQ rules, the Charter or the Bylaws to consummate the Viking Transaction and the other transactions contemplated in this Agreement and the other Transaction Documents. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) No appraisal or dissenters&#146; rights (pursuant to Section&nbsp;262 of the DGCL or otherwise) will be available to holders of shares of
Company Common Stock in connection with the Viking Transaction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.5 <I><FONT STYLE="white-space:nowrap">Non-Contravention</FONT></I>. The
execution and delivery of this Agreement by the Company, the performance by the Company of its covenants and obligations hereunder, and the consummation of the Viking Transaction and the other transactions contemplated by this Agreement and the
other Transaction Documents do not: (a)&nbsp;violate or conflict with any provision of the Charter or the Bylaws; (b)&nbsp;violate, conflict with, result in the breach of, constitute a default (or an event that, with notice or lapse of time or both,
would become a default) pursuant to, result in the termination of, accelerate the performance required by, or result in a right of termination or acceleration or the vesting or receipt of any benefit or value to a third party, pursuant to any
Contract; (c)&nbsp;assuming compliance with the matters referred to in <U>Section</U><U></U><U>&nbsp;3.6</U> and, in the case of the consummation of the Viking Transaction, subject to obtaining the Requisite Stockholder Approval and assuming that
the representations set forth in <U>Section</U><U></U><U>&nbsp;4.6</U> are true and correct, violate or conflict with any Law or order applicable to the Company or any of its Subsidiaries or by which any of their respective properties or assets are
bound; or (d)&nbsp;result in the creation of any Lien (other than Permitted Liens) on any of the properties or assets of the Company or any of its Subsidiaries, except in the case of each of clauses (b), (c) and (d)&nbsp;for such consents as have
been obtained and violations, conflicts, breaches, defaults, terminations, accelerations or Liens that have not had, and would not reasonably be expected to have, a Company Material Adverse Effect or prevent or materially impair or materially delay,
or be reasonably expected to prevent or materially impair or materially delay, the consummation of the Casdin Transaction and/or Viking Transaction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.6 <I>Requisite Governmental Approvals</I>. No Governmental Authorization is required on
the part of the Company in connection with: (a)&nbsp;the execution and delivery of this Agreement by the Company; (b)&nbsp;the performance by the Company of its covenants and obligations pursuant to this Agreement; or (c)&nbsp;the consummation of
the Viking Transaction and the other transactions contemplated by this Agreement, except (i)&nbsp;the filing of the Certificate of Designations and the Certificate of Amendment with the Secretary of State of the State of Delaware, (ii)&nbsp;such
filings and approvals as may be required by any applicable federal or state securities Laws, including compliance with any applicable requirements of the Exchange Act, (iii)&nbsp;compliance with any applicable requirements of NASDAQ;
(iv)&nbsp;compliance with any applicable requirements of the HSR Act and any applicable foreign Antitrust Laws, and (v)&nbsp;such other Governmental Authorizations the failure of which to obtain would not reasonably be expected to have a Company
Material Adverse Effect or prevent or materially impair or materially delay, or be reasonably expected to prevent or materially impair or materially delay, the consummation of the Casdin Transaction and/or Viking Transaction. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.7 <I>Company Capitalization</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Capital Stock</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The authorized capital stock of the Company consists of (i)&nbsp;200,000,000 shares of Company Common Stock and
(ii)&nbsp;10,000,000 shares of preferred stock, par value $0.001 per share, of the Company (the &#147;<B>Company Preferred Stock</B>&#148;). As of 5:00&nbsp;p.m., New York City time, on January&nbsp;13, 2022 (such time and date, the
&#147;<B>Capitalization Date</B>&#148;): (A)&nbsp;76,919,287 shares of Company Common Stock were issued and outstanding; (B)&nbsp;no shares of Company Preferred Stock were issued and outstanding; and (C)&nbsp;no shares of Company Common Stock were
held by the Company as treasury shares. From the Capitalization Date to the date of this Agreement, the Company has not issued or granted any Company Securities other than pursuant to the exercise, vesting or settlement of Company Options, Company
RSUs and Company PSUs granted prior to the date of this Agreement in accordance with their respective terms or pursuant to the terms of the Company Notes in accordance with their terms. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) All issued and outstanding shares of Company Common Stock are duly authorized and validly issued, fully paid,
nonassessable and free of any preemptive or similar rights. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Stock Reservation and Awards</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) As of the Capitalization Date, the Company has reserved 3,539,935 shares of Company Common Stock for issuance pursuant to
the Company Stock Plans, which number excludes shares subject to outstanding awards and 20,312,725 shares of Company Common Stock for issuance pursuant to the Company Notes. As of the Capitalization Date, there were outstanding: (i)&nbsp;Company
Options to acquire 1,596,806 shares of Company Common Stock with a weighted average exercise price of $7.0841; (ii)&nbsp;5,118,456 shares of Company Common Stock subject to outstanding Company RSUs; (iii)&nbsp;2,448,042 shares of Company Common
Stock subject to outstanding Company PSUs (based on maximum achievement, if applicable) (iv)&nbsp;2,633,013 shares of Company Common Stock reserved for issuance under the Company ESPP; and (v)&nbsp;43,750 shares of Company Common Stock estimated to
be subject to outstanding purchase rights under the Company ESPP. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Section&nbsp;3.7(b)(ii) of the Company Disclosure Letter sets forth a
correct and complete list of all equity awards outstanding as of the Capitalization Date, including with respect to each such equity award: (A)&nbsp;the name of the holder thereof; (B)&nbsp;the number of shares subject to such equity award;
(C)&nbsp;the grant or issuance date; (D)&nbsp;any applicable vesting schedule, including the amounts vested and unvested; and (E)&nbsp;with respect to each Company Option, (1)&nbsp;the exercise price and (2)&nbsp;the expiration date. All Company
Options have an exercise price per share of Company Common Stock that may be purchased thereunder that was not less than the &#147;fair market value&#148; of such share on the date of grant, as determined in accordance with the terms of the
applicable granting instrument, the applicable Company Stock Plan and, to the extent applicable, Sections 409A and 422 of the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
<I>Company Securities</I>. Except as set forth in <U>Section</U><U></U><U>&nbsp;3.7(a)</U> or <U>3.7(b)</U>, there are (i)&nbsp;no issued and outstanding shares of capital stock of, or other equity or voting interest in, the Company, (ii)&nbsp;no
outstanding securities of the Company convertible into or exchangeable or exercisable for shares of capital stock of, or other equity or voting interest in, the Company, (iii)&nbsp;no outstanding options, warrants or other rights or binding
arrangements to acquire from the Company, or that obligate the Company to issue, any capital stock of, or other equity or voting interest in, or any securities convertible into or exchangeable or exercisable for shares of capital stock of, or other
equity or voting interest in, the Company, (iv)&nbsp;no obligations of the Company to grant, extend or enter into any subscription, warrant, right, convertible or exchangeable security, or other similar Contract relating to any capital stock of, or
other equity or voting interest (including any voting debt) in, the Company, (v)&nbsp;no outstanding restricted shares, restricted share units, stock appreciation rights, performance shares, contingent value rights, &#147;phantom&#148; stock or
similar securities or rights that are derivative of, or provide economic benefits based, directly or indirectly, on the value or price of, any capital stock of, or other securities or ownership interests in, the Company and (vi)&nbsp;no other
obligations of the Company to make any payment based on the price or value of any of the items in the foregoing clauses&nbsp;(i) through (v) (the items in clauses (i), (ii), (iii), (iv), (v) and (vi), collectively, the &#147;<B>Company
Securities</B>&#148;); (vii)&nbsp;no voting trusts, proxies or similar arrangements or understandings to which the Company is a party or by which the Company is bound with respect to the voting of any shares of capital stock of, or other equity or
voting interest in, the Company; and (viii)&nbsp;no obligations or binding commitments of any character restricting the transfer of any shares of capital stock of, or other equity or voting interest in, the Company to which the Company is a party or
by which it is bound. Other than the Company Notes, the Company is not a party to any Contract that obligates it to repurchase, redeem or otherwise acquire any Company Securities. There are no accrued and unpaid dividends with respect to any
outstanding Company Securities. The Company does not have a stockholder rights plan in effect or outstanding bonds, debentures, notes or other similar obligations which provide such holder the right to vote with the holders of shares of Company
Common Stock on any matter. The announcement or consummation of the Viking Transaction and the other transactions contemplated by this Agreement will not, in and of themselves, result in any vesting, acceleration or the receipt of any rights,
benefits or value under any issued and outstanding Company Securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Other Rights</I>. The Company is not a party to any Contract relating to the voting
of, requiring registration of, or granting any preemptive or similar rights, anti-dilutive rights or rights of first refusal or other similar rights with respect to any Company Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <I>Valid Issuance of Shares</I>. The Acquired Shares and the Underlying Shares to be issued on conversion of the Acquired Shares will be
duly authorized by the Company and, when issued and delivered by the Company in accordance with this Agreement, the Loan Agreement and the Certificate of Designations against payment of the consideration set forth herein, will be validly issued,
fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and will be free and clear of any and all Liens and restrictions on transfer, except for generally applicable transfer restrictions under applicable securities Law, the
Stockholders Agreement or the Charter or such Liens as are created by Purchaser. There are no Persons entitled to statutory, preemptive or other similar contractual rights to subscribe for the Acquired Shares or the Underlying Shares nor are there
any other restrictions on transfer under any contract to which the Company is a party. On issuance in accordance with the Certificate of Designations, the Underlying Shares will be duly authorized, validly issued, fully paid and <FONT
STYLE="white-space:nowrap">non-assessable</FONT> and will be free and clear of any and all Liens and restrictions on transfer, other than (i)&nbsp;restrictions on transfer under the Certificate of Designations, under this Agreement and under
applicable state and federal securities laws and (ii)&nbsp;such Liens as are created by Purchaser. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.8 <I>Subsidiaries</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of the Subsidiaries of the Company (i)&nbsp;is duly organized, validly existing and in good standing (with respect to jurisdictions
that recognize the concept of good standing) under the laws of the jurisdiction of its organization and (ii)&nbsp;has the requisite corporate power and authority to conduct its business as it is presently being conducted and to own, lease or operate
its properties and assets, except in each case as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect. Each of the Subsidiaries of the Company is duly qualified to do business and is in good standing in each
jurisdiction where the character of its properties owned or leased or the nature of its activities make such qualification necessary (with respect to jurisdictions that recognize the concept of good standing), except where the failure to be so
qualified or in good standing has not had, and would not reasonably be expected to have, a Company Material Adverse Effect. The Company has made available to Purchaser true, correct and complete copies of the Organizational Documents of each of the
Subsidiaries of the Company. No Subsidiary is in violation of any of its Organizational Documents in any material respect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of the
Subsidiaries of the Company is wholly owned by the Company, directly or indirectly, free and clear of any Liens. Other than for routine cash management purposes and for securities held by employee benefit plans, the Company does not own, directly or
indirectly, any capital stock or other equity interest of, or any other securities convertible or exchangeable into or exercisable for capital stock or other equity interest of, any Person other than the Subsidiaries of the Company, and the Company
directly or indirectly owns all outstanding Subsidiary Securities. No Subsidiary of the Company owns any shares of capital stock or other securities of the Company. <U>Section</U><U></U><U>&nbsp;3.8(b)</U> of the Company Disclosure Letter sets forth
each of the Subsidiaries of the Company existing as of the date of this Agreement. Neither the Company nor any of its Subsidiaries has any Contract pursuant to which it is obligated to make any investment (in the form of a loan, capital contribution
or otherwise) in any Person (other than the Company with respect to its Subsidiaries and the Subsidiaries with respect to each other). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.9 <I>Company SEC Reports</I>. Since January&nbsp;1, 2019 through the date of this
Agreement, the Company has filed or furnished all forms, reports and documents with the SEC that have been required to be filed or furnished by it pursuant to applicable Laws prior to the date of this Agreement (the &#147;<B>Company SEC
Reports</B>&#148;). Each Company SEC Report complied, as of its filing date (or, if amended or superseded by a filing prior to the date of this Agreement, on the date of such amended or superseding filing), in all material respects with the
applicable requirements of the Sarbanes-Oxley Act of 2002, the Securities Act or the Exchange Act, as the case may be, each as in effect on the date that such Company SEC Report was filed. True, correct and complete copies of all Company SEC Reports
are publicly available in the Electronic Data Gathering, Analysis and Retrieval database of the SEC. As of its filing date (or, if amended or superseded by a filing prior to the date of this Agreement, on the date of such amended or superseded
filing), no Company SEC Report contained any untrue statement of a material fact or omitted to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not
misleading. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.10 <I>Company Financial Statements; Internal Controls</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Company Financial Statements</I>. The consolidated financial statements (including any related notes and schedules) of the Company filed
with the Company SEC Reports: (i)&nbsp;were prepared in accordance Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Exchange Act and with GAAP (except as may be indicated in the notes thereto or as otherwise permitted by Form <FONT
STYLE="white-space:nowrap">10-Q</FONT> with respect to any financial statements filed on <FONT STYLE="white-space:nowrap">Form&nbsp;10-Q);</FONT> (ii) complied, as of their respective date of filing with the SEC, in all material respects with the
published rules and regulations of the SEC with respect thereto and (iii)&nbsp;fairly present, in all material respects, the consolidated financial position of the Company as of the dates thereof and the consolidated results of operations and cash
flows for the periods then ended (subject, in the case of the unaudited financial statements, to normal and recurring <FONT STYLE="white-space:nowrap">year-end</FONT> and audit adjustments). Neither the Company nor any of its Subsidiaries is a party
to or bound by, or has any commitment to become a party to, any joint venture, <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet partnership or any similar Contract (including any Contract or arrangement relating to any transaction or
relationship between or among the Company or any of its Subsidiaries, on the one hand, and any unconsolidated Affiliate, on the other hand), including any structured finance, special purpose or limited purpose entity or Person, or any <FONT
STYLE="white-space:nowrap">&#147;off-balance</FONT> sheet arrangements&#148; (as defined in Item&nbsp;303(a) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated under the Securities Act), where the result, purpose or effect of such
Contract is to avoid disclosure of any material transaction involving, or material liabilities of, the Company or any of its Subsidiaries in the Company SEC Reports (including any audited financial statements and unaudited interim financial
statements of the Company included therein). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Disclosure Controls and Procedures</I>. The Company has established and maintains, and
at all times since January&nbsp;1, 2019 has maintained, &#147;disclosure controls and procedures&#148; and &#147;internal control over financial reporting&#148; (in each case as defined pursuant to Rule <FONT STYLE="white-space:nowrap">13a-15</FONT>
and Rule <FONT STYLE="white-space:nowrap">15d-15</FONT> promulgated under the Exchange Act) that are (i)&nbsp;with respect to disclosure controls and procedures, reasonably designed to ensure that all material information (both financial and <FONT
STYLE="white-space:nowrap">non-financial)</FONT> required to be disclosed by the Company in the reports that it </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and that all such material information
required to be disclosed is accumulated and communicated to the management of the Company, as appropriate, to allow timely decisions regarding required disclosure and to enable the chief executive officer and chief financial officer of the Company
to make the certifications required under the Exchange Act with respect to such reports, and (ii)&nbsp;with respect to internal control over financial reporting, sufficient in all material respects to provide reasonable assurance (A)&nbsp;that
transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP, (B)&nbsp;that transactions are executed only in accordance with the authorization of management and (C)&nbsp;regarding prevention or timely
detection of the unauthorized acquisition, use or disposition of the Company&#146;s properties or assets, in each case that could have a material effect on the Company&#146;s financial statements. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Internal Controls</I>. The Company has established and maintains a system of internal accounting controls that are effective in
providing reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with GAAP. Neither the Company nor, to the Knowledge of the Company, the Company&#146;s independent registered
public accounting firm, has identified or been made aware of: (i)&nbsp;any significant deficiency or material weakness in the system of internal control over financial reporting used by the Company and its Subsidiaries that has not been subsequently
remediated; or (ii)&nbsp;any fraud that involves the Company&#146;s management or other employees who have a role in the preparation of financial statements or the internal control over financial reporting utilized by the Company and its
Subsidiaries. Since January&nbsp;1, 2019, neither the Company nor any of its Subsidiaries nor, to the Company&#146;s Knowledge, any director, officer, employee, auditor, accountant or representative of the Company or any of its Subsidiaries has
received any written complaint, allegation, assertion, or claim (or otherwise has been informed) that the Company or any of its Subsidiaries has engaged in improper or illegal accounting or auditing practices or maintains improper or inadequate
internal accounting controls. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) As of the date of this Agreement, there are no outstanding or unresolved comments in any comment letters
from the staff of the SEC relating to the Company&#146;s SEC Reports and received by the Company prior to the date of this Agreement. None of the Company&#146;s SEC Reports filed on or prior to the date of this Agreement, is, to the Company&#146;s
Knowledge, subject to ongoing SEC review or investigation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.11 <I>No Undisclosed Liabilities</I>. Neither the Company nor any of its
Subsidiaries has any liabilities (accrued, absolute, contingent or otherwise) of a nature required to be reflected or reserved against on a balance sheet prepared in accordance with GAAP, as in effect on the date of this Agreement, or notes thereto,
other than liabilities: (a)&nbsp;reflected or otherwise reserved against in the Audited Company Balance Sheet or in the consolidated financial statements of the Company and its Subsidiaries (including the notes thereto) included in the Company SEC
Reports filed prior to the date of this Agreement; (b)&nbsp;arising pursuant to this Agreement or the Casdin Purchase Agreement or incurred in connection with the Casdin Transaction or the Viking Transaction; (c)&nbsp;incurred in the ordinary course
of business (none of which is a liability resulting from noncompliance with any applicable Laws or licenses, breach of Contract, breach of warranty, tort, infringement, misappropriation, dilution, claim or lawsuit); or (d)&nbsp;that, individually or
in the aggregate, have not had, and would not reasonably be expected to have, a Company Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.12 <I>Absence of Certain Changes</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Since September&nbsp;30, 2021 through the date of this Agreement (i)&nbsp;the business of the Company and its Subsidiaries has been
conducted, in all material respects, in the ordinary course of business and (ii)&nbsp;there has not been any action taken by the Company or any of its Subsidiaries that, if taken during the period from the date of this Agreement through the Closing
without Purchaser&#146;s consent, would constitute a breach of, or require consent of Purchaser under <U>Section</U><U></U><U>&nbsp;5.2(b)</U>, <U>Section</U><U></U><U>&nbsp;5.2(c)</U>, <U>Section</U><U></U><U>&nbsp;5.2(d)</U>,
<U>Section</U><U></U><U>&nbsp;5.2(i)</U>, <U>Section</U><U></U><U>&nbsp;5.2(k)</U> or <U>Section</U><U></U><U>&nbsp;5.2(l)</U> (as it relates to the foregoing sections). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Since December&nbsp;31, 2020 through the date of this Agreement, there has not been any effect, change, development or occurrence that,
individually or in the aggregate, has had, or would reasonably be expected to have, a Company Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.13 <I>Material
Contracts</I>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>List of Material Contracts</I>. Section&nbsp;3.13(a) of the Company Disclosure Letter contains a true, correct and
complete list of all Material Contracts, as of the date of this Agreement, to which the Company or any of its Subsidiaries is a party. Prior to the date of this Agreement, the Company has made available to Purchaser complete and correct copies of
all of the Material Contracts. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Validity</I>. Each Material Contract (other than any Material Contract that has expired in
accordance with its terms) is valid and binding on the Company or each Subsidiary of the Company that is a party thereto (as the case may be) and, to the Knowledge of the Company, any other party thereto and is enforceable in accordance with its
terms, and is in full force and effect, except where the failure to be valid and binding and in full force and effect has not had, and would not reasonably be expected to have, a Company Material Adverse Effect. The Company and each of its
Subsidiaries, and, to the Knowledge of the Company, any other party thereto, has performed all obligations required to be performed by it under each Material Contract, except where the failure to fully perform has not had, and would not reasonably
be expected to have, a Company Material Adverse Effect. No event has occurred that, whether or not with notice or lapse of time or both, would constitute such a breach, default, acceleration of rights or an event of termination pursuant to any
Material Contract by the Company or any of its Subsidiaries, or, to the Knowledge of the Company, any other party thereto, except for such breaches, defaults, acceleration or termination that have not had, and would not reasonably be expected to
have, a Company Material Adverse Effect. As of the date of this Agreement, neither the Company nor any of its Subsidiaries has received written notice that it has breached, violated or defaulted under any Material Contract. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.14 <I>Real Property</I>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
<I>Owned Real Property</I>. Neither the Company nor any of its Subsidiaries owns any real property. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Leased Real Property</I>. Section&nbsp;3.14(b) of the Company Disclosure Letter
contains a true, correct and complete list, as of the date of this Agreement, of all of the existing material leases, subleases, licenses or other agreements pursuant to which the Company or any of its Subsidiaries, leases, subleases, uses or
occupies, or has the right to use or occupy, now or in the future, any real property for which the annual rent is in excess of $100,000 (such property, the &#147;<B>Leased Real Property</B>,&#148; and each such lease, sublease, license or other
agreement, a &#147;<B>Lease</B>&#148;). The Company has made available to Purchaser true, correct and complete copies of the Leases (including all material modifications, amendments and supplements thereto). Except as has not had, and would not
reasonably be expected to have, a Company Material Adverse Effect, the Company or one of its Subsidiaries has valid leasehold estates in the Leased Real Property, free and clear of all Liens (other than Permitted Liens). Each Lease is legal, valid,
binding, enforceable and in full force and effect. Neither the Company&#146;s nor any of its Subsidiaries&#146; possession and quiet enjoyment of the Leased Real Property under any Lease has been disturbed, and there are no disputes with respect to
any such Lease in any material respect. Neither the Company nor any of its Subsidiaries is in material breach of or default pursuant to any Lease. There are no material subleases, licenses or similar agreements granting to any Person, other than the
Company or any of its Subsidiaries, any right to use or occupy the Leased Real Property or any portion thereof, now or in the future. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.15
<I>Environmental Matters</I>. Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect: (a)&nbsp;the Company and its Subsidiaries are, and since January&nbsp;1, 2019, have been, in compliance with all
Environmental Laws and Environmental Permits (including obtaining and maintaining all such Environmental Permits); (b) since January&nbsp;1, 2019 (or earlier if unresolved), no notice, report, order, directive or other information has been received
by the Company or any of its Subsidiaries alleging any violation of, or liability arising out of, any Environmental Law; (c)&nbsp;no Legal Proceeding is pending or, to the Knowledge of the Company, threatened against the Company or any of its
Subsidiaries relating to a violation of, or liability under, any Environmental Law; (d)&nbsp;neither the Company nor any of its Subsidiaries has transported, manufactured, distributed, sold, handled, stored, treated, released, disposed or arranged
for disposal of, or exposed any Person to, any Hazardous Materials, or owned or operated any real property or facility contaminated by any Hazardous Materials, in each case, that has resulted, or would reasonably be expected to result, in an
investigation or required cleanup by, or other liability (contingent or otherwise) for, the Company or any of its Subsidiaries; and (e)&nbsp;the Company and its Subsidiaries have not assumed, provided an indemnity with respect to or otherwise become
subject to the liability of any other Person relating to Environmental Laws. The Company has made available to Purchaser copies of all environmental reports, audits and assessments and all other material documents bearing on environmental, health or
safety matters relating to the Company, any of its Subsidiaries, or any of their current or former facilities, properties or operations. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.16 <I>Intellectual Property</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Within 10 days after the date of this Agreement, the Company shall provide Purchaser with a true, correct and complete (i)&nbsp;list of all
Registered Intellectual Property owned by, or registered in the name of, the Company or any of its Subsidiaries (for each, indicating, as applicable, the owner(s), filing or registration number, title, jurisdiction, filing date and status and, for
Internet domain names, the registrant, registrar, and expiration date) and (ii)&nbsp;description of all material Company Software. All material Registered Intellectual Property is subsisting, and to the Knowledge of the Company, excluding any
pending patent applications, valid and enforceable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company and its Subsidiaries solely and exclusively own all right, title, and
interest in and to all Registered Intellectual Property and all other material Intellectual Property that is owned or purported to be owned by the Company or any of its Subsidiaries, including all Company Software (the &#147;<B>Company Owned
IP</B>&#148;), and is licensed or otherwise possesses adequate rights to use pursuant to a valid license or subscription agreement, all material Intellectual Property used or held for use in, or necessary for, their respective businesses as
currently conducted (collectively, and together with the Company Owned IP, the &#147;<B>Company Intellectual Property</B>&#148;), in each case free and clear of all Liens (other than Permitted Liens). The Company has not (i)&nbsp;sold, transferred,
or otherwise divested any Intellectual Property that would be Company Owned IP, but for such sale, transfer, or divestiture, or (ii)&nbsp;granted any Person any exclusive right to any Company Owned IP. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company and its Subsidiaries have taken commercially reasonable actions to maintain and protect all of the Company Owned IP, including
the secrecy, confidentiality and value of the material Trade Secrets of the Company and its Subsidiaries. All past and present employees, consultants and contractors of the Company and its Subsidiaries who have had access to material Trade Secrets
of the Company and its Subsidiaries or have authored, developed or otherwise created any material Company Intellectual Property for the Company, have executed written agreements pursuant to which such Person (i)&nbsp;is bound to maintain and protect
the confidential information of the Company and its Subsidiaries, and (ii)&nbsp;in accordance with applicable Laws and without further consideration or any restrictions or obligations on the Company or any of its Subsidiaries, assigns to the Company
or its applicable Subsidiaries all of their respective ownership rights in the Intellectual Property authored, developed or otherwise created by such Person in the course of such Person&#146;s employment or other engagement with the Company and its
Subsidiaries. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) No Company Owned IP is subject to any consent, settlement, decree, order, injunction, judgment or ruling prohibiting or
restricting the Company&#146;s or any of its Subsidiaries&#146; use, ownership, enforcement or other exploitation or disposition thereof, except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect. No
Company Owned IP is subject to any proceeding or outstanding decree, order, judgment or settlement agreement to which the Company or one of its Subsidiaries is a party, or, to the Knowledge of the Company, to which any third Person is a party, that
restricts in any manner the use, provision, transfer, assignment or licensing thereof by the Company or its Subsidiaries or affects the validity, use or enforceability of such Company Owned IP, except for any such prohibitions or restrictions that
would not have a Company Material Adverse Effect. The transactions contemplated by this Agreement and the consummation thereof will not impair any right, title or interest of the Company or any of its Subsidiaries in or to any Company Intellectual
Property or material Company Systems, and all of the Company Intellectual Property and material Company Systems will be owned or available for use by the Company and its Subsidiaries immediately after the Closing on terms and conditions identical to
those under which the Company and its Subsidiaries owned or used the Company Intellectual Property and material Company Systems immediately prior to the Closing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) No Company Owned IP was developed by the Company or any of its Subsidiaries using (in
whole or in part) government, public or private foundation, or university funding or facilities nor was it obtained from any Governmental Authority, public or private foundation, or university, and neither the Company nor any of its Subsidiaries has
granted to any Governmental Authority, public or private foundation, or university, either expressly, or by any act or omission, any unlimited, unrestricted or government purpose rights, or any similar rights in Company Owned IP. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) There are no claims by any Person that are either pending or made or, to the Knowledge of the Company, threatened in writing since
January&nbsp;1, 2019, (i)&nbsp;alleging infringement, misappropriation, or other violation by the Company or any of its Subsidiaries of any Intellectual Property of such Person, or (ii)&nbsp;contesting the validity, use, ownership, enforceability,
patentability or registrability of any material Company Owned IP, excluding any ordinary course &#147;office actions&#148; received by the Company or a Subsidiary in connection with the prosecution of Patents. Neither the Company nor any of its
Subsidiaries has received any written notices or written requests for indemnification from any third party related to any of the foregoing matters in clauses (i)&nbsp;and (ii). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;(i) Neither the Company nor any of its Subsidiaries, nor the conduct of the business of the Company and its Subsidiaries, including
the sale or licensing of the Company&#146;s products, infringes, misappropriates, or otherwise violates or, since January&nbsp;1, 2019, has infringed, misappropriated, or otherwise violated, any Intellectual Property of any Person in any material
respect; (ii)&nbsp;neither the Company nor any of its Subsidiaries has received any written notices regarding any of the foregoing matters in clause (i) (including any cease and desist letters, demands or unsolicited offers to license any
Intellectual Property from any Person); and (iii)&nbsp;to the Knowledge of the Company as of the date of this Agreement, no Person is infringing, misappropriating, or otherwise violating any Intellectual Property owned by the Company or any of its
Subsidiaries. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Company and its Subsidiaries have not incorporated in or distributed with any Company Software or Company Product
any Open Source Software in a manner that has subjected any Company Source Code to any requirement under any applicable Open Source License to distribute or otherwise disclose such Company Source Code. Neither the Company nor any of its Subsidiaries
have received a written notice or request from any Person to disclose, distribute or license any Company Source Code pursuant to an Open Source License, or alleging noncompliance with any such Open Source License. The Company and its Subsidiaries
possess all Company Source Code and other documentation and materials reasonably necessary for a developer competent in the programming language for such Software to compile, operate and maintain the Company Software. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Company and its Subsidiaries own, lease, license, or otherwise have the valid right to use all material Company Systems, and such
Company Systems are sufficient in all material respects for the needs of the Company&#146;s and its Subsidiaries&#146; businesses, and the Company and its Subsidiaries have purchased sufficient license rights for all material third party Software
used in their operations. All Company Software operates in all material respects in accordance with its requirements, technical, <FONT STYLE="white-space:nowrap">end-user</FONT> and other documentation. To the Knowledge of the Company, there are no
viruses, &#147;worms&#148;, &#147;time bombs&#148;, <FONT STYLE="white-space:nowrap">&#147;key-locks&#148;,</FONT> Trojan horses or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
similar disabling codes, programs or devices in any of the Company Software, or any other codes, programs or devices designed to disrupt or interfere with the operation of the Company Software or
equipment on which the Company Software operates, or the integrity of the Data, information or signals the Company Software produces in a manner adverse to the Company, any of its Subsidiaries, any customer, licensee or other Person. The Company and
its Subsidiaries have not delivered, licensed, or made available, and is not obligated to deliver, license, or make available any Company Source Code to any escrow agent or other Person who is not an employee, contractor or other service provider of
the Company or any of its Subsidiaries, and any Person providing backup, source code repository, hosting and similar services to Company or its Subsidiaries. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Since January&nbsp;1, 2019: (i) the Company and its Subsidiaries (including the conduct of their respective businesses and their Processing
of Data) have complied with all Data Security Requirements in all material respects; (ii)&nbsp;there has not been any Security Incident; and (iii)&nbsp;the Company and its Subsidiaries have taken commercially reasonable actions, including
instituting commercially reasonable physical, technical, and administrative security measures and policies, to protect the security and integrity of the Company Systems, all Data stored or contained therein or transmitted thereby, and all Sensitive
Information from and against unauthorized access, use, or disclosure. Since January&nbsp;1, 2019, neither the Company nor any of its Subsidiaries has (i)&nbsp;provided or been required under any applicable Data Security Requirement to provide any
notices to data owners in connection with any unauthorized access, use or disclosure of Sensitive Information, (ii)&nbsp;received any written complaint from any Person regarding any Data Security Requirement, Security Incident, or Sensitive
Information, nor (iii)&nbsp;to the Knowledge of the Company, been subject to any investigations or audits by a Governmental Authority concerning any violation of Data Security Requirements, Security Incident, or Sensitive Information. The execution
and delivery of this Agreement by the Company and the consummation of the Viking Transaction will not result in any violation by the Company or its Subsidiaries of any applicable Data Security Requirement, except as would not reasonably be expected
to have a Company Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.17 <I>Tax Matters</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, each of the Company and its
Subsidiaries has: (i)&nbsp;timely filed (taking into account valid extensions) all Tax Returns required to be filed by it, and all Tax Returns are true, correct and complete in all respects; (ii)&nbsp;timely paid all Taxes that are due and payable
by it, except for those being contested in good faith by appropriate proceedings and for which adequate reserves have been established in accordance with GAAP; and (iii)&nbsp;reflected or otherwise reserved against in its books in accordance with
GAAP an amount reasonably adequate for the payment of all material amounts of Taxes for the taxable period subsequent to the latest period to which such Tax Returns apply. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect: (i)&nbsp;no audits or other
examinations with respect to Taxes of the Company or any of its Subsidiaries are presently in progress or have been asserted or proposed in writing, except for any audit or other examination for which adequate reserves have been made (in accordance
with GAAP); (ii) neither the Company nor any of its Subsidiaries has outstanding any waiver or extension of any statute of limitations on, or extended the period for the assessment </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or collection of any Tax; and (iii)&nbsp;no written claim has been made by a Governmental Authority in a jurisdiction where the Company or any of its Subsidiaries does not file Tax Returns of a
particular type that the Company or such Subsidiary, as the case may be, is or may be subject to Tax of such type in that jurisdiction. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, each of the Company and each of its
Subsidiaries (or its agent) has withheld or collected from each payment made to each of its employees or any other Person the amount of all Taxes required to be withheld or collected therefrom, and has paid the same to the proper Tax receiving
officers or authorized depositories. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company is not and has not been, during the five-year period ending on the date hereof, a
&#147;United States real property holding corporation&#148; within the meaning of Section&nbsp;897 of the Code and any applicable regulations promulgated thereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, there are no Liens for Taxes on the
assets of the Company or any of its Subsidiaries other than those described in clause (i)&nbsp;of the definition of Permitted Liens. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.18
<I>Employee Benefits</I>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Employee Plans</I>. Section&nbsp;3.18(a) of the Company Disclosure Letter sets forth a true, correct,
current and complete list of each material Employee Plan as of the date of this Agreement. With respect to each Employee Plan, copies of the following materials have been provided to Purchaser: (i)&nbsp;all current plan documents for each Employee
Plan and all amendments thereto (and for any unwritten Employee Plan, a summary of the material terms); (ii) the most recent determination letter from the IRS with respect to any of the Employee Plans; (iii)&nbsp;all current summary plan
descriptions, summaries of material modifications, annual reports and summary annual reports with respect to any of the Employee Plans; and (iv)&nbsp;all material <FONT STYLE="white-space:nowrap">non-routine</FONT> correspondence from a Governmental
Authority with respect to any of the Employee Plans. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Absence of Certain Plans</I>. Neither the Company, its Subsidiaries nor any
ERISA Affiliate of the Company has maintained, sponsored or participated in, or contributed to, in the <FONT STYLE="white-space:nowrap">six-year</FONT> period preceding the date hereof or otherwise has any liability or obligation with respect to:
(i)&nbsp;a &#147;multiemployer plan&#148; (as defined in Section&nbsp;3(37) or 4001(a)(3) of ERISA); (ii) a &#147;multiple employer plan&#148; (as defined in Section&nbsp;4063 or Section&nbsp;4064 of ERISA) or as described in Section&nbsp;413(c) of
the Code; (iii)&nbsp;a &#147;defined benefit plan&#148; as defined in the Section&nbsp;3(35) of ERISA or a plan that is or was subject to the funding standards of Section&nbsp;302 of ERISA or covered by Section&nbsp;412 of the Code or Title IV of
ERISA; or (iv)&nbsp;a &#147;multiple employer welfare arrangement&#148; (as defined in Section&nbsp;3(40) of ERISA). No event has occurred and, to the Knowledge of the Company, no condition exists that would, either directly or indirectly or by
reason of the Company&#146;s or any Subsidiary&#146;s affiliation with any ERISA Affiliate, subject the Company or any of its Subsidiaries to any material Tax, fine, lien, penalty or other liability imposed by ERISA, the Code or other applicable
Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Compliance</I>. Except as has not had, and would not reasonably be expected to have,
a Company Material Adverse Effect, each Employee Plan has been established, maintained, funded, operated and administered in accordance with its terms and with all applicable Law, including the applicable provisions of ERISA, the Code, the Patient
Protection and Affordable Care Act and any applicable regulatory guidance issued by any Governmental Authority. Each Employee Plan that is intended to be qualified under Section&nbsp;401(a) of the Code (i)&nbsp;has received a favorable determination
letter issued by the IRS regarding such qualified status or is maintained pursuant to a prototype or volume submitter document approved by the IRS and is entitled to rely on a favorable opinion letter issued by the IRS with respect to such prototype
or volume submitter document, and (ii)&nbsp;to the Knowledge of the Company, no events have occurred that would reasonably be expected to adversely affect the qualified status of any such Employee Plan. Except as has not had, and would not
reasonably be expected to have, a Company Material Adverse Effect, neither the Company nor any of its Subsidiaries has incurred or could reasonably be expected to incur any penalty or Tax (whether or not assessed) under Sections 4980B, 4980D or
4980H of the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Contributions</I>. Except as has not had, and would not reasonably be expected to have, a Company Material
Adverse Effect, (i)&nbsp;all contributions, premiums, reimbursements or other payments that are due and owing to or in respect of any Employee Plan have been paid, and (ii)&nbsp;all such contributions, premiums, reimbursements or other payments for
any period ending on or before the Closing Date that are not yet due have been (or will be prior to the Closing Date) paid or properly accrued (in accordance with GAAP, to the extent applicable). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <I>No Post-Termination Welfare Benefit Plan</I>. No Employee Plan that is a welfare benefit plan (as defined in Section&nbsp;3(1) of ERISA)
provides, and neither the Company nor any of its Subsidiaries has committed to or otherwise has any obligation to provide, post-termination or retiree life insurance or welfare benefits to any Person, except as may be required by Section&nbsp;4980B
of the Code or any similar Law for which the covered Person pays the full premium cost of coverage. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <I>Employee Plan Legal
Proceedings</I>. Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, there are no Legal Proceedings or claims pending or, to the Knowledge of the Company, threatened on behalf of, against or in
relation to, any Employee Plan, the assets of any trust pursuant to any Employee Plan, or the plan sponsor, plan administrator or any fiduciary or any Employee Plan, other than routine claims for benefits, and there is no fact or circumstance that
could reasonably be expected to give rise to any such Legal Proceeding or claim. There have been no <FONT STYLE="white-space:nowrap">non-exempt</FONT> &#147;prohibited transactions&#148; (as defined in Section&nbsp;406 of ERISA or Section&nbsp;4975
of the Code), or breaches of duty by a &#147;fiduciary&#148; (as defined in Section&nbsp;3(21) of ERISA) with respect to any Employee Plan involving the Company or any of its Subsidiaries or, to the Knowledge of the Company, any other Person, that
could reasonably be expected to result in material liability to the Company or any of its Subsidiaries. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <I>Impact of the Transaction
on Employee Plans</I>. Neither the execution or delivery of this Agreement nor the consummation of the Viking Transaction (alone or in conjunction with the Casdin Transaction or any other actions contemplated by this Agreement or the Casdin Purchase
Agreement) will constitute a &#147;change in control,&#148; &#147;change of control,&#148; or term of similar meaning under any Employee Plan including, for the avoidance of doubt, any Company Stock Plan. Neither the execution or delivery of this
Agreement nor the consummation of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Viking Transaction (either alone or in conjunction with the Casdin Transaction or any other actions contemplated by this Agreement or the Casdin Purchase Agreement) could (alone or in conjunction
with any other event) result in (i)&nbsp;any of the following with respect to any current or former employee, officer, director, independent contractor or other service provider of the Company or any Subsidiary of the Company: (A)&nbsp;severance pay
upon any termination of employment or service, or any increase thereof, (B)&nbsp;any payment, compensation or benefit becoming due, or increase thereof, (C)&nbsp;the acceleration of the time of payment or vesting of any payment, compensation or
benefit, or (D)&nbsp;any funding (through a grantor trust or otherwise) of any compensation benefit; (ii)&nbsp;any other liability or obligation pursuant to any of the Employee Plans; (iii)&nbsp;result in any limitation on the right of the Company
or any Subsidiary of the Company to amend, merge, terminate or receive a reversion of assets from any Employee Plan or related trust; or (iv)&nbsp;the payment an amount that could, individually or in combination with any other payment or benefit, be
characterized as an &#147;excess parachute payment&#148; within the meaning of Section&nbsp;280G(1) of the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)
<I>Section</I><I></I><I>&nbsp;409A</I>. Each Employee Plan that constitutes in any part a &#147;nonqualified deferred compensation plan&#148; within the meaning of Section&nbsp;409A of the Code has been administered, operated and maintained in all
material respects in operational and documentary compliance with Section&nbsp;409A of the Code and all IRS guidance promulgated thereunder, to the extent such Section and such guidance have been applicable to such Employee Plan. No Employee Plan,
agreement or other arrangement to which the Company or any Subsidiary is a party or by which the Company or any Subsidiary is otherwise bound obligates the Company to compensate, <FONT STYLE="white-space:nowrap">gross-up,</FONT> indemnify or
reimburse any Person in respect of Taxes pursuant to Section&nbsp;409A or 4999 of the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <I>Foreign Benefit Plans</I>. Except as
has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, with respect to each Employee Plan that is subject to the Laws of a jurisdiction other than the United States (whether or not United States Law also
applies) (a &#147;<B>Foreign Benefit Plan</B>&#148;): (i) all employer and employee contributions to each Foreign Benefit Plan required by Law or by the terms of such Foreign Benefit Plan have been made, or if applicable, accrued in accordance with
normal accounting practices, (ii)&nbsp;each Foreign Benefit Plan required to be registered has been registered and each Foreign Benefit Plan has been maintained in good standing with applicable Governmental Authorities and in compliance with all
applicable Laws, (iii)&nbsp;each Foreign Benefit Plan intended to receive favorable tax treatment under applicable tax Laws, to the extent applicable, has been qualified or similarly determined by applicable Governmental Authorities to satisfy the
requirements of such Laws, (iv)&nbsp;no Foreign Benefit Plan is a defined benefit or similar type of plan or arrangement, and (v)&nbsp;no Foreign Benefit Plan has any material unfunded liabilities, nor are any unfunded liabilities reasonably
expected to arise in connection with the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.19 <I>Labor Matters</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Union Activities</I>. There are no collective bargaining agreements, labor union contracts, trade union agreements, works council
agreements or any other agreements or arrangements with an employee representative body (each, a &#147;<B>Collective Bargaining Agreement</B>&#148;) to which the Company or any of its Subsidiaries is a party to or is bound and no employees of the
Company or any of its Subsidiaries are represented by any labor union, works </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
council or other labor organization with respect to their employment with the Company or any of its Subsidiaries. There are no representation or certification proceedings or petitions seeking a
representation proceeding presently pending or, to the Company&#146;s Knowledge, threatened to be brought or filed with or before the National Labor Relations Board or any other labor relations Governmental Authority with respect to representation
of any such employees in respect of their employment with the Company or any of its Subsidiaries. No Collective Bargaining Agreement is being negotiated by the Company or any of its Subsidiaries and no labor union, works council, other labor
organization, or group of employees of the Company or its Subsidiaries has made a demand for recognition or certification. Since January&nbsp;1, 2017, (i) there have been no union organizing or union election activities or attempts to bargain
collectively and (ii)&nbsp;there have been no strikes, lockouts, slowdowns, work stoppages, picketing, concerted refusal to work overtime, handbilling, demonstrations, leafletting, arbitrations, grievances or lockouts (in each case involving labor
matters) or other material labor disputes against or affecting the Company or any of its Subsidiaries pending or, to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Employment Law</I>. Each of the Company and its Subsidiaries is, and has been since January&nbsp;1, 2019, in compliance with all Labor
Laws, except for such noncompliance that has not had, and would not reasonably be expected to have, a Company Material Adverse Effect. Each employee, independent contractor and service provider who is providing, or in the past three (3)&nbsp;years
has provided, services to the Company or any of its Subsidiaries has all work permits, immigration permits, visas or other authorizations required by applicable Law. Each of the Company and its Subsidiaries has met all requirements under Laws
relating to employment of foreign citizens and residents, including all Form <FONT STYLE="white-space:nowrap">I-9</FONT> requirements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
The Company has not incurred any liability or obligation under the WARN Act that remains unsatisfied. With respect to the employees of the Company and its Subsidiaries, during the last 12 months, there has been no mass layoff, plant closing,
shutdown or term of similar import that triggered the WARN Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) No current employee of the Company or any of its Subsidiaries with an
annualized base salary from the Company at or above $250,000 is in any material respect in violation of any term of any employment agreement, nondisclosure agreement, common law nondisclosure obligation, fiduciary duty, noncompetition agreement, <FONT
STYLE="white-space:nowrap">non-solicitation</FONT> agreement, restrictive covenant or other obligation: (i)&nbsp;owed to the Company or any of its Subsidiaries; or (ii)&nbsp;to the Knowledge of the Company, owed to any third party with respect to
such Person&#146;s right to be employed or engaged by the Company or any of its Subsidiaries. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except as has not had, and would not
reasonably be expected to have, a Company Material Adverse Effect, there are no pending, or to the Company&#146;s Knowledge, threatened Legal Proceedings against the Company or any of its Subsidiaries brought by or on behalf of any applicant for
employment, any employee, independent contractor or service provider, any current or former leased employee, intern, volunteer or &#147;temp&#148; of the Company or any of its Subsidiaries, or Person alleging to be a current or former employee, or
any group or class of the foregoing, or any Governmental Authority, alleging: (i)&nbsp;violation of any Labor Laws; (ii)&nbsp;breach of any Collective Bargaining Agreement; (iii)&nbsp;breach of any express or implied contract of Law;
(iv)&nbsp;wrongful termination of employment; or (v)&nbsp;any other discriminatory, wrongful or tortious conduct in connection with any employment relationship, including before the Equal Employment Opportunity Commission. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Since January&nbsp;1, 2019, the Company has not incurred any material liability with
respect to the classification of any Person as (i)&nbsp;an individual independent contractor rather than an employee, or (ii)&nbsp;an &#147;exempt&#148; employee rather than a <FONT STYLE="white-space:nowrap">&#147;non-exempt&#148;</FONT> employee
(within the meaning of the Fair Labor Standards Act and state Law), and no such Person has been improperly included or excluded from any Employee Plan. Neither the Company nor any of its Subsidiaries has notice of any pending or, to the
Company&#146;s Knowledge, threatened, inquiry or audit from any Governmental Authority concerning any such classifications. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Since
January&nbsp;1, 2019, there have been no Legal Proceedings or settlements involving allegations of sexual or other unlawful harassment or discrimination. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.20 <I>Compliance with Laws</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company and each of its Subsidiaries is, and since January&nbsp;1, 2019 has been, in compliance in all material respects with all Laws
that are applicable to the Company or any of its Subsidiaries or to the conduct of the business or operations of the Company or any its Subsidiaries. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect,
as of the date of this Agreement: (i)&nbsp;the Company and its Subsidiaries have all Governmental Authorizations necessary for the ownership and operation of its business as presently conducted, and each such Governmental Authorization is in full
force and effect; (ii)&nbsp;the Company and its Subsidiaries are, and since January&nbsp;1, 2019 have been, in compliance with the terms of all Governmental Authorizations necessary for the ownership and operation of the businesses of the Company or
any of its Subsidiaries; and (iii)&nbsp;since January&nbsp;1, 2019, neither the Company nor any of its Subsidiaries has received written notice from any Governmental Authority alleging any conflict with or breach of any such Governmental
Authorization. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.21 <I>Anti-Corruption; International Trade</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Since January&nbsp;1, 2017, none of the Company, any of its Subsidiaries, or any of their respective directors, officers, or employees has,
nor, to the Knowledge of the Company, have any of their agents or other Person acting on their behalf, violated any Anti-Corruption Laws, nor has the Company, any Subsidiary of the Company, any of their respective directors, officers, or employees
nor, to the Knowledge of the Company, any other Representative of the Company or any of its Subsidiaries offered, paid, promised to pay, or authorized the payment of any money, or offered, given, promised to give, or authorized the giving of
anything of value, including cash, checks, wire transfers, tangible and intangible gifts, favors, services, or those entertainment and travel expenses that go beyond what is reasonable and customary, to any Government Official or to any Person for
the purpose of influencing any act or decision of a Government Official in their official capacity, securing any improper advantage, or assisting the Company or any Subsidiary of the Company in obtaining or retaining business, in each case in
violation of any Anti-Corruption Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company, each of its Subsidiaries, and their respective directors, officers and, to
the Knowledge of the Company, employees and other Representatives are in compliance in all material respects with all applicable Laws relating to imports, exports and economic sanctions, including all applicable Laws administered and enforced by the
U.S. Treasury Department&#146;s Office of Foreign Assets Control (&#147;<B>OFAC</B>&#148;), the U.S. State Department (including the Directorate of Defense Trade Controls), the U.S. Commerce Department&#146;s Bureau of Industry and Security
(&#147;<B>BIS</B>&#148;), or U.S. Customs and Border Protection (&#147;<B>Trade Laws</B>&#148;). Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, since January&nbsp;1, 2017, neither the Company
nor any of its Subsidiaries, nor any of their respective directors, officers or, to the Knowledge of the Company, employees or other Representatives has been a party to any Contract or engaged in any transaction or other business, directly or
indirectly, (i)&nbsp;in breach of any applicable Trade Laws or (ii)&nbsp;to the extent it would be prohibited under applicable Trade Laws, with any Governmental Authority or other Person that (A)&nbsp;appears on any applicable list of sanctioned
parties (including any Person that appears on OFAC&#146;s Specially Designated Nationals and Blocked Persons List or Sectoral Sanctions Identification List or BIS&#146;s Denied Persons, Entity, or Unverified Lists), (B) is located or organized in
any country or territory that is, or at the time of the transaction or business was, subject to comprehensive OFAC sanctions (including Cuba, Iran, North Korea, Syria or the Crimea region of Ukraine) or (C)&nbsp;is 50% or more owned or otherwise
controlled by a Person described in clause (A)&nbsp;or (B). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.22 <I>Compliance with Healthcare Laws and Regulations</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Any preclinical and clinical studies subject to regulatory oversight by a Governmental Authority and conducted by or on behalf of or
sponsored by the Company or its Subsidiaries, or in which the Company or its Subsidiaries have participated, were (and, if still pending, are being) conducted in all material respects in accordance with all applicable statutes and all applicable
rules and regulations of the U.S. Food and Drug Administration (the &#147;<B>FDA</B>&#148;) and comparable regulatory agencies outside of the United States to which they are subject, including the European Medicines Agency (collectively, the
&#147;<B>Healthcare Authorities</B>&#148;) and Good Clinical Practice and Good Laboratory Practice requirements. The Company and its Subsidiaries have operated at all times and are currently in compliance in all material respects with all statutes,
rules and regulations applicable to the ownership, testing, development, marketing, promotion, manufacture, packaging, processing, use, distribution, storage, import, export or disposal of any product manufactured, distributed or sold by or on
behalf of the Company or any of its Subsidiaries (each, a &#147;<B>Company Product</B>&#148;), including all statutes, rules and regulations of the Healthcare Authorities, except where
<FONT STYLE="white-space:nowrap">such&nbsp;non-compliance&nbsp;would</FONT> not, individually or in the aggregate, be material. Neither the Company nor any of its Subsidiaries have received any written notices, correspondence or other communications
from the Healthcare Authorities or any other governmental agency requiring or threatening the termination or suspension of any of the Company&#146;s activities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Since January&nbsp;1, 2019, except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, neither the Company nor any Subsidiary has voluntarily or involuntarily initiated, conducted or issued, caused to be initiated, conducted or issued, any recall, field corrective action, market withdrawal, seizure,
suspension, safety alert, written warning, &#147;dear doctor&#148; letter, investigator notice to healthcare wholesalers, healthcare distributors, healthcare retailers, healthcare professionals or patients
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(including any action required to be reported or for which records must be maintained under 21 C.F.R. Part 806) relating to any Company Product (collectively, a &#147;<B>Recall</B>&#148;) or, as
of the date hereof, currently intends to initiate, conduct or issue any Recall of any Company Product. Except as would not reasonably be expected to be, individually or in the aggregate, material to the Company and its Subsidiaries, taken as a
whole, neither the Company nor any of its Subsidiaries has received any written notice from the FDA or any other Healthcare Authority regarding (i)&nbsp;any Recall of any Company Product, (ii)&nbsp;a change in the marketing status or classification,
or a material change in the labeling, of any such Company Product or (iii)&nbsp;a notice of <FONT STYLE="white-space:nowrap">non-coverage</FONT> from a Healthcare Authority in the reimbursement status of a Company Product (not including any routine
adjustments made to the amount of reimbursement). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.23 <I>Legal Proceedings; Orders</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>No Legal Proceedings</I>. Except as has not been, and would not reasonably be expected to be, individually or in the aggregate, material
to the Company and its Subsidiaries, taken as a whole, there are no current Legal Proceedings pending or, to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries or their respective assets, operations or properties
or relating to the Transaction Documents or the transactions contemplated hereby or thereby, nor, since January&nbsp;1, 2019, has the Company or any of its Subsidiaries made any voluntary or involuntary disclosures of
<FONT STYLE="white-space:nowrap">non-compliance</FONT> with applicable Law to any Governmental Authority. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>No Orders</I>. Except as
has not been, and would not reasonably be expected to be, individually or in the aggregate, material to the Company and its Subsidiaries, taken as a whole, or that would prevent or materially impair or materially delay, or would reasonably be
expected to prevent or materially impair or materially delay, the consummation of the Casdin Transaction and/or Viking Transaction, neither the Company nor any of its Subsidiaries (nor any of its or their respective properties) is subject to any
order of any kind or nature. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.24 <I>Insurance</I>. As of the date of this Agreement, except as has not had, and would not reasonably be
expected to have, individually or in the aggregate, a Company Material Adverse Effect, the Company and its Subsidiaries have all policies of insurance covering the Company and its Subsidiaries and any of their respective employees, properties or
assets, including policies of life, property, fire, workers&#146; compensation, products liability, directors&#146; and officers&#146; liability and other casualty and liability insurance, that is customarily carried by Persons conducting business
similar to that of the Company and its Subsidiaries. As of the date of this Agreement, all such insurance policies are in full force and effect, no notice of cancellation has been received and there is no existing default or event that, with notice
or lapse of time or both, would constitute a default by any insured thereunder, except for such cancellations and defaults that, individually or in the aggregate, have not had, and would not reasonably be expected to have, a Company Material Adverse
Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.25 <I>Related Party Transactions</I>. Except for compensation or other employment arrangements in the ordinary course of
business, there are no Contracts, transactions, arrangements or understandings between the Company or any of its Subsidiaries, on the one hand, and any Affiliate of the Company (including any director or executive officer) thereof, but not including
any wholly owned Subsidiary of the Company, on the other hand, that would be required to be disclosed pursuant to Item 404 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated by the SEC in the Company&#146;s Form <FONT
STYLE="white-space:nowrap">10-K</FONT> or proxy statement pertaining to an annual meeting of stockholders that have not been disclosed in the Company SEC Reports. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.26 <I>Brokers</I>. Except for Jefferies LLC, there is no financial advisor, investment
banker, broker, finder or agent that has been retained by or is authorized to act on behalf of the Company or any of its Subsidiaries who is entitled to any financial advisor&#146;s, investment banking, brokerage, finder&#146;s or other similar fee
or commission in connection with the Viking Transaction or the other transactions contemplated by this Agreement or the other Transaction Documents. The Company has made available to Purchaser the engagement letter of Jefferies. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.27 <I>Other Agreements</I>. The Company has provided to Purchaser, prior to the execution and delivery of this Agreement, a true, complete
and correct copy of the Casdin Purchase Agreement which, on execution of this Agreement, shall be in full force and effect. The Company has not entered into any other agreement, arrangement or understanding with the Casdin Purchaser or any of its
respective Affiliates with respect to any securities of the Company or any of its Subsidiaries, the transactions contemplated by the Casdin Purchase Agreement or the payment of any fees or expenses in connection therewith, except for any <FONT
STYLE="white-space:nowrap">non-disclosure</FONT> agreements or term sheets with the Casdin Purchaser or its Affiliates. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.28 <I>Investment
Company Status</I>. Neither the Company nor any of its Subsidiaries is, and immediately after the Closing hereunder, none of the Company nor any of its Subsidiaries will be, required to be registered as an &#147;investment company&#148; under the
Investment Company Act of 1940. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.29 <I>Sale of Securities</I>. Without limiting the foregoing, neither the Company nor, to the Knowledge
of the Company, any other Person authorized by the Company to act on its behalf, has engaged in a general solicitation or general advertising (within the meaning of Regulation D of the Securities Act) of investors with respect to offers or sales of
the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock, and neither the Company nor, to the Knowledge of the Company, any Person acting on its behalf has made any offers or sales of any security or solicited any offers to buy
any security, under circumstances that would cause the offering or issuance of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock under this Agreement to be integrated with prior offerings by the Company for purposes of the
Securities Act that would result in none of Regulation D or any other applicable exemption from registration under the Securities Act to be available. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.30 <I>No </I><I>Rights Agreement</I><I>; Anti-Takeover</I><I> Provisions</I>. As of the date of this Agreement, neither the Company nor any
of its Subsidiaries is party to a stockholder rights agreement, &#147;poison pill&#148; or similar anti-takeover agreement or plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.31
<I>Registration Rights</I>. Except as contemplated by the Registration Rights Agreement, no Person has the right to require the Company or any of its Subsidiaries to register any securities for sale under the Securities Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.32 <I>Exclusivity of Representations and Warranties</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>No Other Representations and Warranties</I>. The Company acknowledges and agrees that, except for the representations and warranties
expressly set forth in <U>Article</U><U></U><U>&nbsp;IV</U>, in any other Transaction Document or in any certificate delivered pursuant to this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) neither Purchaser nor any other Person makes, or has made, any representation or warranty relating to Purchaser or any of
its businesses, operations or otherwise in connection with this Agreement or the Transactions; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Purchaser hereby
disclaims any other express or implied representations or warranties, notwithstanding the delivery or disclosure to the Company or any of its Representatives of any documentation or other information (including any financial information,
supplemental data, financial projections or other forward-looking statements). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>No Reliance</I>. The Company acknowledges and agrees
that, except for the representations and warranties expressly set forth in <U>Article</U><U></U><U>&nbsp;IV</U>, in any other Transaction Document or in any certificate delivered by Purchaser pursuant to this Agreement, it is not acting, by entering
into this Agreement or consummating the Transactions, in reliance on: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any other representation or warranty, express or
implied; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) any estimate, projection, prediction, data, financial information, memorandum, presentation or other
materials or information provided or addressed to the Company or any of its Representatives, including any materials or information made available in connection with the Transactions, in connection with presentations by Purchaser&#146;s management
or in any other forum or setting; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) the accuracy or completeness of any other representation, warranty, estimate,
projection, prediction, data, financial information, memorandum, presentation or other materials or information. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;IV
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES OF PURCHASER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Purchaser hereby represents and warrants to the Company as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <I>Organization; Good Standing</I>. Purchaser is duly organized, validly existing and in good standing pursuant to the Laws of its
jurisdiction of organization. Purchaser has the requisite power and authority to conduct its business as it is presently being conducted and to own, lease or operate its material properties, rights and assets, except where the failure to have such
power or authority, individually or in the aggregate, would not, individually or in the aggregate, prevent or materially delay the consummation of the Viking Transaction or the other transactions contemplated by this Agreement. Purchaser is not in
violation of its Organizational Documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 <I>Corporate Power; Enforceability</I>. Purchaser has the requisite corporate power and
authority to: (a)&nbsp;execute and deliver this Agreement and the other applicable Transaction Documents; (b)&nbsp;perform its covenants and obligations hereunder and thereunder; and (c)&nbsp;consummate the Viking Transaction and the other
transactions contemplated by this Agreement and the other applicable Transaction Documents. The execution and delivery of this Agreement and the other applicable Transaction Documents by Purchaser, the performance by Purchaser of its covenants and
obligations hereunder and the consummation of the Viking Transaction and the transactions contemplated by this Agreement and the other applicable Transaction Documents have been duly authorized by all necessary action on the part of Purchaser and no
additional action on the part of Purchaser is necessary. This Agreement and each other applicable Transaction Documents have been duly executed and delivered by Purchaser and, assuming the due authorization, execution and delivery by the Company,
constitute legal, valid and binding obligations of Purchaser, enforceable against Purchaser in accordance with their terms, except as such enforceability (i)&nbsp;may be limited by applicable bankruptcy, insolvency, reorganization, moratorium and
other similar Laws affecting or relating to creditors&#146; rights generally and (ii)&nbsp;is subject to general principles of equity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3
<I><FONT STYLE="white-space:nowrap">Non-Contravention</FONT></I>. The execution and delivery of this Agreement by Purchaser, the performance by Purchaser of its covenants and obligations hereunder, and the consummation of the Viking Transaction and
the other transactions contemplated by this Agreement and the other applicable Transaction Documents do not: (a)&nbsp;violate or conflict with any provision of the Organizational Documents of Purchaser; (b)&nbsp;violate, conflict with, result in the
breach of, constitute a default (or an event that, with notice or lapse of time or both, would become a default) pursuant to, or result in the termination of, or accelerate the performance required by, or result in a right of termination or
acceleration pursuant to any of the terms, conditions or provisions of any material note, bond, mortgage, indenture, lease, license, contract, agreement or other instrument or obligation to which Purchaser is a party or by which Purchaser or any of
its properties or assets may be bound; (c)&nbsp;assuming the consents, approvals and authorizations referred to in <U>Section</U><U></U><U>&nbsp;4.4</U> have been obtained, violate or conflict with any Law or order applicable to Purchaser or by
which any of its properties or assets are bound; or (d)&nbsp;result in the creation of any Lien (other than Permitted Liens) on any of the properties or assets of Purchaser, except in the case of each of clauses (b), (c) and (d)&nbsp;for such
violations, conflicts, breaches, defaults, terminations, accelerations or Liens that would not, individually or in the aggregate, prevent or materially delay the consummation of the Viking Transaction or the other transactions contemplated by this
Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4 <I>Requisite Governmental Approvals</I>. No Governmental Authorization is required on the part of Purchaser in connection
with: (a)&nbsp;the execution and delivery of this Agreement by Purchaser; (b)&nbsp;the performance by Purchaser of its covenants and obligations pursuant to this Agreement; or (c)&nbsp;the consummation of the Viking Transaction and the other
transactions contemplated by this Agreement, except (i)&nbsp;such filings and approvals as may be required by any federal or state securities Laws, including compliance with any applicable requirements of the Exchange Act; (ii)&nbsp;compliance with
any applicable requirements of the HSR Act and any applicable foreign Antitrust Laws; and (iii)&nbsp;such other Governmental Authorizations the failure of which to obtain would not, individually or in the aggregate, prevent or materially delay the
consummation of the Viking Transaction or the other transactions contemplated by this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.5 <I>Legal Proceedings; Orders</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>No Legal Proceedings</I>. There are no Legal Proceedings pending or, to the knowledge of Purchaser, threatened against Purchaser that
would, individually or in the aggregate, prevent or materially delay Purchaser&#146;s ability to consummate the Viking Transaction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
<I>No Orders</I>. Purchaser is not subject to any order of any kind or nature that would prevent or materially delay the consummation of the Viking Transaction or the other transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.6 <I>Ownership of Company Common Stock</I>. Neither Purchaser nor any of its &#147;affiliates&#148; or &#147;associates&#148; is or, during
the three years prior to the date of this Agreement, has been an &#147;interested stockholder&#148; (in each case, as such quoted terms are defined under Section&nbsp;203 of the DGCL) of the Company. Neither Purchaser nor any of its
&#147;affiliates&#148; or &#147;associates&#148; (as those terms are defined in Section&nbsp;203 of the DGCL) beneficially owns, directly or indirectly, any shares of Company Common Stock or any other security convertible into, exchangeable for or
exercisable for shares of Company Common Stock. Other than with its Affiliates, Purchaser is not a member of a &#147;group&#148; (as such term is used in Section&nbsp;13(d) of the Exchange Act) of Persons with respect to any securities of the
Company (it being understood that in no event will the Casdin Purchaser or any of its Affiliates be deemed to be Affiliates of Purchaser for purposes of this <U>Section</U><U></U><U>&nbsp;4.6</U>). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.7 <I>Brokers</I>. There is no financial advisor, investment banker, broker, finder, agent or other Person that has been retained by or is
authorized to act on behalf of Purchaser or any of its Affiliates that will be entitled to any financial advisor&#146;s, investment banking, brokerage, finder&#146;s or other fee or commission from the Company or its Subsidiaries in connection with
the Viking Transaction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.8 <I>Sufficient Funds</I>. (a)&nbsp;(i)&nbsp;VGO Drawdown will have at the Closing sufficient funds to enable
VGO Drawdown to pay in full at the Closing the entire amount of the VGO Drawdown Purchase Price and all other amounts payable by VGO Drawdown hereunder in immediately available cash funds and (ii)&nbsp;VGO Drawdown has uncalled capital commitments
or otherwise has available funds in excess of the VGO Drawdown Purchase Price and all other amounts payable by VGO Drawdown pursuant to this Agreement and (b)&nbsp;(i)&nbsp;VGO Illiquid Investments will have at the Closing sufficient funds to enable
VGO Illiquid Investments to pay in full at the Closing the entire amount of the VGO Illiquid Investments Purchase Price and all other amounts payable by VGO Illiquid Investments hereunder in immediately available cash funds (ii)&nbsp;VGO Illiquid
Investments has uncalled capital commitments or otherwise has available funds in excess of the VGO Illiquid Investments Purchase Price and all other amounts payable by VGO Illiquid Investments pursuant to this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.9 <I>Unregistered Securities</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Investor Status; Sophisticated Purchaser</I>. Purchaser is an &#147;accredited investor&#148; within the meaning of Regulation D of the
Securities Act and is able to bear the risk of its investment in the Purchased Shares. Purchaser has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of the purchase of the
Purchased Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Information</I>. Purchaser and its Representatives have been furnished with
(i)&nbsp;materials relating to the business, finances and operations of the Company, (ii)&nbsp;materials relating to the offer and sale of the Purchased Shares and (iii)&nbsp;materials relating to the Viking Transaction, in each case, that have been
requested by Purchaser. Purchaser and its Representatives have been afforded the opportunity to ask questions of the Company. Neither such inquiries nor any other due diligence investigations conducted at any time by Purchaser and its
Representatives shall modify, amend or affect Purchaser&#146;s right (i)&nbsp;to rely on the Company&#146;s representations and warranties contained in <U>Article</U><U></U><U>&nbsp;III</U> above or (ii)&nbsp;to indemnification or any other remedy
based on, or with respect to the accuracy or inaccuracy of, or compliance with, the representations, warranties, covenants and agreements in this Agreement. Purchaser understands that its purchase of the Purchased Shares involves a high degree of
risk. Purchaser has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition of the Purchased Shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Legends</I>. Purchaser understands that any certificate or book-entry position evidencing Acquired Shares will bear the restrictive
legend set forth in the Certificate of Designations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Purchase Representations</I>. Purchaser is purchasing the Purchased Shares for
its own account, the account of its Affiliates, or the accounts of clients for whom Purchaser exercises discretionary investment authority (all of whom Purchaser hereby represents and warrants are &#147;accredited investors&#148; within the meaning
of Regulation D of the Securities Act), not as a nominee or agent, and not with a view to distribution in violation of any securities Laws. Purchaser has been advised and understands that the Purchased Shares have not been registered under the
Securities Act or under the &#147;blue sky&#148; laws of any jurisdiction and may be resold only if registered pursuant to the requirements of the Securities Act (or if eligible, pursuant to Rule 144 promulgated under the Securities Act or pursuant
to another available exemption from the registration requirements of the Securities Act). Purchaser has been advised and understands that the Company, in issuing the Purchased Shares, is relying upon, among other things, the representations and
warranties of Purchaser contained in this <U>Section</U><U></U><U>&nbsp;4.9</U> in concluding that such issuance is a &#147;private offering&#148; and is exempt from the registration provisions of the Securities Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <I>Rule 144</I>. Purchaser understands that there is no public trading market for the Purchased Shares, that none is expected to develop
and that the Purchased Shares shall be held indefinitely unless and until the Purchased Shares are registered under the Securities Act or an exemption from registration is available. Purchaser has been advised of and is knowledgeable with respect to
the provisions of Rule 144 promulgated under the Securities Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <I>Reliance by the Company</I>. Purchaser understands that the Purchased Shares are
being offered and sold in reliance on a transactional exemption from the registration requirements of federal and state securities Laws and that the Company is relying on the truth and accuracy of the representations, warranties, agreements,
acknowledgments and understandings of Purchaser set forth herein in order to determine the applicability of such exemptions and the suitability of Purchaser to acquire the Purchased Shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.10 <I>Stockholder and Management Arrangements</I>. Except for the Transaction Documents or as previously disclosed to the Company in writing,
neither Purchaser nor any of its Affiliates is a party to any Contract, or has authorized, made or entered into, or committed or agreed to enter into, any formal or informal arrangements or other understandings (whether or not binding) with any
stockholder, director, officer, employee or other Affiliate of the Company or any of its Subsidiaries: (a)&nbsp;relating to this Agreement, the Casdin Transaction or the Viking Transaction, (b)&nbsp;pursuant to which any holder of Company Common
Stock has agreed to approve this Agreement or (c)&nbsp;pursuant to which any Person has agreed to provide, directly or indirectly, an equity investment to the Purchaser or the Company to finance any portion of the Transaction. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.11 <I>Exclusivity of Representations and Warranties</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>No Other Representations and Warranties</I>. Purchaser acknowledges and agrees that, except for the representations and warranties
expressly set forth in <U>Article</U><U></U><U>&nbsp;III</U> (as qualified by the Company Disclosure Letter), in any other Transaction Document or in any certificate delivered pursuant to this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) neither the Company nor any other Person makes, or has made, any representation or warranty relating to the Company, its
Subsidiaries, or any of its or their businesses, operations or otherwise in connection with this Agreement or the Transactions; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the Company hereby disclaims any other express or implied representations or warranties, notwithstanding the delivery or
disclosure to Purchaser or any of its Representatives of any documentation or other information (including any financial information, supplemental data, financial projections or other forward-looking statements). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>No Reliance</I>. Purchaser acknowledges and agrees that, except for the representations and warranties expressly set forth in
<U>Article</U><U></U><U>&nbsp;III</U> (as qualified by the Company Disclosure Letter), in any other Transaction Document or in any certificate delivered by the Company pursuant to this Agreement, it is not acting, by entering into this Agreement or
consummating the Transactions, in reliance on: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any other representation or warranty, express or implied; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) any estimate, projection, prediction, data, financial information, memorandum, presentation or other materials or
information provided or addressed to Purchaser or any of its Representatives, including any materials or information made available in the electronic data room hosted by or on behalf of the Company in connection with the Transactions, in connection
with presentations by the Company&#146;s management or in any other forum or setting; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) the accuracy or completeness of any other representation, warranty,
estimate, projection, prediction, data, financial information, memorandum, presentation or other materials or information. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;V </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INTERIM
OPERATIONS OF THE COMPANY </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 <I>Affirmative Obligations</I>. Except (a)&nbsp;as expressly contemplated by this Agreement,
(b)&nbsp;as set forth in Section&nbsp;5.1 or Section&nbsp;5.2 of the Company Disclosure Letter, (c)&nbsp;as required by applicable Law or by <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures or (d)&nbsp;as approved in advance in writing by
Purchaser (which approval shall not be unreasonably withheld, conditioned or delayed), during the period from the execution and delivery of this Agreement until the earlier to occur of the termination of this Agreement pursuant to
<U>Article</U><U></U><U>&nbsp;VIII</U> and the Closing, the Company shall, and shall cause each of its Subsidiaries to, (i)&nbsp;conduct its business in all material respects in the ordinary course of business, and (ii)&nbsp;use reasonable best
efforts to preserve intact in all material respects its current business organization, ongoing businesses and significant relationships with third parties. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <I>Forbearance Covenants</I>. Except (a)&nbsp;as expressly contemplated by this Agreement, (b)&nbsp;as set forth in Section&nbsp;5.1 or
Section&nbsp;5.2 of the Company Disclosure Letter, (c)&nbsp;as required by applicable Law or by <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures or (d)&nbsp;as approved in advance in writing by Purchaser (which approval shall not be
unreasonably withheld, conditioned or delayed), during the period from the execution and delivery of this Agreement until the earlier to occur of the termination of this Agreement pursuant to <U>Article</U><U></U><U>&nbsp;VIII</U> and the Closing,
the Company shall not, and shall not permit any of its Subsidiaries to, directly or indirectly: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) take any action set forth in
Section&nbsp;13(b) or 13(c) of the Certificate of Designations; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) acquire or agree to acquire, directly or indirectly, by purchase,
merger, consolidation or otherwise, any equity or assets constituting all or a material portion of the business of (or any division of the business of) another Person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) sell, assign, transfer, license (other than <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses in the ordinary course of
business consistent with past practice), sublicense, abandon, permit to lapse, grant a covenant not to sue, or otherwise dispose of any material Company Owned IP (other than <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses or
sublicenses granted in the ordinary course of business); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) disclose, release or otherwise fail to maintain the confidential nature of
any source code to Company Software or other Trade Secrets; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;(i) authorize for issuance, issue, deliver, sell or transfer or agree
or commit to issue, deliver, sell or transfer any shares of capital stock of or other equity interest or convertible security in the Company or any of its Subsidiaries or other rights of any kind to acquire, any shares of capital stock of or any
other equity interest in the Company or any of its Subsidiaries, other than (A)&nbsp;the issuance of capital stock or other equity interests pursuant to any Employee Plan, (B)&nbsp;the issuance of capital stock or other equity interests from any
wholly owned Subsidiary to the Company or any other wholly owned Subsidiary of the Company or (C)&nbsp;the issuance of Company Common Stock pursuant to the Company Notes; (ii)&nbsp;amend or modify any term or provision of any of the Company&#146;s
outstanding equity securities; or (iii)&nbsp;accelerate or waive any restrictions pertaining to the vesting of any Company equity-based awards or warrants or other rights of any kind to acquire any shares of capital stock or other equity interests
in the Company; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) reclassify, combine, split or subdivide any capital stock of the Company or any of its
Subsidiaries or issue or authorize the issuance of any other securities in respect of, in lieu of, or in substitution for, shares of capital stock of the Company or any of its Subsidiaries, except for, with respect to any Subsidiary of the Company,
any intercompany restructuring, recapitalization or similar transaction that will not prevent or delay the consummation of the Viking Transaction or the other transactions contemplated by this Agreement or result in any adverse impact on Purchaser;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) except as required under the terms of any Employee Plan or as set forth in Section&nbsp;5.2(g) of the Company Disclosure Letter,
(i)&nbsp;increase the compensation or benefits payable to any current or former (A)&nbsp;director, (B) executive officer, or (C)&nbsp;employee or independent contractor, other than increases with respect to employees at the Director level or below
in the ordinary course of business consistent with past practice, by no more than ten percent of such individual&#146;s compensation or benefits payable immediately prior to such increase, and as otherwise not prohibited by
<U>Section</U><U></U><U>&nbsp;5.2(h)</U>, (ii)&nbsp;accelerate the vesting or payment of any Employee Plan or other compensation or benefit plan, program, agreement or arrangement for, any director, employee or independent contractor,
(iii)&nbsp;enter into, adopt, amend, terminate or increase the coverage or benefits available under any Employee Plan (or other compensation or benefit plan, program, agreement or arrangement that would be an Employee Plan if in effect on the date
of this Agreement), other than ordinary course changes in relation to annual renewals, or (iv)&nbsp;grant any equity or equity-based awards of the Company or any of its Subsidiaries to any director, employee or independent contractor of the Company
or any of its Subsidiaries; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) (i)&nbsp;hire, offer to hire or promote any new Person with an annual salary or annualized fee in excess
of $250,000, (ii)&nbsp;terminate the employment or service of any employee with an annual salary or annualized fee in excess of $250,000 or any employee with a title of Director or above of the Company or any of its Subsidiaries other than for
&#147;cause&#148; or (iii)&nbsp;institute any general layoff of employees or implement any plant closings, reductions in force, furloughs, temporary layoffs, early retirement plan or announce the planning of any such action; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) enter into, amend or extend any Collective Bargaining Agreement or other Contract with any union or similar labor organization; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) waive or release any material noncompetition, nonsolicitation, nondisclosure, noninterference, nondisparagement or other restrictive
covenant obligation of any current or former employee or independent contractor; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) (i)&nbsp;make any loans, advances or capital
contributions to, or investments in, any other Person, other than investments by the Company or a wholly owned Subsidiary of the Company to a wholly owned Subsidiary of the Company or the Company or advances of expenses to any director, officer,
employee or agent of the Company in connection with advancement obligations in effect on the date of this Agreement, (ii)&nbsp;incur, assume or modify any indebtedness or (iii)&nbsp;assume, guarantee, endorse, grant a lien (other than a Permitted
Lien or any lien on Intellectual Property) on any of the Company&#146;s assets as security or otherwise become liable for indebtedness of another Person (excluding the Company or any of its Subsidiaries); or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) agree, resolve, authorize or commit to take any action prohibited by this
<U>Section</U><U></U><U>&nbsp;5.2</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 <I>No Solicitation</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>No Solicitation or Negotiation</I>. From the date hereof until the earlier to occur of the termination of this Agreement pursuant to
<U>Article</U><U></U><U>&nbsp;VIII</U> and the Closing, the Company shall (i)&nbsp;cease and cause to be terminated any discussions or negotiations with any Person and its Affiliates and their respective directors, officers, employees, investment
bankers, attorneys, accountants and other advisors or representatives (collectively, &#147;<B>Representatives</B>&#148;) that would be prohibited by this <U>Section</U><U></U><U>&nbsp;5.3(a)</U> and (ii)&nbsp;terminate all physical and electronic
data room access previously granted to any such Person, its Affiliates and their respective Representatives. From the date hereof until the earlier to occur of the termination of this Agreement pursuant to <U>Article</U><U></U><U>&nbsp;VIII</U> and
the Closing, the Company and its Subsidiaries shall not, and shall cause their respective directors, officers and employees, and shall instruct their other Representatives not to, directly or indirectly: (A)&nbsp;solicit, initiate or propose the
making, submission or announcement of, or knowingly encourage, induce, facilitate or assist, an Acquisition Proposal or any inquiries or the making of any proposal that could reasonably be expected to lead to an Acquisition Proposal;
(B)&nbsp;furnish to any Person (other than Purchaser, the Casdin Purchaser (solely with respect to the Casdin Transaction) or their respective Representatives) any <FONT STYLE="white-space:nowrap">non-public</FONT> information relating to the
Company or any of its Subsidiaries or afford to any Person access to the business, properties, assets, books, records or other <FONT STYLE="white-space:nowrap">non-public</FONT> information, or to any personnel, of the Company or any of its
Subsidiaries, in any such case to knowingly encourage, facilitate or assist an Acquisition Proposal or any inquiries relating to, or the making of, any proposal that could reasonably be expected to lead to an Acquisition Proposal;
(C)&nbsp;participate, continue or engage in discussions or negotiations with any Person with respect to an Acquisition Proposal (other than informing such Persons of the provisions contained in this <U>Section</U><U></U><U>&nbsp;5.3</U> or
contacting such Person making any unsolicited Acquisition Proposal to clarify the terms and conditions thereof); (D)&nbsp;approve, endorse or recommend an Acquisition Proposal; or (E)&nbsp;enter into any letter of intent, memorandum of
understanding, merger agreement, acquisition agreement or other Contract relating to an Acquisition Transaction (any such letter of intent, memorandum of understanding, merger agreement, acquisition agreement or other Contract relating to an
Acquisition Transaction, an &#147;<B>Alternative Acquisition Agreement</B>&#148;). From the date of this Agreement until the earlier to occur of the termination of this Agreement pursuant to <U>Article</U><U></U><U>&nbsp;VIII</U> and the Closing,
the Company shall not be required to enforce, and shall be permitted to waive, any provision of any standstill or confidentiality agreement to permit any proposal to be made to the Company Board (or any committee thereof). In furtherance and not in
limitations of the other provisions of this <U>Section</U><U></U><U>&nbsp;5.3</U>, the Company agrees that if it (i)&nbsp;permits any of its Representatives (other than an employee or consultant of the Company who is not an executive officer of the
Company) to take any action or (ii)&nbsp;is made aware of an action by one of its Representatives (other than an employee or consultant of the Company who is not an executive officer of the Company) and does not use its reasonable best efforts to
prohibit or terminate such action and, in each case, such action would constitute a material breach of this <U>Section</U><U></U><U>&nbsp;5.3</U> if taken by the Company during the period from the earlier to occur of the termination of this
Agreement pursuant to <U>Article VIII</U> and the Closing, then such action shall be deemed to constitute a breach by the Company of this <U>Section</U><U></U><U>&nbsp;5.3</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>No Change in Company Board Recommendation or Entry into an Alternative Acquisition
Agreement</I>. At no time after the date of this Agreement until the earlier of the termination of this Agreement or the Closing Date shall the Company Board (or a committee thereof)&nbsp;(i) withhold, withdraw, amend, qualify or modify, or publicly
propose to withhold, withdraw, amend, qualify or modify, the Company Board Recommendation in a manner adverse to Purchaser; (ii)&nbsp;publicly adopt, approve or recommend an Acquisition Proposal; (iii)&nbsp;in connection with a tender or exchange
offer by a third party, fail to recommend against such offer by the close of business on the 10th Business Day after the commencement of a tender or exchange offer in connection with an Acquisition Proposal (it being understood that the Company
Board (or a committee thereof) may refrain from taking a position with respect to an Acquisition Proposal until the close of business on the 10th Business Day after the commencement of a tender or exchange offer in connection with such Acquisition
Proposal without such action being considered a violation of this <U>Section</U><U></U><U>&nbsp;5.3(b)</U>); (iv)&nbsp;fail to include the Company Board Recommendation in the Proxy Statement; or (v)&nbsp;enter into any Contract or letter of intent
regarding an Acquisition Proposal (any action described in clauses (i)&nbsp;through (iv), a &#147;<B>Company Board Recommendation Change</B>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Company Board Recommendation Change</I>. Notwithstanding anything to the contrary set forth in this Agreement, at any time prior to
obtaining the Requisite Stockholder Approval, the Company Board (or a committee thereof) may effect a Company Board Recommendation Change in response to an Intervening Event if the Company Board (or a committee thereof) determines in good faith
(after consultation with its financial advisor and outside legal counsel) that the failure to do so would be inconsistent with its fiduciary duties pursuant to applicable Law; provided, that, the Company Board (or a committee thereof) shall not
effect such a Company Board Recommendation Change unless: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the Company has provided prior written notice to Purchaser
and the Casdin Purchaser at least five Business Days in advance to the effect that the Company Board (or a committee thereof) has (A)&nbsp;made such determination; and (B)&nbsp;resolved to effect a Company Board Recommendation Change pursuant to
this <U>Section</U><U></U><U>&nbsp;5.3(c)</U>, which notice shall specify the basis for such Company Board Recommendation Change, including a reasonably detailed description of the facts and circumstances relating to such Intervening Event and
copies of all relevant documents relating thereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) prior to effecting such Company Board Recommendation Change, the
Company and its Representatives, during such five Business Day period, shall have negotiated with Purchaser, the Casdin Purchaser and their respective Representatives in good faith (to the extent that Purchaser or the Casdin Purchaser desires to so
negotiate) to make such adjustments to the terms and conditions of this Agreement so that the Company Board (or a committee thereof) would no longer determine that the failure to make a Company Board Recommendation Change in response to such
Intervening Event would be inconsistent with its fiduciary duties pursuant to applicable Law; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) at the end of such five Business Day period and taking into account
any adjustments to the terms and conditions of this Agreement and the Casdin Purchase Agreement, the Company Board (or a committee thereof) has determined in good faith (after consultation with its financial advisor and outside legal counsel) that
the failure to make a Company Board Recommendation Change in response to such Intervening Event would continue to be inconsistent with its fiduciary duties pursuant to applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, the determination by the Company Board (or a committee thereof) that an Intervening Event has occurred or the delivery by the
Company of a notice contemplated by this <U>Section</U><U></U><U>&nbsp;5.3(c)</U> shall not constitute a Company Board Recommendation Change if otherwise in compliance with this <U>Section</U><U></U><U>&nbsp;5.3</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Notice</I>. From the date hereof until the earlier to occur of the termination of this Agreement pursuant to
<U>Article</U><U></U><U>&nbsp;VIII</U> and the Closing, the Company shall promptly (and, in any event, within 24 hours) notify Purchaser if any offers or proposals that constitute an Acquisition Proposal are received by, any <FONT
STYLE="white-space:nowrap">non-public</FONT> information is requested from, or any discussions or negotiations are sought to be initiated or continued with, the Company or any of its Representatives. Such notice shall include a summary of the
material terms and conditions of such offer, proposal, request, inquiry, discussions or negotiations, including the identity of the Person making any such offer, proposal, request or inquiry or seeking to engage in such discussions or negotiations,
and a copy of any written documents in connection therewith (including any updates or amendments thereto). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <I>Certain Disclosures</I>.
Nothing in this Agreement shall prohibit the Company or the Company Board (or a committee thereof) from (i)&nbsp;taking and disclosing to the Company Stockholders a &#147;stop, look and listen&#148; communication by the Company Board (or a committee
thereof) to the Company Stockholders pursuant to Rule <FONT STYLE="white-space:nowrap">14d-9(f)</FONT> promulgated under the Exchange Act (or any substantially similar communication); (ii) informing any Person of the existence of the provisions
contained in this <U>Section</U><U></U><U>&nbsp;5.3</U>; or (iii)&nbsp;complying with the Company&#146;s disclosure obligations under U.S. federal or state Law with regard to an Acquisition Proposal, it being understood that any such statement or
disclosure made by the Company Board (or a committee thereof) shall be subject to the terms and conditions of this Agreement and nothing in this <U>Section</U><U></U><U>&nbsp;5.3(e)</U> shall permit the Company to make a Company Board Recommendation
Change. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4 <I>No Control of the Other Party</I><I>&#146;</I><I>s Business</I>. The Parties acknowledge and agree that the restrictions
set forth in this Agreement are not intended to give Purchaser, on the one hand, or the Company, on the other hand, directly or indirectly, the right to control or direct the business or operations of the other at any time prior to the Closing.
Prior to the Closing Date, Purchaser and the Company shall exercise, consistent with the terms, conditions and restrictions of this Agreement, complete control and supervision over their own business and operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;VI </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADDITIONAL COVENANTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1
<I>Required Action and Forbearance; Efforts</I>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Reasonable Best Efforts</I>. On the terms and subject to the conditions set forth
in this Agreement, Purchaser shall (and shall cause its Affiliates to, if applicable), on the one hand, and the Company shall, on the other hand, use their respective reasonable best efforts to (x)&nbsp;take (or cause to be taken) all actions,
(y)&nbsp;do (or cause to be done) all things and (z)&nbsp;assist and cooperate with the other Parties in doing (or causing to be done) all things, in each case as are necessary, proper or advisable pursuant to applicable Law or otherwise to
consummate and make effective, as promptly as practicable, the Viking Transaction, including by using reasonable best efforts to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) cause the conditions to the Viking Transaction set forth in <U>Article</U><U></U><U>&nbsp;VII</U> to be satisfied; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) (A)&nbsp;obtain all consents, waivers, approvals, orders and authorizations from Governmental Authorities and
(B)&nbsp;make all registrations, declarations and filings with Governmental Authorities, in each case that are necessary or advisable to consummate the Viking Transaction; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) obtain all consents, waivers and approvals and delivering all notifications from or to any third parties in connection
with this Agreement and the consummation of the Viking Transaction that are necessary or advisable to consummate the Viking Transactions; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) execute and deliver any Contracts and other instruments that are reasonably necessary to consummate the Viking
Transaction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Section</U><U></U><U>&nbsp;6.1(a)</U> shall not apply to filings under Antitrust Laws, which shall be governed by the
obligations set forth in <U>Section</U><U></U><U>&nbsp;6.2</U> below. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>No Consent Fee</I>. Notwithstanding anything to the contrary
set forth in this <U>Section</U><U></U><U>&nbsp;6.1</U> or elsewhere in this Agreement, neither the Company nor any of its Subsidiaries shall be required to agree to: (i)&nbsp;the payment of a consent fee, &#147;profit sharing&#148; payment or other
consideration (including increased or accelerated payments); (ii) the provision of additional security (including a guaranty); or (iii)&nbsp;material conditions or obligations, including amendments to existing conditions and obligations, in each
case, in connection with the Viking Transaction, including in connection with obtaining any consent pursuant to any Material Contract. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2
<I>Antitrust Filings</I>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Filing Under Antitrust Laws</I>. Purchaser and the Company shall (i)&nbsp;cooperate and coordinate with
the other in determining whether any filings are required by applicable Antitrust Laws in connection with the Viking Transaction and, solely after the Closing and upon written notice by Purchaser to the Company, the conversion of Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Preferred Stock into Company Common Stock (the &#147;<B>Series <FONT STYLE="white-space:nowrap">B-2</FONT> Conversion</B>&#148;), (ii) cooperate and coordinate </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(and cause its respective Affiliates to cooperate and coordinate) with the other in the making of any required filings with any Governmental Authority as are required by applicable Antitrust Laws
in connection with the Viking Transaction and the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Conversion; (iii)&nbsp;supply the other (or cause the other to be supplied) with any information that may be required in order to make such filings;
(iv)&nbsp;supply (or cause to be supplied) any additional information that reasonably may be required or requested by the FTC, the DOJ or the Governmental Authorities of any other applicable jurisdiction in which any such filing is made; and
(v)&nbsp;use reasonable best efforts to take all action necessary, proper or advisable to (A)&nbsp;cause the expiration or termination of the applicable waiting periods pursuant to the HSR Act and any other Antitrust Laws (to the extent applicable
to this Agreement, the Viking Transaction or the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Conversion (as applicable)) and (B)&nbsp;obtain any required consents pursuant to any HSR Act or Antitrust Laws (to the extent applicable to this
Agreement, the Viking Transaction or the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Conversion (as applicable)), in each case as promptly as reasonably practicable. Purchaser (and its Affiliates, if applicable), on the one hand, and the
Company (and its Affiliates), on the other hand, shall promptly inform the other of any communication from any Governmental Authority regarding the Viking Transaction and the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Conversion (as
applicable) in connection with such filings. If either Party or Affiliate thereof receives any comments or a request for additional information or documentary material from any Governmental Authority with respect to the Viking Transaction or the
Series <FONT STYLE="white-space:nowrap">B-2</FONT> Conversion pursuant to any Antitrust Law applicable to the Viking Transaction or the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Conversion (respectively), then such Party shall make (or
cause to be made), as promptly as practicable and after consultation with the other Parties, an appropriate response to such request; <U>provided</U>, that neither Party may extend any waiting period or enter or propose to enter into any agreement,
commitment or understanding with any Governmental Authority without the permission of the other Party, which shall not be unreasonably withheld, conditioned or delayed. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Cooperation</I>. In furtherance and not in limitation of the foregoing, the Company and Purchaser shall (and shall cause their
respective controlling Persons, controlled Affiliates and Subsidiaries, respectively, to), subject to any restrictions under applicable Laws: (i)&nbsp;promptly notify the other Party of, and, if in writing, furnish the other with copies of (or, in
the case of oral communications, advise the others of the contents of) any material communication received by such Person from a Governmental Authority in connection with the Viking Transaction and the Series
<FONT STYLE="white-space:nowrap">B-2</FONT> Conversion and permit the other Party to review and discuss in advance (and to consider in good faith any comments made by the other Party in relation to) any proposed draft notifications, formal
notifications, filing, submission or other written communication (and any analyses, memoranda, white papers, presentations, correspondence or other documents submitted therewith) made in connection with the Viking Transaction and the Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Conversion (as applicable) to a Governmental Authority; (ii)&nbsp;keep the other Party informed with respect to the status of any such submissions and filings to any Governmental Authority in connection with the
Viking Transaction and the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Conversion (as applicable) and any developments, meetings or discussions with any Governmental Authority in respect thereof, including with respect to (A)&nbsp;the receipt
of any <FONT STYLE="white-space:nowrap">non-action,</FONT> action, clearance, consent, approval or waiver, (B)&nbsp;the expiration of any waiting period, (C)&nbsp;the commencement or proposed or threatened commencement of any investigation,
litigation or administrative or judicial action or proceeding under applicable Laws, including any proceeding initiated by a private party and (D)&nbsp;the nature and status of any objections raised or proposed or threatened to be raised by any
Governmental Authority with respect to the Viking Transaction and the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Conversion (as applicable); and (iii)&nbsp;not independently participate in any meeting, hearing, proceeding or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
discussions (whether in person, by telephone or otherwise) with or before any Governmental Authority in respect of the Viking Transaction or the Series <FONT STYLE="white-space:nowrap">B-2</FONT>
Conversion without giving the other party reasonable prior notice of such meeting or discussions and, unless prohibited by such Governmental Authority, the opportunity to attend or participate. Subject to restrictions under applicable Law, Purchaser
shall not, without the prior written consent of the Company, extend or offer or agree to extend any waiting period under the HSR Act or any other Antitrust Law, or enter into any agreement with any Governmental Authority related to this Agreement,
the transactions contemplated by this Agreement or the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Conversion. However, the Company and Purchaser may each designate any <FONT STYLE="white-space:nowrap">non-public</FONT> information provided
to any Governmental Authority as restricted to &#147;outside counsel&#148; only and any such information shall not be shared with employees, officers or directors or their equivalents of the other Party without approval of the Party providing the <FONT
STYLE="white-space:nowrap">non-public</FONT> information; provided, that each of the Company and Purchaser may redact any valuation and related information before sharing any information provided to any Governmental Authority with the other Party on
an &#147;outside counsel&#148; only basis, and that the Company and Purchaser shall not in any event be required to share information that benefits from legal privilege with the other Party, even on an &#147;outside counsel&#148; only basis, where
this would cause such information to cease to benefit from legal privilege. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Other Action</I>. Purchaser shall not, directly or
indirectly (whether by merger, consolidation or otherwise), acquire (or agree to acquire) any business, corporation partnership, association or other business organization or division or part thereof, or any securities or collection of assets, if
doing so would reasonably be expected to prevent or materially delay the consummation of the Viking Transaction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Limitations on
Action</I>. Notwithstanding anything to the contrary in this Agreement, nothing in this Agreement, including this <U>Section</U><U></U><U>&nbsp;6.2</U>, shall require or obligate Purchaser or any of its Affiliates to agree, propose, commit to, or
effect, or otherwise be required, by consent decree, hold separate, or otherwise, any sale, divestiture, hold separate, or any other action otherwise limiting the freedom of action in any respect with respect to any businesses, products, rights,
services, licenses, assets, or interest therein, of Purchaser or any Affiliate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.3 <I>Proxy Statement</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Proxy Statement</I>. As promptly as practical following the date of this Agreement, the Company (with the assistance and cooperation of
Purchaser as reasonably requested by the Company) shall prepare and file with the SEC a preliminary proxy statement (as amended or supplemented, the &#147;<B>Proxy Statement</B>&#148;) relating to the Company Stockholder Meeting, and the Company
shall use its reasonable best efforts to make such filing within 15 days of the date of this Agreement. Subject to <U>Section</U><U></U><U>&nbsp;5.3(c)</U>, the Company shall include the Company Board Recommendation in the Proxy Statement. Prior to
the filing of the Proxy Statement (or any amendment or supplement thereto), or any dissemination thereof to the Company Stockholders, or responding to any comments from the SEC with respect thereto, the Company shall provide Purchaser and its
counsel with a reasonable opportunity to review and to comment on such document or response, which comments the Company shall consider in good faith. None of the information supplied or to be supplied by or on behalf of the Company or Purchaser for
inclusion or incorporation by reference in the Proxy Statement, as of the date it or any amendment or supplement is mailed to the Company Stockholders and at the time of the Company Stockholder Meeting, shall contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances in which they are made, not misleading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Furnishing Information</I>. The Company, on the one hand, and Purchaser, on the other
hand, shall furnish all information concerning it and its Affiliates, if applicable, as the other Party may reasonably request in connection with the preparation and filing with the SEC of the Proxy Statement. If at any time prior to the Company
Stockholder Meeting any information relating to the Company, Purchaser or any of their respective Affiliates should be discovered by the Company, on the one hand, or Purchaser, on the other hand, that should be set forth in an amendment or
supplement to the Proxy Statement so that such filing would not include any misstatement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading, then the Party that discovers such information shall promptly notify the other, and an appropriate amendment or supplement to such filing describing such information shall be promptly prepared and filed
with the SEC by the appropriate Party and, to the extent required by applicable law or the SEC or its staff, disseminated to the Company Stockholders. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Consultation Prior to Certain Communications</I>. The Company and its Affiliates, on the one hand, and Purchaser and its Affiliates, on
the other hand, shall not communicate in writing with the SEC or its staff with respect to the Proxy Statement without first providing the other Party a reasonable opportunity to review and comment on such written communication, and each Party shall
give due consideration to all reasonable additions, deletions or changes suggested thereto by the other Parties or their respective counsel. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Notices</I>. The Company, on the one hand, and Purchaser, on the other hand, shall advise the other, promptly after it receives notice
thereof, of (i)&nbsp;any receipt of a request by the SEC or its staff for any amendment or revisions to the Proxy Statement, (ii)&nbsp;any receipt of comments from the SEC or its staff on the Proxy Statement; or (iii)&nbsp;any receipt of a request
by the SEC or its staff for additional information in connection therewith. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <I>Dissemination of Proxy Statement</I>. Subject to
applicable Law, the Company shall use its reasonable best efforts to cause the definitive Proxy Statement to be disseminated to the Company Stockholders as promptly as reasonably practicable following the filing thereof with the SEC and confirmation
from the SEC that it will not review, or that it has completed its review of, the Proxy Statement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.4 <I>Company Stockholder Meeting</I>.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Call of Company Stockholder Meeting</I>. Within 10 calendar days after the date of this Agreement (and thereafter as reasonably
determined by the Company in consultation with Purchaser), the Company shall conduct a &#147;broker search&#148; in accordance with <FONT STYLE="white-space:nowrap">Rule&nbsp;14a-13</FONT> of the Exchange Act for a record date for the Company
Stockholder Meeting that is 20 Business Days after the date of such &#147;broker search.&#148; Following the clearance of the Proxy Statement by the SEC, the Company shall duly call and hold a meeting of its stockholders (the &#147;<B>Company
Stockholder Meeting</B>&#148;) as promptly as reasonably practicable (taking into account the time necessary to solicit proxies for the approval of the Transactions and the Certificate of Amendment) following the mailing of the Proxy Statement to
the Company Stockholders, which mailing shall be initiated in accordance with <U>Section</U><U></U><U>&nbsp;6.3(e)</U>. Unless there has been a Company Board Recommendation Change in accordance with <U>Section</U><U></U><U>&nbsp;5.3(c)</U>, the
Company shall use its reasonable best efforts to solicit proxies to obtain the Requisite Stockholder Approval. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Adjournment of Company Stockholder Meeting</I>. Notwithstanding anything to the
contrary in this Agreement, nothing shall prevent the Company from postponing or adjourning the Company Stockholder Meeting: (i)&nbsp;to allow additional solicitation of votes in order to obtain the Requisite Stockholder Approval; (ii)&nbsp;if there
are holders of an insufficient number of shares of Company Common Stock present or represented by proxy at the Company Stockholder Meeting to constitute a quorum at the Company Stockholder Meeting; (iii)&nbsp;if the Company is required to postpone
or adjourn the Company Stockholder Meeting by applicable Law or receives a request from the SEC or its staff to do so; or (iv)&nbsp;if the Company Board (or a committee thereof) has determined in good faith (after consultation with outside legal
counsel) that it is required under applicable Law to postpone or adjourn the Company Stockholder Meeting in order to give the Company Stockholders sufficient time to evaluate any information or disclosure that the Company has sent to the Company
Stockholders or otherwise made available to the Company Stockholders. Notwithstanding the foregoing, (A)&nbsp;the Company shall not, without the prior written consent of Purchaser, postpone the Company Stockholder Meeting for more than 20 Business
Days in the aggregate and (B)&nbsp;the Company shall, at the request of Purchaser, to the extent permitted by applicable Law, adjourn the Company Stockholder Meeting to a date specified jointly by Purchaser and the Company (acting in good faith and
taking into account the time necessary to solicit proxies) if a quorum is absent at the Company Stockholder Meeting or if the Company has not received proxies representing a sufficient number of shares of Company Common Stock to obtain the Requisite
Stockholder Approval (it being understood that Purchaser shall not be able to cause the Company to adjourn the Company Stockholders Meeting to a date that is less than 10 Business Days before the Termination Date). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Meeting Obligation</I>. For the avoidance of doubt, the Company&#146;s obligations pursuant to this
<U>Section</U><U></U><U>&nbsp;6.4</U> shall not be affected by (i)&nbsp;the commencement, public proposal, public disclosure or communication to the Company of an Acquisition Proposal or (ii)&nbsp;any Company Board Recommendation Change. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.5 <I>Anti-Takeover Laws</I>. The Company and Purchaser shall (a)&nbsp;take all actions within their power to ensure that no &#147;control
share acquisition,&#148; &#147;fair price,&#148; &#147;moratorium,&#148; &#147;business combination&#148; or other state anti-takeover Law (including Section&nbsp;203 of the DGCL), statute or similar statute or regulation is or becomes applicable to
the Transactions or any other transactions contemplated by this Agreement or the other Transaction Documents and (b)&nbsp;if any &#147;control share acquisition,&#148; &#147;fair price,&#148; &#147;moratorium,&#148; &#147;business combination&#148;
or other state anti-takeover Law (including Section&nbsp;203 of the DGCL), statute or similar statute or regulation becomes applicable to the Transactions or any other transactions contemplated by this Agreement or the other Transaction Documents,
take all actions within their power to ensure that the Transactions may be consummated as promptly as reasonably practicable on the terms contemplated by this Agreement and otherwise to minimize the effect of such statute or regulation on the
Transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.6 <I>Use of Proceeds</I>. The Company shall use the proceeds of the VGO Drawdown Purchase
Price and the VGO Illiquid Investments Purchase Price paid by Purchaser, together with the proceeds of the purchase price paid by the Casdin Purchaser pursuant to the Casdin Purchase Agreement to pay the Company&#146;s expenses related to the Casdin
Transaction, the Viking Transaction, for working capital, for mergers and acquisitions and for general corporate purposes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.7
<I>Access</I>. At all times during the period commencing with the execution and delivery of this Agreement and continuing until the earlier to occur of the termination of this Agreement pursuant to <U>Article</U><U></U><U>&nbsp;VIII</U> and the
Closing, the Company shall afford Purchaser reasonable access, consistent with applicable Law, during normal business hours, on reasonable advance notice provided in writing to the General Counsel of the Company, or another Person designated in
writing by the Company, to the properties, books and records and personnel of the Company, except that the Company may restrict or otherwise prohibit access to any documents or information to the extent that (a)&nbsp;any applicable Law or Contract
requires the Company to restrict or otherwise prohibit access to such documents or information (in which case, the Company shall use reasonable best efforts to provide such access as can be provided (or otherwise convey such information regarding
the applicable matter as can be conveyed) in compliance with such applicable Law or Contract), (b)&nbsp;access to such documents or information would give rise to a material risk of waiving any attorney-client privilege, work product doctrine or
other privilege applicable to such documents or information (in which case, the Company shall use reasonable best efforts to provide such access as can be provided (or otherwise convey such information regarding the applicable matter as can be
conveyed) without jeopardizing such privilege), (c)&nbsp;such disclosure relates to interactions with other prospective buyers or transaction partners of the Company or the negotiation of this Agreement and the transactions contemplated hereby, or
information relating to the analysis, valuation or consideration of the Transactions or the other transactions contemplated hereby, in each case, subject to <U>Section</U><U></U><U>&nbsp;5.3</U>, which shall not be limited by this
<U>Section</U><U></U><U>&nbsp;6.7</U> or (d)&nbsp;access would result in the disclosure of any trade secrets of third Persons. Nothing in this <U>Section</U><U></U><U>&nbsp;6.7</U> shall be construed to require the Company, any of its Subsidiaries
or any of their respective Representatives to prepare any reports, analyses, appraisals or opinions. Any investigation conducted pursuant to the access contemplated by this <U>Section</U><U></U><U>&nbsp;6.7</U> shall be conducted in a manner that is
consistent with all applicable <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures and (i)&nbsp;that does not unreasonably interfere with the conduct of the business of the Company and its Subsidiaries or otherwise result in any significant
interference with the prompt and timely discharge by officers, employees and other authorized Representatives of the Company or any of its Subsidiaries of their normal duties or (ii)&nbsp;create a risk of damage or destruction to any property or
assets of the Company or its Subsidiaries. Any access to the properties of the Company and its Subsidiaries shall be subject to the Company&#146;s reasonable security measures and insurance requirements and will not include the right to perform
invasive or subsurface testing or any sampling, monitoring or analysis of soil, groundwater, building materials, indoor air, or other environmental media of the sort generally referred to as a &#147;Phase II&#148; environmental investigation. The
terms and conditions of the Confidentiality Agreement shall apply to any information obtained by Purchaser or any of its Representatives in connection with any investigation conducted pursuant to the access contemplated by this
<U>Section</U><U></U><U>&nbsp;6.7</U>. Notwithstanding anything to the contrary in this Agreement, each Party may satisfy its obligations set forth in this <U>Section</U><U></U><U>&nbsp;6.7</U> by electronic means if physical access would not be
permitted under applicable <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.8 <I>Information Rights</I>. Following the Closing
Date, so long as Purchaser Parties, collectively, continue to beneficially own at least 25% of the Acquired Shares (including shares of Company Common Stock issued on conversion of such Acquired Shares), calculated on an as-converted basis (without
giving effect to any limitations on conversion in the Certificate of Designations), the Company shall publicly file with the SEC or provide Purchaser with the following: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) within 90 days after the end of each fiscal year of the Company, the Company&#146;s Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the applicable fiscal year, which shall include: (i)&nbsp;an audited, consolidated balance sheet of the Company and its Subsidiaries as of the end of such fiscal year; (ii)&nbsp;an audited,
consolidated income statement of the Company and its Subsidiaries for such fiscal year; and (iii)&nbsp;an audited, consolidated statement of cash flows of the Company and its Subsidiaries for such fiscal year; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) within 45 days after the end of each of the first three quarters of each fiscal year of the Company, the Company&#146;s Form <FONT
STYLE="white-space:nowrap">10-Q</FONT> for the applicable fiscal quarter, which shall include: (i)&nbsp;an unaudited, consolidated balance sheet of the Company and its Subsidiaries as of the end of such fiscal quarter; (ii)&nbsp;an unaudited,
consolidated income statement of the Company and its Subsidiaries for such fiscal quarter; and (iii)&nbsp;an unaudited, consolidated statement of cash flows of the Company and its Subsidiaries for such fiscal quarter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.9 <I>Notification of Certain Matters</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Notification by the Company</I>. From the date of this Agreement until the earlier to occur of the termination of this Agreement
pursuant to <U>Article</U><U></U><U>&nbsp;VIII</U> and the Closing, the Company shall promptly give written notice to Purchaser on having Knowledge of any matter that may constitute a breach of any representation, warranty, agreement or covenant of
the Company contained in this Agreement that would reasonably be expected to cause any conditions to Closing set forth in <U>Section</U><U></U><U>&nbsp;7.2(a)</U>, <U>Section</U><U></U><U>&nbsp;7.2(b)</U> or <U>Section</U><U></U><U>&nbsp;7.2(c)</U>
to not be satisfied; <U>provided</U>, that the Company&#146;s breach of its obligations pursuant to this <U>Section</U><U></U><U>&nbsp;6.9(a)</U> shall not cause the condition to Closing set forth in <U>Section</U><U></U><U>&nbsp;7.2(b)</U> to not
be satisfied. No such notification shall affect or be deemed to modify any representation or warranty of the Company set forth in this Agreement or the conditions to the obligations of Purchaser to consummate the Viking Transaction or the remedies
available to the Parties under this Agreement. The terms and conditions of the Confidentiality Agreement apply to any information provided to Purchaser pursuant to this <U>Section</U><U></U><U>&nbsp;6.9(a)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Notification by Purchaser</I>. From the date of this Agreement until the earlier to occur of the termination of this Agreement pursuant
to <U>Article</U><U></U><U>&nbsp;VIII</U> and the Closing, Purchaser shall promptly give written notice to the Company on having knowledge of any matter that may constitute a breach of any representation, warranty, agreement or covenant of Purchaser
contained in this Agreement that would reasonably be expected to cause any conditions to Closing set forth in <U>Section</U><U></U><U>&nbsp;7.3(a)</U> or <U>Section</U><U></U><U>&nbsp;7.3(b)</U> to not be satisfied; <U>provided</U>, that
Purchaser&#146;s breach of its obligations pursuant to this <U>Section</U><U></U><U>&nbsp;6.9(b)</U> shall not cause the condition to Closing set forth in or <U>Section</U><U></U><U>&nbsp;7.3(b)</U> to not be satisfied. No such notification will
affect or be deemed to modify any representation or warranty of Purchaser set forth in this Agreement or the conditions to the obligations of the Company to consummate the Viking Transaction or the remedies available to the Parties under this
Agreement. The terms and conditions of the Confidentiality Agreement apply to any information provided to Purchaser pursuant to this <U>Section</U><U></U><U>&nbsp;6.9(b)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.10 <I>Public Statements and Disclosure</I>. The initial press release with respect to the
execution of this Agreement shall be a joint press release to be reasonably agreed on by the Company and Purchaser. Following such initial press release, the Company and Purchaser shall consult with each other before issuing, and give each other the
opportunity to review and comment on, any press release or other public statements with respect to the Casdin Transaction or the Viking Transaction and shall not issue any such press release or make any such public statement prior to such
consultation, except as such party may reasonably conclude may be required by applicable Law, court process or by obligations pursuant to any listing agreement with any national securities exchange or national securities quotation system (and then
only after as much advance notice and consultation as is feasible); <U>provided</U>, that neither the Company nor Purchaser shall be obligated to engage in such consultation with respect to communications that are not materially inconsistent with
public statements previously made in accordance with this <U>Section</U><U></U><U>&nbsp;6.10</U>; <U>provided</U>, <U>further</U>, that the restrictions set forth in this <U>Section</U><U></U><U>&nbsp;6.10</U> shall not apply to any release or
public statement in connection with any dispute between the Parties or the Casdin Purchaser regarding this Agreement or the Transactions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.11 <I>Transaction Litigation</I>. Prior to the Closing, the Company shall provide Purchaser with prompt notice (and in any event within three
Business Days) of all Transaction Litigation commenced or threatened in writing to be commenced, after the date of this Agreement, against the Company or any of its directors or officers by any stockholder relating to this Agreement, the other
Transaction Documents and the transactions contemplated hereby and thereby (including by providing copies of all pleadings with respect thereto) and keep Purchaser reasonably informed with respect to the status thereof. The Company shall
(a)&nbsp;give Purchaser the opportunity to, subject to the entry into a joint defense agreement with terms mutually agreeably to the parties, participate in the defense, settlement or prosecution of any Transaction Litigation, and shall consider
Purchaser&#146;s views and (b)&nbsp;consult with Purchaser with respect to the defense, settlement and prosecution of any Transaction Litigation. The Company shall not compromise, settle or come to an arrangement regarding, or agree to compromise,
settle or come to an arrangement regarding, any Transaction Litigation unless Purchaser has consented thereto in writing (which consent will not be unreasonably withheld, conditioned or delayed). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.12 <I>Listing of Shares</I>. Prior to the Closing and subject to the stockholder approval rules of the NASDAQ, the Company and Purchaser
shall each use their respective reasonable best efforts to obtain approval for listing, subject to notice of issuance, of the Underlying Shares on the NASDAQ, subject to and in accordance with the principles set forth on Section&nbsp;6.12 of the
Company Disclosure Letter. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.13 <I>Certain Governance and Other Matters</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall take all necessary action so that, effective as of the Closing: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <I>Directors</I>. The Company Board is comprised of seven members, including (A)&nbsp;one individual designated by
Purchaser prior to the Closing as the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Director, and (B)&nbsp;the Chief Executive Officer of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <I>Company Name</I>. The name of the Company is changed to
&#147;Standard BioTools Inc.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company and Purchaser shall take the actions specified on Section&nbsp;6.13(b) of the Company
Disclosure Letter. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company shall adopt and take all actions necessary to implement the 2022 Inducement Plan (as defined in the
Company Disclosure Schedule) and take the other actions set forth in Section&nbsp;6.13(c) of the Company Disclosure Schedule, in each case effective as of the Closing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.14 <I>No Inconsistent Agreements</I>. From the date of this Agreement through the Closing, neither the Company nor any of its Affiliates
shall enter into any additional, or modify any existing, agreements with the Casdin Purchaser that have the effect of establishing rights or otherwise benefiting Casdin Purchaser in a manner more favorable in any respect to the rights and benefits
established in favor of Purchaser by this Agreement, unless in any such case, Purchaser has been offered such rights and benefits and the Company has agreed to such amendments to this Agreement as may be necessary to provide such rights and benefits
to Purchaser. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.15 <I>Transfer Restrictions</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the exceptions set forth in <U>Section</U><U></U><U>&nbsp;6.15(b),</U> until the
<FONT STYLE="white-space:nowrap">six-month</FONT> anniversary of the Closing Date, Purchaser agrees not to, without the prior written consent of the Company Board (excluding the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred
Director), directly or indirectly, (i)&nbsp;transfer, sell, hypothecate, pledge, grant any option to purchase or otherwise dispose of any shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock held by Purchaser, including any
Underlying Shares issued or issuable upon conversion of such shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock (&#147;<B><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares</B>&#148;) or (ii)&nbsp;enter into any swap or
other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any of, or Hedge, such <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares (the actions specified in clauses&nbsp;(i) and (ii),
other than any entry into a cash-settled Hedge, a &#147;<B>Transfer</B>&#148;). Thereafter, Purchaser shall not Transfer any shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock held by Purchaser, including any
Underlying Shares issued or issuable upon conversion of such shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock, to an Activist Investor, to a Competitor or to any Person that would beneficially own, after giving
effect to such Transfer, five percent or more of the outstanding Company Common Stock (measured on <FONT STYLE="white-space:nowrap">as-converted</FONT> basis), in each case, to the extent that the identity of the transaction counterparty can be
reasonably ascertained and such Person meets the applicable definition thereof to Purchaser&#146;s knowledge after reasonable inquiry; <U>provided</U>, that the provisions of the foregoing clause shall not apply to (A)&nbsp;any block trade in which
a broker-dealer will attempt to sell the shares to a third-party as agent or other similar transactions with a financial intermediary, (B)&nbsp;any Transfer into the public market pursuant to a <I>bona fide</I>, broadly distributed underwritten
public offering or (C)&nbsp;any Transfers through a <I>bona fide</I> sale to the public that is not directed at a particular transferee, without registration effectuated pursuant to Rule 144 under the Securities Act. Any attempt to Transfer in
violation of the terms of this <U>Section</U><U></U><U>&nbsp;6.15(a)</U> shall be null and void <I>ab initio</I> and no right, title or interest therein or thereto shall be transferred to the purported transferee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything to the contrary herein, the restrictions set forth in
<U>Section</U><U></U><U>&nbsp;6.15(a)</U> shall not apply to the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Transfers to any Affiliate of Purchaser,
including an affiliated investment fund, <FONT STYLE="white-space:nowrap">co-investment</FONT> vehicle or aggregator vehicle (or equivalent) that is controlled, managed or advised by Purchaser or an Affiliate of Purchaser; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Transfers by virtue of laws of the state of the entity&#146;s organization and the entity&#146;s organizational documents
upon dissolution of the entity (any transferees pursuant to clauses (i)&nbsp;and (ii), &#147;<B>Permitted Transferees</B>&#148;); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) Transfers in connection with a change of control of any Purchaser Party; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) Transfers or issuances of any limited partnership interests or other equity interests in any Purchaser Party (or any
direct or indirect parent entity of such Purchaser Party, including any affiliated investment fund, <FONT STYLE="white-space:nowrap">co-investment</FONT> vehicle or aggregator (or equivalent)); <U>provided</U>, that any transferor or transferee
thereof shall be controlled (directly or indirectly) by the Person (directly or indirectly) controlling such Person immediately prior to such transfer; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) Transfers to the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) Transfers in the event of a liquidation, merger, consolidation, stock exchange, business combination, tender offer or
other similar transaction that results in all holders of the Voting Stock of the Company having the right to exchange such Voting Stock for cash, securities or other property (including, for the avoidance of doubt, any tender offer or exchange offer
that is for less than all of the outstanding shares of Company Common Stock); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) Transfers after commencement by
the Company or a significant subsidiary (as such term is defined in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> under the Exchange Act) of the Company of bankruptcy, insolvency or other similar proceedings; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>, that in the case of clauses (i)&nbsp;and (ii), the Permitted Transferees (if not already a party hereto) must agree in writing to be bound by
this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.16 <I><FONT STYLE="white-space:nowrap">Pre-Emptive</FONT> </I><I>Rights</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Following the Closing Date, so long as Purchaser Parties, collectively, continue to beneficially own at least 25% of the Acquired Shares
(including Underlying Shares issued on conversion of such Acquired Shares), calculated on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis (without giving effect to any limitations on conversion in the Certificate of Designations), if
the Company proposes to issue or sell any Equity Securities (other than any Excluded Securities) (&#147;<B>New Securities</B>&#148;) to any Person or Persons (the &#147;<B>Offeree</B>&#148;), the Company shall first offer to sell to each Purchaser
Party a portion of such New Securities equal to the (i)&nbsp;the number of shares of Company Common Stock beneficially owned by such Purchaser Party <I>divided by</I> (ii)&nbsp;the total number of shares of Company Common Stock issued and
outstanding, in each case as of immediately prior </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to such issuance and determined on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis (the &#147;<B>Preemptive Percentage</B>&#148;). The Purchaser Parties shall be entitled to
purchase such New Securities at the same price, on the same terms and subject to the same conditions as are to be offered to the Offeree. The Purchaser Parties electing to purchase their Preemptive Percentage of the New Securities proposed to be
issued or sold to the Offeree (&#147;<B>Participating Parties</B>&#148;) shall take all necessary actions in connection with the consummation of the purchase transactions contemplated by this <U>Section</U><U></U><U>&nbsp;6.16</U> as requested by
the Company Board, including the execution of all agreements, documents and instruments in connection therewith in the form presented by the Company, so long as such agreements, documents and instruments are on customary forms for such a transaction
and do not require such Participating Parties to make or agree to any representation, warranty, covenant or indemnity that is more burdensome than that required of the Offeree in the agreements, documents or instruments in connection with such
transaction. If any Purchaser Party or any Casdin Party elects not to purchase all of the New Securities that it is entitled to purchase pursuant to the first sentence of this <U>Section</U><U></U><U>&nbsp;6.16</U> or the first sentence of
<U>Section</U><U></U><U>&nbsp;6.16</U> of the Casdin Purchase Agreement, as applicable, each Participating Party that has elected to purchase its Preemptive Percentage of the New Securities proposed to be issued or sold to the Offeree (together with
any Casdin Party that has elected to purchase its Preemptive Percentage of such New Securities, the &#147;<B>Fully Participating Parties</B>&#148;) shall be entitled to purchase an additional number of New Securities equal to the aggregate number of
New Securities that the Purchaser Parties and/or Casdin Parties elected not to purchase; <U>provided</U>, that if there is an oversubscription in respect of such remaining New Securities due to more than one Fully Participating Party requesting
additional New Securities, the oversubscribed amount shall be fully allocated among the Fully Participating Parties pro rata based on such Fully Participating Parties&#146; relative Preemptive Percentages. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In order to exercise its purchase rights hereunder, a Purchaser Party shall, within 15 days after receipt of written notice (an
&#147;<B>Offer Notice</B>&#148;) from the Company describing the New Securities being offered, the purchase price thereof, the payment terms and such Purchaser Party&#146;s percentage allotment, deliver a written notice to the Company describing its
election hereunder (which election shall be absolute and unconditional other than being conditioned upon the consummation of the issuance or sale to the Offeree). If the Company receives no such notice from the Purchaser within 15 days after the
Offer Notice is given, the Company shall be deemed to have notified the Company that it does not elect to participate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) In connection
with any exercise by Purchaser of its rights to purchase New Securities pursuant to this Agreement, the Company will cooperate with the Purchaser as reasonably requested by the Purchaser to complete any such purchase, including, to the extent
requested by the Purchaser, entering into &#147;blocker&#148; arrangements with respect to derivative securities and effecting any required filings or notices required by any governmental agency at the Purchaser&#146;s sole cost and expense.
Purchaser shall take all such actions as may be reasonably necessary to complete any such purchase, including, without limitation, providing such information to the Company as requested in order to determine the Purchaser&#146;s Preemptive
Percentage and entering into such additional agreements as may be necessary and appropriate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) During the 90 days following the
expiration of the <FONT STYLE="white-space:nowrap">15-day</FONT> offering period described in <U>Section</U><U></U><U>&nbsp;6.16(b)</U>, the Company shall be entitled to sell any New Securities that the Purchaser Parties have not elected to purchase
to the Offeree at a price no less than the purchase price, and on other terms and subject to other conditions no more favorable than those, stated in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the notice provided under <U>Section</U><U></U><U>&nbsp;6.16(b)</U> (in addition to the New Securities that the Company is not required to offer to the Purchaser Parties pursuant to the first
sentence of <U>Section</U><U></U><U>&nbsp;6.16(a)</U>). Any New Securities proposed to be issued or sold by the Company to the Offeree after such <FONT STYLE="white-space:nowrap">90-day</FONT> period, or at a price or on terms or subject to
conditions not complying with the preceding sentence, shall be reoffered to the Purchaser Parties pursuant to the terms of this <U>Section</U><U></U><U>&nbsp;6.16</U> prior to any issuance or sale to the Offeree. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) For purposes of determining the Purchaser&#146;s beneficial ownership of Company Common Stock, the Company shall be permitted to rely on
any information provided to the Company by Purchaser and any public disclosures made by Purchaser. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) In the case of a proposed issuance
or sale of New Securities for consideration in whole or in part other than cash, including securities acquired in exchange therefor, for purposes of this <U>Section</U><U></U><U>&nbsp;6.16</U> the consideration other than cash shall be deemed to be
cash in an amount equal to the fair value of such consideration as reasonably determined by the Company Board; <U>provided</U>, that such fair value as determined by the Company Board shall not exceed the aggregate market price of the securities
being offered as of the date the Company Board authorizes the offering of such securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Notwithstanding anything in this Agreement
to the contrary, a Purchaser Party may designate any of its Permitted Transferees to purchase all or part of the New Securities offered to such Purchaser Party pursuant to <U>Section</U><U></U><U>&nbsp;6.16(a)</U>; <U>provided</U>, that such
Purchaser Party shall remain obligated to consummate the purchase if such designee fails to do so. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.17 <I>Standstill</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Purchaser agrees that, from and after the Closing until the later of (x)&nbsp;the first anniversary of the Closing and (y)&nbsp;such time
as the Purchaser Preferred Percentage is no longer equal to or greater than 7.5%, Purchaser shall not, directly or indirectly, do any of the following unless requested or approved in advance in writing by the Company (acting through the Company
Board): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) (A)&nbsp;make, or in any way participate in, any &#147;solicitation&#148; of &#147;proxies&#148; (within the
meaning of Rule <FONT STYLE="white-space:nowrap">14a-1</FONT> under the Exchange Act) to vote any Voting Stock of the Company or its Subsidiaries, (B)&nbsp;call or seek to call a meeting of the Company&#146;s stockholders or initiate any stockholder
proposal for action by the Company&#146;s stockholders or (C)&nbsp;seek the removal of any director from the Company Board (other than the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Director); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) make any public announcement with respect to, or submit a proposal or offer for, any merger, consolidation, business
combination, tender or exchange offer, restructuring, recapitalization or other extraordinary transaction involving the Company or any of its Subsidiaries (other than (A)&nbsp;any nonpublic proposal to the Company Board that would not require the
Company, Purchaser or any other Person to make any public announcement or other disclosure with respect thereto or (B)&nbsp;any public disclosure in any filings by Purchaser or its Affiliates with the SEC to the extent required by applicable Law or
stock exchange rules); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) form, join or in any way participate in a &#147;group&#148; (as
defined in Section&nbsp;13(d)(3) of the Exchange Act) in connection with any Voting Stock of the Company or its Subsidiaries, including with the Casdin Purchaser; <U>provided</U>, that taking any action contemplated by this Agreement shall not
constitute a violation of this <U>Section</U><U></U><U>&nbsp;6.17(a)(iii)</U>; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) take any action that would
reasonably be expected to require the Company to make a public announcement regarding any actions prohibited by this <U>Section</U><U></U><U>&nbsp;6.17(a);</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>, that nothing contained in this <U>Section</U><U></U><U>&nbsp;6.17(a)</U> shall limit, restrict or prohibit (x)&nbsp;any confidential, <FONT
STYLE="white-space:nowrap">non-public</FONT> discussions with or communications or proposals to management or the Company Board by Purchaser or its Affiliates or Representatives related to any of the foregoing, (y)&nbsp;any Purchaser Party&#146;s
ability to vote, Transfer, convert, exercise its rights under <U>Section</U><U></U><U>&nbsp;6.16</U> or otherwise exercise rights with respect to its <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock or Company Common Stock in
accordance with the terms and conditions of this Agreement and the Certificate of Designations or (z)&nbsp;the ability of the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Director to vote or otherwise exercise his or her duties or
otherwise act in his or her capacity as a member of the Company Board. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the foregoing, the restrictions set forth in
<U>Section</U><U></U><U>&nbsp;6.17(a)</U> shall not apply if any of the following occurs: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the Company enters into a
definitive agreement providing for a merger, consolidation or other business combination transaction as a result of which the stockholders of the Company would own Voting Stock of the resulting corporation having 50% or less of the votes that may be
cast generally in an election of directors if all outstanding Voting Stock were present and voted at a meeting held for such purpose; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) a tender offer or exchange offer for a majority of the capital stock of the Company is commenced by a third person (other
than Purchaser and its Affiliates), which tender offer or exchange offer, if consummated, would result in a Change of Control (as defined in the Certificate of Designations), and either the Company Board recommends that the stockholders of the
Company tender their shares in response to such offer or does not recommend against the tender offer or exchange offer within ten Business Days after the commencement thereof; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) the Company solicits from one or more Persons, or enters into discussions with one or more Persons, regarding a proposal
with respect to a merger of, or a business combination transaction involving, the Company without similarly soliciting a proposal from Purchaser, or the Company makes a public announcement, with the approval of the Company Board, that it is seeking
to sell itself. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.18 <I>Voting Threshold</I>. Purchaser hereby grants a proxy to the Chief Financial Officer and the General Counsel of
the Company in office from time to time, each of them individually, with full power of substitution and resubstitution, to vote any shares in excess of the Voting Threshold (as such term is defined in the Certificate of Designations) in the manner
contemplated by the Certificate of Designations. The proxy granted herein is irrevocable and coupled with an interest and shall continue to apply following the transfer of any shares purchased herein to any Viking Party (as such term is defined in
the Certificate of Designations). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;VII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDITIONS TO THE VIKING TRANSACTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1 <I>Conditions to Each Party</I><I>&#146;</I><I>s Obligations to Effect the Viking Transaction</I>. The respective obligations of the
Parties to consummate the Viking Transaction are subject to the satisfaction or waiver (where permissible pursuant to applicable Law) prior to the Closing of each of the following conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Requisite Stockholder Approval</I>. The Company shall have received the Requisite Stockholder Approval at the Company Stockholder
Meeting (or any adjournment, postponement or other delay thereof). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Regulatory Approval</I>. The waiting periods (and any extensions
thereof) applicable to the Viking Transaction pursuant to the HSR Act shall have expired or otherwise been terminated. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>No
Prohibitive Laws or Injunctions</I>. No temporary restraining order, preliminary or permanent injunction or other judgment or order or other legal or regulatory restraint or prohibition preventing the consummation of the Viking Transaction issued by
a court or other Governmental Authority of competent jurisdiction in the United States shall be in effect, and no statute, rule, regulation or order shall have been issued, enacted, entered, enforced, promulgated, entered into, enforced, or deemed
applicable to the Viking Transaction by a Governmental Authority of competent jurisdiction in the United States that, in each case, prohibits, makes illegal or enjoins the consummation of the Viking Transaction. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>NASDAQ Matters</I>. The consummation of the Viking Transaction shall not be prohibited by NASDAQ, and the Company shall not have
received a written notice from NASDAQ (which notice has not been withdrawn or remedied) that such consummation will result in a delisting by NASDAQ of the Company Common Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2 <I>Conditions to the Obligations of Purchaser to Effect the Viking Transaction</I>. The obligations of Purchaser to consummate the Viking
Transaction are subject to the satisfaction or waiver (where permissible pursuant to applicable Law) prior to the Closing of each of the following conditions, any of which may be waived exclusively by Purchaser: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Representations and Warranties</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The representations and warranties of the Company set forth in <U>Section</U><U></U><U>&nbsp;3.1</U>,
<U>Section</U><U></U><U>&nbsp;3.2</U>, <U>Section</U><U></U><U>&nbsp;3.3</U>, <U>Section</U><U></U><U>&nbsp;3.4</U>, <U>Section</U><U></U><U>&nbsp;3.5(a)</U>, <U>Section</U><U></U><U>&nbsp;3.7(a)(ii)</U>,
<U>Section</U><U></U><U>&nbsp;3.7(b)(ii)</U>, <U>Section</U><U></U><U>&nbsp;3.7(c)</U> through <U>(e)</U>, <U>Section</U><U></U><U>&nbsp;3.8(b)</U> and <U>Section</U><U></U><U>&nbsp;3.26</U> shall be true and correct in all material respects
(without giving effect to any materiality or Company Material Adverse Effect qualifications set forth therein) as of the date of this Agreement and as of the Closing Date as if made at and as of the Closing Date (except to the extent that any such
representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty will be true and correct as of such earlier date). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) The representations and warranties of the Company set forth in
<U>Section</U><U></U><U>&nbsp;3.7(a)(i) </U>and <U>Section</U><U></U><U>&nbsp;3.7(b)(i)</U> shall be true and correct as of the date of this Agreement and as of the Closing Date as if made at and as of the Closing Date (except to the extent that any
such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date), in each case except for inaccuracies that are <I>de minimis</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) The representation and warranty of the Company set forth in <U>Section</U><U></U><U>&nbsp;3.12(b)</U> shall be true and
correct in all respects as of the date of this Agreement and as of the Closing Date as if made at and as of the Closing Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) Except as provided elsewhere in this <U>Section</U><U></U><U>&nbsp;7.2(a)</U>, all other representations and warranties of
the Company set forth in this Agreement shall be true and correct (without giving effect to any materiality or Company Material Adverse Effect qualifications set forth therein) as of the date of this Agreement and as of the Closing Date as if made
at and as of the Closing Date (except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty will be true and correct as of such earlier date), except for such
failures to be so true and correct that, individually or in the aggregate, have not had and would not reasonably be expected to have, a Company Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Performance of Obligations of the Company</I>. The Company shall have performed and complied in all material respects with the
covenants, obligations and conditions of this Agreement required to be performed and complied with by it at or prior to the Closing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
<I>Company Material Adverse Effect</I>. Since the date of this Agreement, no change, event, effect, occurrence or circumstance shall have occurred that, individually or in the aggregate, has had, or would reasonably be expected to have a Company
Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Officer&#146;s Certificate</I>. Purchaser shall have received a certificate of the Company, validly
executed for and on behalf of the Company and in its name by a duly authorized officer thereof, certifying that the conditions set forth in <U>Section</U><U></U><U>&nbsp;7.2(a)</U>, <U>Section</U><U></U><U>&nbsp;7.2(b)</U> and
<U>Section</U><U></U><U>&nbsp;7.2(c)</U> have been satisfied. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <I>Certificate of Designations</I>. The Company shall have delivered to
Purchaser a copy of the Certificate of Designations that has been filed with and accepted (as of the Closing) by the Secretary of State of the State of Delaware. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <I>Evidence of Issuance</I>. The Company shall have delivered to Purchaser evidence of the issuance (as of the Closing) of the Acquired
Shares credited to book-entry accounts maintained by the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <I>Reservation and Approval for Listing of Underlying Shares</I>.
The Underlying Shares shall have been reserved by the Company and approved for listing on the NASDAQ, subject to official notice of issuance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <I>Casdin Purchase Agreement. </I>Each of the conditions precedent to the obligations of
the parties to the Casdin Purchase Agreement shall have been satisfied or waived (other than those conditions that by their terms are to be satisfied concurrently with the Closing, but subject to the satisfaction or waiver (to the extent permitted
under the Casdin Purchase Agreement) of such conditions) and the Casdin Transaction shall be consummated at substantially the same time as the Closing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <I>Opinion. </I>The Company shall have delivered to Purchaser an opinion addressed to Purchaser from Wilson Sonsini Goodrich&nbsp;&amp;
Rosati, Professional Corporation, counsel to the Company, dated as of the Closing Date, substantially in the form included in Section&nbsp;7.2(i) of the Company Disclosure Letter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3 <I>Conditions to the Company</I><I>&#146;</I><I>s Obligations to Effect the Viking Transaction</I>. The obligations of the Company to
consummate the Viking Transaction are subject to the satisfaction or waiver (where permissible pursuant to applicable Law) prior to the Closing of each of the following conditions, any of which may be waived exclusively by the Company: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Representations and Warranties</I>. The representations and warranties of Purchaser set forth in this Agreement shall be true and
correct on and as of the date of this Agreement and as of the Closing Date with the same force and effect as if made on and as of such date, except for (i)&nbsp;any failure to be so true and correct that would not, individually or in the aggregate,
prevent or materially delay the consummation of the Viking Transaction or the other transactions contemplated by this Agreement and (ii)&nbsp;those representations and warranties that expressly speak as of an earlier date, which representations
shall have been true and correct as of such earlier date, except for any failure to be so true and correct that would not, individually or in the aggregate, prevent or materially delay the consummation of the Viking Transaction or the other
transactions contemplated by this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Performance of Obligations of Purchaser</I>. Purchaser shall have performed and
complied in all material respects with the covenants, obligations and conditions of this Agreement required to be performed and complied with by Purchaser at or prior to the Closing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Officer&#146;s Certificate</I>. The Company shall have received a certificate of Purchaser, validly executed for and on behalf of
Purchaser and in its name by a duly authorized officer thereof, certifying that the conditions set forth in <U>Section</U><U></U><U>&nbsp;7.3(a)</U> and <U>Section</U><U></U><U>&nbsp;7.3(b)</U> have been satisfied. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Payment of Purchase Price</I>. VGO Drawdown shall have delivered to the Company payment of the VGO Drawdown Purchase Price and VGO
Illiquid Investments shall have delivered to the Company payment of the VGO Illiquid Investments Purchase Price, in each case payable by wire transfer of immediately available funds to accounts designated in advance of the Closing Date by the
Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;VIII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TERMINATION, AMENDMENT AND WAIVER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1 <I>Termination</I>. This Agreement may be validly terminated only as follows (it being understood and agreed that this Agreement may not
be terminated for any other reason or on any other basis): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) at any time prior to the Closing (whether prior to or after the receipt of
the Requisite Stockholder Approval) by mutual written agreement of Purchaser and the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) by Purchaser or the Company, at any time
prior to the Closing (whether prior to or after the receipt of the Requisite Stockholder Approval) if (i)&nbsp;any permanent injunction or other judgment or order issued by any court of competent jurisdiction or other legal or regulatory restraint
or prohibition preventing the consummation of the Viking Transaction is in effect, or any action has been taken by any Governmental Authority of competent jurisdiction, that, in each case, prohibits, makes illegal or enjoins the consummation of the
Viking Transaction and has become final and <FONT STYLE="white-space:nowrap">non-appealable</FONT> or (ii)&nbsp;any statute, rule, regulation or order has been enacted, entered, enforced or deemed applicable to the Viking Transaction that
permanently prohibits, makes illegal or enjoins the consummation of the Viking Transaction; <U>provided</U>, that the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(b)</U> shall not be available to any Party
that has breached its obligations to resist, appeal, obtain consent pursuant to, resolve or lift, as applicable, such injunction, judgment, action, statute, rule, regulation or order; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) by Purchaser or the Company, at any time prior to the Closing (whether prior to or after the receipt of the Requisite Stockholder Approval)
if the Closing has not occurred by 11:59 p.m., New York City time, on June&nbsp;30, 2022 (the &#147;<B>Termination Date</B>&#148;); <U>provided</U>, that the<I> </I>right to terminate this Agreement pursuant to this
<U>Section</U><U></U><U>&nbsp;8.1(c)</U> shall not be available to any Party whose action or failure to act (which action or failure to act constitutes a breach by such Party of this Agreement) has been the primary cause of, or primarily resulted
in, either (i)&nbsp;the failure to satisfy the conditions to the obligations of the terminating Party to consummate the Viking Transaction set forth in <U>Article</U><U></U><U>&nbsp;VII</U> prior to the Termination Date or (ii)&nbsp;the failure of
the Closing to have occurred prior to the Termination Date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) by Purchaser or the Company, at any time prior to the Closing if the
Company fails to obtain the Requisite Stockholder Approval at the Company Stockholder Meeting (or any adjournment, postponement or other delay thereof) at which a vote on the Transactions is taken; <U>provided</U>, that the right to terminate this
Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(d)</U> shall not be available to any Party whose action or failure to act (which action or failure to act constitutes a breach by such Party of this Agreement) has been the primary cause
of, or primarily resulted in, the failure to obtain the Requisite Stockholder Approval at the Company Stockholder Meeting (or any adjournment or postponement thereof); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) by Purchaser, if the Company has breached or failed to perform in any material respect any of its representations, warranties, covenants or
other agreements contained in this Agreement, which breach or failure to perform would result in a failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;7.2(a)</U> or <U>Section</U><U></U><U>&nbsp;7.2(b)</U>; <U>provided</U>, that if
such breach is capable of being cured by the Termination Date, Purchaser shall not be entitled to terminate this Agreement prior to the delivery by Purchaser to the Company of written notice of such breach, delivered at least 30 days prior to such
termination or such shorter period of time as remains prior to the Termination Date (the shorter of such periods, the &#147;<B>Company Breach Notice Period</B>&#148;) stating Purchaser&#146;s intention to terminate this Agreement pursuant to this
<U>Section</U><U></U><U>&nbsp;8.1(e)</U> and the basis for such termination, it being understood that Purchaser shall not be entitled to terminate this Agreement if (i)&nbsp;such breach has been cured within the Company Breach Notice Period (to the
extent capable of being cured) or (ii)&nbsp;Purchaser is then in breach of any representation, warranty, agreement or covenant contained in this Agreement which breach would result in a failure of a condition set forth in
<U>Section</U><U></U><U>&nbsp;7.3(a)</U> or <U>Section</U><U></U><U>&nbsp;7.3(b)</U>; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) by the Purchaser, if at any time the Company Board (or a committee thereof) has effected
a Company Board Recommendation Change; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) by the Company, if Purchaser has breached or failed to perform in any material respect any of
its respective representations, warranties, covenants or other agreements contained in this Agreement, which breach or failure to perform would result in a failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;7.3(a)</U> or
<U>Section</U><U></U><U>&nbsp;7.3(b)</U>; <U>provided</U>, that if such breach is capable of being cured by the Termination Date, the Company shall not be entitled to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(g)</U>
prior to the delivery by the Company to Purchaser of written notice of such breach, delivered at least 30 days prior to such termination or such shorter period of time as remains prior to the Termination Date (the shorter of such periods, the
&#147;<B>Purchaser Breach Notice Period</B>&#148;) stating the Company&#146;s intention to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(g)</U> and the basis for such termination, it being understood that the Company
shall not be entitled to terminate this Agreement if (i)&nbsp;such breach has been cured within the Purchaser Breach Notice Period (to the extent capable of being cured) or (ii)&nbsp;the Company is then in breach of any representation, warranty,
agreement or covenant contained in this Agreement which breach would result in a failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;7.2(a)</U> or <U>Section</U><U></U><U>&nbsp;7.2(b)</U>; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) by Purchaser or the Company, if the Casdin Purchase Agreement has been terminated in accordance with its terms. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2 <I>Manner and Notice of Termination; Effect of Termination</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Manner of Termination</I>. The Party terminating this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.1</U> (other than pursuant
to <U>Section</U><U></U><U>&nbsp;8.1(a)</U>) shall deliver prompt written notice thereof to the other Party specifying the provision of <U>Section</U><U></U><U>&nbsp;8.1</U> pursuant to which this Agreement is being terminated and setting forth in
reasonable detail the facts and circumstances forming the basis for such termination pursuant to such provision. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Effect of
Termination</I>. Any proper and valid termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.1</U> shall be effective immediately on the delivery of written notice by the terminating Party to the other Party. In the event of the
termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.1</U>, this Agreement shall be of no further force or effect without liability of either Party (or any partner, member, stockholder, director, officer, employee, Affiliate or
Representative of such Party) to the other Party, as applicable, except that this <U>Section</U><U></U><U>&nbsp;8.2</U>, <U>Section</U><U></U><U>&nbsp;8.3</U> and <U>Article</U><U></U><U>&nbsp;IX</U> shall each survive the termination of this
Agreement. Notwithstanding the foregoing, nothing in this Agreement or the termination hereof shall relieve either Party from any liability for intentional fraud in respect of the statements made in this Agreement or any Willful Breach prior to its
termination. The rights and obligations under the Confidentiality Agreement shall survive in accordance with the terms of the Confidentiality Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.3 <I>Fees and Expenses</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>General</I>. Except as set forth in this <U>Section</U><U></U><U>&nbsp;8.3</U> and in <U>Section</U><U></U><U>&nbsp;9.2(b)</U>, all fees
and expenses incurred in connection with this Agreement and the Viking Transaction will be paid by the Party incurring such fees and expenses whether or not the Viking Transaction is consummated. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Company Payments</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Company shall, at or prior to the earlier to occur of (A)&nbsp;the date that is three Business Days following the
termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.1</U> (other than any termination pursuant to <U>Section</U><U></U><U>&nbsp;8.1(g)</U>) and (B)&nbsp;the Closing, reimburse Purchaser (or cause Purchaser to be reimbursed) for
an amount not to exceed $1,250,000 in cash, by wire transfer of immediately available funds, for Purchaser&#146;s documented expenses incurred in connection with this Agreement and the transactions contemplated hereby (collectively, the
&#147;<B>Expense Reimbursement</B>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) If this Agreement is terminated by Purchaser or the Company pursuant to
<U>Section</U><U></U><U>&nbsp;8.1(d)</U>, then the Company shall promptly (and in any event within two Business Days) after such termination pay, or cause to be paid, to Purchaser an amount equal to $1,250,000 in cash, less any amount previously
paid to Purchaser pursuant to <U>Section</U><U></U><U>&nbsp;8.3(b)(i)</U> (the &#147;<B>Company Termination Fee</B>&#148;), by wire transfer of immediately available funds (and, following such payment, no additional amounts shall be payable under
<U>Section</U><U></U><U>&nbsp;8.3(b)(i)</U>). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) If this Agreement is terminated by Purchaser pursuant to
<U>Section</U><U></U><U>&nbsp;8.1(f)</U>, then the Company shall promptly (and in any event within three Business Days) after such termination pay, or cause to be paid, to Purchaser an amount equal to $5,000,000 in cash (the &#147;<B>Change of
Recommendation Termination Fee</B>&#148;), by wire transfer of immediately available funds. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) If, within 12 months
following termination of this Agreement by Purchaser or the Company pursuant to <U>Section</U><U></U><U>&nbsp;8.1(d)</U> or by Purchaser pursuant to <U>Section</U><U></U><U>&nbsp;8.1(e)</U>, either (A)&nbsp;an Acquisition Transaction is consummated
(other than in connection with the conversion of the Company&#146;s Convertible Notes) or (B)&nbsp;the Company enters into a definitive agreement providing for an Acquisition Transaction, then the Company shall promptly (and in any event within
three Business Days) after the earlier to occur of the events described in clauses&nbsp;(A) and (B), pay, or cause to be paid, to Purchaser an amount equal to $2,500,000 in cash (the &#147;<B>Acquisition Termination Fee</B>&#148;), by wire transfer
of immediately available funds. For purposes of this <U>Section</U><U></U><U>&nbsp;8.3(b)(ii)</U>, all references to &#147;10%&#148; in the definition of &#147;Acquisition Transaction&#148; shall be deemed to be references to &#147;20%.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Payments; Default</I>. The Parties acknowledge that the agreements contained in this
<U>Section</U><U></U><U>&nbsp;8.3</U> are an integral part of the Viking Transaction, and that the damages resulting from the termination of this Agreement under circumstances where the Company Termination Fee, Change of Recommendation Termination
Fee, Acquisition Termination Fee or Expense Reimbursement is payable are uncertain and incapable of accurate calculation and that, without these agreements, the Parties would not enter into this Agreement, and, therefore, the Company Termination
Fee, Change of Recommendation Termination Fee, Acquisition Termination Fee or Expense Reimbursement, if, as and when required to be paid pursuant to this<U> Section</U><U></U><U>&nbsp;8.3</U>, shall not constitute a penalty, but rather liquidated
damages, and in a reasonable amount that will compensate the Party receiving such amount in the circumstances in which it is payable for the efforts and resources expended and opportunities foregone while negotiating this Agreement and in reliance
on this Agreement and on the expectation of the consummation of the Viking Transaction. Accordingly, if the Company fails to timely pay any amount due pursuant to <U>Section</U><U></U><U>&nbsp;8.3(b)</U> and, in order to obtain such payment,
Purchaser commences a Legal Proceeding that results in a judgment against the Company for the amount set forth in <U>Section</U><U></U><U>&nbsp;8.3(b)</U> or any portion thereof, the Company shall pay to Purchaser its costs and expenses (including
reasonable attorneys&#146; fees) in connection with such Legal Proceeding, together with interest on such amount or portion thereof at the annual rate of 5% plus the prime rate as published in <I>The Wall Street Journal</I> in effect on the date
that such payment or portion thereof was required to be made through the date that such payment or portion thereof was actually received, or a lesser rate that is the maximum permitted by applicable Law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Exclusivity of Remedies</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Notwithstanding anything in this Agreement to the contrary, but subject to the last sentence of
<U>Section</U><U></U><U>&nbsp;8.3(c)</U> and to this <U>Section</U><U></U><U>&nbsp;8.3(d)</U>, in the event of any valid termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.1</U> where the Company Termination Fee, the Change of
Recommendation Termination Fee or the Acquisition Termination Fee is payable pursuant to <U>Section</U><U></U><U>&nbsp;8.3(b)</U> and such fee is actually paid to Purchaser or its designee, such fee (together with any Expense Reimbursement
previously paid to Purchaser and any other fee that may be payable pursuant to <U>Section</U><U></U><U>&nbsp;8.3(b)</U>) shall constitute the sole and exclusive remedy of Purchaser against the Company Related Parties for any loss suffered as a
result of the failure of the transactions contemplated by this Agreement and the Transaction Documents to be consummated, and on payment of the Company Termination Fee, the Change of Recommendation Termination Fee or Acquisition Termination Fee, as
applicable (together with any Expense Reimbursement payable hereunder and any other fee that may be payable pursuant to <U>Section</U><U></U><U>&nbsp;8.3(b)</U>), none of the Company Related Parties shall have any further liability or obligation
relating to or arising out of this Agreement and the Transaction Documents (except that Purchaser may be entitled to remedies with respect to the Confidentiality Agreement, <U>Section</U><U></U><U>&nbsp;8.3(a)</U> and the last sentence of
<U>Section</U><U></U><U>&nbsp;8.3(c)</U>, as applicable); <U>provided</U>, that this <U>Section</U><U></U><U>&nbsp;8.3(d)(i)</U> shall not apply in the case of intentional fraud in respect of the statements made in this Agreement or any Willful
Breach prior to its termination. The Parties acknowledge and agree that, subject to the last sentence of <U>Section</U><U></U><U>&nbsp;8.3(c)</U>, in no event shall the Company be required to pay the Expense Reimbursement on more than one occasion,
the Company Termination Fee on more than one occasion, the Change of Recommendation Termination Fee on more than one occasion or the Acquisition Termination Fee on more than one occasion. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Subject to <U>Section</U><U></U><U>&nbsp;8.1</U> and
<U>Section</U><U></U><U>&nbsp;8.3(d)(iii)</U>, if Purchaser breaches this Agreement, the Company&#146;s right to (A)&nbsp;seek an injunction, specific performance or other equitable relief in accordance with the terms and limitations of
<U>Section</U><U></U><U>&nbsp;9.8(b)</U> or (B)&nbsp;terminate this Agreement and seek money damages from Purchaser in the event of intentional fraud in respect of the statements made in this Agreement or Willful Breach by Purchaser prior to
termination shall be the sole and exclusive remedies (whether such remedies are sought in equity or at law, in contract, in tort or otherwise) of any of the Company Related Parties against any of the Purchaser Related Parties for any losses,
damages, costs, expenses, obligations or liabilities arising out of or related to this Agreement (or any breach of any representation, warranty, covenant, agreement or obligation contained herein), the transactions contemplated by this Agreement (or
any failure of such transactions to be consummated) or in respect of any oral representations made or alleged to be made in connection with this Agreement, the transactions contemplated herein or therein or otherwise (except that the Parties (or
their Affiliates) shall remain obligated with respect to, and the Company and its Subsidiaries may be entitled to remedies with respect to, the Confidentiality Agreement and <U>Section</U><U></U><U>&nbsp;8.3(a)</U>). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) While each of the Company and Purchaser may pursue a grant of specific performance in accordance with
<U>Section</U><U></U><U>&nbsp;9.8(b)</U>, under no circumstances shall the Company or Purchaser be permitted or entitled to receive both (A)&nbsp;a grant of specific performance that results in the Closing occurring and (B)&nbsp;any money damages
(including the Company Termination Fee, the Change of Recommendation Termination Fee and the Acquisition Termination Fee but, for the avoidance of doubt, excluding the Expense Reimbursement). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.4 <I>Amendment</I>. Subject to applicable Law and subject to the other provisions of this Agreement, this Agreement may be amended by the
Parties at any time by execution of an instrument in writing signed on behalf of Purchaser and the Company (pursuant to authorized action by the Company Board (or a committee thereof)); <U>provided</U>, that in the event that the Company has
received the Requisite Stockholder Approval, no amendment may be made to this Agreement that requires the approval of the Company Stockholders pursuant to the NASDAQ rules without such approval. Notwithstanding the foregoing, (a)&nbsp;no Transaction
Document shall be amended or waived in any manner that would impair, impede or materially delay the consummation of the Casdin Transaction (or terminated (other than a termination (excluding a termination due to mutual agreement) in accordance with
its terms)) without the prior written consent of the Casdin Purchaser and (b)&nbsp;any amendment or waiver that expands the rights or limits the obligations or liabilities of Purchaser hereunder shall, at the Casdin Purchaser&#146;s option, be
deemed to be made with respect to the Casdin Purchase Agreement and apply to the Casdin Purchaser. In furtherance of the preceding sentence, the Company shall provide prompt written notice to the Casdin Purchaser of any amendment or waiver of this
Agreement. The Casdin Purchaser is an express third-party beneficiary of the prior two sentences of this <U>Section</U><U></U><U>&nbsp;8.4</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.5 <I>Extension; Waiver</I>. At any time and from time to time prior to the Closing, either Party may, to the extent legally allowed and
except as otherwise set forth herein (a)&nbsp;extend the time for the performance of any of the obligations or other acts of the other Party, as applicable, (b)&nbsp;waive any inaccuracies in the representations and warranties made to such Party
contained herein or in any document delivered pursuant hereto and (c)&nbsp;subject to the requirements of applicable Law, waive compliance with any of the agreements or conditions for the benefit of such Party contained herein. Any agreement on the
part of either Party to any such extension or waiver shall be valid only if set forth in an instrument in writing signed by such Party. Any delay in exercising any right pursuant to this Agreement shall not constitute a waiver of such right. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;IX </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GENERAL PROVISIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.1
<I>Notices</I>. All notices and other communications hereunder shall be in writing and will be deemed to have been duly delivered and received hereunder: (a)&nbsp;four Business Days after being sent by registered or certified mail, return receipt
requested, postage prepaid; (b)&nbsp;one Business Day after being sent for next Business Day delivery, fees prepaid, via a reputable nationwide overnight courier service; or (c)&nbsp;immediately on delivery by electronic mail (provided that no
bounceback or similar &#147;undeliverable&#148; message is received by such sender) or by hand (with a written or electronic confirmation of delivery), in each case to the intended recipient as set forth below (<U>provided</U>, that any notice sent
pursuant to clauses (a)&nbsp;or (b) shall be accompanied by notice sent by email within one Business Day after dispatch by such method): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to Purchaser to: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Viking Global Opportunities Illiquid Investments <FONT STYLE="white-space:nowrap">Sub-Master</FONT> LP / Viking </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Global Opportunities Drawdown (Aggregator) LP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">c/o Viking Global Investors LP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">55 Railroad Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Greenwich,
CT 06830 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Legal and Compliance Department </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;legalnotices@vikingglobal.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">with a copy (which will not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Kirkland&nbsp;&amp; Ellis LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">601 Lexington Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">New York,
NY 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Michael Movsovich, P.C. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;mmovsovich@kirkland.com </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to the Company (prior to the Closing) to: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Fluidigm Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">2 Towers
Place, Suite 2000 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">South San Francisco, CA 94080 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Nicholas S. Khadder </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: nick.khadder@fluidigm.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">with a copy (which will not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Wilson Sonsini Goodrich&nbsp;&amp; Rosati </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Professional Corporation 650 Page Mill Road </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Palo Alto, CA 94304 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention:
&nbsp;&nbsp;&nbsp;&nbsp;Robert F. Kornegay </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Zachary Myers
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Douglas K.
Schnell </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-mail:</FONT> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;rkornegay@wsgr.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;zmyers@wsgr.com
</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
dschnell@wsgr.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice received at the addressee&#146;s location on any Business Day after 5:00&nbsp;p.m., addressee&#146;s local
time, or on any day that is not a Business Day will be deemed to have been received at 9:00 a.m., addressee&#146;s local time, on the next Business Day. From time to time, either Party may provide notice to the other Party of a change in its address
or <FONT STYLE="white-space:nowrap">e-mail</FONT> address through a notice given in accordance with this <U>Section</U><U></U><U>&nbsp;9.1</U>, except that that notice of any change to the address or any of the other details specified in or pursuant
to this <U>Section</U><U></U><U>&nbsp;9.1</U>, shall not be deemed to have been received until, and shall be deemed to have been received on, the later of the date (A)&nbsp;specified in such notice or (B)&nbsp;that is five Business Days after such
notice would otherwise be deemed to have been received pursuant to this <U>Section</U><U></U><U>&nbsp;9.1</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.2 <I>Tax Matters</I>.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Withholding</I>. The Company and its paying agent shall be entitled to deduct or withhold on all applicable payments made to
Purchaser whether in the form of cash or otherwise such Tax amounts as the Company reasonably determines are required to be deducted or withheld therefrom under any provision of applicable Law (and, to the extent such amounts are paid to the
relevant taxing authority in accordance with applicable Law, such amounts will be treated for all purposes of this Agreement as having been paid to the Person in respect of which such withholding was made); <U>provided</U>, for the avoidance of
doubt, that if the Company determines that an amount is required to be deducted or withheld on any payment with respect to Purchaser, the Company shall provide reasonable prior notice to Purchaser in writing of its intent to deduct or withhold Taxes
on such payment and shall reasonably cooperate with Purchaser in obtaining any available exemption or reduction of such withholding. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
<I>Transfer Taxes</I>. The Company shall pay any and all Transfer Taxes due on (i)&nbsp;the issue of the Acquired Shares and (ii)&nbsp;the issue of shares of Company Common Stock on conversion of the Acquired Shares. However, the Company shall not
be required to pay any Transfer Tax that may be payable in respect of the issue or delivery (or any transfer involved in the issue or delivery) of Acquired Shares or shares of Company Common Stock issued on conversion of the Acquired Shares to a
beneficial owner other than the initial beneficial owner of the Acquired Shares, and no such issue or delivery shall be made unless and until the person requesting such issue or delivery has paid to the Company the amount of any such Transfer Tax or
has established to the reasonable satisfaction of the Company that such Transfer Tax has been paid or is not payable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Intended Tax Treatment</I>. Purchaser and the Company agree not to treat the Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Preferred Stock (based on the terms set forth in the Certificate of Designations) as &#147;preferred stock&#148; for purposes of Section&nbsp;305 of the Code and the Treasury Regulations promulgated thereunder,
and, as a consequence, no difference between the purchase price paid for the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock and the Liquidation Preference (as defined in the Certificate of Designations) thereof shall, by reason
of Section&nbsp;305(b)(4) of the Code or Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.305-5,</FONT> be treated as a distribution of property until paid in cash. The Company and Purchaser (and their respective Affiliates)
shall file all Tax Returns in a manner consistent with the foregoing intended Tax treatment and shall not take any Tax position that is inconsistent with such intended Tax treatment except in connection with, or as required by, any of the following:
(i)&nbsp;a change in relevant Law or official guidance from a taxing authority occurring after the Closing Date, (ii)&nbsp;after the Closing Date, the promulgation of relevant final U.S. Treasury Regulations addressing instruments similar to the
Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock (from and after the effective date of such regulations), (iii) an amendment to the terms of the Certificate of Designations or (iv)&nbsp;a &#147;determination&#148; within the
meaning of section 1313(a) of the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.3 <I>Assignment</I>. No Party may assign either this Agreement or any of its rights, interests,
or obligations hereunder, by operation of Law or otherwise, without the prior written approval of the other Party; <U>provided</U>, that Purchaser or any Purchaser Party may assign its rights, interests and obligations under this Agreement, in whole
or in part, to one or more Permitted Transferees that agree in writing to be bound by the provisions of this Agreement, including the rights, interests and obligations so assigned, so long as such assignment does not impede or delay the consummation
of the Closing; provided, further, that no such assignment will relieve any Purchaser Party of its obligations hereunder prior to the Closing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.4 <I>Entire Agreement</I>. This Agreement and the documents and instruments and other agreements between the Parties as contemplated by or
referred to herein, including the Confidentiality Agreement and the Company Disclosure Letter, constitute the entire agreement between the Parties with respect to the subject matter hereof and supersede all prior agreements and understandings, both
written and oral, between the Parties with respect to the subject matter hereof. Notwithstanding anything to the contrary in this Agreement, the Confidentiality Agreement shall: (a)&nbsp;not be superseded; (b)&nbsp;survive any termination of this
Agreement in accordance with its terms; and (c)&nbsp;continue in full force and effect until the earlier to occur of the Closing and the date on which the Confidentiality Agreement expires in accordance with its terms or is validly terminated by the
parties thereto. Purchaser and its Representatives shall hold and treat all documents and information concerning the Company and its Subsidiaries furnished or made available to Purchaser or its Representatives pursuant to
<U>Section</U><U></U><U>&nbsp;6.7</U> in accordance with the Confidentiality Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.5 <I>Survival</I>. All of the covenants or other
agreements of the Parties contained in this Agreement shall survive until fully performed or fulfilled, unless and to the extent that <FONT STYLE="white-space:nowrap">non-compliance</FONT> with such covenants or agreements is waived in writing by
the party entitled to such performance. Except for the Company Fundamental Representations and the Purchaser Fundamental Representations, which shall survive until the sixth anniversary of the Closing Date, the representations and warranties made
herein shall survive for 12 months following the Closing Date and shall then expire; <U>provided</U>, that nothing herein shall relieve any party of liability for any inaccuracy or breach of such representation or warranty to the extent that any
good faith allegation of such inaccuracy or breach is made in writing prior to such expiration by a Person entitled to make such claim pursuant to the terms and conditions of this Agreement. For the avoidance of doubt, claims may be made with
respect to the breach of any representation, warranty or covenant </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
until the applicable survival period therefor as described above expires. Notwithstanding anything to the contrary in this Agreement, in no event shall Purchaser be entitled to any recourse
against the Company in excess of the sum of the VGO Drawdown Purchase Price and the VGO Illiquid Investments Purchase Price for any breach of any representation or warranty in this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.6 <I>Third Party Beneficiaries</I>. Unless expressly set forth herein, this Agreement is not intended to and shall not confer any rights or
remedies on any person other than the Parties, their respective successors and permitted assigns. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.7 <I>Severability</I>. In the event
that any provision of this Agreement, or the application thereof, becomes or is declared by a court of competent jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect and the
application of such provision to other Persons or circumstances will be interpreted so as reasonably to effect the intent of the Parties. On such a determination, the Parties agree to negotiate in good faith to replace such void or unenforceable
provision of this Agreement with a valid and enforceable provision that will achieve, to the extent possible, the economic, business and other purposes of such void or unenforceable provision. If any provision of this Agreement is so broad as to be
unenforceable, such provision will be interpreted to be only so broad as it is enforceable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.8 <I>Remedies</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Remedies Cumulative</I>. Except as otherwise provided herein, any and all remedies herein expressly conferred on a Party will be deemed
cumulative with and not exclusive of any other remedy conferred hereby or by Law or equity on such Party, and the exercise by a Party of any one remedy will not preclude the exercise of any other remedy. Except as set forth in
<U>Section</U><U></U><U>&nbsp;8.3(d)(iii)</U>, the Parties agree that (i)&nbsp;by seeking the remedies provided for in this <U>Section</U><U></U><U>&nbsp;9.8</U>, a Party shall not in any respect waive its right to seek any other form of relief that
may be available to a Party under this Agreement and (ii)&nbsp;nothing set forth in this <U>Section</U><U></U><U>&nbsp;9.8</U> shall require any Party to institute any Legal Proceeding for (or limit any Party&#146;s right to institute any Legal
Proceeding for) injunctive relief or specific performance under this <U>Section</U><U></U><U>&nbsp;9.8</U> prior or as a condition to exercising any termination right under <U>Article</U><U></U><U>&nbsp;VIII</U> (and pursuing damages after such
termination), nor shall the commencement of any Legal Proceeding pursuant to this <U>Section</U><U></U><U>&nbsp;9.8</U> or anything set forth in this <U>Section</U><U></U><U>&nbsp;9.8</U> restrict or limit any Party&#146;s right to terminate this
Agreement in accordance with the terms of <U>Article</U><U></U><U>&nbsp;VIII</U> or pursue any other remedies under this Agreement or applicable Law that may be available then or thereafter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Specific Performance</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Parties agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy
would occur in the event that the Parties do not perform the provisions of this Agreement (including any Party failing to take such actions as are required of it hereunder in order to consummate this Agreement) in accordance with its specified terms
or otherwise breach such provisions. The Parties acknowledge and agree that: (A)&nbsp;the Parties shall be entitled, in addition to any other remedy to which they are entitled at Law or in equity, to an injunction, specific performance and other
equitable relief to prevent breaches (or threatened breaches) of this Agreement in accordance with its specified terms and to enforce specifically the terms and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
provisions hereof; (B)&nbsp;the provisions of <U>Section</U><U></U><U>&nbsp;8.3</U> are not intended to and do not adequately compensate the Company, on the one hand, or Purchaser, on the other
hand, for the harm that would result from a breach of this Agreement, and will not be construed to diminish or otherwise impair in any respect any Party&#146;s right to an injunction, specific performance and other equitable relief; and (C)&nbsp;the
right of specific enforcement (including specific performance of the Parties&#146; obligations to effect the Closing) is an integral part of the Viking Transaction and without that right, neither the Company nor Purchaser would have entered into
this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) The Parties agree not to raise any objections based on the adequacy of legal remedies or the
enforceability of this <U>Section</U><U></U><U>&nbsp;9.8</U> to: (A)&nbsp;the granting of an injunction, specific performance or other equitable relief to prevent or restrain breaches or threatened breaches of this Agreement by the Company, on the
one hand, or Purchaser, on the other hand; and (B)&nbsp;the specific performance of the terms and provisions of this Agreement to prevent breaches or threatened breaches of, or to enforce compliance with, the covenants, obligations and agreements of
Purchaser pursuant to this Agreement. Any Party seeking an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement will not be required to provide any bond or other
security in connection with such injunction or enforcement, and each Party irrevocably waives any right that it may have to require the obtaining, furnishing or posting of any such bond or other security. Each Party agrees that it shall use
reasonable best efforts to cooperate with the other Party in seeking and agreeing to an expedited schedule in any litigation seeking an injunction or order of specific performance to attempt to fully resolve any dispute between the Parties prior to
the Termination Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.9 <I>Governing Law</I>. This Agreement and all actions, proceedings or counterclaims (whether based on contract,
tort or otherwise) arising out of or relating to this Agreement, any transaction contemplated hereby or the actions of Purchaser or the Company in the negotiation, administration, performance and enforcement thereof, shall be governed by, and
construed in accordance with the Laws of the State of Delaware, including its statute of limitations, without giving effect to any choice or conflict of Laws provision or rule (whether of the State of Delaware or any other jurisdiction) that would
cause the application of the Laws of any jurisdiction other than the State of Delaware. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.10 <I>Consent to Jurisdiction</I>. Each of the
Parties: (a)&nbsp;irrevocably consents to the service of the summons and complaint and any other process (whether inside or outside the territorial jurisdiction of the Chosen Courts) in any Legal Proceeding relating to the Viking Transaction, for
and on behalf of itself or any of its properties or assets, in accordance with <U>Section</U><U></U><U>&nbsp;9.1</U> or in such other manner as may be permitted by applicable Law, and nothing in this <U>Section</U><U></U><U>&nbsp;9.10</U> shall
affect the right of any Party to serve legal process in any other manner permitted by applicable Law; (b)&nbsp;irrevocably and unconditionally consents and submits itself and its properties and assets in any Legal Proceeding to the exclusive general
jurisdiction of the Court of Chancery of the State of Delaware and any state appellate court therefrom within the State of Delaware (or, solely if the Court of Chancery of the State of Delaware declines to accept jurisdiction over a particular
matter, any other state or federal court within the State of Delaware) (the &#147;<B>Chosen Courts</B>&#148;) in the event of any dispute or controversy relating to or arising out of this Agreement or the transactions contemplated hereby or thereby;
(c)&nbsp;agrees that it will not attempt to deny or defeat such personal </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
jurisdiction by motion or other request for leave from any such court; (d)&nbsp;agrees that any Legal Proceeding relating to or arising out of this Agreement or the transactions contemplated
hereby or thereby will be brought, tried and determined only in the Chosen Courts; (e)&nbsp;waives any objection that it may now or hereafter have to the venue of any such Legal Proceeding in the Chosen Courts or that such Legal Proceeding was
brought in an inconvenient court and agrees not to plead or claim the same; and (f)&nbsp;agrees that it will not bring any Legal Proceeding relating to or arising out of this Agreement or the transactions contemplated hereby or thereby in any court
other than the Chosen Courts unless the Chosen Courts issue a final judgment determining that such court lacks jurisdiction. Purchaser and the Company agree that a final judgment and any interim relief (whether equitable or otherwise) in any Legal
Proceeding in the Chosen Courts will be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable Law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.11 <I>WAIVER OF JURY TRIAL</I>. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE PURSUANT TO THIS AGREEMENT IS LIKELY
TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT THAT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL PROCEEDING (WHETHER FOR BREACH OF CONTRACT, TORTIOUS
CONDUCT OR OTHERWISE) DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTION. EACH PARTY ACKNOWLEDGES AND AGREES THAT (i)&nbsp;NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR
OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER; (ii)&nbsp;IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER; (iii)&nbsp;IT MAKES THIS WAIVER VOLUNTARILY; AND (iv)&nbsp;IT
HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS <U>SECTION</U><U></U><U>&nbsp;9.11</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.12 <I>No Recourse</I>. All claims, obligations, liabilities, or causes of action (whether in contract or in tort, in law or in equity, or
granted by statute) that may be based on, in respect of, arise under, out or by reason of, be connected with, or relate in any manner to this Agreement, or the negotiation, execution, or performance of this Agreement (including any representation or
warranty made in, in connection with, or as an inducement to, this Agreement), may be made only against (and such representations and warranties are those solely of) the Persons that are expressly identified as parties in the preamble to this
Agreement (the &#147;<B>Contracting Parties</B>&#148;). No Person who is not a Contracting Party, including any current, former or future director, officer, employee, incorporator, member, partner, manager, stockholder, Affiliate, agent, attorney,
Representative or assignee of, and any financial advisor or lender to, any Contracting Party, or any current, former or future director, officer, employee, incorporator, member, partner, manager, stockholder, Affiliate, agent, attorney,
Representative or assignee of, and any financial advisor or lender to, any of the foregoing (collectively, the &#147;<B>Nonparty Affiliates</B>&#148;), shall have any liability (whether in contract or in tort, in law or in equity, or granted by
statute) for any claims, causes of action, obligations, or liabilities arising under, out of, in connection with, or related in any manner to this Agreement or based on, in respect of, or by reason of this Agreement or its negotiation, execution,
performance, or breach, and, to the maximum extent permitted by applicable Law, each </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Contracting Party hereby waives and releases all such liabilities, claims, causes of action, and obligations against any such Nonparty Affiliates. Without limiting the foregoing, to the maximum
extent permitted by applicable Law: (a)&nbsp;each Contracting Party hereby waives and releases any and all rights, claims, demands, or causes of action that may otherwise be available at law or in equity, or granted by statute, to avoid or disregard
the entity form of a Contracting Party or otherwise impose liability of a Contracting Party on any Nonparty Affiliate, whether granted by statute or based on theories of equity, agency, control, instrumentality, alter ego, domination, sham, single
business enterprise, piercing the veil, unfairness, undercapitalization, or otherwise; and (b)&nbsp;each Contracting Party disclaims any reliance on any Nonparty Affiliates with respect to the performance of this Agreement or any representation or
warranty made in, in connection with, or as an inducement to this Agreement. Notwithstanding anything to the contrary in this <U>Section</U><U></U><U>&nbsp;9.12</U>, nothing in this <U>Section</U><U></U><U>&nbsp;9.12</U> shall be deemed to limit any
liabilities or obligations of, or claims against, (x)&nbsp;any party to any other Transaction Document or serve as a waiver of any right on the part of any party to such other Transaction Document to initiate any Legal Proceedings permitted by,
pursuant to, and in accordance with the specific terms of such other Transaction Document or (y)&nbsp;any Person in respect of intentional fraud in respect of the statements made in this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.13 <I>Company Disclosure Letter References</I>. The Parties agree that the disclosure set forth in any particular Section or subsection of
the Company Disclosure Letter shall be deemed to be an exception to (or, as applicable, a disclosure for purposes of): (a) the representations and warranties (or covenants, as applicable) of the Company that are set forth in the corresponding
Section or subsection of this Agreement; and (b)&nbsp;any other representations and warranties (or covenants, as applicable) of the Company that are set forth in this Agreement, but in the case of this <U>clause (b)</U>&nbsp;only if the relevance of
that disclosure as an exception to (or a disclosure for purposes of) such other representations and warranties (or covenants, as applicable) is reasonably apparent on the face of such disclosure. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.14 <I>Counterparts</I>. This Agreement and any amendments hereto may be executed in one or more counterparts, all of which will be considered
one and the same agreement and will become effective when one or more counterparts have been signed by each of the Parties and delivered to the other Parties, it being understood that all Parties need not sign the same counterpart. Any such
counterpart, to the extent delivered by fax or .pdf, .tif, .gif, .jpg or similar attachment to electronic mail (any such delivery, an &#147;<B>Electronic Delivery</B>&#148;), will be treated in all manner and respects as an original executed
counterpart and will be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. No Party may raise the use of an Electronic Delivery to deliver a signature, or the fact that any
signature or agreement or instrument was transmitted or communicated through the use of an Electronic Delivery, as a defense to the formation of a contract, and each Party forever waives any such defense, except to the extent such defense relates to
lack of authenticity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature pages follow.</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed and delivered by
their respective duly authorized officers as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">FLUIDIGM CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ S. Christopher Linthwaite</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">S. Christopher Linthwaite</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS <FONT STYLE="white-space:nowrap">SUB-MASTER</FONT> LP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Katerina Novak</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Katerina Novak</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">VIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Katerina Novak</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Katerina Novak</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock
Purchase Agreement] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Exhibit A </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CERTIFICATE OF
DESIGNATIONS OF RIGHTS, PREFERENCES AND PRIVILEGES </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OF SERIES B-2 CONVERTIBLE PREFERRED STOCK, PAR VALUE $0.001 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OF </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">STANDARD BIOTOOLS INC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>Pursuant to Section&nbsp;151(g) of the General Corporation Law of the State of Delaware (as amended, supplemented or restated from time to time,
the &#147;<B><I>DGCL</I></B>&#148;), STANDARD BIOTOOLS INC., a corporation organized and existing under the laws of the State of Delaware (the &#147;<B><I>Company</I></B>&#148;), in accordance with the provisions of Section&nbsp;103 of the DGCL,
DOES HEREBY CERTIFY:<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>That, the Eighth Amended and Restated Certificate of Incorporation of the Company, as filed with the
Secretary of State of the State of Delaware on February&nbsp;15, 2011 (as amended from time to time prior to the filing of this Certificate of Designations, the &#147;<B><I>Certificate of Incorporation</I></B>&#148;), authorizes the issuance of
410,000,000 shares of capital stock, consisting of 400,000,000 shares of Common Stock, par value $0.001 per share (&#147;<B><I>Common Stock</I></B>&#148;), and 10,000,000 shares of Preferred Stock, par value $0.001 per share (&#147;<B><I>Preferred
Stock</I></B>&#148;).<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">That, subject to the provisions of the Certificate of Incorporation, the board of directors of the Company (the
&#147;<B><I>Board</I></B>&#148;) is authorized to fix by resolution the designations, powers, preferences and rights, and the qualifications, limitations or restrictions, of any wholly unissued series of Preferred Stock, including to fix the number
of shares constituting any such series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">That, pursuant to the authority conferred on the Board by the Certificate of Incorporation, the Board, on
January&nbsp;23, 2022, adopted the following resolution designating a new series of Preferred Stock as &#147;Series B-2 Convertible Preferred Stock&#148;: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RESOLVED, that, pursuant to the authority vested in the Board in accordance with the provisions of Article IV of the Certificate of Incorporation and the
provisions of Section&nbsp;151 of the DGCL, a series of Preferred Stock of the Company is hereby created and authorized, and the number of shares to be included in such series out of the authorized and unissued shares of Preferred Stock, and the
designations, powers, preferences and rights, and the qualifications, limitations or restrictions of the shares of Preferred Stock included in such series, shall be as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. Designation and Number of Shares. The shares of such series of Preferred Stock shall be designated as &#147;Series B-2 Convertible Preferred
Stock&#148; (the &#147;<B><I>Series B-2 Preferred Stock</I></B>&#148;). The number of authorized shares constituting the Series B-2 Preferred Stock shall be 128,267. That number from time to time may be increased (but not above the total number of
authorized shares of the class of Preferred Stock of the Company) or decreased (but not below the number of shares of Series B-2 Preferred Stock then outstanding) by further resolution duly adopted by the Board, or any duly authorized committee
thereof, and by the filing of a certificate pursuant to the provisions of the DGCL stating that such increase or decrease, as applicable, has been so authorized. The Company shall not have the authority to issue fractional shares of Series B-2
Preferred Stock. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. Ranking. Except as otherwise provided herein, the Series B-2 Preferred Stock shall rank,
with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) on a parity basis with the Series B-1 Preferred Stock and, subject to <U>1(b)</U>, each other class or series of Capital Stock of the
Company hereafter authorized, classified or reclassified, the terms of which expressly provide that such class or series ranks on a parity basis with the Series B-2 Preferred Stock as to dividend rights and rights on the distribution of assets on
any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company (such Capital Stock, &#147;Parity Stock&#148;); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) subject to <U>1(b)</U>, junior to each other class or series of Capital Stock of the Company hereafter authorized, classified or
reclassified, the terms of which expressly provide that such class or series ranks senior to the Series B Preferred Stock as to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or
winding up of the affairs of the Company (such Capital Stock, &#147;Senior Stock&#148;); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) senior to the Common Stock, each other
currently existing class or series of Capital Stock of the Company (other than the Series B-1 Preferred Stock) and each class or series of Capital Stock of the Company hereafter authorized, classified or reclassified, the terms of which do not
expressly provide that such class or series ranks on a parity basis with or senior to the Series&nbsp;B-2 Preferred Stock as to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or
winding up of the affairs of the Company (such Capital Stock, &#147;Junior Stock&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. Definitions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) As used in this Agreement, the following terms shall have the meanings ascribed to them below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Affiliate</I></B>&#148; means, with respect to any Person, any other Person that, directly or indirectly, controls, is controlled by
or is under common control with such Person; <U>provided</U>, that (i)&nbsp;the Company and its Subsidiaries shall not be deemed to be Affiliates of any Investor Party or any of its Affiliates, (ii)&nbsp;&#147;portfolio companies&#148; (as such term
is customarily used among institutional investors) in which any Investor Party or any of its Affiliates has an investment (whether as debt or equity) shall not be deemed an Affiliate of such Investor Party and (iii)&nbsp;no Investor Party shall be
deemed to be an Affiliate of any other Investor Party solely as a result of the Transactions. For purposes of this definition, the term &#147;control&#148; (including, with correlative meanings, the terms &#147;controlling,&#148; &#147;controlled
by&#148; and &#147;under common control with&#148;), as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of that Person, whether through the
ownership of voting securities or partnership or other ownership interests, by contract or otherwise.<B><I> </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Beneficially Own</I></B>&#148; means, with respect to any securities, having
&#147;beneficial ownership&#148; of such securities (as determined pursuant to Rule 13d-3 under the Exchange Act), and the terms &#147;Beneficial Ownership&#148; and &#147;Beneficial Owner&#148; shall have correlative meanings. <B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Business Day</I></B>&#148; means any weekday that is not a day on which banking institutions in New York, New York are authorized or
required by law, regulation or executive order to be closed.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Bylaws</I></B>&#148; means the Amended and Restated
Bylaws of the Company, as may be amended from time to time.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Capital Stock</I></B>&#148; means, with respect to
any Person, any and all shares of, interests in, rights to purchase, warrants to purchase, options for, participations in or other equivalents of or interests in (however designated) stock issued by such Person.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Casdin</I></B>&#148; means, collectively, Casdin Private Growth Equity Fund II, L.P., a Delaware limited partnership and Casdin
Partners Master Fund, L.P., a Cayman Islands exempted limited partnership.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Casdin Parties</I></B>&#148; means
Casdin and each Permitted Transferee of Casdin to whom shares of Series B-1 Preferred Stock or Common Stock are Transferred pursuant to Section&nbsp;6.15(b) of the Casdin Purchase Agreement.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Casdin Purchase Agreement</I></B>&#148; means the Series B-1 Convertible Preferred Stock Purchase Agreement by and between the
Company and Casdin, dated as of January&nbsp;23, 2022, as it may be amended, modified or supplemented from time to time.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Certificate of Designations</I></B>&#148; means this Certificate of Designations relating to the
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock, as it may be amended from time to time.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Change of Control</I></B>&#148; means the occurrence of one of the following, whether in a single transaction or a series of
transactions, directly or indirectly:<B><I> </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i) any &#147;person&#148; or &#147;group&#148; (as such terms are used in
Sections&nbsp;13(d) and 14(d) of the Exchange Act) is or becomes the Beneficial Owner, directly or indirectly, of a majority of the total voting power of the Voting Stock of the Company, other than as a result of a transaction, or a series of
related transactions, in which (A)&nbsp;the holders of securities that represented 100% of the Voting Stock of the Company immediately prior to such transaction are the same as the holders of securities that represent at least a majority of the
Voting Stock of the surviving Person or its Parent Entity immediately following such transaction and (B)&nbsp;the holders of securities that represented 100% of the Voting Stock of the Company immediately prior to such transaction own directly or
indirectly Voting Stock of the surviving Person or its Parent Entity in substantially the same proportion to each other as immediately prior to such transaction; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii) the merger or consolidation of the Company with or into another Person or the merger
of another Person with or into the Company, or the sale, transfer, license or lease of all or substantially all of the assets of the Company (determined on a consolidated basis), whether in a single transaction or a series of related transactions,
to another Person, or any recapitalization, reclassification or other transaction in which all or substantially all of the Common Stock is exchanged for or converted into cash, securities or other property, other than (A)&nbsp;in the case of a
merger or consolidation, a transaction, or a series of related transactions, following which holders of securities that represented 100% of the Voting Stock of the Company immediately prior to such transaction own directly or indirectly (in
substantially the same proportion to each other as immediately prior to such transaction, other than changes in proportionality as a result of any cash/stock election provided under the terms of the definitive agreement regarding such transaction)
at least a majority of the voting power of the Voting Stock of the surviving Person or Parent Entity in such merger or consolidation transaction immediately after such transaction or (B)&nbsp;in the case of a sale, transfer, license or lease of all
or substantially all of the assets of the Company, to a Subsidiary or a Person that becomes a Subsidiary of the Company; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iii) shares
of Common Stock or shares of any other Capital Stock into which the Series B-2 Preferred Stock is convertible are not listed for trading on any U.S. national securities exchange or cease to be traded in contemplation of a delisting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, the Transactions shall not constitute a Change of Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Change of Control Purchase Date</I></B>&#148; means, with respect to a share of Series <FONT STYLE="white-space:nowrap">B-2</FONT>
Preferred Stock, (i)&nbsp;in the case of a conversion pursuant to <U>1(a)(i)</U>, the date on which the Company issues the shares of Common Stock on conversion of such share and (ii)&nbsp;in the case of a Change of Control Put, the date on which the
Company makes the payment in full of the Change of Control Put Price for such share to the Holder thereof or to the Transfer Agent, irrevocably, for the benefit of such Holder. <B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>close of business</I></B>&#148; means 5:00&nbsp;p.m. (New York City time) on any Business Day.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Code</I></B>&#148; means the U.S. Internal Revenue Code of 1986, as amended.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Conversion Agent</I></B>&#148; means the Transfer Agent, acting in its capacity as conversion agent for the Series B-2 Preferred
Stock, and its successors and assigns.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Conversion Price</I></B>&#148; means, for each share of Series B-2
Preferred Stock at any time, a dollar amount equal to the Liquidation Preference <B><I></I></B><I>divided by</I><B><I></I></B> the Conversion Rate as of such time. <B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Conversion Rate</I></B>&#148; means 294.1176, subject to adjustment in accordance with <U>11</U>.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Effective Date</I></B>&#148; means the first date on which the shares of Common Stock trade on the applicable exchange or in the
applicable market, regular way, reflecting the relevant share split or share combination, as applicable. <B><I> </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Ex-Dividend Date</I></B>&#148; means the first date on which shares of Common
Stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive the issuance, dividend or distribution in question, from the Company or, if applicable, from the seller of Common Stock on such exchange or
market (in the form of due bills or otherwise) as determined by such exchange or market. For the avoidance of doubt, any alternative trading convention on the applicable exchange or market in respect of shares of Common Stock under a separate ticker
symbol or CUSIP number shall not be considered &#147;regular way&#148; for the purposes of this definition and the &#147;Effective Date&#148; definition. <B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Exchange Act</I></B>&#148; means the Securities Exchange Act of 1934, as amended, or any similar successor federal statute and the
rules and regulations thereunder, all as the same shall be in effect from time to time. <B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Governmental
Authority</I></B>&#148; means any government, political subdivision, governmental, administrative or regulatory entity or body, department, commission, board, agency or instrumentality, or other legislative, executive or judicial governmental
entity, and any court, tribunal, judicial or arbitral body, in each case whether federal, national, state, county, municipal, provincial, local, foreign or multinational.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Holder</I></B>&#148; means a Person in whose name shares of the Series B-2 Preferred Stock are registered, which Person shall be treated by the
Company, Transfer Agent, Registrar, paying agent and Conversion Agent as the absolute owner of the shares of Series B-2 Preferred Stock for the purpose of making payment and settling conversions and for all other purposes; <U>provided</U>, that, to
the fullest extent permitted by law, (a)&nbsp;no Person that has received shares of Series B-2 Preferred Stock in violation of the Viking Purchase Agreement shall be a Holder, (b)&nbsp;the Transfer Agent, Registrar, paying agent and Conversion
Agent, as applicable, shall not, unless directed otherwise by the Company, recognize any such Person as a Holder and (c)&nbsp;the Person in whose name the shares of the Series B-2 Preferred Stock were registered immediately prior to such transfer
shall remain the Holder of such shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Investor Parties</I></B>&#148; means, collectively, the Casdin Parties and the Viking
Parties.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Issuance Date</I></B>&#148; means, with respect to any share of Series B-2 Preferred Stock, the date of
issuance of such share.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Last Reported Sale Price</I></B>&#148; of the Common Stock (or other security for which a
closing sale price must be determined) on any date means the closing sale price per share (or if no closing sale price is reported, the average of the bid and ask prices or, if more than one in either case, the average of the average bid and the
average ask prices) on that date as reported in composite transactions for the principal U.S. national or regional securities exchange on which the Common Stock (or such other security) is traded. If the Common Stock (or such other security) is not
listed for trading on a U.S. national or regional securities exchange on the relevant date, the &#147;Last Reported Sale Price&#148; shall be the last quoted bid price for the Common Stock (or such other security) in the over-the-counter market on
the relevant date as reported by OTC Markets Group Inc. or a similar organization. If the Common Stock (or such other security) is not so quoted, the &#147;Last Reported Sale Price&#148; shall be the average of the mid-point of the last bid and ask
prices per share of the Common Stock (or such other security) on the relevant date from each of at least three nationally recognized independent investment banking firms selected by the Company for this purpose. The &#147;Last Reported Sale
Price&#148; shall be determined without regard to after-hours trading or any other trading outside of the regular trading session hours. <B><I> </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Law</I></B>&#148; means any federal, national, state, county, municipal,
provincial, local, foreign or multinational law, act, statute, constitution, common law, ordinance, code, decree, writ, order, judgment, injunction, rule, regulation, ruling or requirement issued, enacted, adopted, promulgated, implemented or
otherwise put into effect by or under the authority of any Governmental Authority.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Liquidation
Preference</I></B>&#148; means, with respect to any share of Series B-2 Preferred Stock, as of any date, $1,000 per share.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Mandatory Conversion Price</I></B>&#148; means, at any time, 250% of the Conversion Price as of such time. <B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Market Disruption Event</I></B>&#148; means any of the following events:<B><I> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i) any suspension of, or limitation imposed on, trading of the Common Stock or options contracts relating to the Common Stock by any exchange
or quotation system on which the Last Reported Sale Price is determined pursuant to the definition of &#147;Last Reported Sale Price&#148; (the &#147;Relevant Exchange&#148;) during the one-hour period prior to the close of trading for the regular
trading session on the Relevant Exchange (or for purposes of determining the VWAP per share of Common Stock, any period or periods aggregating one half-hour or longer during the regular trading session on the relevant day) whether by reason of
movements in price exceeding limits permitted by the Relevant Exchange or otherwise; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii) any event that disrupts or impairs (as
determined by the Company in its reasonable discretion) the ability of market participants during the one-hour period prior to the close of trading for the regular trading session on the Relevant Exchange (or for purposes of determining the VWAP per
share of Common Stock, any period or periods aggregating one half-hour or longer during the regular trading session on the relevant day) to effect transactions in, or obtain market values for, the Common Stock on the Relevant Exchange or to effect
transactions in, or obtain market values for, options contracts relating to the Common Stock on the Relevant Exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>NASDAQ</I></B>&#148; means the Nasdaq Stock Market and any successor stock exchange or inter-dealer quotation system operated by the
Nasdaq Stock Market or any successor thereto.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Neutral Manner</I></B>&#148; means in the same proportion as the
outstanding Common Stock (excluding any and all Common Stock Beneficially Owned, directly or indirectly, by the Investor Parties) voted on the relevant matters.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Officers&#146; Certificate</I></B>&#148; means a certificate signed by the Chief Executive Officer, the Chief Financial Officer or
the Secretary of the Company.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Original Issuance Date</I></B>&#148; means the Closing Date, as defined in the
Viking Purchase Agreement.<B><I> </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Parent Entity</I></B>&#148; means, with respect to any Person, any other Person of
which such first Person is a direct or indirect wholly owned Subsidiary.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Permitted Transferee</I></B>&#148; has
the meaning set forth in the Casdin Purchase Agreement or the Viking Purchase Agreement, as applicable.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Person</I></B>&#148; means any individual, corporation, estate, partnership, joint venture, association, joint-stock company,
limited liability company, trust, series, unincorporated organization or any other entity.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Record
Date</I></B>&#148; means, with respect to any dividend, distribution or other transaction or event in which holders of Common Stock have the right to receive any cash, securities or other property or in which Common Stock is exchanged for or
converted into any combination of cash, securities or other property, the date fixed for determination of holders of Common Stock entitled to receive such cash, securities or other property (whether such date is fixed by the Board or a duly
authorized committee thereof or by statute, contract or otherwise).<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Registrar</I></B>&#148; means the Transfer
Agent, acting in its capacity as registrar for the Series&nbsp;B-2 Preferred Stock, and its successors and assigns.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Registration Rights Agreement</I></B>&#148; means the Registration Rights Agreement by and among the Company and the purchasers
party thereto dated as of January&nbsp;23, 2022 as it may be amended, supplemented or otherwise modified from time to time.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Related Person</I></B>&#148; means (a)&nbsp;any executive officer of the Company, (b)&nbsp;any director of the Company or any
Affiliate of such director and (c)&nbsp;any Person that, together with its Affiliates, holds 5% of more of the outstanding shares of Common Stock (measured on an as-converted basis). <B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Securities Act</I></B>&#148; means the Securities Act of 1933, as amended, or any similar successor federal statute and the rules
and regulations thereunder, all as the same shall be in effect from time to time. <B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Series B Preferred
Stock</I></B>&#148; means, collectively, the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock and the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Series B-1 Certificate of Designations</I></B>&#148; means the Certificate of Designations relating to the Series B-1 Preferred
Stock, as it may be amended from time to time.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Series B-1 Preferred Stock</I></B>&#148; means the Series B-1
Convertible Preferred Stock of the Company.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Subsidiary</I></B>&#148; means, with respect to any Person, any
corporation of which a majority of the total voting power of shares of stock entitled to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by such Person or one or more of the
other Subsidiaries of such Person or a combination thereof or any partnership, limited liability company, trust, association or other business entity of which a majority of the partnership, limited liability company, trust, association or other
similar ownership interest is at the time owned or controlled, directly or<B><I> </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>
</I></B>indirectly, by such Person or one or more Subsidiaries of such Person or a combination thereof. For purposes of this definition, a Person is deemed to have a majority ownership interest
in a partnership, limited liability company, trust, association or other business entity if such Person is allocated a majority of the gains or losses of such partnership, limited liability company, trust, association or other business entity or is
or controls the managing director, managing member or general (or equivalent) partner of such partnership, limited liability company, trust, association or other business entity.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Tax</I></B>&#148; or &#147;<B><I>Taxes</I></B>&#148; means any taxes and similar assessments, fees, and other governmental charges
imposed by any Governmental Authority, including income, profits, gross receipts, net proceeds, ad valorem, value added, turnover, sales, use, property, personal property (tangible and intangible), stamp, excise, duty, franchise, capital stock,
transfer, payroll, employment, severance, and estimated tax, together with any interest and any penalties, additions to tax or additional amounts imposed by any Governmental Authority, whether disputed or not.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Tax Return</I></B>&#148; means any return, estimates, report, statement, information return or other document (including any related
or supporting information such as a schedule or attachment thereto) filed or required to be filed with any Governmental Authority in connection with the determination, assessment, collection or administration of any Taxes, including any amendment
thereof. <B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Trading Day</I></B>&#148; means a Business Day on which the Relevant Exchange is scheduled to be open
for business and on which there has not occurred a Market Disruption Event.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Transactions</I></B>&#148; has the
meaning set forth in the Viking Purchase Agreement.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Transfer</I></B>&#148; has the meaning set forth in the
Casdin Purchase Agreement or the Viking Purchase Agreement, as applicable.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Transfer Agent</I></B>&#148; means the
Person acting as transfer agent, Registrar and paying agent and Conversion Agent for the Series B-2 Preferred Stock and its successors and assigns. The initial Transfer Agent shall be Computershare Trust Company, N.A.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Viking</I></B>&#148; means, collectively, Viking Global Opportunities Illiquid Investments Sub-Master LP, a Cayman Islands exempted
limited partnership and Viking Global Opportunities Drawdown (Aggregator) LP, a Cayman Islands exempted limited partnership.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Viking Parties</I></B>&#148; means Viking and each Permitted Transferee of Viking to whom shares of Series B-2 Preferred Stock or
Common Stock are Transferred pursuant to Section&nbsp;6.15(b) of the Viking Purchase Agreement.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Viking Preferred
Percentage</I></B>&#148; means, as of any time, (a)&nbsp;the number of shares of Common Stock into which the shares of Series&nbsp;B-2 Preferred Stock beneficially owned by the Viking Parties are convertible (without regard to any limitations on
conversion) <B><I></I></B><I>divided by</I><B><I></I></B> (b)&nbsp;the total number of shares of Common Stock issued and outstanding, in each case as of such time and assuming that all shares of Series&nbsp;B Preferred Stock outstanding are
converted into shares of Common Stock (without regard to any limitations on conversion). <B><I> </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Viking Purchase Agreement</I></B>&#148; means the Series B-2 Convertible Preferred
Stock Purchase Agreement by and between the Company and Viking, dated as of January&nbsp;23, 2022, as it may be amended, modified or supplemented from time to time.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>Voting Stock</I></B>&#148; means (i)&nbsp;with respect to the Company, the Common Stock, the Series&nbsp;B Preferred Stock (subject
to the limitations set forth herein) and any other Capital Stock of the Company having the right to vote generally in any election of directors of the Board and (ii)&nbsp;with respect to any other Person, all Capital Stock of such Person having the
right to vote generally in any election of directors of the board of directors of such Person or other similar governing body.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>&#147;<B><I>VWAP</I></B>&#148; means, for any Trading Days, the per share volume-weighted average price of the Common Stock as displayed under
the heading &#147;Bloomberg VWAP&#148; on Bloomberg page &#147;FLDM &lt;equity&gt; AQR&#148; (or its equivalent successor if such page is not available) in respect of the period from the scheduled open of trading until the scheduled close of trading
of the primary trading session on such Trading Day (or if such volume-weighted average price is unavailable, the market value of one share of the Common Stock on such Trading Day reasonably determined, using a volume-weighted average method, by a
nationally recognized independent investment banking firm retained for this purpose by the Company). The &#147;VWAP&#148; shall be determined without regard to after-hours trading or any other trading outside of the regular trading session trading
hours. <B><I> </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(b) The following terms have the meanings set forth in the Sections referenced below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Term</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Section</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1% Exception</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(j)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Board</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Preamble</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cap</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;6</TD>
<TD NOWRAP VALIGN="bottom">(a)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Incorporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Preamble</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change of Control Call</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(e)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change of Control Effective Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(c)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change of Control Election Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(b)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change of Control Put</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(a)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change of Control Put Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(a)&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Clause A Distribution</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">(1)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Clause B Distribution</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Clause C Distribution</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Preamble</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Preamble</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Constituent Person</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">(iii)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(a)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">(i)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DGCL</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Preamble</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Distributed Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(c)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">(iii)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Final Change of Control Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(c)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Junior Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">(b)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mandatory Conversion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(a)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mandatory Conversion Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(a)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice of Mandatory Conversion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(b)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice of Redemption</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(b)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parity Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">(a)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Preamble</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redemption</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(a)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redemption Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(b)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redemption Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(a)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reorganization Event</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">(iii)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">(b)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B-2 Preferred Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">(a)&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Spin-Off</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(c)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third Party Transfer Taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">(b)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trigger Event</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(c)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(c)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Voting Threshold</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">(a)&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. Dividends. Subject to the provisions of this Certificate of Designations (including <U>1(b)</U>), dividends
may be declared by the Board or any duly authorized committee thereof on any Junior Stock from time to time. The Holders shall fully participate, on an as-converted basis (without regard to any limitations on conversion), in any dividends declared
and paid or distributions on the Common Stock as if the Series B-2 Preferred Stock were, though the Series&nbsp;B-2 Preferred Stock shall not be, converted, at the Conversion Rate in effect on the Record Date for such dividend or distribution,
pursuant to <U>1(a)</U> into shares of Common Stock (without regard to any limitations on conversion) immediately prior to such Record Date, as and when paid with respect to the Common Stock and using the same Record Date as is used for the Common
Stock. No dividend shall be declared or paid on the Series&nbsp;B-1 Preferred Stock unless a dividend in an equal amount per share is also declared or paid (as applicable) on the Series&nbsp;B-2 Preferred Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. Liquidation Rights. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
<U>Liquidation</U>. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, the Holders shall be entitled, out of assets legally available therefor, before any distribution or payment out of
the assets of the Company may be made to or set aside for the holders of any Junior Stock, and subject to the rights of the holders of any Senior Stock or Parity Stock and the rights of the Company&#146;s existing and future creditors, to receive in
full a liquidating distribution in cash in the amount per share of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock equal to the greater of (i)&nbsp;the Liquidation Preference with respect to such share of <FONT
STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock as of the date of such voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company and (ii)&nbsp;the amount per share of Series B-2 Preferred Stock
that such Holders would have received had all holders of Series&nbsp;B Preferred Stock, immediately prior to such voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, converted all shares of Series B
Preferred Stock into Common Stock (pursuant to <U>1(a)</U> or 1(a) of the Series&nbsp;B-1 Certificate of Designations, as applicable (without regard to any of the limitations on convertibility contained therein)). Holders shall not be entitled to
any further payments in the event of any such voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company other than what is expressly provided for in this <U>5</U> and shall have no right or claim to any of the
Company&#146;s remaining assets. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Partial Payment</U>. If in connection with any distribution described in <U>1(a)</U>
the assets of the Company or proceeds therefrom are not sufficient to pay in full the aggregate liquidating distributions required to be paid pursuant to (i)&nbsp;<U>1(a)</U> to all Holders, (ii)&nbsp;Section&nbsp;5(a) of the Series&nbsp;B-1
Certificate of Designations to all holders of the Series B-1 Preferred Stock, and (iii)&nbsp;the liquidating distributions payable to all holders of any other Parity Stock, the amounts distributed to the Holders, the holders of the Series B-1
Preferred Stock and to the holders of all other Parity Stock shall be paid <I>pro rata</I> in accordance with the respective aggregate liquidating distributions to which they would otherwise be entitled if all amounts payable thereon were paid in
full. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Merger, Consolidation and Sale of Assets Not Liquidation</U>. For purposes of this <U>5</U>, the sale, conveyance, lease,
exchange or transfer (for cash, shares of stock, securities or other consideration) of all or substantially all of the property and assets of the Company shall not be deemed a voluntary or involuntary liquidation, dissolution or winding up of the
affairs of the Company, nor shall the merger, consolidation, statutory exchange or any other business combination transaction of the Company into or with any other Person or the merger, consolidation, statutory exchange or any other business
combination transaction of any other Person into or with the Company or a Subsidiary of the Company be deemed to be a voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, and the holders of Series B
Preferred Stock shall not be entitled to any payments pursuant to <U>1(a)</U> herein or Section&nbsp;5(a) of the Series B-1 Certificate of Designations on account of such sale, conveyance, lease, exchange or transfer. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. Right of the Holders to Convert. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each Holder shall have the right, at such Holder&#146;s option, subject to the conversion procedures set forth in <U>8</U>, to convert each
share of such Holder&#146;s <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock at any time into a number of shares of Common Stock equal to the Conversion Rate; <U>provided</U>, that each Holder shall receive cash in lieu of any
fractional shares or as otherwise set out in <U>8(f)</U>. The right of conversion may be exercised as to all or any portion of such Holder&#146;s <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock from time to time;
<U>provided</U>, that in each case, no right of conversion may be exercised by a Holder and its Affiliates in respect of fewer than 10,000 shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock (unless (i)&nbsp;such
conversion relates to all shares of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock held by such Holder or (ii)&nbsp;with respect to Viking and its Affiliates, such lesser number of shares of Series B-2 Preferred Stock as
Viking and its Affiliates represent is required so that, immediately following such conversion, Viking and its Affiliates would not beneficially own shares of Common Stock in excess of the Cap); <U>provided</U>, <U>further</U>, that neither Viking
nor its Affiliates shall be entitled to convert shares of its Series B-2 Preferred Stock unless such conversion would not result in Viking, together with its Affiliates, beneficially owning more than 9.5% of the outstanding shares of the
Company&#146;s Common Stock (the &#147;<U>Cap</U>&#148;) (it being understood that this Cap shall only apply with respect to a voluntary conversion pursuant to this <U>Section&nbsp;6(a)</U> and not pursuant to any other section in this Certificate
of Designations, even if such section references this <U>Section&nbsp;6(a)</U>). For so long Viking holds any shares of Series B-2 Preferred Stock, any amendment or waiver of this Cap shall require the approval of (i)&nbsp;Viking and (ii)&nbsp;the
Company. In addition to any requirements contained in this Certificate of Designations, in connection with a voluntary conversion pursuant to this <U>Section&nbsp;6(a)</U> by Viking or its Affiliates, the Holder requesting conversion shall represent
(which may be included </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in the Conversion Notice), and the Company shall be entitled to rely upon such representation without independent investigation, that the issuance of such shares of Common Stock to such Holder
pursuant to this <U>Section&nbsp;6(a)</U> will not result in Viking, together with its Affiliates, beneficially owning outstanding shares of the Company&#146;s Common Stock in excess of the Cap. Any shares of Common Stock issued to Viking and its
Affiliates pursuant to this <U>Section&nbsp;6(a)</U> in reliance on the representation described herein shall be validly issued, fully paid and non-assessable. This Cap shall only apply for so long as Viking represents to the Company that Viking or
any of its Affiliates holds shares of Series B-2 Preferred Stock. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company shall at all times reserve and keep available out of its
authorized and unissued Common Stock, solely for issuance on the conversion of the <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock, such number of shares of Common Stock as shall from time to time be issuable on the
conversion to Common Stock of all the shares of Series B-2 Preferred Stock then outstanding (without regard to any limitations on conversion). The Company shall use its reasonable best efforts to maintain the listing on the NASDAQ of such number of
shares of Common Stock as shall from time to time be issuable on the conversion of all the shares of Series B-2 Preferred Stock then outstanding (without regard to any limitations on conversion). Any shares of Common Stock issued on conversion of
Series B-2 Preferred Stock shall be duly authorized, validly issued, fully paid and nonassessable and shall not be subject to preemptive rights or subscription rights of any other stockholder of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. Mandatory Conversion by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) At any time after the five year anniversary of the Original Issuance Date, if the Last Reported Sale Price of the Common Stock was greater
than the Mandatory Conversion Price for at least twenty consecutive Trading Days immediately preceding the date of the Notice of Mandatory Conversion, the Company may elect to convert (a &#147;Mandatory Conversion&#148;) all, but not less than all,
of the outstanding shares of Series B Preferred Stock into shares of Common Stock without regard to any limitations on conversion (the date selected by the Company for any Mandatory Conversion pursuant to this <U>1(a)</U> and in accordance with
<U>1(b)</U>, the &#147;Mandatory Conversion Date&#148;). In the case of a Mandatory Conversion, each share of Series B-2 Preferred Stock then outstanding shall be converted into (A)&nbsp;a whole number of shares of Common Stock at the Conversion
Rate <I>plus</I> (B)&nbsp;cash in lieu of fractional shares or as otherwise set forth in <U>8(f)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Notice of Mandatory
Conversion</U>. If the Company elects to effect a Mandatory Conversion, the Company shall, within five Business Days following the completion of the applicable period of 20 Trading Days referred to in <U>1(a)</U>, provide notice of such Mandatory
Conversion to <B><I>each</I></B> Holder (such notice, a &#147;<B><I>Notice of Mandatory Conversion</I></B>&#148;). For the avoidance of doubt, a Notice of Mandatory Conversion shall not limit a Holder&#146;s right to convert its shares of Series B-2
Preferred Stock on any Conversion Date prior to the Mandatory Conversion Date. The Mandatory Conversion Date selected by the Company shall be no less than ten Business Days and no more than 20 Business Days after the date on which the Company
provides the Notice of Mandatory Conversion to the Holders. The Notice of Mandatory Conversion shall specify: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the Mandatory
Conversion Date selected by the Company; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the applicable procedures a Holder must follow for issuance of the shares of Common
Stock pursuant to <U>1(a)</U>; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) the Conversion Rate as anticipated to be in effect on the Mandatory Conversion Date and the
number of shares of Common Stock to be issued to the Holder on conversion of each share of Series B-2 Preferred Stock held by such Holder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. Conversion Procedures and Effect of Conversion. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Conversion Procedure</U>. A Holder must do each of the following in order to convert shares of Series B-2 Preferred Stock pursuant to
this <U>1(a)</U> (the first Business Day on which such Holder has complied with all such procedures (including the satisfaction of any conditions to conversion set forth in the Conversion Notice), the &#147;<B><I>Conversion Date</I></B>&#148;): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) in the case of a conversion pursuant to <U>1(a)</U>, complete and manually sign the conversion notice provided by the Conversion Agent, a
form of which is attached hereto as <U>Exhibit A</U> together with such additional information as the Conversion Agent may reasonably require (the &#147;Conversion Notice&#148;), and deliver such notice to the Conversion Agent; <U>provided</U>, that
a Conversion Notice may be conditional on the completion of a Change of Control or other condition, transaction or event as such Holder may specify; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) deliver to the Conversion Agent the certificate or certificates (if any) representing the shares of Series B-2 Preferred Stock to be
converted; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) if required, furnish appropriate endorsements and transfer documents; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) if required, pay the amount of any Third Party Transfer Taxes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the forgoing, with respect to a Mandatory Conversion pursuant to <U>7</U>, the Conversion Date shall mean the Mandatory Conversion Date,
regardless of whether the foregoing has occurred or been complied with. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Effect of Conversion</U>. Effective immediately prior to
the close of business on the Conversion Date applicable to any shares of Series B-2 Preferred Stock, such shares of Series B-2 Preferred Stock shall cease to be outstanding and the corresponding shares of Common Stock pursuant to the conversion
shall be issued and outstanding. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Record Holder of Underlying Securities as of Conversion Date</U>. The Person or Persons entitled
to receive the Common Stock and, to the extent applicable, cash, securities or other property issuable on conversion of Series B-2 Preferred Stock on a Conversion Date shall be treated for all purposes as the record holder(s) of such shares of
Common Stock and/or cash, securities or other property as of the close of business on such Conversion Date. As promptly as practicable on or after the Conversion Date and, if applicable, compliance by the applicable Holder with the relevant
procedures contained in <U>1(a)</U> (and in any event no later than three Trading Days thereafter; <U>provided</U>, that if a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
written notice from the Holder in accordance with <U>8(i)</U> specifies a date of delivery for any shares of Common Stock, such shares shall be delivered on the date so specified, which shall be
no earlier than the second Business Day and no later than the seventh Business Day following the date of such notice), the Company shall issue the number of whole shares of Common Stock issuable on conversion (and deliver payment of cash in lieu of
fractional shares or as otherwise set out in <U>8(f)</U>) and, to the extent applicable, any cash, securities or other property issuable thereon. Such delivery of shares of Common Stock, securities or other property shall be made by book-entry or,
at the request of the Holder, by delivering a notice to the Conversion Agent, through the facilities of The Depositary Trust Company or in certificated form. Any such certificate or certificates shall be delivered by the Company to the appropriate
Holder on a book-entry basis, through the facilities of The Depositary Trust Company, or by mailing certificates evidencing the shares to the Holders, in each case at their respective addresses as set forth in the Conversion Notice (in the case of a
conversion pursuant to <U>1(a)</U>) or as set forth in the records of the Company or in a notice from the Holder to the Conversion Agent, as applicable (in the case of Mandatory Conversion). In the event that a Holder shall not by written notice
designate the name in which shares of Common Stock (and payments of cash in lieu of fractional shares) and, to the extent applicable, cash, securities or other property to be delivered on conversion of shares of Series&nbsp;B-2 Preferred Stock
should be registered or paid, or the manner in which such shares, cash, securities or other property should be delivered, the Company shall be entitled to register and deliver such shares, securities or other property, and make such payment, in the
name of the Holder and in the manner shown on the records of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Status of Converted or Reacquired Shares</U>. Shares of
Series&nbsp;B-2 Preferred Stock converted in accordance with this Certificate of Designations, or otherwise acquired by the Company or any of its Subsidiaries in any manner whatsoever, shall not be reissued as shares of Series B-2 Preferred Stock
and shall be retired promptly after the conversion or acquisition thereof. All such shares shall, on their retirement and any filing required by the DGCL, become authorized but unissued shares of Preferred Stock, without designation as to series
until such shares are once more designated as part of a particular series by the Board pursuant to the provisions of the Certificate of Incorporation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Partial Conversion</U>. In case any certificate for shares of Series&nbsp;B-2 Preferred Stock shall be surrendered for partial
conversion, the Company shall, at its expense, execute and deliver to or on the written order of the Holder of the certificate so surrendered a new certificate for the shares of Series B-2 Preferred Stock not converted. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>No Fractional Shares</U>. No fractional shares of Common Stock shall be delivered to the Holders on conversion of shares of Series B-2
Preferred Stock. In lieu of fractional shares otherwise issuable, each Holder shall be entitled to receive, at the Company&#146;s sole discretion, either (i)&nbsp;cash in lieu of delivering any fractional share of Common Stock issuable on conversion
based on the VWAP of the Common Stock for the relevant Conversion Date (or, if such Conversion Date is not a Trading Day, the next following Trading Day) or (ii)&nbsp;one additional whole share of fully paid and nonassessable Common Stock. In order
to determine whether the number of shares of Common Stock to be delivered to a Holder on the conversion of such Holder&#146;s shares of Series B-2 Preferred Stock would include a fractional share, such determination shall be based on the aggregate
number of shares of Series B-2 Preferred Stock of such Holder that are being converted and/or issued on any single Conversion Date or Change of Control Purchase Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. Change of Control. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Change of Control Put</U>. In the event of a Change of Control, each Holder of outstanding shares of Series&nbsp;B-2 Preferred Stock
may, at such Holder&#146;s election, (i)&nbsp;effective as of immediately prior to the Change of Control Effective Date, convert all or a portion of its shares of Series&nbsp;B-2 Preferred Stock pursuant to <U>1(a)</U> (without regard to any
limitations on conversion) or (ii)&nbsp;require the Company to purchase all of such Holder&#146;s shares of Series&nbsp;B-2 Preferred Stock that have not been so converted at a purchase price per share of Series&nbsp;B-2 Preferred Stock (a
&#147;<B><I>Change of Control Put</I></B>&#148;) for an amount in cash (in the case of clause&nbsp;(A)) or the applicable consideration (in the case of clause (B)) for each such share of Series&nbsp;B-2 Preferred Stock (the &#147;<B><I>Change of
Control Put Price</I></B>&#148;) equal to, at the Holder&#146;s election (or if the Holder does not so elect, the greater of, as determined by the Board acting in good faith) (A)&nbsp;the Liquidation Preference of such share of Series&nbsp;B-2
Preferred Stock or (B)&nbsp;the amount of cash and/or other assets such Holder would have received in the transaction constituting a Change of Control had such Holder, immediately prior to such Change of Control, converted such share of
Series&nbsp;B-2 Preferred Stock into Common Stock pursuant to <U>1(a)</U> but without regard to any of the limitations on convertibility contained therein (<U>provided</U>, that if the kind or amount of securities, cash and other property receivable
in such transaction is not the same for each share of Common Stock held immediately prior to such transaction by a Person, then the kind and amount of securities, cash and other property receivable on Change of Control Put following such transaction
shall be deemed to be the weighted average of the types and amounts of consideration received by all holders of Common Stock). The Company shall not take any action that would be reasonably expected to impair the Company&#146;s ability to pay the
Change of Control Put Price when due, including by investing available funds in illiquid assets. For clarity, but subject to <U>1(e)</U>, any shares of Series B-2 Preferred Stock that a Holder does not convert as set forth in clause&nbsp;(i) above
or subject to the Change of Control Put as set forth in clause&nbsp;(ii) above shall remain outstanding as provided herein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Initial
Change of Control Notice</U>. On or before the 20th Business Day prior to the date on which the Company anticipates consummating a Change of Control (or, if later, promptly after the Company discovers that a Change of Control may occur), a written
notice (the &#147;<B><I>Initial Change of Control Notice</I></B>&#148;) shall be sent by or on behalf of the Company to the Holders as they appear in the records of the Company, which notice shall contain (i)&nbsp;the date on which the Change of
Control is anticipated to be effected (or, if applicable, the date on which a Schedule TO or other schedule, form or report disclosing a Change of Control was filed), (ii)&nbsp;a description of the material terms and conditions of the Change of
Control and (iii)&nbsp;the then-applicable Conversion Rate. No later than the later of (x)&nbsp;ten Business Days prior to the Change of Control Effective Date as set forth in the Initial Change of Control Notice and (y)&nbsp;the 20th Business Day
following receipt of the applicable Initial Change of Control Notice, any Holder that desires to exercise its rights pursuant to <U>1(a)</U> shall notify the Company in writing thereof (a &#147;<B><I>Change of Control Election Notice</I></B>&#148;)
and shall specify (A)&nbsp;whether such Holder is electing to exercise its rights pursuant to <U>1(a)(i)</U>, <U>(ii)</U>&nbsp;or both, and (B)&nbsp;the number of shares of Series&nbsp;B-2 Preferred Stock subject thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Final Change of Control Notice</U>. Within ten days prior to the effective date of
the Change of Control (the &#147;<B><I>Change of Control Effective Date</I></B>&#148;), a final written notice (the &#147;<B><I>Final Change of Control Notice</I></B>&#148;) shall be sent by or on behalf of the Company to the Holders as they appear
in the records of the Company on the Business Day immediately prior to the date such notice is sent, which notice shall contain: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) a
statement setting forth in reasonable detail the calculation of the Change of Control Put Price with respect to such Holder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the
Change of Control Purchase Date, which shall be no later than ten Business Days after such notice is sent; <U>provided</U>, that a reasonable amount of time shall be provided between delivery of such notice and the Change of Control Purchase Date to
allow such Holder to comply with the instructions delivered pursuant to <U>9(iii)</U>; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) the instructions that a Holder must
follow to receive the Change of Control Put Price in connection with such Change of Control. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Change of Control Put Procedure</U>.
To receive the Change of Control Put Price, a Holder must surrender to the Transfer Agent in accordance with the instructions delivered pursuant to <U>9(iii)</U>, the certificates representing the shares of Series B-2 Preferred Stock to be
repurchased by the Company or lost stock affidavits therefor, to the extent applicable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Change of Control Call</U>. In the event of
a Change of Control following which the Company merges with another person and is not the surviving corporation or the Common Stock is no longer listed on a U.S. national securities exchange, if a Holder has not delivered a Change of Control
Election Notice in accordance with <U>1(a)</U> within the time specified therein or has delivered a Change of Control Election Notice for less than all of its shares of Series B-2 Preferred Stock, the Company may elect to redeem (a
&#147;<B><I>Change of Control Call</I></B>&#148;), subject to the right of such Holders to convert the Series B-2 Preferred Stock pursuant to <U>1(a)</U> at any time prior to any such redemption, all of such Holders&#146; shares of Series B-2
Preferred Stock that are not subject to the Change of Control Election Notice (if any) at a redemption price per share, payable in cash, equal to the Change of Control Put Price. In order to elect a Change of Control Call, the Company must send an
irrevocable notice of such election at the same time as the Initial Change of Control Notice, which notice shall contain the anticipated redemption date (which shall be contingent upon the closing of the Change of Control transaction or if the
Change of Control transaction has already occurred, such date as elected by the Company no less than 30 nor more than 60 calendar days following the date of such notice), instructions for Holders to receive the Change of Control Put Price, the
amount of the Change of Control Put Price, and the last date for a Holder to convert its shares of Series B-2 Preferred Stock in advance of the Change of Control Call (which shall be the Business Day immediately preceding the redemption date). The
Company shall not have the right to elect a Change of Control Call unless, as of the date of delivery of notice of a Change of Control Call, it has set aside sufficient funds legally available for the payment of the full Change of Control Put Price
for all outstanding shares of Series B-2 Preferred Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Delivery on Change of Control Put/Call</U>. On a Change of Control Put or a Change of
Control Call, the Company (or its successor) shall deliver or cause to be delivered to the Holder by wire transfer of immediately available funds, the Change of Control Put Price for such Holder&#146;s shares of Series B-2 Preferred Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Treatment of Shares</U>. Until a share of Series B-2 Preferred Stock is purchased by the payment in full of the applicable Change of
Control Put Price, such share of Series&nbsp;B-2 Preferred Stock shall remain outstanding and shall be entitled to all of the powers, designations, preferences and other rights provided herein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Change of Control Agreements</U>. The Company shall not enter into any agreement for, or otherwise willingly engage in, a transaction
constituting a Change of Control unless (i)&nbsp;such agreement provides for or does not interfere with or prevent (as applicable) the exercise by the Holders of their Change of Control Put and payment in full of the Change of Control Put Price
after payments required pursuant to any credit agreement, indenture or similar agreement evidencing indebtedness for borrowed money specified in <U>Section&nbsp;9(l)</U> below pursuant to this <U>9</U> and (ii)&nbsp;the acquiring or surviving Person
in such Change of Control represents or covenants, in form and substance reasonably satisfactory to the Board acting in good faith, that at the closing of such Change of Control such Person shall have sufficient funds (which may include, without
limitation, cash and cash equivalents on the Company&#146;s balance sheet, the proceeds of any debt or equity financing, available lines of credit or uncalled capital commitments) to consummate such Change of Control and the payment of the Change of
Control Put Price in respect of shares of Series B-2 Preferred Stock that have not been converted into Common Stock prior to the Change of Control Effective Date pursuant to <U>1(a)</U> and <U>7</U> after all payments required to be made by the
Company pursuant to any credit agreement, indenture or similar agreement evidencing indebtedness for borrowed money have been made. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)
<U>Effect of Change of Control Put/Call</U>. On full payment of the Change of Control Put Price for any shares of Series B-2 Preferred Stock subject to a Change of Control Put or Change of Control Call, such shares of Series B-2 Preferred Stock
shall no longer be deemed to be outstanding for any purpose and all rights (except the right to receive the Change of Control Put Price) of the Holder of such shares of Series B-2 Preferred Stock shall cease and terminate with respect to such
shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Withdrawal of Election for Change of Control Put</U>. Notwithstanding anything to the contrary herein, any Holder&#146;s
Change of Control Election Notice may be withdrawn (in whole or in part) by means of a written notice of withdrawal delivered to the Company at any time prior to the close of business on the fourth Business Day immediately succeeding the date of
delivery of a Final Change of Control Notice (or, if earlier, the close of business on the second Business Day immediately preceding the relevant Change of Control Purchase Date), specifying the number of shares of Series B-2 Preferred Stock with
respect to which such notice of withdrawal is being submitted. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) The above provisions of this <U>9</U> shall similarly apply to
successive Changes of Control (or anticipated Changes of Control). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) For the avoidance of doubt, and not in limitation of the rights in this section, in the
event of a Change of Control Put, the Company shall be permitted to pay the Change of Control Put Price required above in cash following the prior payment in full in cash all obligations of the Company and its Subsidiaries under any credit
agreement, indenture or similar agreement evidencing indebtedness for borrowed money (including the termination of all commitments to lend, to the extent required by such credit agreement, indenture or similar agreement), which requires prior
payment of the obligations thereunder (and termination of commitments thereunder, if applicable) as a condition to the payment of such Change of Control Put Price in cash. Nothing contained in this Section (9)(l)&nbsp;shall limit a Holder&#146;s
right to pursue any remedies available to it hereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. Redemption at the Option of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) At any time after the seventh anniversary of the Original Issuance Date, the Company shall have the right (but not the obligation) to
redeem all (but not less than all) of the then-outstanding shares of Series&nbsp;B Preferred Stock, at a redemption price per share of Series&nbsp;B Preferred Stock (payable by the Company in cash) equal to the Liquidation Preference (a
&#147;<B><I>Redemption</I></B>&#148; and such amount, the &#147;<B><I>Redemption Price</I></B>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In connection with any
Redemption, a written notice (a &#147;<B><I>Notice of Redemption</I></B>&#148;) shall be sent by or on behalf of the Company to each Holder as they appear in the records of the Company at least ten days and not more than 60 days before the date
fixed for such redemption (the &#147;<B><I>Redemption Date</I></B>&#148;). The Notice of Redemption shall specify (i)&nbsp;the Redemption Date, (ii)&nbsp;the total number of shares of Series B-2 Preferred Stock to be redeemed from the applicable
Holder, (iii)&nbsp;the amount per share payable to such Holder and (iv)&nbsp;the procedures that such Holders of shares of Series B-2 Preferred Stock must follow in order to receive the Redemption Price for their shares of Series B-2 Preferred Stock
to be redeemed. The Company shall deliver or cause to be delivered to each Holder that has complied with the instructions set forth in such Notice of Redemption, cash by wire transfer in an amount equal to the Redemption Price for each share of
Series B-2 Preferred Stock held by such Holder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Prior to any Redemption, each Holder of outstanding shares of Series&nbsp;B-2
Preferred Stock may, at such Holder&#146;s election, effective prior to such Redemption on a date designated by the Holder, convert all or a portion of its shares of Series&nbsp;B-2 Preferred Stock pursuant to <U>1(a) </U>(following a Notice of
Redemption, without regard to any limitations on conversion). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) On full payment of the Redemption Price for all shares of
Series&nbsp;B-2 Preferred Stock subject to a Redemption, such shares of Series B-2 Preferred Stock shall no longer be deemed to be outstanding for any purpose and all rights (except the right to receive the Redemption Price) of the Holder of such
shares of Series B-2 Preferred Stock shall cease and terminate with respect to such shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. Adjustment of Conversion Rate. The Conversion Rate shall be adjusted from time to time
by the Company if any of the following events occurs, except that the Company shall not make any adjustments to the Conversion Rate if Holders of the Series&nbsp;B-2 Preferred Stock participate (other than in the case of a share split or share
combination or a tender or exchange offer), at the same time and on the same terms as holders of the Common Stock and solely as a result of holding the Series B-2 Preferred Stock, in any of the transactions described in this <U>11</U>, without
having to convert their shares of Series B-2 Preferred Stock, as if they held a number of shares of Common Stock equal to the Conversion Rate <I>multiplied by</I> the number of shares of Series B-2 Preferred Stock held by such Holder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If the Company exclusively issues shares of Common Stock as a dividend or distribution on shares of the Common Stock, or if the Company
effects a share split or share combination, the Conversion Rate shall be adjusted based on the following formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g243622dsp567.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">where, </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB>&nbsp;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Conversion Rate in effect immediately prior to the open of business on the Ex-Dividend Date of such
dividend or distribution, or immediately prior to the open of business on the Effective Date of such share split or share combination, as applicable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>&nbsp;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Conversion Rate in effect immediately after the open of business on such Ex-Dividend Date or Effective
Date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">OS<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB>&nbsp;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the number of shares of Common Stock outstanding immediately prior to the open of business on such Ex-Dividend
Date or Effective Date (before giving effect to any such dividend, distribution, split or combination); and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left">OS<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>&nbsp;=</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the number of shares of Common Stock outstanding immediately after giving effect to such dividend,
distribution, share split or share combination. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any adjustment made under this <U>1(a)</U> shall become effective immediately after the
open of business on the Ex-Dividend Date for such dividend or distribution, or immediately after the open of business on the Effective Date for such share split or share combination, as applicable. If any dividend or distribution of the type
described in this <U>1(a)</U> is declared but not so paid or made, the Conversion Rate shall be immediately readjusted, effective as of the date the Board determines not to pay such dividend or distribution, to the Conversion Rate that would then be
in effect if such dividend or distribution had not been declared. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If the Company issues to all or substantially all holders of the
Common Stock and/or the Series&nbsp;B-1 Preferred Stock any rights, options or warrants (other than in connection with a stockholder rights plan) entitling them, for a period of not more than 45 calendar days after the announcement date of such
issuance, to subscribe for or purchase shares of the Common Stock at a price per share that is less than the average of the Last Reported Sale Prices of the Common Stock for the ten consecutive Trading Day period ending on, and including, the
Trading Day immediately preceding the date of announcement of such issuance, the Conversion Rate shall be increased based on the following formula: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g243622dsp568.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately prior to the open of business on the Ex-Dividend Date for such issuance;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the open of business on such Ex-Dividend Date;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OS<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately prior to the open of business on such Ex-Dividend Date;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">X</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the total number of shares of Common Stock issuable pursuant to such rights, options or warrants; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Y</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock equal to the aggregate price payable to exercise such rights, options or warrants, divided by the average of the Last Reported Sale Prices of the Common Stock over the ten consecutive Trading Day
period ending on, and including, the Trading Day immediately preceding the date of announcement of the issuance of such rights, options or warrants.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any increase made under this <U>1(b)</U> shall be made successively whenever any such rights, options or warrants are issued
and shall become effective immediately after the open of business on the Ex-Dividend Date for such issuance. To the extent that shares of the Common Stock are not delivered after the expiration of such rights, options or warrants, the Conversion
Rate shall be decreased to the Conversion Rate that would then be in effect had the increase with respect to the issuance of such rights, options or warrants been made on the basis of delivery of only the number of shares of Common Stock actually
delivered. If such rights, options or warrants are not so issued, the Conversion Rate shall be decreased to the Conversion Rate that would then be in effect if such Ex-Dividend Date for such issuance had not occurred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this <U>1(b)</U>, in determining whether any rights, options or warrants entitle the holders to subscribe for or purchase shares of the Common
Stock at less than such average of the Last Reported Sale Prices of the Common Stock for the ten consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement for such issuance, and in
determining the aggregate offering price of such shares of Common Stock, there shall be taken into account any consideration received by the Company for such rights, options or warrants and any amount payable on exercise or conversion thereof, the
value of such consideration, if other than cash, to be determined by the Company in good faith and in a commercially reasonable manner. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If the Company distributes shares of its Capital Stock, evidences of its indebtedness,
other assets or property of the Company or rights, options or warrants to acquire its Capital Stock or other securities, to all or substantially all holders of the Common Stock, excluding (i)&nbsp;dividends, distributions or issuances (including
share splits) as to which an adjustment was effected (or would be required to be effected, notwithstanding the 1%&nbsp;Exception in <U>1(j)</U>) pursuant to <U>1(a)</U> or <U>1(b)</U>, (ii)&nbsp;dividends or distributions paid exclusively in cash
that are also paid to the Holders of the Series&nbsp;B-2 Preferred Stock pursuant to <U>4</U>, (iii)&nbsp;except as otherwise described below, rights issued pursuant to a stockholder rights plan of the Company, (iv)&nbsp;distributions of Exchange
Property in a Reorganization Event and (v)&nbsp;Spin-Offs, as to which the provisions set forth below in this <U>1(c)</U> shall apply (any of such shares of Capital Stock, evidences of indebtedness, other assets or property or rights, options or
warrants to acquire Capital Stock or other securities, the &#147;<B><I>Distributed Property</I></B>&#148;), then the Conversion Rate shall be increased based on the following formula: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g243622dsp569.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">where: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR0</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately prior to the open of business on the Ex-Dividend Date for such distribution;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the open of business on such Ex-Dividend Date;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SP<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Last Reported Sale Prices of the Common Stock over the ten consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the Ex-Dividend Date for such distribution; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FMV</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the fair market value (as determined by the Company in good faith and in a commercially reasonable manner) of the Distributed Property with respect to each outstanding share of the Common Stock on the Ex-Dividend Date for such
distribution.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any increase made under the portion of this <U>1(c)</U> above shall become effective immediately after the open of business on
the Ex-Dividend Date for such distribution. If such distribution is not so paid or made, the Conversion Rate shall be decreased to the Conversion Rate that would then be in effect if such distribution had not been declared. If the Company issues
rights, options or warrants that are only exercisable on the occurrence of certain triggering events, then the Company shall not adjust the Conversion Rate pursuant to the clauses above until the earliest of these triggering events occurs, and the
Company shall readjust the Conversion Rate to the extent that any of these rights, options or warrants are not exercised before they expire. In the case of any distribution of rights, options or warrants, to the extent any such rights, options or
warrants expire unexercised, the Conversion Rate shall be immediately readjusted to the Conversion Rate that would then be in effect had the increase made for the distribution of such rights, options or warrants been made on the basis of delivery of
only </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the number of shares of the Common Stock actually delivered on exercise of such rights, options or warrants. Notwithstanding the foregoing, if &#147;FMV&#148; (as defined above) is equal to or
greater than &#147;SP<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB>&#148; (as defined above), in lieu of the foregoing increase, each Holder of shares of Series&nbsp;B-2 Preferred Stock shall receive, in respect of each such share, at the
same time and on the same terms as holders of the Common Stock, the amount and kind of Distributed Property such Holder would have received if such Holder owned a number of shares of Common Stock equal to the Conversion Rate in effect on the
Ex-Dividend Date for the distribution. If the Company determines the &#147;FMV&#148; (as defined above) of any distribution for purposes of this <U>1(c)</U> by reference to the actual or when-issued trading market for any securities, it shall in
doing so consider the prices in such market over the same period used in computing the Last Reported Sale Prices of the Common Stock over the ten consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the
Ex-Dividend Date for such distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>With respect to an adjustment pursuant to this <U>1(c)</U> where there has been a payment of a
dividend or other distribution on the Common Stock of shares of Capital Stock of any class or series, or similar equity interest, of or relating to a Subsidiary or other business unit of the Company, that are, or, when issued, will be, listed or
admitted for trading on a U.S. national securities exchange (a &#147;<B><I>Spin-Off</I></B>&#148;), the Conversion Rate shall be increased based on the following formula:<B><I> </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g243622dsp570.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately prior to the end of the Valuation Period;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the end of the Valuation Period;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FMV<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Last Reported Sale Prices of the Capital Stock or similar equity interest distributed to holders of the Common Stock applicable to one share of the Common Stock (determined by reference to the definition of Last
Reported Sale Price as set forth in <U>1(a)</U> as if references therein to Common Stock were to such Capital Stock or similar equity interest) over the first ten consecutive Trading Day period after, and including, the Ex-Dividend Date of the
Spin-Off (the &#147;Valuation Period&#148;); <U>provided</U>, that if there is no Last Reported Sale Price of the Capital Stock or similar equity interest distributed to the holders of the Common Stock on such Ex-Dividend Date, the &#147;Valuation
Period&#148; shall be the first ten consecutive Trading Day period after, and including, the first Trading Day such Last Reported Sale Price is available; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">MP<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Last Reported Sale Prices of the Common Stock over the Valuation Period.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The adjustment to the Conversion Rate under the preceding paragraph shall occur at the close of business on
the last Trading Day of the Valuation Period; <U>provided</U>, that if the relevant Conversion Date occurs during the Valuation Period, references to &#147;ten&#148; in the preceding paragraph shall be deemed to be replaced with such lesser number
of Trading Days as have elapsed from, and including, the Ex-Dividend Date of such Spin-Off to, and including, the Conversion Date in determining the Conversion Rate. If any dividend or distribution that constitutes a Spin-Off is declared but not so
paid or made, the Conversion Rate shall be immediately decreased, effective as of the date the Board of Directors determines not to pay or make such dividend or distribution, to the Conversion Rate that would then be in effect if such dividend or
distribution had not been declared or announced. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this <U>1(c)</U> (and subject in all respect to <U>1(h)</U>), rights, options or
warrants distributed by the Company to all holders of the Common Stock entitling them to subscribe for or purchase shares of the Company&#146;s Capital Stock, including Common Stock (either initially or under certain circumstances), which rights,
options or warrants, until the occurrence of a specified event or events (a &#147;<B><I>Trigger Event</I></B>&#148;) (i)&nbsp;are deemed to be transferred with such shares of the Common Stock, (ii)&nbsp;are not exercisable and (iii)&nbsp;are also
issued in respect of future issuances of the Common Stock, shall be deemed not to have been distributed for purposes of this 1(c) (and no adjustment to the Conversion Rate under this <U>1(c)</U> shall be required) until the occurrence of the
earliest Trigger Event, whereupon such rights, options or warrants shall be deemed to have been distributed and an appropriate adjustment (if any is required) to the Conversion Rate shall be made under this <U>1(c)</U>. If any such right, option or
warrant, including any such existing rights, options or warrants distributed prior to the Original Issuance Date, are subject to events, on the occurrence of which such rights, options or warrants become exercisable to purchase different securities,
evidences of indebtedness or other assets, then the date of the occurrence of any and each such event shall be deemed to be the date of distribution and Ex-Dividend Date with respect to new rights, options or warrants with such rights (in which case
the existing rights, options or warrants shall be deemed to terminate and expire on such date without exercise by any of the holders thereof). In addition, in the event of any distribution (or deemed distribution) of rights, options or warrants, or
any Trigger Event or other event (of the type described in the immediately preceding sentence) with respect thereto that was counted for purposes of calculating a distribution amount for which an adjustment to the Conversion Rate under this
<U>1(c)</U> was made, (A)&nbsp;in the case of any such rights, options or warrants that shall all have been purchased without exercise by any holders thereof, on such final redemption or purchase (1)&nbsp;the Conversion Rate shall be readjusted as
if such rights, options or warrants had not been issued and (2)&nbsp;the Conversion Rate shall then again be readjusted to give effect to such distribution, deemed distribution or Trigger Event, as the case may be, as though it were a cash
distribution, equal to the per share redemption or purchase price received by a holder or holders of Common Stock with respect to such rights, options or warrants (assuming such holder had retained such rights, options or warrants), made to all
holders of Common Stock as of the date of such redemption or purchase and (B)&nbsp;in the case of such rights, options or warrants that shall have expired or been terminated without exercise by any holders thereof, the Conversion Rate shall be
readjusted as if such rights, options and warrants had not been issued. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of <U>1(a)</U>, <U>1(b)</U> and <U>1(c)</U>, if any dividend or distribution to which this
<U>1(c)</U> is applicable also includes one or both of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a dividend or distribution of shares of Common Stock to which <U>1(a)</U> is applicable (a &#147;<B><I>Clause A
Distribution</I></B>&#148;); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a dividend or distribution of rights, options or warrants to which <U>1(b)</U> is applicable (a
&#147;<B><I>Clause B Distribution</I></B>&#148;), </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>then, in either case, (1)&nbsp;such dividend or distribution, other
than the Clause A Distribution and/or Clause B Distribution, shall be deemed to be a dividend or distribution to which this <U>1(c)</U> is applicable (a &#147;<B><I>Clause C Distribution</I></B>&#148;) and any Conversion Rate adjustment required by
this <U>1(c)</U> with respect to such Clause C Distribution shall then be made and (2)&nbsp;the Clause A Distribution and/or Clause B Distribution shall be deemed to immediately follow such Clause C Distribution and any Conversion Rate adjustment
required by <U>1(a)</U> and/or <U>1(b)</U> with respect thereto shall then be made, except that, if determined by the Company (I)&nbsp;the &#147;Ex-Dividend Date&#148; of the Clause A Distribution and/or Clause B Distribution shall be deemed to be
the Ex-Dividend Date of the Clause C Distribution and (II)&nbsp;any shares of Common Stock included in the Clause A Distribution and/or Clause B Distribution shall be deemed not to be &#147;outstanding immediately prior to the open of business on
such Ex-Dividend Date or Effective Date&#148; within the meaning of <U>1(a)</U> or &#147;outstanding immediately prior to the open of business on such Ex-Dividend Date&#148; within the meaning of <U>1(b)</U>.<B><I> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If the Company or any of its Subsidiaries make a payment in respect of a tender or exchange offer for the Common Stock that is subject to
the then-applicable tender offer rules under the Exchange Act, other than an odd-lot tender offer, to the extent that the cash and value of any other consideration included in the payment per share of the Common Stock exceeds the average of the Last
Reported Sale Prices of the Common Stock over the ten consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the last date on which tenders or exchanges may be made pursuant to such tender or exchange offer, the
Conversion Rate shall be increased based on the following formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g243622dsp572.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">where, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately prior to the close of business on the tenth Trading Day immediately following, and including, the Trading Day next succeeding the date such tender or exchange offer expires;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CR<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the close of business on the tenth Trading Day immediately following, and including, the Trading Day next succeeding the date such tender or exchange offer expires;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the aggregate value of all cash and any other consideration (as determined by the Company in good faith and in a commercially reasonable manner) paid or payable for shares of Common Stock purchased in such tender or exchange
offer;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OS<SUB STYLE="font-size:85%; vertical-align:bottom">0</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately prior to the date such tender or exchange offer expires (prior to giving effect to the purchase of all shares of Common Stock accepted for purchase or exchange in such
tender or exchange offer);</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">OS<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately after the date such tender or exchange offer expires (after giving effect to the purchase of all shares of Common Stock accepted for purchase or exchange in such tender or
exchange offer); and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SP<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Last Reported Sale Prices of the Common Stock over the ten consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the date such tender or exchange offer expires.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The adjustment to the Conversion Rate under this <U>1(d)</U> shall occur at the close of business on the tenth Trading Day
immediately following, and including, the Trading Day immediately following the expiration date of such tender or exchange offer expires; provided that if the relevant Conversion Date occurs during the ten Trading Days immediately following, and
including, the Trading Day next succeeding the expiration date of any tender or exchange offer, references to &#147;ten&#148; or &#147;tenth&#148; in the preceding paragraph shall be deemed replaced with such lesser number of Trading Days as have
elapsed from, and including, the Trading Day next succeeding the date that such tender or exchange offer expires to, and including, the Conversion Date in determining the Conversion Rate. For the avoidance of doubt, no adjustment under this
<U>1(d)</U> shall be made if such adjustment would result in a decrease in the Conversion Rate (other than, for the avoidance of doubt, any readjustment described in the immediately succeeding paragraph). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Company or one of its Subsidiaries is obligated to purchase the Common Stock pursuant to any such tender or exchange offer described in this
<U>1(d)</U> but the Company or such Subsidiary is permanently prevented by applicable law from effecting any such purchase or all such purchases are rescinded, the Conversion Rate shall be decreased to be the Conversion Rate that would then be in
effect if such tender or exchange offer had not been made or had been made only in respect of the purchases that have been effected. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)
Notwithstanding this <U>11</U> or any other provision of this Certificate of Designations, if (i)&nbsp;a Conversion Rate adjustment becomes effective on any Ex-Dividend Date, (ii)&nbsp;a Holder has converted its shares of Series&nbsp;B-2 Preferred
Stock and the Conversion Date for such conversion occurs on or after such Ex-Dividend Date and on or prior to the related Record Date, (iii)&nbsp;the consideration due on such conversion includes any whole shares of Common Stock based on a
Conversion Rate that is adjusted for such Ex-Dividend Date and (iv)&nbsp;such shares of Common Stock would be entitled to participate in such dividend, distribution, or other event giving rise to such adjustment, then the Conversion Rate adjustment
relating to such Ex-Dividend Date shall not be made for such conversion, and, instead, the shares of Common Stock issuable on conversion on an unadjusted basis shall be entitled to participate in the related dividend, distribution or other event
giving rise to such adjustment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Except as stated herein, the Company shall not adjust the Conversion Rate for the
issuance of shares of the Common Stock or any securities convertible into or exchangeable for shares of the Common Stock or the right to purchase shares of the Common Stock or such convertible or exchangeable securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) In addition to those adjustments required by <U>Sections&nbsp;1(a)</U>, <U>(b)</U>, <U>(c)</U>&nbsp;and <U>(d)</U>, and to the extent
permitted by applicable law and subject to the applicable rules of any exchange on which any of the Company&#146;s securities are then listed, the Company from time to time may increase the Conversion Rate by any amount for a period of at least 20
Business Days if the Board determines that such increase would be in the Company&#146;s best interest. In addition, to the extent permitted by applicable law and subject to the applicable rules of any exchange on which any of the Company&#146;s
securities are then listed, the Company may (but is not required to) increase the Conversion Rate to avoid or diminish income Tax to holders of Common Stock or rights to purchase Common Stock in connection with a dividend or distribution of shares
of Common Stock (or rights to acquire shares of Common Stock) or similar event. Whenever the Conversion Rate is increased pursuant to either of the preceding two sentences, the Company shall deliver to the Holder of each share of Series B-2
Preferred Stock and the Conversion Agent a notice of the increase at least 15 days prior to the date the increased Conversion Rate takes effect, and such notice shall state the increased Conversion Rate and the period during which it will be in
effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) If the Company has a stockholder rights plan in effect on conversion of any shares of Series&nbsp;B-2 Preferred Stock, each
share of Common Stock, if any, issued on such conversion shall be entitled to receive the appropriate number of rights, if any, and the certificates representing the Common Stock issued on such conversion shall bear such legends, if any, in each
case as may be provided by the terms of any such stockholder rights plan, as the same may be amended from time to time. However, if, prior to any conversion of shares of Series B-2 Preferred Stock, the rights have separated from the shares of Common
Stock in accordance with the provisions of the applicable stockholder rights plan, the Conversion Rate shall be adjusted at the time of separation as if the Company distributed to all or substantially all holders of the Common Stock Distributed
Property as provided in <U>1(c)</U>, subject to readjustment in the event of the expiration, termination or redemption of such rights. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)
Notwithstanding anything to the contrary in this <U>11</U>, the Conversion Rate shall not be adjusted: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) on the issuance of shares of
Common Stock at a price below the Conversion Price or otherwise, other than any such issuance described in <U>1(a)</U>, <U>(b)</U>&nbsp;or <U>(c)</U>; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) on the issuance of any shares of Common Stock pursuant to any present or future plan providing for the reinvestment of dividends or
interest payable on the Company&#146;s securities and the investment of additional optional amounts in shares of Common Stock under any plan; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) on the issuance of any shares of Common Stock or options or rights to purchase those
shares pursuant to any present or future employee, director or consultant benefit or incentive plan (including pursuant to any evergreen plan) or program of or assumed by the Company or any of the Company&#146;s Subsidiaries or in connection with
any such shares withheld by the Company for Tax withholding purposes; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) on the issuance of any shares of Common Stock pursuant to any
option, warrant, right or exercisable, exchangeable or convertible security not described in clause&nbsp;(ii) of this subsection and outstanding as of the Original Issuance Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) for a tender offer by any party other than a tender offer by the Company or one or more of the Company&#146;s Subsidiaries as described in
<U>1(d)</U>; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) on the repurchase of any shares of the Common Stock pursuant to an open-market share repurchase program or other
buy-back transaction (including, without limitation, through any structured or derivative transactions such as accelerated share repurchase transactions or similar forward derivatives), or other buy-back transaction, that is not a tender offer or
exchange offer of the nature described under 1(d); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) solely for a change in the par value (or lack of par value) of the Common
Stock. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) The Company shall not adjust the Conversion Rate pursuant to the clauses above unless the adjustment would result in a change
of at least 1% in the then effective Conversion Rate; <U>provided</U>, that the Company shall carry forward any adjustment to the Conversion Rate that the Company would otherwise have to make and take that adjustment into account in any subsequent
adjustment. Notwithstanding the foregoing, all such carried-forward adjustments shall be made with respect to the Series B-2 Preferred Stock (i)&nbsp;in connection with any subsequent adjustment to the Conversion Rate of at least 1% of the
Conversion Rate and (ii)&nbsp;regardless of whether the aggregate adjustment is less than 1% of the Conversion Rate, on the Conversion Date, in each case, unless the adjustment has already been made. The provisions described above in this
<U>1(j)</U> are referred to as the &#147;<B><I>1% Exception</I></B>&#148;. All calculations and other determinations under this <U>11</U> shall be made by the Company and shall be made to the nearest 1/10,000th of a share. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Whenever the Conversion Rate is adjusted as herein provided, the Company shall promptly file with the Conversion Agent an Officers&#146;
Certificate setting forth the Conversion Rate after such adjustment and setting forth a brief statement of the facts requiring such adjustment. Unless and until the Conversion Agent shall have received such Officers&#146; Certificate, the Conversion
Agent shall not be deemed to have knowledge of any adjustment of the Conversion Rate and may assume without inquiry that the last Conversion Rate of which it has knowledge is still in effect. Promptly after delivery of such certificate, the Company
shall prepare a notice of such adjustment of the Conversion Rate setting forth the adjusted Conversion Rate and the date on which each adjustment becomes effective and shall deliver such notice of such adjustment of the Conversion Rate to each
Holder. Failure to deliver such notice shall not affect the legality or validity of any such adjustment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) For purposes of this<U> 11</U> the number of shares of Common Stock at any time
outstanding shall not include shares of Common Stock held in the treasury of the Company so long as the Company does not pay any dividend or make any distribution on shares of Common Stock held in the treasury of the Company, but shall include
shares of Common Stock issuable in respect of scrip certificates issued in lieu of fractions of shares of Common Stock. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. Reorganization
Events. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Reorganization Events</U>. In the event of: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) any reclassification, statutory exchange, merger, consolidation or other similar business combination of the Company with or into another
Person, in each case, pursuant to which at least a majority of the Common Stock is changed or converted into, or exchanged for, cash, securities or other property of the Company or another Person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) any sale, transfer, lease or conveyance to another Person of all or a majority of the property and assets of the Company, in each case
pursuant to which the Common Stock is converted into cash, securities or other property; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) any statutory exchange of securities of
the Company with another Person (other than in connection with a merger or acquisition) or reclassification, recapitalization or reorganization of the Common Stock into other securities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>(each, a &#147;<B><I>Reorganization Event</I></B>&#148;), each share of Series B-2 Preferred Stock outstanding immediately prior to such
Reorganization Event shall, without the consent of the Holders and subject to <U>12(d)</U> and <U>1(b)</U>, remain outstanding but shall become convertible into the number, kind and amount of securities, cash and other property (the
&#147;<B><I>Exchange Property</I></B>&#148;) (without any interest on such Exchange Property and without any right to dividends or distributions on such Exchange Property that have a record date that is prior to the applicable Conversion Date) that
the Holder of such share of Series B-2 Preferred Stock would have received in such Reorganization Event had such Holder converted its shares of Series B-2 Preferred Stock into the applicable number of shares of Common Stock immediately prior to the
effective date of the Reorganization Event using the Conversion Rate applicable immediately prior to the effective date of the Reorganization Event; <U>provided</U>, that the foregoing shall not apply if such Holder is a Person with which the
Company consolidated or into which the Company merged or which merged into the Company or to which such sale or transfer was made, as the case may be (any such Person, a &#147;<B><I>Constituent Person</I></B>&#148;), or an Affiliate of a Constituent
Person, to the extent such Reorganization Event provides for different treatment of Common Stock held by such Constituent Persons or such Affiliate thereof. If the kind or amount of securities, cash and other property receivable on such
Reorganization Event is not the same for each share of Common Stock held immediately prior to such Reorganization Event by a Person (other than a Constituent Person or an Affiliate thereof), then for the purpose of this <U>1(a)</U>, the kind and
amount of securities, cash and other property receivable on conversion following such Reorganization Event shall be deemed to be the weighted average of the types and amounts of consideration received by the holders of Common Stock. For the
avoidance of doubt, if any Reorganization Event constitutes a Change of Control, the provisions of <U>9</U> shall also apply.<B><I> </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Successive Reorganization Events</U>. The above provisions of this <U>12</U> shall
similarly apply to successive Reorganization Events and the provisions of <U>11</U> shall apply to any shares of Capital Stock (as though such Capital Stock were Common Stock) received by all the holders of the Common Stock in any such
Reorganization Event. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Reorganization Event Notice</U>. The Company (or any successor) shall, no less than 30 days prior to the
anticipated effective date of any Reorganization Event, provide written notice to the Holders of such occurrence of such event and of the kind and amount of the cash, securities or other property that constitutes the Exchange Property. Failure to
deliver such notice shall not affect the operation of this <U>12</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Reorganization Event Agreements</U>. The Company shall not
enter into any agreement for a transaction constituting a Reorganization Event unless (i)&nbsp;such agreement provides for or does not interfere with or prevent (as applicable) conversion of the Series B-2 Preferred Stock into the Exchange Property
in a manner that is consistent with and gives effect to this <U>12</U> and (ii)&nbsp;to the extent that the Company is not the surviving corporation in such Reorganization Event or shall be dissolved in connection with such Reorganization Event,
proper provision shall be made in the agreements governing such Reorganization Event for the conversion of the Series&nbsp;B-2 Preferred Stock into Capital Stock of the Person surviving such Reorganization Event or such other continuing entity in
such Reorganization Event. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. Voting Rights. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>General</U>. Holders of shares of Series B-2 Preferred Stock shall be entitled to vote as a single class with the holders of the Common
Stock and the holders of any other class or series of Capital Stock of the Company then entitled to vote with the Common Stock on all matters submitted to a vote of the holders of Common Stock (and, if applicable, holders of any other class or
series of Capital Stock of the Company). The Holders shall be entitled to notice of any meeting of holders of Common Stock in accordance with the Certificate of Incorporation and Bylaws. Each Holder shall be entitled to the number of votes with
respect to the shares of Series B-2&nbsp;Preferred Stock held by such Holder equal to (i)&nbsp;the largest number of whole shares of Common Stock into which all shares of Series&nbsp;B-2 Preferred Stock could be converted pursuant to
<U>(a)</U>&nbsp;(for the avoidance of doubt, without regard to any limitations on conversion) <I>multiplied by</I> (ii)&nbsp;(A)&nbsp;the number of shares of Series&nbsp;B-2 Preferred Stock held by such Holder <I>divided by</I> (B)&nbsp;the
aggregate number of issued and outstanding shares of Series&nbsp;B-2 Preferred Stock, in each case at and calculated as of the record date for the determination of stockholders entitled to vote or consent on such matters; <U>provided</U>, that to
the extent the Series&nbsp;B-2 Preferred Stock held by the Viking Parties would, in the aggregate, represent voting rights with respect to more than 19.9% of the Company&#146;s outstanding Common Stock (including the Series B-2 Preferred Stock on an
as-converted basis) (the &#147;<B><I>Voting Threshold</I></B>&#148;), the Viking Parties shall not be permitted to exercise the voting rights with respect to any shares of Series&nbsp;B-2 Preferred Stock held by them in excess of the Voting
Threshold and the Chief Financial Officer or the General Counsel of the Company in office from time to time, each of them individually, with full power of substitution and resubstitution, shall exercise the voting rights with respect to such shares
of <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> Preferred Stock in excess of the Voting Threshold in a Neutral Manner. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Investor Consent Rights</U>. In addition to, and not in limitation of, <U>1(a)</U>,
the vote or written approval or election of the Holders of at least 60% of the shares of Series&nbsp;B Preferred Stock outstanding at such time, voting or providing such approval or election together as a single class, and for the avoidance of
doubt, without giving effect to limitations associated with the Cap or the Voting Threshold, given in person or by proxy, either in writing without a meeting or by vote at any meeting called for the purpose, shall be necessary for, directly or
indirectly, taking any of the following actions, whether or not such approval is required pursuant to the DGCL: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) any amendment or
alteration (whether by merger, consolidation or otherwise) of, or any supplement (whether by a certificate of designations or otherwise) to, the Certificate of Incorporation or any provision thereof, or any other action, to authorize or create, or
increase the number of authorized or issued shares of, or any securities convertible into shares of, or reclassify any security into, or issue, any Parity Stock (other than Series B-1 Preferred Stock in connection with the Transactions) or Senior
Stock or any other class or series of Capital Stock of the Company ranking senior to, or on a parity basis with, the <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> Preferred Stock or Series&nbsp;B-2 Preferred Stock as to dividend rights or
rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the declaration or payment of any dividend or distribution on any Capital Stock of the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) the purchase, redemption or other acquisition for consideration by the Company, directly or indirectly, of any Common Stock or other
Junior Stock, except for (A)&nbsp;the &#147;net&#148; or &#147;cashless&#148; exercise of stock options or warrants, (B)&nbsp;the withholding or repurchase of Capital Stock to satisfy applicable tax withholding obligations arising in connection with
exercised stock options or the vesting or settlement of restricted stock units or other stock awards or (C)&nbsp;settlement in cash of restricted stock units or other stock-based awards, in each case of (A)&nbsp;through (C), in the ordinary course
of business pursuant to an existing equity plan of the Company or any equity plan approved by the Board; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) any amendment or alteration
(whether by merger, consolidation, operation of law or otherwise) to the rights, preferences, privileges or voting powers of the Series&nbsp;B-1 Preferred Stock or Series B-2 Preferred Stock; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) any amendment, alteration or repeal (whether by merger, consolidation, operation of law or otherwise) of any provision of the Certificate
of Incorporation (including this Certificate of Designations) or Bylaws that would have an adverse effect on the rights, preferences, privileges or voting power of the Series B-2 Preferred Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Director Consent Rights</U>. For so long as the Viking Preferred Percentage is equal
to or greater than 7.5%, the vote or consent of at least a majority of the whole Board, including the Series B-2 Preferred Director, if such Series B-2 Director is then in office, either in writing without a meeting or by vote at any meeting, shall
be necessary for, directly or indirectly, taking any of the following actions, whether or not such approval is required pursuant to the DGCL: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) (A)&nbsp;any amendment, alteration, modification or repeal (whether by merger, consolidation, operation of law or otherwise) of any
provision of the Certificate of Incorporation (including this Certificate of Designations) or Bylaws that increases the size of the Board above seven directors after the Original Issuance Date or (B)&nbsp;the authorization or adoption of any
resolution that would have the effect of increasing the number of directors constituting the Board above seven directors; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the
hiring, promotion, demotion or termination of the Chief Executive Officer (whether on an interim basis or otherwise) of the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) entering into or modifying (including by waiver) any transaction, agreement or arrangement with, or for the benefit of, any Related
Person unless such transaction, agreement or arrangement has been approved by a majority of the disinterested directors of the Company; other than (A)&nbsp;employment or indemnification arrangements with directors (except in a manner that treats the
Series B-2 Preferred Director materially differently from the other directors), officers or employees of the Company or any of its Subsidiaries and any benefit plans or employment benefits in the ordinary course of business, (B)&nbsp;routine
non-compensatory employment matters such as invention assignment agreements in the ordinary course of business consistent with past practice, (C)&nbsp;transactions, agreements or arrangements involving less than $120,000 per year,
(D)&nbsp;transactions, agreements or arrangements contemplated by the Casdin Purchase Agreement or the Viking Purchase Agreement, (E)&nbsp;transactions, agreements or arrangements approved by the Compensation Committee or the Nominating and
Corporate Governance Committee of the Board in accordance with their charters as in effect as of the Original Issuance Date (or as may be amended from time to time by the Board (including the Series B-2 Preferred Director if such Series B-2 Director
is then in office)), (F)&nbsp;transactions pursuant to agreements already in effect (but excluding any modifications to such agreements) or (G)&nbsp;transactions, agreements or arrangements under the Company&#146;s and its Subsidiaries&#146; benefit
plans (including any assumed plans), including, without limitation, option exercises, vesting of restricted stock units, or otherwise, (1)&nbsp;the &#147;net&#148; or &#147;cashless&#148; exercise of stock options or warrants, (2)&nbsp;the
withholding or repurchase of Capital Stock to satisfy applicable tax withholding obligations arising in connection with exercised stock options or the vesting or settlement of restricted stock units or other stock awards or (3)&nbsp;settlement in
cash of restricted stock units or other stock-based awards, in each case of (1)&nbsp;through (3), in the ordinary course of business pursuant to the Company&#146;s and its Subsidiaries&#146; equity plans (including any assumed plans); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) any voluntary petition under any applicable federal or state bankruptcy or insolvency law effected by the Company or any Subsidiary of
the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) any change in the principal business of the Company or entry by the Company into any material new line of business; or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) for a period of three years after the Original Issuance Date (or such shorter period
ending immediately when the Viking Preferred Percentage is less than 7.5%), (A)&nbsp;any acquisition (including by merger, consolidation or acquisition of stock or assets) of any assets, securities or property of any other Person or (B)&nbsp;any
sale, lease, license, transfer or other disposition of any assets of the Company or any of its Subsidiaries (in each case other than acquisitions or dispositions of inventory or equipment in the ordinary course of business and consistent with past
practice) for consideration in excess of $50,000,000 in the aggregate in any six month period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Each Holder of Series B-2 Preferred
Stock shall have one vote per share on any matter on which Holders of Series&nbsp;B-2 Preferred Stock are entitled to vote either (i)&nbsp;separately as a single class or (ii)&nbsp;together with Holders of the Series&nbsp;B-1 Preferred Stock as a
single class, in each case whether at a meeting or by written approval or election, without giving effect to limitations associated with the Cap or the Voting Threshold. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The vote or written approval of the Holders of 75% of the shares of Series&nbsp;B-2 Preferred Stock outstanding at such time, voting
together as a single class and, for the avoidance of doubt, without giving effect to limitations associated with the Cap or the Voting Threshold, given in person or by proxy, either in writing without a meeting or by vote at any meeting called for
the purpose, shall be sufficient to waive or amend the provisions of <U>1(h)</U> of this Certificate of Designations, and any amendment or waiver of any of the provisions of <U>1(h)</U> approved by such percentage of the Holders shall be binding on
all of the Holders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) For the avoidance of doubt and notwithstanding anything to the contrary in the Certificate of Incorporation or
Bylaws, to the fullest extent permitted by applicable law, the holders of Series B Preferred Stock shall have the exclusive approval, election and voting rights set forth in <U>1(b)</U> and may effectuate such rights by delivering an approval,
election or consent in writing or by electronic transmission of the requisite holders of the Series B Preferred Stock. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) On the
acquisition of shares of Series B-2 Preferred Stock, the Holder of such shares shall be deemed to irrevocably appoint as its proxy and attorney-in-fact, the Chief Financial Officer and the General Counsel of the Company in office from time to time,
each of them individually, with full power of substitution and resubstitution, to consent, approve or vote any shares of Series B-2 Preferred Stock held by them in excess of the Voting Threshold as indicated in <U>1(a)</U> with respect to any
matters that must be voted in a Neutral Manner. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. Series B-2 Preferred Director. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) For so long as the Viking Preferred Percentage is equal to or greater than 7.5%, the Holders of a majority of the outstanding shares of
Series&nbsp;B-2 Preferred Stock, voting separately as a single class, and for the avoidance of doubt, without giving effect to limitations associated with the Cap or the Voting Threshold, shall be entitled, at each annual meeting of the stockholders
of the Company or at any special meeting called for the purpose of electing directors, to nominate and elect one member of the Board (a &#147;<B><I>Series B-2 Preferred Director</I></B>&#148;). The Series&nbsp;B-2 Preferred Director shall not be
subject to the classified board of directors provisions of Article&nbsp;V, Section&nbsp;2 of the Certificate of Incorporation nor </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
classified into Class I, Class II or Class III. The initial Series&nbsp;B-2 Preferred Director, designated by Viking pursuant to <U>14(b)</U>, shall take office effective as of the Original
Issuance Date. Each Series&nbsp;B-2 Preferred Director appointed or elected to the Board of Directors shall continue to hold office until the next annual meeting of the stockholders of the Company and until his or her successor is elected and
qualified in accordance with this <U>14(a)</U> and the Bylaws or until such individual&#146;s earlier resignation, death or removal. A majority of the outstanding shares of the Series B-2 Preferred Stock, voting separately as a single class, at a
meeting called for such purpose shall have the sole right to remove the Series B-2 Preferred Director. Any vacancy created by the removal, resignation or death of the Series B-2 Preferred Director may be filled by a majority of the directors in
office from time to time, but shall solely be filled with the approval of the holders of a majority of the outstanding shares of the Series&nbsp;B-2 Preferred Stock, voting as a single class and, for the avoidance of doubt, without giving effect to
limitations associated with the Cap or the Voting Threshold. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The initial Series B-2 Preferred Director shall be Dr, Martin Madaus, who
shall serve until the 2022 annual meeting of the Company&#146;s stockholders or such individual&#146;s earlier resignation, death or removal. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) In accordance with the provisions of this 14, at each meeting of the Company&#146;s stockholders at which the election of the Series B-2
Director is to be considered, the Board of Directors shall duly nominate the Series B-2 Preferred Director designated by the holders of a majority of the Series B-2 Preferred Stock for election to the Board of Directors by the holders of the
Series&nbsp;B-2 Preferred Stock, subject to the terms and conditions of the Viking Purchase Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Without prejudice to the rights
of Viking pursuant to the Viking Purchase Agreement, after the Original Issuance Date, and subject to applicable Law and the listing standards of Relevant Exchange, the Series B-2 Preferred Director shall be offered the opportunity, with respect to
each standing committee of the Board, at Viking&#146;s option, to sit on such committee. If the Series&nbsp;B-2 Preferred Director fails to satisfy the applicable qualifications under Law or stock exchange listing standard to sit on any committee of
the Board, then the Board shall offer such Series B-2 Preferred Director the opportunity to attend (but not vote at) the meetings of such committee as an observer. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Series&nbsp;B-2 Preferred Director shall be entitled to receive similar compensation, benefits, reimbursement (including of reasonable
travel expenses), indemnification and insurance coverage for his or her service as director as the other non-employee directors of the Company. For so long as the Company maintains directors and officers liability insurance, the Company shall
include the Series&nbsp;B-2 Preferred Director as an &#147;insured&#148; for all purposes under such insurance policy for so long as the Series&nbsp;B-2 Preferred Director is a director of the Company and for the same period as for other former
directors of the Company when the Series&nbsp;B-2 Preferred Director ceases to be a director of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. Term. Except as expressly
provided in this Certificate of Designations, the shares of Series B-2 Preferred Stock shall not be redeemable or otherwise mature and the term of the Series B-2 Preferred Stock shall be perpetual. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. No Sinking Fund. Shares of Series B-2 Preferred Stock shall not be subject to or
entitled to the operation of a retirement or sinking fund. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. Transfer Agent, Conversion Agent, Registrar and Paying Agent. The duly
appointed Transfer Agent, Conversion Agent, Registrar and paying agent for the Series&nbsp;B-2 Preferred Stock shall be Computershare Trust Company, N.A. The Company may appoint any other Person reasonably satisfactory to the Holders to serve as
Transfer Agent, Conversion Agent, Registrar or paying agent for the Series B-2 Preferred Stock and thereafter may remove or replace such other Person at any time, subject to the appointment of a replacement reasonably satisfactory to the Holders. On
any such appointment or removal, the Company shall send notice thereof to the Holders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. Replacement Certificates. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Mutilated, Destroyed, Stolen and Lost Certificates</U>. If physical certificates evidencing the Series B-2 Preferred Stock are issued,
the Company shall replace any mutilated certificate at the Holder&#146;s expense on surrender of that certificate to the Transfer Agent. The Company shall replace certificates that become destroyed, stolen or lost at the Holder&#146;s expense on
delivery to the Company and the Transfer Agent of reasonably satisfactory evidence that the certificate has been destroyed, stolen or lost, together with any reasonable indemnity that may be required by the Transfer Agent and the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Certificates Following Conversion</U>. If physical certificates representing the Series&nbsp;B-2 Preferred Stock are issued, the Company
shall not be required to issue replacement certificates representing shares of Series B-2 Preferred Stock on or after the Conversion Date applicable to such shares (except if any certificate for shares of Series B-2 Preferred Stock shall be
surrendered for partial conversion, the Company shall, at its expense, execute and deliver to or on the written order of the Holder of the certificate so surrendered a new certificate for the shares of Series B-2 Preferred Stock not converted). In
place of the delivery of a replacement certificate following the applicable Conversion Date, the Transfer Agent, on receipt of the satisfactory evidence and indemnity described in <U>clause (a)</U>&nbsp;above, shall deliver certificates representing
the shares of Common Stock issuable on conversion of such shares of Series B-2 Preferred Stock formerly evidenced by the physical certificate. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. Taxes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
<U>Withholding</U>. The Company and its paying agent shall be entitled to deduct or withhold on all applicable payments made to the relevant Holder whether in the form of cash or otherwise such Tax amounts as the Company reasonably determines are
required to be deducted or withheld therefrom under any provision of applicable law (and, to the extent such amounts are paid to the relevant taxing authority in accordance with applicable law, such amounts shall be treated for all purposes of this
Certificate of Designations as having been paid to the Person in respect of which such withholding was made); provided, for the avoidance of doubt, that if the Company determines that an amount is required to be deducted or withheld on any payment
with respect to any Holder, the Company shall provide reasonable prior notice to such Holder in writing of its intent to deduct or withhold Taxes on such payment and shall reasonably cooperate with such Holder in obtaining any available exemption or
reduction of such withholding<U>.</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Transfer Taxes</U>. The Company shall pay any and all stock transfer, documentary,
stamp and similar Taxes due on the issuance of shares of Series B-2 Preferred Stock or the issuance of shares of Common Stock on conversion of Series B-2 Preferred Stock pursuant hereto. However, in the case of conversion of Series B-2 Preferred
Stock, the Company shall not be required to pay any such Tax that may be payable in respect of any transfer involved in the issuance or delivery of shares of Series B-2 Preferred Stock or Common Stock to a Beneficial Owner other than the initial
Beneficial Owner of Series B-2 Preferred Stock (&#147;<B><I>Third Party Transfer Taxes</I></B>&#148;), and shall not be required to make any such issuance, delivery or payment unless and until the Person requesting such issuance, delivery or payment
has paid to the Company the amount of any such Tax or has established, to the reasonable satisfaction of the Company, that such Tax has been paid or is not payable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Tax Treatment</U>. It is intended that (i)&nbsp;the Series B-2 Preferred Stock shall not be treated as &#147;preferred stock&#148; for
purposes of Section&nbsp;305 of the Code and the Treasury Regulations promulgated thereunder, and (ii)&nbsp;as a consequence, no difference between the purchase price paid for the Series B-2 Preferred Stock and the Liquidation Preference thereof
shall, by reason of Section&nbsp;305(b)(4) of the Code or Treasury Regulations Section&nbsp;1.305-5, be treated as a distribution of property until paid in cash. The Company and Holders (and their respective affiliates) shall file all Tax Returns in
a manner consistent with the foregoing intended Tax treatment and shall not take any Tax position that is inconsistent with such intended Tax treatment except in connection with, or as required by, any of the following: (A)&nbsp;a change in relevant
law or official guidance from a Taxing authority occurring after the Original Issuance Date, (B)&nbsp;after the Original Issuance Date, the promulgation of relevant final U.S. Treasury Regulations addressing instruments similar to the Series B-2
Preferred Stock (from and after the effective date of such regulations), (C)&nbsp;an amendment to the terms of this Certificate of Designations or (D)&nbsp;a &#147;determination&#148; within the meaning of section 1313(a) of the Code. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. Notices. All notices referred to herein shall be in writing and, unless otherwise specified herein, all notices hereunder shall be deemed
to have been given on the earlier of receipt thereof or three Business Days after the mailing thereof if sent by registered or certified mail with postage prepaid, or by private courier service, or the date of such delivery, if delivered by
electronic mail (provided that no bounceback or similar &#147;undeliverable&#148; message is received by such sender), addressed: (a)&nbsp;if to the Company, to its office at Standard BioTools Inc., 2 Tower Place, Suite 2000, South San Francisco,
California 94080 (Attention: General Counsel) (or such e-mail address as specified by the Company, in the case of delivery by electronic mail), (b)&nbsp;if to any Holder, to such Holder at the address (or email address, in the case of delivery by
electronic mail) of such Holder as listed in the stock record books of the Company (which may include the records of the Transfer Agent) or (c)&nbsp;to such other address (or email address, in the case of delivery by electronic mail) as the Company
or any such Holder, as the case may be, shall have designated by notice similarly given. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. Facts Ascertainable. When the terms of this Certificate of Designations refer to a
specific agreement or other document to determine the meaning or operation of a provision hereof, the Secretary of the Company shall maintain a copy of such agreement or document at the principal executive offices of the Company and a copy thereof
shall be provided free of charge to any Holder who makes a request therefor. The Secretary of the Company shall also maintain a written record of the Issuance Date and the number of shares of Series&nbsp;B-2 Preferred Stock issued to a Holder and
the date of each such issuance, and shall furnish such written record free of charge to any Holder who makes a request therefor. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22.
Waiver. Notwithstanding any provision in this Certificate of Designations to the contrary, any provision contained herein and any right of the Holders of shares of Series&nbsp;B-2 Preferred Stock granted hereunder may be waived as to all shares of
Series B-2 Preferred Stock (and the Holders thereof) on the vote or written approval or election of the Holders of a majority of the shares of Series&nbsp;B-2 Preferred Stock then outstanding and, for the avoidance of doubt, without giving effect to
limitations associated with the Cap or the Voting Threshold. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23. Severability. If any term of the Series B-2 Preferred Stock set forth
herein is invalid, unlawful or incapable of being enforced by reason of any rule of law or public policy, all other terms set forth herein which can be given effect without the invalid, unlawful or unenforceable term shall, nevertheless, remain in
full force and effect, and no term herein set forth shall be deemed dependent on any other such term unless so expressed herein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24.
Business Opportunities. To the fullest extent permitted by Section&nbsp;122(17) of the DGCL (or any successor provision) and except as may be otherwise expressly agreed in writing by the Company and the Viking Parties, the Company, on behalf of
itself and its Subsidiaries, renounces any interest or expectancy of the Company and its Subsidiaries in, or in being offered an opportunity to participate in, business opportunities, that are from time to time presented to the Viking Parties or any
of their respective officers, representatives, directors, agents, stockholders, members, partners, Affiliates, Subsidiaries (other than the Company and its Subsidiaries), or any of their respective designees on the Company&#146;s Board and/or any of
their respective representatives who, from time to time, may act as officers of the Company, even if the opportunity is one that the Company or its Subsidiaries might reasonably be deemed to have pursued or had the ability or desire to pursue if
granted the opportunity to do so, and no such person shall be liable to the Company or any of its Subsidiaries for breach of any fiduciary or other duty, as a director or officer or otherwise, by reason of the fact that such person pursues or
acquires such business opportunity, directs such business opportunity to another person or fails to present such business opportunity, or information regarding such business opportunity, to the Company or its Subsidiaries unless, in the case of any
such person who is a director or officer of the Company, such business opportunity is expressly offered to such director or officer in his or her capacity as a director or officer of the Company. Any Person purchasing or otherwise acquiring any
interest in any shares of Capital Stock of the Company shall be deemed to have notice of and consented to the provisions of this <U>24</U>. Neither the alteration, amendment or repeal of this <U>24</U>, nor the adoption of any provision of the
Certificate of Incorporation or this Certificate of Designations inconsistent with this <U>24</U>, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
nor, to the fullest extent permitted by Delaware law, any modification of law, shall eliminate or reduce the effect of this <U>24</U> in respect of any business opportunity first identified or
any other matter occurring, or any cause of action, suit or claim that, but for this <U>24</U>, would accrue or arise, prior to such alteration, amendment, repeal, adoption or modification. If any provision or provisions of this <U>24</U> shall be
held to be invalid, illegal or unenforceable as applied to any circumstance for any reason whatsoever: (a)&nbsp;the validity, legality and enforceability of such provisions in any other circumstance and of the remaining provisions of this <U>24</U>
(including, without limitation, each portion of any paragraph of this <U>24</U> containing any such provision held to be invalid, illegal or unenforceable that is not itself held to be invalid, illegal or unenforceable) shall not in any way be
affected or impaired thereby and (b)&nbsp;to the fullest extent possible, the provisions of this <U>24</U> (including, without limitation, each such portion of any paragraph of this <U>24 </U>containing any such provision held to be invalid, illegal
or unenforceable) shall be construed so as to permit the Company to protect its directors, officers, employees and agents from personal liability in respect of their good faith service to or for the benefit of the Company to the fullest extent
permitted by law. This <U>24</U> shall not limit any protections or defenses available to, or indemnification or advancement rights of, any director, officer, employee or agent of the Company under the Certificate of Incorporation, the Bylaws, any
other agreement between the Company and such director, officer, employee or agent or applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I>[<I>Signature Page
Follows</I>]<I> </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Certificate of Designations to be executed this
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] day of [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2022. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">STANDARD BIOTOOLS INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I>[<I>Signature Page to Certificate of Designations</I>] <I> </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONVERSION NOTICE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I></I></B>Reference is made to the Certificate of Designations of Series&nbsp;B-2 Convertible Preferred Stock, par value $0.001, of Standard BioTools Inc.
(the &#147;<B><I>Certificate of Designations</I></B>&#148;). In accordance with and pursuant to the Certificate of Designations, the undersigned hereby elects to convert the number of shares of Series&nbsp;B-2 Convertible Preferred Stock, par value
$0.001 per share (the &#147;<B><I>Series&nbsp;B-2 Preferred Stock</I></B>&#148;), of Standard BioTools Inc., a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), indicated below into shares of Common Stock, par value $0.001 per share (the
&#147;<B><I>Common Stock</I></B>&#148;), of the Company, [as of the date specified below // on // immediately prior to[, and subject to the occurrence of,] [&#149;]].<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date of Conversion (if applicable):
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of shares of Series B-2 Preferred Stock to be converted:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share certificate no(s). of Series B-2 Preferred Stock to be converted:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tax ID Number (if
applicable):
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please confirm the following information:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Conversion
Rate:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of shares
of Common Stock to be issued:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please issue the shares of Common Stock into which the shares of Series B-2
Preferred Stock are being converted in the following name and to the following address: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Issue to:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Telephone Number:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Authorization:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Account Number (if electronic book entry transfer):
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Transaction Code Number (if electronic book entry transfer):
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment Instructions for cash payment in lieu of fractional shares:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>d243622dex105.htm
<DESCRIPTION>EX-10.5
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Exhibit 10.5 </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION RIGHTS AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>by and among </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FLUIDIGM
CORPORATION, </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CASDIN PRIVATE GROWTH EQUITY FUND II, L.P., </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CASDIN PARTNERS MASTER FUND, L.P., </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS <FONT STYLE="white-space:nowrap">SUB-MASTER</FONT> LP, </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>VIKING GLOBAL
OPPORTUNITIES DRAWDOWN (AGGREGATOR) LP </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dated as of January&nbsp;23, 2022 </B></P>
<P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE I </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">RESALE SHELF
REGISTRATION </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Resale Shelf Registration Statement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effectiveness Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsequent Shelf Registration Statement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supplements and Amendments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsequent Holder Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwritten Offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Take-Down Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Piggyback Registration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE II</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ADDITIONAL PROVISIONS REGARDING REGISTRATION RIGHTS</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Registration Procedures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Suspension</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expenses of Registration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Information by Holders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rule 144</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchasers Holdback Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE III</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">INDEMNIFICATION</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnification by Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnification by Holders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notification</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contribution</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE IV</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">TRANSFER AND TERMINATION OF REGISTRATION RIGHTS</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer of Registration Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination of Registration Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE V</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">MISCELLANEOUS</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendments and Waivers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Extension of Time, Waiver</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assignment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Counterparts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entire Agreement; No Third Party Beneficiary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governing Law; Jurisdiction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Specific Enforcement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Waiver of Jury Trial</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notices</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Severability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interpretation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Inconsistent Agreements; Most Favored Nations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Opt-Out</FONT> Requests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION RIGHTS AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This <B>REGISTRATION RIGHTS AGREEMENT</B> (this &#147;<B>Agreement</B>&#148;) is entered into as of January&nbsp;23, 2022, by and among
Fluidigm Corporation, a Delaware corporation (the &#147;<B>Company</B>&#148;), and the undersigned purchasers (together with their successors and assigns, each, a &#147;<B>Purchaser</B>&#148; and collectively, the &#147;<B>Purchasers</B>&#148;).
Capitalized terms used but not defined elsewhere herein are defined in <U>Exhibit A</U>. The Purchasers and any other party that may become a party hereto pursuant to <U>Section</U><U></U><U>&nbsp;4.1</U> are referred to collectively as the
&#147;<B>Holders</B>&#148; and individually each as a&nbsp;&#147;<B>Holder</B>&#148;. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company and the Purchasers have entered into those certain separate Series B Convertible Preferred Stock Purchase Agreements,
dated as of January&nbsp;23, 2022 (as may be amended from time to time in accordance with the terms thereof, collectively, the &#147;<B>Purchase Agreements</B>&#148;), by and between the Company and each of the Purchasers, pursuant to which, among
other things, upon the terms and subject to the conditions set forth therein, at the closing of the transactions contemplated by the Purchase Agreements, the Company will issue and sell to each of the Purchasers, and the Purchasers will purchase
from the Company, certain shares of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock, par value $0.001 per share, of the Company (the &#147;<B>Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred
Stock</B>&#148;), and the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock, par value $0.001 per share, of the Company (the &#147;<B>Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock</B>&#148; and,
together with the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock, the &#147;<B>Series B Preferred Stock</B>&#148;), which Series B Preferred Stock will be convertible into shares of common stock, par value $0.001 per share, of
the Company (the &#147;<B>Common Stock</B>&#148;) in accordance with the terms of the Certificates of Designations; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company
and the Purchasers have entered into those certain separate Loan Agreements, dated as of January&nbsp;23, 2022 (as may be amended from time to time in accordance with the terms thereof, the &#147;<B>Loan Agreements</B>&#148;), by and between the
Company and each of the Purchasers, pursuant to which, among other things, upon the terms and subject to the conditions set forth therein, at the closing of the transactions contemplated by the Loan Agreements, the Purchasers will loan to the
Company, and the Company will borrow from each of the Purchasers, $12.5&nbsp;million ($25&nbsp;million in the aggregate) (the &#147;<B>Convertible Loans</B>&#148;), which principal amounts shall be convertible into either shares of the Series B
Preferred Stock or shares of the Common Stock in accordance with the terms of the Loan Agreements; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, as a condition to the
obligations of the Company and the Purchasers under the Purchase Agreements and the Loan Agreements, the Company and the Purchasers are entering into this Agreement for the purpose of granting certain registration rights to the Holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the mutual covenants and agreements contained in this Agreement, the receipt and sufficiency of which are
hereby acknowledged, the parties to this Agreement hereby agree as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RESALE SHELF REGISTRATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1 <U>Resale Shelf Registration Statement</U>. Subject to the other applicable provisions of this Agreement, the Company shall
use reasonable best efforts to prepare and file within the period of time commencing on the date hereof and ending on the later of (a) 120 days after the date hereof or (b) 20 days after the date of the first Company stockholder meeting held to
approve the authorization and terms of the Series B Preferred Stock, a registration statement covering the sale or distribution from time to time by the Holders, on a delayed or continuous basis pursuant to Rule 415 of the Securities Act (or any
similar provision adopted by the SEC then in effect), of all of the Registrable Securities on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (except if the Company is not then eligible to register for resale the Registrable Securities on Form <FONT
STYLE="white-space:nowrap">S-3,</FONT> then such registration shall be on another appropriate form and shall provide for the registration of such Registrable Securities for resale by the Holders in accordance with any reasonable method of
distribution elected by the Holders) (the &#147;<B>Resale Shelf Registration Statement</B>&#148;), and if the Company is a WKSI as of the filing date, the Resale Shelf Registration Statement shall consist of an Automatic Shelf Registration
Statement, or a prospectus supplement to an effective Automatic Shelf Registration Statement, that shall become effective upon filing with the SEC pursuant to Rule 462(e). If the Resale Shelf Registration Statement is not an Automatic Shelf
Registration Statement, then the Company shall use reasonable best efforts to cause such Resale Shelf Registration Statement to be declared effective by the SEC as promptly as is reasonably practicable after the filing thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2 <U>Effectiveness Period</U>. Once declared effective, the Company shall, subject to the other applicable provisions of this
Agreement, use reasonable best efforts to cause the Resale Shelf Registration Statement to be continuously effective and usable with respect to any Holder, until the earlier to occur of the following: (a)&nbsp;the date as of which the Holders no
longer hold Registrable Securities and (b)&nbsp;the date on which the Holders shall have sold all of the Registrable Securities covered by such Resale Shelf Registration Statement (the &#147;<B>Effectiveness Period</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.3 <U>Subsequent Shelf Registration Statement</U>. If any Shelf Registration Statement ceases to be effective under the
Securities Act for any reason at any time during the Effectiveness Period, the Company shall use reasonable best efforts to as promptly as is reasonably practicable cause such Shelf Registration Statement to again become effective under the
Securities Act (including obtaining the prompt withdrawal of any order suspending the effectiveness of such Shelf Registration Statement), and shall use reasonable best efforts to as promptly as is reasonably practicable amend such Shelf
Registration Statement in a manner reasonably expected to result in the withdrawal of any order suspending the effectiveness of such Shelf Registration Statement or file an additional registration statement (a &#147;<B>Subsequent </B><B>Shelf
Registration Statement</B>&#148;) for an offering to be made on a delayed or continuous basis pursuant to Rule 415 of the Securities Act registering the resale from time to time by the Holders thereof of all securities that are Registrable
Securities as of the time of such filing. If a Subsequent Shelf Registration Statement is filed, the Company shall use reasonable best efforts to (a)&nbsp;cause such Subsequent Shelf Registration Statement to become effective under the Securities
Act as promptly as is reasonably practicable after the filing thereof (it being agreed that if the Company is a WKSI as of the filing date, the Subsequent Shelf Registration Statement shall be an Automatic Shelf Registration Statement, or a
prospectus supplement to an effective Automatic Shelf Registration Statement, that shall become </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
effective upon filing with the SEC pursuant to Rule 462(e)) and (b)&nbsp;keep such Subsequent Shelf Registration Statement continuously effective and usable until the end of the Effectiveness
Period. Any such Subsequent Shelf Registration Statement shall be a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> to the extent that the Company is eligible to use such form. Otherwise, such Subsequent Shelf Registration
Statement shall be on another appropriate form and shall provide for the registration of such Registrable Securities for resale by the Holders in accordance with any reasonable method of distribution elected by the Holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.4 <U>Supplements and Amendments</U>. The Company shall supplement and amend any Shelf Registration Statement if required by the
Securities Act or the rules, regulations or instructions applicable to the registration form used by the Company for such Shelf Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.5 <U>Subsequent Holder Notice</U>. If a Person entitled to the benefits of this Agreement becomes a Holder after a Shelf
Registration Statement becomes effective under the Securities Act, the Company shall, as promptly as is reasonably practicable following delivery of written notice to the Company of such Person becoming a Holder and requesting for its name to be
included as a selling securityholder in the prospectus related to the Shelf Registration Statement (a &#147;<B>Subsequent Holder Notice</B>&#148;): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) if required and permitted by applicable law, file with the SEC a supplement to the related prospectus or a post-effective amendment to the
Shelf Registration Statement so that such Holder is named as a selling securityholder in the Shelf Registration Statement and the related prospectus in such a manner as to permit such Holder to deliver a prospectus to purchasers of the Registrable
Securities in accordance with applicable law; <I>provided</I>, <I>however</I>, that the Company shall not be required to file more than one post-effective amendment or a supplement to the related prospectus for such purpose in any <FONT
STYLE="white-space:nowrap">30-day</FONT> period; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) if, pursuant to <U>Section</U><U></U><U>&nbsp;1.5(</U><U>a)</U>, the Company shall
have filed a post-effective amendment to the Shelf Registration Statement that is not automatically effective, use reasonable best efforts to cause such post-effective amendment to become effective under the Securities Act as promptly as is
reasonably practicable; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) notify such Holder as promptly as is reasonably practicable after the effectiveness under the Securities
Act of any post-effective amendment filed pursuant to <U>Section</U><U></U><U>&nbsp;1.5(</U><U>a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.6 <U>Underwritten
Offering</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) One or more Holders of Registrable Securities that have been specified in any Shelf Registration Statement filed with
the SEC in accordance with <U>Section</U><U></U><U>&nbsp;1.1</U>, <U>Section</U><U></U><U>&nbsp;1.3</U> or <U>Section</U><U></U><U>&nbsp;1.5</U>, may, after the Resale Shelf Registration Statement becomes effective, deliver a written notice to the
Company (the&nbsp;&#147;<B>Underwritten Offering Notice</B>&#148;) specifying that the sale of some or all of the Registrable Securities subject to such Resale Shelf Registration Statement, is intended to be conducted through an Underwritten
Offering, which shall specify the number or amount of Registrable Securities intended to be included in such Underwritten Offering; <I>provided</I>, <I>however</I>, that, without the Company&#146;s prior written consent, (i)&nbsp;the Holders may not
launch an Underwritten Offering if the anticipated gross proceeds are less than $25,000,000 (unless the Holder, collectively </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with all of its Affiliates, is proposing to sell all of their remaining Registrable Securities), (ii)&nbsp;each Holder may not launch more than three Underwritten Offerings at the request of such
Holder within any <FONT STYLE="white-space:nowrap">365-day</FONT> period (or more than two Underwritten Offerings at the request of such Holder within any <FONT STYLE="white-space:nowrap">365-day</FONT> period if the Resale Shelf Registration
Statement is a Long-Form Registration Statement), (iii) the Holders may not launch a Underwritten Offering at the request of the Holders within 60 days following a prior offering in which Holders sold Registrable Securities or had the opportunity to
sell Registrable Securities pursuant to this Section&nbsp;1.6 or Section&nbsp;1.8 (or 90 days if the requested Underwritten Offering would be a Long-Form Registration), or (iv)&nbsp;the Holders may not launch an Underwritten Offering during any
Company blackout period under its insider trading policy applicable to all directors and executive officers of the Company, but no longer than the period commencing on the fifteenth (15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>)
calendar day of the last month of each fiscal quarter and ending at the start of the third full trading day following the date of public disclosure of the financial results for that fiscal quarter or year, which public disclosure shall be no later
than the filing deadline (without extension) of the Form <FONT STYLE="white-space:nowrap">10-Q</FONT> or Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the applicable fiscal period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In the event of an Underwritten Offering, the Holder(s) delivering the Underwritten Offering Notice shall select the managing
underwriter(s) to administer the Underwritten Offering; <I>provided</I> that the choice of such managing underwriter(s) shall be subject to the consent of the Company, which shall not be unreasonably withheld. The Company and the Holders
participating in an Underwritten Offering will enter into an underwriting agreement in customary form with the managing underwriter or underwriters selected for such offering. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Upon receipt of an Underwritten Offering Notice (which, in the case of an Underwritten Offering that is an underwritten block trade or
bought deal, shall be received by the Company not less than two Business Days prior to the day such offering is first anticipated to commence), the Company shall, as promptly as is reasonably practicable, deliver to each other Holder written notice
thereof and if, within three Business Days after the date of the delivery of such notice (or one Business Day in the case of an Underwritten Offering that is an underwritten block trade or bought deal), a Holder shall so request in writing, the
Company shall as expeditiously as possible use reasonable best efforts to facilitate such Underwritten Offering (which, in the case of an Underwritten Offering that is an underwritten block trade or bought deal, may close as early as two Business
Days after the date it commences) and include in such Underwritten Offering all or any part of such Holder&#146;s Registrable Securities as such Holder requests to be registered, subject to <U>Section</U><U></U><U>&nbsp;1.6(d)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Company will not include in any Underwritten Offering pursuant to this Section&nbsp;1.6 any securities that are not Registrable
Securities without the prior written consent of the Holder(s) of a majority of the Registrable Securities participating in such Underwritten Offering. If the managing underwriter or underwriters advise the Company and the Holder(s) participating in
any Underwritten Offering in writing that in its or their good faith opinion the number of Registrable Securities (and, if permitted hereunder, other securities requested to be included in such offering) exceeds the number of securities which can be
sold in such offering in light of market conditions or is such so as to delay or adversely affect the success of such offering (including the price per share of any securities proposed to be sold in such underwritten offering), the Company will
include in such offering only such number of securities that can be sold without delaying or adversely affecting the marketability of the offering, which securities will be so included in the following order of priority: (i)&nbsp;first, the
Registrable Securities of the Holders that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
have requested to participate in such Underwritten Offering, allocated <I>pro rata</I> among such Holders on the basis of the percentage of the Registrable Securities then-currently owned by such
Holders, and (ii)&nbsp;second, any other securities of the Company that have been requested to be so included (including securities to be sold for the account of the Company) allocated in such manner as the Company may determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.7 <U>Take-Down Notice</U>. Subject to the other applicable provisions of this Agreement, including the limitations and
requirements in <U>Section</U><U></U><U>&nbsp;1.6</U> regarding Underwritten Offerings, at any time that any Shelf Registration Statement is effective, if a Holder delivers a notice to the Company (a &#147;<B>Take-Down Notice</B>&#148;) stating that
it intends to effect a sale or distribution of all or part of its Registrable Securities included by it on any Shelf Registration Statement (a &#147;<B>Shelf Offering</B>&#148;) and stating the number of the Registrable Securities to be included in
such Shelf Offering, then the Company shall amend, subject to the other applicable provisions of this Agreement, or supplement the Shelf Registration Statement as may be necessary in order to enable such Registrable Securities to be sold and
distributed pursuant to the Shelf Offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.8 <U>Piggyback Registration</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except with respect to a Resale Shelf Registration Statement and a Subsequent Shelf Registration Statement for which notice and an
opportunity to participate is provided under Section&nbsp;1.6(c), until the Termination Date, if the Company proposes to file a registration statement under the Securities Act with respect to an offering of Common Stock or securities convertible
into, or exchangeable or exercisable for, Common Stock, whether or not for sale for its own account (other than a registration statement (i)&nbsp;on Form <FONT STYLE="white-space:nowrap">S-4,</FONT> Form <FONT STYLE="white-space:nowrap">S-8</FONT>
or any successor forms thereto, (ii)&nbsp;filed to effectuate an exchange offer or any employee benefit or dividend reinvestment plan or (iii)&nbsp;filed with respect to <FONT STYLE="white-space:nowrap">non-convertible</FONT> debt securities only),
then the Company shall give prompt written notice of such filing, which notice shall be given, to the extent reasonably practicable, no later than seven Business Days prior to the filing date (except in the case of an offering that is an
&#147;overnight offering&#148;, in which case such notice must be given no later than two (2)&nbsp;Business Days prior to the filing date) (the &#147;<B>Piggyback Notice</B>&#148;) to the Holders (other than any Holder that has sold all of its
Registrable Securities). The Piggyback Notice shall offer such Holders the opportunity to include (or cause to be included) in such registration statement the number of shares of Registrable Securities as each such Holder may request (each, a
&#147;<B>Piggyback Registration Statement</B>&#148;). Subject to <U>Section</U><U></U><U>&nbsp;1.8(</U><U>b)</U>, the Company shall include in each Piggyback Registration Statement all Registrable Securities with respect to which the Company has
received written requests for inclusion therein (each, a &#147;<B>Piggyback Request</B>&#148;) within five (5)&nbsp;Business Days after the date of the Piggyback Notice or, in the case of an offering that is an &#147;overnight offering&#148;, such
shorter time as is reasonably specified by the Company in light of the circumstances but not less than one (1)&nbsp;Business Day. The Company shall not be required to maintain the effectiveness of a Piggyback Registration Statement beyond the
earlier of (x)&nbsp;180 days after the effective date thereof and (y)&nbsp;consummation of the distribution by the Holders of the Registrable Securities included in such registration statement. The Company may abandon, postpone or withdraw a
Piggyback Registration Statement at any time prior to effectiveness of such Piggyback Registration Statement whether or not any Holder has elected to include securities in such registration without incurring any liability to the Holders.
Notwithstanding anything to the contrary contained in this Agreement, the Company shall not be required to effect or permit any Piggyback Registration Statement or cause any Piggyback Registration Statement to become effective, with respect to any
Registrable Securities held by any Holders, until after the expiration of the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares Period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If any of the securities to be registered pursuant to the registration giving rise to
the rights under this <U>Section</U><U></U><U>&nbsp;1.8</U> are to be sold in an Underwritten Offering, the Company shall use reasonable best efforts to cause the managing underwriter or underwriters of a proposed Underwritten Offering to permit
Holders who have timely submitted a Piggyback Request in connection with such offering to include in such offering all Registrable Securities included in each Holder&#146;s Piggyback Request on the same terms and subject to the same conditions as
any other shares of capital stock, if any, of the Company included in the offering. The right of any Holder to registration pursuant to this Section&nbsp;1.8 shall be conditioned upon such Holder&#146;s participation in such underwriting and the
inclusion of Registrable Securities in the underwriting to the extent provided herein. Notwithstanding the foregoing, if the managing underwriter or underwriters of such offering advise the Company in writing that in its or their good faith opinion
the number of securities exceeds the number of securities which can be sold in such offering in light of market conditions or is such so as to delay or adversely affect the success of such offering, the Company will include in such offering only
such number of securities that can be sold without adversely affecting the marketability of the offering (including the price per security proposed to be sold in such offering), which securities will be so included in the following order of
priority: (i)&nbsp;first, the securities proposed to be sold by the Company for its own account; (ii)&nbsp;second, the Registrable Securities of the Holders that have requested to participate in such offering and any other persons with piggyback
registration rights who have the right to participate and that have requested to participate in such offering, allocated <I>pro rata</I> among such selling holders on the basis of the total amount of securities entitled to be included therein then
owned by each selling holder and its Affiliates (other than the Company); and (iii)&nbsp;third, any other securities of the Company that have been requested to be included in such offering, allocated <I>pro rata</I> among such holders on the basis
of the percentage of securities of the Company then held by such holders; <I>provided</I> that Holders may, prior to the earlier of (a)&nbsp;the effectiveness of the registration statement and (b)&nbsp;the time at which the offering price or
underwriter&#146;s discount is determined with the managing underwriter or underwriters, withdraw their request to be included in such registration pursuant to this <U>Section</U><U></U><U>&nbsp;1.8</U>. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADDITIONAL
PROVISIONS REGARDING REGISTRATION RIGHTS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1 <U>Registration Procedures</U>. Subject to the other applicable provisions
of this Agreement, in the case of each registration of Registrable Securities effected by the Company pursuant to <U>Article</U><U> I</U>, the Company will: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) prepare and as promptly as reasonably practicable file with the SEC a registration statement with respect to such Registrable Securities
and use reasonable best efforts to cause such registration statement to become (unless it is automatically effective upon filing) and remain effective for the period of the distribution contemplated thereby, in accordance with the applicable
provisions of this Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) prepare and file with the SEC such amendments (including post-effective amendments) and
supplements to such registration statement and the prospectus used in connection with such registration statement as may be necessary to keep such registration statement effective for the period specified in paragraph&nbsp;(a) above but no longer
than is necessary to complete the distribution of the securities covered by such registration statement, and (i)&nbsp;use reasonable efforts to cause such filings not to contain any untrue statements of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; and (ii)&nbsp;comply in all material respects with the applicable provisions of the Securities
Act and the rules and regulations of the SEC with respect to the disposition of all securities covered by such registration statement in accordance with the Holders&#146; intended methods of distribution set forth in such registration statement for
such period; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) furnish to any selling Holders copies of the registration statement and the prospectus included therein (including each
preliminary prospectus) proposed to be filed and provide such selling Holders with a reasonable opportunity to review and comment on such registration statement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) if requested by the managing underwriter or underwriters, if any, or the selling Holder(s), promptly include in any prospectus supplement
or post-effective amendment such information as the managing underwriter or underwriters, if any, or the selling Holder(s) may reasonably request in order to permit the intended method of distribution of such Registrable Securities and make all
required filings of such prospectus supplement or post-effective amendment as soon as reasonably practicable after the Company has received such request; <I>provided</I>, <I>however</I>, that the Company shall not be required to take any actions
under this <U>Section</U><U></U><U>&nbsp;2.1(</U><U>d)</U> that are not, in the opinion of counsel for the Company, in compliance with applicable law; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) in the event that the Registrable Securities are being offered in an Underwritten Offering, furnish to the Holder(s) participating in such
Underwritten Offering and to the underwriters of the securities being registered such reasonable number of copies of the registration statement, preliminary prospectus and final prospectus as such underwriters may reasonably request in order to
facilitate the public offering or other disposition of such securities; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) as promptly as reasonably practicable notify the selling
Holder(s) at any time when a prospectus relating thereto is required to be delivered under the Securities Act or of the Company&#146;s discovery of the occurrence of any event as a result of which the prospectus included in such registration
statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading or incomplete in the light of the circumstances
then existing (which, for the avoidance of doubt, shall commence a Suspension Period (as defined below)), and, subject to <U>Section</U><U></U><U>&nbsp;2.2</U>, at the request of any selling Holder, as promptly as is reasonably practicable, prepare
and file with the SEC a supplement or post-effective amendment to such registration statement or the related prospectus or any document incorporated therein by reference or file any other required document and at the request of any selling Holder,
furnish to such Holder a reasonable number of copies of a supplement to or an amendment of such prospectus as may be necessary so that, as thereafter delivered to the purchasers of such securities, such prospectus shall not include an untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading or incomplete in the light of the circumstances then existing; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) use reasonable best efforts to register and qualify (or exempt from such registration or
qualification) the securities covered by such registration statement under such other securities or &#147;blue sky&#148; laws of such jurisdictions within the United States as shall be reasonably requested in writing by any selling Holder;
<I>provided</I>, <I>however</I>, that the Company shall not be required in connection therewith or as a condition thereto to (i)&nbsp;qualify to do business in any jurisdictions where it would not otherwise be required to qualify but for this
subsection, (ii)&nbsp;subject itself to taxation in any such jurisdiction or (iii)&nbsp;take any action that would subject it to general service of process in any such jurisdictions; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) in the event that the Registrable Securities are being offered in a public offering, enter into an underwriting agreement, a placement
agreement or equivalent agreement customary for a transaction of that nature, in each case in accordance with the applicable provisions of this Agreement, and take all such other actions reasonably requested by the Holders of the Registrable
Securities being sold in connection therewith (including any customary and reasonable actions requested by the managing underwriters, if any) to facilitate the disposition of such Registrable Securities, and in such connection, (i)&nbsp;the
underwriting agreement shall contain indemnification provisions and procedures substantially to the effect set forth in <U>Article III</U> hereof with respect to all parties to be indemnified pursuant to <U>Article III</U> except as otherwise agreed
by the Holders and (ii)&nbsp;deliver such other documents and certificates as may be reasonably requested by the managing underwriters; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) in connection with an Underwritten Offering with anticipated gross proceeds from such sale of more than $50,000,000 (without regard to any
underwriting discount or commission), the Company shall cause its officers to use reasonable best efforts to support the marketing of the Registrable Securities covered by such offering (including participation in &#147;road shows&#148; or other
similar marketing efforts) to the extent reasonably necessary, in the view of the managing underwriter(s), to support the proposed sale of Registrable Securities pursuant to such Underwritten Offering; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) use reasonable best efforts to furnish, on the date that such Registrable Securities are delivered to the underwriters for sale, if such
securities are being sold through underwriters, (i)&nbsp;an opinion, dated as of such date, of the legal counsel representing the Company for the purposes of such registration, in form and substance as is customarily given to underwriters in an
underwritten public offering, addressed to the underwriters, if any, (ii)&nbsp;a &#147;negative assurances letter&#148;, dated as of such date, of the legal counsel representing the Company for the purposes of such registration, in form and
substance as is customarily given to underwriters in an underwritten public offering and (iii)&nbsp;&#147;comfort&#148; letters dated the date of pricing and closing of such offering, as reasonably requested by the underwriters, from the independent
certified public accountants of the Company, in form and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the underwriters, such letter to be in customary
form and covering matters of the type customarily covered in &#147;cold comfort&#148; letters in connection with underwritten offerings; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) in the event that the Registrable Securities covered by such Registration Statement are
shares of Common Stock, use reasonable best efforts to list the Common Stock covered by such Registration Statement with any securities exchange on which the Common Stock is then listed; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) provide a transfer agent and registrar for all such Registrable Securities not later than the effective date of such registration
statement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) in connection with a customary due diligence review in connection with an Underwritten Offering, make available for
inspection by the Holders participating in any such Underwritten Offering, any underwriter participating in any such disposition of Registrable Securities, if any, and any counsel or accountants retained by the Holders or underwriter (collectively,
the &#147;<B>Offering Persons</B>&#148;), at the offices where normally kept or, if requested, via virtual platform, during reasonable business hours, all relevant financial and other records, pertinent corporate documents of the Company and its
subsidiaries, and cause the officers, directors and employees of the Company and its subsidiaries to supply relevant information and participate in customary due diligence sessions in each case reasonably requested by any such underwriter, counsel
or accountant in connection with such Registration Statement; <I>provided</I>, <I>however</I>, that any information that is not generally publicly available at the time of delivery of such information shall be kept confidential by such Offering
Persons, unless (i)&nbsp;disclosure of such information is required by court or administrative order or in connection with an audit or examination by a regulatory or self-regulatory authority, bank examiner or auditor, (ii)&nbsp;disclosure of such
information, in the reasonable judgment of the Offering Persons, is required by law or applicable legal process (including in connection with the offer and sale of securities pursuant to the rules and regulations of the SEC), (iii)&nbsp;such
information is or becomes generally available to the public other than as a result of a <FONT STYLE="white-space:nowrap">non-permitted</FONT> disclosure or failure to safeguard by such Offering Persons in violation of this Agreement or
(iv)&nbsp;such information (A)&nbsp;was known to such Offering Persons (prior to its disclosure by the Company) from a source other than the Company when such source, to the knowledge of the Offering Persons, was not bound by any contractual, legal
or fiduciary obligation of confidentiality to the Company with respect to such information, (B)&nbsp;becomes available to the Offering Persons from a source other than the Company when such source, to the knowledge of the Offering Persons, is not
bound by any contractual, legal or fiduciary obligation of confidentiality to the Company with respect to such information or (C)&nbsp;was developed independently by the Offering Persons or their respective representatives without the use of, or
reliance on, information provided by the Company. In the case of a proposed disclosure pursuant to (i)&nbsp;or (ii) above, such Offering Person shall be required to give the Company prompt written notice of the proposed disclosure prior to such
disclosure (except in the case of (ii)&nbsp;above when a proposed disclosure was or is to be made in connection with a registration statement or prospectus under this Agreement and except in the case of clause&nbsp;(i) above when a proposed
disclosure is in connection with a routine audit or examination by a regulatory or self-regulatory authority, bank examiner or auditor); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) reasonably cooperate with the selling Holders and each underwriter or agent participating in the disposition of Registrable Securities and
their respective counsel in connection with any filings required to be made with FINRA, including the use of reasonable best efforts to obtain FINRA&#146;s <FONT STYLE="white-space:nowrap">pre-clearance</FONT> or
<FONT STYLE="white-space:nowrap">pre-approval</FONT> of the registration statement and applicable prospectus upon filing with the SEC; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) as promptly as is reasonably practicable notify the selling Holder(s) (i)&nbsp;when the
prospectus or any prospectus supplement or post-effective amendment has been filed and, with respect to such registration statement or any post-effective amendment, when the same has become effective, (ii)&nbsp;of any request by the SEC or other
federal or state governmental authority for amendments or supplements to such registration statement or related prospectus or to amend or to supplement such prospectus or for additional information, (iii)&nbsp;of the issuance by the SEC or any state
securities authority of any stop order, injunction or other order or requirement suspending the effectiveness of such registration statement or the initiation of any proceedings for such purpose (which, for the avoidance of doubt, shall commence a
Suspension Period), or (iv)&nbsp;of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the
initiation or threatening of any proceeding for such purpose; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) promptly furnish counsel for each underwriter, if any, and for the
Holder(s) and their respective counsel copies of any correspondence with the SEC or any state securities authority relating to the registration statement or prospectus (for the avoidance of doubt, including, but not limited to, any comment letters
received from the SEC or any state securities authority). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Holders agree that, upon receipt of any notice from the Company of the
happening of any event of the kind described in <U>Section</U><U></U><U>&nbsp;2.1(f)</U>, <U>Section</U><U></U><U>&nbsp;2.1(o)(ii)</U> or <U>Section</U><U></U><U>&nbsp;2.1(o)(iii)</U>, the Holders shall discontinue (and direct any other Persons
making offers and sales of Registrable Securities on their behalf to discontinue) disposition of any Registrable Securities covered by such registration statement or the related prospectus until receipt of the copies of the supplemented or amended
prospectus, which supplement or amendment shall, subject to the other applicable provisions of this Agreement, be prepared and furnished as soon as reasonably practicable, or until the Holders are advised in writing by the Company that the use of
the applicable prospectus may be resumed, and have received copies of any amended or supplemented prospectus or any additional or supplemental filings which are incorporated, or deemed to be incorporated, by reference in such prospectus (such period
during which disposition is discontinued being an &#147;<B>Interruption Period</B>&#148;) and, if requested by the Company, the Holders shall use reasonable best efforts to return to the Company all copies then in their possession, of the prospectus
covering such Registrable Securities at the time of receipt of such request. As soon as practicable after the Company has determined that the use of the applicable prospectus may be resumed, the Company will notify the Holders thereof. In the event
the Company invokes an Interruption Period hereunder and in the sole discretion of the Company the need for the Company to continue the Interruption Period ceases for any reason, the Company shall, as soon as reasonably practicable, provide written
notice to the Holders that such Interruption Period is no longer applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2 <U>Suspension</U>. The Company shall be
entitled, on two occasions during any <FONT STYLE="white-space:nowrap">12-month</FONT> period, for a period of time not to exceed an aggregate of 75 days during any <FONT STYLE="white-space:nowrap">12-month</FONT> period (any such period a
&#147;<B>Suspension Period</B>&#148;), to (x)&nbsp;postpone or defer any registration of Registrable Securities and shall have the right not to file and not to cause the effectiveness of any registration statement covering any Registrable
Securities, (y)&nbsp;suspend the use of any prospectus and registration statement covering any Registrable Securities and (z)&nbsp;require the Holders to suspend any offerings or sales of Registrable Securities pursuant to a registration statement,
if the Company delivers to the Holders affected thereby a certificate signed by the chief executive officer of the Company certifying that such registration and offering would (i)&nbsp;require the Company to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
make an Adverse Disclosure or (ii)&nbsp;materially interfere with any <I>bona fide</I> material financing, acquisition, disposition or other similar transaction involving the Company or any of
its subsidiaries then under consideration whether due to commercial reasons related thereto or a desire to avoid premature disclosure of information. Such certificate shall contain an approximation of the anticipated length of such suspension. The
Holders shall keep the information contained in such certificate confidential subject to the same terms set forth in <U>Section</U><U></U><U>&nbsp;2.1(m)</U>. If the Company defers any registration of Registrable Securities in response to an
Underwritten Offering Notice or requires the Holder(s) to suspend any Underwritten Offering, the selling Holder(s) shall be entitled to withdraw such Underwritten Offering Notice and if they do so, such request shall not be treated for any purpose
as the delivery of an Underwritten Offering Notice pursuant to <U>Section</U><U></U><U>&nbsp;1.6</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3 <U>Expenses of
Registration</U>. All Registration Expenses incurred in connection with any registration or offering pursuant to <U>Article I</U> shall be borne by the Company. All Selling Expenses relating to securities registered on behalf of the Holders shall be
borne, pro rata, by the Holders included in such registration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4 <U>Information by Holders</U>. The Holder or Holders
included in any registration shall, and the Purchasers shall cause such Holder or Holders to, furnish to the Company or its representatives in writing such information regarding such Holder or Holders and their Affiliates, the Registrable Securities
held by them and the distribution proposed by such Holder or Holders and their Affiliates as the Company or its representatives may reasonably request and as shall be required in connection with any registration, qualification or compliance referred
to in this Agreement, including, but not limited to, the number of shares of Common Stock (or convertible, exchangeable or exercisable for Common Stock within 60 days of any such filing) owned by such Holder or Holders and their Affiliates, the
number of such Registrable Securities proposed to be sold, the name and address of such Holder or Holders proposing to sell and the distribution proposed by such Holder or Holders and their Affiliates as shall be required in connection with any
registration, qualification or compliance referred to in this Agreement. It is understood and agreed that the obligations of the Company under <U>Article I</U> are conditioned on and contingent upon the timely provision in writing of any required
information under this Section&nbsp;2.4 by such Holder or Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5 <U>Rule </U><U>144</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) With a view to making available the benefits of Rule 144 to the Holders, the Company agrees that, for so long as a Holder owns Registrable
Securities, the Company will use reasonable best efforts to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) make and keep public information available, as those
terms are understood and defined in Rule 144, at all times after the date of this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) file with the SEC in a
timely manner all reports and other documents required of the Company to be filed under the Securities Act and the Exchange Act; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) furnish to the Holder upon written request a written statement by the Company as to its compliance with the reporting
requirements of the Exchange Act; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) take such further action as any Holder may reasonably request, all to
the extent required from time to time to enable such Holder to sell Registrable Securities without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 or any similar rule or regulation hereafter adopted
by the SEC (including the removal of any restrictive legend thereon to the extent such removal is permitted under Rule 144 or other applicable law and subject to the Holder providing reasonable evidence of compliance therewith). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) For as long as a Holder owns Registrable Securities issued or issuable upon conversion thereof, upon a Holder&#146;s satisfaction of the
relevant holding period under Rule 144 and the other applicable requirements therein, the Company will use reasonable best efforts to take such further necessary action as any Holder of Registrable Securities may reasonably request in connection
with the removal of any restrictive legend on the Registrable Securities, provided that the Holder shall provide reasonable evidence of compliance with applicable securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6 <U>Purchasers Holdback Agreement</U>. If during the Effectiveness Period, the Company shall file a registration statement
(other than in connection with the registration of securities issuable pursuant to an employee stock option, stock purchase or similar plan or pursuant to a merger, exchange offer or a transaction of the type specified in Rule 145(a) under the
Securities Act) with respect to an Underwritten Offering of Common Stock or securities convertible into, or exchangeable or exercisable for, such securities or otherwise informs the Holders that it intends to conduct such Underwritten Offering
utilizing an effective registration statement and provides each Holder the opportunity to participate in such Underwritten Offering in accordance with and to the extent required by the terms of this Agreement, each Holder shall for so long as such
Holder together with its respective Affiliates beneficially owns, on an as converted basis (as defined in the Certificates of Designations) greater than 5% of the then outstanding Common Stock or has a right to nominate a director to the Company
Board (as defined in the Purchase Agreements), if requested by the managing underwriter or underwriters, enter into a customary <FONT STYLE="white-space:nowrap">&#147;lock-up&#148;</FONT> agreement relating to the sale, offering or distribution of
Registrable Securities, in the form reasonably requested by the managing underwriter or underwriters, covering the period commencing on the date of the prospectus or prospectus supplement pursuant to which such offering may be made and continuing
until the earlier of 90 days from the date of such prospectus or prospectus supplement, as applicable or such shorter period as may be agreed to by the managing underwriter or underwriters; provided that nothing herein will prevent (i)&nbsp;any
Holder that is a partnership or corporation from making a transfer to an Affiliate that is otherwise in compliance with applicable securities laws, (ii)&nbsp;any pledge of Registrable Securities by a Holder or (iii)&nbsp;any foreclosure in
connection with or transfer in lieu of a foreclosure under any pledge of Registrable Securities by a Holder, in each case that is otherwise in compliance with applicable securities laws. Notwithstanding the foregoing, any discretionary waiver or
termination of this holdback provision by such underwriters with respect to any of the Holders shall apply to the other Holders as well, pro rata based upon the number of Registrable Securities subject to such obligations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEMNIFICATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1 <U>Indemnification by Company</U>. To the extent permitted by applicable law, the Company will, with respect to any
Registrable Securities covered by a registration statement or prospectus, or as to which registration, qualification or compliance under applicable &#147;blue sky&#148; laws has been effected pursuant to this Agreement, indemnify and hold harmless
each Holder, each Holder&#146;s current and former officers, directors, partners, members, managers, shareholders, accountants, attorneys, agents, employees and Affiliates, and each Person controlling such Holder within the meaning of
Section&nbsp;15 of the Securities Act and such Holder&#146;s current and former officers, directors, partners, members, managers, shareholders, accountants, attorneys, agents, employees and Affiliates, and each underwriter thereof, if any, and each
Person who controls any such underwriter within the meaning of Section&nbsp;15 of the Securities Act (collectively, the &#147;<B>Company Indemnified Parties</B>&#148;), from and against any and all expenses, claims, losses, damages, costs (including
costs of preparation and reasonable and documented attorney&#146;s fees and expenses and any legal or other documented fees or expenses actually incurred by such party in connection with any investigation or proceeding), judgments, fines, penalties,
charges, amounts paid in settlement and other liabilities, joint or several, (or actions or proceedings, in respect thereof) (collectively, &#147;<B>Losses</B>&#148;) to the extent arising out of or based on any untrue statement (or alleged untrue
statement) of a material fact contained in any registration statement, prospectus, preliminary prospectus, offering circular, &#147;issuer free writing prospectus&#148; (as such term is defined in Rule 433 under the Securities Act) or other
document, in each case related to such registration statement, or any amendment or supplement thereto, or based on any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances in which they were made, not misleading, or any violation by the Company of the Securities Act, the Exchange Act, any state securities law or any rules or regulations thereunder applicable to the Company in
connection with any registration or offering hereunder and (without limiting the preceding portions of this <U>Section</U><U></U><U>&nbsp;3.1</U>), the Company will reimburse each of the Company Indemnified Parties for any reasonable and documented <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> legal expenses and any other reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses
actually incurred in connection with investigating, defending or, subject to the last sentence of this <U>Section</U><U></U><U>&nbsp;3.1</U>, settling any such Losses or action, as such expenses are incurred; <I>provided</I> that the Company&#146;s
indemnification obligations shall not apply to amounts paid in settlement of any Losses or action if such settlement is effected without the prior written consent of the Company (which consent shall not be unreasonably withheld or delayed), nor
shall the Company be liable to a Holder in any such case for any such Losses or action to the extent that it arises out of or is based upon a violation or alleged violation of any state or federal law (including any claim arising out of or based on
any untrue statement or alleged untrue statement or omission or alleged omission in the registration statement or prospectus) which occurs in reliance upon and in conformity with written information regarding such Holder furnished to the Company by
such Holder or its authorized representatives expressly for use in connection with such registration by or on behalf of any Holder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2 <U>Indemnification by Holders</U>. To the extent permitted by applicable
law, each Holder will, if Registrable Securities held by such Holder are included in the securities as to which registration or qualification or compliance under applicable &#147;blue sky&#148; laws is being effected, indemnify, severally and not
jointly with any other Holders, the Company, each of its representatives, and each Person who controls the Company within the meaning of Section&nbsp;15 of the Securities Act (collectively, the &#147;<B>Holder Indemnified Parties</B>&#148;), against
all Losses (or actions in respect thereof) to the extent arising out of or based on any untrue statement (or alleged untrue statement) of a material fact contained in any registration statement, prospectus, preliminary prospectus, offering circular,
&#147;issuer free writing prospectus&#148; or other document, in each case related to such registration statement, or any amendment or supplement thereto, or based on any omission (or alleged omission) to state therein a material fact required to be
stated therein or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading, and will reimburse each of the Holder Indemnified Parties for any reasonable and documented <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> legal expenses and any other reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses
actually incurred in connection with investigating, defending or, subject to the last sentence of this <U>Section</U><U></U><U>&nbsp;3.2</U>, settling any such Losses or action, as such expenses are incurred, in each case to the extent, but only to
the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in such registration statement, prospectus, offering circular, &#147;issuer free writing prospectus&#148; or other document in reliance
upon and in conformity with written information regarding such Holder furnished to the Company by such Holder or its authorized representatives and stated to be specifically for use therein; <I>provided</I>, <I>however</I>, that in no event shall
any indemnity under this <U>Section</U><U></U><U>&nbsp;3.2</U> payable by any of the Purchasers and any Holder exceed an amount equal to the net proceeds (after deducting Selling Expenses) actually received by such Holder in respect of the sale of
the Registrable Securities giving rise to such indemnification obligation. The indemnity agreement contained in this <U>Section</U><U></U><U>&nbsp;3.2</U> shall not apply to amounts paid in settlement of any Losses or action if such settlement is
effected without the prior written consent of the applicable Holder (which consent shall not be unreasonably withheld or delayed). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3 <U>Notification</U>. If any Person shall be entitled to indemnification under this <U>Article</U><U> III</U> (each, an
&#147;<B>Indemnified Party</B>&#148;), such Indemnified Party shall give prompt notice to the party required to provide indemnification (each, an &#147;<B>Indemnifying Party</B>&#148;) of any claim or of the commencement of any proceeding as to
which indemnity is sought. The Indemnifying Party shall have the right, exercisable by giving written notice to the Indemnified Party as promptly as reasonably practicable after the receipt of written notice from such Indemnified Party of such claim
or proceeding, to assume, at the Indemnifying Party&#146;s expense, the defense of any such claim or litigation, with counsel reasonably satisfactory to the Indemnified Party and, after notice from the Indemnifying Party to such Indemnified Party of
its election to assume the defense thereof, the Indemnifying Party will not (so long as it shall continue to have the right to defend, contest, litigate and settle the matter in question in accordance with this paragraph) be liable to such
Indemnified Party hereunder for any legal expenses and other expenses subsequently incurred by such Indemnified Party in connection with the defense thereof; <I>provided</I>, <I>however</I>, that an Indemnified Party shall have the right to employ
separate counsel in any such claim or litigation, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party unless (i)&nbsp;the use of counsel chosen by the Indemnifying Party to represent the Indemnified Party
would present such counsel with a conflict of interest; (ii)&nbsp;such action includes both the Indemnified Party and the Indemnifying Party and the Indemnified Party shall have reasonably concluded that there may be legal defenses available to it
and/or other Indemnified Parties that are different from or additional to those available to the Indemnifying Party; (iii)&nbsp;the Indemnifying Party shall have failed within a reasonable period of time to employ counsel reasonably satisfactory to
the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Indemnified Party and assume such defense and the Indemnified Party is or would reasonably be expected to be materially prejudiced by such delay or (iv)&nbsp;the Indemnifying Party agrees to pay
such fees and expenses. The failure of any Indemnified Party to give notice as provided herein shall relieve an Indemnifying Party of its obligations under this <U>Article III</U> only to the extent that the failure to give such notice is materially
prejudicial or harmful to such Indemnifying Party&#146;s ability to defend such action. No Indemnifying Party, in the defense of any such claim or litigation, shall, except with the prior written consent of each Indemnified Party (which consent
shall not be unreasonably withheld or delayed), consent to entry of any judgment or enter into any settlement which (A)&nbsp;does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a
release from all liability in respect to such claim or litigation and (B)&nbsp;does not include any statement as to any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Party. The indemnity agreements contained
in this <U>Article III</U> shall not apply to amounts paid in settlement of any claim, loss, damage, liability or action if such settlement is effected without the prior written consent of the Indemnifying Party, which consent shall not be
unreasonably withheld or delayed. The indemnification set forth in this <U>Article III</U> shall be in addition to any other indemnification rights or agreements that an Indemnified Party may have. An Indemnifying Party who is not entitled to, or
elects not to, assume the defense of a claim will not be obligated to pay the fees and expenses of more than one counsel (together with one local counsel, if appropriate) for all parties indemnified by such Indemnifying Party with respect to such
claim, unless in the reasonable judgment of any Indemnified Party a conflict of interest may exist between such Indemnified Party and any other Indemnified Parties with respect to such claim. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4 <U>Contribution</U>. If the indemnification provided for in this <U>Article</U><U> III</U> is held by a court of competent
jurisdiction to be unavailable to an Indemnified Party, other than pursuant to its terms, with respect to any Losses or action referred to therein, then, subject to the limitations contained in this <U>Article</U><U> III</U>, the Indemnifying Party,
in lieu of indemnifying such Indemnified Party hereunder, shall contribute to the amount paid or payable by such Indemnified Party as a result of such Losses or action in such proportion as is appropriate to reflect the relative fault of the
Indemnifying Party, on the one hand, and the Indemnified Party, on the other, in connection with the actions, statements or omissions that resulted in such Losses or action, as well as any other relevant equitable considerations. The relative fault
of the Indemnifying Party, on the one hand, and the Indemnified Party, on the other hand, shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or
omission or alleged omission to state a material fact, has been made (or omitted) by, or relates to information supplied by such Indemnifying Party or such Indemnified Party, and the parties&#146; relative intent, knowledge, access to information
and opportunity to correct or prevent any such action, statement or omission. The Company and the Holders agree that it would not be just and equitable if contribution pursuant to this <U>Section</U><U></U><U>&nbsp;3.4</U> was determined solely upon
<I>pro rata</I> allocation or by any other method of allocation which does not take account of the equitable considerations referred to in the immediately preceding sentence of this <U>Section</U><U></U><U>&nbsp;3.4</U>. Notwithstanding the
foregoing, the amount any Purchaser or any Holder will be obligated to contribute pursuant to this <U>Section</U><U></U><U>&nbsp;3.4</U> will be limited to an amount equal to the net proceeds actually received by such Purchaser or Holder in respect
of the sale of the Registrable Securities giving rise to such obligation to contribute. No Person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any
Person who was not guilty of such fraudulent misrepresentation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TRANSFER AND TERMINATION OF REGISTRATION RIGHTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1 <U>Transfer of Registration Rights</U>. Any rights to cause the Company to register securities granted to a Holder under this
Agreement may be transferred or assigned to any Person only in connection with a Transfer (both as defined in the Purchase Agreements) of Series B Preferred Stock or Common Stock, as applicable, permitted under Section&nbsp;6.15(b) of the Purchase
Agreements; <I>provided</I>, <I>however</I>, that (a)&nbsp;such transfer may otherwise be effected in accordance with applicable securities laws, (b)&nbsp;prior written notice of such assignment of rights is given to the Company, (c)&nbsp;such
transferee agrees in writing to be bound by, and subject to, this Agreement as a &#147;Holder&#148; pursuant to a written instrument in form and substance reasonably acceptable to the Company and (d)&nbsp;such Transfer represents 3% or more of the
outstanding Common Stock on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2 <U>Termination of
Registration Rights</U>. The rights of any particular Holder to cause the Company to register securities under <U>Article I</U> shall terminate with respect to such Holder upon the date upon which such Holder no longer holds any Registrable
Securities. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1 <U>Amendments and Waivers</U>. Subject to applicable law and subject to the other provisions of this Agreement, this
Agreement may be amended by the parties hereto at any time by execution of an instrument in writing signed on behalf of each of the Purchasers (with respect to each Purchaser, for so long as such Purchaser owns Registrable Securities), Holders
representing a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">majority-in-interest</FONT></FONT> of the Registrable Securities then outstanding and the Company; provided that an amendment that adversely affects any Purchaser or
Holder disproportionately to the others shall not bind such Purchaser or Holder without its consent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2 <U>Extension of
Time, Waiver</U>. The parties hereto may, to the extent legally allowed and except as otherwise set forth herein: (a)&nbsp;extend the time for the performance of any of the obligations or other acts of the other parties, as applicable; and
(b)&nbsp;subject to the requirements of applicable law, waive compliance with any of the agreements or conditions for the benefit of such party contained herein. Any agreement on the part of a party hereto to any such extension or waiver will be
valid only if set forth in an instrument in writing signed by such party; <I>provided</I> that any Purchaser may execute such waivers on behalf of any Holder. Any failure or delay in exercising any right, power or privilege pursuant to this
Agreement will not constitute a waiver of such right, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3 <U>Assignment</U>. Except as provided in <U>Section</U><U></U><U>&nbsp;4.1</U>, neither this Agreement nor any of the rights,
interests or obligations hereunder shall be assigned, in whole or in part, by operation of law or otherwise, by any of the parties hereto without the prior written consent of the other parties hereto; <I>provided</I>, <I>further</I>, that if the
Company consolidates or merges with or into any Person and the Common Stock or any other Registrable Securities are, in whole or in part, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
converted into or exchanged for securities of a different issuer, and any Holder would, upon completion of such merger or consolidation, hold Registrable Securities of such issuer, then as a
condition to such transaction the Company will cause such issuer to assume all of the Company&#146;s rights and obligations under this Agreement in a written instrument delivered to the Holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4 <U>Counterparts</U>. This Agreement and any amendments hereto may be executed in one or more counterparts, all of which will
be considered one and the same agreement and will become effective when one or more counterparts have been signed by each of the parties hereto and delivered to the other parties hereto, it being understood that all parties need not sign the same
counterpart. Any such counterpart, to the extent delivered by fax or .pdf, .tif, .gif, .jpg or similar attachment to electronic mail (any such delivery, an &#147;<B>Electronic Delivery</B>&#148;), will be treated in all manner and respects as an
original executed counterpart and will be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. No party may raise the use of an Electronic Delivery to deliver a signature, or the
fact that any signature or agreement or instrument was transmitted or communicated through the use of an Electronic Delivery, as a defense to the formation of a contract, and each party forever waives any such defense, except to the extent such
defense relates to lack of authenticity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5 <U>Entire Agreement; No Third Party Beneficiary</U>. This Agreement and the
documents and instruments and other agreements among the parties hereto as contemplated by or referred to herein, including the Purchase Agreements, constitute the entire agreement among the parties hereto with respect to the subject matter hereof
and supersede all prior agreements and understandings, both written and oral, among the parties hereto with respect to the subject matter hereof. This Agreement is not intended to and shall not confer any rights or remedies upon any person other
than the parties hereto, their respective successors and permitted assigns and any Indemnified Party hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6
<U>Governing Law; Jurisdiction</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) This Agreement shall be governed by, and construed in accordance with, the laws of the State of
Delaware applicable to contracts executed in and to be performed entirely within that State, regardless of the laws that might otherwise govern under any applicable conflict of laws principles. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each party hereto irrevocably submits to the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of the Court of Chancery of
the State of Delaware and any state appellate court therefrom within the State of Delaware any suit, action or other proceeding arising out of or relating to this Agreement, and hereby irrevocably agrees that all claims in respect of such suit,
action or proceeding may be heard and determined in such court. Each party hereto hereby irrevocably waives, to the fullest extent that it may effectively do so, the defense of an inconvenient forum to the maintenance of such suit, action or other
proceeding. The parties hereto further agree, to the extent permitted by law, that final and unappealable judgment against any of them in any suit, action or other proceeding contemplated above shall be conclusive and may be enforced in any other
jurisdiction within or outside the United States by suit on the judgment, a certified copy of which shall be conclusive evidence of the fact and amount of such judgment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7 <U>Specific Enforcement</U>. The parties acknowledge and agree that in the
event of a breach by the Company or a Purchaser of any of their obligations hereunder (a)&nbsp;the parties shall be entitled to an injunction or injunctions, specific performance or other equitable relief to enforce specifically the terms and
provisions hereof in the courts described in <U>Section</U><U></U><U>&nbsp;5.6</U> without proof of damages or otherwise, this being in addition to any other remedy to which they are entitled under this Agreement and (b)&nbsp;the right of specific
enforcement is an integral part of this Agreement and without that right, neither the Company nor the Purchasers would have entered into this Agreement. The parties hereto agree not to assert that a remedy of specific enforcement is unenforceable,
invalid, contrary to law or inequitable for any reason, and agree not to assert that a remedy of monetary damages would provide an adequate remedy or that the parties otherwise have an adequate remedy at law. The parties hereto acknowledge and agree
that any party seeking an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in accordance with this <U>Section</U><U></U><U>&nbsp;5.7</U> shall not be required to
provide any bond or other security in connection with any such order or injunction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8 <U>Waiver of Jury Trial</U>. EACH
PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE PURSUANT TO THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT
PERMITTED BY APPLICABLE LAW, ANY RIGHT THAT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL PROCEEDING (WHETHER FOR BREACH OF CONTRACT, TORTIOUS CONDUCT OR OTHERWISE) DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT
OR THE TRANSACTION. EACH PARTY ACKNOWLEDGES AND AGREES THAT (i)&nbsp;NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE
FOREGOING WAIVER; (ii)&nbsp;IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER; (iii)&nbsp;IT MAKES THIS WAIVER VOLUNTARILY; AND (iv)&nbsp;IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND
CERTIFICATIONS IN THIS <U>SECTION</U><U></U><U>&nbsp;5.8</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9 <U>Notices</U>. All notices and other communications
hereunder must be in writing and will be deemed to have been duly delivered and received hereunder: (a)&nbsp;four Business Days after being sent by registered or certified mail, return receipt requested, postage prepaid; (b)&nbsp;one Business Day
after being sent for next Business Day delivery, fees prepaid, via a reputable nationwide overnight courier service; or (c)&nbsp;immediately upon delivery by electronic mail (provided that no bounceback or similar &#147;undeliverable&#148; message
is received by such sender) or by hand (with a written confirmation of delivery), in each case to the intended recipient as set forth below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If to the Company, to it at: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Fluidigm Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">2 Towers
Place, Suite 2000 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">South San Francisco, CA 94080 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Nicholas S. Khadder </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: nick.khadder@fluidigm.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Wilson Sonsini Goodrich&nbsp;&amp; Rosati </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Professional Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">650
Page Mill Road </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Palo Alto, CA 94304 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Robert F. Kornegay </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Zachary Myers </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Douglas K. Schnell </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-mail:</FONT> &nbsp;&nbsp;&nbsp;&nbsp;rkornegay@wsgr.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;zmyers@wsgr.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dschnell@wsgr.com </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If to the Holders or the Purchasers: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To Viking Global Opportunities Illiquid Investments <FONT STYLE="white-space:nowrap">Sub-Master</FONT> LP /
Viking Global Opportunities Drawdown (Aggregator) LP at: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">c/o Viking Global Investors LP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">55 Railroad Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Greenwich,
CT 06830 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Legal and Compliance Department </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;legalnotices@vikingglobal.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Kirkland&nbsp;&amp; Ellis LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">601 Lexington Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">New York,
NY 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attn: &nbsp;&nbsp;&nbsp;&nbsp;Michael Movsovich </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;mmovsovich@kirkland.com </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to Casdin Private Growth Equity Fund II, L.P. / Casdin Partners Master Fund, L.P. at: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">c/o Casdin Capital, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">1350
6th Avenue, Suite 2600 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">New York, NY 10019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Kevin O&#146;Brien </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;kevin@casdincapital.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Paul, Weiss, Rifkind, Wharton&nbsp;&amp; Garrison LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">1285 Avenue of the Americas </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">New York, NY 10019 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attn:
&nbsp;&nbsp;Krishna Veeraraghavan </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: kveeraraghavan@paulweiss.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice received at the addressee&#146;s location on any Business Day after 5:00 p.m., addressee&#146;s local time, or on any day that is
not a Business Day will be deemed to have been received at 9:00 a.m., addressee&#146;s local time, on the next Business Day. From time to time, any party hereto may provide notice to the other parties hereto of a change in its address or <FONT
STYLE="white-space:nowrap">e-mail</FONT> address through a notice given in accordance with this <U>Section</U><U></U><U>&nbsp;5.9</U>, except that that notice of any change to the address or any of the other details specified in or pursuant to this
<U>Section</U><U></U><U>&nbsp;5.9</U> will not be deemed to have been received until, and will be deemed to have been received upon, the later of the date (A)&nbsp;specified in such notice or (B)&nbsp;that is five Business Days after such notice
would otherwise be deemed to have been received pursuant to this <U>Section</U><U></U><U>&nbsp;5.9</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10
<U>Severability</U>. In the event that any provision of this Agreement, or the application thereof, becomes or is declared by a court of competent jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement will continue in
full force and effect and the application of such provision to other Persons or circumstances will be interpreted so as reasonably to effect the intent of the parties hereto. Upon such a determination, the parties hereto agree to negotiate in good
faith to replace such void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent possible, the economic, business and other purposes of such void or unenforceable provision. If any
provision of this Agreement is so broad as to be unenforceable, such provision will be interpreted to be only so broad as it is enforceable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11 <U>Expenses</U>. Except as provided in <U>Section</U><U></U><U>&nbsp;2.3</U> and <U>Article</U><U> III</U>, all costs and
expenses, including fees and disbursements of counsel, financial advisors and accountants, incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12 <U>Interpretation</U>. The rules of interpretation set forth in Section&nbsp;1.3 of the Purchase Agreements shall apply to
this Agreement, <I>mutatis mutandis</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13 <U>No Inconsistent Agreements; Most Favored Nations</U>. The Company is not
currently a party to any agreement with any holder or prospective holder of any securities of the Company giving such holder or prospective holder any registration rights the terms of which are on parity with or senior to, or inconsistent with, the
registration rights granted to the Holders pursuant to this Agreement. The Company shall not enter into any agreement with respect to its securities (a)&nbsp;that is inconsistent with or violates the rights granted to the Holders by this Agreement,
(b)&nbsp;that would allow any holder or prospective holder of any securities of the Company to include such securities in any Underwritten Offering or registration giving rights to the rights under Section&nbsp;1.8 unless, under the terms of such
agreement, such holder or prospective holder may include such securities in any such registration only to the extent that their inclusion would not reduce the amount of the Registrable Securities of the Holders included therein or (c)&nbsp;on terms
otherwise more favorable than this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14 <U><FONT STYLE="white-space:nowrap">Opt-Out</FONT> Requests</U>. Subject
to Section&nbsp;2.6, each Holder shall have the right, at any time and from time to time (including after receiving information regarding any potential public offering), to elect to not receive any notice that the Company or any other Holders
otherwise are required to deliver pursuant to this Agreement regarding an Underwritten Offering, a Take-Down Notice or a Piggyback Registration Statement (except any Suspension Notice or any other notice as required by law, rule or regulation) by
delivering to the Company a written statement signed by such Holder that it does not want to receive any such notices hereunder (an <FONT STYLE="white-space:nowrap">&#147;Opt-Out</FONT> Request&#148;), in which case, and notwithstanding anything to
the contrary in this Agreement, the Company and other Holders shall not be required to, and shall not, deliver any such notice or other related information required to be provided to Holders hereunder to the extent that the Company or such other
Holders reasonably expect such notice or information would result in a Holder acquiring material <FONT STYLE="white-space:nowrap">non-public</FONT> information within the meaning of Regulation FD promulgated under the Exchange Act. An <FONT
STYLE="white-space:nowrap">Opt-Out</FONT> Request may state a date on which it expires or, if no such date is specified, shall remain in effect indefinitely. A Holder that has previously given the Company an
<FONT STYLE="white-space:nowrap">Opt-Out</FONT> Request may revoke such request at any time, and there shall be no limit on the ability of a Holder to issue and revoke subsequent <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Requests; provided,
that each Holder shall use reasonable best efforts to minimize the administrative burden on the Company arising in connection with any such <FONT STYLE="white-space:nowrap">Opt-Out</FONT> Requests. Notwithstanding the foregoing, this shall not
prohibit any communications or notices to employees, officers and directors or agents of the Company, or notices or communications pursuant to any other agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature pages follow</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>COMPANY:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">FLUIDIGM CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Vikram Jog</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Vikram Jog</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: &nbsp;&nbsp;Chief Financial Officer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S<SMALL>IGNATURE</SMALL>
P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> R<SMALL>EGISTRATION</SMALL> R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>PURCHASERS:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CASDIN PRIVATE GROWTH EQUITY FUND II, L.P.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Casdin Private Growth Equity Fund II</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kevin O&#146;Brien</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Kevin O&#146;Brien</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: &nbsp;&nbsp;General Counsel</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CASDIN PARTNERS MASTER FUND, L.P.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Casdin Partners GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kevin O&#146;Brien</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Kevin O&#146;Brien</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: &nbsp;&nbsp;General Counsel</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS <FONT STYLE="white-space:nowrap">SUB-MASTER</FONT> LP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Viking Global Opportunities Portfolio GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Katerina Novak</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Katerina Novak</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: &nbsp;&nbsp;Authorized Signatory</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">VIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Viking Global Opportunities Drawdown Portfolio GP LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Katerina Novak</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Katerina Novak</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: &nbsp;&nbsp;Authorized Signatory</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S<SMALL>IGNATURE</SMALL>
P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> R<SMALL>EGISTRATION</SMALL> R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINED TERMS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
following capitalized terms have the meanings indicated: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Adverse Disclosure</B>&#148; means public disclosure of material <FONT
STYLE="white-space:nowrap">non-public</FONT> information that, in the good faith judgment of the Chief Executive Officer of the Company (after consultation with legal counsel): (i)&nbsp;would be required to be made in any registration statement
filed with the SEC by the Company so that such registration statement would not be materially misleading; (ii)&nbsp;would not be required to be made at such time but for the filing, effectiveness or continued use of such registration statement; and
(iii)&nbsp;the Company has a <I>bona fide</I> business purpose for not disclosing publicly. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Affiliates</B>&#148; shall have the
meaning given to such term in the Certificates of Designations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Automatic Shelf Registration Statement</B>&#148; means an
&#147;automatic shelf registration statement&#148; as defined under Rule 405. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Business Day</B>&#148; means any day except a
Saturday, a Sunday or other day on which the SEC or banks in the City of New York are authorized or required by law to be closed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Certificates of Designations</B>&#148; means the Certificates of Designations setting forth the designations, powers, preferences,
qualifications, limitations and restrictions of the Series B Preferred Stock, to be dated as of the Closing Date (as defined in the Purchase Agreements), as may be amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Exchange Act</B>&#148; means the Securities Exchange Act of 1934, as amended, and any successor statute thereto, and the rules and
regulations of the SEC promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>FINRA</B>&#148; means the Financial Industry Regulatory Authority, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Legal Proceeding</B>&#148; means any claim, action, charge, lawsuit, litigation, audit, investigation, arbitration or other similar
legal proceeding brought by or pending before any governmental authority, arbitrator or other tribunal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Shares Period</B>&#148; means with respect to the Series B Preferred Stock that are held by the Purchasers or their Permitted Transferees, the period ending on the
<FONT STYLE="white-space:nowrap">six-month</FONT> anniversary of the closing date of the Purchase Agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Long-Form
Registration Statement</B>&#148; means a registration statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> or any similar long-form registration statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Person</B>&#148; means any individual, corporation, limited liability company, partnership, joint venture, association, trust,
unincorporated organization or any other entity, including a governmental authority. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>register</B>&#148;, &#147;<B>registered</B>&#148; and
&#147;<B>registration</B>&#148; refer to a registration effected by preparing and filing a registration statement in compliance with the Securities Act, and the declaration or ordering of the effectiveness of such registration statement or the
automatic effectiveness of such registration statement, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Registrable Securities</B>&#148; means, as of any date of
determination, (x)&nbsp;any shares of Series B Preferred Stock or Common Stock held by a Holder acquired pursuant to the Purchase Agreements (including pursuant to Section&nbsp;6.16 of the Purchase Agreements) and the Loan Agreements or otherwise in
a primary issuance of the Company pursuant to which such Holder has a preemptive right under Section&nbsp;6.16 of the Purchase Agreement, including (i)&nbsp;any shares of Common Stock hereafter acquired by any Holder pursuant to the conversion of
the Series B Preferred Stock in accordance with the Certificate of Designations and (ii)&nbsp;any shares of Series B Preferred Stock or Common Stock hereafter acquired by any Holder pursuant to the conversion of the Convertible Loans in accordance
with the Loan Agreements and (y)&nbsp;any other securities issued or issuable with respect to any such shares of Common Stock or Series B Preferred Stock or the Convertible Loans by way of share split, share dividend, distribution, recapitalization,
merger, exchange, replacement or similar event or otherwise (including, for the avoidance of doubt, a redemption, put or call transaction pursuant to the Certificate of Designations or the Loan Agreements). As to any particular Registrable
Securities, once issued, such securities shall cease to be Registrable Securities when (i)&nbsp;such securities are sold or otherwise transferred pursuant to an effective registration statement under the Securities Act, (ii)&nbsp;such securities
shall have ceased to be outstanding, (iii)&nbsp;such securities have been transferred in a transaction in which the Holder&#146;s rights under this Agreement are not assigned to the transferee of the securities, (iv)&nbsp;such securities are sold in
a broker&#146;s transaction under circumstances in which all of the applicable conditions of Rule 144 (or any similar provisions then in force) under the Securities Act are met, (v)&nbsp;such securities are eligible to be resold in a broker&#146;s
transaction under Rule 144 without regard to Rule 144&#146;s volume and manner of sale restrictions and the Holder, together with its Affiliates, beneficially owns less than 3% of the Company&#146;s then-outstanding shares of Common Stock and has no
representative on the Company&#146;s board of directors or (vi)&nbsp;such securities have been sold or transferred by any Holder thereof pursuant to Rule 144 (or any similar provision then in force under the Securities Act) and the transferee
thereof does not receive &#147;restricted securities&#148; as defined in Rule 144. For purposes of this Agreement, a Person will be deemed to be a holder of Registrable Securities, and the Registrable Securities will be deemed to be in existence,
whenever such Person has the right to acquire, directly or indirectly, such Registrable Securities (upon conversion or exercise in connection with a transfer of securities or otherwise, but disregarding any restrictions or limitations upon the
exercise of such right), whether or not such acquisition has actually been effected, and such Person will be entitled to exercise the rights of a holder of Registrable Securities hereunder. Notwithstanding anything contained in this Agreement, the
Company shall not register the Series B Preferred Stock and a Holder of Registrable Securities may only request that Registrable Securities in the form of Common Stock be registered pursuant to this Agreement and the Company will only file a
Registration Statement with respect to Common Stock (even if such Holder does not yet hold its Registrable Securities in the form of Common Stock)). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Registration Expenses</B>&#148; means all (a)&nbsp;expenses incurred by the Company
in complying with <U>Article I</U> or <U>Article II</U>, including all registration, qualification, listing and filing fees, printing expenses, FINRA fees, escrow fees and fees and disbursements of counsel and independent accountants for the
Company, blue sky fees and expenses and (b)&nbsp;reasonable, documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> fees and expenses of outside legal counsel to the Purchasers retained in connection
with registrations or Underwritten Offerings contemplated hereby; <I>provided</I>, <I>however</I>, that the Company shall only be responsible for the fees and expenses of each such outside legal counsel (no more than one counsel per Purchaser, up to
a maximum of two counsel), up to an amount not to exceed $75,000 per Purchaser not to exceed an aggregate of $150,000 per registration or offering. For the avoidance of doubt, Registration Expenses shall not be deemed to include any Selling
Expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Registration Statement</B>&#148; means any registration statement of the Company filed or to be filed with the SEC
under the rules and regulations promulgated under the Securities Act, including the related prospectus, amendments and supplements to such registration statement, and including <FONT STYLE="white-space:nowrap">pre-</FONT> and post-effective
amendments, and all exhibits and all material incorporated by reference in such registration statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rule 144</B>&#148; means
Rule 144 promulgated under the Securities Act and any successor provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rule 405</B>&#148; means Rule 405 promulgated under
the Securities Act and any successor provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Rule 462(e)</B>&#148; means Rule 462(e) promulgated under the Securities Act and
any successor provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>SEC</B>&#148; means the U.S. Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Securities Act</B>&#148; means the Securities Act of 1933, as amended, and any successor statute thereto, and the rules and
regulations of the SEC promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Selling Expenses</B>&#148; means all underwriting discounts, selling commissions
and stock transfer taxes applicable to the securities registered by the Holders and the fees and expenses of any accountants or other persons (except as set forth in the definition of &#147;Registration Expenses&#148;) retained or employed by the
Purchasers and the Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Shelf Registration Statement</B>&#148; means the Resale Shelf Registration Statement or a Subsequent
Shelf Registration Statement, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Termination Date</B>&#148; means the first date on which there are no Registrable
Securities or there are no Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Underwritten Offering</B>&#148; means a registered offering in which securities of the
Company are sold to one or more underwriters on a firm commitment basis for reoffering to the public, including through a block trade or a bought deal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>WKSI</B>&#148; means a &#147;well-known seasoned issuer&#148; as defined under Rule 405. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following terms are defined in the Sections of the Agreement indicated: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEX OF TERMS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Term</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Section</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preamble</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Recital</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preamble</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Indemnified Parties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effectiveness Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Electronic Delivery</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Holder</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preamble</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Holder Indemnified Parties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Holders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preamble</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnified Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnifying Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interruption Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Losses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Offering Persons</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1(m)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Piggyback Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.8(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Piggyback Registration Statement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.8(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Piggyback Request</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.8(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase Agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Recitals</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchaser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preamble</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchasers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preamble</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Resale Shelf Registration Statement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Recitals</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Recitals</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Recitals</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shelf Offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.7</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsequent Holder Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.5</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsequent Shelf Registration Statement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.3</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Suspension Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Take-Down Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.7</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwritten Offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.6(a)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwritten Offering Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.6(a)</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>7
<FILENAME>d243622dex106.htm
<DESCRIPTION>EX-10.6
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.6</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Exhibit 10.6 </I></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TRANSITION AGREEMENT AND RELEASE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Transition Agreement and Release (&#147;Transition Agreement&#148;) is made by and between Chris Linthwaite (&#147;Executive&#148;) and
Fluidigm Corporation (the &#147;Company&#148;) (collectively, Executive and the Company referred to as the &#147;Parties&#148; or individually referred to as a &#147;Party&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS,
Executive is employed by the Company as its Chief Executive Officer; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Executive signed an offer letter with the Company on
July&nbsp;14, 2016 (the &#147;Offer Letter&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Executive signed an <FONT STYLE="white-space:nowrap">At-Will</FONT>
Employment, Confidential Information, Invention Assignment, and Arbitration Agreement with the Company on July&nbsp;20, 2016 (the &#147;Confidentiality Agreement&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company granted Executive certain (i)&nbsp;stock options to purchase Company common stock (&#147;Options&#148;), and
(ii)&nbsp;time-based and performance-based restricted stock units covering Company common stock (&#147;RSUs&#148;) (collectively, Employee&#146;s Options and RSUs are referred to as &#147;Equity Awards&#148;) that entitle Executive to purchase or to
receive shares of the Company&#146;s common stock subject to the terms and conditions of the Company&#146;s equity incentive plans (the &#147;Stock Plans&#148;) and the respective stock option and/or RSUs agreements (collectively, the &#147;Equity
Agreements&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Executive signed an Indemnification Agreement with the Company dated August&nbsp;1, 2016 (the
&#147;Indemnification Agreement&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Executive signed an Amended and Restated Employment and Severance Agreement effective
August&nbsp;1, 2016 (the &#147;Severance Agreement&#148;), which was subsequently superseded in full by the Company&#146;s 2020 Change of Control and Severance Plan (the &#147;Severance Plan&#148;) and Executive&#146;s Participation Agreement
thereunder; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties agree that Executive&#146;s employment with the Company will terminate as of the earliest to occur of
(i)&nbsp;immediately prior to the Closing Date of the sale of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock to Casdin Private Growth Equity Fund II, L.P., a Delaware limited partnership and Casdin Partners Master Fund, L.P., a
Cayman Islands exempted limited partnership (collectively, the &#147;<B>Purchaser</B>&#148;), pursuant to that certain Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock Purchase Agreement by and between the Company and
the Purchaser (the &#147;<B>Purchase Agreement</B>&#148;, with the transactions contemplated therein, the &#147;<B>Purchase</B>&#148;), (ii) May&nbsp;15, 2022 and (iii)&nbsp;such earlier date as the Parties mutually agree to terminate the employment
relationship (the earliest date under clause (i), (ii), or (iii)&nbsp;shall be referred to as the &#147;Separation Date&#148;), and that the execution of this Transition Agreement and his termination of employment with the Company on the Separation
Date constitute a triggering event entitling Executive to the benefits set forth in the Severance Plan and the Executive&#146;s Participation Agreement thereunder; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties desire to continue Executive&#146;s employment with the Company until the Separation Date in accordance with the terms
hereof; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties wish to resolve certain disputes, claims, complaints, grievances, charges, actions, petitions, and
demands that the Executive may have against the Company and any of the Releasees as defined below, including, but not limited to, certain claims arising out of or in any way related to Executive&#146;s employment with or separation from the Company.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the mutual promises made herein, the Company and Executive hereby agree as follows: </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COVENANTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Consideration</U>. In consideration of Executive&#146;s execution of this Transition Agreement and Executive&#146;s fulfillment of all
of its terms and conditions, the Company agrees as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. <I>Continued Employment; Service on the Board of Directors</I>. The
Company agrees that beginning on the Transition Agreement Effective Date, the Company will continue to employ Executive as an <FONT STYLE="white-space:nowrap">at-will</FONT> employee until the Separation Date or, if earlier, the date
Executive&#146;s employment with the Company terminates (such period the &#147;Transition Period&#148;). Executive agrees that during the Transition Period, Executive will continue to serve in the role of President and Chief Executive Officer of the
Company and carry out all duties and responsibilities associated with that role and any other duties and responsibilities reasonably assigned to him by the Company&#146;s Board of Directors (the &#147;Board&#148;), including transitioning
Executive&#146;s duties and responsibilities to a new chief executive officer and assisting the Company as reasonably needed to close the Purchase. Executive will perform the requested transition and other services in good faith and to the best of
Executive&#146;s abilities. During the Transition Period, Executive will continue to receive Executive&#146;s regular base salary as of the Transition Agreement Effective Date, be eligible to receive a bonus under the Company&#146;s 2021 bonus plan
on the same terms as in effect as of the Transition Agreement Effective Date, be eligible to participate in then-available Company benefit plans at the same level as Executive would have been eligible to participate in such plans immediately prior
to the start of the Transition Period, subject to the terms and conditions, including eligibility requirements, of such plans, and vest in the Equity Awards, subject to the terms and conditions of the Equity Agreements. In addition, Executive will
continue to serve on the Company&#146;s Board of Directors during the Transition Period and at the end of the Transition Period, Executive hereby resigns from the Company&#146;s Board of Directors (and the boards of directors of all of the
Company&#146;s subsidiaries) and any positions Executive occupied with the Company or any subsidiary or affiliate of the Company immediately prior to the end of the Transition Period.&nbsp;Executive acknowledges that his resignation from the
Company&#146;s Board of Directors is not because of any disagreement with the Company on any matter relating to the Company&#146;s operations, policies or practices.&nbsp;Executive also agrees to execute any necessary documents or other forms
necessary to effectuate or document his resignation as a matter of local, state, federal, or international law. Executive will not participate in the Company&#146;s 2022 bonus plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <I>Legal Fees</I>. The Company will reimburse Executive&#146;s reasonable attorneys&#146; fees incurred in connection with the review and
negotiation of this Transition Agreement and its enclosed exhibits, up to a maximum of Fifty Thousand Dollars ($50,000). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Separation
Agreement and Release</U>. Within ten (10)&nbsp;days following the Separation Date (and no earlier than the Separation Date), in exchange for Executive&#146;s execution and <FONT STYLE="white-space:nowrap">non-revocation</FONT> of the Separation
Agreement and Release herein and attached hereto as <U>Exhibit A</U> (the &#147;Separation Agreement&#148;) within the timeframe set forth therein, the Company agrees to provide Executive with the consideration set forth in the Separation Agreement.
Executive acknowledges that, but for his signing of the Separation Agreement, Executive is otherwise not entitled to the consideration set forth in the Separation Agreement or any other post-employment benefits, except as set forth under the
Severance Plan and the Executive&#146;s Participation Agreement thereunder. The Company may modify the Separation Agreement to comply with any new laws that become applicable prior to the end of the Transition Period and to insert applicable dates
and other information as may be needed. Executive acknowledges that his execution of the Separation Agreement is not a condition of employment or continued employment. For the avoidance of doubt in the event a Change of Control (as such term is
defined in the Severance Plan) of the Company occurs within the Change of Control Period (as such term is defined in the Severance Plan), such that Executive would otherwise become entitled to receive the payments and benefits pursuant to
Section&nbsp;5 of the Severance Plan, Executive shall automatically become entitled to receive the payments and benefits set forth in Section&nbsp;5 of the Severance Plan (and the Executive&#146;s Participation Agreement thereunder) in lieu of the
payments and benefits set forth in the Separation Agreement; provided, however, that Executive&#146;s entitlement to any such benefits in Section&nbsp;5 of the Severance Plan (and the Executive&#146;s Participation Agreement thereunder) will
terminate once the Change of Control Period expires. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Release of Claims</U>. In exchange for the consideration provided under this
Transition Agreement, Executive (on Executive&#146;s own behalf and on behalf of Executive&#146;s respective heirs, family members, executors, agents, and assigns) agrees to release, with the exception of any rights or claims Executive may have
under the California Fair Employment and Housing Act (the &#147;FEHA&#148;), any and all claims Executive may have against the Company and its current and former officers, directors, employees, agents, investors, attorneys, shareholders,
administrators, affiliates, benefit plans, plan administrators, professional employer organization or <FONT STYLE="white-space:nowrap">co-employer,</FONT><B> </B>insurers, trustees, divisions, parents, subsidiaries, predecessor and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
successor corporations, and assigns (collectively the &#147;Releasees&#148;) as of the date Executive signs this Transition Agreement, including, but not limited to, the following:
(a)&nbsp;claims arising under the federal or any state constitution; (b)&nbsp;claims for breach of contract, breach of public policy, physical or mental harm or distress; (c)&nbsp;any claim for attorneys&#146; fees and costs, except as set forth
herein; (d)&nbsp;any and all claims relating to, or arising from, Executive&#146;s right to purchase, or actual purchase of shares of stock of the Company other than pursuant to the Equity Agreements in accordance with the terms in effect as of the
date this Transition Agreement is executed; and (e)&nbsp;any and all other claims arising from Executive&#146;s employment relationship with the Company or the termination of that relationship. Executive agrees that, with respect to the claims
released herein, Executive will not file any legal action asserting any such claims. Executive agrees that the release set forth in this section shall be and remain in effect in all respects as a complete general release as to the matters released.
This release does not extend to: (i)&nbsp;claims with respect to benefits pursuant to the Severance Plan and the Executive&#146;s Participation Agreement thereunder, to the extent not paid pursuant to this Transition Agreement, (ii)&nbsp;any
obligations incurred or rights preserved under this Transition Agreement; (iii)&nbsp;any rights to indemnification as a result of Executive&#146;s service as an officer or director of the Company, including any such rights under the Indemnification
Agreement or (iv)&nbsp;claims that cannot be released as a matter of law (including FEHA claims). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>California Civil Code
Section</U><U></U><U>&nbsp;1542</U>. Executive acknowledges that Executive has been advised to consult with legal counsel and that Executive is familiar with the provisions of California Civil Code Section&nbsp;1542, a statute that otherwise
prohibits the release of unknown claims, which provides as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR
RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive, being aware of said code section, agrees to expressly waive any rights Executive may have thereunder with respect only to the claims released
herein, as well as under any other statute or common law principles of similar effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Trade Secrets and Confidential
Information/Company Property; Insider Trading Policy</U>. Executive acknowledges that the Confidentiality Agreement remains in effect and agrees to continue complying with the terms thereof during the Transition Period, provided, however, that the
Company will not enforce Section&nbsp;8 (&#147;Solicitation of Employees&#148;). Executive acknowledges and agrees to continue to abide by the terms and conditions of the Company&#146;s Insider Trading Policy in accordance with its terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Protected Activity Not Prohibited</U>. Executive understands that nothing in this Transition Agreement shall in any way limit or
prohibit Executive from engaging in any Protected Activity. Protected Activity includes: (i)&nbsp;filing and/or pursuing a charge, complaint, or report with, or otherwise communicating, cooperating, or participating in any investigation or
proceeding that may be conducted by any federal, state or local government agency or commission, including the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, and
the National Labor Relations Board (&#147;Government Agencies&#148;); and/or (ii)&nbsp;disclosing information pertaining to sexual harassment or any other unlawful or potentially unlawful conduct in the workplace, to the extent protected by
applicable law. Executive understands that in connection with such Protected Activity, Executive is permitted to disclose documents or other information as permitted by law, without giving notice to, or receiving authorization from, the Company.
Executive further understands that &#147;Protected Activity&#148; does not include the disclosure of any Company attorney-client privileged communications or attorney work product. Any language in the Confidentiality Agreement regarding
Executive&#146;s right to engage in Protected Activity that conflicts with, or is contrary to, this section is superseded by this Transition Agreement. In addition, pursuant to the Defend Trade Secrets Act of 2016, Executive is notified that an
individual will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i)&nbsp;is made in confidence to a federal, state, or local government official (directly or indirectly)
or to an attorney <I>solely</I> for the purpose of reporting or investigating a suspected violation of law, or (ii)&nbsp;is made in a complaint or other document filed in a lawsuit or other proceeding, if (and only if) such filing is made under
seal. In addition, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the individual&#146;s attorney and use the trade secret information in the court
proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Governing Law and No Oral Modification</U>. This Transition Agreement shall be
governed by the laws of the State of California, without regard for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">choice-of-law</FONT></FONT> provisions. This Transition Agreement may only be amended in a writing signed by
Executive and an authorized member of the Company&#146;s Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Transition Agreement Effective Date</U>. Executive
understands that this Transition Agreement shall be null and void if not executed by Executive on or before January&nbsp;23, 2022.&nbsp;This Transition Agreement will become effective on the date it has been signed by both Parties (the
&#147;Transition Agreement Effective Date&#148;). In the event that Executive signs this Agreement and returns it to the Company in less than five (5)&nbsp;business days, Executive hereby acknowledges that Executive has knowingly and voluntarily
chosen to waive the time period allotted for considering this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Entire Agreement</U>. This Transition Agreement represents
the entire agreement and understanding between the Company and Executive concerning the subject matter hereof, and supersedes and replaces any and all prior agreements and understandings concerning the subject matter hereof, with the exception of
the Confidentiality Agreement (subject to Section&nbsp;5 above), the Severance Plan, and Executive&#146;s Participation Agreement under the Severance Plan, the Indemnification Agreement, and the Equity Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Severability and Counterparts</U>. In the event that any provision or any portion of any provision hereof or any surviving agreement
made a part hereof becomes or is declared by a court of competent jurisdiction or arbitrator to be illegal, unenforceable, or void, this Transition Agreement shall continue in full force and effect without said provision or portion of provision.
This Transition Agreement may be executed in counterparts and each counterpart shall be deemed an original and all of which counterparts taken together shall have the same force and effect as an original and shall constitute an effective, binding
agreement on the part of each of the undersigned.&nbsp;The counterparts of this Transition Agreement may be executed and delivered by facsimile, photo, email PDF, or other electronic transmission or signature. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Voluntary Execution of Transition Agreement</U>. Executive understands and agrees that he executed this Transition Agreement
voluntarily, without any duress or undue influence on the part or behalf of the Company or any third party, with the full intent of releasing his claims against the Company as set forth herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally blank; signature page follows</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have executed this Transition Agreement on the respective dates set forth
below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">CHRIS LINTHWAITE, an individual</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated: January&nbsp;21, 2022</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Chris Linthwaite</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Chris Linthwaite</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">FLUIDIGM CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated: January&nbsp;23, 2022</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Vikram Jog</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Vikram Jog</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Financial Officer</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I><U>EXHIBIT A TO TRANSITION AGREEMENT </U></I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SEPARATION AGREEMENT AND RELEASE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Separation Agreement and Release (&#147;Agreement&#148;) is made by and between Chris Linthwaite (&#147;Executive&#148;) and Fluidigm
Corporation (the &#147;Company&#148;) (collectively referred to as the &#147;Parties&#148; or individually referred to as a &#147;Party&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS,
Executive was employed as the Company&#146;s Chief Executive Officer; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Executive signed an offer letter with the Company on
July&nbsp;14, 2016 (the &#147;Offer Letter&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Executive signed an <FONT STYLE="white-space:nowrap">At-Will</FONT>
Employment, Confidential Information, Invention Assignment, and Arbitration Agreement with the Company on July&nbsp;20, 2016 (the &#147;Confidentiality Agreement&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Executive signed an Amended and Restated Employment and Severance Agreement effective August&nbsp;1, 2016 (the &#147;Severance
Agreement&#148;), which was subsequently superseded in full by the Company&#146;s 2020 Change of Control and Severance Plan (the &#147;Severance Plan&#148;) and Executive&#146;s Participation Agreement thereunder; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Executive signed an Indemnification Agreement with the Company dated August&nbsp;1, 2016 (the &#147;Indemnification Agreement&#148;);
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company granted Executive certain (i)&nbsp;stock options to purchase Company common stock (&#147;Options&#148;), and
(ii)&nbsp;time-based and performance-based restricted stock units covering Company common stock (&#147;RSUs&#148;) (collectively, Employee&#146;s Options and RSUs are referred to as &#147;Equity Awards&#148;) that entitle Executive to purchase or to
receive shares of the Company&#146;s common stock subject to the terms and conditions of the Company&#146;s equity incentive plans (the &#147;Stock Plans&#148;) and the respective stock option and/or RSUs agreements (collectively, the &#147;Equity
Agreements&#148;) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Executive separated from employment with the Company effective
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U></U>, 2022 (the &#147;Separation Date&#148;); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties wish to resolve any and all disputes, claims, complaints, grievances, charges, actions, petitions, and demands that the
Executive may have against the Company and any of the Releasees as defined below, including, but not limited to, any and all claims arising out of or in any way related to Executive&#146;s employment with or separation from the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the mutual promises made herein, the Company and Executive hereby agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COVENANTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.
<U>Consideration</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. <I>Separation Payments</I>. The Company shall pay Executive a total of one million one hundred ninety thousand
Dollars ($1,190,000), less applicable withholdings, in equal installments over the course of twenty-four (24)&nbsp;months beginning as of the Company&#146;s first regular payroll date following the Separation Date in accordance with the
Company&#146;s regular payroll practices. The first such payment will include payment for the period from the Separation Date through the first payment date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <I>Consulting Agreement</I>. Commencing on the Separation Date and continuing through November&nbsp;30, 2022 (the &#147;Consulting
Period&#148;), Executive agrees to provide consulting services to the Company pursuant to the terms of the Consulting Agreement attached hereto as <U>Exhibit 1</U> (the &#147;Consulting Agreement&#148;). During the Consulting Period, Executive
agrees to reasonably assist the Company in connection with the transitioning of Executive&#146;s duties, and to provide </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such other services as are set forth in the Consulting Agreement. Nothing in this Agreement or the Consulting Agreement pertaining to Executive&#146;s subsequent role as a Consultant shall in any
way be construed to constitute Executive continuing as an agent, employee, officer, or representative of the Company. Executive shall perform the services under the Consulting Agreement solely as an independent contractor. During the Consulting
Period, Executive shall receive only that compensation set forth in Schedule A to <U>Exhibit 1</U> for his consulting services. All other aspects of the consulting arrangement shall be governed by the terms of <U>Exhibit 1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. <I>2022 Performance Share Unit Vesting</I>. In March 2020, the Company granted Executive restricted stock unit awards (the &#147;2022
PSUs&#148;) that have two vesting components that must be met before the award vests, (i)&nbsp;a relative TSR performance component, with a performance period ending December&nbsp;31, 2022, and (ii)&nbsp;a time-based vesting component. The Company
shall amend the 2022 PSUs to remove the time-based vesting component, such that, notwithstanding the termination of Executive&#146;s service to the Company on the Separation Date, the 2022 PSUs will remain outstanding and eligible to vest to the
extent of achievement of the performance component alone. Except as provided in this paragraph, the terms and conditions of the Equity Agreements governing the 2022 PSUs shall remain in full force and effect, including settlement and payment terms.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. <I>Split Dollar Life insurance</I>. The Company shall assign to Executive and reimburse Executive for payment of premiums paid by
Executive to maintain the life insurance policy insuring Executive&#146;s life (as referenced in the Endorsement Split-Dollar Life Insurance Agreement, dated as of September&nbsp;9, 2017 with the Company) for thirty (30)&nbsp;months following
Executive&#146;s Separation Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. <I>Outplacement Services</I>. The Company shall provide reasonable outplacement services in
accordance with any applicable Company policy in effect as of the Separation Date (or if no such policy is in effect, as determined by the Company, in its sole discretion). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">f. <I>COBRA</I>. The Company shall reimburse Executive for the payments Executive makes for COBRA coverage for a period of twelve
(12)&nbsp;months following the Separation Date, or until Executive has secured health insurance coverage through another employer, whichever occurs first, provided Executive timely elects and pays for continuation coverage pursuant to the
Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#147;COBRA&#148;), within the time period prescribed pursuant to COBRA. COBRA reimbursements shall be made by the Company to Executive consistent with the Company&#146;s normal
expense reimbursement policy, provided that Executive submits documentation to the Company substantiating Executive&#146;s payments for COBRA coverage. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">g. <I>T</I><I>ransaction Bonus</I>. Within fifteen (15)&nbsp;days following the closing date of the Purchase, the Company shall pay to
Executive a lump sum cash transaction bonus in the amount of Two Hundred Thousand Dollars $200,000 (the &#147;Transaction Bonus&#148;), provided Executive remains employed by the Company through the earlier of (i)&nbsp;the Closing Date of the
Purchase and (ii)&nbsp;May&nbsp;15, 2022. In the event the Purchase does not close, Executive shall not be eligible to receive a bonus pursuant to this Section&nbsp;1.g. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">h. <I>Supplemental Release Agreement</I>. Executive agrees to execute, within <FONT STYLE="white-space:nowrap">twenty-one</FONT>
(21)&nbsp;days after the termination of the consulting relationship, the Supplemental Release Agreement attached hereto as <U>Exhibit 2</U> in exchange for the consideration set forth in such Supplemental Release Agreement, which agreement will
serve to cover the time period from the Effective Date of this Agreement through the Supplemental Release Effective Date; provided, however, that the Parties agree to modify the Supplemental Release to comply with any new laws that become applicable
prior to the end of the Consulting Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">i. <I>No Further Severance</I>. Except as explicitly set forth in this Agreement and the
Supplemental Release Agreement, Executive acknowledges and agrees that he is not entitled to receive any severance compensation or benefits from the Company, including, but not limited to, under the Severance Plan. Executive hereby waives his right
to receive any such severance not explicitly set forth in this Agreement and acknowledges that without this Agreement, he is not otherwise entitled to the consideration listed in this Section&nbsp;1. Notwithstanding the foregoing, in the event a
Change of Control (as such term is defined in the Severance Plan) of the Company occurs within the Change of Control Period (as such term is defined in the Severance Plan) beginning on Executive&#146;s Separation Date, such that Executive would
otherwise become entitled to receive the payments and benefits pursuant to Section&nbsp;5 of the Severance Plan, Executive shall </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-7- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
automatically become entitled to receive the payments and benefits set forth in Section&nbsp;5 of the Severance Plan (and the Executive&#146;s Participation Agreement thereunder) in lieu of the
payments and benefits set forth in this Section&nbsp;1; provided, however, that, to avoid duplication of benefits provided to Executive, any payments and benefits to which Executive becomes entitled pursuant to this sentence or the accelerated
vesting provision of Section&nbsp;5 below will be reduced by any payments and benefits that were received by Executive pursuant to Section&nbsp;1 hereof prior to the date of such Change of Control . For the avoidance of doubt, that in the event that
a Change of Control has not occurred by the end of the three (3)-month period following the Separation Date, Executive&#146;s eligibility for any payments and benefits under Section&nbsp;5 of the Severance Plan will terminate immediately as of such
time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Termination</U>. Effective as of the Separation Date, Executive&#146;s employment with the Company is terminated, and
Executive resigned from the Company&#146;s Board of Directors (and the boards of directors of all of the Company&#146;s subsidiaries) and any positions Executive occupied with the Company or any subsidiary or affiliate of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Stock</U>. The Parties agree that Executive will continue vesting in Executive&#146;s Equity Awards on and following the Separation Date
and through the end of the Consulting Period, so long as Executive is available to provide services to the Company during the Consulting Period. In the event the Company terminates the Consulting Period prior to November&nbsp;30, 2022,
Executive&#146;s Equity Awards that vest solely based on Executive&#146;s continued service shall vest on an accelerated basis as if Executive had provided services through November&nbsp;30, 2022. At the end of the Consulting Period, Executive
further acknowledges that he may exercise any outstanding vested Options at any time within his applicable post-termination exercise period for each Option which is set forth in the Equity Agreements, which period shall run from the last day of the
Consulting Period. If Executive does not exercise any vested Options after the end of the applicable post-termination exercise period, then any such unexercised Options will terminate. Except with respect to the 2022 PSUs, any Equity Awards that are
not vested on the date that Executive ceases to be a service provider to the Company will terminate on such date without any payment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.
<U>Benefits</U>. Executive&#146;s health insurance benefits shall cease on the last day of the month in which the Separation Date occurs, subject to Executive&#146;s right to continue Executive&#146;s health insurance under COBRA. Executive&#146;s
participation in all benefits and incidents of employment, including, but not limited to, vesting in stock options, and the accrual of bonuses, vacation, and paid time off, ceased as of the Separation Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Payment of Salary and Receipt of All Benefits</U>. Executive acknowledges and represents that, other than the consideration set forth in
this Agreement, the Company has paid or provided all salary, wages, bonuses, accrued vacation/paid time off, premiums, leaves, housing allowances, relocation costs, interest, severance, outplacement costs, fees, reimbursable expenses, commissions,
stock, stock options, equity awards, vesting, and any and all other benefits and compensation due to Executive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Release of
Claims</U>. Executive agrees that the foregoing consideration represents settlement in full of all outstanding obligations owed to Executive by the Company and its current and former officers, directors, employees, agents, investors, attorneys,
shareholders, administrators, affiliates, benefit plans, plan administrators, professional employer organization or <FONT STYLE="white-space:nowrap">co-employer,</FONT><B> </B>insurers, trustees, divisions, subsidiaries, predecessor and successor
corporations, and assigns (collectively, the &#147;Releasees&#148;). Executive, on Executive&#146;s own behalf and on behalf of Executive&#146;s respective heirs, family members, executors, agents, and assigns, hereby and forever releases the
Releasees from, and agrees not to sue concerning, or in any manner to institute, prosecute, or pursue, any claim, complaint, charge, duty, obligation, demand, or cause of action relating to any matters of any kind, whether presently known or
unknown, suspected or unsuspected, that Executive may possess against any of the Releasees arising from any omissions, acts, facts, or damages that have occurred up until and including the Effective Date of this Agreement, including, without
limitation: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. any and all claims relating to or arising from Executive&#146;s employment relationship with the Company and the
termination of that relationship; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. any and all claims relating to, or arising from, Executive&#146;s right to purchase, or actual
purchase of shares of stock of the Company, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law;
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-8- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. any and all claims for wrongful discharge of employment, termination in violation of
public policy, discrimination, harassment, retaliation, breach of contract (both express and implied), breach of covenant of good faith and fair dealing (both express and implied), promissory estoppel, negligent or intentional infliction of
emotional distress, fraud, negligent or intentional misrepresentation, negligent or intentional interference with contract or prospective economic advantage, unfair business practices, defamation, libel, slander, negligence, personal injury,
assault, battery, invasion of privacy, false imprisonment, conversion, and disability benefits; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. any and all claims for violation of
any federal, state, or municipal statute, including, but not limited to, Title&nbsp;VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Rehabilitation Act of 1973, the Americans with Disabilities Act of 1990, the Equal Pay Act,
the Fair Labor Standards Act, the Fair Credit Reporting Act, the Age Discrimination in Employment Act of 1967, the Older Workers Benefit Protection Act, the Employee Retirement Income Security Act of 1974, the Worker Adjustment and Retraining
Notification Act, the Family and Medical Leave Act, the Immigration Reform and Control Act, the National Labor Relations Act, the California Family Rights Act, the California Labor Code, the California Workers&#146; Compensation Act, and the
California Fair Employment and Housing Act; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. any and all claims for violation of the federal or any state constitution; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">f. any and all claims arising out of any other laws and regulations relating to employment or employment discrimination; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">g. any claim for any loss, cost, damage, or expense arising out of any dispute over the nonwithholding or other tax treatment of any of the
proceeds received by Executive as a result of this Agreement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">h. any and all claims for attorneys&#146; fees and costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive agrees that the release set forth in this section shall be and remain in effect in all respects as a complete general release as to the matters
released. This release does not extend to any obligations incurred under this Agreement. This release does not release (i)&nbsp;claims that cannot be released as a matter of law (ii)&nbsp;any obligations incurred or rights preserved under this
Agreement; or (iii)&nbsp;any rights to indemnification as a result of Executive&#146;s service as an officer or director of the Company, including any such rights under the Indemnification Agreement. This release does not extend to any right
Executive may have to unemployment compensation benefits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Acknowledgment of Waiver of Claims under ADEA</U>. Executive acknowledges
that Executive is waiving and releasing any rights Executive may have under the Age Discrimination in Employment Act of 1967 (&#147;ADEA&#148;), and that this waiver and release is knowing and voluntary. Executive agrees that this waiver and release
does not apply to any rights or claims that may arise under the ADEA after the date Executive signs this Agreement. Executive acknowledges that the consideration given for this waiver and release is in addition to anything of value to which
Executive was already entitled. Executive further acknowledges that Executive has been advised by this writing that: (a)&nbsp;Executive should consult with an attorney <U>prior</U> to executing this Agreement; (b)&nbsp;Executive has had more than <FONT
STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;days from the date Executive first received a copy of this Agreement within which to consider this Agreement; (c)&nbsp;Executive has seven (7)&nbsp;days following Executive&#146;s execution of
this Agreement to revoke this Agreement; (d)&nbsp;this Agreement shall not be effective until after the revocation period has expired; and (e)&nbsp;nothing in this Agreement prevents or precludes Executive from challenging or seeking a determination
in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties, or costs for doing so, unless specifically authorized by federal law. In the event Executive signs this Agreement and returns it to
the Company in less than the <FONT STYLE="white-space:nowrap">21-day</FONT> period identified above, Executive hereby acknowledges that Executive has knowingly and voluntarily chosen to waive the time period allotted for considering this Agreement.
Executive acknowledges and understands that revocation must be accomplished by a written notification to the person executing this Agreement on the Company&#146;s behalf that is received prior to the Effective Date. The Parties agree that changes,
whether material or immaterial, do not restart the running of the <FONT STYLE="white-space:nowrap">21-day</FONT> period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>California
Civil Code Section</U><U></U><U>&nbsp;1542</U>. Executive acknowledges that Executive has been advised to consult with legal counsel and is familiar with the provisions of California Civil Code Section&nbsp;1542, a statute that otherwise prohibits
the release of unknown claims, which provides as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-9- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT
KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive, being aware of said code section, agrees to expressly waive any rights Executive may have thereunder, as well as under any other statute or common
law principles of similar effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>No Pending or Future Lawsuits</U>. Executive represents that Executive has no lawsuits, claims,
or actions pending in Executive&#146;s name, or on behalf of any other person or entity, against the Company or any of the other Releasees. Executive also represents that Executive does not intend to bring any claims on Executive&#146;s own behalf
or on behalf of any other person or entity against the Company or any of the other Releasees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Trade Secrets and Confidential
Information/Company Property</U>. Executive acknowledges that, separate from this Agreement, Executive remains under continuing obligations to the Company under the Confidentiality Agreement, including the provisions therein regarding nondisclosure
of the Company&#146;s trade secrets and confidential and proprietary information. Executive acknowledges that the Company will not enforce Section&nbsp;8 (&#147;Solicitation of Employees&#148;) of the Confidentiality Agreement; provided, however,
that Executive remains bound by all other continuing obligations under the Confidentiality Agreement, including Executive&#146;s confidentiality obligations thereof. Executive&#146;s signature below constitutes Executive&#146;s certification under
penalty of perjury that Executive has returned all documents and other items provided to Executive by the Company (with the exception of a copy of the Employee Handbook and personnel documents specifically relating to Executive), developed or
obtained by Executive in connection with Executive&#146;s employment with the Company, or otherwise belonging to the Company; provided that Executive may retain any such documents or items that may be needed in order to perform the services under
the Consulting Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>No Cooperation</U>. Subject to the Protected Activity provision, Executive agrees that Executive will
not knowingly encourage, counsel, or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against any of the Releasees, unless under a
subpoena or other court order to do so or upon written request from an administrative agency or the legislature or as related directly to the ADEA waiver in this Agreement. Executive agrees both to immediately notify the Company upon receipt of any
such subpoena or court order or written request from an administrative agency or the legislature, and to furnish, within three (3)&nbsp;business days of its receipt, a copy of such subpoena or other court order or written request from an
administrative agency or the legislature. If approached by anyone for counsel or assistance in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints against any of the Releasees, Executive shall
state no more than that Executive cannot provide counsel or assistance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Protected Activity Not Prohibited</U>. Executive
understands that nothing in this Agreement shall in any way limit or prohibit Executive from engaging in any Protected Activity. Protected Activity includes: (i)&nbsp;filing and/or pursuing a charge, complaint, or report with, or otherwise
communicating, cooperating, or participating in any investigation or proceeding that may be conducted by any federal, state or local government agency or commission, including the Securities and Exchange Commission, the Equal Employment Opportunity
Commission, the Occupational Safety and Health Administration, and the National Labor Relations Board (&#147;Government Agencies&#148;); and/or (ii)&nbsp;discussing or disclosing information about unlawful acts in the workplace, such as harassment
or discrimination or any other conduct that Employee has reason to believe is unlawful. Executive understands that in connection with such Protected Activity under prong (i)&nbsp;of this section, Executive is permitted to disclose documents or other
information as permitted by law, without giving notice to, or receiving authorization from, the Company. Notwithstanding the foregoing, Executive agrees to take all reasonable precautions to prevent any unauthorized use or disclosure of any
information that may constitute Company trade secrets, proprietary information or confidential information that does not involve unlawful acts in the workplace or the activity otherwise protected herein. to any parties other than the Government
Agencies. Executive further understands that &#147;Protected Activity&#148; does not include the disclosure of any Company attorney-client privileged communications or attorney work product. Any language in the Confidentiality Agreement regarding
Executive&#146;s right to engage in Protected Activity that conflicts with, or is contrary to, this section is superseded by this Agreement. In addition, pursuant to the Defend Trade </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-10- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Secrets Act of 2016, Executive is notified that an individual will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that
(i)&nbsp;is made in confidence to a federal, state, or local government official (directly or indirectly) or to an attorney <I>solely</I> for the purpose of reporting or investigating a suspected violation of law, or (ii)&nbsp;is made in a complaint
or other document filed in a lawsuit or other proceeding, if (and only if) such filing is made under seal. In addition, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the
trade secret to the individual&#146;s attorney and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court
order. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Mutual Nondisparagement</U>. Subject to the Protected Activity provision, Executive agrees to refrain from any
disparagement, defamation, libel, or slander of any of the Releasees, and agrees to refrain from any tortious interference with the contracts and relationships of the Company. The Company agrees to instruct its officers and directors to refrain from
any disparagement, defamation, libel, or slander of Executive and to refrain from any tortious interference with the contracts and relationships of Executive for so long as they remain officers or directors of the Company. The Company and Executive
agree to use reasonable good faith efforts to reach a mutual agreement on a statement that can be provided to prospective employers and other third parties relating to Executive&#146;s separation from the Company. Executive acknowledges that the
Company will reference Executive&#146;s separation in press release(s) and any required corporate filings and disclosures. The Company shall consult with Executive on a statement addressing Executive&#146;s separation of employment in such press
release(s). Nothing herein shall restrict the parties from speaking truthfully in a legal proceeding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Breach</U>. In addition to
the rights provided in the &#147;Attorneys&#146; Fees&#148; section below, Executive acknowledges and agrees that any material breach of this Agreement as determined by a court or arbitrator of competent jurisdiction, unless such breach constitutes
a legal action by Executive challenging or seeking a determination in good faith of the validity of the waiver herein under the ADEA, or of any provision of the Confidentiality Agreement (except Section&nbsp;8 of the Confidentiality Agreement) shall
entitle the Company immediately to recover and/or cease providing the consideration provided to Executive under this Agreement and to obtain damages, except as provided by law, provided, however, that the Company shall not recover One Hundred
Dollars ($100.00) of the consideration already paid pursuant to this Agreement and such amount shall serve as full and complete consideration for the promises and obligations assumed by Executive under this Agreement and the Confidentiality
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>No Admission of Liability</U>. Executive understands and acknowledges that with respect to all claims released herein,
this Agreement constitutes a compromise and settlement of any and all actual or potential disputed claims by Executive unless such claims were explicitly not released by the release in this Agreement. No action taken by the Company hereto, either
previously or in connection with this Agreement, shall be deemed or construed to be (a)&nbsp;an admission of the truth or falsity of any actual or potential claims or (b)&nbsp;an acknowledgment or admission by the Company of any fault or liability
whatsoever to Executive or to any third party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Costs</U>. The Parties shall each bear their own costs, attorneys&#146; fees, and
other fees incurred in connection with the preparation of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>ARBITRATION</U>. EXCEPT AS PROHIBITED BY LAW, THE
PARTIES AGREE THAT ANY AND ALL DISPUTES ARISING OUT OF THE TERMS OF THIS AGREEMENT, THEIR INTERPRETATION, EXECUTIVE&#146;S EMPLOYMENT WITH THE COMPANY OR THE TERMS THEREOF, OR ANY OF THE MATTERS HEREIN RELEASED, SHALL BE SUBJECT TO ARBITRATION UNDER
THE FEDERAL ARBITRATION ACT (THE &#147;FAA&#148;) AND THAT THE FAA SHALL GOVERN AND APPLY TO THIS ARBITRATION AGREEMENT WITH FULL FORCE AND EFFECT; HOWEVER, WITHOUT LIMITING ANY PROVISIONS OF THE FAA, A MOTION OR PETITION OR ACTION TO COMPEL
ARBITRATION MAY ALSO BE BROUGHT IN STATE COURT UNDER THE PROCEDURAL PROVISIONS OF SUCH STATE&#146;S LAWS RELATING TO MOTIONS OR PETITIONS OR ACTIONS TO COMPEL ARBITRATION. EXECUTIVE AGREES THAT, TO THE FULLEST EXTENT PERMITTED BY LAW, EXECUTIVE MAY
BRING ANY SUCH ARBITRATION PROCEEDING ONLY IN EXECUTIVE&#146;S INDIVIDUAL CAPACITY. ANY ARBITRATION WILL OCCUR IN SAN MATEO COUNTY, BEFORE JAMS, PURSUANT TO ITS EMPLOYMENT ARBITRATION RULES&nbsp;&amp; PROCEDURES (&#147;JAMS RULES&#148;), EXCEPT AS
EXPRESSLY PROVIDED IN THIS SECTION. THE PARTIES AGREE THAT THE ARBITRATOR SHALL HAVE THE POWER TO DECIDE ANY MOTIONS BROUGHT BY ANY PARTY TO THE ARBITRATION, INCLUDING MOTIONS FOR </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-11- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
SUMMARY JUDGMENT AND/OR ADJUDICATION, AND MOTIONS TO DISMISS AND DEMURRERS, APPLYING THE STANDARDS SET FORTH UNDER THE CALIFORNIA CODE OF CIVIL PROCEDURE. THE PARTIES AGREE THAT THE ARBITRATOR
SHALL ISSUE A WRITTEN DECISION ON THE MERITS. THE PARTIES ALSO AGREE THAT THE ARBITRATOR SHALL HAVE THE POWER TO AWARD ANY REMEDIES AVAILABLE UNDER APPLICABLE LAW, AND THAT THE ARBITRATOR MAY AWARD ATTORNEYS&#146; FEES AND COSTS TO THE PREVAILING
PARTY, WHERE PERMITTED BY APPLICABLE LAW. THE ARBITRATOR MAY GRANT INJUNCTIONS AND OTHER RELIEF IN SUCH DISPUTES. THE DECISION OF THE ARBITRATOR SHALL BE FINAL, CONCLUSIVE, AND BINDING ON THE PARTIES TO THE ARBITRATION. THE PARTIES AGREE THAT THE
PREVAILING PARTY IN ANY ARBITRATION SHALL BE ENTITLED TO INJUNCTIVE RELIEF IN ANY COURT OF COMPETENT JURISDICTION TO ENFORCE THE ARBITRATION AWARD. THE PARTIES TO THE ARBITRATION SHALL EACH PAY AN EQUAL SHARE OF THE COSTS AND EXPENSES OF SUCH
ARBITRATION, AND EACH PARTY SHALL SEPARATELY PAY FOR ITS RESPECTIVE COUNSEL FEES AND EXPENSES; PROVIDED, HOWEVER, THAT THE ARBITRATOR MAY AWARD ATTORNEYS&#146; FEES AND COSTS TO THE PREVAILING PARTY, EXCEPT AS PROHIBITED BY LAW. THE PARTIES HEREBY
AGREE TO WAIVE THEIR RIGHT TO HAVE ANY DISPUTE BETWEEN THEM RESOLVED IN A COURT OF LAW BY A JUDGE OR JURY. NOTWITHSTANDING THE FOREGOING, THIS SECTION WILL NOT PREVENT EITHER PARTY FROM SEEKING INJUNCTIVE RELIEF (OR ANY OTHER PROVISIONAL REMEDY)
FROM ANY COURT HAVING JURISDICTION OVER THE PARTIES AND THE SUBJECT MATTER OF THEIR DISPUTE RELATING TO THIS AGREEMENT AND THE AGREEMENTS INCORPORATED HEREIN BY REFERENCE. SHOULD ANY PART OF THE ARBITRATION AGREEMENT CONTAINED IN THIS SECTION
CONFLICT WITH ANY OTHER ARBITRATION AGREEMENT BETWEEN THE PARTIES, INCLUDING, BUT NOT LIMITED TO THE ARBITRATION SECTION OF THE CONFIDENTIALITY AGREEMENT, THE PARTIES AGREE THAT THIS ARBITRATION AGREEMENT IN THIS SECTION SHALL GOVERN. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <U>Tax Consequences</U>. The Company makes no representations or warranties with respect to the tax consequences of the payments and any
other consideration provided to Executive or made on Executive&#146;s behalf under the terms of this Agreement. Executive agrees and understands that Executive is responsible for payment, if any, of local, state, and/or federal taxes on the payments
and any other consideration provided hereunder by the Company and any penalties or assessments thereon. The Parties agree and acknowledge that the payments made pursuant to section 1 of this Agreement are not related to sexual harassment or sexual
abuse and not intended to fall within the scope of 26 U.S.C. Section&nbsp;162(q). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <U>Section 409A.</U> It is intended that this
Agreement comply with, or be exempt from, Code Section&nbsp;409A and the final regulations and official guidance thereunder (&#147;Section&nbsp;409A&#148;) and any ambiguities herein will be interpreted to so comply and/or be exempt from
Section&nbsp;409A. The Parties reasonably anticipate that any consulting services during the Consulting Period shall be at a level equal to twenty percent (20%) or less of the average level of services performed by Executive during the immediately
preceding <FONT STYLE="white-space:nowrap">thirty-six</FONT> (36)-month period and, accordingly, the Separation Date will be a &#147;separation from service&#148; within the meaning of Section&nbsp;409A (as defined below). Each payment and benefit
to be paid or provided under this Agreement is intended to constitute a series of separate payments for purposes of <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-2(b)(2)</FONT> of the Treasury Regulations. The Company and Executive will work
together in good faith to consider either (i)&nbsp;amendments to this Agreement; or (ii)&nbsp;revisions to this Agreement with respect to the payment of any awards, which are necessary or appropriate to avoid imposition of any additional tax or
income recognition prior to the actual payment to Executive under Section&nbsp;409A. In no event will the Releasees reimburse Executive for any taxes that may be imposed on Executive as a result of Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <U>Limitation on Payments</U>. In the event that the severance and other benefits provided for in this Agreement or otherwise (&#147;280G
Payments&#148;) payable to Executive (i)&nbsp;constitute &#147;parachute payments&#148; within the meaning of Section&nbsp;280G of the Code, and (ii)&nbsp;but for this Section&nbsp;20, would be subject to the excise tax imposed by Section&nbsp;4999
of the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), then the 280G Payments will be either: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delivered in full, or </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delivered as to such lesser extent as would result in no portion of such benefits being subject to excise tax
under Section&nbsp;4999 of the Code, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section&nbsp;4999, results in the receipt by the Executive on an <FONT
STYLE="white-space:nowrap">after-tax</FONT> basis, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-12- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the greatest amount of benefits, notwithstanding that all or some portion of such benefits may be taxable under Section&nbsp;4999. If a reduction in severance and other benefits constituting
&#147;parachute payments&#148; is necessary so that benefits are delivered to a lesser extent, reduction will occur in the following order: (a)&nbsp;cancellation of awards granted &#147;contingent on a change in ownership or control&#148; (within
the meaning of Code Section&nbsp;280G); (b) a pro rata reduction of (i)&nbsp;cash payments that are subject to Section&nbsp;409A as deferred compensation and (ii)&nbsp;cash payments not subject to Section&nbsp;409A; (c)&nbsp;a pro rata reduction of
(i)&nbsp;employee benefits that are subject to Section&nbsp;409A as deferred compensation and (ii)&nbsp;employee benefits not subject to Section&nbsp;409A; and (d)&nbsp;a pro rata cancellation of (i)&nbsp;accelerated vesting equity awards that are
subject to Section&nbsp;409A as deferred compensation and (ii)&nbsp;equity awards not subject to Section&nbsp;409A. In the event that acceleration of vesting of equity awards is to be cancelled, such acceleration of vesting will be cancelled in the
reverse order of the date of grant of the Executive&#146;s equity awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the Executive and the Company otherwise agree in
writing, any determination required under this Section&nbsp;20 will be made in writing by the Company&#146;s independent public accountants immediately prior to the change in ownership or control or such other person or entity to which the parties
mutually agree (the &#147;Firm&#148;), whose determination will be conclusive and binding upon the Executive and the Company. For purposes of making the calculations required by this Section&nbsp;20 the Firm may make reasonable assumptions and
approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Executive and the Company will furnish to the Firm such information and documents
as the Firm may reasonably request in order to make a determination under this Section&nbsp;20. The Company will bear all costs the Firm may incur in connection with any calculations contemplated by this Section&nbsp;20. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. <U>Authority</U>. The Company represents and warrants that the undersigned has the authority to act on behalf of the Company and to bind
the Company and all who may claim through it to the terms and conditions of this Agreement. Executive represents and warrants that Executive has the capacity to act on Executive&#146;s own behalf and on behalf of all who might claim through
Executive to bind them to the terms and conditions of this Agreement. Each Party warrants and represents that there are no liens or claims of lien or assignments in law or equity or otherwise of or against any of the claims or causes of action
released herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. <U>Severability</U>. In the event that any provision or any portion of any provision hereof or any surviving
agreement made a part hereof becomes or is declared by a court of competent jurisdiction or arbitrator to be illegal, unenforceable, or void, this Agreement shall continue in full force and effect without said provision or portion of provision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23. <U>Attorneys</U><U>&#146;</U><U> Fees</U>. Except with regard to a legal action challenging or seeking a determination in good faith of
the validity of the waiver herein under the ADEA, in the event that either Party brings an action to enforce or effect its rights under this Agreement, the prevailing Party shall be entitled to recover its costs and expenses, including the costs of
mediation, arbitration, litigation, court fees, and reasonable attorneys&#146; fees incurred in connection with such an action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24.
<U>Entire Agreement</U>. This Agreement represents the entire agreement and understanding between the Company and Executive concerning the subject matter of this Agreement and Executive&#146;s employment with and separation from the Company and the
events leading thereto and associated therewith, and supersedes and replaces any and all prior agreements and understandings concerning the subject matter of this Agreement and Executive&#146;s relationship with the Company, including the Offer
Letter, the Severance Agreement, the Severance Plan (except as preserved herein), and Executive&#146;s Participation Agreement under the Severance Plan (except as preserved herein), but with the exception of the Confidentiality Agreement, the
Indemnification Agreement, and the Equity Agreements, except as otherwise modified or superseded herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25. <U>No Oral Modification</U>.
This Agreement may only be amended in a writing signed by Executive and an authorized member of the Company&#146;s Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">26. <U>Governing Law</U>. This Agreement shall be governed by the laws of the State of California, without regard for <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">choice-of-law</FONT></FONT> provisions, except that any dispute regarding the enforceability of the arbitration section of this Agreement shall be governed by the FAA. Executive consents to
personal and exclusive jurisdiction and venue in the State of California. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-13- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">27. <U>Effective Date</U>. Executive understands that this Agreement shall be null and void
if not executed by Executive within ten (10)&nbsp;days following the Separation Date. Executive further understands that Executive may not execute this Agreement before the Separation Date. Each Party has seven (7)&nbsp;days after that Party signs
this Agreement to revoke it. This Agreement will become effective on the eighth (8th) day after Executive signed this Agreement, so long as it has been signed by the Parties and has not been revoked by either Party before that date (the
&#147;Effective Date&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">28. <U>Counterparts</U>. This Agreement may be executed in counterparts and each counterpart shall be deemed
an original and all of which counterparts taken together shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned.&nbsp;The counterparts of this Agreement may be
executed and delivered by facsimile, photo, email PDF, or other electronic transmission or signature. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29. <U>Voluntary Execution of
Agreement</U>. Executive understands and agrees that Executive executed this Agreement voluntarily and without any duress or undue influence on the part or behalf of the Company or any third party, with the full intent of releasing all of
Executive&#146;s claims against the Company and any of the other Releasees. Executive acknowledges that: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Executive has read this Agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Executive has a right to consult with an attorney regarding this Agreement, and has been represented in the
preparation, negotiation, and execution of this Agreement by an attorney of Executive&#146;s own choice; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Executive understands the terms and consequences of this Agreement and of the releases it contains;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Executive is fully aware of the legal and binding effect of this Agreement; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Executive has not relied upon any representations or statements made by the Company that are not specifically
set forth in this Agreement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally blank; signature page follows</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-14- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have executed this Agreement on the respective dates set forth below. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">CHRIS LINTHWAITE, an individual</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated: ________________, 2022</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Chris Linthwaite</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">FLUIDIGM CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated: ________________, 2022</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-15- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT 1 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FLUIDIGM CORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSULTING AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Consulting Agreement (this &#147;<B><I>Agreement</I></B>&#148;) is made and entered into as of
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U></U>, 2022 (the &#147;<B><I>Effective Date</I></B>&#148;) by and between Fluidigm Corporation (the
&#147;<B><I>Company</I></B>&#148;), and Chris Linthwaite (&#147;<B><I>Consultant</I></B>&#148;) (each herein referred to individually as a &#147;<B><I>Party</I></B>,&#148; or collectively as the &#147;<B><I>Parties</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company desires to retain Consultant as an independent contractor to perform consulting services for the Company that are outside the
usual course of the Company&#146;s business. Consultant is customarily engaged in an independently established trade, occupation, or business of the same nature of the services to be performed, and Consultant is willing to perform such services, on
the terms described below. In consideration of the mutual promises contained herein, the Parties agree as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <B>Services and
Compensation</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Consultant shall perform the services described in <B>Schedule A</B> (the &#147;<B><I>Services</I></B>&#148;) for the
Company (or its designee), and the Company agrees to pay Consultant the compensation described in <B>Schedule A</B> for Consultant&#146;s performance of the Services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <B>Confidentiality</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
<B><I>Definition of Confidential Information</I></B><B>.</B> &#147;<B><I>Confidential Information</I></B>&#148; means any information (including any and all combinations of individual items of information) that relates to the actual or anticipated
business and/or products, research or development of the Company, its affiliates or subsidiaries, or to the Company&#146;s, its affiliates&#146; or subsidiaries&#146; technical data, trade secrets, or
<FONT STYLE="white-space:nowrap">know-how,</FONT> including, but not limited to, research, product plans, or other information regarding the Company&#146;s, its affiliates&#146; or subsidiaries&#146; products or services and markets therefor,
customer lists and customers (including, but not limited to, customers of the Company on whom Consultant called or with whom Consultant became acquainted during the term of this Agreement), software, developments, inventions, discoveries, ideas,
processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances, and other business information disclosed by the Company, its affiliates or subsidiaries, either directly or indirectly, in
writing, orally or by drawings or inspection of premises, parts, equipment, or other property of Company, its affiliates or subsidiaries. Notwithstanding the foregoing, Confidential Information shall not include any such information which Consultant
can establish (i)&nbsp;was publicly known or made generally available prior to the time of disclosure to Consultant; (ii)&nbsp;becomes publicly known or made generally available after disclosure to Consultant through no wrongful action or inaction
of Consultant; or (iii)&nbsp;is in the rightful possession of Consultant, without confidentiality obligations, at the time of disclosure as shown by Consultant&#146;s then-contemporaneous written records; provided that any combination of individual
items of information shall not be deemed to be within any of the foregoing exceptions merely because one or more of the individual items are within such exception, unless the combination as a whole is within such exception. Nothing in this Agreement
is intended to deny workers the right to disclose information pertaining to sexual harassment or any unlawful or potentially unlawful conduct, as protected by applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <B><I>Nonuse and Nondisclosure</I></B><B>.</B> During and after the term of this Agreement, Consultant will hold in the strictest
confidence, and take all reasonable precautions to prevent any unauthorized use or disclosure of Confidential Information, and Consultant will not (i)&nbsp;use the Confidential Information for any purpose whatsoever other than as necessary for the
performance of the Services on behalf of the Company, or (ii)&nbsp;subject to Consultant&#146;s right to engage in Protected Activity (as defined below), disclose the Confidential Information to any third party without the prior written consent of
an authorized representative of the Company, except that Consultant may disclose Confidential Information to the extent compelled by applicable law; <I>provided however</I>, prior to such disclosure, Consultant shall provide prior written notice to
Company and seek a protective order or such similar confidential protection as may be available under applicable law. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Consultant agrees that no ownership of Confidential Information is conveyed to the Consultant. Without limiting the foregoing, Consultant shall not use or disclose any Company property,
intellectual property rights, trade secrets or other proprietary <FONT STYLE="white-space:nowrap">know-how</FONT> of the Company to invent, author, make, develop, design, or otherwise enable others to invent, author, make, develop, or design
identical or substantially similar designs as those developed under this Agreement for any third party. Consultant agrees that Consultant&#146;s obligations under this Section&nbsp;2(b) shall continue after the termination of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <B><I>Other Client Confidential Information</I></B><B>.</B> Consultant agrees that Consultant will not improperly use, disclose, or induce
the Company to use any proprietary information or trade secrets of any former or current employer of Consultant or other person or entity with which Consultant has an obligation to keep in confidence. Consultant also agrees that Consultant will not
bring onto the Company&#146;s premises or transfer onto the Company&#146;s technology systems any unpublished document, proprietary information, or trade secrets belonging to any third party unless disclosure to, and use by, the Company has been
consented to in writing by such third party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <B><I>Third Party Confidential Information</I></B><B>.</B> Consultant recognizes that
the Company has received and in the future will receive from third parties their confidential or proprietary information subject to a duty on the Company&#146;s part to maintain the confidentiality of such information and to use it only for certain
limited purposes. Consultant agrees that at all times during the term of this Agreement and thereafter, Consultant owes the Company and such third parties a duty to hold all such confidential or proprietary information in the strictest confidence
and not to use it or to disclose it to any person, firm, corporation, or other third party except as necessary in carrying out the Services for the Company consistent with the Company&#146;s agreement with such third party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <B>Ownership</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
<B><I>Assignment of Inventions</I></B><B>.</B> Consultant agrees that all right, title, and interest in and to any copyrightable material, notes, records, drawings, designs, inventions, improvements, developments, discoveries, ideas and trade
secrets conceived, discovered, authored, invented, developed or reduced to practice by Consultant, solely or in collaboration with others, during the term of this Agreement and arising out of, or in connection with, performing the Services under
this Agreement and any copyrights, patents, trade secrets, mask work rights or other intellectual property rights relating to the foregoing (collectively, &#147;<B><I>Inventions</I></B>&#148;), are the sole property of the Company. Consultant also
agrees to promptly make full written disclosure to the Company of any Inventions and to deliver and assign (or cause to be assigned) and hereby irrevocably assigns fully to the Company all right, title and interest in and to the Inventions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <B><I><FONT STYLE="white-space:nowrap">Pre-Existing</FONT> Material</I></B><B>s.</B> Subject to Section&nbsp;3(a), Consultant will provide
the Company with prior written notice if, in the course of performing the Services, Consultant incorporates into any Invention or utilizes in the performance of the Services any invention, discovery, idea, original works of authorship, development,
improvements, trade secret, concept, or other proprietary information or intellectual property right owned by Consultant or in which Consultant has an interest, prior to, or separate from, performing the Services under this Agreement
(&#147;<B><I>Prior Invention</I></B><I>s</I>&#148;), and the Company is hereby granted a nonexclusive, royalty-free, perpetual, irrevocable, transferable, worldwide license (with the right to grant and authorize sublicenses) to make, have made, use,
import, offer for sale, sell, reproduce, distribute, modify, adapt, prepare derivative works of, display, perform, and otherwise exploit such Prior Inventions, without restriction, including, without limitation, as part of or in connection with such
Invention, and to practice any method related thereto. Consultant will not incorporate any invention, discovery, idea, original works of authorship, development, improvements, trade secret, concept, or other proprietary information or intellectual
property right owned by any third party into any Invention without Company&#146;s prior written permission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <B><I>Moral
Rights</I></B><B>.</B> Any assignment to the Company of Inventions includes all rights of attribution, paternity, integrity, modification, disclosure and withdrawal, and any other rights throughout the world that may be known as or referred to as
&#147;moral rights,&#148; &#147;artist&#146;s rights,&#148; &#147;droit moral,&#148; or the like (collectively, &#147;<B><I>Moral Rights</I></B>&#148;). To the extent that Moral Rights cannot be assigned under applicable law, Consultant hereby
waives and agrees not to enforce any and all Moral Rights, including, without limitation, any limitation on subsequent modification, to the extent permitted under applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <B><I>Maintenance of Records</I></B><B>.</B> Consultant agrees to keep and maintain
adequate, current, accurate, and authentic written records of all Inventions made by Consultant (solely or jointly with others) during the term of this Agreement, and for a period of three (3)&nbsp;years thereafter. The records will be in the form
of notes, sketches, drawings, electronic files, reports, or any other format that is customary in the industry and/or otherwise specified by the Company. Such records are and remain the sole property of the Company at all times and upon
Company&#146;s request, Consultant shall deliver (or cause to be delivered) the same. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <B><I>Further Assurances</I></B><B>.</B>
Consultant agrees to assist Company, or its designee, at the Company&#146;s expense, in every proper way to secure the Company&#146;s rights in Inventions in any and all countries, including the disclosure to the Company of all pertinent information
and data with respect thereto, the execution of all applications, specifications, oaths, assignments and all other instruments that the Company may deem necessary in order to apply for, register, obtain, maintain, defend, and enforce such rights,
and in order to deliver, assign and convey to the Company, its successors, assigns and nominees the sole and exclusive right, title, and interest in and to all Inventions and testifying in a suit or other proceeding relating to such Inventions.
Consultant further agrees that Consultant&#146;s obligations under this Section&nbsp;3(e) shall continue after the termination of this Agreement.<I> </I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <B><I><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Attorney-in-Fact</FONT></FONT></I></B><B>.</B> Consultant agrees
that, if the Company is unable because of Consultant&#146;s unavailability, dissolution, mental or physical incapacity, or for any other reason, to secure Consultant&#146;s signature with respect to any Inventions, including, without limitation, for
the purpose of applying for or pursuing any application for any United States or foreign patents or mask work or copyright registrations covering the Inventions assigned to the Company in Section&nbsp;3(a), then Consultant hereby irrevocably
designates and appoints the Company and its duly authorized officers and agents as Consultant&#146;s agent and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact,</FONT></FONT> to act for and on Consultant&#146;s
behalf to execute and file any papers and oaths and to do all other lawfully permitted acts with respect to such Inventions to further the prosecution and issuance of patents, copyright and mask work registrations with the same legal force and
effect as if executed by Consultant. This power of attorney shall be deemed coupled with an interest, and shall be irrevocable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.
<B>Conflicting Obligations</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Consultant represents and warrants that Consultant has no agreements, relationships, or commitments to any
other person or entity that conflict with the provisions of this Agreement, Consultant&#146;s obligations to the Company under this Agreement, and/or Consultant&#146;s ability to perform the Services. Consultant will not enter into any such
conflicting agreement during the term of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <B>Return of Company Materials</B><B> </B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the termination of this Agreement, or upon Company&#146;s earlier request, Consultant will immediately deliver to the Company, and will
not keep in Consultant&#146;s possession, recreate, or deliver to anyone else, any and all Company property, including, but not limited to, Confidential Information, tangible embodiments of the Inventions, all devices and equipment belonging to the
Company, all electronically-stored information and passwords to access such property, those records maintained pursuant to Section&nbsp;3(d) and any reproductions of any of the foregoing items that Consultant may have in Consultant&#146;s possession
or control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <B>Term and Termination</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <B><I>Term</I></B><B>.</B> The term of this Agreement will begin on the Effective Date of this Agreement and will continue through
November&nbsp;30, 2022 (the &#147;<B><I>Term</I></B>&#148;), at which point the Agreement and Consultant&#146;s relationship with the Company will terminate, unless the Term is extended by mutual, written agreement between Consultant and the
Company&#146;s Chief Executive Officer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <B><I>Survival</I></B><B>.</B> Upon any termination, all rights and duties of the Company and
Consultant toward each other shall cease except: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Company will pay, within thirty (30)&nbsp;days after the effective date of
termination, all amounts owing to Consultant for Services completed and accepted by the Company prior to the termination date and related reimbursable expenses, if any, submitted in accordance with the Company&#146;s policies and in accordance with
the provisions of Section&nbsp;1 of this Agreement; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The sections entitled Confidentiality, Ownership, Conflicting Obligations, Return of
Company Materials, Independent Contractor; Benefits, Indemnification, Limitation of Liability, Arbitration and Equitable Relief, and Miscellaneous will survive termination or expiration of this Agreement in accordance with their terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <B>Independent Contractor; Benefits</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <B><I>Independent Contractor.</I></B><I> </I>It is the express intention of the Company and Consultant that Consultant perform the
Services as an independent contractor to the Company. Nothing in this Agreement shall in any way be construed to constitute Consultant as an agent, employee or representative of the Company. Without limiting the generality of the foregoing,
Consultant is not authorized to bind the Company to any liability or obligation or to represent that Consultant has any such authority. Consultant agrees to furnish (or reimburse the Company for) all tools and materials necessary to accomplish this
Agreement and shall incur all expenses associated with performance. Consultant acknowledges and agrees that Consultant is obligated to report as income all compensation received by Consultant pursuant to this Agreement. Consultant agrees to and
acknowledges the obligation to pay all self-employment and other taxes on such income. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <B><I>Benefits</I></B><B>.</B> The Company and
Consultant agree that Consultant will receive no Company-sponsored benefits from the Company where benefits include, but are not limited to, paid vacation, sick leave, medical insurance and 401k participation. If Consultant is reclassified by a
state or federal agency or court as the Company&#146;s employee, Consultant will become a reclassified employee and will receive no benefits from the Company, except those mandated by state or federal law, even if by the terms of the Company&#146;s
benefit plans or programs of the Company in effect at the time of such reclassification, Consultant would otherwise be eligible for such benefits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <B>Limitation of Liability</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN NO EVENT SHALL COMPANY BE LIABLE TO CONSULTANT OR TO ANY OTHER PARTY FOR ANY INDIRECT, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES, OR
DAMAGES FOR LOST PROFITS OR LOSS OF BUSINESS, HOWEVER CAUSED AND UNDER ANY THEORY OF LIABILITY, WHETHER BASED IN CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHER THEORY OF LIABILITY, REGARDLESS OF WHETHER COMPANY WAS ADVISED OF THE POSSIBILITY OF SUCH
DAMAGES AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY. IN NO EVENT SHALL COMPANY&#146;S LIABILITY ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT EXCEED THE AMOUNTS PAID BY COMPANY TO CONSULTANT UNDER THIS AGREEMENT
FOR THE SERVICES, DELIVERABLES OR INVENTION GIVING RISE TO SUCH LIABILITY. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <B>Arbitration and Equitable Relief</B><B> </B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <B><I>Arbitration</I></B><B>.</B> IN CONSIDERATION OF CONSULTANT&#146;S CONSULTING RELATIONSHIP WITH THE COMPANY, ITS PROMISE TO ARBITRATE
ALL DISPUTES RELATED TO CONSULTANT&#146;S CONSULTING RELATIONSHIP WITH THE COMPANY AND CONSULTANT&#146;S RECEIPT OF THE COMPENSATION AND OTHER BENEFITS PAID TO CONSULTANT BY COMPANY, AT PRESENT AND IN THE FUTURE, CONSULTANT AGREES THAT ANY AND ALL
CONTROVERSIES, CLAIMS, OR DISPUTES WITH ANYONE (INCLUDING COMPANY AND ANY EMPLOYEE, OFFICER, DIRECTOR, SHAREHOLDER OR BENEFIT PLAN OF THE COMPANY IN THEIR CAPACITY AS SUCH OR OTHERWISE), ARISING OUT OF, RELATING TO, OR RESULTING FROM
CONSULTANT&#146;S CONSULTING OR OTHER RELATIONSHIP WITH THE COMPANY OR THE TERMINATION OF CONSULTANT&#146;S CONSULTING OR OTHER RELATIONSHIP WITH THE COMPANY, INCLUDING ANY BREACH OF THIS AGREEMENT, SHALL BE SUBJECT TO BINDING ARBITRATION PURSUANT
TO THE FEDERAL ARBITRATION ACT (9 U.S.C. SEC. 1 ET SEQ.) (THE &#147;FAA&#148;). THE FAA&#146;S SUBSTANTIVE AND PROCEDURAL PROVISIONS SHALL EXCLUSIVELY GOVERN AND APPLY WITH FULL FORCE AND EFFECT TO THIS ARBITRATION AGREEMENT, INCLUDING ITS
ENFORCEMENT AND ANY STATE COURT OF COMPETENT JURISDICTION SHALL COMPEL ARBITRATION IN THE SAME MANNER AS A FEDERAL COURT UNDER THE FAA.&nbsp;CONSULTANT FURTHER AGREES THAT, TO THE FULLEST EXTENT PERMITTED BY LAW, CONSULTANT MAY BRING ANY ARBITRATION
PROCEEDING ONLY IN </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
CONSULTANT&#146;S INDIVIDUAL CAPACITY, AND NOT AS A PLAINTIFF, REPRESENTATIVE, OR CLASS MEMBER IN ANY PURPORTED CLASS, COLLECTIVE, OR REPRESENTATIVE LAWSUIT OR PROCEEDING. CONSULTANT MAY,
HOWEVER, BRING A PROCEEDING AS A PRIVATE ATTORNEY GENERAL AS PERMITTED BY LAW. <B>TO THE FULLEST EXTENT PERMITTED BY LAW, CONSULTANT AGREES TO ARBITRATE ANY AND ALL COMMON LAW AND/OR </B><B>STATUTORY CLAIMS UNDER LOCAL, STATE, OR FEDERAL LAW,
INCLUDING, BUT NOT LIMITED TO, CLAIMS UNDER</B><B> THE LABOR LAWS OF THE STATE IN WHICH CONSULTANT PERFORMS SERVICES, CLAIMS RELATING TO EMPLOYMENT OR INDEPENDENT CONTRACTOR STATUS, CLASSIFICATION, AND RELATIONSHIP WITH THE COMPANY, AND CLAIMS OF
BREACH OF CONTRACT, EXCEPT AS PROHIBITED BY LAW.</B> <B>CONSULTANT ALSO AGREES TO ARBITRATE ANY AND ALL DISPUTES ARISING OUT OF OR RELATING TO THE INTERPRETATION OR APPLICATION OF THIS AGREEMENT TO ARBITRATE, BUT NOT DISPUTES ABOUT THE
ENFORCEABILITY, REVOCABILITY OR VALIDITY OF THIS AGREEMENT TO ARBITRATE OR THE CLASS, COLLECTIVE AND REPRESENTATIVE PROCEEDING WAIVER HEREIN. WITH RESPECT TO ALL SUCH CLAIMS AND DISPUTES THAT CONSULTANT AGREES TO ARBITRATE, CONSULTANT HEREBY
</B><B>EXPRESSLY AGREES TO WAIVE, AND DOES WAIVE, ANY RIGHT TO A TRIAL BY JURY. </B>CONSULTANT FURTHER UNDERSTANDS THAT THIS AGREEMENT TO ARBITRATE ALSO APPLIES TO ANY DISPUTES THAT THE COMPANY MAY HAVE WITH CONSULTANT. CONSULTANT UNDERSTANDS THAT
NOTHING IN THIS AGREEMENT REQUIRES CONSULTANT TO ARBITRATE CLAIMS THAT CANNOT BE ARBITRATED UNDER APPLICABLE LAW, SUCH AS CLAIMS UNDER THE SARBANES-OXLEY ACT OR OTHER LAW THAT EXPRESSLY PROHIBITS ARBITRATION OF A CLAIM NOTWITHSTANDING THE
APPLICATION OF THE FAA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <B><I>Procedure</I></B><B>.</B> CONSULTANT AGREES THAT ANY ARBITRATION WILL BE ADMINISTERED BY JAMS PURSUANT
TO ITS EMPLOYMENT ARBITRATION RULES&nbsp;&amp; PROCEDURES (THE &#147;<B><I>JAMS RULES</I></B>&#148;), WHICH ARE AVAILABLE AT http://www.jamsadr.com/rules-employment-arbitration/. IF THE JAMS RULES CANNOT BE ENFORCED AS TO THE ARBITRATION, THEN THE
PARTIES AGREE THAT THEY WILL ARBITRATE THIS DISPUTE UTILIZING JAMS COMPREHENSIVE ARBITRATION RULES AND PROCEDURES OR SUCH RULES AS THE ARBITRATOR MAY DEEM MOST APPROPRIATE FOR THE DISPUTE. CONSULTANT AGREES THAT THE USE OF THE JAMS RULES DOES NOT
CHANGE CONSULTANT&#146;S CLASSIFICATION TO THAT OF AN EMPLOYEE. TO THE CONTRARY, CONSULTANT REAFFIRMS THAT CONSULTANT IS AN INDEPENDENT CONTRACTOR. CONSULTANT AGREES THAT THE ARBITRATOR SHALL HAVE THE POWER TO DECIDE ANY MOTIONS BROUGHT BY ANY PARTY
TO THE ARBITRATION, INCLUDING MOTIONS FOR SUMMARY JUDGMENT AND/OR ADJUDICATION AND MOTIONS TO DISMISS AND DEMURRERS APPLYING THE STANDARDS SET FORTH FOR SUCH MOTIONS UNDER THE RULES OF CIVIL PROCEDURE OF THE STATE IN WHICH CONSULTANT PERFORMS
SERVICES. CONSULTANT AGREES THAT THE ARBITRATOR SHALL ISSUE A WRITTEN DECISION ON THE MERITS. CONSULTANT ALSO AGREES THAT THE ARBITRATOR SHALL HAVE THE POWER TO AWARD ANY REMEDIES AVAILABLE UNDER APPLICABLE LAW, AND THAT THE ARBITRATOR SHALL AWARD
ATTORNEYS&#146; FEES AND COSTS TO THE PREVAILING PARTY, WHERE PERMITTED BY APPLICABLE LAW.&nbsp;CONSULTANT AGREES THAT THE DECREE OR AWARD RENDERED BY THE ARBITRATOR MAY BE ENTERED AS A FINAL AND BINDING JUDGMENT IN ANY COURT HAVING JURISDICTION
THEREOF. CONSULTANT AGREES THAT THE ARBITRATOR SHALL ADMINISTER AND CONDUCT ANY ARBITRATION HEARING OR PROCEEDING APPLYING SUBSTANTIVE AND DECISIONAL LAW OF THE STATE IN WHICH CONSULTANT PERFORMS SERVICES AND THE RULES OF CIVIL PROCEDURE OF THE
STATE IN WHICH CONSULTANT PERFORMS SERVICES, INCLUDING THE CALIFORNIA CIVIL DISCOVERY ACT. CONSULTANT FURTHER AGREES THAT ANY ARBITRATION UNDER THIS AGREEMENT SHALL BE CONDUCTED IN SAN MATEO COUNTY, CALIFORNIA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <B><I>Remedy</I></B><B>.</B> FOR PURPOSES OF SEEKING PROVISIONAL REMEDIES ONLY, CONSULTANT AGREES THAT THE COMPANY AND CONSULTANT SHALL BE
ENTITLED TO PURSUE ANY PROVISIONAL REMEDY PERMITTED BY THE CALIFORNIA ARBITRATION ACT (CALIFORNIA CODE CIV. PROC. &#167; 1281.8) OR OTHERWISE PROVIDED BY THIS AGREEMENT. EXCEPT FOR SUCH PROVISIONAL RELIEF, CONSULTANT AGREES THAT ANY RELIEF OTHERWISE
AVAILABLE TO THE COMPANY OR CONSULTANT UNDER APPLICABLE LAW SHALL BE PURSUED SOLELY AND EXCLUSIVELY IN ARBITRATION PURSUANT TO THE TERMS OF THIS AGREEMENT. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(D) <B><I>Administrative Relief.</I></B> CONSULTANT UNDERSTANDS THAT THIS AGREEMENT DOES NOT
PROHIBIT CONSULTANT FROM PURSUING AN ADMINISTRATIVE CLAIM WITH LOCAL, STATE OR FEDERAL ADMINISTRATIVE BODIES OR GOVERNMENT AGENCIES SUCH AS THE DEPARTMENT OF FAIR EMPLOYMENT AND HOUSING, THE EQUAL EMPLOYMENT OPPORTUNITY COMMISSION, THE NATIONAL
LABOR RELATIONS BOARD, THE SECURITIES AND EXCHANGE COMMISSION, OR THE WORKERS&#146; COMPENSATION BOARD. THIS AGREEMENT DOES, HOWEVER, PRECLUDE CONSULTANT FROM BRINGING ANY ALLEGED WAGE CLAIMS WITH THE DEPARTMENT OF LABOR STANDARDS ENFORCEMENT.
LIKEWISE, THIS AGREEMENT DOES PRECLUDE CONSULTANT FROM PURSUING COURT ACTION REGARDING ANY ADMINISTRATIVE CLAIMS, EXCEPT AS PERMITTED BY LAW. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(E) <B><I>Voluntary Nature of Agreement.</I></B> CONSULTANT ACKNOWLEDGES AND AGREES THAT CONSULTANT IS EXECUTING THIS AGREEMENT VOLUNTARILY AND
WITHOUT ANY DURESS OR UNDUE INFLUENCE BY THE COMPANY OR ANYONE ELSE. CONSULTANT FURTHER ACKNOWLEDGES AND AGREES THAT CONSULTANT HAS CAREFULLY READ THIS AGREEMENT AND THAT CONSULTANT HAS ASKED ANY QUESTIONS NEEDED FOR CONSULTANT TO UNDERSTAND THE
TERMS, CONSEQUENCES AND BINDING EFFECT OF THIS AGREEMENT AND FULLY UNDERSTAND IT, INCLUDING THAT <B><I>CONSULTANT IS WAIVING CONSULTANT&#146;S RIGHT TO A JURY TRIAL</I></B>. CONSULTANT AGREES THAT CONSULTANT HAS BEEN PROVIDED AN OPPORTUNITY TO SEEK
THE ADVICE OF AN ATTORNEY OF CONSULTANT&#146;S CHOICE BEFORE SIGNING THIS AGREEMENT. FINALLY, CONSULTANT AGREES THAT THIS ARBITRATION AGREEMENT IS NOT SUBJECT TO CALIFORNIA LABOR CODE SECTION 432.6. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <B>Miscellaneous</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
<B><I>Governing Law; Consent to Personal Jurisdiction</I></B><B>.</B> This Agreement shall be governed by the laws of the State of California, without regard to the conflicts of law provisions of any jurisdiction, except that any dispute regarding
the enforceability of the arbitration section of this Agreement shall be governed by the FAA. To the extent that any lawsuit is permitted under this Agreement, the Parties hereby expressly consent to the personal and exclusive jurisdiction and venue
of the state and federal courts located in California. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <B><I>Assignability</I></B><B>.</B> This Agreement will be binding upon
Consultant&#146;s heirs, executors, assigns, administrators, and other legal representatives, and will be for the benefit of the Company, its successors, and its assigns. There are no intended third-party beneficiaries to this Agreement, except as
expressly stated. Except as may otherwise be provided in this Agreement, Consultant may not sell, assign or delegate any rights or obligations under this Agreement. Notwithstanding anything to the contrary herein, Company may assign this Agreement
and its rights and obligations under this Agreement to any successor to all or substantially all of Company&#146;s relevant assets, whether by merger, consolidation, reorganization, reincorporation, sale of assets or stock, change of control or
otherwise. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <B><I>Entire Agreement</I></B><B>.</B> This Agreement constitutes the entire agreement and understanding between the
Parties with respect to the subject matter herein and supersedes all prior written and oral agreements, discussions, or representations between the Parties. Consultant represents and warrants that Consultant is not relying on any statement or
representation not contained in this Agreement. To the extent any terms set forth in any exhibit or schedule conflict with the terms set forth in this Agreement, the terms of this Agreement shall control unless otherwise expressly agreed by the
Parties in such exhibit or schedule. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <B><I>Headings</I></B><B>.</B> Headings are used in this Agreement for reference only and shall
not be considered when interpreting this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <B><I>Severability</I></B><B>.</B> If a court or other body of competent
jurisdiction finds, or the Parties mutually believe, any provision of this Agreement, or portion thereof, to be invalid or unenforceable, such provision will be enforced to the maximum extent permissible so as to effect the intent of the Parties,
and the remainder of this Agreement will continue in full force and effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <B><I>Modification, Waiver.</I></B><I> </I>No modification of or amendment to this
Agreement, nor any waiver of any rights under this Agreement, will be effective unless in a writing signed by the Parties. Waiver by the Company of a breach of any provision of this Agreement will not operate as a waiver of any other or subsequent
breach. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <B><I>Notices</I></B><B>.</B> Any notice or other communication required or permitted by this Agreement to be given to a Party
shall be in writing and shall be deemed given (i)&nbsp;if delivered personally or by commercial messenger or courier service, (ii)&nbsp;when sent by confirmed facsimile, or (iii)&nbsp;if mailed by U.S. registered or certified mail (return receipt
requested), to the Party at the Party&#146;s address written below or at such other address as the Party may have previously specified by like notice. If by mail, delivery shall be deemed effective three business days after mailing in accordance
with this Section&nbsp;11.G. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">If to the Company, to: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">2 Tower Place, Suite 2000 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">South San Francisco, CA 94080 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: General Counsel </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">If to Consultant, to the address for notice on the signature page to this Agreement or, if no such address is provided, to the last address of
Consultant provided by Consultant to the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <B><I>Attorneys&#146; Fees</I></B><B>.</B> In any court action at law or equity that
is brought by one of the Parties to this Agreement to enforce or interpret the provisions of this Agreement, the prevailing Party will be entitled to reasonable attorneys&#146; fees, in addition to any other relief to which that Party may be
entitled. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <B><I>Signatures.</I></B><I> </I>This Agreement may be signed in two counterparts, each of which shall be deemed an
original, with the same force and effectiveness as though executed in a single document. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <B><I>Protected Activity Not
Prohibited.</I></B> Consultant understands that nothing in this Agreement shall in any way limit or prohibit Consultant from engaging in any Protected Activity. For purposes of this Agreement, &#147;<B><I>Protected Activity</I></B>&#148; shall mean
filing a charge, complaint, or report with, or otherwise communicating, cooperating, or participating in any investigation or proceeding that may be conducted by, any federal, state or local government agency or commission, including the Securities
and Exchange Commission (&#147;<B><I>Government Agencies</I></B>&#148;). Consultant understands that in connection with such Protected Activity, Consultant is permitted to disclose documents or other information as permitted by law, and without
giving notice to, or receiving authorization from, the Company. Notwithstanding the foregoing, Consultant agrees to take all reasonable precautions to prevent any unauthorized use or disclosure of any information that may constitute Company
confidential information to any parties other than the Government Agencies. Consultant further understands that &#147;<B><I>Protected Activity</I></B>&#148; does not include the disclosure of any Company attorney-client privileged communications.
Pursuant to the Defend Trade Secrets Act of 2016, Consultant is notified that an individual will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i)&nbsp;is made in
confidence to a federal, state, or local government official (directly or indirectly) or to an attorney <I>solely</I> for the purpose of reporting or investigating a suspected violation of law, or (ii)&nbsp;is made in a complaint or other document
filed in a lawsuit or other proceeding, if (and only if) such filing is made under seal. In addition, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the
individual&#146;s attorney and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(<I>signature page follows</I>) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-7- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties hereto have executed this Consulting Agreement as of the
Effective Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CONSULTANT</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>FLUIDIGM CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Address for Notice:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SERVICES AND COMPENSATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <B><I>Contact</I></B><B>.</B> Consultant&#146;s principal Company contact: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="65%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Email:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Phone:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <B><I>Services</I></B>. The Services will include, but will not be limited to, the following:
Consultant&#146;s reasonable assistance with the transition of duties of the Company&#146;s Chief Executive Officer, and other related projects. The Company anticipates that Consultant will perform Services for no more than fifteen (15)&nbsp;hours
per week. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <B><I>Compensation</I></B><B>.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company will pay Consultant a monthly fee of Twenty-Five Thousand Dollars ($25,000) for each month Consultant is available to the
Company to perform Services during the first six (6)&nbsp;months of the Term. This payment will be made to Consultant no later than ten (10)&nbsp;business days following the end of each month of the first six (6)&nbsp;months of the Term.
Notwithstanding the foregoing, in the event the Company terminates the Consulting Period prior to November&nbsp;30, 2022, any unpaid consulting fees that would otherwise have been paid during the first six (6)&nbsp;months of the Term shall become
due and payable within ten (10)&nbsp;business days following the last date of the Consulting Period. If the Services in a given month exceed sixty (60)&nbsp;hours per month, then Consultant&#146;s monthly fee will be increased by $350 per each hour
in excess of sixty (60)&nbsp;hours. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company will reimburse Consultant, in accordance with Company policy, for all reasonable
expenses incurred by Consultant in performing the Services pursuant to this Agreement, if Consultant receives written consent from an authorized agent of the Company prior to incurring such expenses and submits receipts for such expenses to the
Company in accordance with Company policy. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Every month during the Term in which Services for the month exceed sixty (60)&nbsp;hours,
Consultant shall submit to the Company a written invoice for Services, and such statement shall be subject to the approval of the contact person listed above or other designated agent of the Company, which shall not be unreasonably withheld. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company previously granted Consultant certain (i)&nbsp;stock options to purchase Company common stock (&#147;Options&#148;), and
(ii)&nbsp;time-based and performance-based restricted stock units covering Company common stock (&#147;RSUs&#148;) (collectively, Consultant&#146;s Options and RSUs are referred to as &#147;Equity Awards&#148;) that entitle Consultant to purchase or
to receive shares of the Company&#146;s common stock subject to the terms and conditions of the Company&#146;s equity incentive plans and the respective stock option and/or RSUs agreements (collectively, the &#147;Equity Agreements&#148;). During
the Term, Consultant will continue to vest in the Equity Awards, subject to the terms and conditions of the Equity Agreements, and subject to any vesting acceleration as set forth in Section&nbsp;3 of the Separation Agreement and Release to which
this Agreement is attached. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">All payments and benefits provided for under this Agreement are intended to be exempt from or otherwise comply
with the requirements of Section&nbsp;409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance thereunder (together, &#147;<B>Section</B><B></B><B>&nbsp;409A</B>&#148;), so that none of the payments and benefits to be
provided hereunder will be subject to the additional tax imposed under Section&nbsp;409A, and any ambiguities or ambiguous terms herein will be interpreted to be exempt or so comply. Each payment and benefit payable under this Agreement is intended
to constitute a separate payment for purposes of <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-2(b)(2)</FONT> of the Treasury Regulations. In no event will the Company reimburse Consultant for any taxes that may be imposed on Consultant as a
result of Section&nbsp;409A. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This <B>Schedule A</B> is accepted and agreed upon as of the Effective Date of the
Agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>CONSULTANT</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>FLUIDIGM CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT 2 </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SUPPLEMENTAL RELEASE AGREEMENT </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Supplemental Release Agreement (&#147;Supplemental Release&#148;) is made by and between Chris Linthwaite (&#147;Consultant&#148;) and
Fluidigm Corporation (the &#147;Company&#148;) (jointly referred to as the &#147;Parties&#148; and individually referred to as a &#147;Party&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Consideration</U>. In consideration for the continued payment of the consideration set forth in Section&nbsp;1.a. of the Separation
Agreement and Release signed between Consultant and the Company, dated _______, 2022 (the &#147;Separation Agreement&#148;), Consultant hereby extends his release and waiver of claims to any claims that may have arisen between the Effective Date (as
such term is defined in the Separation Agreement) and the Supplemental Release Effective Date, as defined below, provided that, for the avoidance of doubt, such release and waiver of claims shall not extent to (i)&nbsp;claims that cannot be released
as a matter of law; (ii)&nbsp;any obligations incurred or rights preserved under the Separation Agreement or this Agreement; and (iii)&nbsp;any rights to indemnification as a result of Consultant&#146;s prior service as an officer or director of the
Company, including such rights under the Indemnification Agreement.. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Incorporation of Terms of Release Agreement</U>. The
undersigned Parties further acknowledge that the terms of the Separation Agreement, including, but not limited to, Sections 1.i. (No Further Severance), 5 (Payment of Salary and Receipt of All Benefits), 6 (Release of Claims), 7 (Acknowledgment of
Waiver of Claims under ADEA), 8 (California Civil Code Section&nbsp;1542), 10 (Trade Secrets and Confidential Information/Company Property), 12 (Protected Activity Not Prohibited), and 13 (Mutual Nondisparagement) shall apply to this Supplemental
Release and are incorporated herein to the extent that they are not inconsistent with the express terms of this Supplemental Release. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.
<U>Supplemental Release Effective Date</U>. Consultant understands that this Supplemental Release shall be null and void if not executed by him within <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;days after the termination of
Consultant&#146;s consulting relationship with the Company. This Supplemental Release will become effective on the date that it has been signed by both Parties. The Company will continue to provide Consultant with the consideration provided by
Section&nbsp;1.a. of the Separation Agreement in accordance with the terms of that agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Voluntary Execution of Agreement</U>.
Consultant understands and agrees that he executed this Supplemental Release voluntarily, without any duress or undue influence on the part or behalf of the Company or any third party, with the full intent of releasing all of his claims against the
Company and any of the other Releasees. Consultant acknowledges that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">he has read this Supplemental Release; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">he cannot sign the Supplemental Release before the termination of his consulting relationship with the Company,
but that he must sign the Supplemental Release no later than 21 days thereafter; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">he has been represented in the preparation, negotiation, and execution of this Supplemental Release by legal
counsel of his own choice or has elected not to retain legal counsel; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">he understands the terms and consequences of this Supplemental Release and of the releases it contains; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">he is fully aware of the legal and binding effect of this Supplemental Release. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally blank; signature page follows</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have executed this Agreement on the respective dates set forth below. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">CHRIS LINTHWAITE, an individual</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated: ________________, 2022</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Chris Linthwaite</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">FLUIDIGM CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated: ________________, 2022</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>8
<FILENAME>d243622dex107.htm
<DESCRIPTION>EX-10.7
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.7</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Exhibit 10.7 </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PERSONAL&nbsp;&amp; CONFIDENTIAL </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">January&nbsp;23, 2022 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Michael Egholm </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Re: Offer of Employment with Fluidigm Corporation
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Michael, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are pleased to offer you employment
with Fluidigm Corporation (the &#147;<B>Company</B>&#148;), effective on or about the closing (the &#147;<B>Closing,</B>&#148; and the date of Closing, the &#147;<B>Closing Date</B>&#148;) of that certain private placement of convertible preferred
stock (the &#147;<B>Transaction</B>&#148;) of the Company to Casdin Capital, LLC and/or one or more of its affiliates and Viking Global Investors LP and/or one or more of its affiliates, or as otherwise agreed between you and the Company (the
<B>&#147;Effective Date</B>&#148;). The terms of your employment will be governed by the terms and conditions described herein. This offer is contingent upon the consummation of the Transaction. If the Transaction does not occur, this offer is null
and void <I>ab initio</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a summary of your position, compensation, and benefits to be associated with your employment with the Company
as of the Effective Date. Capitalized terms not defined herein will have the meanings set forth in the Severance Plan (as defined below). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Position</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Reporting Line</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Board of Directors of the Company (the &#147;<B>Board</B>&#148;).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Work Location</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Boston, Massachusetts will be your expected primary location of work.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Base Salary:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The annual base salary payable to you will be $500,000 (&#147;<B>Base Salary</B>&#148;), payable in substantially equal installments on a regular basis in accordance with the Company&#146;s standard payroll procedures. Your Base
Salary may be subject to annual review and adjustment, as determined by the Board in its sole discretion.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Annual Bonus</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">During each fiscal year of your employment, you will be eligible to receive an annual cash bonus with a target bonus of 100% of your Base Salary (the &#147;<B>Annual Bonus</B>&#148;), based on the performance of the Company and/or
your individual performance as determined by the Board or its delegate (the &#147;<B>Committee</B>&#148;) in its sole discretion. Your 2022 Annual Bonus (if any) will be prorated based on your partial year of employment. Payment of the Annual Bonus
will be made as soon as practicable following the end of the fiscal year during which the Annual Bonus was earned and after the Annual Bonus is approved by the Committee, but in no event later than the fifteenth (15<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>) day of the third (3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP>) month of the fiscal year following the date the Annual Bonus has been earned and is no longer subject to a substantial
risk of forfeiture. Unless otherwise determined by the Committee, you must be employed by the Company or any affiliate on the date the Annual Bonus is paid to receive such payment.</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Equity</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a material inducement for you commencing employment with the Company, promptly following the Closing, you will receive an equity award in
the form of nonqualified stock options (&#147;<B>Option Award</B>&#148;) to purchase up to 2.8% of the outstanding shares of common stock of the Company at the Closing, calculated on a fully diluted basis (such shares, the &#147;<B>Option
Shares</B>&#148;) (with such share number subject to reduction under the terms of the immediately following paragraph), with a per share exercise price (the &#147;<B>Exercise Price</B>&#148;) of the greater of (i) $3.40 (the &#147;<B>Conversion
Price</B>&#148;) or (ii)&nbsp;the fair market value of a share of common stock on the Option Award grant date, pursuant to the Company&#146;s 2022 Inducement Equity Incentive Plan (the &#147;<B>Inducement Plan</B>&#148;). Subject to your continued
employment with the Company through the applicable vesting date, 25% of the shares subject to the Option Award will vest on the first anniversary of the vesting commencement date, and the remaining 75% of the shares subject to the Option Award will
vest in equal monthly installments thereafter (resulting in the Option Award being 100% vested on the fourth anniversary of the vesting commencement date). If you terminate due to your death or Disability (as defined in the Severance Plan), a number
of unvested shares underlying your Option Award that otherwise would vest during the period between your termination date and the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of your termination date immediately will vest.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, if the Exercise Price exceeds the Conversion Price, then, as a material
inducement for you commencing employment with the Company, promptly following the Closing, you will receive an equity award in the form of restricted stock units (&#147;<B>RSU Award</B>&#148;) covering a number of shares of common stock of the
Company equal to (i)&nbsp;the amount by which the Exercise Price exceeds the Conversion Price, multiplied by the number of Option Shares <I>divided by </I>(ii)&nbsp;the Exercise Price (rounded to the nearest whole share). The shares of common stock
of the Company underlying your RSU Award will reduce on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">share-by-share</FONT></FONT> basis the number of Option Shares. Subject to your continued employment with the Company, 25% of
your RSU Award (if any) will vest in equal annual installments over a four-year period beginning on the first anniversary of the vesting commencement date (resulting in your RSU Award being 100% vested on the fourth anniversary of the vesting
commencement date). If you terminate due to your death or Disability (as defined in the Severance Plan), a number of unvested shares underlying your RSU Award that otherwise would vest during the period between your termination date and the <FONT
STYLE="white-space:nowrap">one-year</FONT> anniversary of your termination date immediately will vest.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The Option Award and RSU Award (if any) will be subject to the terms of the Inducement Plan and the applicable award agreement thereunder (the &#147;<B>Equity
Documents</B>&#148;). The Inducement Plan will include provisions with respect to the treatment of awards upon a Change in Control (as to be defined in the Inducement Plan) that are substantially similar to the provisions set forth in the
Company&#146;s 2011 Equity Incentive Plan, as amended.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Severance Benefits</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to any accrued obligations owed by the Company to you, upon a qualifying termination of employment, you will be eligible to
receive severance benefits under the 2020 Change of Control and Severance Plan (the &#147;<B>Severance Plan</B>&#148;), subject to the terms and conditions provided thereunder and a participation agreement to be provided to you separately by the
Company.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Under the Severance Plan and as provided in a participation agreement under
such plan that will be separately provided to you, if (i)&nbsp;you terminate your employment with the Company (or any parent or subsidiary of the Company) for Good Reason, or (ii)&nbsp;the Company (or any parent or subsidiary of the Company)
terminates your</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Offer of Employment (Page
<B>2</B> of <B>7</B>) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">employment for a reason other than Cause or your death or Disability, in each case, within three months prior to or 12 months following a
Change of Control (the &#147;<B>COC Period</B>&#148;), subject to your execution and <FONT STYLE="white-space:nowrap">non-revocation</FONT> of a general release of claims provided to you by the Company, you will be entitled to receive the following
benefits:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(i)&#8195;a lump sum cash payment
equal to 250% of the sum of (x)&nbsp;your Base Salary (as in effect immediately prior to the Change of Control or your termination of employment, whichever is greater), plus (y)&nbsp;the greater of (A)&nbsp;your target Annual Bonus (as in effect
immediately prior to the Change of Control or your termination of employment, whichever is greater) or (B)&nbsp;the average of the Annual Bonus payments actually paid to you for the three fiscal years preceding the year in which your termination of
employment occurs;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(ii)&#8194;&#8201;a lump
sum cash payment equal to (i)&nbsp;your target Annual Bonus (as in effect immediately prior to the Change of Control or termination of employment, whichever is greater), multiplied by (ii)&nbsp;a fraction, the numerator of which is the number of
days worked by you during the year in which your termination of employment occurs and the denominator of which is 365;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(iii)&#8201;&#8201;payment by the Company of continued health coverage under COBRA (or, for any period after
expiration of COBRA eligibility, reimbursement of health insurance monthly costs up to the amount of the COBRA premium that would be payable if COBRA were available at such time) for a period of 30 months following your termination of
employment;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(iv)&#8194;acceleration and
vesting of 100% of your then-outstanding and unvested equity awards; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(v)&#8194;&#8201;&#8202;reasonable outplacement services in accordance with any applicable Company policy in effect as
of your termination of employment (or, if no such policy is in effect, as determined by the Company, in its sole discretion).</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Severance Plan and as provided in your participation agreement, if the Company (or any parent or subsidiary of the Company) terminates your
employment for a reason other than for Cause, your death or Disability, in each case, outside of the COC Period, subject to your execution of a general release of claims provided to you by the Company, you will be entitled to receive the following
benefits:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(i)&#8195;an aggregate amount equal
to 200% of your Base Salary in effect as of the date of your termination of employment, paid in equal installments over a period of 24 months following your termination date;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(ii)&#8194;&#8201;payment by the Company of continued health coverage under COBRA for a period of 12 months following
your termination of employment;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(iii)&#8201;&#8201;acceleration and vesting of a number of unvested shares underlying your then-outstanding equity
awards that otherwise would vest during the period between your termination date and the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of your termination date (with the remainder forfeited on termination); and</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(iv)&#8194;reasonable outplacement services in
accordance with any applicable Company policy in effect as of your termination of employment (or, if no such policy is in effect, as determined by the Company, in its sole discretion).</P></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Offer of Employment (Page
<B>3</B> of <B>7</B>) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of your severance benefits provided under the Severance Plan and as provided in your participation agreement, &#147;<B>Good
Reason</B>&#148; will mean the occurrence of one or more of the following events effected without your prior consent, provided that you terminate your employment with the Company within one year following the initial existence of the &#147;Good
Reason&#148; condition: (i) the assignment to you of any duties or the reduction of your then-current duties, either of which results in a material diminution in your then-current position or responsibilities with the Company, including a
requirement that you be required to report to a corporate officer or employee instead of reporting directly to the board of directors of the Company or, if the Company becomes a subsidiary of another corporation, the board of directors of the
Company&#146;s parent company; (ii)&nbsp;a material reduction by the Company in your then-current base salary; (iii)&nbsp;a material change in the geographic location at which you must perform services (it being understood that a relocation to a
facility or location less than 25 miles from your then-present location will not be considered a material change in geographic location); or (iv)&nbsp;any material breach by the Company of any material provision of your participation agreement under
the Severance Plan. You will not resign for Good Reason without first providing the Company with written notice of the acts or omissions constituting the grounds for &#147;Good Reason&#148; within 90 days of the initial existence of the grounds for
&#147;Good Reason&#148; and a reasonable cure period of not less than 30 days following the date of such notice.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Please note that the foregoing is a summary of the benefits that the Company will offer you under the Severance Plan, but does not include all of the terms and
conditions of the official Severance Plan document. The official Severance Plan document will govern your eligibility for any severance benefits and upon execution of a participation agreement under the Severance Plan, any rights to severance
benefits in this &#147;Severance Benefits&#148; section will be superseded and replaced with the benefits under the participation agreement.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Paid Time Off (PTO)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">You will be eligible for paid time off (&#147;<B>PTO</B>&#148;) in accordance with the Company&#146;s PTO policy, as it may be amended from time to time.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Benefit Plans</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">From the Effective Date, you will be eligible to participate in the various group health, disability, and life insurance plans and other employee programs, including sick and vacation time, as generally are offered by the Company to
similarly situated senior management executives from time to time, subject to the terms and conditions of such plans and programs.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Restrictive Covenants</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">As a condition to your employment and in consideration of your employment with the Company, the consideration set forth in this letter (including, but not limited to, the annual bonus opportunity, the Option Award, RSU Award (if
any) and severance benefits), you will be required to sign the <FONT STYLE="white-space:nowrap">At-Will</FONT> Employment, Confidential Information, Invention Assignment and Arbitration Agreement (the &#147;<B>Confidentiality Agreement</B>&#148;)
enclosed with this letter, which, among other things, will provide for post-termination restrictive covenants, including, but not limited to, confidentiality, <FONT STYLE="white-space:nowrap">12-month</FONT>
<FONT STYLE="white-space:nowrap">non-competition</FONT> and <FONT STYLE="white-space:nowrap">12-month</FONT> <FONT STYLE="white-space:nowrap">non-solicitation</FONT> covenants. You acknowledge that you have been provided an opportunity to consult
with an attorney prior to signing the Confidentiality Agreement.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Offer of Employment (Page
<B>4</B> of <B>7</B>) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Withholding Taxes</B>.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Company will be entitled to deduct and withhold from any amounts payable under this letter such federal, state, local, <FONT STYLE="white-space:nowrap">non-U.S.</FONT> or other taxes as are required to be withheld pursuant to
any applicable law or regulation.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This offer letter and your employment with the Company are subject to you agreeing to the following terms and conditions: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Company Policies, Guidelines, and Training</U>. The Company maintains policies and guidelines, and provides
training, that establish certain expectations and rules concerning your conduct and performance. These policies and guidelines may affect your ability to participate in certain benefits and programs and may contain additional terms and conditions
with respect to your employment. By accepting this offer, you agree to adhere to such policies and guidelines and participate in all required training sessions. All Company policies and guidelines are subject to change and your employment with the
Company is your acceptance and agreement to abide by such changes. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>References and Background Checks</U>. This offer and your employment with the Company are at all times
contingent upon the Company&#146;s review and satisfaction with your references and verification of background information, even if you commence employment with the Company prior to the completion of the Company&#146;s reference and background
checks. You agree that the Company may check your references and background information at any time during your employment and you authorize the Company to do so. In accepting this offer, you agree to cooperate with the Company and seek the
cooperation of others in completing the references and background check processes in an expeditious manner. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Employment Must Not Infringe Upon the Rights of Others</U>. In accepting this offer, you warrant as follows:
(a)&nbsp;you have disclosed and provided to the Company any and all restrictive covenant obligations or agreements in which you are subject to and affirm your continued compliance with such obligations and agreements, (b)&nbsp;you will not disclose
to the Company any trade secrets or proprietary information from your prior employers and (c)&nbsp;you will not refer to or otherwise solicit for employment at the Company any former <FONT STYLE="white-space:nowrap">co-workers</FONT> or others in
contravention of any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">still-in-effect</FONT></FONT> <FONT STYLE="white-space:nowrap">non-solicitation</FONT> obligations. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Best Efforts</U>. In accepting this offer, you agree to devote all of your business time, attention, skills,
and best efforts to your position on a full-time basis. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Employment <FONT STYLE="white-space:nowrap">At-Will</FONT></U>. In accepting this offer, you agree that your
employment with the Company is &#147;at will&#148; meaning that either you or the Company may terminate the employment relationship at any time with or without cause or advance notice, subject to the above Severance Benefits terms. You should also
be aware that your position, job responsibilities, compensation, benefits, and other terms and conditions of employment might be changed at any time in the sole discretion of the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Governing Law</U>. All issues and questions concerning the construction, validity, enforcement and
interpretation of this letter will be governed by, and construed in accordance with, the laws of the Commonwealth of Massachusetts, without giving effect to any choice of law or conflict of law rules or provisions (whether of the Commonwealth of
Massachusetts or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the Commonwealth of Massachusetts. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This offer letter, along with the Confidentiality Agreement, the Equity Documents and the Severance Plan and applicable participation agreement, constitutes
the entire agreement between you and the Company regarding the terms and conditions of your employment with the Company and supersedes and cancels any prior offer letters, agreements, promises, representations, or statements that have been made
between you and the Company regarding your employment. This offer letter may only be amended or modified through a written agreement signed by you and any authorized member of the Board. Please carefully review these terms and conditions to make
sure they are consistent with your understanding. If so, please sign this offer letter to confirm your acceptance and send a signed copy by January&nbsp;23, 2022. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Offer of Employment (Page
<B>5</B> of <B>7</B>) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are confident you will find your employment with the Company a challenging and rewarding endeavor. We
look forward to working with you! </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Offer of Employment (Page
<B>6</B> of <B>7</B>) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><B>Fluidigm Corporation</B></TD></TR></TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="25%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Vikram Jog</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By: Vikram Jog</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Financial Officer</TD></TR></TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="58%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Agreed&nbsp;and&nbsp;Accepted:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael Egholm</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Michael Egholm</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Date: January&nbsp;19, 2022</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I>[<I></I><I>Signature Page to Offer Letter</I><I></I>]<I> </I></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>9
<FILENAME>d243622dex108.htm
<DESCRIPTION>EX-10.8
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Exhibit 10.8 </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FLUIDIGM CORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEMNIFICATION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Indemnification Agreement (&#147;<B>Agreement</B>&#148;) is made as of January&nbsp;23, 2022 by and between Fluidigm Corporation, a
Delaware corporation (the &#147;<B>Company</B>&#148;), and Michael Egholm (&#147;<B>Indemnitee</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>WHEREAS</I></B>, the
Company and Indemnitee recognize the significant cost of directors&#146; and officers&#146; liability insurance and the general reductions in the coverage of such insurance; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>WHEREAS</I></B>, the Company and Indemnitee further recognize the substantial increase in corporate litigation in general, subjecting
officers and directors to expensive litigation risks at the same time as the coverage of liability insurance has been severely limited; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>WHEREAS</I></B>, the Company desires to attract and retain the services of highly qualified individuals, such as Indemnitee, to serve as
officers and directors of the Company and to indemnify its officers and directors so as to provide them with the maximum protection permitted by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>NOW, THEREFORE</I></B>, in consideration for Indemnitee&#146;s services as an officer or director of the Company, the Company and
Indemnitee hereby agree as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <B>Definitions.</B><B> </B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) A &#147;<B><I>Change in Control</I></B>&#148; shall be deemed to occur upon the earliest to occur after the date of this Agreement of any
of the following events (excluding any such event arising in connection with the closing of the proposed equity transaction made, individually or collectively, by any of the following entities (the &#147;<B><I>Casdin/Viking
Transaction</I></B>&#148;): Casdin Private Growth Equity Fund II, L.P., Casdin Partners Master Fund, L.P., Viking Global Opportunities Illiquid Investments <FONT STYLE="white-space:nowrap">Sub-Master</FONT> LP and Viking Global Opportunities
Drawdown (Aggregator) LP or any of such entities&#146; parent, subsidiary or affiliated entities): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) <I>Acquisition of Stock by Third
Party.</I> Any Person (as defined below) is or becomes the Beneficial Owner (as defined below), directly or indirectly, of securities of the Company representing fifteen percent (15%) or more of the combined voting power of the Company&#146;s then
outstanding securities; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) <I>Change in Board Composition.</I> During any period of two consecutive years (not including any period
prior to the execution of this Agreement), individuals who at the beginning of such period constitute the Company&#146;s board of directors, and any new directors (other than a director designated by a person who has entered into an agreement with
the Company to effect a transaction described in Sections&nbsp;1(a)(i), 1(a)(iii) or 1(a)(iv)) whose election by the board of directors or nomination for election by the Company&#146;s stockholders was approved by a vote of at least <FONT
STYLE="white-space:nowrap">two-thirds</FONT> of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute
at least a majority of the members of the Company&#146;s board of directors; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) <I>Corporate Transactions.</I> The effective date of a merger or consolidation of the
Company with any other entity, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or
by being converted into voting securities of the surviving entity) more than 50% of the combined voting power of the voting securities of the surviving entity outstanding immediately after such merger or consolidation and with the power to elect at
least a majority of the board of directors or other governing body of such surviving entity; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) <I>Liquidation.</I> The approval by the
stockholders of the Company of a complete liquidation of the Company or an agreement for the sale or disposition by the Company of all or substantially all of the Company&#146;s assets; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) <I>Other Events.</I> Any other event of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A of
Regulation 14A (or in response to any similar item on any similar schedule or form) promulgated under the Securities Exchange Act of 1934, as amended, whether or not the Company is then subject to such reporting requirement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Section&nbsp;1(a), the following terms shall have the following meanings: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) &#147;<B><I>Person</I></B>&#148; shall have the meaning as set forth in Sections&nbsp;13(d) and 14(d) of the Securities Exchange Act of
1934, as amended; <I>provided, however,</I> that &#147;<B><I>Person</I></B>&#148; shall exclude (i)&nbsp;the Company, (ii)&nbsp;any trustee or other fiduciary holding securities under an employee benefit plan of the Company, and (iii)&nbsp;any
corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) &#147;<B><I>Beneficial Owner</I></B>&#148; shall have the meaning given to such term in
<FONT STYLE="white-space:nowrap">Rule&nbsp;13d-3</FONT> under the Securities Exchange Act of 1934, as amended; <I>provided, however,</I> that &#147;<B><I>Beneficial Owner</I></B>&#148; shall exclude any Person otherwise becoming a Beneficial Owner
by reason of (i)&nbsp;the stockholders of the Company approving a merger of the Company with another entity or (ii)&nbsp;the Company&#146;s board of directors approving a sale of securities by the Company to such Person. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) &#147;<B><I>Corporate Status</I></B>&#148; describes the status of a person who is or was a director, trustee, general partner, managing
member, officer, employee, agent or fiduciary of the Company or any other Enterprise. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) &#147;<B><I>DGCL</I></B>&#148; means the General
Corporation Law of the State of Delaware. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) &#147;<B><I>Disinterested Director</I></B>&#148; means a director of the Company who is not
and was not a party to the Proceeding in respect of which indemnification is sought by Indemnitee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 2 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) &#147;<B><I>Enterprise</I></B>&#148; means the Company and any other corporation,
partnership, limited liability company, joint venture, trust, employee benefit plan or other enterprise of which Indemnitee is or was serving at the request of the Company as a director, trustee, general partner, managing member, officer, employee,
agent or fiduciary. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) &#147;<B><I>Expenses</I></B>&#148; include all reasonable attorneys&#146; fees, retainers, court costs, transcript
costs, fees and costs of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, and all other disbursements or expenses of the types customarily incurred in
connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in, or otherwise participating in, a Proceeding. Expenses also include (i)&nbsp;Expenses incurred in connection with any
appeal resulting from any Proceeding, including without limitation the premium, security for, and other costs relating to any cost bond, supersedeas bond or other appeal bond or their equivalent, and (ii)&nbsp;for purposes of Section&nbsp;12(d),
Expenses incurred by Indemnitee in connection with the interpretation, enforcement or defense of Indemnitee&#146;s rights under this Agreement or under any directors&#146; and officers&#146; liability insurance policies maintained by the Company.
Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)
&#147;<B><I>Independent Counsel</I></B>&#148; means a law firm, or a partner or member of a law firm, that is experienced in matters of corporation law and neither presently is, nor in the past five years has been, retained to represent (i)&nbsp;the
Company or Indemnitee in any matter material to either such party (other than as Independent Counsel with respect to matters concerning Indemnitee under this Agreement, or other indemnitees under similar indemnification agreements), or (ii)&nbsp;any
other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term &#147;<B><I>Independent Counsel</I></B>&#148; shall not include any person who, under the applicable standards of
professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee&#146;s rights under this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) &#147;<B><I>Proceeding</I></B>&#148; means any threatened, pending or completed action, suit, arbitration, mediation, alternate dispute
resolution mechanism, investigation, inquiry, administrative hearing or proceeding, whether brought in the right of the Company or otherwise and whether of a civil, criminal, administrative or investigative nature, including any appeal therefrom and
including without limitation any such Proceeding pending as of the date of this Agreement, in which Indemnitee was, is or will be involved as a party, a potential party, a <FONT STYLE="white-space:nowrap">non-party</FONT> witness or otherwise by
reason of (i)&nbsp;the fact that Indemnitee is or was a director or officer of the Company (or has accepted employment with, has been in discussions with, or has otherwise agreed to provide services for, the Company), (ii)&nbsp;any action taken by
Indemnitee or any action or inaction on Indemnitee&#146;s part while acting as a director or officer of the Company (or in connection with discussions regarding employment with, or agreement to provide services for, the Company, and prior to the
commencement of such employment or services), or (iii)&nbsp;the fact that he or she is or was serving at (or agreed to serve at) the request of the Company as a director, trustee, general partner, managing member, officer, employee, agent or
fiduciary of the Company or any other Enterprise, in each case whether or not serving in such capacity at the time any liability or Expense is incurred for which indemnification or advancement of expenses can be provided under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 3 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Reference to &#147;<B><I>other enterprises</I></B>&#148; shall include employee benefit
plans; references to &#147;<B><I>fines</I></B>&#148; shall include any excise taxes assessed on a person with respect to any employee benefit plan; references to &#147;<B><I>serving at the request of the Company</I></B>&#148; shall include any
service as a director, officer, employee or agent of the Company which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants or beneficiaries; and a person
who acted in good faith and in a manner he or she reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner &#147;<B><I>not opposed to the best
interests of the Company</I></B>&#148; as referred to in this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <B>Indemnity in Third-Party Proceedings.</B> The Company shall
indemnify Indemnitee in accordance with the provisions of this Section&nbsp;2 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding, other than a Proceeding by or in the right of the Company to procure a
judgment in its favor. Pursuant to this Section&nbsp;2, Indemnitee shall be indemnified to the fullest extent permitted by applicable law against all Expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred by
Indemnitee or on his or her behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Company and,
with respect to any criminal action or proceeding, had no reasonable cause to believe that his or her conduct was unlawful; provided, however, that (a)&nbsp;the Company shall not be obligated to provide advancement of expenses or indemnify
Indemnitee hereunder for any claims against Indemnitee to the extent such claims arise out of acts or omissions of wrongdoing by Indemnitee during his employment with Standard BioTools, LLC or its parent, subsidiaries, affiliates, successors or
assigns (collectively, &#147;<B><I>SBT</I></B>&#148;) that occurred before he commenced discussions with the Company about potential employment with the Company or that were unrelated to his discussions with the Company about potential employment
with the Company; (b)&nbsp;the Company shall not be obligated to indemnify Indemnitee hereunder if Indemnitee violates the Prior Employer Rep and Warranty (as defined below) (the &#147;<B><I>Indemnity Exclusions</I></B>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <B>Indemnity in Proceedings by or in the Right of the Company.</B> The Company shall indemnify Indemnitee in accordance with the provisions
of this Section&nbsp;3 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding by or in the right of the Company to procure a judgment in its favor. Pursuant to this Section&nbsp;3, Indemnitee shall be
indemnified to the fullest extent permitted by applicable law against all Expenses and, to the fullest extent permitted by law, amounts paid in settlement actually and reasonably incurred by Indemnitee or on Indemnitee&#146;s behalf in connection
with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Company. No indemnification shall be made under this
Section&nbsp;3 in respect of any claim, issue or matter that (a)&nbsp;falls within the Indemnity Exclusions or (b)&nbsp;as to which Indemnitee shall have been adjudged by a court of competent jurisdiction to be liable to the Company, unless and only
to the extent that the Delaware Court of Chancery or any court in which the Proceeding was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, Indemnitee is fairly
and reasonably entitled to indemnification for such expenses as the Delaware Court of Chancery or such other court shall deem proper. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 4 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <B>Indemnification for Expenses of a Party Who is Wholly or Partly Successful.</B> To the
extent that Indemnitee is a party to or a participant in and is successful (on the merits or otherwise) in defense of any Proceeding or any claim, issue or matter therein, the Company shall indemnify Indemnitee against all Expenses actually and
reasonably incurred by Indemnitee or on Indemnitee&#146;s behalf in connection therewith. To the extent permitted by applicable law, and subject to the Indemnity Exclusions, if Indemnitee is not wholly successful in such Proceeding but is
successful, on the merits or otherwise, in defense of one or more but less than all claims, issues or matters in such Proceeding, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on
Indemnitee&#146;s behalf in connection with (a)&nbsp;each successfully resolved claim, issue or matter and (b)&nbsp;any claim, issue or matter related to any such successfully resolved claim, issuer or matter. For purposes of this section, and
except with respect to the Indemnity Exclusions, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <B>Indemnification for Expenses of a Witness.</B> To the extent that Indemnitee is, by reason of his or her Corporate Status, a witness in
any Proceeding to which Indemnitee is not a party, Indemnitee shall be indemnified to the extent permitted by applicable law against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee&#146;s behalf in connection therewith.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <B>Additional Indemnification.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding any limitation in Sections&nbsp;2, 3 or 4 other than the Indemnity Exclusions, the Company shall indemnify Indemnitee to
the fullest extent permitted by applicable law if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor) against all
Expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred by Indemnitee or on his or her behalf in connection with the Proceeding or any claim, issue or matter therein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) For purposes of Section&nbsp;6(a), the meaning of the phrase &#147;<B><I>to the fullest extent permitted by applicable law</I></B>&#148;
shall include, but not be limited to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the fullest extent permitted by the provision of the DGCL that authorizes or contemplates
additional indemnification by agreement, or the corresponding provision of any amendment to or replacement of the DGCL; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the
fullest extent authorized or permitted by any amendments to or replacements of the DGCL adopted after the date of this Agreement that increase the extent to which a corporation may indemnify its officers and directors. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <B>Exclusions.</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
Notwithstanding any provision in this Agreement, the Company shall not be obligated under this Agreement to make any indemnity in connection with respect to the Indemnity Exclusions or any Proceeding (or any part of any Proceeding): </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 5 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) for which payment has actually been made to or on behalf of Indemnitee under any
statute, insurance policy, indemnity provision, vote or otherwise, except with respect to any excess beyond the amount paid; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) for an
accounting or disgorgement of profits pursuant to Section&nbsp;16(b) of the Securities Exchange Act of 1934, as amended, or similar provisions of federal, state or local statutory law or common law, if Indemnitee is held liable therefor (including
pursuant to any settlement arrangements); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) for any reimbursement of the Company by Indemnitee of any bonus or other incentive-based
or equity-based compensation or of any profits realized by Indemnitee from the sale of securities of the Company, as required in each case under the Securities Exchange Act of 1934, as amended (including any such reimbursements that arise from an
accounting restatement of the Company pursuant to Section&nbsp;304 of the Sarbanes-Oxley Act of 2002 (the &#147;<B><I>Sarbanes-Oxley Act</I></B>&#148;), or the payment to the Company of profits arising from the purchase and sale by Indemnitee of
securities in violation of Section&nbsp;306 of the Sarbanes-Oxley Act), if Indemnitee is held liable therefor (including pursuant to any settlement arrangements); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against the Company or its
directors, officers, employees, agents or other indemnitees, unless (i)&nbsp;the Company&#146;s board of directors authorized the Proceeding (or the relevant part of the Proceeding) prior to its initiation, (ii)&nbsp;the Company provides the
indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law, (iii)&nbsp;otherwise authorized in Section&nbsp;12(d) or (iv)&nbsp;otherwise required by applicable law; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) if prohibited by applicable law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <B>Advances of Expenses.</B> The Company shall advance the Expenses incurred by Indemnitee in connection with any Proceeding, and such
advancement shall be made as soon as reasonably practicable, but in any event no later than 30 days, after the receipt by the Company of a written statement or statements requesting such advances from time to time (which shall include invoices
received by Indemnitee in connection with such Expenses but, in the case of invoices in connection with legal services, any references to legal work performed or to expenditure made that would cause Indemnitee to waive any privilege accorded by
applicable law shall not be included with the invoice). Advances shall be unsecured and interest free and made without regard to Indemnitee&#146;s ability to repay such advances. Indemnitee hereby undertakes to repay any advance to the extent that
it is ultimately determined that Indemnitee is not entitled to be indemnified by the Company. This Section&nbsp;8 shall not apply to the extent advancement is prohibited by law and shall not apply to any Proceeding for which indemnity is not
permitted under this Agreement, but shall apply to any Proceeding referenced in Section&nbsp;7(a)(iii) prior to a determination that Indemnitee is not entitled to be indemnified by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 6 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <B>Procedures for Notification and Defense of Claim.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Indemnitee shall notify the Company in writing of any matter with respect to which Indemnitee intends to seek indemnification or
advancement of Expenses as soon as reasonably practicable following the receipt by Indemnitee of notice thereof. The written notification to the Company shall include, in reasonable detail, a description of the nature of the Proceeding and the facts
underlying the Proceeding. The failure by Indemnitee to notify the Company will not relieve the Company from any liability which it may have to Indemnitee hereunder or otherwise than under this Agreement, and any delay in so notifying the Company
shall not constitute a waiver by Indemnitee of any rights, except to the extent that such failure or delay materially prejudices the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If, at the time of the receipt of a notice of a Proceeding pursuant to the terms hereof, the Company has directors&#146; and officers&#146;
liability insurance in effect, the Company shall give prompt notice of the commencement of the Proceeding to the insurers in accordance with the procedures set forth in the applicable policies. The Company shall thereafter take all
commercially-reasonable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of such policies. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) In the event the Company may be obligated to make any indemnity in connection with a Proceeding, the Company shall be entitled to assume
the defense of such Proceeding with counsel approved by Indemnitee, which approval shall not be unreasonably withheld, upon the delivery to Indemnitee of written notice of its election to do so. After delivery of such notice, approval of such
counsel by Indemnitee and the retention of such counsel by the Company, the Company will not be liable to Indemnitee for any fees or expenses of counsel subsequently incurred by Indemnitee with respect to the same Proceeding. Notwithstanding the
Company&#146;s assumption of the defense of any such Proceeding, the Company shall be obligated to pay the fees and expenses of Indemnitee&#146;s counsel to the extent (i)&nbsp;the employment of counsel by Indemnitee is authorized by the Company,
(ii)&nbsp;counsel for the Company or Indemnitee shall have reasonably concluded that there is a conflict of interest between the Company and Indemnitee in the conduct of any such defense such that Indemnitee needs to be separately represented,
(iii)&nbsp;the Company is not financially or legally able to perform its indemnification obligations or (iv)&nbsp;the Company shall not have retained, or shall not continue to retain, such counsel to defend such Proceeding. The Company shall have
the right to conduct such defense as it sees fit in its sole discretion. Regardless of any provision in this Agreement, Indemnitee shall have the right to employ counsel in any Proceeding at Indemnitee&#146;s personal expense. The Company shall not
be entitled, without the consent of Indemnitee, to assume the defense of any claim brought by or in the right of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)
Indemnitee shall give the Company such information and cooperation in connection with the Proceeding as may be reasonably appropriate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)
The Company shall not be liable to indemnify Indemnitee for any settlement of any Proceeding (or any part thereof) without the Company&#146;s prior written consent, which shall not be unreasonably withheld. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 7 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Company shall not settle any Proceeding (or any part thereof) without
Indemnitee&#146;s prior written consent, which shall not be unreasonably withheld. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <B>Procedures upon Application for
Indemnification.</B><B> </B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) To obtain indemnification, Indemnitee shall submit to the Company a written request, including therein or
therewith such documentation and information as is reasonably available to Indemnitee and as is reasonably necessary to determine whether and to what extent Indemnitee is entitled to indemnification following the final disposition of the Proceeding.
The Company shall, as soon as reasonably practicable after receipt of such a request for indemnification, advise the board of directors that Indemnitee has requested indemnification. Any delay in providing the request will not relieve the Company
from its obligations under this Agreement, except to the extent such failure is prejudicial. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Upon written request by Indemnitee for
indemnification pursuant to Section&nbsp;10(a), a determination with respect to Indemnitee&#146;s entitlement thereto shall be made in the specific case (i)&nbsp;if a Change in Control shall have occurred, by Independent Counsel in a written opinion
to the Company&#146;s board of directors, a copy of which shall be delivered to Indemnitee or (ii)&nbsp;if a Change in Control shall not have occurred, (A)&nbsp;by a majority vote of the Disinterested Directors, even though less than a quorum of the
Company&#146;s board of directors, (B)&nbsp;by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than a quorum of the Company&#146;s board of directors, (C)&nbsp;if there are no
such Disinterested Directors or, if such Disinterested Directors so direct, by Independent Counsel in a written opinion to the Company&#146;s board of directors, a copy of which shall be delivered to Indemnitee or (D)&nbsp;if so directed by the
Company&#146;s board of directors, by the stockholders of the Company. If it is determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten days after such determination. Indemnitee shall cooperate with
the person, persons or entity making the determination with respect to Indemnitee&#146;s entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or information that is
not privileged or otherwise protected from disclosure and that is reasonably available to Indemnitee and reasonably necessary to such determination. Any costs or expenses (including attorneys&#146; fees and disbursements) reasonably incurred by
Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Company, to the extent permitted by applicable law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) In the event the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section&nbsp;10(b), the
Independent Counsel shall be selected as provided in this Section&nbsp;10(c). If a Change in Control shall not have occurred, the Independent Counsel shall be selected by the Company&#146;s board of directors, and the Company shall give written
notice to Indemnitee advising him or her of the identity of the Independent Counsel so selected. If a Change in Control shall have occurred, the Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection
be made by the Company&#146;s board of directors, in which event the preceding sentence shall apply), and Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel so selected. In either event,
Indemnitee or the Company, as the case may be, may, within ten days after such written notice of selection shall have </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 8 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
been given, deliver to the Company or to Indemnitee, as the case may be, a written objection to such selection; <I>provided</I>, <I>however</I>, that such objection may be asserted only on the
ground that the Independent Counsel so selected does not meet the requirements of &#147;Independent Counsel&#148; as defined in Section&nbsp;1 of this Agreement, and the objection shall set forth with particularity the factual basis of such
assertion. Absent a proper and timely objection, the person so selected shall act as Independent Counsel. If such written objection is so made and substantiated, the Independent Counsel so selected may not serve as Independent Counsel unless and
until such objection is withdrawn or a court has determined that such objection is without merit. If, within 20 days after the later of (i)&nbsp;submission by Indemnitee of a written request for indemnification pursuant to Section&nbsp;10(a) hereof
and (ii)&nbsp;the final disposition of the Proceeding, the parties have not agreed upon an Independent Counsel, either the Company or Indemnitee may petition a court of competent jurisdiction for resolution of any objection which shall have been
made by the Company or Indemnitee to the other&#146;s selection of Independent Counsel and for the appointment as Independent Counsel of a person selected by the court or by such other person as the court shall designate, and the person with respect
to whom all objections are so resolved or the person so appointed shall act as Independent Counsel under Section&nbsp;10(b) hereof. Upon the due commencement of any judicial proceeding or arbitration pursuant to Section&nbsp;12(a) of this Agreement,
the Independent Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company agrees to pay the reasonable fees and expenses of any Independent Counsel and to fully indemnify such counsel against any and
all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.
<B>Presumptions and Effect of Certain Proceedings.</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) In making a determination with respect to entitlement to indemnification
hereunder, the person, persons or entity making such determination shall, to the fullest extent not prohibited by law, presume that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for
indemnification in accordance with Section&nbsp;10(a) of this Agreement, and the Company shall, to the fullest extent not prohibited by law, have the burden of proof to overcome that presumption in connection with the making by such person, persons
or entity of any determination contrary to that presumption. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The termination of any Proceeding or of any claim, issue or matter
therein, by judgment, order, settlement or conviction, or upon a plea of <I>nolo</I> <I>contendere</I> or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect the right of Indemnitee to
indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that
Indemnitee had reasonable cause to believe that his or her conduct was unlawful. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 9 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) For purposes of any determination of good faith, Indemnitee shall be deemed to have
acted in good faith to the extent Indemnitee relied in good faith on (i)&nbsp;the records or books of account of the Enterprise, including financial statements, (ii)&nbsp;information supplied to Indemnitee by the officers of the Enterprise in the
course of their duties, (iii)&nbsp;the advice of legal counsel for the Enterprise or its board of directors or counsel selected by any committee of the board of directors that was provided following the date of this Agreement or
(iv)&nbsp;information or records given or reports made to the Enterprise by an independent certified public accountant, an appraiser, investment banker or other expert selected with reasonable care by the Enterprise or its board of directors or any
committee of the board of directors. The provisions of this Section&nbsp;11(c) shall not be deemed to be exclusive or to limit in any way the other circumstances in which Indemnitee may be deemed to have met the applicable standard of conduct set
forth in this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Neither the knowledge, actions nor failure to act of any other director, officer, agent or employee of the
Enterprise shall be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <B>Remedies
of Indemnitee.</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to Section&nbsp;12(e), in the event that (i)&nbsp;a determination is made pursuant to Section&nbsp;10 of
this Agreement that Indemnitee is not entitled to indemnification under this Agreement, (ii)&nbsp;advancement of Expenses is not timely made pursuant to Section&nbsp;8 or 12(d) of this Agreement, (iii)&nbsp;no determination of entitlement to
indemnification shall have been made pursuant to Section&nbsp;10 of this Agreement within 90 days after the later of the receipt by the Company of the request for indemnification or the final disposition of the Proceeding, (iv)&nbsp;payment of
indemnification pursuant to this Agreement is not made (A)&nbsp;within ten days after a determination has been made that Indemnitee is entitled to indemnification or (B)&nbsp;with respect to indemnification pursuant to Sections&nbsp;4, 5 and 12(d)
of this Agreement, within 30 days after receipt by the Company of a written request therefor, or (v)&nbsp;the Company or any other person or entity takes or threatens to take any action to declare this Agreement void or unenforceable, or institutes
any litigation or other action or proceeding designed to deny, or to recover from, Indemnitee the benefits provided or intended to be provided to Indemnitee hereunder, Indemnitee shall be entitled to an adjudication by a court of competent
jurisdiction of his or her entitlement to such indemnification or advancement of Expenses. Indemnitee shall commence such proceeding seeking an adjudication within 180 days following the date on which Indemnitee first has the right to commence such
proceeding pursuant to this Section&nbsp;12(a); <I>provided, however,</I> that the foregoing clause shall not apply in respect of a proceeding brought by Indemnitee to enforce his or her rights under Section&nbsp;4 of this Agreement or with respect
to the Indemnity Exclusions. The Company shall not oppose Indemnitee&#146;s right to seek any such adjudication in accordance with this Agreement. For the sake of clarity, nothing in this Agreement prohibits Indemnitee from seeking an adjudication
to enforce his or her rights under Section&nbsp;4 of this Agreement, and Indemnitee expressly has not waived his or her right to seek such an adjudication. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Neither (i)&nbsp;the failure of the Company, its board of directors, any committee or subgroup of the board of directors, Independent
Counsel or stockholders to have made a determination that indemnification of Indemnitee is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor (ii)&nbsp;an actual determination by the Company, its board of
directors, any committee or subgroup of the board of directors, Independent Counsel or stockholders that Indemnitee has not met the applicable standard of conduct, shall be a defense to the action or create a
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 10 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
presumption that Indemnitee has or has not met the applicable standard of conduct. In the event that a determination shall have been made pursuant to Section&nbsp;10 of this Agreement that
Indemnitee is not entitled to indemnification, any judicial proceeding commenced pursuant to this Section&nbsp;12 shall be conducted in all respects as a <I>de novo</I> trial, on the merits, and Indemnitee shall not be prejudiced by reason of that
adverse determination. In any judicial proceeding commenced pursuant to this Section&nbsp;12, the Company shall, to the fullest extent not prohibited by law, have the burden of proving Indemnitee is not entitled to indemnification or advancement of
Expenses, as the case may be. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) To the fullest extent not prohibited by law, the Company shall be precluded from asserting in any
judicial proceeding commenced pursuant to this Section&nbsp;12 that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court that the Company is bound by all the provisions of
this Agreement. If a determination shall have been made pursuant to Section&nbsp;10 of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding commenced pursuant to
this Section&nbsp;12, absent (i)&nbsp;a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee&#146;s statements not materially misleading, in connection with the request for indemnification, or
(ii)&nbsp;a prohibition of such indemnification under applicable law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) To the extent not prohibited by law and except with respect to
the Indemnity Exclusions, the Company shall indemnify Indemnitee against all Expenses that are incurred by Indemnitee in connection with any action for indemnification or advancement of Expenses from the Company under this Agreement unless as a part
of such action, the court of competent jurisdiction determines that each of the material assertions made by Indemnitee as a basis for such action were not made in good faith or were frivolous or to the extent Indemnitee is successful in such action,
and, if requested by Indemnitee, shall (as soon as reasonably practicable, but in any event no later than 30 days, after receipt by the Company of a written request therefor) advance such Expenses to Indemnitee, subject to the provisions of
Section&nbsp;8. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding anything in this Agreement to the contrary, no determination as to entitlement to indemnification
shall be required to be made prior to the final disposition of the Proceeding. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <B>Contribution.</B> To the fullest extent permissible
under applicable law, if the indemnification provided for in this Agreement is unavailable to Indemnitee, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amounts incurred by Indemnitee, whether for Expenses, judgments, fines
or amounts paid or to be paid in settlement, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Proceeding in order
to reflect (i)&nbsp;the relative benefits received by the Company and Indemnitee as a result of the events and transactions giving rise to such Proceeding; and (ii)&nbsp;the relative fault of Indemnitee and the Company (and its other directors,
officers, employees and agents) in connection with such events and transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 11 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <B><FONT STYLE="white-space:nowrap">Non-exclusivity.</FONT></B> Except with respect to
the Indemnity Exclusions, the rights of indemnification and to receive advancement of Expenses as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law, the
Company&#146;s certificate of incorporation or bylaws, any agreement, a vote of stockholders or a resolution of directors, or otherwise. To the extent that a change in Delaware law, whether by statute or judicial decision, permits greater
indemnification or advancement of Expenses than would be afforded currently under the Company&#146;s certificate of incorporation and bylaws and this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the
greater benefits so afforded by such change, subject to the restrictions expressly set forth herein or therein. Except as expressly set forth herein, no right or remedy herein conferred is intended to be exclusive of any other right or remedy, and
every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. Except as expressly set forth herein, the assertion or employment of any
right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.
<B>Primary Responsibility. </B>The Company acknowledges that Indemnitee has or may have certain rights to indemnification and advancement of expenses provided by other entities and/or organizations (collectively, the &#147;<B><I>Secondary
Indemnitors</I></B>&#148;). The Company hereby agrees, except for SBT&#146;s obligations with respect to the Indemnity Exclusions, (i)&nbsp;that it is the indemnitor of first resort (i.e., its obligations to Indemnitee are primary and any obligation
of the Secondary Indemnitors to advance Expenses or to provide indemnification for the same Expenses or liabilities incurred by Indemnitee in connection with a Proceeding are secondary), (ii) that it shall be required to advance the full amount of
Expenses incurred by Indemnitee and shall be liable for the full amount of all Expenses, judgments, penalties, fines and amounts paid in settlement to the extent legally permitted and as required by the terms of this Agreement and the certificate of
incorporation or bylaws of the Company (or any other agreement between the Company and Indemnitee), without regard to any rights Indemnitee may have against the Secondary Indemnitors, and (iii)&nbsp;that, to the extent not in contravention of any
insurance policy or policies providing liability or other insurance for the Company or any director, trustee, general partner, managing member, officer, employee, agent or fiduciary of the Company or any other Enterprise, it irrevocably waives,
relinquishes and releases the Secondary Indemnitors from any and all claims against the Secondary Indemnitors for contribution, subrogation or any other recovery of any kind in respect thereof.&nbsp;The Company further agrees that, except with
respect to SBT&#146;s obligations with respect to the Indemnity Exclusions, no advancement or payment by the Secondary Indemnitors on behalf of Indemnitee with respect to any claim for which indemnification is required under the terms of this
Agreement shall affect the foregoing and the Secondary Indemnitors shall have a right of contribution and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery of Indemnitee against the Company.&nbsp;The
Company and Indemnitee agree that the Secondary Indemnitors are express third party beneficiaries of the terms of this Section&nbsp;15. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <B>No Duplication of Payments.</B> The Company shall not be liable under this Agreement to make any payment of amounts otherwise
indemnifiable hereunder (or for which advancement is provided hereunder) if and to the extent that Indemnitee has otherwise actually received payment for such amounts under any insurance policy, contract, agreement or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 12 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <B>Insurance.</B> The Company shall, from time to time, make the good faith
determination whether or not it is practicable for the Company to obtain and maintain a policy or policies of insurance with reputable insurance companies providing the officers and directors of the Company with coverage for losses from wrongful
acts, or to ensure the Company&#146;s performance of its indemnification obligations under this Agreement. Among other considerations, the Company will weigh the costs of obtaining such insurance coverage against the protection afforded by such
coverage. In all policies of director and officer liability insurance, Indemnitee shall be named as an insured in such a manner as to provide Indemnitee the same rights and benefits as are accorded to the most favorably insured of the Company&#146;s
directors, if Indemnitee is a director; or of the Company&#146;s officers, if Indemnitee is not a director of the Company but is an officer. Notwithstanding the foregoing, the Company shall have no obligation to obtain or maintain such insurance if
the Company determines in good faith that such insurance is not reasonably available, if the premium costs for such insurance are disproportionate to the amount of coverage provided, if the coverage provided by such insurance is limited by
exclusions so as to provide an insufficient benefit, or if Indemnitee is covered by similar insurance maintained by a subsidiary or parent of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <B>Subrogation.</B> In the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all
of the rights of recovery of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <B>Services to the Company.</B> Indemnitee agrees to serve as a director or officer of the Company or, at the request of the Company,
as a director, trustee, general partner, managing member, officer, employee, agent or fiduciary of another Enterprise, for so long as Indemnitee is duly elected or appointed or until Indemnitee tenders his or her resignation or is removed from such
position. Indemnitee may at any time and for any reason resign from such position (subject to any other contractual obligation or any obligation imposed by operation of law), in which event the Company shall have no obligation under this Agreement
to continue Indemnitee in such position. This Agreement shall not be deemed an employment contract between the Company (or any of its subsidiaries or any Enterprise) and Indemnitee. Indemnitee specifically acknowledges that any employment with the
Company (or any of its subsidiaries or any Enterprise) is at will, and Indemnitee may be discharged at any time for any reason, with or without cause, with or without notice, except as may be otherwise expressly provided in any executed, written
employment contract between Indemnitee and the Company (or any of its subsidiaries or any Enterprise), any existing formal severance policies adopted by the Company&#146;s board of directors or, with respect to service as a director or officer of
the Company, the Company&#146;s certificate of incorporation or bylaws or the DGCL. No such document shall be subject to any oral modification thereof. Indemnitee represents and warrants that Indemnitee has not used, disclosed or transmitted to the
Company at any time since commencing discussions about prospective employment with the Company, and will not use, disclose or bring on to the Company&#146;s premises, computer systems or communication systems at any time hereafter, any trade secret,
confidential or proprietary information of any of his prior employers (the &#147;<B><I>Prior Employer Rep and Warranty</I></B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 13 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <B>Successors.</B> This Agreement shall be binding upon the Company and its successors
and assigns, including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business or assets of the Company, and shall inure to the benefit of Indemnitee and Indemnitee&#146;s heirs,
executors and administrators. The Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets of the Company, by written agreement,
expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. <B>Severability.</B> Nothing in this Agreement is intended to require or shall be construed as requiring the Company to do or fail to do
any act in violation of applicable law. The Company&#146;s inability, pursuant to court order or other applicable law, to perform its obligations under this Agreement shall not constitute a breach of this Agreement. If any provision or provisions of
this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (i)&nbsp;the validity, legality and enforceability of the remaining provisions of this Agreement (including without limitation, each portion of any
section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the
fullest extent permitted by law; (ii)&nbsp;such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto; and (iii)&nbsp;to the fullest
extent possible, the provisions of this Agreement (including, without limitation, each portion of any section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or
unenforceable) shall be construed so as to give effect to the intent manifested thereby. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. <B>Enforcement.</B> The Company expressly
confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in order to induce Indemnitee to serve as a director or officer of the Company, and the Company acknowledges that Indemnitee is relying upon
this Agreement in serving as a director or officer of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23. <B>Entire Agreement.</B> This Agreement constitutes the entire
agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof; <I>provided</I>,
<I>however</I>, that this Agreement is a supplement to and in furtherance of the Company&#146;s certificate of incorporation and bylaws and applicable law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24. <B>Modification and Waiver.</B> No supplement, modification or amendment to this Agreement shall be binding unless executed in writing by
the parties hereto. No amendment, alteration or repeal of this Agreement shall adversely affect any right of Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee in his or her Corporate Status prior to such
amendment, alteration or repeal. No waiver of any of the provisions of this Agreement shall constitute or be deemed a waiver of any other provision of this Agreement nor shall any waiver constitute a continuing waiver. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 14 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25. <B>Notices.</B> All notices and other communications required or permitted hereunder
shall be in writing and shall be mailed by registered or certified mail, postage prepaid, sent by facsimile or electronic mail or otherwise delivered by hand, messenger or courier service addressed: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) if to Indemnitee, to Indemnitee&#146;s address, facsimile number or electronic mail address as shown on the signature page of this
Agreement or in the Company&#146;s records, as may be updated in accordance with the provisions hereof; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) if to the Company, to the
attention of the Chief Executive Officer or Chief Financial Officer of the Company at 2 Tower Place, Suite 2000, South San Francisco, CA 94080, or at such other current address as the Company shall have furnished to Indemnitee, with a copy (which
shall not constitute notice) to Robert Kornegay, Wilson Sonsini Goodrich&nbsp;&amp; Rosati, P.C., 650 Page Mill Road, Palo Alto, California 94304. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each such notice or other communication shall for all purposes of this Agreement be treated as effective or having been given (i)&nbsp;if
delivered by hand, messenger or courier service, when delivered (or if sent <I>via</I> a nationally-recognized overnight courier service, freight prepaid, specifying <FONT STYLE="white-space:nowrap">next-business-day</FONT> delivery, one business
day after deposit with the courier), or (ii)&nbsp;if sent <I>via</I> mail, at the earlier of its receipt or three days after the same has been deposited in a regularly-maintained receptacle for the deposit of the United States mail, addressed and
mailed as aforesaid, or (iii)&nbsp;if sent <I>via</I> facsimile, upon confirmation of facsimile transfer or, if sent <I>via</I> electronic mail, upon confirmation of delivery when directed to the relevant electronic mail address, if sent during
normal business hours of the recipient, or if not sent during normal business hours of the recipient, then on the recipient&#146;s next business day. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">26. <B>Applicable Law and Consent to Jurisdiction.</B> This Agreement and the legal relations among the parties shall be governed by, and
construed and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict of laws rules. The Company and Indemnitee hereby irrevocably and unconditionally (i)&nbsp;agree that any action or proceeding arising out of
or in connection with this Agreement shall be brought only in the Delaware Court of Chancery, and not in any other state or federal court in the United States of America or any court in any other country, (ii)&nbsp;consent to submit to the exclusive
jurisdiction of the Delaware Court of Chancery for purposes of any action or proceeding arising out of or in connection with this Agreement, (iii)&nbsp;appoint, to the extent such party is not otherwise subject to service of process in the State of
Delaware, The Corporation Trust Company, Wilmington, Delaware as its agent in the State of Delaware as such party&#146;s agent for acceptance of legal process in connection with any such action or proceeding against such party with the same legal
force and validity as if served upon such party personally within the State of Delaware, (iv)&nbsp;waive any objection to the laying of venue of any such action or proceeding in the Delaware Court of Chancery, and (v)&nbsp;waive, and agree not to
plead or to make, any claim that any such action or proceeding brought in the Delaware Court of Chancery has been brought in an improper or inconvenient forum. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 15 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">27. <B>Counterparts.</B> This Agreement may be executed in one or more counterparts, each of
which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement. This Agreement may also be executed and delivered by facsimile signature and in counterparts, each of which shall for all
purposes be deemed to be an original but all of which together shall constitute one and the same Agreement. Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this
Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>28.</B> <B>Termination of Obligations</B>. The Company&#146;s obligations under this Agreement to provide indemnification
and/or advancement of expenses to Indemnitee shall terminate as of the date of termination of either (x)&nbsp;the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock Purchase Agreement, dated as of January&nbsp;23, 2022,
by and between the Company, Casdin Private Growth Equity Fund II, L.P. and Casdin Partners Master Fund, L.P. or (y)&nbsp;the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock Purchase Agreement, dated as of
January&nbsp;23, 2022, by and between the Company, Viking Global Opportunities Illiquid Investments <FONT STYLE="white-space:nowrap">Sub-Master</FONT> LP and Viking Global Opportunities Drawdown (Aggregator) LP, each in accordance with its terms.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29. <B>Captions.</B> The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to
constitute part of this Agreement or to affect the construction thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(<I>signature page follows</I>) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 16 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>FLUIDIGM CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Vikram Jog</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>Signature of Authorized Signatory</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Vikram Jog</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>Print Name</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Chief Financial Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>Title</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">2 Tower Place, Suite 2000</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">South San Francisco, CA 94080</TD></TR></TABLE></DIV>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="65%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>AGREED TO AND ACCEPTED:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>INDEMNITEE:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael Egholm</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>Signature</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Michael Egholm</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>Print Name</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CEO</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>Title</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">[***]</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>10
<FILENAME>d243622dex109.htm
<DESCRIPTION>EX-10.9
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.9</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Exhibit 10.9 </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PERSONAL&nbsp;&amp; CONFIDENTIAL </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">January&nbsp;23, 2022 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hanjoon Alex Kim </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***] </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Re: Offer of Employment with Fluidigm Corporation
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Alex, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are pleased to offer you employment with
Fluidigm Corporation (the &#147;<B>Company</B>&#148;), effective on or about the closing (the &#147;<B>Closing</B>,&#148; and the date of Closing, the &#147;<B>Closing Date</B>&#148;) of that certain private placement of convertible preferred stock
(the &#147;<B>Transaction</B>&#148;) of the Company to Casdin Capital, LLC and/or one or more of its affiliates and Viking Global Investors LP and/or one or more of its affiliates, or as otherwise agreed between you and the Company (the
<B>&#147;Effective Date</B>&#148;). The terms of your employment will be governed by the terms and conditions described herein. This offer is contingent upon the consummation of the Transaction. If the Transaction does not occur, this offer is null
and void ab initio. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a summary of your position, compensation, and benefits to be associated with your employment with the Company as of
the Effective Date. Capitalized terms not defined herein will have the meanings set forth in the Severance Plan (as defined below). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Position:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Operating Officer.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Reporting Line:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Work Location:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">For an initial period of time, you will work remotely from your home in Greer, SC, with required business travel as appropriate and expected for your role. You and the Company shall mutually agree on the timing of relocating your
residence to Boston, Massachusetts, anticipated before the first anniversary of the Effective Date. Boston, Massachusetts will then be your expected primary location of work. In connection with such relocation, the Company shall provide Executive
with an executive-level relocation package to include, without limitation, reimbursement on an <FONT STYLE="white-space:nowrap">after-tax</FONT> basis for temporary living, moving of household goods, closing costs, brokers fees on the sale of
Executive&#146;s current primary residence and other expenses normally included in an executive-level relocation package, up to a maximum aggregate reimbursement of $150,000, grossed up for any applicable taxes. Any reimbursements payable to you are
subject to the provisions of Section&nbsp;409A of the Internal Revenue Code of 1986, as amended, any such reimbursements will be paid no later than December&nbsp;31 of the year following the year in which the expense was incurred, the amount of
expenses reimbursed in one year will not affect the amount eligible for reimbursement in any subsequent year, and the right to reimbursement will not be subject to liquidation or exchange for another benefit.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Base Salary:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The annual base salary payable to you will be $400,000 (&#147;<B>Base Salary</B>&#148;), payable in substantially equal installments on a regular basis in accordance with the Company&#146;s standard payroll procedures. Your Base
Salary may be subject to annual review and adjustment, as determined by the Company&#146;s board of directors or its delegate (the &#147;<B>Committee</B>&#148;) in its sole discretion.</TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Annual Bonus</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">During each fiscal year of your employment, you will be eligible to receive an annual cash bonus with a target bonus of 55% of your Base Salary (the &#147;<B>Annual Bonus</B>&#148;), based on the performance of the Company and/or
your individual performance as determined by the Committee in its sole discretion. Your 2022 Annual Bonus (if any) will be prorated based on your partial year of employment. Payment of the Annual Bonus will be made as soon as practicable following
the end of the fiscal year during which the Annual Bonus was earned and after the Annual Bonus is approved by the Committee, but in no event later than the fifteenth (15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) day of the third (3<SUP
STYLE="font-size:85%; vertical-align:top">rd</SUP>) month of the fiscal year following the date the Annual Bonus has been earned and is no longer subject to a substantial risk of forfeiture. Unless otherwise determined by the Committee, you must be
employed by the Company or any affiliate on the date the Annual Bonus is paid to receive such payment. Your Annual Bonus target may be subject to annual review and adjustment, as determined by the Committee in its sole discretion.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Equity</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a material inducement for you commencing employment with the Company, promptly following the Closing, you will receive an equity award in
the form of nonqualified stock options (&#147;<B>Option Award</B>&#148;) to purchase up to 1% of the outstanding shares of common stock of the Company at the Closing, calculated on a fully diluted basis (such shares, the &#147;<B>Option
Shares</B>&#148;) (with such share number subject to reduction under the terms of the immediately following paragraph), with a per share exercise price (the &#147;<B>Exercise Price</B>&#148;) of the greater of (i) $3.40 (the &#147;<B>Conversion
Price</B>&#148;) or (ii)&nbsp;the fair market value of a share of common stock on the Option Award grant date, pursuant to the Company&#146;s 2022 Inducement Equity Incentive Plan (the &#147;<B>Inducement Plan</B>&#148;). Subject to your continued
employment with the Company through the applicable vesting date, 25% of the shares subject to the Option Award will vest on the first anniversary of the vesting commencement date, and the remaining 75% of the shares subject to the Option Award will
vest in equal monthly installments thereafter (resulting in the Option Award being 100% vested on the fourth anniversary of the vesting commencement date). If you terminate due to your death or Disability (as defined in the Severance Plan), a number
of unvested shares underlying your Option Award that otherwise would vest during the period between your termination date and the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of your termination date immediately will vest.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">In addition, if the Exercise Price exceeds the Conversion Price, then, as a material
inducement for you commencing employment with the Company, promptly following the Closing, you will receive an equity award in the form of restricted stock units (&#147;<B>RSU Award</B>&#148;) covering a number of shares of common stock of the
Company equal to (i)&nbsp;the amount by which the Exercise Price exceeds the Conversion Price, multiplied by the number of Option Shares <I>divided by </I>(ii)&nbsp;the Exercise Price (rounded to the nearest whole share). The shares of common stock
of the Company underlying your RSU Award will reduce on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">share-by-share</FONT></FONT> basis the number of Option Shares. Subject to your continued employment with the Company, 25% of
your RSU Award (if any) will vest in equal annual installments over a four-year period beginning on the first anniversary of the vesting commencement date (resulting in your RSU Award being 100% vested on the fourth anniversary of the vesting
commencement date). If you terminate due to your death or Disability (as defined in the Severance Plan), a number of unvested shares underlying your RSU Award that otherwise would vest during the period between your termination date and the <FONT
STYLE="white-space:nowrap">one-year</FONT> anniversary of your termination date immediately will vest.</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Offer of Employment (Page
<B>2</B> of <B>7</B>) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Option Award and RSU Award (if any) will be subject to the terms of the Inducement Plan and the applicable award agreement thereunder (the &#147;<B>Equity Documents&#148;). The Inducement Plan will include provisions with
respect to the treatment of awards upon a Change in Control (as to be defined in the Inducement Plan) that are substantially similar to the provisions set forth in the Company&#146;s 2011 Equity Incentive Plan, as amended.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Severance&nbsp;Benefits</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to any accrued obligations owed by the Company to you, upon a qualifying termination of employment, you will be eligible to
receive severance benefits under the 2020 Change of Control and Severance Plan (the &#147;<B>Severance Plan</B>&#148;), subject to the terms and conditions provided thereunder and a participation agreement to be provided to you separately by the
Company.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Severance Plan and as provided in a participation agreement
under such plan that will be separately provided to you, if (i)&nbsp;you terminate your employment with the Company (or any parent or subsidiary of the Company) for Good Reason, or (ii)&nbsp;the Company (or any parent or subsidiary of the Company)
terminates your employment for a reason other than Cause or your death or Disability, within three months prior to or 12 months following a Change of Control (the &#147;<B>COC Period</B>&#148;), subject to your execution and <FONT
STYLE="white-space:nowrap">non-revocation</FONT> of a general release of claims provided to you by the Company, you will be entitled to receive the following benefits:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(i)&#8195;a lump sum cash payment equal to 150% of the sum of (x)&nbsp;your Base Salary (as in effect immediately
prior to the Change of Control or your termination of employment, whichever is greater), plus (y)&nbsp;the greater of (A)&nbsp;your target Annual Bonus (as in effect immediately prior to the Change of Control or your termination of employment,
whichever is greater) or (B)&nbsp;the average of the Annual Bonus payments actually paid to you for the three fiscal years preceding the year in which your termination of employment occurs;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(ii)&#8194;&#8201;a lump sum cash payment equal
to (i)&nbsp;your target Annual Bonus (as in effect immediately prior to the Change of Control or termination of employment, whichever is greater), multiplied by (ii)&nbsp;a fraction, the numerator of which is the number of days worked by you during
the year in which your termination of employment occurs and the denominator of which is 365;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(iii)&#8201;&#8201;payment by the Company of continued health coverage under COBRA (or, for any period after
expiration of COBRA eligibility, reimbursement of health insurance monthly costs up to the amount of the COBRA premium that would be payable if COBRA were available at such time) for a period of 18 months following your termination of
employment;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(iv)&#8194;acceleration and
vesting of 100% of your then-outstanding and unvested equity awards; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(v)&#8194;&#8201;&#8202;reasonable outplacement services in accordance with any applicable Company policy in effect as
of your termination of employment (or, if no such policy is in effect, as determined by the Company, in its sole discretion).</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Offer of Employment (Page
<B>3</B> of <B>7</B>) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Severance Plan and as provided in your participation agreement, if the Company (or any parent or subsidiary of the Company)
terminates your employment for a reason other than for Cause, your death or Disability, in each case, outside of the COC Period, subject to your execution of a general release of claims provided to you by the Company, you will be entitled to receive
the following benefits:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(i)&#8195;an
aggregate amount equal to 75% of your Base Salary in effect as of the date of your termination of employment, paid in equal installments over a period of nine months following your termination date;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(ii)&#8194;&#8201;payment by the Company of
continued health coverage under COBRA for a period of nine months following your termination of employment;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(iii)&#8201;&#8201;acceleration and vesting of a number of unvested shares underlying your then-outstanding equity
awards that otherwise would vest during the period between your termination date and the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of your termination date (with the remainder forfeited on termination); and</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(iv)&#8194;reasonable outplacement services in
accordance with any applicable Company policy in effect as of your termination of employment (or, if no such policy is in effect, as determined by the Company, in its sole discretion).</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of your severance benefits provided under the Severance Plan and as
provided in your participation agreement, &#147;<B>Good Reason</B>&#148; will mean the occurrence of one or more of the following events effected without your prior consent, provided that you terminate your employment with the Company within one
year following the initial existence of the &#147;Good Reason&#148; condition: (i) the assignment to you of any duties or the reduction of your then-current duties, either of which results in a material diminution in your then-current position or
responsibilities with the Company, including, without limitation, any negative change in reporting hierarchy involving you or the person to whom you directly report; (ii)&nbsp;a material reduction by the Company in your then-current total base
salary; (iii)&nbsp;a material change in the geographic location at which you must perform services (it being understood that a relocation to a facility or location less than 25 miles from your then-present location will not be considered a material
change in geographic location); or (iv)&nbsp;any material breach by the Company of any material provision of your participation agreement under the Severance Plan. You will not resign for Good Reason without first providing the Company with written
notice of the acts or omissions constituting the grounds for &#147;Good Reason&#148; within 90 days of the initial existence of the grounds for &#147;Good Reason&#148; and a reasonable cure period of not less than 30 days following the date of such
notice.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Please note that the foregoing is a summary of the benefits that the Company
will offer you under the Severance Plan, but does not include all of the terms and conditions of the official Severance Plan document. The official Severance Plan document will govern your eligibility for any severance benefits and upon execution of
a participation agreement under the Severance Plan, any rights to severance benefits in this &#147;Severance Benefits&#148; section will be superseded and replaced with the benefits under the participation agreement.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Paid Time Off (PTO)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">You will be eligible for paid time off (&#147;<B>PTO</B>&#148;) in accordance with the Company&#146;s PTO policy, as it may be amended from time to time.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Offer of Employment (Page
<B>4</B> of <B>7</B>) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Benefit Plans</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">From the Effective Date, you will be eligible to participate in the various group health, disability, and life insurance plans and other employee benefit plans and programs, including sick and vacation time, as generally are offered
by the Company to similarly situated senior management executives from time to time, subject to the terms and conditions of such plans and programs.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Restrictive Covenants</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">As a condition to your employment and in consideration of your employment with the Company, the consideration set forth in this letter (including, but not limited to, the annual bonus opportunity, the Option Award, RSU Award (if
any) and severance benefits), you will be required to sign the <FONT STYLE="white-space:nowrap">At-Will</FONT> Employment, Confidential Information, Invention Assignment and Arbitration Agreement (the &#147;<B>Confidentiality Agreement</B>&#148;)
enclosed with this letter, which, among other things, will provide for post-termination restrictive covenants, including, but not limited to, confidentiality, <FONT STYLE="white-space:nowrap">12-month</FONT>
<FONT STYLE="white-space:nowrap">non-competition</FONT> and <FONT STYLE="white-space:nowrap">12-month</FONT> <FONT STYLE="white-space:nowrap">non-solicitation</FONT> covenants. You acknowledge that you have been provided an opportunity to consult
with an attorney prior to signing the Confidentiality Agreement.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Withholding Taxes</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Company will be entitled to deduct and withhold from any amounts payable under this letter such federal, state, local, <FONT STYLE="white-space:nowrap">non-U.S.</FONT> or other taxes as are required to be withheld pursuant to
any applicable law or regulation.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This offer letter and your employment with the Company are subject to you agreeing to the following terms and conditions: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Company Policies, Guidelines, and Training</U>. The Company maintains policies and guidelines, and provides
training, that establish certain expectations and rules concerning your conduct and performance. These policies and guidelines may affect your ability to participate in certain benefits and programs and may contain additional terms and conditions
with respect to your employment. By accepting this offer, you agree to adhere to such policies and guidelines and participate in all required training sessions. All Company policies and guidelines are subject to change and your employment with the
Company is your acceptance and agreement to abide by such changes. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>References and Background Checks</U>. This offer and your employment with the Company are at all times
contingent upon the Company&#146;s review and satisfaction with your references and verification of background information, even if you commence employment with the Company prior to the completion of the Company&#146;s reference and background
checks. You agree that the Company may check your references and background information at any time during your employment and you authorize the Company to do so. In accepting this offer, you agree to cooperate with the Company and seek the
cooperation of others in completing the references and background check processes in an expeditious manner. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Employment Must Not Infringe Upon the Rights of Others</U>. In accepting this offer, you warrant as follows:
(a)&nbsp;you have disclosed and provided to the Company any and all restrictive covenant obligations or agreements in which you are subject to and affirm your continued compliance with such obligations and agreements; (b)&nbsp;you will not disclose
to the Company any trade secrets or proprietary information from your prior employers; and (c)&nbsp;you will not refer to or otherwise solicit for employment at the Company any former <FONT STYLE="white-space:nowrap">co-workers</FONT> or others in
contravention of any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">still-in-effect</FONT></FONT> <FONT STYLE="white-space:nowrap">non-solicitation</FONT> obligations. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Best Efforts</U>. In accepting this offer, you agree to devote all of your business time, attention, skills,
and best efforts to your position on a full-time basis. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Employment <FONT STYLE="white-space:nowrap">At-Will</FONT></U>. In accepting this offer, you agree that your
employment with the Company is &#147;at will&#148; meaning that either you or the Company may terminate the employment relationship at any time with or without cause or advance notice, subject to the above Severance Benefits terms. You should also
be aware that your position, job responsibilities, compensation, benefits, and other terms and conditions of employment might be changed at any time in the sole discretion of the Company. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Offer of Employment (Page
<B>5</B> of <B>7</B>) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Governing Law</U>. All issues and questions concerning the construction, validity, enforcement and
interpretation of this letter will be governed by, and construed in accordance with, the laws of the Commonwealth of Massachusetts, without giving effect to any choice of law or conflict of law rules or provisions (whether of the Commonwealth of
Massachusetts or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the Commonwealth of Massachusetts. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Agreement, along with the Confidentiality Agreement, the Equity Documents and the Severance Plan and applicable participation agreement, constitutes the
entire agreement between you and the Company regarding the terms and conditions of your employment with the Company and supersedes and cancels any prior offer letters, agreements, promises, representations, or statements that have been made between
you and the Company regarding your employment. This Agreement may only be amended or modified through a written agreement signed by you and the Company&#146;s Chief Executive Officer. Please carefully review these terms and conditions to make sure
they are consistent with your understanding. If so, please sign this offer letter to confirm your acceptance and send a signed copy by January&nbsp;23 , 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are confident you will find your employment with the Company a challenging and rewarding endeavor. We look forward to working with you! </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Offer of Employment (Page
<B>6</B> of <B>7</B>) </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="right"><B>Fluidigm Corporation</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Vikram Jog</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By: Vikram Jog</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title: Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Agreed and Accepted:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Alex Kim</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Hanjoon Alex Kim</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: January&nbsp;19, 2022</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Offer Letter</I>] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>11
<FILENAME>d243622dex1010.htm
<DESCRIPTION>EX-10.10
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.10</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Exhibit 10.10 </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January&nbsp;23, 2022 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Fluidigm Corporation&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear <U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U>, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In recognition of your commitment and loyalty to Fluidigm Corporation (the &#147;<B><I>Company</I></B>&#148;) and to incentivize you to continue to provide
your best efforts to the Company, the Company would like to offer you the following. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you remain continuously employed with the Company through
December&nbsp;31, 2022 (the &#147;<B><I>Retention Date</I></B>&#148;), then the Company will pay you a lump sum cash amount equal to
$<U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;</U>, less applicable withholdings (the &#147;<B><I>Retention Bonus</I></B>&#148;). The Retention Bonus is separate and in
addition to your regular salary and incentive compensation that you already receive. The Retention Bonus will be paid on, or on the next Company payroll date following, the Retention Date. If your employment with the Company terminates for any
reason prior to the Retention Date, then you forfeit any rights to the Retention Bonus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[Additionally, in March 2020, the Company granted you
performance-based restricted stock unit awards (the &#147;<B><I>2022 PSUs</I></B>&#148;) that have two vesting components that must be met before the award vests, (i)&nbsp;a relative TSR performance component, with a performance period ending
December&nbsp;31, 2022, and (ii)&nbsp;a time-based vesting component. The Company has amended the 2022 PSUs to provide that, if your employment with the Company is terminated by the Company without Cause (excluding by reason of your death or
Disability) (as such terms are defined in the Company&#146;s 2020 Change of Control and Severance Plan (the &#147;<B><I>Severance Plan</I></B>&#148;)) (such termination, a &#147;<B><I>Qualifying Termination</I></B>&#148;) before the date the
achievement of the applicable TSR performance component is certified (the &#147;<B><I>Certification Date</I></B>&#148;), the time-based vesting component of the 2022 PSUs is removed, such that, notwithstanding the termination of your employment
prior to the Certification Date, the 2022 PSUs will remain outstanding and eligible to vest and be settled in shares to the extent of achievement of the TSR performance component alone (the &#147;<B><I>Vesting Amendment</I></B>&#148;). If your
employment terminates for any reason other than a Qualifying Termination prior to the Certification Date, then you forfeit any rights to the Vesting Amendment.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[<B>For certain executives</B>: Lastly, the Company granted you an award of restricted stock units covering 50,000 shares of the Company&#146;s common stock
(the &#147;<B><I>Retention RSUs</I></B>&#148;). Your Retention RSUs will be subject to the terms of our 2011 Equity Incentive Plan, as amended and restricted stock unit award agreement thereunder. Your Retention RSUs will be scheduled to vest on
February&nbsp;20, 2023 (the &#147;<B><I>Vesting Date</I></B>&#148;), subject to your continued employment with the Company through that date. If your employment with the Company is terminated in a Qualifying Termination prior to the Vesting Date,
your Retention RSUs will become fully vested as of the date your employment terminates. If your employment with the Company terminates for any reason other than a Qualifying Termination prior to the Vesting Date, then you forfeit any rights to the
Retention RSUs.] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The receipt of any termination benefits described in this letter is conditioned upon you signing and not revoking a separation and
release of claims agreement in substantially the form attached as Appendix B to the Severance Plan by the Release Deadline Date (as defined in the Severance Plan). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g243622snap10_10.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company intends that all payments made under this letter comply with, or be exempt from, the requirements
of Section&nbsp;409A of the Internal Revenue Code of 1986, as amended, and any guidance promulgated thereunder (&#147;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A</I></B>&#148;) so that none of the payments or benefits will be subject to the
additional tax imposed under Section&nbsp;409A, and any ambiguities herein will be interpreted to so comply. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nothing in this letter is intended to change
or otherwise restrict your right to receive the severance and other benefits under the Severance Plan if your employment with the Company terminates in an Involuntary Termination (as defined in the Severance Plan). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please note that nothing in this letter shall be construed as a guarantee right to employment, and your employment will continue to be &#147;at will&#148;, as
described in your original offer letter. Except as otherwise provided herein or previously amended, your original offer letter shall remain in full force and effect. If the terms of this letter contradict the terms of your offer letter or employment
agreement, the terms of this letter will control. The letter represents the entire agreement between you and the Company related to the subject matter herein and supersedes all prior or contemporaneous agreements related to the subject matter herein
whether written or oral, other than the Severance Plan. The letter may be amended only by a written agreement signed by you and an authorized officer of the Company. The letter will be governed by the internal substantive laws, but not the choice of
law rules, of California. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please sign and date stating your acknowledgement of this letter and return an executed copy of to the Company&#146;s human
resources department. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sincerely,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Carlos Paya, Chair of Board of Directors</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>ACKNOWLEDGED AND AGREED:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Employee Signature:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name (printed):</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>12
<FILENAME>d243622dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Exhibit 99.1 </I></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Fluidigm Announces $250 Million Strategic Capital Infusion from </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Mission to Reinvigorate Growth through Optimization of Mass Cytometry and Microfluidics Platforms and Portfolio Expansion via Strategic
Acquisitions </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Dr.&nbsp;Michael Egholm, Former CTO of Danaher Life Sciences, to Assume Role of CEO and Join Board of Directors
Following Close; Alex Kim, Former President of Milliken&nbsp;&amp; Company&#146;s Healthcare Division, to Assume Role of COO </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Eli
Casdin, CIO of Casdin Capital, and Dr.&nbsp;Martin Madaus, Former Chairman and CEO of Millipore and Ortho Clinical Diagnostics, to Join Board of Directors Following Close </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SOUTH SAN FRANCISCO, Calif., Jan. 24, 2022 &#150; Fluidigm Corporation (NASDAQ:FLDM), today announced that its Board of Directors has unanimously approved a
$250&nbsp;million investment by leading life sciences investors Casdin Capital, LLC (&#147;Casdin&#148;) and Viking Global Investors LP (&#147;Viking&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The investment will significantly advance the Company&#146;s mission through new organic and inorganic growth initiatives while optimizing its cost structure.
Upon closing of the investment, which is expected in late Q1, Fluidigm will change its name to Standard BioTools Inc., better reflecting its ambitions to become an essential solutions partner to the life science industry focused on the highest
growth areas of biological discovery and development. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Carlos&nbsp;V. Paya, chairman of Fluidigm, said, &#147;This investment is the culmination
of our Board&#146;s comprehensive review of a wide range of options to maximize stockholder value. Casdin and Viking are leading investors with proven records of partnering with life sciences and biotechnology-focused companies to drive growth,
scale, financial performance and value creation. This significant capital infusion and strategic initiative will not only strengthen our balance sheet but accelerate growth and innovation to create significant value for all stakeholders.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>A New Chapter of Focused Execution, Cost Structure Optimization and High Growth Initiatives </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon closing, it is expected that the $250&nbsp;million of new capital will fuel a realization of identified growth and cost opportunities within the
Company&#146;s two major platforms, mass cytometry and microfluidics, and allow for new growth drivers as management pursues and consolidates complementary technologies across the life science ecosystem. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Optimizing the cost structure. </B>The management team, led by Dr.&nbsp;Michael Egholm, will focus on cost
structure optimization, including improvements in manufacturing. Further, as the Company continues to work toward being sustainably cash flow positive, it intends to have a leaner general and administrative expense structure and sales and marketing
spend aligned to support high growth areas. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Achieving significantly greater</B> <B>breadth and scale. </B>Researchers are dependent on a wide variety of
technologies that are most often supplied by under resourced and under scaled providers. With a strong platform and deeply experienced management team, the Standard BioTools corporate mission will accelerate growth both organically and, importantly,
inorganically to deliver breadth and scale to the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Leveraging a larger menu to expanding customer base. </B>Currently,<B> </B>customer<B> </B>reach is
constrained to basic research, and the Company will invest in direct sales and marketing that expand its relationships deeper into the life science ecosystem, including large <FONT STYLE="white-space:nowrap">bio-pharma,</FONT> emerging biotech and
diagnostic companies and the broader CRO and CMO service provider network. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Accelerating growth in mass cytometry. </B>With particular emphasis to expand its CyTOF<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and IMC platforms to further support translational and clinical research, the Company intends to simplify the design and execution of deep cell profiling, standardize sample analysis with
reproducible workflows and automation and significantly advance capabilities for novel therapeutic development. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Realizing and rationalizing opportunities in targeted high profit areas within microfluidics. </B>The Company
will focus on targeted <FONT STYLE="white-space:nowrap">end-applications</FONT> (e.g., proteomics, biomarker analysis) and key partnerships (e.g., Olink Bioscience) while rationalizing business processes and execution. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are witnessing the next wave of innovation in the life science tools industry, one that promises to advance biologic insight, deliver powerful
products, and substantial returns for investors,&#148; said Chief Investment Officer and Casdin Founder, Eli Casdin. &#147;That said, to fully realize this vision requires scale and execution, a persistent bottleneck in our industry. This
transformative transaction brings a world class team, a large quantum of capital, and a clear strategic vision to optimize, consolidate and drive profitability towards becoming a leading diverse life science tools provider. It&#146;s an exciting
time and a great way to kick off the new year!&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The Company has vast untapped potential in bringing its leading technologies, such as CyTOF<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, to a broader set of biopharma and pharma customers worldwide,&#148; said Dr.&nbsp;Martin&nbsp;D. Madaus, former chairman and CEO of Millipore Corporation and Ortho Clinical Diagnostics. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Management Transitions and Governance </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon closing,
Dr.&nbsp;Egholm will serve as President and CEO and as a member the Board of Directors. Egholm will succeed Chris Linthwaite, who continues as Fluidigm&#146;s Chief Executive Officer until the earlier of closing or May&nbsp;15, 2022, and who will
remain in an advisory role until November&nbsp;30, 2022 to ensure a smooth transition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Egholm has over 25 years of proven leadership in developing and
commercializing innovative technologies. His prior senior roles include being the Chief Technology Officer of Danaher Life Sciences and leading Danaher&#146;s corporate venture fund. While at Danaher, he led Pall&#146;s Biopharm business and
redesigned its <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">go-to-market</FONT></FONT> structure, leading to its multibillion-dollar revenue today. Egholm was the Chief Technology Officer at Pall, where he reestablished Pall as
a technology leader, and at 454 Life Sciences Corporation, the first company to successfully commercialize Next Gen Sequencing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, Alex Kim
will join as Chief Operating Officer and lead transformation activities. Kim was most recently President of the Healthcare Division at Milliken&nbsp;&amp; Company. Previously, Kim was Senior Vice President, Corporate Strategy and Business
Development at Pall Corporation and spent a decade at Danaher in various roles. He has an MBA from Stanford University. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;I look forward to leading
this outstanding team as we continue to pioneer new technologies and capabilities within discovery and translational research,&#148; said Egholm. &#147;Our new vision will focus on the highest ROI areas, while balancing growth with a reset cost
structure. I am eager to work closely alongside Alex and the management team to achieve this transformation, and am confident that our tool set will accelerate breakthroughs in human health.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Paya added, &#147;On behalf of the entire Board, I want to thank Chris for his contributions. With the investment, the Company will now be able to fully fund
the execution of many key strategic initiatives that began under Chris&#146; tenure, including expanding mass cytometry and CyTOF<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> XT capabilities, and focusing on protein biomarkers and
proteomics within microfluidics. We will continue to benefit from Chris&#146; expertise as he transitions to an advisory role and wish him the best in his future endeavors.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the investment, Casdin and Viking each will be entitled to appoint one director to the Standard BioTools Board. Casdin has chosen Eli
Casdin as its Board appointee and Viking has selected Dr.&nbsp;Martin&nbsp;D. Madaus. Two current company directors will step down at the closing of the investment such that the Board will continue to comprise seven directors. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Paya concluded, &#147;Casdin and Viking&#146;s capital infusion is a strong endorsement of Standard
BioTools&#146; growth prospects and long-term success. On behalf of the entire Board, I look forward to working with Eli and Martin as they bring their additive expertise in life sciences, healthcare, diagnostic tools and investment management to
help the Company realize the highest growth opportunities within biological discovery and development.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investment Terms and Approvals </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the agreement, Casdin and Viking will purchase $250&nbsp;million aggregate principal amount of
<FONT STYLE="white-space:nowrap">zero-coupon</FONT> convertible preferred shares with a conversion price of $3.40 per share. The conversion price represents a conversion premium of approximately 19.7&nbsp;percent over the closing price of
Fluidigm&#146;s common stock of $2.84 per share on January&nbsp;21, 2022. On an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, the preferred shares will represent approximately 42.4&nbsp;percent of Fluidigm&#146;s pro forma shares
outstanding. From the $250&nbsp;million aggregate investment commitment, Casdin and Viking are providing immediate financing of $25&nbsp;million in the form of convertible unsecured term loans to support Fluidigm&#146;s continuing operations. It is
expected that these loans, which will bear an initial interest rate of 10&nbsp;percent per annum, payable in kind, will be converted into preferred shares in connection with the approval of the investment by Fluidigm stockholders. Additional
information may be found in the Form <FONT STYLE="white-space:nowrap">8-K</FONT> that will be filed today with the U.S. Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction, which is expected to close in the first quarter of 2022, is subject to the satisfaction of customary closing conditions, including approval
by Fluidigm stockholders and applicable regulatory approvals. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Advisors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jefferies is serving as financial advisor to Fluidigm and Wilson Sonsini Goodrich &amp; Rosati, Professional Corporation is serving as legal advisor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Centerview Partners LLC is serving as financial advisor to Casdin and Viking. Legal advisors are Paul, Weiss, Rifkind, Wharton&nbsp;&amp; Garrison LLP serving
Casdin and Kirkland&nbsp;&amp; Ellis LLP serving Viking. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Eli Casdin </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Eli Casdin, Chief Investment Officer and Founder, founded Casdin Capital in 2011. For the last 16 years he has analyzed and invested in disruptive technologies
and business models in life sciences and healthcare. Prior to founding Casdin Capital, Mr.&nbsp;Casdin was a vice president at Alliance Bernstein &#147;thematic&#148; based investment group where he researched and invested in the implications of new
technologies for the life science and healthcare sectors. Mr.&nbsp;Casdin&#146;s Alliance Bernstein black book, &#147;The Dawn of Molecular Medicine&#148; detailed the early yet already accelerating wave of innovations in life sciences, and the next
wave of investment opportunities. His prior experience includes time at Bear Stearns and Cooper Hill Partners, a healthcare focused investment firm. He earned a B.S. from Columbia University and an MBA from Columbia Business School. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Dr.&nbsp;Martin&nbsp;D. Madaus </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Martin&nbsp;D. Madaus is a serial global healthcare CEO, board member, investor and strategy consultant with 30 years of experience in Diagnostics and
Life Science Tools. He has a track record for delivering outstanding results by transforming large and complex businesses. He currently works for The Carlyle Group as an Operating Executive and serves as Chairman of Unchained Labs, Ultivue, Inc.,
Emulate Bio, Lead Director at Quanterix Corporation (QTRX) and Director at Candela Medical. He was Chairman and Chief Executive Officer at Ortho-Clinical Diagnostics, Inc. (OCD) from June 2015 until February of 2019 leading the <FONT
STYLE="white-space:nowrap">carve-out</FONT> from JNJ and the business turnaround. He was Chairman, President and Chief Executive Officer of Millipore Corporation (NYSE: MIL) from January 2005 to July 2010 until the $7.2&nbsp;billion acquisition by
Merck KGaA, Germany. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Fluidigm </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fluidigm&nbsp;(Nasdaq:FLDM) focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using
proprietary CyTOF<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>&nbsp;and microfluidics technologies, we develop, manufacture, and market multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to
inform decisions, and accelerate the development of more effective therapies. Our customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, we
strive to increase the quality of life for all. For more information, <U>visit&nbsp;fluidigm.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fluidigm, the&nbsp;Fluidigm&nbsp;logo and CyTOF are
trademarks and/or registered trademarks of&nbsp;Fluidigm Corporation&nbsp;or its affiliates in&nbsp;the United States&nbsp;and/or other countries.&nbsp;All other trademarks are the sole property of their respective owners. Fluidigm products are
provided for<B>&nbsp;Research Use Only</B>. Not for use in diagnostic procedures. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Available Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fluidigm uses its website (fluidigm.com), investor site (investors.fluidigm.com), corporate Twitter account (@fluidigm), Facebook page (facebook.com/Fluidigm),
and LinkedIn page (linkedin.com/company/fluidigm-corporation) as channels of distribution of information about its products, its planned financial and other announcements, its attendance at upcoming investor and industry conferences, and other
matters. Such information may be deemed material information, and Fluidigm may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Fluidigm&#146;s website and our social media
accounts in addition to following its press releases, SEC filings, public conference calls, and webcasts. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Casdin Capital </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Casdin Capital, LLC is a New York-based research investment firm focused on the innovations currently reshaping life sciences and healthcare. Founded in 2011,
and with an eye to long-term returns and disruptive technologies, Casdin Capital is a trusted investor-partner in both private and public companies, collaborating with industry leaders to fuel their visions, adding energy, insight, and experience to
the firm&#146;s over $3&nbsp;billion under management. For more information, please visit&nbsp;<U>casdincapital.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Viking Global Investors
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Founded in 1999, Viking is a global investment management firm that manages approximately&nbsp;$48 billion&nbsp;of capital for its investors. It has
offices in&nbsp;Greenwich, New York,&nbsp;Hong Kong,&nbsp;London, and&nbsp;San Francisco&nbsp;and is registered as an investment adviser with the U.S. Securities and Exchange Commission. For more information, please
visit&nbsp;<U>www.vikingglobal.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, among others,
statements regarding: Fluidigm&#146;s planned use of the proceeds from the transactions described in this communication (the &#147;Transaction&#148;); cost structure optimization; acceleration of growth; investments to expand Fluidigm&#146;s
customer base; plans for Fluidigm&#146;s products; the expected timing and closing of the investment; and other expectations for Fluidigm following the closing of the Transaction. Forward-looking statements are subject to numerous risks and
uncertainties that could cause actual results to differ materially from currently anticipated results, including but not limited to risks relating to: Fluidigm&#146;s liquidity position and financing requirements; any failure to obtain
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
required stockholder approval of the Transaction; the possibility that the conditions to the closing of the Transaction are not satisfied; potential litigation relating to the Transaction;
uncertainties as to the timing of the consummation of the Transaction; the ability of each party to consummate the Transaction; possible disruption related to the Transaction to Fluidigm&#146;s current plans and operations, including through the
loss of customers and employees; changes in Fluidigm&#146;s business or external market conditions; the impact of the <FONT STYLE="white-space:nowrap">Covid-19</FONT> pandemic and related government mandate; interruptions or delays in the supply of
components or materials for, or manufacturing of, Fluidigm products; Fluidigm&#146;s ability to achieve its expected strategic, financial and operational plans. Information on these and additional risks and uncertainties and other information
affecting Fluidigm&#146;s business and operating results is contained in its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2020, and in its other filings with the Securities and Exchange
Commission (the &#147;SEC&#148;). These forward-looking statements speak only as of the date of this communication. Fluidigm disclaims any obligation to update these forward-looking statements except as may be required by law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Information and Where to Find It </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fluidigm,
its directors and certain executive officers are participants in the solicitation of proxies from shareholders in connection with the Transaction. Fluidigm plans to file a proxy statement (the &#147;Transaction Proxy Statement&#148;) with SEC in
connection with the solicitation of proxies to approve the Transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nicolas M. Barthelemy, Gerhard F. Burbach, Laura M. Clague, Bill W. Colston, S.
Christopher Linthwaite, Carlos V. Paya and Ana K. Stankovic, all of whom are members of Fluidigm&#146;s Board of Directors, and Vikram Jog, who is Fluidigm&#146;s Chief Financial Officer, are participants in Fluidigm&#146;s solicitation. Other than
Mr.&nbsp;Linthwaite, none of such participants owns in excess of 1% of Fluidigm&#146;s common stock. Mr.&nbsp;Linthwaite may be deemed to own approximately 1% of Fluidigm&#146;s common stock. Additional information regarding such participants,
including their direct or indirect interests, by security holdings or otherwise, will be included in the Transaction Proxy Statement and other relevant documents to be filed with the SEC in connection with the Transaction. Information relating to
the foregoing can also be found in Fluidigm&#146;s definitive proxy statement for its 2021 Annual Meeting of Shareholders (the &#147;2021 Proxy Statement&#148;), which was filed with the SEC on April&nbsp;14, 2021. To the extent that holdings of
Fluidigm&#146;s securities by such persons have changed since the amounts printed in the 2021 Proxy Statement, such changes have been or will be reflected on Statements of Change in Ownership on Form 4 filed with the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, Eli Casdin and Dr.&nbsp;Martin&nbsp;D. Madaus are participants in Fluidigm&#146;s solicitation. Neither Mr.&nbsp;Casdin nor Dr.&nbsp;Madaus owns
in excess of 1% of Fluidigm&#146;s common stock. Additional information regarding such participants, including their direct or indirect interests, by security holdings or otherwise, will be included in the Transaction Proxy Statement and other
relevant documents to be filed with the SEC in connection with the Transaction. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Promptly after filing the definitive Transaction Proxy Statement with the SEC, Fluidigm will mail the
definitive Transaction Proxy Statement and a WHITE proxy card to each shareholder entitled to vote at the special meeting to consider the Transaction. SHAREHOLDERS ARE URGED TO READ THE TRANSACTION PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR
SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT FLUIDIGM WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Shareholders may obtain, free of charge, the preliminary and definitive versions
of the Transaction Proxy Statement, any amendments or supplements thereto, and any other relevant documents filed by Fluidigm with the SEC in connection with the Transaction at the SEC&#146;s website (http://www.sec.gov). Copies of Fluidigm&#146;s
definitive Transaction Proxy Statement, any amendments or supplements thereto, and any other relevant documents filed by Fluidigm with the SEC in connection with the Transaction will also be available, free of charge, at Fluidigm&#146;s investor
relations website (investors.fluidigm.com) or by writing to Fluidigm Corporation, Attention: Investor Relations, 2 Tower Place, Suite 2000, South San Francisco, CA 94080. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contacts: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mark Spearman </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VP, Corporate Communications </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fluidigm Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">650 243 6621 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>mark.spearman@fluidigm.com </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investors: </B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Peter DeNardo </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">415 389 6400 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>ir@fluidigm.com</U> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>13
<FILENAME>fldm-20220123.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 1/25/2022 3:12:22 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2021-01-31"
  xmlns:fldm="http://fluidigm.com/20220123"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://fluidigm.com/20220123"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" namespace="http://xbrl.sec.gov/dei/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fldm-20220123_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fldm-20220123_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>fldm-20220123_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 1/25/2022 3:12:22 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>fldm-20220123_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 1/25/2022 3:12:22 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="fldm-20220123.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g243622dsp309.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g243622dsp309.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M3+'X@T:PLW($2WEB[-G;DC?YZ ]"> ./IF@"O(_B.&WCGE\4>'TAEQLD;3)
MK9&1@_:>>.: +FEKKTLL%S<:UI-Y8.N[_1=/="X(X*N9V&,X/0Y'YT ;E !0
M 4 % !0!3ETG39]1BU&;3[62^A&V.X>%3(@] V,CK0!<H * "@ H K6.G6.E
MVYM]/LX+2$L7,<$81=QZG [T 6: .7U"2XM?$]Y>O8W-R8[!8[$11,RL[,V]
M<CA22(^6QQWQF@#.NK&\TS0-+L[,77]M:3:K+"R6[203.5*M$QZ8/U!&0<]:
M -NPUN236?[-^P1PVRAXXW27+;XPNX%-H"K\PP<G/H.,@&]0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 5H].L8;^:_BLH$O)E"R3K$!(X'0%L9(% %F@ H __
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g243622dsp310.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g243622dsp310.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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/(89Z$'H: )J "@ H __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g243622dsp311.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g243622dsp311.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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D 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g243622dsp312.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g243622dsp312.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MAR?28=4>.U.M/)."L0O-+GAC@0%FV!VB4 9)^\2>@ST% '6T % %6\TZUOS
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E34!>(ML&25X3"2YD5652'W<+AN1M/U&30!MT % !0 4 % '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g243622dsp313.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g243622dsp313.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1  (! @0$ P0'!00$  $"=P ! @,1
M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_  !$( "L AP,!$0 "$0$#$0'_V@ ,
M P$  A$#$0 _ /?Z "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * ,_6UN9=(N+>QN8[>]F0I TC%07QG&1R. >1R.O:@
M#E;N^:Y\*1M9+J4-U?Z@ENT'VIFEC9' E5'W# Q&_.X#DGOB@#6T:^73;V32
M[ZYF^TW$S26\3^9-Y*$?*C2G(W':S8+>N,@4 =)0 4 % !0!BZK>7;:UIVD6
M<I@,ZO//,J@E8TP,#((R691R#QGO@T 8FMZC?Z7>VEBVM71\NVFGFEB@BWN3
M(JP@Y0JHRQ&?E'&30!T^F7$C6D-O>3P/J44*&Y2)A\K$<G'8$@XH HZOXGMM
M'O!;2VSR,5#9%S;Q_I)(I_2@"]I^IQ:AIHOE0QQD$X+HY&/=&9?R- &1I-UJ
M%WH\'B"\U%X+=U>Y:U$:;!"5)122-P(&UB<]<]N@!1\*:KJ=SY<^H:D\MO%9
M++>&YCCB$4K ,NW"J=H4G)(QTP>#0!U4%Y#?V NM-N(+F.128I8W#QMZ?,.H
MSZ4 9.A^(SKEY-;Q6PB^R I=%I <29(VIC[R\'YN!VZ[@H!/?>);#3[R2UFM
M]3>1,9,&EW,R<C/#I&5/7L?:@"A<^)=!O51;K3-4G6-MZ"70+MMK>HS%P>3S
M0 W_ (2+P]MMU_LG4MMLVZ$?\(_=XB.",K^ZX.">GK0!3EU31)=;34R/$*[2
MK-;C1+KRG=00KG]QNR 2.& Z9'% &K_PF6E_\^NL_P#@DO/_ (U0!J:;J<&J
MV[3V\=TB*VPBYM9;=LX!X615)'/7&/RH N4 % %&]TBRU":.:>-Q-&C1K)%*
M\;!6QN&5(..!^5 $,WA[2[A;A9;9BMQ;+:R 2N 8US@#!XQD\CGWH ;;Z7>P
M>(I]0-["UI) D*P>0WF+M)()D+G/+'^'T_$ TVBC<Y>-6/J1F@!1&@38$4)T
MVXXH RD\,Z5'9R6:P2_9WMS;&,W$A"QGJJ_-\OX8Z#T% !>^';2YM[P0%H+B
MY@2$R%F<80Y3*DX."?J1QF@"73-+>STV2VNIUGEG=Y)GC0Q*6<DG:NXE1SZD
M^] %B/3K*&6"6*VCC>WC\J,HNW:G'RC';@<>U &-XAO[RRU"TC-S/9Z?<*81
M=PQH_ESLP$>\,#A3G@],\'&10!GPZCK%[X@O4LKNXD@M[^.#RS"@A$2HOFDO
MLR3DL  V<X[9H ZFSU*QU&W>>QO(+N)&*,\$@D 8=1\N>1Z4 4X_$5C+*L2P
M:B&8[06TRX4?B2F!]30!'JMY=MK6G:19RF SJ\\\RJ"5C3 P,@C)9E'(/&>^
M#0!I64$]O:K%<W;W<H+'S715)!)(&% ' P/PH L4 % !0 4 % !0 4 % !0
M4 % &?)HEA+=R7,D3N\DB2LK3.4+J %.S.WC [=@: 'Q:3:6]C<V<"O'%<-(
M[_O&8[G)+$$DXY)H JZ#H\^DP3"ZNX[F>4KEHH?*4*JA5&W<W.!R<\^@Z4 :
M] %&]TBRU":.:>-Q-&C1K)%*\;!6QN&5(..!^5 %N*)((4BC7;&BA5'H!TH
B?0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g243622dsp314.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g243622dsp314.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MP?0X(/XT 16>IV&H%Q97UO<E "PAE5]H/0G![X- %J@"&ZNH;*W:>=]J @<
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MN5EFM[=X&!\K=+ 8RP7IP<$J"3C\<=<T 8-E:>(5\67LDM_8F(P0!B-/D4,
MTF0#YIP??GJ./4 O^(@8Y-(NF.+:WO5:;T *,H)]@S+0!GL9V\4I=V4%TT$[
MF&^@N;9@@$08I*C$=<X QG<"" "": *.F65W9>'4\07ZEIK8W%^EHRM"5>3<
M2'+9)(4D#@#VZ8 .KU,";1Y@89Y"Z?*ENVV0GMM;(P<XYR .] &;X<@U:":Y
M&N,TU\57$Z-F$ICA5&!A@<[N.<YZ850#(U*WO9F\3VZV4\E_J!6TMG,3>6(3
M&!G?]T %I">0<]LXH M:I'.-5M7TV*Z>YMC'9S136[&"Y@<J6.[& 5&3G/4$
M$'(H TSJL=SX=O;JZB6)(S-"R [P=K,G' SG'3'?% %K0K>:T\/Z=;W.?/BM
MHTDR<_,% - &A0!F>(KNXL/#>I7=HN;B&W=X^,_,%.#B@#E-2@T&T\(7O]FO
M;3WWV5;%KE6!9VG*C+MT))(8YR><]^0"SH#V6C3:I,ELD&RZAL'M;4*%BQ@(
MYY&2WF DX!Q@8.,T =1JLMY#I\CV"[K@$;1Y7F=^?EWIG_OH4 9NBW>O3WI3
M4H0D&PD'[&(N?J)W_+'XT 4=3FL)?%TT>MR0BRM;-#!#/RLCR.RLP!^\P"JH
MQDC<?6@#)\51V4&HQVZ65I+::+I;.8YP&6)794#!3R=JHQQD?7F@#H]$U6UB
MDM]#A6YE2WA\J.\D*E)R@4, =Q;(R.2 /0G% %37;_5;?4Y4T^29[+8OVR18
M@QM!Q\T?]YB,DK@XX;_98 W;Z74([*-M)MK:[E)'%S<M"NW'7<J.2>G&._7U
M ,W[9XP_Z 6C?^#>7_Y&H /MGC#_ * 6C?\ @WE_^1J #[9XP_Z 6C?^#>7_
M .1J  W?B\@@Z%HI!Z@ZO+_\C4 (MUXN10JZ#HJJHP -7E  _P# :@"&]7Q)
MJ5H]I?>&- NK:3[\4VIR.C?4&VP: 'V[^*;.WCM[;PYH4$$8VI''JLBJH] !
M;8% $GVSQA_T M&_\&\O_P C4 'VSQA_T M&_P#!O+_\C4 !N_%Y&#H6BD?]
MA>7_ .1J *5C9:WI<9CT_P (>&[1"_F%8-1= 6_O8%MU]Z .EL7O)+.-K^"&
M"Z.=\<$QE0<\88JI/&/X1_6@"Q0 4 % %'5=(M-9M5MKT3&)760"&XDA.X'(
MY1@>#SCVH NJH1 HS@#')R?SH 6@ H * *$.BV%OJLVIQQ.+J488F5RHSC)"
M$[5)VC) !..: +] !0 4 % 'GVNO!>R>)4N8UGU+Y;+3K9L%UW(I#H".,LQ)
M8=D_V: +>OM;2:I:(SVVIF'987EA,,OB7;^\3W Y/8C/(Q0!T&DZ[;ZG<36\
M-M/"(E#1O(%VS)DKN7#$XRI'S 'VQ0!D7&H:FFN-"DT_]B&X4278B&Z-_P#G
MDI[IG +X^7)&>Z !XRNX8_*>.:UFN]/'VIM.N.1<H0R8'^UG.TX//!'.: *6
MIZ5!J7B.QTBTL+(PZ?IKD1W(!6#S"%4A<'<0$;C(^M '3Z))&EJVFJ9F?3ME
ML\DV,R$(I#<$]010!IT % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!
M0L-%L-+GN)K2)T>X.7W2NX').%#$A1DDX7 YZ4 7Z "@ H H6.C6>G7EW=V_
?GB6[??+YES)(I/3(5F(7@ < < 4 7Z "@ H * /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g243622dsp567.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g243622dsp567.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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>:A0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g243622dsp568.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g243622dsp568.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MZ7?J+^U-V'=8]L*9P/,PYP3V S^AQJX-.2[6_'H2W9*ZZM?=N='4#"@ H *
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M'_A(-($3>:+DO=IF)EQ@'YOE.<C!]*47=^5K_BOT')67G>WX/]4C3UN:YO\
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* % !0 4 % '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g243622dsp569.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g243622dsp569.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1  (! @0$ P0'!00$  $"=P ! @,1
M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_  !$( "D H0,!$0 "$0$#$0'_V@ ,
M P$  A$#$0 _ /?Z "@ H * "@ H * "@ H * "@ H * &R.(XV=LX4$G R:
MF4E%-OH-*[LCGO#_ (AU/78K>^&D01:3=0&:"X%YND[;5>/8-I()Z,V,<U<T
MX)\VZ^[[Q:-V7>Q1T#QG?ZI/I8O]'@M(-464VSPWAF/R9)+*8UP"!D$$]1G%
M-*^G6R?WV_'5$R?*_FX_/7\-&=C4E!0 4 % !0 C,J(69@JJ,DDX %#=MP,N
M+Q/X?GL[B\AUS3I+6V($\R72%(L]-S9POXT;)/H.SOR]2QINL:9K,+3:7J-K
M?1(=K/;3+( ?0E2:=FE<FZV+M(84 % % ZYI"ZJNEG5;,:BW(M3.OFGO]S.>
MWI0O>O;H#TW(K3Q)H5_?-8V>M:?<WBY#00W2/(,=<J#GBA>\KK8'[KLS4H *
M "@ H * *NHW%S:V$L]G9->SH,K DBH7YZ L0!QZTGH-''1Z?K5G8>)[_2]%
MDM)+Z(?9--,L0;SL,&E)#E%R2"<-SMSU.*4X_NO9^?W)V_X+^94&O;*;Z+[V
MOZM?_((=&M?!WANPN[&S=-4*6]DCW\[W'V?>RJ1C>0J@G)5& . ,UO-\U3EB
M]&W^";]>FAC!6AS3U:7X]^WJ^QT?AG5+G5M'\^[2-;B.>6"0Q A',<C)N4$D
M@';G&3CU-0TK)KJD_O+:<9.+Z?\ #FQ4@% !0 4 <IXT O)] T>8@6>H7X2Y
M4])$1&DV'V8J 1W&13IJ]2_9-_/1+[KW^02=J;MULOOW_P OF4?'$5D/#=['
MI4-O+>ZS-#IQ"R85SNVE21G&%WYP./3BE%MS@EWYONU?_I-@LHJ4MK*WI?1?
MC(?X<N8A>:YXEU,Q64T6+&>WC8ND(A+'.[ +D[\C@<8XI\R5.]_B=_TM\K,%
M%N:@OLJWWV?^1VD<BR1+(ARK ,#ZBE)..C$FFKHX6;Q)K23R*NI856( _P"$
M/U!\<_WA)@_44EJBI*SL=%JFI7-EX,O-33]Y=0V+3#]PT6Y@A/\ JVRR\_PG
MD=*5?1-+3^NY5!*<XIF?H>E:)I^A:2)&@EN;.'[=YI?YV=D(>4^N=S<GU^E:
MUI*FY..BBK>B[?@94G*I%<V\M?G_ ,#\#DO":W6K7&AVVHP16:2RRZ_ Z2%W
MN-SM\I!4;,"5,C+9&.E-1Y-]X)+[UJ_S^?4<Y<U[;2>_^%JWY+Y7T/1-,\0Z
M7K$\\%C<F22#!8&-TRI) 92P&Y<@C<N1QUK-:QYD-^Z^5_U_PW7L<_XJU?4]
M'U0'12][--%FYM2ID%M&#C[0 /3GY.KXXY!I1W:;LN_;_A_PWV+MHGUZ+O\
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M7]!O6U^A<H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
$* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g243622dsp570.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g243622dsp570.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$  @&!@<&!0@'!P<*"0@*#18.#0P,#1L3%! 6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$ :(   $% 0$! 0$!           ! @,$!08'" D*"P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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J0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g243622dsp572.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g243622dsp572.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M#I;=1+X=@'A^>"!3$OV>2:%I4"\=5W*2<9[@YZ^E7*]]2([?U_5RG]C\8?\
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% * /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g243622g0124171246184.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g243622g0124171246184.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  A FX# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HJ*YN([2UEN9FVQ1(7=O0 9-96EWFKWZV]_*MK!83Q
ME_L[(WG1@_=);=M/'48&/4T ;5%<CH'BF]U6ZT]'6TF2\CDE=;<$-;*I^4O\
MQ^]^'(/6NNH **SY-;TZ&1HWN,.IP1L;C]*-4U>#2]%FU-E>6-$#(B?>D)P%
M49[DD#\: -"BL*XO=8TS2]0U+4&L/)@M&G2.*-PT;J"2K$MAQQU&WZ5%H&N7
MFHWS6MP+68+:13O-:@A8I&ZQ').2!SG(X(XH Z*BBL:'Q-8SW"6D:3F_,IC>
MSVCS8L=689P$Q@[LX.1C)(% $.L7-Q/KVF:-!,\,<Z27%S)&VU_+3 V@]LLP
MR1@X!Q6+!<ZQ/X?U(V#7%U#;:F8X@L_[Z6V0J'59&Y+9#@$G/N*ZR]TFSU":
M.:=)/.B5E22*9XF"MU&5(.#@<>P]*A?P_IK"U"PR1"UC:.$03R1!5;J/E89S
MCO\ 6@"+P_=:?+IUN;*^GF2Y3[1$EU,7E"' Q\QW8!XYSSWK8K)CTQK75;)[
M2WMX[*"W>$@.0PR5Q@;>?N]SWK6H **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
5110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g243622g0124171246872.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g243622g0124171246872.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  A FX# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^Y6XMS>^8H('FW\\J\_[+N1^E '.ZGX=\)V.J6=A#X,\/2O<I)(6DM(HUC5
M"2?W9]0*JW6E>%;"_P!'L[OP'HB2Z@[(^RU@808. 2=G()(_.N@OO#<>K^)3
M>:G:VMS8QVGDP*[%F5RV6.-N!P%Y!]:CUOPU<:YJ#/)<K;P(L7D21G=(K*^Y
MN",#( &<GZ4 <R\7@UCJC6O@319H;":. R-9PJ)&8X./D/ ]:Z31=&T&VU^Y
M.F^&-)LWLP%%[;6T:-O8?,HP@(P#SSW%5#X4OCX8UBP7['%=7EP9(=LC&-5
M4("=H(P%&1@UU&GV2V%DD"DLPRSN>KL>23]30!:HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
6**** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>g243622g0124171247341.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g243622g0124171247341.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  A FX# 2(  A$! Q$!_\0
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M_/\ LT7VD1B?:/,$6=N[OC/.*EH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
..**** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>g243622g0124171247950.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g243622g0124171247950.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  A G # 2(  A$! Q$!_\0
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MGSYD9@SX R 20O ' P.*MT %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
G %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>g243622g0124171248513.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g243622g0124171248513.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  A G # 2(  A$! Q$!_\0
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MGT-(-)T^PTI$@AL)HGBA+L%*H?NEN3TYR<\U<TBR;3=)MK1F#-$F&(Z9ZG%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M""",]><5TG_"">#_ /H5-#_\%T/_ ,358V$7AG1--2VBC@F4V]G/=@AFCCR
M?F8=,^H YS@5M:)<7%UHEG/=',[Q@L< ;O0\<<CF@#._X03P?_T*FA_^"Z'_
M .)H_P"$$\'_ /0J:'_X+H?_ (FN@HH IZ;I.FZ-;M;Z7I]I8P,^]H[6%8E+
M8 R0H S@#GV%7*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>g243622g0124171249075.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g243622g0124171249075.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  B G # 2(  A$! Q$!_\0
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M5].]S=(UWY!VH4 A:%MR,GR]<G)W9!K4LK-[3SC)>W-TTLF_,Y7Y!@#:H50
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MY)91GMC/)H V:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7D5M=?;%61FWRR,) R$H,\@KR!P>^*V/#-_=7\$SSW'VB,"(I)A>K1JS+\H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@"$VMNURMRUO$;A1M64H-P'/&>O<_F:FHHH
M **** (KBW@NX'@N88YH9!M>.10RL/0@\&GQQI%&L<:*B*,*JC  ]A110 ZB
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
0* "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>g243622snap10_10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g243622snap10_10.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1  (! @0$ P0'!00$  $"=P ! @,1
M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_  !$( %$ M@,!$0 "$0$#$0'_V@ ,
M P$  A$#$0 _ /?Z "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H 3.*0&?JFMZ;HT'FZA>1P#L&/S-]!U--)O8UITIU':*.3F^)ME
M(I.GVDLPZ;I#L'Y<FKY&MSOCETOMNQD7/CK6+G(CDCMU](UY_,YHY;'=3P%&
M.^IK>!_&AU)SIFHRYN@3Y,C'_6#T/O\ SI2C8QS'+_9+VM)>[U\CO<U!X84
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MULO"&DPJH4_9D9L#J2,D_K7!+63.*H[R9MU) 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 M,04 % "8I <]K7@G0]=F>XNK4I<OUFB;:QQP,]C^(JXSE'8
MN,W$XC5_@_.T4@TW45<$<).NT_F/\*V5;NC55NYZG:P?9K." =(HU3\ABN<P
M9+0(* "@ H * "@ H * "@ H * "@ H * "@ H 6@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
5@ H * "@ H * "@ H * "@ H __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm139970366617016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 23, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FLUIDIGM CORP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001162194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 23,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0513190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2 Tower Place<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 2000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South San Francisco<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">266-6000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FLDM<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>d243622d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="fldm-20220123.xsd" xlink:type="simple"/>
    <context id="duration_2022-01-23_to_2022-01-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2022-01-23</startDate>
            <endDate>2022-01-23</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2022-01-23_to_2022-01-23"
      id="Hidden_dei_EntityRegistrantName">FLUIDIGM CORP</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2022-01-23_to_2022-01-23">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2022-01-23_to_2022-01-23"
      id="Hidden_dei_EntityCentralIndexKey">0001162194</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="duration_2022-01-23_to_2022-01-23"
      id="Hidden_dei_CurrentFiscalYearEndDate_duration_2022-01-23_to_2022-01-23">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="duration_2022-01-23_to_2022-01-23">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2022-01-23_to_2022-01-23">2022-01-23</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2022-01-23_to_2022-01-23">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2022-01-23_to_2022-01-23">001-34180</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2022-01-23_to_2022-01-23">77-0513190</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2022-01-23_to_2022-01-23">2 Tower Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2022-01-23_to_2022-01-23">Suite 2000</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2022-01-23_to_2022-01-23">South San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2022-01-23_to_2022-01-23">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2022-01-23_to_2022-01-23">94080</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2022-01-23_to_2022-01-23">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2022-01-23_to_2022-01-23">266-6000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2022-01-23_to_2022-01-23">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2022-01-23_to_2022-01-23">true</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2022-01-23_to_2022-01-23">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2022-01-23_to_2022-01-23">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2022-01-23_to_2022-01-23">Common stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-01-23_to_2022-01-23">FLDM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-01-23_to_2022-01-23">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2022-01-23_to_2022-01-23">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>36
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%
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M?^:+X3]>?P%02P$"% ,4    " #]BCA4!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( /V*.%3#>K23
M[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( /V*.%297)PC$ 8  )PG   3              "  <T!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ _8HX5(Y#Z8%N!   ?1$
M !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( /V*.%2?H!OPL0(  .(,   -              "  ;(,  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ _8HX5)>*NQS     $P(   L
M         ( !C@\  %]R96QS+RYR96QS4$L! A0#%     @ _8HX5!PX9>H_
M 0  / (   \              ( !=Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( /V*.%0D'INBK0   /@!   :              "  >,1  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( /V*.%1ED'F2&0$
M ,\#   3              "  <@2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     )  D /@(  !(4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>118</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d243622d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d243622d8k.htm">d243622d8k.htm</File>
    <File>d243622dex101.htm</File>
    <File>d243622dex1010.htm</File>
    <File>d243622dex102.htm</File>
    <File>d243622dex103.htm</File>
    <File>d243622dex104.htm</File>
    <File>d243622dex105.htm</File>
    <File>d243622dex106.htm</File>
    <File>d243622dex107.htm</File>
    <File>d243622dex108.htm</File>
    <File>d243622dex109.htm</File>
    <File>d243622dex991.htm</File>
    <File>fldm-20220123.xsd</File>
    <File>fldm-20220123_lab.xml</File>
    <File>fldm-20220123_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>42
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d243622d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d243622d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "fldm-20220123_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fldm-20220123_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "fldm-20220123.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 4,
    "total": 4
   },
   "keyCustom": 0,
   "keyStandard": 118,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "fldm",
   "nsuri": "http://fluidigm.com/20220123",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d243622d8k.htm",
      "contextRef": "duration_2022-01-23_to_2022-01-23",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d243622d8k.htm",
      "contextRef": "duration_2022-01-23_to_2022-01-23",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://fluidigm.com//20220123/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>43
<FILENAME>0001193125-22-016151-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-016151-xbrl.zip
M4$L#!!0    ( /V*.%3OJ-?J+D   )F, 0 .    9#(T,S8R,F0X:RYH=&WM
M?6E3&]G9Z/=4Y3]TD9D45 DA"; -]O@M#'B&C!<N>"9Y[Y=42WV$.FYU*[T
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M_I7R@/ ?N?94/3+SK\3V,!7^5S17AX$X]*\3@)"E#ZY/5^?.ZUG0Y#G@=$B
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M3T,!5P_B4W3CS[,-3J+!.B9:U +-.TD/_W9 _WNM-C2[=2QP.W(1[4[_A\W
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M*HR+E 9&#4#HD)O&8PIC+0V@L?Y:7C/01!_H;L=1[5DX%S5Z,:H6@1A%2):
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ME"H5C\8V'X3+<$QR6,ZB=_,;LI.,P97,5#_#;"8VA-;#]K.3\ ]7".D919=
M4<,PDCB:R]H?R"7L.@JU[">1N5O,8>AQ7]?,<+K3-PW17:GHTA,J6CYF.U2U
M+6/QHJ G\U)9$W+UK,;7EA$"5I(!. *FE=E7U;1O,,U&]<\CL]0%FZ[67?;J
MKADOOM>^>A.79(4X5+(6RO8SLH$3K&@3K64$L.:3AKYR.I\,;*=8*H2HYM3*
M%N2P0S%,]2YT@]3GCE/8KHQ#P,=^87-GC1.D]<BJI3!<"^"BH+"ZFA!M<8H=
MJ^[!DD9('-(J!@"J9)RT%BB00S6LKNY.N([,ZJ=MGUW5(&S@X,D""QLMF.UX
MM+0MLWV8]5DU6]>A[)LPU9AB&HQM$RV:^QT&_7")Q SL\LC ^VK[5VWS5+D:
MWV'296M,\:("(NOB%KGK(JCX+_%6[22;$0"+A'7J\*P)F?IP(D"%(>?JC95&
MN<I9W*=NC\*N^Z<;E6WQ(D.A+\PFNMX%-@H'HALX)'BF(5+YLL)K.,(KRPDO
M<7"D7J$:$[Z."G5C5?ET'[2V$5?5NW\EH\;DIK;+=A.<6L'"+DUCZJ81%^-^
MK>NA\XT82NM+L41@)N(085A']VONUJE(-%P7"#VJ1$H1S )B;D8(\O6O*E8Y
M0 H<#K47F0M^X*^(J-=)5,2,E1B$;#YRTJS/05<P1@:_\!"8.,=I6L5,:T_C
ML1]6<GZPNEHI<O2QI^RT4T9R_=L364AGHH)PB"LRP5-U,*?FU0?KW7/S[HIU
MH<J54FE#'/MC\A\-RM9DTZ$61$J-=*AS)!V)RZD8B1"3:"9^0-52K.R"%J^Q
MY?T&RL,P23,\\H69NFRXU@JYJI-O,>_7J=A4$I:=\F>66FY=2;52E_*3<VDB
ME<_H4%A'!C;AD#D+%9(P+7':.G(-1:A<Q7.B*HV%;'+2:O$P%,)G)KO+9""8
M[1,N+R;(?K:MSUI1YJ&?A4!([I2^M02</SZ9O:R6*D)G[G802EAT:FG!SIHO
MM$QNU7BVUMI*7=2M6L705-9]XE0Q,<F)5,C.B4EN*4[H7+I#K:PZ=1<(/ZN2
M(R6+<VJ6K)T6D9EK<+#7[?=?OGCM+1):5>4C!5N<OVD26\8IZRR^P?)<Y89I
M+;TAHZD4 +.02'38JJ6(([%;)HLJ-D93]9&?3=J7N1D2YZ(ZCH9FHS]593]C
M4@;,)0SEYD+)%*J)4!?#,\!X,T[,M"^RZQU9MV_BCL;AF%I*Q"%NW-(1M< M
MHTZIDBC7/\,@*S_"**S0)(\]YP>M+3_HKW\I&4^T&$'ASX/]WH^&_94J2[)9
MFA@N00+%;V)^#5[OH,>A6A@,R#EDQ%P#./T2XP8@UV7U;/LVZ/L2)J;HFLJ3
M=&XAE:N]4;6S2%%!)F9<=DW&SENI^LORZWHJ]OC\X<S-GR'CSQ4:0+11D;,Y
MN-(C%2ES,_1L.E(J4]#."'2"JZI[6>*I/*8.Q2,HK1PX!OI294/#/)8X\8F(
MR!9D"X@U4I,CY1E=HL/9!61:<PX/A11E,JM;G36=*?JY&JP0SZ"3XU 8$5OR
M874+5-I4KXG)WE("=,<N[8P<H-,L_A\M%O_5YI>8EP3_=U6Y'P$0.1'\OJ.S
M;X"EPG:HWT&SO$^G9$N2BM.%SI60.F .<[GUUIRY*LMRK!'G6"+.>9$;';VB
M^M5@6AA;IG^=#961!,>2,.V'RF*H%DOR8(!N)5RRA)!-!4XA?A3I-<C-E#9D
M>G0D=BJ=V8Q\V8N2&"MOP! 1-E,D.=OW?NM>=CV6D5 :,*YV5;ZEQNI%5^(;
M=$:\$M.5L7\5=)6DN0[]EI&4^&A\!2:JSF7&>ZN[9;PX5%=X^ZG NJR2/MYU
M$83)ECVCC,O?(;J::Z[5SA\%.Q^?H1YI"34CW&Z746LJR=IE$DI2!X$!NA84
MRV3DN8?LL0BL[L$BZF%K/89%R\:PQ"$8NG2=4$@HV9^Q\ ;ZR=DEAV)AC"5M
MW>)';L7J,%E!"$',*9DX8'K!8:H('=C;'-M%&RVO5 ;#9?72!&X]0QFNA'@\
M#H9K\&K@1\'I*Z84O"L(YI,2TZ2U&6=IV;X")SCU\QQG=FJR^/QB2;$OB;DK
MZ\X--:")JO#%4&?"_*%\'P_3H$")G72 IKHC74BJ2HNI;]!$0;(U=30*C;VB
MP3.[)8DHMSE2\2(JNZUC0OL5D#>$!4P3DFIAD_V#[L&/M;"VZ79>:03Q^QK>
MMMPF5+SN+Q-8+0*2J;2XU(':<I"5FY.XA:O;#\?UM7\K@%5I1V$!VE16T\-\
M,7F5Y7/D&"344,9 _-,R)6";UPJ'9'CS-^966WP21.EC4>18E8XI_A+>-(H-
MDQ2J+-KHN322S/2J#-_1SEPFU+IRAG)570N35V;BZE2( X=\$?;[Y,QCL5.^
M.[:T<Z(=-8?+=-2,+$GY&LP/ID)BQW1$JF075M=>6VN0TO1860&4<(OV=TP>
MJE7/D=+H-3'X(A/UA,CJ3,1WJ8;:[%'94O7_!0>88 ;5B,W*6"/W01&((,1P
M &TW>]G=_[%=<G0]KDS0_<R2Q(E0U[5 _'R#98LGX0P/&(V5_I4P)-LINRHI
M]2->R.!I+J21%*WU0N3QME_(?5Q<5OV4]BBZLH *].,_26HU_FA57[X!%D(D
MFTV>RGRI31-QPA4/N-A$)%TTW!SSV<NP3B\#&^?1 36E5G=N^0D;->X%62>R
MEFNYS/Q#U&6N&[LQ*DC+%NHMN_JYZK="),>M16\*].G2QJ:R-4*S$%:WN-DL
M":GFC>]$MB'UN;>:I19^?SQ5([E!9G>2XEQQPM8RZDBIOOX6<EOB, ">7 F1
MB@_)TD L/FL]?8$'MRQ=:@BHBP^7U0PLJ;).D3YT([E!U\/B&$(1>^-YMVH9
MQQ9^#<4\H0KUUR)^70KBF80IV;W@G*>)#(P1ZB\TWUI%6UP]1 /F\2048^_T
M5CG[/K/:\IK#H7DJ(EI4FA0-@##N- G"\9RCU*W:@=Z-CZ8Y#J*V_%H=-\F%
M,N"OK&!]?/Q"6H+.V=2.X@E[)TOZ^G+Q!:TMI5Y;+3W=$+&9R+E2ATQ\B^=V
M/,\8@ HU&80J"B*U>OY0K))N^1/Y-Z:^FUL["2:WYS9-B_ 9TUQ*5VXIJ8]<
MZ#.=ERLR<1R'79@M!A(>A9R%K4:3A<NN=>]7]JEQ)1B:":[)FPL?Z]J4M8:.
M,7;3P5@5F%PHX+KB%&J%]4D#[1)QJHR/N4(+?4]!@EO*R*::A%D>D,2R=CNF
M..F9P5")=W:^A(^*.PJ!^ \ =(Q_J,HAIMY<$&9V=18S>\VY6Q7NW 9JKEYD
M%2"S]DM;*,V&/=1B<HWCK<*C,ZZ4)1N=48-A\IM3V37K&NEDT7&D$&B&PNZ,
M(DFP/1W534DHG4_ZHQQ=_8=]77RI8ME2]?UT>18)'>O.5*AIQM3*;M:79>"6
M)1Y3SU"L)90ML\[:*BL+:L.OG%!@'?NK/V<N>;\^A=1-0ZT:R9VDB;-<R"R/
M0;>WV]59#FM*/[UCLD<U'_48G96*ODF!QGL?8EM+9!.?=<=+IG'V%XH++I8=
M06K8?N='F&2E9,C+B0!Q[,CB]8F;IK-JNNJ#I)$@E;%K?SG*-UZYU^_V^KQ4
MH!?'U"LPAS4344F6.(J:[* PNW-RT#,N/RPN[W9[@^\7EW^+.165DF$O0<8A
M!B.-MY=:7'HBO+*2H0U:^4,N\+,4<B'N+,8PP"N-3YF+4D[+1<8OUE5M6;+L
MFD5SO]3*9=:HGU' R5)V<N+1Y7Q2[1US@INMRS-IH>;:O".NY-@_V-UE)Q36
M[A1E$XO]N#%,4.==V7@XT>4<91P"N0*<+&9MQQ@2X.!WC"![F_[6YF#+:,+V
M='R6W/L7%55M<C523*F*>UN1O/*A*5_/G,0CN5_LL"N"D /RY+S*BH.RKYQ'
MMO7 95_H[LK>2=,VGJGL8U/9[UABTBV!/Z*90Z8_(GQ?:!^@A">5 _Y,<5V*
M^XQ>CXI>^]^U$'."WOE<5MTW!E8L2"M-==(&F;WV3I7?QW[TM7?$QG.E553?
M0RXD@$63=<720;*ZQY^1MX*\S[ZUM?C6%I?IT:8C MQZ6ST)5-KELYYR#&=W
MZ63G% ]I+8S2\2YS,<.@R>-)"E)K,D.CZ@? ^<F-'^9N)+SV9<#L&95FHA-I
M.RU?N3(3JR1W1V7NX:&['GPV1V*WN*&(DINN]S'M,BTV:S+1]=:M!6$@]8!K
M= Z0;140WZ]6*U*"LUWKO6Z3: 77-1RH_9>RC[/YMSW,Z $*C"P&6[IT-G.7
MRC*UW^K3PNXRU>];RU+E9MN^4T4'KI1<?K8>5W=&;J/S&A#KXIJ<W/.Z83IU
MKS)LEQRFB(S)G!7>^R%4)M)KX3HN"Y@JXI/UTRC$J&CT'F*A7\J<4$ZHVE(
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MTDU).9@^E?V?"*I=HV4N0RN;ANYZ[YW]UR@&#5=63_&F($9Z)&3[(%V VDR
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MTWKC>Q,0.W[:" 9[NR\&@T#<]H$-3G(8[@[*GJM,=<A@J8R9#6$*0]G:=YJ
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MH+BZ,\R<15/YQ)E!,OPTG]J#C&N5(12L"?*>>?B 7.#:3M)+RB2S7$UW Y8
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M\MZ?=K>NZ+UO:^]%C4%>3:8?5A%006::7>8664 66:833G2KJ2^4[E(-RVS
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MTH0X]1:E23%2Q;"XS"GOT31B<54-<#]^3PWX/_*785*Q6L X0]8&"-1X^L*
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M6!]XJ:B.2#+7N:\:-\]RQ:0I9[7?E!9:/CK!/=ZV.$L(52YDIDY1VQ80A?#
MQ-!&OPKF90]!:NE>C8SR!!_4U:7EX2>V61V6 C>(PG6#!&""P"\<(@^4$@MN
M4E@C>:)5KDK$H8NR5EUA4 ELH 8YLPW.K,?T>=5<[/X*N2$[7\),>E3R,;<0
M"V<L?GNEYH^DT 6BW2G=N:H)X0B.97AX5Q-#PU0[_0+W-B!@+&Y\6)2VFX!
MB;=THU9'?HVR+%8O*DL>/N0ZE7Y"KHN4JH2:NQ5@11 &66-X?C>K;*!7(+/B
M.@O139UUI,YU9)6@:H*10\&Y2S+VD3>7\/5LBA "VEO-K%L59QE/G&UM2='!
M3NKK<?ZF^(1!!KY<@]?'E.$0$L0*%\'"_(P#FTX*18W%Q;2T0N85HA5@N]%,
M2L(,Q!WAB2RUD&=7/%+.,9J$6W4Z)&L'9Z*G[G1O;Y7B4:<&HL$=?,1DDEYG
M\VO?SXP=@=)K+X]#LS9VEH.U*+AH(*E(1S;]7^\59W#$+D?3)$VP2]V/"1($
M1#5U64%D!DQOF<TF\FJO\++/BB\L=E;B%;>V.;K_R!P#"9&4 @>)VVQWI.[:
MB%G,6?>4V"F!\,K%PZQOHAY"9[W]>E"_5EN>,06>$O7%(3R/IILE[ "6*@@\
M+[ NJLK+>S>6.%8\&I.;US:8(H3_=(^G9'LI!7/180#D0_FY-1SN2#.'5SJ<
M-G,2^TIY>Q*.!O? GH>C:M(PW"5P#*[^%03,E:XD<KJAI66</7H\@LY9'\FD
M]^)YT:#&3E,]R<!D(-'%!BC@$T=7@;"SF<NOTGDY6J]"<EMNA]JYK\[$@DAV
M$X:!O4;;4=@#KXY_# >,(5DGX0B,!A5UAA*+0Q<D92D3NK3;+8EJ$KW4LI5W
MGV.Z<IUKNFW<>[K["J,I K;O;[ %\%GUT.0M9LP61Y;Q;YJYKRD\XFO2EG6\
MEIS^AS6Z]BVN5VIN'5O$_=7;6Q-OIR]R&\7VGM:1:6G=Z&>-"0?640(FS:+6
MX#K!)N9CM=I\HVO?WKK9SEK_4F]\?;ZH9NDUISM*+S$""&\T$Q/ZQ.)@[KBS
M[Q(DKA$L'9^[SO+L>GY-XH][,H5]K+MGO?-.[!1D >PG$U6<BB56DJFQ8LQ\
MVF2S:!D)#7@L]O5SX=X6WD&KZWV'=O-1,D S2VKI*S[%4IMOHW]68[>3Y):9
MI^XM:1ZSH ?WY[?>7F[KK^XAW'?-&N^,_KF'*&TDZ.>(9H4[E =U<&0?QL/;
M-WX>7M47[/F(2S=-'Z.OW//Q:[/678<UI^M@@[I?K$!ME_R55/H-AF!J@01N
MT1+;QK2Y.898)1EJ]VE$R4)2#11(NLI7="V6E%)YNMC<6%(2);8GZ>LD*]R0
MTG0M2#QH0!7$M: D_MF- "NDI"\5(ED5FM/DFS-(/R1#E&1Q3^V[W<Y3E*JN
MC;(%_LM;YM*X"^?B.=_<\"FXKCJJLK9Z)G$R,KCD1(7R$?9)D<IK*V<P#CN.
M?.<!<PL<4-S!8AWZQLOHYXLWW5^ZQ_WSZ.1==-A]U[DXZ@=5.E]S1E@A)QI#
M6)2CG9VT53AJ,*G&X482A]MR:@VF4=2B=*:VP5*E.X9OMWQG=_=[F.4+W@A?
MOW,J',%04+,-+2I>)!]<-+#IW!D;/U[-<^/U2VS4B-9L' 1OIY)KPJ+4,B&'
MFPX$[!,E WA'B1$3+Z_SKWJC[BUMZ+9T.$P]]M#/C9!G:)+SRC#7&Y;V,9DQ
MT\.R[NV=Z-!W_C1C<KC6=).[5H>R[('N)RI3V3ASA2<:CM4]\Q714JG1$K3_
M[(8YCZ,MGSHOI?J6N-8#*U*C9-CO/+V<4+G%K'".(*)!1T(FX%-%/^[LQ?#/
M"_SG1_SG)_P']!<8BBJ3O8E1B<M,UFZP"21N1%;K&AJ!K;0)<?0I3:>Q%(R1
M^>BO)AH)L5=R8H_X&?L%%R9$0:VW;"O@>LE0$W4_5APS:0OC!%]0[(!%@OZ*
MZ-#!/K]4&6B:!#QX 5( !.\<\#W&%B34]9>0S-$894"MU$V4>=;FQC@#QH0
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M,#6=?#8WN*YJ!6EKO+\/6A)U4I5^K5X<BOJJN@4%$C%??4V6]"MEE(VRB(
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MXK@"33&]39T!6*\GYKQ&NG<$ V!BKD.QCDL5PS<"@R;SD6;3/"'^F6?DRG*
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M,8S5E*"60\?678D6?PZO0]2BSL&'Z+1SUO\---NS;O^$_O/VMZAW=M;]Y>0
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M]7=7,D()D]%V-EA.&]0/897=9^[I!#V]:5+4RE>%@(/>T^W[Z&H#/BIZQ:'
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MAO#0B,Q-;&,Z)X(] WXJP+X-+N -RSO< ??7A'MJ(,W1O0^]X,%M5XKFV&^
MXBZ&BMR^6^#45<$(UG=Z'8S=1:^M,HMY]?6-_72;7,*$G4)IRZ%31W"%:*EU
M#Z6F+]X1&*TH4V.D+7 9RB29&(;?QEY)T\4-%\3/6'$< _Z*R72E,CP5AQP'
M<:!:/@\NG'I58+C#SPUS\&X?L$"3]O+Y0*(//[0Q79GC(GKG);3&^_#4ZN%6
M#A>!E"K0[U6C<:]6Z,[6TH9JV RKB>N!M%RJ&X[ K]*$U(Z&NK$\.7DE2S*
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M[>CG29,57*6;&W^VK[1!'?J"R.YW*(\I;1H_9L%<N!S[(->5:F$,] *U8&#
MUN&0D5P9%0IU'->!DX D6DIXW#SOO)O8*A<C<X)**AI#D7N-0=N;\P6<:8]Z
M?-=-,IG[U003HT("$R3@&D0MK7,]IALY]-B( $YOG% 407 1,.9UC=,A]F,
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M-8G4MW4ZCO(D/"QMY@M$_41-$>!>J:KV[B64V(M&BU*BH^&38^\**5A;&!W
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M[K_=/?YP.)"719=Z%RZFJ\^C*I>ISH$3Z<D_DNG"7.>TY(\>Q]&CAX\>!2B
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M+S,7DEL>7[>8']2?5+W6N(E0P+Y@9;.H+Y9G>@*XK=?[;P[ POGP_@CY"VX
M$G*UP6SO2-+K-?D@H&&8JX327;M.D&P$_74Q7*"W1[&5"^B.0@*)!UN:N4'2
M96H,K:)<UCYHG&+[,<X<(]Z_]D&;H6( %2(Y_4]6_%%IL\)? %VC_V!$3/["
M9PJM1-N/#?36 JK;;;L6-,CR18GY9S"8L,P,*&, L0E95*[GH$@?N@.@]L:P
M6B=E,OR4<BAG"@0X9M#;:CWKK7O@?:X&Q=;Q@I0C,[4%[[H/<=AG99IQ(R5V
M:?FQQO"CAT:HC:695LX QDE[SD[ZV3B=R)JYF%+&?Q0=F%>?F%L,$W0"/JA[
M-@<X0K %Q*EQJ"#^'EW4OVT?;4>ODNFGZ+UDTG>=:0$?/BZ!)285\Q^UPIOT
MI'06_Q,P^'>>Q"&\3P_H36:47'2TF,WRE,$8FXP1.\#>Y""O?7-=:]-?-FZZ
MWNO(;G6_=S?V^GUQCK<H>W>/<!U?KDP;?.&%M#>76L>LBANO8"EKQ)REQR&
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M7P%S1W[%X5*&4ZB/*J(W@O;DV:=4+#P"%+"A?F&<=[20$-%DZ;*,QLG.D;B
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M^P<IU>+FQ7G]W9WJ=(OK;0T>AVV6&A#AH'O(1QLY)0I,TK;PF^U5M2IC*@D
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ML8U"^!T&NI7 4^R#:0;^05TR]:N/OE&ZC^L[23 ,-4L D\\HR$3*,AIEMFL
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M_@<-N>LX,]@&)\VE#F;&!FISY]H^3-/+=6YNQ*X -;LKJM4:T[_^OB=IEUW
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M")O>,Y8JB3+D[-1P2UPW\1J%PLUK*B&>RWEKV]CFQLHV\_K*#%(52Y%O!7I
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MW'[8QN/D&B>R[2D-=PTV>YG#48Z)S<#!7.-!X'<J4@B\^DOG<+1<N#MR7&9
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MJ"$K@YHU)E(^? :L"VYFS9C$V#"-EPEXBL2TPTC4JO&+EHO/D71.[,BO8WX
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M=C6R+)_Q8F:T)CGS,Y6 G:0@Z@3:T@/6'X.BC0QG#T5$-N1\L/:=P[LNF*)
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M=BQ>.&]'$=_^^"X<RVY' M/6+D:I':&/8\R^0E%KM1C6U:0"OUXZHV[J"@:
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MDO%O1-$T P["B:@E)9!7"").V-".?VM3L9JA^0_@0XRWB]E]($RI'68 ^+K
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MGFMFDL@WNZF:V"<=T]-$(?','M],5MC%P)JOWOAWVOV*J&KAXPQ&Q;>SK9'
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M3/,=^X1Y*DR1=NA:LET[#*JV/Z?D:=I1\Q).B6UY2]1\B?24))S8X?7-[IS
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M(CR^TU^/3@:,R-<_VJ?3['_H(<,(X!*5HF[@-;2JS0T8=:]W>@J_.A@V?)Q
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MF&CUT3CR?H4Y^@9/%\7H$T*;8.; AS3%;*6.3[+ 1Z1T5#V+7%?B<049U"
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MS('54%O<(?GK5QMQFQMHGAC#[2'Y&/;T=Y[<^_BSCFN72D+ U:1*@Z9 L$D
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M'#F^0Q)EV[&U)DNVLY)FEB0G1ZY!5TDZ43]4J9$TN)NYIOM4S52F1,J&\K$
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M5<VQ&N!D,3-*K4FZRBOFXFG4M7MDP 7']Z(?D(*]0MC4'BZ?$S 64@O/J7@
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MH5_:/)P(S[1?QM+M)B,S-JJ2/(K'M:WN])0H)D#:/U0!XP9 EHXF4X4S+PM
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M!^J=.OW:!!_1==%60)V/F4.09B\S-ERQ3');P9F6*3G]@.G#V85&7KCEBJ$
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M'[GE@<_B,I.V5PJJ4ND"W7.88JI8)I1*M5L3 AO;*U%=H2^94C*-SM,"W2?
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M$4_JV^0J$-&5J BR"<C'[ 0!A2M)ET?$L[7@"I^RWA5:!4?NCG*3P\$-9^@
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M(,D5M>HI43.<!BTUR'OY/=G/C@W4:+GLO[P'T^5=]W\_]=[W+LZ]FHGD/.3
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M/N'7&*,9P!^7\!S4PR7F#J]6RKM1 9S2:1:EU.^'CKHLQN9&935PY*!D\>2
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M#8RP$$T]C5S0#2A#BDL.]*-L04'UF17?'9MDY&70^GF0H\L[;$JJFINES0$
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M,L4J/,%G\9^HCU)28&X4.;-</&N"$N#6#.I;8!6FJIN>+J6CNF4(XHRWPI+
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M%/KFO1U@N4>5I4">V[54;:[\P*O\65;X&%?8_37*9 G.3;@.?^64UB[QH[/
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M9<\9^#/3WC: A;<[YP:RT3GEMV$MS!^HA$GNJX_?F6A-_$FMF5Y@)4#;DHK
MKJF,B\E$%DH!XIO'ZV)]MG:QWI?&$-8T!B.TD6T&G"?&Q8CLVF#-RA3=.NJ!
M,4" [,B70HZ)6VH=Z(%,T/U#\!""TE,HFVTK!;_R4JI0<6C95%[94JP[F4&!
MK;-U,IJJ*R &*'PQ*2>N%[;:A&228M7#*+A"*&9Q3.NDB4SCK8N*'['@@)^,
MW)"IT"HO7.(1L/(PG9!1H#U7MU]LU!L<)4BQQ#:BA//BFL27/+9J1Q / L'
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MJ'.---RS,Z7TKX8F;D5J+I)+G*??0OXO9>B$6E0 K>R4N:JU):RV:#1+5^E
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MUTW%#Y,/+Q6J&UA!@4:=49_PN7%Z354C%4\B5A)H8#\TI<@Y$Q(/XB;//E8
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M?B'NQF,V8MQ^FU?WP)U;RW#N*T[?5A6G>&>*F O!?9!>2U[Q[\  /S0X"??
MSEORVKBIF?>15T:\KY58#6..'=]#RGJ+=II6X.[?>['YN'/#GOS%<\.^&X_B
M.RH7GV#EXJ& %O0T9K=N!-UKHRDO]K_Y_5)AM:<!-\:JUPF>::I^K!;%8M6V
M)WDO!-BD"R*EZWWE(?.OGBTEW=PHDYA:!ADH*<2?IGZ<NW<=HG?NH$MVOUU&
M VPBU#S IFMG@9\8:9A[ 8#J['N+1OOS=W$@NTC- QA^VO>V(J?E[76:A;G
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ME3LV(>/_K8Z>?03'(LAR9]>KMWW9/=^%!:"+6B"!$9. [11@6FUL;@@<8K6
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MH#%WS6JF]J(2^%,&8A6CNP937WG229)<U13D-FC[P%I@P#@-QID?(F(4Y0#
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M&\'%- DZ&6E"M3-"("7_2D4-T1CQ0>17[;TC6O+42-*$G*:JK"S8!78PM$#
M!W6/JD/@F1."=$X8^Y#&%N(U$>Z"\4T\ :^K7M'F*UOS!F;T9840'T)3V%XE
M";<-@U-"X5K[0U?L0[4^4O&3<KD/_$*F-:CX1RLJ&VQ].1Z9!ZB%X<.,Z2&L
M!:R^\#K;"@,M$BNF1Y9CC2XW)X-T9KYA^MFMAZ8)OH)0F6@A!X^*U_A^=(7=
M:O$_?8WA<\:*/H#*J:*U&3<\J)9 S);]L*F*F?@%6<[W-VXM30>O--5@X@(_
M'H_>NWAO)PJ3AH_#BB%^)(M-*T\]A8=,=EB<)\8KB#3@(O;PL#8B$P]&(QJ4
M[1UDS9[5&VOG0Z32<L WG:."%[ ;\]!&FE\M.Z]R84##7&2CX&PL^=9@I@*'
MG,U&ZC=,*S,.0"Y-B3:Y 0*05O._R[71!XKV1 0G6N;.]V)THF#4K>D= PS'
M_8C*\829HT,SSLK2;/[,5O1\<X2KE!>E"1=UTDM63;Z\9F4G>$S0H>3UI5$(
M9H"[%'5F]8R5P0*"+[=]YG'LO#VX!S%'#X(N84BJ/_#B:4/&"4@H?4@9%D V
MQB5T1W!X64D%B>FR*Z@/:K@M'LT+* R_SI5Q+/^U2!:%D?P 3MTP=-X_\_S%
MV#7MW8CO,09W\B,&=U]W(\>[\4]DP3E7Y9M$&.+N2<@D(H+J=Q !RRT<<-WI
MQ'@OG R-E6.&#Y."C3"%%J,"NKG*2RUM>HF#HA&5.'U)K%W/+A@><_^(F2JF
M+.(3YB),PTK[U$ZS/RN(KQ_$_>PRAU*PBEA<?@,F$C'VN<PS:P\A1,E\@>"\
M\"^O<!KL;+:@4DW_Y9A_-)R;OPE=J-4SF-30?<_'_W%?'5U_WZE[5644J*EY
MM-2<BYH;S#UFI\""D4[:NOH,L(B;MF)B;"6"??DY8W$/W97%$:O$19Y:/A4
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MV5S]3EVZ'L-KDEC,N+/Z N-G_]*E*FT#LX;L-[DM>8F_HY=H"Z$H$1%/+1.
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MO<=&T:F^./Y<U2W66&3-@+NFR89**NVE!;@N\ALZ*UC11B?_($FL$U#\OU4
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MGR.WU![/?!GHG5./_C+5%#)D% 'S,UXI<T9A#%2;89R*>07&"DZ$V0WD+=@
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M^!C1I'C'H;NF>K;KQN5%J"TN*A=5S6J8I']@6,4'@#XXC()K9Y%O%0PD# )
MP3?K9>[1!%>4?$4*R& '+/:RK"LZER#DP2H?=)C9QFCG7FPG54T-QJ.%D?Z/
MH*^[B/#<(R%&V("4% CSW>\E0ADNB*G+)P(!$B^R$BE37E ]R?.7NIGL*L]*
MCFMYQ(O/7_SLCALG1 -/K+:-O!NO43#N)P8A#F$;Y0_GLNA4%)=<@M9EPX<J
M0+@%Z"WL((\4"VQ]JO*?<H\<BW^A?1),"32*MGU)@V+/PW!:/4=.*Q8;R:N\
M-$,\-+N\'<Z'95;V,,H_'\0HCYMJ=KM+@Y%:RI(HN3P(53"C^$QY(]H+$GJ,
M;![:RD89[3TD#2@K%Q4T6-;TI=JZM6%$S8?Y%P]P:N>SAB$Z.ABAU@CGP ZS
M(K]LB>L2Z,78_:30H1B9P?@S[H)M8[TN_8UD[6QRXU^JID5E@,TR-;,RH;]<
MCYCSCQ=1KCU^A7\R7FIK6"^!#(R6PM%O-+9S-RV\@\^%E*!"J.H:Y,DS@S_=
M8K!DOE^K\=H5&]0&O:X@P)]+AAL/<K.NX*[-<@Z\]MG[\6&2[//'>3"RX4@;
M*'7_(YBI--J<$Z?V]N/YQ5ERM@#"%WM%O4)ZN-P%YQW,J5A#DS?.1Y#W4JP9
MM99*CD)@:T#_Q7IY[[XUQ1<T%F33V&98PV6PJ2YE,X1H&[_!W]:ON@UW50L$
MMCQ6T!2-K<)Z/((+P=;%$5;<+ K&M_OR]>C)SQ-XU]/CXQ,C:(^>H*S%595[
M[;W!"$^Q/>MDX$N>'O_TA"+\_H=/W:M0 3>^:O6_?O($['ME ODR83RB0<H8
MIJ3?]!#]$<)CPJ5XYB9/8',4*Y;6A:J" C(Q*2'"R$%6$U[)?_#QJ??86848
M!O#:@RF>>B8>F"Y8L&<\+?D]M_2]#J?=W9N;?+G(T!Q"RCN0$X/.P]-C=0+Z
M&A$,ZY0!51M2,$>DW;I$TA8>$5.CM/?1_YI*6I,?;1%E0=6P"RY8=!@+!"\W
M%L@*U4]TF"7(TM1Q&61?@&FJ1 P=> _KO,R6?'=;GT2O6%%D;,K#2+U]9B9M
MOU[_$&89-2Y_;=&=#TEWFOK6RWB$YHLEZE3Q[S31(AUN( *!' >C2W7G^UK-
M),**0$:2MP4A1X?ZJZU>;NQM<5M*__7!'#^X.1\HAR[Y/7/^8"3PD-=P0<\X
M78%@]ZX[5QE+Y')3T-"+IMDXXLBX!<!$SKX1*#(,TO;EW 8 _FT,'.J$3DGJ
M0$*?>*;W7+DY?@5!LLBNC4<+HXX:?6[88OFY9#$A1=U F*D-9$&CMCE@H )<
M0H7Q0//%ZVJY(99']+(<AI&R+M?^JVV?'JR&9J),D#>E-Q%CLY<[IQ :6E(>
M;L<% ;WO,RCY]/A'4/+.W%:]IS%D;!FB/U'WLG_HM0':2_[*>$VL:5^(DNM>
MLX6#[ON"]^&D_EU2-;:=,-I3NU<"OXM/4_H9@I9'?B<E "H@"]Y\XHO#)GGZ
MXOGQJQ3_[PU:R^8__JXEXV%"FJBJV5V!<=Y56T/F\ X;YP<E]$  (YVOB@W@
MP.J\6$VAY)-;:(NUP]'M2+:=HB/$Y5N45L;R6?45FXJ<9,4\O&*6>[QO=%!.
MMV=X$A[I!($1Z 72C$X!\T6\ 1?/3@F6>@LLHYM<#15R <)>$6-KP(=,*.C.
M:=6\AIM,'=^#[*?NO,[/P01DJ^R5@U2*YGA"C0?QH6K:1Y^47? O=DXX"HE;
MR=Y_U6.Y9-:CT:[='F?F9(*Q#_8Q.;;6W)U_ 1"7#%2LX@Z\\MD=CB\%@LWV
MD;:,L)*K+8 MT$AD2&LVFQIWLZK#F5K/0TJ\'8$1)TQM7F>Z#1HVH>0*W4H4
M^8S^-F9NT&-(_%,!EP-+,7FZ2#V,-\=\B<*G^&6CW@\@ !=>")G=A9 __T$;
M-H0IB' LJ*V(Q^"NG/X T\NOLN4"6)>A#($ /"(IEW+TTJZL3"W^H+6*OZTW
M3;?/2/ S ?; ^G+\+*5_*4 QE3; KQ?%?#.C9IQU]'$NH<*!3EF4!8I4.O.Z
M1PNFZX"AI46S>E;4QJ*"@(NTM]MG EP2"65CRSBXHTO0:T&V1UJL.(EM7C\H
M<IM_R5?K5F* %)L1RB@8BF)Y&A8XTY&CSM7^^9F^V1,B;N&.A_"7^<88.P@.
MH9'8G1D4"3H]49&@:%S9E]1%:4S?ZX#?;6=F;6"KQ_%()[?385ON0*ZN2YR-
MQG0)"7O&> "Q=HEB[=R,S-5$>#C>*DC01.+F#E&,)6J]@&+%R3 $07R4+9%*
MKF;TN?#_N=JV?Q:(]_2&J_$) QG.X*RKQTDBS'UC0O:3ZF<J9YP:B_, V[I:
M2F,[[\^HN;P_5]0(%,%&K!HE%^\ _.&!Y^!0ZM!=UQ6':N#Z59MIF_H596TU
M^YR0?]6W85!+>&\[QN]XN(U+]NP;W5M]DI"#U!^1>R\ZP!-UFQ4'BF*FD)1J
M3$IU.U:XPCQ&JTB[H II+><Y:&?XR5?4[?7VI(:N3F="ZYR#]03'Q5A9R6;-
MQ,F>H;@(V$;Y_;8TU9S"&JDV6@&C'+U22\1^3$IU[V9S96_%C,8>*4@WN:&'
M1A[X6E4UA0V"$<*+O887#OM;)]=,.T2&!A"U\3B^VZ#8R8^@V)V#8CV'C]BJ
MWJCC*NFT(V/S5IM+0',@Z1W6B6V:L ,1F['>X_G9&N;OY$E?@C4T@8/,/GD7
M/@[!+Z-Q,& !B!%EPBVE [X?D!JI43_U):026!@P^P?&W,VJU#D2^#%PF(QZ
M6Y+EZRG\'9--P1H&2<16@?8=Q)] MC/*U$%:S@B[#58:BA99345&!3);20&[
MS\8Z,ZH 9&G.M6G@+[-2YAZV:_C[%2AS?L)P>-SI\^._D;<?A.0>-N)QA;8;
MCRQY>OSBC-W/GHR,LU\L$P%@$JPQ8UP*%[(UECI2__NG726XW3J-1WT+!6/R
MP@$VOZ8S9D$R3:5A=E%46&(#J/: 2C:ADJBWG5Z#NP<EF"7(L]CD5QS3&,2\
MH WFS#X^$2X2]Q15N>!R;9*^\;:H&XQ*%=FRR]JZ!/NN=M(><9TE2^8L]\ ?
MJ<9FR"TOY :-EQP7IAH\(OD ?HW+NFJ:1YNUI=00_CKF_>, J2[V],.RA+#4
M(C2RO1 U?_'BT#>TP!OZSJA;H_R\^.,#1XJHKFHG<M#&/@/("9+Y8_F%5]<1
M=&_UH<A!KB/X*P0!LV53T9W(FXDQT%TOE-AJJ0XH5/6/_>T$?()(>)F*%WN7
MF8Y'L:?J0"8.BJX'FIB8K)=2D.B/_1HALF477F,Q":!'XN<EU.0NI4B1".S!
MZ9E!O-A9$KA+NX=.J775*\U5ZZ@/;;% SU0:F8D6O5A3:&N4PB8/43Q P67]
M/?U> \Q)J@V<_N%I&(&8)"YUWF9?J!&GHUKSD WP=WI97[HB=0O@]%]EJ7W,
MM1.< :,A!BP"R'BCG9H%G2?-G62/E2S!M2N\BL^_04HQ'VKFQD>52N /F2\C
MQX%2$IRCVO<*22A83;LI">AB35C+JHDP+P3P=K^A1967'L9H: ^#ZBW(Z ^#
M97\!0OR7;&HFWZG(?M!@738Q4S__Z^\(%3D#RA)<=1K-)X^_V/:D2J9F%-(<
MV3:629,ESF>#CY+ 0X/-$>8Y?ZR_?E/5GV%W-N6L6.H.-7[<QO_<'<-&K'8G
MJ.N<ZSV)'F1:S;?)$35KS'1G+)G(>/3*S<2>"*49=MI#L8BP,HPX_2MM=#!C
M5^FRIUL5LMJI.?246NYP,1U^#[]3F4F6Q7^<K^/I[18I:52,IM/]95=XV3LC
M>@/(3YY!+U7+([SV4TGKO.5F!$V>8\ M"Q^AFHNX6MY([BG 5=IPO)=[@HH!
MH]FFZ)A3/ TK\W'"?C;\-_$#Z))^S*4PZ565U7/_B-(BU_8K X'MX6(I)(L[
M);Z=>LNM"BE8L9V!O<6QLX_G%:D RORR:@LG,X>=5#KD_2?S.XZ>G?Z(GMTY
M>M8GC-#$-=[;9NW"Q''9&$4S$&T>TS%C"L/8<M6EU*T%TF<'=]+/J1!_A4E3
M/,1@ >&@.<=*NBR7PO?,JDV\&RU8&X1Y8$69Z'Z.(8BN^TZ@OOT,MA&P14)-
M?YHTR^IF7MV4K#:!DFH-)PB@0,7L<TY,!<3X U>VSA>;AEJ[X/=!(D&,FSK.
M&]MJB3\P*P<!G%J*B99YM@"\*/S16+SUM'!_NS3+?@VV-\Y2AH90'M<]TJ50
M:;.9:'OB-))+9N(7H,$51H\4$(#P?K?(P]X5BR#O]%_3RPAYL'JCMT[@&P-?
M1>3B]#:A29+:.F'BENIG$(,^PU$OB[0@>1>*#P.5E<^F;&FMOUU;,IRZ2X'U
MY+LP<A:FNIC?TO)-II+!HQ@RG@6 -!T]X>L)%5$D;*2P,?7X)@>>4'2&S#KB
M95QC-2VPXJU6Q24GHNR'UT63*1B?E*"S;:'C"[[K>XLC@;(SQ^Z>8 DJ/Y(R
MQ1B?(7N&<(PZ@;= 'GUP]V9&YOT'BI3A)<9*0;*P3M-GXQRN]H?PSA^]D."=
M'M"!2D@^^15XPA OM4/]96ZT?K !_SK[^!N61G S.8B#P/J2"U_D\V[I+482
M AWH@J+Q?A*NWM\(5'-\3TX3(]+;JR:UVJRQBF65-8WYVK9:+ C_9"X, 3;-
MH;[:M*!A8C@"J/VI>29&-UU>YC5SP\@L#[%/V S2)L>M$SC<KQ+_D>ID,:DS
M!25F%"?RKDNEK]T!TDY3HTR3_SI]=IP>'Q]330JIC#"G ,:[Q[HGJ7'Y;W6M
M,MVVH51$A^H/ -Z$@H[L)OB..X"I J\!>"H5Z<R>EG[<(#P8=[? AUNN;?L,
M]".I?> UX2[+3*<6W,!4P6=U0_)^V"YQKF]PS8$\'==:D9M'JUW\IJB6(GYJ
M[R%Z>M085?P@=R/_5*BK;T]3,1Y%0:)L?!'*\A;.>!=<&C?'>J^ON/%3$L(*
M5ZJ)14JR5-Q52]75VV$^.*#*>"3F@U""AW <[$,P]YYIELY<1BBE,?])60NF
MCS??$L36<+[LRC+CV"86=$ZSW>@@>B1[6 @.;12/ [?#L=_3@8OQ2+7CDY>J
M6]P1;,Y$U, %0G/*=_9$'SQT@O]+;NZ'YAI3),MFP5?,:U^JL/=-7967B\VR
M'XA$8N4ZA%>,1R!6ZP)_A(3C]E%XO(T356T:VP*JA\-6R74;%<(>9<XR4J&F
MMY A2)2-_WX-ZM8XF2WB[KAUX2%4[&(767;JG=ZHF11!KH9R&+& <"Q=E+#R
M^D<! 8+"S"DH1]_5-1:U321Z+/:>)E'@#?#7^4ZZ6+)^R- 6#PY!38\3C6F?
M>A2'@L _WT&O6[I$%U**;RXA%]="N1N:^9-4HFRZY[>U\LSED&(;.FRLPK[P
M?\<1-G=K+2<]?192FW:7H"Q<"K#W2?XAMR*,<5=[T)#9F JDO#/T'9/]/WWR
M(]!XCU#T/?(KC+U%2UY<LW+H5&Q#7*@5A3C3>$OY%Q!*UOC=E,92!\T!L#''
MF*D4C"-^?-#LX^FQSY% ,ADT]P')M#X%08M>'D*)9_6'L:PT3 /00"_V2\6Y
M;K#K.E<_^@BKP54A5J_U=8K4/95ZS,"X2_%]T@)'T)<(Q+Z\!!J%=A#>"%G8
M=W*9:0[O_1&P:^H"%M,P$FOS6[#!,VV[62KSU7V0D'Y:-AC#A9*MY%.0\[+A
MP4:5U?]NBBI@P>)XA&UMZ:>X%$%[C]T3Q1Y0>Z\+"\#POC@\A6"7[G7)])V(
M)7UZ _$=?N%=[4V_JK=HT+YP3Q-UYYP1IKM<&.G1NO2RY]%TCH#UN/YS.,UP
M@O1F95L\>EW5T +,#.0EM@"M2\F(?P(\QP$UQ:XL7HE%.=T*O%ZOVD'E_;8]
M4D[3V!(;^KZ-SR*M+,*7!N2<2-SH5R&+K@KSB[-#>:]*6N]12".U;7?Q(<'^
M<%H&SO15UG2GW@O53V\[^_'(A:>'3=R!)#[ZV)SA45KLJ@O"D_@1 $1=-*1=
MUMF6-M'1].I: +YH*W,FZ'OV45!.6_K/@H]B#[M$5F"L8S0/ ^<-/;;K;+G)
MM4,_RYJK-)E=Y;//D*0M:D:A+7#MC$-W65!W-FP])/^\+!:0,4'H8>,R2URR
M#&2M:%P#@)++&[ &]SI?HIHM&VGV< G1H&T%:IDQM[H-$_"&8B,[I"_GZ*B3
M/<E[[!>9<9!#>=^H?6A1-S40@.$6&;FVR<N9"#HJ:T[F^:RP]1S1I[N.DO+)
M+#->-(:8J#D3/U&\6""!R<QJ7?+6--"'N2<QW%^1 LC^:<O!)@0)R#]$^Z#B
MTUEL: 09Q+=BM^XP&>%/^H;UV<FV_'SOS4X4&=YXU'^7W=UWS3;]6TU0M=O:
MW &"UTL\4N8)D\Z.WS0WFM5<W%G29&6WP5CLD1Z9&CZB1*O*Q?1_?WSQV&@V
M[".V3=[DD#20"AZ(7> 9QC41L.L9E2R]IBK<Y,CB"]^_.WNM,(04)L/G(UA=
M/3QL)/>&-X?-VS?Y GNWHL*5%S7Z@:^I@5H>&?"KC9G,!AYS;LS/IJVWWS&=
MU],?(9$[8Z_@N-OV5NZ4OCJ_\ ZID8MTI%!/T$5[5=60SE;\?^[W="@I:& ?
M<]_5)^-1;_E)K\G_\ZU-_E3_<9#$'&3[>!T.XN+2U:XYT#!.^[7-;;CT(]?7
MM7Z%.SW8*;(X&:GBNC*/\1T1)2S=ID:SKESF4 AY&[(_66X09AF(/2UUN9$>
MSTEF,A[9#A#&C+%UYN:I",3A^G+U$J%!%UV04\(W:-.I\@D4W''/ W$M0O/"
M;#IUHWR#W9#1Y!8H,-\)0+Y9<J$F^:4@T-H%2>YE<B%**3D'%>_2&O)-<_/D
M?6_RLLCG,F>S3&^!U)&,U=]+LU!4. *_!+E_]&H"EIT9028ML0B7Z$X'%O]0
M,-U<G!J[YDH9%ME0E%^5@O>@6@+=5(EBW&1-JDNW0*O7^14T$C+W M;-:6"]
MV*\WTRQ-SFNH-_P-&>W_862L^>AB:ZXRF;:01J_-&#*L,R(KZ_?/-10*(5C0
M5NR;^3X[_E_PT0H29A!.")J!,0\&MUC+9)^C70[D/,$;7DT.XF*?8L%%&'W]
M>YXMVZL9V$]DL9BC]M'UPSA8=8@Q>[?( ;XLL \K^1+RCZ8U.YY[]7V*];7"
M F].T6?C45_0!+L:<(PLELV'"+QE/=_?XY$Q??'"C7@D4/.H&UD%68$CM(H+
M(UA:(&JQ* >B-3/_.5&#WE%4;!1P4*@7&*C<B:NQ-<.:0G>SS 5>YWJC\+5%
M=?T."NK@"V_JS:51DJX_+FAK^)JK@GQSIDM;I)E$5H=LO1";F*'KO6D!U&=?
MZ)5<ZM*8+2X+GP)$D6JS]NT&G+FL3'[-YV:5C6Q)SN 5QAS1P&BR:^UPU8U0
M57#A#/X&\W\MY_$#5SRZ/V%"E:9E_^@##,/$0_R$N')RA$VB_.0M,P-D#,9R
M&P)H]WL_LOUISV9W4Q VH@K4"DW+0&ZS@M6:\"U&# @B'"(<%0'#S(W>  /9
M!B+"QNO^G%W*5[@7-3<<GL,!XG+7%)L?H_]-KIAX8IS)6E> ,@>*0DP!UQ7F
M.]2KYNIY7 )9+:.W?& X*%;/13_Z0&_WK%K?+=RWUCR*^,FSP&=J/T>(@/%H
M5T>%S>Q*:B3+1^Y4,$8%3"@!"!BK>$B:9.I:E]PE90\<<K&>R-RA.0T;=5CS
M$I"'FU)RZYR@[U\JOSSJ4HO]C"X^74&.QP@80.1%0#/9;)JUW[S0/RV6,M^6
M81PH5[8KU9P_4![-H1/O1%>L@F@P3L*OF>,C[],?8'\HTIA.$U;"-&X^!)-+
MJLGW?1E>;LZFF1E 6*&E&W<_0K*8F8@P$&PH.^=U=@-=X9N\^ ](-*#-D&-B
M/LT6.:9C<I!8<LQO,L2,I(ETVLB0V]H(. ;_$%5ZJMIM5[6D?F 3W&&_N:J,
M ('GFUNC/K>RK@K^@#''SM>-P%SDB.X"]Z("YAFDW._X+FR=^R7Z@+X%64PK
MZ3A0H0@*^GBL@&X(188MP2<?[?0D>?WXW>./CY,/0-;R_/BGB1=U(ZB>)U5#
M5:WD[T?<-JV8P3T.LK7"Q&4U)9?@-T1P38<C=1ES/ADX%'J!)>(*1J9C#D.N
MTG3017(=HOR\?QR%WV:?L9,LD/S"R?C*K&-7-BN1:\PX7[Y&9/!6]2?P^.:\
MI0SW6--$9(GC(42PFM@4JK^!#[DB[](MG/_[93;-J>9,IS_#0T9!!S<&BS S
MLGP(6EW(?$6M<J>IZ KQP#SZ;,TJW[T!#&]4UU+H7[/Y'^:N40F--+O$ V5;
M6'JOF7S'Z+1G/T*Q]Q<+>((T$"'D[&7R'N*N!VYM^%L$#-?',$3@D:'&S" )
MK%H:WE$$>U4*@I+OXOONMWAT)RHL#"T3ZUWJ@<%J+#> AJO\*ZV8X5V:X?2-
M[9W(6=I^XA-8#/*Z6OI/QB[L@LX$<()=TZ-2;/-'L1 #@W&;N'HEE*\#_"??
M:Q*9'I(& <M2)Z/M]Q,Z4-FNN4'Z(GO79CSZ1O?FJRT7/"&V/\NZINYIE:O<
M7F)^'M#J_H=S<U I=+VKM8LQ8JH[/)7AE$,H@\U$_Q_SC"XA\.VMLJ/@C[%+
M[&[K)* ZHRO##+MHNIH1H:UNG%MS#PX2?GZ*Y-S2K(%.YMD>9.77NJ^ E;HO
M'.C>,^VPG6NL721QX]I3H(T88DCBV$EN41W+"MKD7IKXXIIENHZ!ZG% KPS[
MDRWXNA".@[)P,TF*9'CTF*D$U1I70^/(GN47",C@Y"1_Y"IN'%ICEC4;[!\$
M'ZG6?K(VJ62*+%H(_'QC-]<%1=XEZ<5NFH;02+$PWF]\S(!*]"%'S[; <5MH
M%Y3A)MC8(X3)8OLI5Z(R@U\N&=)C\Z[*Y?)[-6"W1R25SA<9L.163.6-<TN%
M<H^>#M0F:RB0A.%C8JU.S)V]2OER>"SO\D!F<<)9!82@(<."'CL=2WY(PZ/9
M?['P4GPS2@:&ECRL)'L&DNPC\P)_P/2Y$O:^TH6E#"F<F9]=U6!K<C%>P@J<
M:.)_10I1L\,VUX[^N#,Q)6=/E&=V'*G_W*JF((R0(,)!;&_@+ ZSM%)A9P:D
MZQ4FJ41.]381#H))(CVH, QY^Q&1B?*#67 @5C/=M$G'YQV/P$Z 8X:9V!W@
M4ADG+C.-5!D6NND/A0C90 Q:)9X;$S9Y>HRM=EU"=']!WL6C?]A.QHIWE].'
M%V]?RPX'461%5['3.#TY=B^HL,75ERU5Z>%96A-HTP;4$F[&O<IS895OH)6"
M64LX# G3IO E1=GDUL,?*0[^(S7U_HX#"3_]""3<GRS\"63AJ[KZ''H;(/C^
M#RA$M&A^^>5UZJFYA1%N)2)QL_EUT50V^ V'>#R:9N5G4$A3?#+V"IY3,3OB
MUQ-+]L/*E*/,Y&<"%Z+"4E>$$[Y#RH])>W+5\!2^VAD[7V$]A01F@&%'F@)F
M,FD6J@4S]\5@MI,%L.63ON#2ZSZ:T8CS(54OY&8,IR'U?QCU\1]W:&G(Z;[.
MS+ Y/RP-2[@I"R+'\/'<!=8LKST-!V$^/?T93NI[G*6=O*,;]:8GC$O>Q%*_
MX:#K.T-F45_?&;!BVGJ34QL1LQHY(2,YRV3^?VTU6&_S%\JOH&93_6ZZKVJN
M,NJ-V&>;=N<*4A\%#(I[<1Y;CP'5LR0ZAD2G%8X["][=LMR?H/2MR=!$.\\0
M*+\M;D-7FNX)1+$&[E]D*3CPJS@6#*2T90_^G42A!E/PK&?XX<! DPM/=6AN
M&D;3K<S&YKF -_I6&M;#+>M!?/SG"#$[=U+0=6^"]$:WW=:06(C4W1:K53Z'
MN6%GWE:>P(T_E1<3J<7:^0)N*)KN("+7/3>TGIHY&^[Y2T7"%5F",ZK'/7GQ
M]/@@>X/,SQ?9$I?FPMXOVA-@!*N,U8V]6"1&H7A:5/S*Y4%O6XDEI69.-P>8
M.J>JL:B52]! 2FDH<F(L@!P KYHB"BZ ?(X-G-L"CT4/[X4RZ-_(B-V:P%Y-
M*'@#VUC539>\&$NZJ$@_6SHQM=\]0!5(AN^K1R=RYS_4TJ,$&YWM;+0Z<-$[
ME7UN4942QSO1F8J2P500RVN=S_4OX)ILMMZ74[X$NM-DH]TO!&>0Q8'F "%Q
M(.<NS=_N<1GMC?0L'@&&M/DE0>M0K))VET$U'=(M$.M<B];$CTSBM1>7%D<B
MC?PCYS&-NYP"<;C =S"#3!*H#BG^PM<2(9.88P<QKYX<<^(!Y F$1P!^VVAN
M<_SX)56S?<H^YQ -Y4\A+7:-)7S-T+CPCH Z1L-B!.FNTD&[P,2^UFAKA[N/
M5@5V\37:P74Z%%L]@VFT/ V_N<T:>6T>7L(_.4'M^U&?&=J&, T4,XLB/_/6
MN]*,/XA?$-(ZUII#G2J":J-B#4V]!8N@WJ-^F*-]BE2X0&34 ,YO2[=9<ZA3
M;/1?:"4[I7K !#KY.4,&Z:&09Y]%HW 2 @Z Q'J5>4OXE>[#;^S#QR,F3EO"
M#N.O6HBD)__[][^> >9]:<S=W_]J_L7_1Z+\_)_PSU2*2OJ=4@XV8^6)Y=K.
MQ0\+0GDA7<>.C?FI9U_X(PBRX!GZZEY*(L"<"5]Z2H%OVRK[S(4%HK(%LA@V
M/."UWWIY^X@K-AYIQI \1 &H^I9H\"$6.]#1;\H)?;?!P9]_! >_V:$WI]Z=
M1X:%H/>++<S=T8]0+@;"!L-D3MB >FKA?-J0!)H.-B93*PS(;CZEL$Z236';
MC\]/X110S,VP@"#5X6*$ZDM0U&9LO9R!(L:VR5+US75=_9'/_(L(@M-,=/YH
M656?D0_"AOJ;KR\C^PJ R<=<T#'?4(LD5HF8>1]"BT#JV1[9?I620FEJ0<$T
M\K=2^"G>33@1&%CKRDZ'*^$C^\E+WQ78]XP+>H#)N'^W'TQMN?7LUT!IY :_
M_!,H71X^(.Q7F)MV%P[^.^=V@&GG8GI7>)6O*C/-^6:5)N$*^)TF"%2GA80-
M+(/4F<]AC?914@<2*?63HMZ[/'D4A.A[$@GA@>M\R;^=^CI(&L,L;N8BPW2;
MI/&*&<YFA6X3]?9 %^K@I[B@CBO0L7!39[-MPCEZ",X33=ZB]YRG^I3'#A*@
M*+_)2=*_W27X3Y]^ [OH?[_ZZ]G'3^>O?WDK$C:!NHL==_I;6&=0\_'VP\>W
M%\8$.OMT_OZWB^3LMS?0"^#CV6^?SM]>)._?)1]^__CZ[V<7;S_N&^&W\1<[
M%HX]/YYRZ_3PR,#]72ZKFV:G?_)M!OWT,?*OO5<=DEY2&>L%6U2DYMWDC"J;
M;Q#SPSP *3!3%7-LEL@()FZ>Z;?>])6H:\F*"2*_*^LBT2V;]-MM# )"#TT!
M?:^K&^Z>FME""V0.8+[L@"21U+6C2J368ZY #%%9%4!-4B)9QSM)I;CX, MV
M=2"\U$:28!2,L/9*-S&H;B0RFZ&(N@"<E9$9./RJ=J,?@JVR2*HA7XY#7Q'E
M>AN0ZUWSS,'A(7A/P'8%"ZO/H%E>E81^Z(C:T\>G1%=;KXD9Z0-LTLOD+5$X
M,8@QO!C=HSFS#["'=#S2I_0OR5$FC6,QNYOKG')H-S)@L!L[CN;N7R;&9*=G
MFV,*"@1763IF,*66[9;1N#R:0R;B/YGZ<L8/LZ<EWX&&=N,<CVX#2;C=%,G[
M&)J/O^7#/9.',LR\CFB5>_X!GV!O;8TEM&MQ;P$M'Y+=_IJ).C9J%.Q^E@Y@
M!8YB541!R?GR&C.;;B&()]X<\OF\X'N\[R>%HG"%#>W,A(B#[C05OE1S?3)"
MWX[PC(W9"QL^@")0S8N:]ITQ/XN90E;8PFZ!J'O)NA%_-2VXZD<="[T2J5#$
M$8$BU_JHA>HVX&X1(XY4N1HP3PT]/6'E:C)7&6)N,=_;:>H%V"5@&YRA%FJJ
MY374SD-^W.^AN"*&BV*SXJ/NP9F(3L:VU LJBF9@)2LD.>M.SN%VNA7Z!0Z2
MZ5T;[WI6K#EI"1+75MU\C\''YS^"C_>FN['"<6\:^;>J?$3P:;"-"MMJRD6U
MO#L_'NU0+%^I*>):.+VKIK@]$+!/7XQ'<2D[QRH'9;PP5S!'MA0%-5.T7%N6
M5GA-GZ'G24-EOO#34__9J<JTPU,MPUP:+WXXPNC*WHH*S)/$*BJF^:Q:J0=.
MM$.3DI#3X_'[ %&I^FR6+\F3" ^):K(8/"OC?"LLGL]28A^' 2;E72G"$M8-
MX-\4-KYL=\0&/,0OP!I!8'VI0"L:*=]>$A,/WD;D\4&GR/R?6;2RH4W!&H34
MSX5+G+QI:QMP55T++9639P@()R$L_;;S!3\\%JN!2EBY8?_SE\YF]=0[G(X<
MNT::DVY6@FGVK&7N^EXRH 3I(B#P?$&1GEC@^>GCI_!O98 0_R^ZQ[MN!]22
M8EU$P&08IO#L>NQ; F0+H_D#M\&<E\ _G#.H*::323Q*OQ1FR$<L.J !T0=L
M#MHB%:#9Z(GP(/*YBKXZL&;('I$W9E3*(C201(_7P"U/8:-(Z\MH;1V2]1(;
M=_V;E"\[=J/DLJ14WP[86W4Y<(PX#074P:/^7;C/!P@*/:5")W%D_2IGN34,
MZJSV=)6PHJW?!>A$G_\R'EGE<AO,M:=LE0KY.IW<G_ZA.S93;_EJ98U.Q([S
M8"^6M>CQH@#Z%SL:0@C*R34K$KTNO@ANGJ,A#1<-.:(5&H?X4Q71?-B>V>=#
M]=KY\I3??F$REC._>TCD448 [7[6WR\^)M*4+'BU] 4&;)E1-$W+W0##9AT;
MZT+N:B6BHW3FW<PU6+$HO]>@&[F*WUQL/&S4[-E^;I&O+MN\?VZ13[JB<A!9
MQV>-OO4L_PY5A_TKMWC",_2UYZ>3B1,GG^+>N\-S!V*JZY)3=*+".W@,$I_&
M(-E+%]&KGHG1ZOXOVO<8=7CQ(^IP;[(/RR'?V\Y3YMA*?N\U]=!&6+I?!Q-!
M '(ZC'#(F:WI<3!D_DO35#/]EX(8XE5O=A!&>;)%SG&O?JT/6.V8X5V]"]3
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M*D'7'Y*V8N4[Z0G&>:>Y(*6O-BW(2.X5 JFM)E].G)Z1CN) F5LE3>6R4D8
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MU\')N#*XJMJU>9>$FIGH<5"7-'1HXEKAH!K#Z&/0E.^5I^M@+)>.U(QV'H6
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M?R?V7:[C'2)-*07VBFHUFF]B$CK_P)0:_,WB4!6SH:N>.]H]V]_]K\4>$SI
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M4WSKB1._HFP=B+\+!EDWM5PN76><[WQV>>6GSYHB7:I8VP&A"ZU2&E#;6F!
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MG0"D;>5KJH[PO@5,]=YF:=ZHE<(5X4OKC'WT&F3\<DYQ=P5/UI9?2[UW75
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M\<[KK7AK:PO/5%)>Q;<MB8_QYJAD9_JY,4E3)%BYS_EM[@1C#IV-GMED,M:
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M()U48DXQ<?V]FI;;3HHWCR=QBUH0-0-)$9DO4A,HHVS46!U)4)65H0(OIT$
M=H/ XF!&6J3-W5.,TYN2;"H,W';J+#(J? X7!TR*2PKL4N&&T/SF8T_XL7?
MFXIT(23C,1@?!>.6O/YK-!G.RDBZ(5+Z"Q ' .-U>45WTM\)YN]W6("SJ9'8
M:?0/:%2@P+OK9[:)1QOOU")0-ZPO6%[FJ2%"TQ>RGML_SIP$0H$2N!:F$H?
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M#AJ5G-$'5 Z0W1BG6.T\YXAK4#&T2KE<294E%:I<!!P!]A,(^:'("(9V-FV
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M(+?$9!:C _M)%==(9@:? <S):)*2];0TET@-!QA:.ZYNU"O3]VS]#:>Z_3]
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MS:Y&R6;TS'YS;Q07.2'QF9$U!&/S6E902F#Y!-XT*;V(AD5Y@9(!*M'D'JL
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MK^W6D;H4ZSU14.&* 7F4)F,VETL6ENV7VP"_H _W.D(O2)RV6\($W>5UE*N
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MH\#"P$F@&N#!@,A1L +VV"W%TP4QY0JEY_C>7>)[Y.("2 /C+!@EAZ@Z]I*
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MYB=,0#'+((6-.EY=BP3H8A^**D9K*HT8P !-JL*#<(GYRH?$0=IWB"!HE-D
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ML/E3^7M___3+]DON4N 63P9G9#U=J%MYC]WR6K/-84II4PV?0GWH:.6XGTG
M;/<1U7 [WBJ!(%8P1\& 0*+*U2R7R&[%ZF,6M&]:3*,-7!YO<V+/<#FAY:DS
M0=[>!9S]WAPDC0+XI['$&:/;BF)EXU<@B1!L7;DHENE8A==8^M[5>:AK$BF
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MIT!*L=#RW'[9?_%2[$U7!=/]VC,&_J6YLWK3CLOC:&7D)@]3]P;J5$_X(?Z
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MH!>')%W.46ZYA5E:ME]N]"D'M/T*_L4+Z+F@X&$!6B["E9446@I]RWG!*+/
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MFM8OB;ZJ;"GP(S?^7=/I0V7 #CNI%$RLFG.'.( ;E;2J5PI)M5:T/I@*-<\
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M'[S]\M9'/^O,WZ:F;7A[7RUUE['R8/7QM]$Z%TT9 44AJ9# XQX$;I>G[8-
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MTV*%&8M\X[:\05;DUH'JF^$)_%@/1Y:D)K*2(BW@.P"Y<^S"KDP]TK9Y+2_
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M6PCWY' 7_NFQ<_EQ)]37IUDR__SNFPBHM[^RFI4 X'9D;X*%7;=%]JYU>!K
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M&XDW#;$$A,!&EB[RQ=(Z?O>Y2]]"U_;D8T&T23^;\[>??(RO]$V)X]L"TX2
M]1APO0I<:':U,.(LV(>:!SG%0=XV:[SY4GVW3]158!1@$^BTT18Z-6;@*3#<
M9)0L?9]AQ23^CD+:Z.6X*.ZF#[S !YJK_U1SQ?>%\K,2"5IC"8E(A!D>5TOL
M.LU$-F_WC_Q>"=BX6C+6(>+57KW7;-YE8T22!HTOP$S#X(O1J.V+PGV\]:J4
M%2]*XJ])#TJ"#[Z9 3H.,$V.LE(EQ2P;YYH$GV>L^B&G82*&E\FR(\EC\ ?M
M2T4@=PO!>:?:L'A/K%Q@MGF[USDA9="=(A*[8!>VH'^^AX[";@G4+;!%/OA_
M+A<%ULFE< \M*F.AF;\:H9CE9!Z^*6M_K$ST.4TNSJYK\Z-9XO5WSI$ :^Q7
M@MWN]H"#262!L;T6Z<3C*;/QJ!&]3H V/$E6,;E]T']F(JE1\W'];98;_Z3&
M.JC(0/1R@#1GTKP=$G*RPC6ML!'C&2SPJB':SO5!+SFYL/W1>7Y <,)X?[BE
M(F9,U61M-7GK4-/$1S13SV?K<["' 9TA"=A!*0U+L<&!H&"\ECW8,^$>8E3X
MZ2XJW"_=L%8]R<^6W,5=E"OTD64I%XW4'W:X6R]9BYLE'W!O\&'O'FP?:J\^
M -?ZP-TN161>OU2O"++T\'N6PH%PN%I93,OJCOJ&6(W,N>$+($S/9JI34&3%
M,<0'&$+6F\ A"/0DZ-9 ;)RZ>I$YSNQ7 D OJXE#QC@@8Z@>Z](;6H8%:^&2
M].[!@219(OH1DFS332,Y8;D<0C-K./#')H<G"#H&PI!&-'2:2+O%"]M]+7ZM
M4$B)+P&X1L95<4+.KSG-XUFVK*&'*>(>N#@,Z' $?2*[U'V&V]IP0(B;^E,B
MQZ+J*J5%NI]=H1#(S$W=7FXQ1;0-+^Z9L5*R3_DV@.S9",%%_W+%U,V^<U(2
M[/DTT<#H))\LQU04P \4Q+Z28F9BI<ZY-HDBJ0H^TU('Q>!XV$,0!RJAU@$1
ME!>S>K;Y:!"'5.:5]/T <I J!P8II_&QX2D,GF!,.'P UJ)3@K -5T/LD6WY
M6'MN(A3IQFN'5\$*%)/&Q!?9)UQ=(K[B#G9!IC4$]GM/MCNR8%Q,(Y+)F=GA
MH".P!>MWEB$X ^U+/59V)HNY3>J44]T?69?D2VODT8\VKM9=@T/L8GYT4NT8
M_AI* ZBQI&:#Z]@^3K&PR#4S4O!+DKB892#],9793'TWY[91IM>B6M4E4*DK
M!%0H#Q@Y&7CD;39+^(DQW<=NBI7<<4E1J%SU_W,O+4\@T&XK\2\SXUK!6,VM
M:NF!0=IA!%K+JNTR*F"?6A)MI_.MO<1P4=I:7UYDQ!Z/94@0/2"*"/YN:B1I
MO(1%S*IK\(:R\PNR*#A/PRL^6>9B5122:NVYSD(8)>+/#_N6^1=@#V^7!/1P
M -IK44(#N:O\$I:(]:FP2/3]ZC7M:]E(J[RU"VI^R1ZJ5C.6RVV:,W7\I43J
M]3I7UGZ\OHM-];8..\L]QV0?E:1< 8&6JF%?*+18\W-]C&DXV-.H\..SHII@
MUZ+K)#Q209<CIV<B^W,.T&*[0;*ZJ3)@':$Z,^$YV*VZ*>"93*JRQI,@IJ&O
M&]4&4/43EF$-!R XD/DT7S,O,3)3U&>YNWV5UK86L"9&E-@QRIZ51!M8P9%0
M#@Y6B*7R 4<\OME%//IE)P9Q.09;"Z27HQMHF>"U/T%(3+;P^Q7VG[T2:\_(
M+:F""_MIO!]56EL;@EX%Q9/'W[AC,<E5M-*<H64%])>GT%J/Z+>,-;R<G>)+
MT3Q&RS@-6B4C.!BKX(P*P",_+RWW'R303_+%5<X(%TL 9<RK,=O'_2=-DC>N
MRPA_A@.LE'C@X,2). VQ93+VRM[3D;=89IS1=5HK?J6>?K!OGO_H&RE^#/8V
M:[16L:0NI'9QT9AEJNF_24YKC]>BJ.1RQ:*1Z;28 >"Z'K%PF7_G:&.!D'_(
M%\MJ7GL]M4,&%?;2\M,2DX'V".#M+H<DN'46<LW ARR5C'3K+N;A.QB#$7VR
M(S -6+^H6U&M(]MIE(?Z!\71HZB3K(,F[,M3OL9/E^S#H'N8P7@H#VH]N'(\
M7E94T[P2YN<H>%9^E/&V= A9&.PHI_B-W_8_[L>E,IM, .Y #&E&H);DBXN)
MS'?G[>HIN7,3K0O8ZG9*KDYIPKXGU8&[ 8Z0H)(\/2$9\,"B:Q 5(+'+2[N7
MI!:]KI^L%$$^V(0\S[,Y>VXU2\_!$RR,U8=]"]&AP\< AP!_L]Y/CNCDP#\2
MN]Q00F4T6*&:O2M7% ,2;*2IL F4+F+=$WTU33+U:*O554-Z+ H?#N!E4.V#
M-A*17; S)74$*(T4@!3-BJH<&+F>"PG32V,I*+DX-SXKQPSQ"\ HB02MH(LA
MK8YAW-*&&_,)?H7)F\H:*V/-Q0=*,$V$<J.X!.$ "JC"H>-2<<X\"11[% GW
M^1^H*X8#Q2Z []RS."'45.9:.S&VZ3@_R<A'D*-$8@?+B$\#ZY'%[AP8\ZF4
MEZ&$C@RCQI@U&.AT4//)#Q"%)5DNIH%MC,8N<A%2@9$9ST=!F3XORN.RG-50
M![F?)H?),1:POX>@<YI\7 (APB&P6"4?2Z.RDH_FS/T,Z+:B'I<IH)9GA='H
M\R)+GCU]_/UCHQXA! ]'XX>PW'[D2-16ZHS\$2RCW'(\3=#03B;#/D6!UVJ=
M!Y_[ 1X+ZN-DE-!">=$=/U;#*55Y.XP^A^\;]4T_VNBE5HSDZ36"?IV#2I$*
M;D9\4I9_-H!X>Q1' Q]80Q[I*_;3?K"?R$K'EL!* S\:,TM630P[0#=F%H13
MR\KYA;*T_!%\'OGPDB1 3>'7.G#HC _)[)ITR/VC/ X/]I.?C4=8#P='-6B5
MK)B3@_<OP5VO?]^@*J9X  OQV">"9WYKCD]10)!#F_[M4X5X,Q=LEAZ/=#^/
MJYP:Z?EB1.LNX%LTP2^NK7CJ,0%7#0^'#X,CB,QMNP#2*]$B6WZV9SUC_$;4
MX[0B3#L0')_F_H'$ C<(,]28"<,P 0?;H<SS>/4<LUE=ZHE*AI /&7_'9WID
MXW<XN,MNZMPN$Z5!] $[('+E4"&$'Q%QIO'4&-M%+3%U?UJW6-/[MUP.S6%"
M<BBT8$(V)"7::P!N0]JD-'@$_-P(@C5H+%<552,+*:OBQ>A_YT^![9A'0.83
MAS21(FM"330I<MUG7%)\.@=<I",Y8LML.-B@8W,G<\@=K-D"M*U'[M8'6=MZ
M;9@?<##OVUTPKR\M]03H@]! QW(4A"AAV+F!K;^=/^SHT5A#88S#G,*"'+3L
M:KJ<$?/T.+L@>,34: \4\KGY)B,77' *U=N2/L?1B8OER<P8'U2=0DX=)R30
MF&F,@:S.L3']C9HB=XX/E!PS2F)$AKF<\Z@(C02K11$T<[W">IHOSM#>K,#^
M1"6//%KX'6*\P3=)\WEZA'BR=J"!!VK^<Y'C5DMRESG3D1 2GB"M><J$2SOL
MG;"-._#IOG-ZW]DZNP*<^>/53'Y^@/#P<._@.QN/@*9GU 2"#'(F.+%7XHC6
M6"I=X"Z"J*L* KC2%S0,)SIL$%" 6^ GE[("SBNOO70?0H].<K-=4\Y_Y[-I
ME$\>1&*./G.=,+\X-CS"Z^@3!"61WR-B<S;XHR%R@4>&#XH4HT(=HE?5.!P@
M-@WL6^1H3A4+NMX6S@<!3*/92H/13:XXQ%\.173="+%*W5OJ0%(9_*).-2<4
M8FOJU*-N2)D/"MH]FO?,\6]'-F*;!H3:?O[1]BR.+M\H[1HR.6YY;IM[!_P2
MW"1M/OFZXR'!;,%&36,\*%BP(7U/I/5/D*G#1FP,$=&["Q60<P>4=G,&R0@E
MYASM006N<*I%8EN8/Z=XTUE&<B^UBL@G4YL-PS0V?@Y&))9?.#)P](Q;7EH=
M)X2GH,&M9H-2R%D>ICT[6-/!/(+;&FD+J5_(M)@LQP6W5F=W<[FX3B5W("5X
ME2QOT/W#NUA0+<%NN-PHCYFF7%M&>F2.A-]'3I-M,-WQ$?)@:+P7EH_>5E^S
M['2\ @EV"[B(SLEK!A;V:F)3SO%Q-9>ZL<9TC32B)3;ZP:,%GZMH7>) @-N7
MH:B5-K85]2POL4<#JY J_06+80P/:M_NH/@2F)3>VTV%])L$(.S]0#LL[IK5
MTD)P[P MD6;I@;?>/&0<""JGEI#?TZP10I&__V:N4\RS#@=OF4D9SZ;JM.DQ
M$W.;S<;W4R2#H_B?UU5RPY:_^) 5;FLSBQ49RSJLOL/!RWP&W6 8^Q=V,V(C
M4$)O.7A#<VZMB=BOL"^F/XX(W"8JJ-.B A$ :XABM:*F<#N$]E\27_9^&2.<
M&![,?/7ULL ]&L^RXASU#'%A3651W0H-!]3;,QN/JR416E>HLPB,9YLXQ<0@
M92%(U597WKI9>U_M?=4I?DZD"2):4L:%363@[CK-(A9R5A-^DV-#L"A%-5Z>
M@^<[)D2Z ZR:.9LEJ4LPI%4" '80WX-:#%^$AQX,/7D57U0<\E,3*;2][+V;
M"O,YX'S.8,+.)=A;T8\*[R:0&GVXLLK8F=G%6>1Y'+ZA!*I5L2KVN<%"2P(9
M4LQLA6[R_9'*4/.277&/->D!!/>%T6Y%)1"($]J#O1,7BX\=Y[*NBY.92^$&
MZXM0[$T6F%;I)JN<W'*11^X08//<"NPEXW)1B(OTE@_B@LN\7(!Z@:O6V;Q"
MC@=6K6OTB-$[-(;)6*3;U@Q$TT9HA46&YVE93L!Z +^1R3"HC*39US4<W2I7
MS.A6B$M'% $("FZ-J)%%/G9]:_(IDGHH7.ZB3#'^'I)\@ *87,*!I-);X14B
M72\K9EMCNN7";TH]H9Z6:DO7<8\Q"1;SRSL5X;(%&JNC_0G/.ND>6*7 Z\,!
M+N8-4CZWB9G]&VAS\6(&!H7WD("E,C4$1_[GX<8"O]O% GL"]KU^:X9__/;5
MQX_)OWY]]>'5NY]]0#. 0]&2F:R5KSC)I;(-@!/PA7__]W__]W^228;W,_XC
M14+'QF%0PSYTHM<JB5KR<%UYX5&'X+K__?CH^9M7R8M7;]Y\?'_TXO7;7_[Q
MU>.O\-_OCUZ^E'_S[CV%S7O^[L/+5Q_PQSPJ^LDCL^-OCMY_?/6#_*5S6<,]
M@#TEJ3S^\!/_Y:6\^+N_?67$]_BE^\7O/!6:K),O^:#__6>'\G/SQP?U)IF"
MDNX"60!_P!Q#LN$4@L&9C3%K^0Z6]BV<C9\^'A^]?7GTX67R_/6[XW?F%\GK
MMR_VW<#\0:FGJX?_^NKU+[\>FZE^ZT]5_=R]\U!/^[ZF_-/SZQ_TR(*]LD+9
M_ 1^>^V3?0 _.L':3_>C3PEVR$O^UV/\OPV/NCHO][]LMUBSM\:U^>%A#?D8
MZ@-_T(?2_ >TT4]T76W7!@ :^'8U[DR#W>5ZNZ6'"I7??GKU?WY]_?SU<7*4
M@ $-%2DW2<G<<APOWKW]_=6'CZ_?O4W>OCM^_>)5<M.!W,K:^& 1Z(5?#-L)
M;;UYZIW*QQ?@@4:868W?"*&%99[\U^/]QX\/4D0G1,&$R1Z,4A<>K3A!7H^)
M"(,PTDB%?8E7D:^A<X,9"LKO"7JMYOX[,%?\8#O8YR;D$EVKF(2+J!IC-M:,
MGB_+0S_S_\7O#CZR:O?;6W<VBL!:=]BX@8D--^J09W/GR31N/-HU&3K)C8]%
M_3;B-9";+9O^9FQ".N ^'/S;]<- \)7"F.*POOX:DEOF3]WE5^**_VZP[V)^
M!X.;.8%2TO\D_X:W/_OQ/_^Y<X_VIY=\&!01Q%ZA:]!'/V ,B03G2_MS./@<
M1K&;]V[>F_UI"^_OT@SZZ6WD%NP!?&@9]8GU9J=_MCV*W;RW<;J0G]9CF)J7
M>[6Q=G>G[(N2MK_*O&]*!K/1H8$*WM<O$[Z9=I;L3L9W\_Y+_GD_=_#[&?0=
M@%MR6E3G?G&_A@C^<.>*3?GG'XPML%-EVQ[%;MZ[>?]5YWTOIEHL>D"16(XM
M"W ,BU]W"F_;H]C-^W.?][T<6S:)B,_<+^#U"9DA.^.Z;K9$"&_*5P:A$2K/
MLA$,1^PK!MH<6EAAF5D9_(:)*^[>;'M-RU3NU->V1[&;]V[>NWG?[,_[<;:/
M6"GO5.5G,9;=O'?SWLU[TS_O1U4>Y[/\X@PJU,F+WNG,;8]B-^_=O/]*\[Z7
M6,(K((3<Z:YMCV(W[]V\=_/N]\][<IF)&/Y_* F]4Z2?Q5AV\][-^\N<]_TH
MO>?7.TVW[5'LYKV;]V[>]S7O^X%.8TW]3K-^%F/9S7LW[]V\^_KS?NQ2**7>
MX12W/HK=O'?SWLV[WS_O*9HY'F-+9E6]IYJ'08^S))\O*M>U>U?1M_51[.;]
M.<[[?AQ&.(7< 1W;%N_.[4Y^OY1YWU/]:7:-;,FOD0^;*:"!>!I:<B<7_-MB
MGLR*? G%%=.*#F0F#>%V)VW;H]C-N_WD1.@O__[U\W<O_Z_YX:_'_WSST_\'
M4$L#!!0    ( /V*.%2Z%(KK<,,! (FL"@ 1    9#(T,S8R,F1E>#$P-"YH
M=&WLO6M3VUJV+OR=*OZ#:IWN4U E6$#NBW2J'' 2N@FP#<G:_7Z3[6FL%5ER
M2S*$_O7ON,V;+-N0& 0YWK5[!8P\-2]CCOMXQMM/%Y^/W[W]U&X=OEM?>WMQ
M=''<?M?^WZW=G>WG;W_G7^'SW^6!X.W[T\-_!^\_'IP>GW;^\=N?GXXNVK^]
M"];7X*$#E98J?_?V\.AK<'[Q[^/V/WZ[COOE\(_7VR_B]+<@2N++]!^_)6I0
M_D9CG>G'1E%^&:=;93;^8V=<[@?R>S<KRVS$'PVRM-PJXO^J/W;M[X-H%"<W
M?US$(U4$)^HZZ&2C"-[4.C[Z>/*/W_+X<@BO>OO^W=NC=^WOP[@;EP&N+'C[
M^]&[M[_#Y[^?X?+J)K*[M\29]&AK:"KG[<Y1^SQX^^'TY,)LTS NU58QCGKJ
MCS2[SJ/Q;^_>;^V]_1T?>A<<G)Y\;7<NCMX?MX.S3OM#N]-I'\)W3P_^%32T
MBK,OG8-/K?-VT/K8:;<_MV$M>B;UYWI?$^G>K*]%:3_HJO):J;2A67PX_G)T
M>/3Q,QQ5Y^RTT[HX.CT)FSJ;KT?_.CKY&'P\/GW?.@Y.SV!"%U].CBZ0[(Z.
MCX_^!^8:' %)G5_@P=V"%L^_O-_ZW#J_:'<T21Z?-;4Z/.QF#MG;U_4U?V,/
M.ZT_#T__/ DV6A_A2GQL79QV-MUM>MBY'D:EZ@=1$62#X)]1.HGRF_^;=HOQ
M_MZS,-C;V=NK/3[GI:^=><WFR[^]XU%EH-^!]<.@(@B Q=/_OQT'17F3*'_A
M:C0U'GXTCB[55C=7T;>MKAIDN?HC2JZCFP(EQMM/G>#\Z/^#B3[[30])@NB/
M__.&_N^WX,^CPXM/__AM=V?G[V9;#H#(VYU'*Z6<4[MH(8L__8 <_X*OYOQ3
M0NJI3&ON&>%I\$L.VL?'YV>M Z#H?_RV\QO]?M8Z/-2_>QOY_K1SV.[0YS('
M_F0+=O^X=7;>_D/_,'?)U?V9V@(\()IBYYW\<*@G\NSOL$._7QS:/WR5+_-*
M[8SU@_[WW_SH /-_AO]T^(..WAJ'@N.TB/M P5=9W ]NO36O\<SJYVB.TJ[O
M_IY8^!R0*=(0?+!7JR/ 1C#]WFHNM)66 I:VG41IU??#;7&F_^RW&>RYYI[O
M.A\AD_AC=WN'.%>IOI<PQ3YLP!];^L.[,(1W+=#Q#H[;O"='P6'[PQ%*E].3
M<SF0:#3>!\D-W S4P O2,I!%G-UBBY= %A6U^J7[Z,GIGYW6V<+C]8_6V1SG
MB#ZUCSY^NOC';Z_]>VP_=LENX2//?[N_BSJ3LEQJJ@C1H%9NN/3T;&GTM+N]
M>SOBF/?$@<K+*$Z#0S6(T[B,L[184=N*VNJH;>_GJ>T(9O =E58B-U!A+U0^
M:H3@]O96%/?H*>[9\OC;$>HMXUR546,\;N_YO9.<I_,\2MIZY%K9D>/QNC@-
MSL%L"EHGAX%VB.V+M^X<=+/&5+.]E;1\[+QK;QFZV7F4J  =8F>3O#>,"@74
MEZ57*B^ A:$4=7YKC;))6JZH<46-M=2X!-WM8JB"@R0KXO1R168K,JLELR4H
M;*W^7Y.B',$LFE'25F3V^,GL^7(LT;&B:00G43G)%0I4+6CS__M_=I^_W"^"
MTVX27[+)0)*X@U32#&&^6ED/C]YZ. HZ[;-.^QS,!W'?HO'P9ZO3:9U0'/'T
M0W#QJ0W+^ RK^'=S%L3]$].*R_T<93U;A@5QFE]&:?Q?8F#[P<<LZP?G)?"Q
MIG2X%=D]?K);@JEPD.7C+(]*%9QEURK?#]KI(,M[*NK&25S>-$)ZKU>D]^A)
M;QG^WFPTCM*;X'T6Y?V@-1[GV564[ >MM(RW+J)O*KM2>7 <73>CQ*VH\/%3
MX1*LBX[ZSR0N8F" YV76^S;,DCY0G:;&1BCOS8KR'CWEO?AYREN8['F2I5L'
M,(T\NH*I@EXH.9\KHEP192U1OEPF._R(XC=%[UZ4&'[8B"A^MK.BO4=/>Z^6
MIQ >1.,8B$Z,X17%K2BNEN)>+R%L.^G"WL11'JMF.-LJM>GQT]F;Y7&V\_9!
MT%'C+&\F,/'LV8K<'CVY[>XLC]X^Q&F4]F)0X,[+J%04JMWG!+L4/B3C(FM(
MJ5O1XA.@Q24$-DZRX$O:CXM>DA6J'QS'[%IN2N+>?V;GBNQ^FNR6$-AH=0N5
M]BA50"<6'PRC]+(ALGNQ(KO'3W9+"&I\!C&;QUJV1KV&%+T5N3T!<EM*] )(
M[2S/QL#B&@G6KBCM*5#:$J(5[?0JSC/M#P8V!WRN&=ZV2OM\ A2WA% $FJE)
MHGKEI&D>MZ*X)T!Q2PA 7$3?&^5LJQCK$Z"S)80=VJ-QDMTH%;Q7J1K$S=@(
MSU<QKB= ;4L(/AQ'W2QODJ\]7T6Y'C^E[2TI[)#$$;K=KN-RV%CNYO.5D_<)
M$-P28@N4*GR0Y?EDS'43$MK"7\!HN,BCOGHR! @/_TZ0</B]X.UX1L74U!$%
M[M:_KL#,/1AH7AP(K-WZKXD^B$>YPNN[RP#S?W[[T"!SCX?Q+:5LQY>TGU24
ME,->E"L2NEP JRXG27,8.L]7GN$G0(M+"'D=JTMVT/64PG+%8C\XS?M-V1HK
M7]T3H+JEH (4DQP9X(K*5E163V5+B'IU5$+XW6=17MZ@/9$64:\YD;HBNR=
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ML!T\58_4BY5#:DF$^H%U,3'C1"?&.V?TKU'T#9B9M*;(U1C$*+PI$BYX'>7
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MWH%O?T8EW, 7.[*B!%>Z(;(#" 2C?? ;?HQ1H"[\,(1Q4-&7J#Z\6JG@1D5
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MDY,/'(,5M2&8NP51PL!DY:(2)JX''"%62W!TA?8K/9WS0@DP$O2<N28Q6D%
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M0RFB#$OQ(BK4I;T,!3$?E/*)3'28%7Z3B9'"=E@)?A.3:-#.'R@;Y:76K19
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MJR> L]YL#9))EF=1\NTFL3M0$-N]Z0T3.+V45XN5J^D-72Z%C36BHHM5:%@
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M@VXK 3(%MOI@)L"._F>224E4<5-@)JI4S)OLUKK7S*]);V2C, L.K'9.@]/
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MZ$FVX/PNF<^W=QD >]%C>[=[[-E&M$E=-RGHN.#A5_C[XSB",U!3X\5T9K]
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MY,B@9$X1-8,!6*)K<IXSBA?FZD7:WZ9AA /&U1R-)R7BK8',O\RC$3KTN$R
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MCE#K"(34]?JK-B7,?@)O,V?OQA*FM&DL>/!<,/1T(9$'Z5]A8PV$45H?2_
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ME)FG*L:_A1K923[-<G\G$<#$^X"_-K6QF?DH5W3(U/RB !MS'MS&_6Q%?Y,
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ME8"56_%O"3--N-F'12MG!'V\&AZUR,>"= F,RNNX+(B$UH]8@VHH:BZ9+9X
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M A:<_HDG]BKY85=>3+AH#:Q@J:0E;L/_#,[F@,SOV>F#_Y9AIFIBR7?!1^F
M28!A2'_G@_\>/9=;(8P\/O%6<6^;&* .LSF+C^XZC- :XTF//&R<H)97V!K#
M&CT[SS!G_&1E +88I7TQ4=<_ M\NG5C2+EZN@@YJWQ)I(AA^RQB43[N7(^P
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M5?!MPMI2KKJ3 #4R#VRHI(,A>R/6&3P?2^><WI.I?L&/\P$?A["L6\HF_2G
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MZ\MJ7'&#)%2U0D'#J%BSLU:SAAR5K@ M$47OX+-[+]5*U[+MW-<"0'DO>75
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MQXOPEGO$9%V8Z7ZNF(9S8]8@]0A3VYNT6!$2WN^UW.R]+<Y#W<5/"/MT#-)
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MYFDYJ;2I(WEU+U4IGTP*%ZUA<HDTF?B*$BT!"TSA9NN"7TT+\LX]Y>#^MA0
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M7]D[3<WEN"6QGOM=#D07LLT'IFI2'5;THW=T^\"G#>,#G>QLZ\9*KSS%(J-
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M_YR\DKB00+$:#=)1#WXOI8S2KPB#R]>=]#S%AEB'PC6[6&'PZKM7$-(4D$S
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M9(+^Y>=*S4-$U'N]!XV6L?,=7@?9FD'OA+BI_Q3<3O:1+Y%6E=F*:"U#\S6
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M]BUJ4"TUVM.,_5XM'()S;G6G+]VW/K0/+>)W-."8HXY Q7MA[!,&ZLD)79,
MO-,9-$XRCR L&^.$J-JEL/]*T@G4VR2,M_9N/K4Z:PAVY30M^AQ*1J.$A1@
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M4*%(AR"2WD]_E& A)B.Q7SR2G)59ED*))!>USA2&XXPU=/@1C)JY!!3&Z'*
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MT^/M@Y/M'?C3LJ$U1F]NI;)_6-\D$@Y-GMR5'K8K!K.@* /_4$:'BG<3/L[
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MP<BXNML(3 DKDY5NAT2!E^"2%!WNLCC'RY N,6LC0OC##:H/\:K"N1PR]D[
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MLXWI;;W$])IUY#5C?$JU4/C@G6YM"E7/ZD3T=1$?UFRB&]&7\"B\.4IGN_/
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MW1 ^8H)\/*3EK -62MQG:C:/2)BPX!>-FF2<<IQBN$2%] I)Z-SO?E85G%R
M.*]V*S!$_97C6O[J'PB-(N&>UK_F@S.F$21QH"('67):P5'2_U)ZU\[R-G\2
M^O M<J%B^9!9>HY563/11;%\'TS?_%ZVOU9J1.JA5X4M GBQ93!']X@0T"H>
M0DF42)E0$;JQYT6]421%(!6;Z#'J1#<W$65K>^_W[G%T^"'ZY^?C/Z/3X[WM
M?78#MG=^C8ZVCT__C+9W?CLX_&._N_NQ>Q)M'^Q&VQ^/N^:?I[]NGYJ?_XQV
M#@].CP_-@T[^I%]^VC;?.MX[Z49'GX]//F\?G$:GA^9/>R?TW4]&LT?FA_V]
MW[K[?[9;YH][![\?[O_>-<_Z=+2_M[-]VMW%=^WN??BPM_-Y'SY_\KE[$N-O
M3W_M'G<_'!YW]3CA=^__C/:.C[N_'^YLO]__$S_[^<",;W?O=._P8'O?_ [G
M?((#/][[^.LI#?GDLWT.C/[7;3,6,ZQM6I/(/!=7:.\@.NZ>''5W3F'1X!G[
MW8_$@+?3[0).?[3VQZ]=&%]DQA>]/\8!FL_B(FWOG,;FL<=F,)]/VBT8V&=X
ME-D"^,H?9LDZ9LK'YOEFI.;7>P?V)UA0>/[A9WRW^>-Q=W_[%'Y575SS5_-
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MB]+"L49>?*7CJ]+:EF#X/@=(1?*%\V&'HL]<.DX60Y&J@E9JV<02"D3,HH@
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M_O>]WZ!<YN/^X?OM_>CPR&BHT\\'>Z=[W9-H;W]_[[^-\H+JK.[)*52EG*Q
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M9N0+HC*)WN*XLL<";^SOM0UN><R\!$U-]3W.H2+:9 $M2Z$P=N-O*PPZRL;
M(TQ<V[;\F/9&,S07"HTIH35>92 (N)HF@#\;+G*[53>L<EY<$#$C1U(9EOF(
M(-2Z!+RJ!^TBSM51AW2_C[)VQAW6TM=N.?&K??J*2S!!C+\9 -)9TEW<'N"L
MRPM!O5-)5%"\JXSXW;/%0WHA';M#E9YU.&53G!'*/A3B09]M7<N$S1("_;HY
M>%XVA%'1Z$E8:QU\P/NRKU(+%FPH_)JQ^0QUGGV$&D,D?0:.1'C!(C@5C#F(
M.4#.+ 8I0(]_C)#1>);@,4(&M'/=2SNJU>= ZAM,W-;=&740@"2[%&_?AE7X
M?E'O=?F/)9/W7)$,?#BZ0 >(@DF;"U8X7L+ *YV4YW$0E+:4JD")Z5]W]H8*
MP#R3=JM!?N+%=V+]$BIE3]-^"@I=F1.0+6FW[DLO>RM.VX>!#_=@A/.NV![
MT6"V\^\4"T%,2!B$K;)S859;18 I#TX176@<3D)!K[MM.^U6\V6_LBU5=_G5
M7'SFU4UZR3L>:EFIIJ*ZF84S$4+A757M8-;V>GJ'X.5=-I;2E3I];.U9_U/>
M4]"\?GAC'ZX&BH&@,O=T2UZH\(C+7?HE+ZABZ 0O*;>C!+F-#X ="L'L489=
M&:"[S.Z@/'+%R.?UD_6(G%BHZG5*030>2@QN'D6EX?M4S^!(#RU,)N#X8:W0
M [2[?N"[#C$5!*1^D,][7%JAL[HJ*VW+XX%,L>*J/GB;[D+'V<5S=E>OL^!&
M/1=MNP;R0:6".W;5$9733H*&B+$Z.(?5B4G'?$]J+!B=T>92O"L$0LUET&GB
MGY")?I--CIT+T;.KGZB,L&Y!9PTC<E&Q<?*%1S1-KE"+FP</Y\HXJ'LLQ)C[
M!)*M!LCVV:]X[\(_$5C7E85)A#/:)KHD1<(=TW&%=D3TSF=V[O2TIY1EPU05
MC$](+VI#/F]_WMB@G9JNC]>C-9LQV\$N _.ZCJ@EG;9[2J&M?%![#'&;4)7N
M@8<"JO0X)?)<^ JLS.9//WY/K1D4PGM2L[+'"\6P<8:AM#+IB#D>X' ;DSSI
MLT&E3BP2@5E9KKN[N#<JMD571LJ!S![Z;IE&WOAUY1/*E;C9X:FOU\PP931;
M0X5<URH3,=<T8B7 36HL=\ G'P/\-Z3RC$BQSMAWM9R\AAA!]8=K_DG%I)#&
MPU]Z?V8=;*=QC&0?K@L.0\I/2,$$0ZV5T*V?WJQO;O[PO==UD0S^FG/56DT;
M*MQ51+CY=*;:M5#]39<^A<@1Z[AZL3;<HFBV21&QHI[29E[&Z2'U9S/-+^E,
MZA4 YOP*?ABB4\3]A<PL,6,Y+\V79]:NA=JTGF5(\CK3:N7K.8;17LC=[N$4
M?'VU*\7PUSX'X1G@"^8:AR!:=@8NF0$.#P!2+AEE4Z3]-./2;8$%B5U1?U[X
MY?OF5?\RQB\=#<KH*<L8JCNRH=?):3]3IJ,1!09"4QFUMYI/NT7#AU +I]:(
MA&TP!YZ(T<B%JHBRW:\TDQ(0O4+T0"J4;7+ ,+L\0E,(59EXG6@73,AA7+@-
M/&J?R:E!MU% !J)ATZ0 09AE_2\0.2VOQKT< WT[GT_VCJ1/V"M15CP:)']J
MFUG8Q'994!5L2^SH&;X.Y\>X3S^EFU6G!A>4']BX@/X\V;6OWVB[UL9HA6+%
M&G/1,!T@UI00\5DP@V(^$L "6Q=7DK?$?*>P89Q'P^"@;5P'7D+B-ZFFQ&OO
MET=9Y(^YL5XFQ"#8;FU+9W5C0>*9_7R,M=)&H&'=YCW0)52=?:8>"2@DYKR"
M;K'<NKR2>7$E](N0\\T'5T )"15(]'3L6.>"[Q[UMA/_H4^WPL2'-JH]2L^R
MDLH^8Z]\,?IK/J!$\IDW9QJ#8_D%BG%PQ4$93F &]GL@/D4OFX&DT'AAC[$U
M#!Q[22VP,,4V>!43R5M,W$'F:\@%DTWA+QB[15+A.!H9]WJ$UGD*E$.@:^:C
M62:/>7!+4,L)>?;U8J'([RZ1CWO"!T$A*BQJQ"W 4CN#0& !IY1N2GZF/4["
M5$2 !38F$E=<OV-\5)%@">(58MN<"?%4Z$_*R4UZV':64L6S#6&O MD0J&#X
M]#C!@ER)T2"?>3J;C>PU4Y26B@RYER& 0RD9UN,-#4$Q%G#B73DWUZRQ+NKH
M6[&,UW*V3G(O%@TM,VP,#%:;H-G5BRP?>;G"WS.<84U1ET-8X6!0[/CIZASU
MU78+F-C)K_<!).Q]"02E(XC*4 ('4H!B.%A()1$8\X'\###Z'"@4KQ#F6S@B
MA@&\OAIYK9#[8K)$T)'>RDGZLES1$ T%0D1(QPE;23P\+]KX '!6S3>(U\S4
M4* 9%K_J<DC%V^9$BPI9 :CKR=R4>X*F=XV(-^&7A"&6:B6=B_L.H7O.PO:I
M/7XZ"[$/B<'C%#*5,(,$JSVKL::Z?/6:O:8YGX,T99+Y;K<@6HLI27CH%,/6
MXWG)#7MB^MM0+*Z8,P5KOJS0 <%H&!I54?<QI'FD^<3L.)@;_,P6_?4R!MDJ
MO] W2O&!D*<0T[A0(PCF0(;3ZV,]?,VCY$=Y)(4U^)?N^9U(%/: XU\R0,IO
M 0UU-O-*%TIW%15@41CS(LBAD>VU()\6I$'\?5.<FK)Y6+!':;?U:*]AOYN^
MAVWM#>F_ZP_<"_<,T-IR3D^3Q'I-0SW2YB/X[+_F.5ZF9I.F-GERC=G1>,#,
M?&7^\8J9$L5UA/NL,EYOC\V5=7BZ$WW"SY?0'#"? LS<.A=7L /#8+,)>6XW
MV   7J*YWG2Y O$>9X-7TSR;V Y67$YU?@ 6#P^0.YI-BJ)VW'5;30Z6D(':
MVH79.13]BQ"-KMS%#X?(N!HI)LYU^[#T4@TS;'G'"@N'L"7Q#Q(&LX)LKA%@
M5=/:04"]9O%4*$,B-E22@1<'E#B\,K\L2G<N"I6%M[^<SR!&(&LH$0+Y,W?,
M1OBD?YNHY@M7XGU<ZI>-/O]U'%J&O5S-HR57!<E+.?(2*Y! </RY?QP_ET.Y
M$@4N^_D PI> *P?-:$8UQ-2@B-[Z&040LLE?\PG76T$<1_<VXF_X5'$+)&5B
ML+\LCM))TD>MR"![Z*B;L9\E^$,VUN#B[99"/$,>;"@+H]A/#\,5KC#+8==Q
M58T.P$0V_O*$K#V7TY/4("3U[M@ 3FR5$=W=_[&)2-#VDGA"6;!/YB:CZ-5J
MR58O?;KUUM4OAE]_REE.LD2BW:PLYL3#WKUHRL<S5L=,=\M$4',P*^O:6VX!
M5W;S_I9R;F1TPG4[&#UT@+-PNJ&_.4)(#;EH:XP4<&:XXU60&RKM5OXWL.7M
MRAJN6&X(]A>]M[PRQO#8-\.;;+$H:^R[UR6?%+)9R:Q3R*_'8EU)2%U0PP?&
M"N/<JO%WT$"!,YKE Q_QWE;=R/*)_<P&"C9#>18*VW65-Z,E. R 3V3B,I;?
M_]@^\@U*'ST,UIR'F<N C9R>G8'%16CWQGLSEMF0I@3BD$^@*%5-N,FVJEJD
MQDR56# BJB=8_FH\^['1]6/L>L9B7]A&(.%.B1(=!+#T0WGU2Z+38H]5.$K'
M"$\U^ZFD&C!I9PX0@G2M)25@XNB<G5=A1]4YM$"89S,/ 6X&*$+FN&PVXKN2
M?2?;50ZK>%?BV+2GMY-&#-X]#7%T]H@7,,BH6C_OS2"ZR"N,] K<PU]5>4T+
M0XM-+_%;'9>_Y9I*M&D,CUHA>[!]LKO]WXUIRH.D'"3_X@GP92H))Y>&Y+I^
M+^</CN @32"I7KTIC.QX29&ZUTC2T[X%LY>S_.F8F ?I''-JQK*:-.28.*(2
MME]0^L9<HPXR.X@CF,5DK@B-=>%])@31 0._J<F4-5@8\^Y 6X2C<K"';YP8
M35[4!K$?24Z9D1B!V[Y_IQO'&W)[&@T<BAV5&J\G.X[5'S^@PX;-N_1'])8X
M;^](>-2E\'2D\K#(S)/-T)<&_FG\'%;>1?\EX1(,2SC1;C7FS/Y= +Z^?PG+
MW+D0>AU3=P!G"58H5Z*!FTDE:I+9A./N(/-$[0DS#Z3&!ZJ#Z>F<U#JPEV"M
MSL$2Q0 U(8%!0AZ,C]FY7"V-R"?2N=IX?L/BT:>C[&EC&YUTV.&+;#"'$)W'
M+Y1R>$_! <717QC6!X-_7J"&*W.CV>D+^+=79+[T.<\.R1U"%1IE8L?W;<]<
M,2\AZL>\+'.S)S("#*FYO(8?]Z9BG:<C>L<IE&VW6]?+"4O=91R )M<U!D.I
M_@47B5=:93T[QF+S5JH^I7%T<1\PUYC22Y:U&;=;09\QE4[9BFH8W2JMQS;S
M/<R^\L/%G[+/:9HP"L.(\%9EJ@2(O7RN%B@6OX CR$H>A"94H80;L*EX=#&6
M3D5W3D%)J@IC5Z$\'YQW;I'@<MW-TI8:5WO3V%-3R,."9II&4/&;--0\D@Z5
MA4)A/"8HO.6H6 N_)<A7!(FL(R)2!".0>H6YM::($<Q.VW(PK 8LK) /U64L
M+$K64T9N.F80@04WFJUXHPBK+?P4QR/HVK95::20B4TQA!&@N\><@ I&M/V&
M5R?F;"];KW=&:@:O@1!@&Q1;&;W%C !6DO#KM3O;4%F^9B9=SID^$&&*7CF%
M3& 73RE_H,JT5ZSF=D7<KV]7Q(VYOQ)P+_]MB[BK]"2UM*?-M7BK]V-O-J#!
MV=6^ :E]R,WUE,36@1M>&Y>OPA.Y"):O%H#2M9_>&&GO<06RBJ:Y HXDU'8W
M TD^U7"1<XQOY*:#/>VQ6'--Y(J(=HHJLF(:0VA2O%R+&9,K"N&8,? +-)31
M-4O3TEJV$!>@=C(4-HH#$%H+$P LC)?J FNX82?41>6N.RZ?\ DMY)YU7TP\
M]T*9W9A.T9[J<K]3.:_.-Q"$ -N5TKP)=_"Z=LM6\578 *Z[Y/\F <0?7@*(
MMU)+L&PD :L?P9L<NA682!(55'2D*!BAT*>I(OF J4BT57=^G#-_<G#$1E"?
MAOY4Y82?)1DQ#X^0=\0NS;TH&F *PEH0X1.B6EI0RJ#E15''[E?CE'AEB\CX
MYFCU0F;:X:IW9*#W.? G9*B=)E_#]H,B"CY0WYI"Q5GP5VK48J6<(-L,%FO$
MQK-(F:J:UD$W$ )^6W$&#H:4#7&13WUAGV:OAY@G%(5-BWR8P7O."B-L%,J:
MPL\3*'@H<J@0@?</(&MN#NTXIO2Y^0UZ1+-Y,8&7Q=C3 .'4DI[*,3:"\36C
M<-$OXUV>$0[7!.-W_&,'"S''4^B<[&?PE,$<GC LDDG_''_!\(9D9\2<ZD=,
MM6ER!7>3^>YX.LJO*#1> I _%6TB.'MI+C2" TR^ANXQQ:3Y"I3L^#0U(R>>
M$C/=C'VW'+Z/"HI_9T9$B"1EM.(^2 !PD)73.4=%)OE3 F,W,AL=I["[C8);
MX)]CNZYES$T$7*(KE;#06T^'F;[ASO0@[\^).LL))CUY1#P9.8&G0\8=9=8]
M"O4*]LR5_?-T '0OL".S6=(_'U-A$ :M.D O+7R'3#="D&WT>[OY]5O%B&X3
MMEPMMZL7)X[5B74>+E]BJ@69\>#,RU CZ..( 3CPK> 9EB;[";GYIUSJTT@8
MXX%3^76$U8H=<P'*MLEV&.TP:;<@AFLU/2H]]: BQ192Z!UAC'2X/1O*0Y^.
M=Z8A]ZJI0?)"&E.#U\O</][\AI7B&9Y;8];3$F?<3]KS<==B,618NR5-OY36
M2$K;=4LMR*HW&4_!\F;R14AB*DJV(.V!C41H1!L%Z,_#Q20A]#&'LJ)S8B*!
M!DD;UCY8WWY"-Q@)SRI12!:SCZ.\!]5">-_,)Q0*WAL122R775$%K7%<7C''
MS?[1 FX;EX8.*7,6O7*W2"X'  ^\MLUEF7G16?RB54ET'G4K%C5IRX(L)='A
MSRT@T:D*/F2,[X1%YQDH8QFB"^.:E80@A]$=#3TBMOV%VD1L+@MFS-A S2A#
M 0AON!_-U,X]7?E(02;.??O2$A%<F@O*KM6T+$ZN5 ]%B4VN#NRB<TT00 \S
M@D*>RY>!N,'08G$)M "D)>BQ$>T['U-=-33K:"XT?PFK4JT2=>8;E:*(IN3=
M*LNGH$+J4WG/,<3WXTN([][4S0TXN[;J.;L$E6XETBZO>('&\JUQ=FG\^_K:
M! &"#K- 7DE"V.F@<[--&FB-$461DP(^KI6(,_?!<<LF'1M5J<-R#VH?B!76
M+RC#5!)''$?HF&.Q15U221Y'550^''9=+LQGT\ B_7!T.GSK1M=NW69X/2KR
M"OX2!LRI4HQ#@Q3]@[<#"-A3$L,_MH_J[8LAI\E4!(&IOEW7W$4^FH_35Y<I
MK"8<7D9VH#ZUNOY'*'+/RNDHN1+N":JQ/4_I+32V]Z,\AYO[#!NC)#H[B=SO
M08OSAS_L[WZ*_G,T>T>D[?]Y9E9C^[^/I44Q)P(E%^=6Y1^9#713< .I<B\2
MLV40V SP&GGJT(+EH"MM- 3B(+I=;#Z99:/@,V%/&1(HS A]90Q]#36-63@^
MM0>"2H._7[S^9D+SB9U.S D"UTH%(X&\3C.D1MW[;>O=E6HFA?@Q&C2-0QJG
MQGP98&HI:;=NC+ !L<@$>R1"1(V@4["C$3:4%#T.F(;=\ 6H&@_9C&E\HU.O
MUYK(7VPYL)!?5P-;PM 7V;9^N-G-4WZNM-*I(6TY\[+1VO2L2_.<T^WW^]UH
MI[N_?W*TO;-W\/'_?+?Q'?Y\M+V[*S][]MC[P^/=[C'^GL= OWEEC+C][:.3
M[L_RCX4+%*YFQ20%.P^'>/P+_V-7!O+3UM^,OOW[Z:[[R^_\;9JJ';+]('UL
M\;_-?X[I%\<R-67(9HCZ^C-BUT8K3PTM^OHQPHUQ:D2"A-..I?(QVC'9M\;/
M16;9S2::7VQ5UM*\B65JM9>YY7"[<&=+@KL=OM](['?Z>$:^)$>U!Y1_!5;^
MSYOK&^AZZ$/[2GYYK8.[^3<(QJ=36JZCN]B;7Y;O'O^(-I,9@_[HP>$?Q]M'
ME6>N_=4)=^L;VRFT81]KBXS%GXS-G;_"3GWCVV0<AL?:)#]BN<JA2K[U0Q44
MQ^Y-5 'DRUE[\KM789K:,;;XD[[&TF_^Q%7V+&1T><*[UW_9O<KN26#K()\A
M_-@3WK[>R_;54/,]Z2U[L5":V12?V<:9_T  YEFF#'_Z-T\9?@/1L=?7CHY]
M<\&@G5$RAT0KU%!:1(A'TS(KJ9G-;_Y^H#U[_XSV;.MESW#/=E[V[!GMF4IC
MOD2&GL%N0<[V9:.>_D81TCZDY057Y9'TX-8J>C"S]4/?\I9)R\&3#]B]A _<
M9CUN@.['E4[7M[Y=NQ]W]E\NK2>_2V*V Q@8MS,_:37XS><M;,/IHV_7BY6Q
MVHY]0-CK:O3[&:29OOG3]L_Y!(@O'M577NF<??,)P3H>J2=]MKYY@[Z6^>O%
M#WOJVT;7%EQDS^[(??-*TNW=<3J /ON7'7OB.W:4(&;/TS= OGF]6$%F?8E]
M/.T->R8J\)L_6&Z?GKYU^,W?5VJSGF-EWS>W6QXW$),0O\03G_2FG:0O,:GG
MLE,U %Z[C(SQ:.?LS<U4XS^><='SYL9+U?,3K7K^X?XP ;ZYJN>3J7GFX7#X
MI(VN;SZG='J>%0/$ KQRH*0,J/Y(^_;3RW6^RL:9Y0+:^,<UDU_.V I;]7LR
MFI-/<X2P5"^[]:1WBP#_3L^+M 02OR>]6U7+&&Q*MHUO#%3UYKHX56_6C2=!
MO+?E.L W_Z4P$*=%?I&5A'S*=#*+R-,45\$_/O^R:33]/_[^^9=.;)EURW:+
MD24':7^4%'6LKL#[.!]=18MI70E#4)=5U%$! @#7KTQ32ZADPSD H@$6=-;/
MIDBGW,34>'T\V%BP#>U\[3R)Z'":9#A)S2^,#ZD#\<N&RV#++],",>?R^=GY
M*ORNO 8 P=<C,ER:;RRT5BJ!?IS,-,\BCY&(E3%^&@USH>GEV88SB]LM#1^-
M(I&@2-PM#&^4C<?I ,@[86L+D AX.@Q-C9> \<TH+\_3">U$ ^RGV@7S<4+=
MLQR4>@5@DTJ@=1&H//DZ([6N1P>Y6QT%B\>R#W1-*!&3FMVK</1%\\D(N1_<
M(U'< '?1\JPHY$BD4BKSZNO6/(: 3OWK*\*S7@&?NV_5]'8]VD>$><W72\.X
MN8+\Z=I ?DG'3/KS+VHH(,+KT1YS]R$-...$ S3C9 8XD\BXYWX<N6\CO7AI
M_B)$*)<9057/IX)QF R'2>;04#TH6E^?&7$24L$8D!)Q(&69SLIH9(X/*#L+
M3TG:<PB,511M8%WE<YU/DRLBFL"'$70H/S& HF55/DX&J')!':0S\UD :Y3S
MH$C"0X5-U$.E?^,41,K,;PJ^K2.6\#J=U':\LMX3>*R 3/G].V %,+,5-/WA
M?#8'!'4CXAD1+BK&\@PH5^9 0.OV#DF_U&H! TY26MS&R@DT8UA*N!J<NB8>
M5SKCO$AGQH:;$>BZ;1" W^O3<F3!(RMJ#C5C,$*CL6X]QL2N^D!S,M_KF0@@
MC)NVH?D2!0%/9C12.5J7^7PT(*1.%@?X:8#PQTHD%T) QPMNI7O6$LZ.J0/-
MC]ZW6^'.X77L7\)--[<9"?Q;7AK>60O,PX"9INF>YP?77O>SS/+B31BC=L88
MVIWU0#.2E:,I5\$&NS*GOD!X6=9SI>5@U7K\ 02706[/$Z!Q2I!<-/TZ-5M5
MHKSD1,,PQ%>3Z6VVX2WN06*M"9312<Y0X$!5.$JRL;^4R/"AE6"1CLW:$;L.
MZ/5U"6H_OWC\YK]Y//Y:*WD[,Z?7 0%#:A%STQS1Z6!+9UA']E8Q'@9IV3<_
M(,JTUAF+; @P.)A*D<T3\.) :\/Y+>=#($))20V9$PM/QEL9G\@<0&GC#5V&
MS'9H_VK5YAKLE(Z#XV/>P?HD5O>+!RCYMED/FC.WP$_FYZNKI(EJ7%M**F=-
M"K)ISF:=R-RKO$8A^BO3*5;62^F>18NF3,XXM,E"@O!:\OF\8LF9,54'X>Q9
MW*-_[/UBY"(JDED""-[HZ?3!\TJL14-@X&C5@,&VBC1H0IXKON9Q*)<9H)NK
MVR*C<<JBV"7%^,,$/6\:J-B)#^^7]/' ?DJ+,Z#YA+;Q?"36'ZS\23)"T=NF
M@W=@SE/%AZEE#)9[)F:O=R2Q@BMB#!VE29D:YSZ5%C*D)^<$Q!K<6& 5QR'[
M.;".]N<%,7E9^@;S8' 8"&"T8^4#0@L](/&9$0T2_E*0_)DNE4F":K2*9P$P
MT7%R1_>YL2(:[*Y)7O";"=^=-J:O-X;X/^=8[*Z7SQU,2_'H,3P[GL1PJFBZ
MY8JJ53-V"%O@+<<"!$J-@ZF\TQM1H.L3QVQ]%<[$;17IZKO:L$8[63S&BDE?
M9R(W&97,<\^V9)/53$8J#&_)#1(M,:(Q6FD4X9QL57+E&DYH5'= 'SZ,\_TZ
MA6YDHF*FH\N!5OVMQW23H$[43:S+IZUI&T/ J*CR"\5\SJ=\>OS(A0M(DD4S
MF(/R\\@=C$3\R(HU%X\&2=#:+>NIUKSPKF((P*+&7'9T2)/E[&U>W"$(#[^#
M"8FG(A=&0C/R%U:"*A(M&67IG'6'N3T+4B:)\U4+C"78BQD6$1Q%7L*U88=N
MKU-+@F2>I=:? U/IU[0 NFQDO&)CB/4;\B:3_KK'!:]D)-YA)+%FR3097JP<
MNL73 J(766BA,-TV%O,(H@YEP*TS3"_%W]S<B#<V-M26W]6$USA$;:UJ6%Q-
M.,C\U78[[GX(Y^D(%T9M*VQZ,\N5HM?TUR^F9\"$S#/J3LHB1EES:38^&<C
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MJ\ BWR,GKS*OUA>=N]ATHO<\J\E^*G*N[L*+"#ZA#K J4R2 VZ*H)SZ@R4R
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MNZ]X2LR:(0/"M;./E<11=<AH6M(]9/'/9>-^):O2V>0<*5P/%Q)DA5<F"D8
MH67+5,?;)+$]*BL0DS(,@7J&K1]KU/<CIFC(Y6>[%QZL7G1?]01<W_ZKS4?\
M"Z!)TVN8Y8G#[V>UO]-LV @JT\'/Z6^US?N;[79%MHT@NYE[*HME)H,7E=WP
M5.H*(F4$MBA )[%\SZ%CR\%(:#FY9H,6&/6G6CSXD2V88,.BHB6C%,Y>/6B"
M$! QY,WR:U<ET34;5U(;/2#XED8(ZJB&!US,%U-\P!Q#LR-9%)B$C1%%?#;,
MCGB+CMH%'5LVXM099#E1!3G3_#(#H) RN#T4E&?<2[P=8JMHED#\*UL(4'5Q
M7N5!H@36)\<)M,&/8?@/-X[S=!?'N3$>Z:H"EACK>U"2V\42(C5DF(<H2!C)
M_$7E9I-N;).ZE%)<T?O7BR+ZP&_GEN&#LE:E?94Y;.S$\E< .VO\Z\K<YO8(
M0+02K'G?_^5(L'=8X)-PBL[]C_KY!:\V?Z9=5C\8C=<2_MS%;RB3U)&4CVC>
M/>TJ67*)25@+</,Z@,&J6P,=^@UNC@45^0$;$K#;B BTQJ]6/->* Q)E&!4Z
M+,N_'IE!8EV3L?LX\<8 3+],)H4O\!#0_%CA:,).5I8/:)*-H%Z^H#'#Q7R<
MFZNK0#3I:07Q'%6<!>A3YU#A?7?!, P$7'?X7A&1#S(</%[ER/1[+L:7Z45!
M]J6;3B1%JQC2W^8+@&75P\R1-V<4^(5AE:LNQN"L:%%YI:;C,=3IDP6P.B($
M 2<_UN)!DUJ"+0,6_\;SR=R(55*#@FM3?JWR$I R!$.-^2N#@/L&;]W,K_A!
M<,QUXFOD?F_,<&=6+!E6(CD=&*6#(N(L+K!K*HYFZGFE0EA#&9#A[REPWYH,
M78E6WB2P]+$^80A;=U;4BUR1,:6V1#.;S>B.4F%->LE: W8OL8..:?4& I<&
MU(QGR:N[7IIR&/"OG&.LM$LI2ZJYS&"#/7TF" LU93/RJYD#E,:$>_O.T!B=
MH1,HD%6>SH(V[H-1#URS<X++1([/B3/W5Q&Q:;!&I+!]59V [ 3>BG8L@<:5
M4EZNJI&ZVX(JPP@BA!L ]"-U:<YRE?K0MBH7WW0];"R1W%E!J_(%CLLY(];O
MT&>IHAG47$5!#'_FWI'(O;:J4I83U,<++K.@0G# _9#*MP55O"#00AAPV,:1
MR36M($"<+ C6S:\1.A" TMCM 5<4UK@4_=[2'"E_M)B?@AW%5+U5>[B4P#Y(
M\5OB(5Q.LXH?Y=,AAN&#D(XQ#Z7D]<Q(TKRD8OI[2"7E'H=( TPSXRL5[#$U
M\$E9K:].G7C5$ 2#X 2[YG-ZK;Y;HT"<C- @^<=Y/J,J:4#DY9X*I IVUDER
MB5%ZRU=GXIVKZ8!]KX9F;F2S0N%\UPY+PU&TVN(>MG3"8*GD9W?-:J5G?A,Q
MW(,[/&(>^D;7ZOLU"M9!F>J H%D=*;9]&BE.;ER)&)M2G)A>10; XX%R8%3E
ME%WAVD=;-1::)]IX!QT5C')--ZK?,U:Q<R1__^/H?12E*K(E<9A&A&</Z/^D
M1"_\I;EW0-XR'7*A,S0S0J0<2?7[@5]>6\YRG8=3'B/N41>T6D\$=Q8/' 8,
MQ[FY.2Z,2^N%Q=<$%GA"ERED07@318O!USJE5('*U7#F'>$N<X! ID%WB!4_
M;VLMCTT<.-$5Q?3&SV9YE7.)J6*%H_"C ]&C<C2?F38#@N9SS23C^V4U.@=-
M3O'&!QMK^V87:[LCG,NS_::8W!^4)2*P"VN".+\UGD+WKPCS\RZH>X?7=P&J
M,\X@@N!#O#SLK9';'!F%_*/DD:CM&Y-SZ34J;A#PC=!=:+*+& RVW=1J8[.)
M%_/T>QT4S=X=H2NO57QH+FJ%R9[64,;M8T?MQ_2("TJ3UJ56@G#-V3?.L6(C
M0AG:_H*]K-_S0#YQJ?.@/AQ&EG2X\,>&09?1-%O6.;UZ[V@PD!B!BM-XM%DM
M#P"T/KV20',>[>O*Z35 3#(_1-/*!*4[GS]-88VQ1E1<_L$8D5H</F_C,B<;
MQ&P6?HS,#\=XBP$K:PX$_/%PZ1(4[0RH%":9D=.!*X6 #[9PY'HIN\CZ1'#B
ME:N&\"$.N*=\R5+ A%G*].T<XYCE7=1X'=AG8YLNB;0X<OJ!EU8]MXMV-J+J
MW'GP9K\Z@-%DC&U3%N!EWR73:[+7FO:#I_U5$!&]VPX7P4KMUH31,]H".%E8
MU8Z+H;>!#6.""U[DZE!%;7C$GK9OA'XR<OA0DAQ%?>9F@6&-&TX#5C*JD4)"
M&346A4GPB-C0!\ZAH@+TIMF<[,Q&]1;7<T:S"E5B.0F4DQ7OX77(1ZD7+5H@
MBXL.\46D]1AQA,CL]I4+J5H 'WCT(X8J%^8I115SX#(6+"84Q3AE?*6HC _;
M!8R74#5H8:/#:V$B@%-IBZTG2VCY8.2GF!)#G278_9FH>8'NDDKK5-4H'I:<
M 9;K EJ"H+M5F_;R#Q('WI52#,PJE)? X%*%-&;QI>A^G#S/LH5 T;*/FJD=
M$I2.\7W!E%[/"HH2-2=*V1HR%-_-"%TU*=E..7P<IE4]LZRUV$9AZ!$(42\O
M+K)6;2[>.:9UTUCD5!X+(8CR$GGT2!*:#P-,)V+% *\J42S(,%-2*KS@>64B
M#Y*%\2]Y%X@#8WIXS1&S86Y^/@FS4T&XAY SR.D I;N=F2W)D?.X&9Y%UX+/
M?Q_9A*;14L3*&LC\-O^4#=#IHN:CL^0$X,E+<^9/W[F\2,T_3!-"-$.0&HQO
MW*QI6;?M.I063XII/AYHKN&,Z33FNA;P @0#=@D,(%*\"JLN"]><=81 &"Z;
M1\JD#.H_,+07P NFMNW 1WE0HT1M(V\EFN!<)8@TF6LUE<;A!$RY7'-X_\QM
M7EW->-6+2!WK< H$\CEE+#1\1.! =?UM-I"]S(J)GZ.!=!]<ZI20QM9&>UG<
M['8K*-9S]%CJ' P#NIT!+,$S;8@68H_#&-:>%H-FD! .1!9IS2@ :-2F.0[,
M6:TMY/9P5D>T7VXGJ@1XP,&F;W?!IKM%JOZ,S [=U_@?5'0-6FK<4$XNYL*8
M*((B1V[E5E^X1:T%9Q*NWPF.-D"H-1Z\:DZ?Z@:V7%YMX!+ZK6?_M(:H".6F
MBF**&D?8=9'?3Y5P9EP>XWI2%MG<0Z@$[5VD6'G&N1GDE&,L4\C8>ES<7>Y#
MK/D.;<*]5)@,VCT>%=0/<8DAU+!9F(X&:F33VU"ZF5Y>Y^4BNXM]JZL>RQ=7
M$,+SP'CJ999NKGM:U 0&"W:]3$E)(.=KAV,N9O6B6H[(K'()I. F?(8FU>=0
MO.N-U_<-H6Q3["'=X6J5Y$;(*.-AI/M"Y[0-7E>O]GNG:\\X#4J[;19?%)NM
M5:*"M):>%)N*3AHB"!0_\$TJV,R76>9CD"#CABR(<@IX\8MQ=@F&WL)VAFM#
MS6U_D_.637YI#G TFX/5E(V/.T>@Z9MC7X1:>B=P,(U*5Q"GIJ)^R^JRN*0\
MJD782%P^R-^CLBQGT.(9"-LXQYK\:_]D/Z'4+Z2%':Y.:/K)\=2US/!V)T&1
MV?5[@3?0 G(_<#269!"!_X>J5I#H-KQ:TJL[7QOZ(!@/]9BBVI)-\>(L;T\T
M;Y7Y3)Y?K)%K(:$(K*Y8;\$@L:3JNVFCURM4]TFC%#&9-81L%S&8P@6W#&@F
MMFH*2Z[)36-3^M0<:47@+MPD6R#+UZ^,*\Q^I;;=#2>HTJ -0+L*=; -]"6G
MQ)$4WZY@VU'CYACV-M:HF?1E25YZP%IDDT>9BL<3*5R]5OB@,YZ$$0(5'E*K
MA&;M7F 7P?>,5@ %A$2VJ,HYU--J'08%V87PB'=^$ YE-C5&T_C:5H *K(0C
M*2WD0AZGT)/'V*?&,0A]^QA,6K/P644^TCKE(MX=!X=?G::U;UN<M#+]5M[.
M;.1-@5!O+$BZS+/BNMF>(FFL)!M?:M*6N*PV]GV%-Z0)_ (1HCR'Y1!7B0Z_
M_<CJ \1T^&FD\::VD]WY:3^)Q0+ER_5O59W7**O1["8K4#-5TP/_Q/9L'?N(
M= ^D"3LY!%NI=Q]B\.>[7?#G;@&IQU; 6_*<7SLS\=TL*OD@D:@_(N'RYOVT
MQ^SY1@\"!7=92?A%(,-8T+NT->,M2%<LBD'LB_@2 =@GR":F*]TTVX9]<]CB
M/2"TSG#W3@'.(4I#HXG_A4#Z;"V"IZ).&HZ.Z")I$]F,^7?!6-(-,3+MZ4Y=
M!N$U"U-M[,HKK#8;>Y4=<]4MPR7X)0X?2Z%N=?O.6WRRHS.@/H8*+<<!T+S@
M4*EPZRG(C,J7$O0\O:(6H-L'1*KQ!69G@#<HP'SVT0HKL3&Q;D3JK98%$8Y0
MJ9+H!8P3MH'\)Z@MJ,C)W/.JY0;L*G/&A&7P5X=O6&"E2DM*W96UA>+:>7M2
MI,T6Q-EBE[!_"[4U=]--$]IU:'D.*J,P6PRLR78Y5'$D?')H+$FT;B:8T:DJ
M(Z]C8S?.\FOE-5(IKM<OX-G>E)$_.42<8GR[SRS9;M"Z&TN9N%>)<[D)'N.0
M.<WU4?S_H(=+LUGFE53+B;E8;C4/)W3D@48L^Q?4.+*J;@>32?!R$1KZ+>/"
M'S,91NUZS#6L*]55A4'DMNQ(PRH5\@?_ GM_"<;[0O&E>&B783;%&=?G><Y8
M.MMOMR0V'MAJY(4R#UM<8Z("I2!5=]$4#%V$]I!4F8\O9\9M +4VRN9F>.!"
M79AQHE0.V!@GL$/>MCIBT <69)>*#IJ:K0^5\:&@NOZN 63;*('=&A2 <# S
M W%T'+E#&N>6S 6I#5]HUV";1QK7!]<&AK+]:%\Q0)9MQ2*TVJI#G=DF/"VF
MTMH *Q5>Z; >VQRJM>F&!'3G8H8A_$X;%C(#IJ AX!W8(&0@[$%_F/G"=R+7
M],=M(U*'?+\99Q*>:BYSB>>_I#_%]J7L3[1?("L\KK(KZO=EPV23EF*7A52Z
M^<1A9A\@EGJFR)V,>6)N$;+.-'B$M7$LQ!,&Z9C\[XJ'2-ANJJ*B"G\H<QP@
MPT&>$>0G"]/*YF=7;HH-3\0BTV)Q2[G7HF1<DQ)Z_[4'/M Y:K0N@+)_%X[(
MDNXDMX5@,0U*VCVD&#=*5RQ&RN*Z$X40/";PC'QSPUHL:AN@Y%Y5]4=WR1A&
M5*=E],X%[.9X^Z?C+^HT1%C.L-A86VX,+Z+[QK9F@N0JN\>@;VB):[W&>ZB^
M7'2U^9'! P[R?+\+\MR5)$X'W?T!N&<EEMF*<2SW%]^%TG"QEEHK(:7H*OX"
M;=]"FS&'*VW!D%'AM>RR-JR%1^=)BGW\\#KIW= /E,]BN& XY7YW#52.='[U
MN!VPE:@R%XW'^"GLQ8!$6=>UEM0L2OD#L&208@C3RYJI@3B&-K1P!Y+,X2<Q
MPJO?"ZQ"O8B8Z*15VM.V"@_=&[;]:  *'B!MCH/>6H8&]]H6G\?'5YA-1L/B
MG"MT@V:A)U(G]6Q@C@0',5 @HVTOS(4C1A^Z#CDW)(7;$.))UIV# HE%8B=W
MVYMFXW+1@\?[R0>7%F%W^IV'=/X,>TT)N]H&G:::JB3(\NQ)HR5?3 =XFW+Z
M&Q-0T89,UFA',/<:E:J1AKG=R>"53TCV)%L\;&";0;X'?O*XI?XNS/ [Z?"S
M^AS(@3@>)@Z;9.M*KF*UB?=2=_(ZTM<7"F8_:&Q  QS:UEZG;6TV!X3J2N=-
M2C)47S-!ULJ5["66\3>JB&:,M :3XB-3M@0 B28>5FUF!%<;-J-1GPX \#K(
M&#PS#6*0BQ*"61N:^^2ITW&%N0GYFKLQA.TN#<LP. 'N#IP<)Q\LRM'22_5-
MQ;"*(2X/UK+NR'43$]W"04<-PB,EJ=^BR=L3#W'XRQ-+#ZR31=/2RC&]L-U#
M W_G%9?@ L7$A>.JC=P<\F3)#GEJ++HD7D5H9S/*UN8D6R9\?J_A2GH];L*!
MT,0KK<6!X&#X?I6L6F+$SV$T03%I>>F63TQ[D(#;N^=,=]6@S-?BF[<YO0?L
M;$OH-"K3J$;7)[;SHJ9Z83:-)6XG'AI.N24(JAOJWED4-/&"H \QX/%L%_"X
M*X?H8#\Y&O]I[F(YD(UJ3+HS_19=UM[+\+O6\E"-G?N]T"R?:/(%I]+0M^'F
M$G6:V)/CTZ"I;/Z%K<NW U?=U_V!FI?Z:?'52ABI$3%.F.P1"@*MRD;;(KIO
M:V,$8$(&_PG8@(NA=>KA-E@0DA]N:89;FZ^;-P[2")!T9MFXZ(=4:UMKZH(&
M[AL=$^J=CK$!<[274]Q*^);$2;I0T,S**1Z=@SK47 D\5*$!N)@.J'S )HJ-
M:\GY"(5H7M-(0Q0A(5&OR3S)5O.K^;#@8,^-^7YA5J @\VQXC0UD;Q!*_Q2-
MW&X4% B;P7X<39<0Z9;6X77;,J$\C L,KB$YR;@P)FIA/'HV;MSW0K%*'4!8
M7MSOD<54MPA_HF2_T9.F16UX#'1.)P!T8CG-&L5Y:ND.W?W4>EVM=STUOQ9>
M.*#$S::__NV7Y.3#RW]^=7;X],FWAX?C>O[-M]_M_SD_@V^<_O.K-^]^>4<*
MO/6%=]-+Z I":&G[ZGR[Z>*8V9T>O7CS2A[UXMV'XU<?'IF;[LW1^Y-7S^4O
MG>,*)_%50H_YYU>/OTI>OGKSYOW1\?'KM[_8?Y^\/WHI_]:W*(WG ]VWR3^3
MK]0-72#%RW.,SO,'C^7+S\P%_#OOG9FWW4>Z6%]^^/'D7R^:B_7]-^90(O7/
M*)L^PKOX.2W35S\]_O%K\QU>J7_^^/7IL;Q2/]I[J=Z1Q-^$Y+8[_T,2S"EZ
MY]E6F:V5LN4\G\62FJ\^/CH6=7&L /C]7IL6(3VQ\7M\+(N7\N_4*AX,CNI8
M<5/,'Q_@#Y#AW9'XI$?BX&]S)%R /2:G*)'- U$YX>WWX$<[*;RM%+X[^7LJ
MYI5FK(XH;*1#0]DD2?2$DUF7.0A^1H!6/@2Z3% 4>QJH=:N%E?X=N&KS->5]
M<S-M)_ /5^W>6.!)$S>$U!=0,$(\"5UA+>RO%M0[-\R/O+ $H6LIY=]H,"W.
M$':'R*.M*NT%U>^M;;'9]-;:%EOW-1@QU^PK-K37]L&3)0ZY-I?4D3MBSYY(
M[$&6KX#@!% ;<D,-YFY%BG>H,\W&^0HG5*\!E+>22ZKS D%]HX/H6QY8+M0G
M8,Z*96\)5RA:24BF(Y6"LE<FW8]%'E8++Y<5N9]DLQ^FX-"$%!]54@8!-=+3
M!B.GX,\;S2J;,;N#1J0&T288>3?"/>=T1Y5<954%U1AA'*^1$B=>"AJ-K7F:
M9K,!UU!Q$.TBY<+?N1E/.4ZHQE5EGI]^$Y0TNZ.5S6;E<C8BN-/8<ZT*1FZD
MI/*&)/52'&2IHMMC-<PI'> GB)RV5K@-0K5Y-*IO()?^ <D"837-X"D?$7^/
M5-XNJ)(!J"3PG*BN#+(V.2EYU $SZ5" Q1VXT_H;[:A962=O\<195,O6><IG
M(ZBZ63?6] #3(8>/O]1TR.TB=]]O%KEKTYMW&KB[A;T<FK&AF>OMBS*'[];.
MCJP_F= _\5^LB?S$6-=HG-E?B.W*)J\=L7S0__[!+;__[*G\'*U#-U)9D193
M/]EL17X*!H>&^2U"D7HFP819+$0XFI_#=__SUD_XU$%':U^*BO_!;9._16JM
MU5+_^NKU+[^:0_V]O^_NQXD1;G-4S'P.U_](Y/6?F80</$ )N4$,[@N4AEM$
MR#X3:=A>+.Q+E9'__DQVNAW'&F\WIU%OA,MM]^0P_OCE;>W_?"9;NQDNPS:4
M$]?4X8LM=<6J#4\Y\&%1E[?R7\O+?*4#V^^MX\$FMW-@$2XL!1OBT'8LP[ZV
M4[<5QQ3/.1[%'/I13/J0J\($3MOS? ;-?14E84>,!D(6U!G0[^:[3GCT%J;E
M?G+J5881H+TCU,(DB(JFTHXB_S@O*EO/M5JT?2NIW_,#%^-< A=K!PZ5C05A
M00*E\R:&2-!-1=!Q-,CB#K.ZP$725=;E;'K="K;R5W*T6$(DT%9I0]CR]1H#
ML3R4)0O,B@C0[192 K"K1<F&8H4EL1,M=C?G]&>*$ (&V2N7EO.)X#Z)5A,7
M+75B6!4R9?(H7*]SQ[&X67BRW[/Q21>%I"*JSR$,>1LEWMA]>0&(LUMN_QY$
MX"?\F"[$)M.%C\"#C5)R#/VH9LQB-1IA:0A6V[8VO=+1>%?UU'6RN)^YE ;Q
MA6T>:R]L3 C;X[.@WB$<U+W,IDLW*V]<6,:JHO#$[BJU-F%3/57)YRB0>'VQ
M^M7LE1D.YA$4FSNUE7^XN/;#@R\UD/M):HR"?)3-FGEX6:C0><E$4GSLN!C=
M_5Z7I*?]GM=:L51=\():Q;+J/&QXC*D?:6,0JK63ZKZW?BHM4"2(&$9]9@L2
M)9]8^[@/'**HM%H5VW,E"B5[:RQ#M^0B4*KF<M[05$JWM=(M\SSJ*?E0"I>F
MQW #,SCX!PWT%=8#8"_$&=UL?^+--FAEP#*O]&Y 5V9I)QUF46O*&WO(:E)2
MT)J%N:^SJ>27PQ[R:U86^.-]:D=G>_%2Z4.F&\B[)#BRVJ6698*::'M,76UI
MS$ P4U7.&>S]Q)@Y5*0 -74LUJAS/^1E=9;-BO^E:^85<EE@::@\ZF1N#O"[
MR81X@:UP<,&H4+JXNDABZ?-2^R/M4Q"WRQY7)H079=>1U<<U:3^ML>/9[\7.
MYSIG,R@@/K;:9IS(2C9XXA?2=O..LI?:U/P,H?+/[@TJ?Z>%! \VX_;TOC-N
M3^XSX_;X,PFB;25SIO7Z%Q@+WV7/=ID1MYXG[Q]Z]NR31[WO,EZRIE;Z,E,Y
M/__V^V<B4Q/H4VXLG;^,14Z1FSULOW2GP1C+:Q"SAQLQ:23_:%!^Q(5ZQ0WH
M@\4_H_Q)KOE!&JZ/;F=^\]P']1-=[QRZF+L'*^869)LAJN\FTKX.O#F*-68:
MNK9XB_CQF*+@@*;$-W$A*6S/^1#HBX>-F<PSSRAJ2TP%GML6<A-0'"0Z=Y^/
M/N=6]C5O^1(;4& 6">EG:\D3 B51. 1+EL!$YF%3'T&SQ_>@F>]RU?]UOE;J
M1<+!8T6R=4WYK]RVQ[-4"3KXQH+?G1?S6P&V9P^5MT[O-LMHAW8C]/_=Y-KP
MP$N6(ISZW23:^CT4XP<;ZC[<A;IO>+60<H^E5YO):DZQJFRUE\M9 WC08!^G
M\%.5GY5H%AJE36$O8]@P4R*9$1.T(5"Y#;#7NT!#X-B>01\>R071]V]AI+>^
M-R6BWGSI6&=XX/:L-AC'-F@1S[H6$VYIT"""*-ELT%+(7OJ]V[&]D%+C_!P\
MX*]BAH4H4?M*T_B1\D(24)LCE!M79G^%2W=+^A6G%TLF/HX:(J%J;-SIJL;*
M!5<[I2QVUTQ:$^1L<0U!_0L;J""7\-S@.0!Z4XZU+]C[89O9-G504>!BP5*!
M>6 4M+JTF5".A:.C)JR _##KHZ$DL#.VK*GV#:@&E[8E[V?M_+5L=L3J_-1Q
M7PK#2\C]C\#3\%-6L59!5D P@,RY>"!^Q.LYTQQVF4^/0<F!D&JGN3.3MGR&
M"+*Q$&O4QC5JHE0S47/3'.P898S%%+$W%?09R!;,Q90Y?NYK-R[K)BQGQ4*)
M#&6&Q$B&=Z4H_19C YVQS.13VUO8Z/%LS-3D>*)90,JUF@Z'-+.2/HHE2>X@
M/T(O2>3IGW^VY+O'GR.QT!>4+?GFOK,EA[OZI*UF67*RI."OOV?3)5.%X]7X
M!0;-O[P4RF[_PT#U ]<!&V=-0IA'B[&EH&08,.IDYW0=8,'WG>4=,>T]/_C>
M<$O0W2DDC@33 0[HQGR2+* ?]]H#(MFF:O:ZH*YA2=B-\ JM7B[)67=E!L[?
MF!05T_2O\#KP $8]CA@;'?H88BMJWO[PR++]^ /,7OK7$N**B!$F;-)CH+M5
M-FXK&AH^W9+&B&9I-:#(SJS?TU/S>\+?P7+3(_17<&BM2U.HSBY?:#;OMUUF
M.7I?QO-M#S%._607I[ZA*WEZGNL82TNT4*5%;1QIGAF1K++Y.:LXS';IWL=A
M0T8*B4^S0'VU&7.=5X)JU>B&2K</)MV2\;*24%SXY-2[6$O6WT8IL\9F#O'V
MF88M!ZI\/LU&TF0$U3$4TI@5HQAMOV?FJ*9,X6.(\>;3;%XS+_O:ERN^P%ZN
MBS+ZQ7!9@@*CR":OYOW"];=MU2$IZH81)_J"3FLW8OJR.>JUB+XPLFZV:U%6
M=0OK%P[AK_S.V+^B&7'[5!_7$$^/(_$\%RMU4H%]ZAHTCJ#N<1-T;-!1S*A1
MAHO%XD?/"=2?=F=YM745P%.X.*++V/+)O#8L9]/-S0/TN>M(Z)OS>8$15[39
M,0U75JSO!%PP*JK1\H*:P]>NIR M 9#^1;+C#BG@ Q8R[CH%I/?<:K(2O$ 0
M:STE0 &A^,->7K9$!-P43QM)>Z+*4TA='/*N]") #J!#1)VEO(] C04QHE'J
M0V74)DOLQNB*4Z)O#/4H'U3795R+4#0Y!&)+(FO\@O4OL&@-@RIZ&;1N'+HT
M%O7A[4U*V8?E7/R$+MQ Y J)3YO*_, UK<IY!7I1SW./&W44M1I[R^3]ZN_X
M4ECM[R8@X]>'6Q\C^^G\HQDV_*1KWGIJ7D"OK3<BUC&Y?D$"ZXG"@%3[Y&[,
M!F&UE'13,TS2)N-B@G;!0F<+H2-L2]F*2]=0X8K"'(V=(QPJ .[,ZE+/I ;B
MIH5^EG>EP",:QD&(U)L9]=^U'DX]2$<D["8.:PFP(#+8UMK=R.A=>R.<+B%_
MY(2,9;C0#<M"'8;7NL6)+6BF\M4!0I:R,;54E8:]B>O7&R:5H:J-AZ-_/EB)
M;,*<F7F:=\C=9M,;]Q0+:MB )6])O4+?19"#0;!3,$$\#1D5YF'9<$3S&3=U
MM.3481;( X$-)I@-;Y;[K52+QBG1V50S"++8]HY8[X>===9ABQ":!J@3D]ZF
MJ.?DR(U;92#8_-1*S@1UA>H*J>V!O0/5 +%5#2H@668F7JR!]O(L.+[X\&(\
M7/E"U G9&1@2_KO-GIR!6=M@4M8&:42 86#!_4/=.6ES+HRU"PE@_%FY/#L'
MO /&"3.NE?3?X,%$'#%IRPK/N7FUJU_/>*_@8\JN\\.4L09GG5RP1J,N+ZCA
MO?DHOP%VP9P4ZH*\ZAG&4,/[CDS.?J]M;(%78>%6\?GCIK^(GXE-S@.Y?Z@4
MT1- P;(J<X-ST27IT")8B7K2)NDPJ2Y1?\#%^D]WD:$[<AA5?B+UR(6PV8"[
M/%+I(=<>1W!5Q^'%4V@F<JKE)H,3QC!#8@LSH7,SGHYBT2^T?0<4CC9CR0XG
MT='JP-R;^CN?1Z^"KJ9HK:!'*UL!"[V2JL#-?HD(_^2HWSM6KPC\[1^0KV#7
M0>83BN#A@Q/!%;PA2@Z'<3GTF]JS(+Y(.N0PO8=N&3Y&$\Q9=+XX;C9">+8U
MO%<UM8#O(%L'8RWY\'ESEJ8"T05I!H_(4^[8*N^^2=JOF[AB>-FU'Y:,*33!
ME.]E"56&US#S$+@:,XVCK];^A 1SFC[(Q@L:6T_MOG+W]XYQK5X#,$3M(OA(
M!QJ9/B51W[@Y=Z\)+1H=[561>Z_5$M$>A\$33OY(N/).EG&8M]3X^6^)+.?>
M:QDQUXM%R5G),K)!ASL8- =BA[)*-^7[[?=6-V;3RPY[SK.XR#-,4?DF)WSS
M=D.*0SA6OY^D<G\%-'D;C=F#T@NN;&#Z*XLB!_@V-5^VZ'<_1-_>[=B6?/@F
M%;<H<<%8DFHXC(\T<HJ?BD^JEM.\5GEC82Q*CD:+5'/, ?'1>/QH6BZ\!X3U
MA;;3-(0P\(A8'CM<!+J+/)*]\'C(:K@81S3]9)1*/J9X2@1V$<5RW;ZH ^NS
M9Z,U"SMF9E&(Q=75\V->G2(8$L.E]:SU/M<<'J+;HT'JW"883!UX5^U;/FM$
M_^$.T;_K.+)#]&\/T1_#"HG>-)9@6T6;52XW4I>H*3MU'D=GZR\05?[E517L
M9/!SD\&CEY^)*#EB:&=Q&JO'VJ%MYN<GX>D1.)V0/F/9;MP[=#E6J6)N2AD@
M$XV8*?%ZT##@;_[FR9Z=37=7-MW6U-BN)U2YX5V7[-DO-EI-HQLOJ7A6Q*V-
M*R XZ$ T_!WU5E:+_5[;B 9?X+5[BZ;G#UU>G36XB;"V-$7_%)+J1M/OA9+Z
M959VW82.Z/.2UJUQAMX^PKC^J=@ZD>-F54R2@1MK$/C*\J6X.]COW<P?C'Z+
M ]ZV/Y4'2%OI(R92+7730BF0(J],J7UJ9MJ;"4]D5E@/TAIP[J[1LMD@W)#-
M"[=6E6PE+15;1O&N*ME:ZQ@1$G"M&^8."[Q^YO0.ZE]I*38NE\-%&I11-(#!
MXU@C.<$3ZKXB6"1EQKV<4A61+>6R6<K@5.ZY9%!J$U"Q$6(SK%R]JQ-UK5;=
MBL%@"[V^FDDZQ*U%DG3 %CDT5U/&8&![]3?TO-<_1(#7K8(3+$NXA5"=%XR0
M*@H=#949F;DUS'3,*A. '6#&#/=U";]I=H7'0$KT=$V(MF/0]M$_)(I2(R0C
M2(=NU!ENF$<_'"W0,X?5K]!K73(/\TJDGO1#S?))[694(E7;> SN=1!WZ9O3
M5=GW:3+%^:#?:_)!\J5W(,ET%[:R?5]L<=5+L)PF9I=)41_GM3&@4'G7"+1P
MQ6==N!>JMJE5 2>B$:XC- JJ DUH#L^Q#@(>#H)7+'0[J%;.1]O*CAAW&TK2
MLMRI[FA\#Q+.FZSY.':!F2"Q.XWR;)',S0SQ@YENI294*,B)'QD<+UTAC!J(
M!;K"&EV=E].\S6.P2=:LF9.5;+W%?=LY1R?DF@QU-+ESS:&XX2#IJPSLZV+.
MMX^'_$I#W)=?/,/N4@7 =LD].\GI:+GC0XH<BUY\@H[Q>:CH?H-UQ]L5$&UF
MM3+61:NZ(9<S3X(0Q;"<V24G*F"KP#H630M0?.V"I>OWNM?N 4/UO_V;1V^W
MV%=O,DA>V39EYA( \2(&H=2[^]>B1&>;C I^;2/:=C[C!N.JZ/$"C@YVQE0W
M<"2-$7LB'A3 VWJ64O=WU$&G=X>O=4/L- P_S35]-M#UC'2;@-?ISG*=!*C)
M$[A'S55"Q].KQK!]].#O!"T5_"!69[#UQV3T&EJ%K;29(+1IWVE2 .'==9\@
ME!?[<LZFFMD:Q+#=HM3F*^'(B+=UQHREOH"B>8D\S/!R^"_@ERR%>TQ<N5!*
M%41F$@.!@4*36PBR'#[N]UZ(=T_>+HV4*"4\7F/QU5R;9KD/K4_CS6X()>)"
M-A64K?JPMNTO?;^W[MK#2N^!M\!=)E1CR$'W%H";@B$^1&*#1UKCXD'Q]6GV
M,6!C"X\MUR+K<Q[ 7N%0S^@LD ._3JD(LK#XU _>RZ2-8/SN'WAT8I=XT_XA
MK=.CB(-:H>*T \>X>?$?'"_S56D+A.N8FF9Z>+^O96)9S 712,9Q8NQBZ [I
MDZ%'[.*C,VS? #NLF-3L]MKS<O!-,H93TLSJZ,^/F[*0_65]@)1EV@R77T<S
MPQMJQ7-DZ'R4.6Q%P@X%KH4@$<7KV[[C==Z Z((3T][PT^-@U_8DEU>ORW%/
M[/C2^[4,&U13.5XJ9<L1SR-JJ7*-K^@=2T+A F12_R(OD"T:.?<1KC CXB#7
M+BH56-3=8\HJ"<^=42-<.YT93QO+;S.+;+514$9<$&&_+EEOV0];1HWL[OPT
M\U<(430OHGUS *_@],.(4G<LN-FWVLMP'Y/H%EH#AZFAZAS"5@O[ZHA7(MXN
MA-E&X'RB<88*D52+[>?*IUI='ZUKT!F*<<7$9"KB@L 4:;!8;F OTF9+Y_%-
MFR/KQ@FJYVU6N]T6!DTI0E4WIQ<T#&DC_.!T:FNPV?729>!>]?3VU4L1B>N8
M]87"A3.+I31/J#"$ISKV'@A]6MO.LH<LN]M :6\XM8,G-YB;9%BB3@:V3E(9
M4[BPB(F ^A,'4V-2T,IU: Y*#E@1V'=Y(=.PT)E-:U*_5*O$4O;#;;V&FZQ4
M?*DZRH3"Z#'K8U@?9FO"VXA.$H/U.3!1F"7E<X,$-*XQ-R2 F$Q5L&AEU!;6
MUN9,.C#IIXII#*T\YOP7,MZI_T9\4I2@P.E,(5O\8*,>W^VB'G=X-C8^'* D
M7/ENQ/5 IYQMJWJ-LV1NBVEYG><0Q2-*0O@E!("74[COC,::Y9,"OV*L73",
M+OD$[CENK? ]8&B<54B=8SXYX!;I9U5VD5!+$>1+:<),78U8Y&AZV2@<3NA8
M$0^2C@S#3\_S:>-%H#/ M</?FXN<)X'L$3_<PWUR>4LM*;1^:6*9SRC\A#$D
MRQ^6^@$EVFD;;V+==XT7K'?'4%M!4CBDTCGU F81;P#F&Q16R1'5Q"G3[N,V
M,LM,$1:O^(]#,!#KOO8NWL;'8JG2*KDHO>*\5IE%A+5;52_/>0]"=^FTC_%Z
M-/C+$[L5Z5VL77W$':>$BTGQ+_&IKZ26?KB\?C3,H$X3B!\SDIT]A180*J%I
M<5$LQ,H]KY :"D>VJ)8CT%T4/#$^RF6&2DD]L.8\0XUHM6E.GDEC=-XW5,#$
MR,@51=7DX4#/9#,;L2D(W2_%G@+):2+@9&&-Y;ZLM$%'A@)(A>7PV+)0&*FH
MRREA:."H.% ?>FEF>;BQK_GM-*/&4O:G U]BV.7;OO/QYR YW31QL*J7*B!N
MR"_MPH^X2@45C/J'+!]&+UV&.1A"&XET,[@V,EK^VLHI!I!7XLD:CZ+!6Z>#
M''GS92K'!NL7_D+=N[1'BM%')/W#*>.5:ZZ!_[?$\+Q.[JWH\VB1%C"=(A\_
MLA-2204?PQ/R3\ 3V^,4+O4?B\)Z U]C 8,M%9;56.C/(02@&*<:H^P@\V?.
M]XNNU-&K6R<L9T:UVI>$0TF=]^(A!FR8B7E.XD*+8;XIA!FN'6)D'P^,"L(X
MG40'P$?G_,E\&*A0><E!+G1?1>(@,).@Y%Z#CF0_.4)19I9(H7;C5G>Y"FW4
M(1CR( +O"NYGC-UZ'^!MG>49.H('7Q\\3A\_?HS\7!#WA.OA'C)K?PU6AN8U
M*QZW5A$U$0N]F]]=S $*-2FF*L+6#*//DG>323$R/R2#Q0BSPM+4^6+!#G;S
M"23J#G^BY M7WOMNE@S-$9U0Y/Q"A;(FYO:4O*&E3]0:Y%\DP?!(1W7<F(@B
M*;1<C_@H?WH:*10&F/H]_2@.,06DQW_-RJMI/CYSS+ANTO&#B@.'V"PY/-:X
M*68PXVNGDY$/(:)P;,8 #JU[/YC>BP)[@B:2/W@ONTZ[HOHZLY)M3AZ%!KU%
ME!H(B^9><B7<VI99-B7%2FQ;8L3G?D"=U0G&<L=9$DLZ,;/^4"&EA7%X2DCM
M)S]GQ71);8EB3U:F U=+P&X9O3T%3ZE$N\=8^(MK+V;_MT"X?+^+]=R5CI\.
MDEA' W.5)7R7X<VTJA8HH\[UD,<P%J9RMIV4,BRO[0D8#!%C%'*7RRJ,MT!W
MX6E)'KR7&"FY1P4TJ @9,]EF##BMR]: Z!KC2!'[*ZV/<58VL-4*=?,AKV#!
MS/T$GVL#(#V\)Y5U =L6_K8.S---!>;@<#_YD)?5638K_I?[="%Y\CTD<K(!
MF%S^:(C)N68J?C]']?P^T@P#QMMC>V/:;&+?,Q;'<E%6#G22)A=Y=0:)4(AR
MED9Y9SYP4:( MIC&7$5#FV/SCPK:5AB+Q& (QSC>FPN'.=^5,:[]2T:]B#>1
MF27YLZSX%HFDG=FM'*N0'0HQ5%LHF!C"9U,L]D]U*L/.;2ZYR& >&'BEC]#@
M[RM7A/HG@TBE- 9)<8U<L/(ZX^Z%_H"E:A%C%N%JVFDC P)V/V@H&[U9_5YS
MLZ*[XFW%&NM^/T&=PJYLXS10.MP->$)D:9Y\!PNM*F#BX"8Z7[@3 %*J"^YC
M4$7.I_D)];T1Q8*?\E1-]$0@+)..JQU]I\Q^"G+1/1"8-/%Y.&.*LD&+VH:!
M:@0P5E:K4TUX[*5T=;J *B?<:V4<_\H8A@"[!Q[VH13@6+YL@6Q6^05T!] C
M<Q<U]RQI0&B=>9,F?Q4S[A=#H$=/!%-'51*HK#V,MNBEMBQ] K%HM!V2N1.'
M"6> 2TNN&'R=F.755RR$5^>2/1.G[GB:*[')0,ZAW,)5TQ4!-DV!78*@S@"_
M0.?2H>A<EFN%!%&4S_>-I?XA*C902(2_Y9=UE[5$WVFW7,UJI7';1L8@"#GP
M G6CFNC@X<Z.EA/JH;1WZU[[15VA6AOAU,ZC>?NUK>SBE87(CFA5U)WVID$$
MR9S!66RDT.V/2^O=2(1^!9V+'Z#?\;_M1JB+WGZ?1"BC1*!<MZJ92K--![2P
M8@]7;)R A)C;[<%6T"<:J@]-C>1H,BFFA415$_4]9S[YV.-V@>5MJ#%AX;HB
M@5MA0P%-YV/($VD.N;9H?#?*!36PV!?().HPF,I&*HP.H,!/.E0WYY$LO ]F
MYM\9$6^J[7J(KQKV0HE<Z5ED11J;QLLQX-HG@>"P?VO3PQXVR2X;%F3?9N$4
M8-$5H[?/M+U7U54."A[BJCZO 71)JM451>V,O*HXW5,&OM*"$+=5S&;&D2)A
M[CT1';;?NO*E-==> FBNG*81U*19[V<J,HX-*5#SQ/B 'V1,ZMDN)G57?OT0
M_?H3*#PW)OEE_)YC%Q]R0Y0&"F&Z?,H/G=CU>^Q!3Z_YVB,]U/D:!Y@/!=K+
M]=CG!= 8KY/ZGNLE%6DTC[VE_%H)KS\4\;9WPGL+!\J,Z^_M!VE&K4$:2,(6
MH]SMHV69E\HWVIJR&HC',"M5$O+)XV8E!0"MI"YT'+&:VG1:*G=U<E5!'=%,
MHNQ>D4AM[5N_%Z%J/XA7Q,2[4M15S%;+JAA(HT$P?*]AQNL,0;^W=HH OJS\
M5WU,MB\=XW;I. *<WH5_TANP"6."@QJ3,)<Y)?(MP5,I,(]=4>K[%S?3*:UG
MT_.4-+$/]2PZ,.HD](P^'-AW-O+&; ]XZ)V)/PB*&E; !*R9W-A]  YC0 D(
M+:WGAJ9 C6;IE1!B0G.\VJ/4\E2CCPIH88NW=)O*_%M6EU1";1S(>6G)XCOL
M':I.99.G,"=[RCY?&*II?43:[]$I46P+ 9?*C#$,(CW)&= [S;HM,;$3VS:G
MM6:(=LA7Y/Q-ME#=.G4O#*J5!?.?&A%=(A$:%!)=(R:O]=O;SP$\V4]^+_$4
M?5 U'%O%)E#L_Y?<"'\V)06A=?0ZL8!HM=9EN< BJ"P!?WV*8*NZ=E"%Z.T;
MTF6H#RE66WP0[#0-J6$=!)%O0F2%0U.8"8V^IC;C%YFYNBH$OW(U+&A%^F(Y
M"8?FUW 2><-$J:JT>QY0 +O.1 :DNF5WHJONDN44,L@7W#FD;;@MI5H!X<KK
MF59-L#LOKJ?9E9'75YD+=D1'Y&<]805K1G('&*^8J)&V".7-<^[YW;9IZ)ZF
M.3$FZAG$ ]T .FE,5.3%IT=<I;M&4G[M(FDJO8" *G:2&6'=12LEX4G"E8DI
M[,"RM>\@F_/[^J>+Y711&'E#"Q=<0'43V8ZY;0GH5;.+K;=Y)T5,W0M?N-<8
MZ]%"W]P;59O:(+.];EFISN!0JGQLT66$G2J%9,X%8V6M/;P9KH K.:R;"H*+
M)/!6X;N8U4)K9+"4!M5\YZ^^]'3EPN_%7[ <[X&0!0X)R%3JKF%>S]05L,(X
M71_L!G 20>N$,GRV_^P?@381_+K>"5^1N>*/%;85J@2SY?4C)_[(.#/ B+X7
M/N3K[O3<#!26OA$\C*R$!]AR! 6 \Y%FM/"M[M78J(!9[\L%2MW'$>,[<7SX
MIG[/SL+5L9\#".YG(V0SX$P7=)H0AO U:Q9Z:21K&MY4D'/!+S2K>SFA1%^
M(>'I6T*M*FF,9+($A%=Y)<F#(9OHK+ !P>Q^)$WK-EA 572#V.<??W[W]M1&
M/,Z+1?ZHGF>C_/FLO*HRX$+UU_C'K^$+/T7LONCJ.A$AU/7;?+F I?L-[?2'
MB[DRSO8NOG6G\:W76+UI3MA+5M=D2UODBF*T(4H <C/5C9I WVH=R28]+M>
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M"B"'=MS:?<5B)$?J!#D6C\)\\[($\4!)*8L9AN/ ]$(M18?<3*V:Y==F3H^
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M1T(?(5!%2J"P*^8J@C'T[3 K1QEM 3S6W <#YKHV&&F]M>GW:'%4%[#&4JQ
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M+2&N28CWPYO?CD9Q,F%)W)^+'W5CDGA+AFN3X?UPY7=FX\ [>++BG=H2WD]
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M1"9_<D6E..)R<48BG/GERA?"Y:7E)&,"=QLG[,<4DC/MNI<KG^T1'?_"31@
M@;*-V'<XI/() )MVE9,1*R="V>C PK]()QK.M!95MILE=VS9'5F9'UF\<-DU
M\B_1LU"4"94KW@FCP7C&JG ?+7:U2)X:7;EAXM_X8Q9[8* G.%9*K=&&ZNG
MV1*E4RR:K4CL;[M3Y'FUWETEE4AY 9J.HB"QQPJ^3%DU(0TOG8TSY?3[;ON
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M,9*6<=)"/E0)I*L"ET*4.^'T%M#=2-^HO,P2@L "=SLW;6UZJ)('HNJS2FV
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M93,BSZ_J-&_.9L/-A [W#TDH:J68\<EZA61:;%H9", B9TW>Q%@*ZS-?%@:
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M0:*^"1 A^UZLAZ3QB]*R">Q%ZH<T?%'%]2LB0\**)Y-@B&R*K6?)_%X[\BZ
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M/!ZZ6Y>)>9)G@'YD)$V5<#* %GE1:"Y;;A;UFN7&I25I#,E9IG &Z/=5RS!
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MBW."=:*"AHU0G$2CO$^'8 4-@S=B4VQP^ZQ(^)5B99:"I[_$M!L%!8=9-X0
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M64WUTSPIRCR=XMQXW,T*+^8TNTKR='6Q\]VC\5FQC>GRO2<^_M/K(I!ILOB
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M8(F3RVQ3X(-=,#=BY!K_Z\?GX?/GSR53XR$-_I=DLKE.P,;L&C;CWL-6(?V
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M=VZ-K5%J'JK4\D:4)V2PD)\-ML*8OJ%Q]3H;E:[0T<![I_IZR*ERE]EBAB.
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M!\LSJB$/NBV8R.XG5HXJRBJ:W>*I,BEE'/=:8D:*/2X\57*0T6(*]B&2H9G
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MU&CF^0GP[7"\CC^%T[TIT_\ZHQ8YN+EXK*##K4JQO9:;@DK@ETFI%6\X*+V
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M,0QF.+K/T*>HUX5JC^MQG*]B"%?Y9)6/>L?@\-NORLC?X'DR4WXC_[!\]>_
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M)TLM5BOH30[H6;B5<3H]'IDT$RF KF Y<+ZT)2^@<\QK5GW.XMQ<8_D:(8O
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M=;W ">ME=EY*S(*(H6AW0*(4$&8G)#LP^>-DQKT)D<,#H:0Y@J],N6M@P48
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M>96K;(F9GX6]?CY8]MW<D3ZOI$^QP]S\1I*X8GA_6GK:^C1)B!9<YQ:MV/'
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M^V7?[3&NZOO;+:"!8U))!M6YC*+_.@/5>.P^[\U/]I^W'+0-H"90^,SWQJ7
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MY3VQ7.&V0SPT"H:(=VZ<*8&^XL)"6@J<-M)\.#TDL[MD_ES1+'A'8V__J"B
M(")XP.$H*>"*B;?Y0":ICNE"64=!)-Z>AH QQ^='#UH5$=Q6%$C^+:W&%"X!
M13:I]7"C(<-TA3&P+\06Z8,L,R2%L9YLE&UQFVTWZI6& TD"0#AJOCB&>[DD
M_96?=A@>#,#-)-H\D%(B Q/R<<A&&\P,9#@Q3I":=@]M;3;%8(@86W&<C)1+
M![65SLBEKJ%WEBVSUGUI#M".R^56!K,K&$]PKULCU@'1S7"P0^:(5P'Y.IJP
M+'"C7=P4\I:I7I2"44(T3L9+R5^>NV+JL5O(;BAQEE+^LQR:FT:"R&VDW<.H
MA24"C$"MFZ-.^G*.,#Q5=6\%9SKM>0L#10YAU5WN*J0M\+#+V(Y";S??H@>1
M@&REIL_MDXH/FQAITB7O2Q#?NV:/+^/QK8&8VR>H01)%R34N@CM/UY/]^\:3
M_0N!L;Z=]@!JBHIL /BDF",CY!C]9^I8@-M77FY >0Q40YF'M+UE(X&73@U&
M*QM:U.9*GB5I8D1[F%M_TCD[NP3H@?.__GRU]PH_7[3:;?G9FIF/7[OM3A>_
MYS;0-Z^AW+EU<=DYEK_<.&;% 88)(Y'K=9O\2UN^^?#OKX1L]MKZ#_]@ :&N
MZ2;*"^W[#_:7?<"B^ZMN^G6M%O]TC?&1 V\H7(BQUV/W1Q+ZSAT'OM X(3RO
MH'9=2,0YJ&O3JNK'X[;1UN(X2/DJ7P'/7>+68I,^G5V=MD__^B*^![ +3+=4
MC<,!LP?+Z+71Z<\=R$@54W!DM\WX7K^XL89K*GKR<-/>_#@[7F)R;VUP]^&K
M/J[G^JN?#N8>.7_;PY\[6F!MU]8BG<]GY#:J<S_5.7?'P3,1@94KSS,:NXWZ
MW$]]>A!6>"8RL'+]>4Z#=Q\%LO>&SUI1K*ZVC) OI=XL(P1KO'4SZ;>?]$>D
MJQLYV\C91LXV<K:1LW7*&7COT9&+U[UX1_XR,1& B3WYW&E? 8@? <>N.-H$
M+3 QHBR<BP4->IB"\%U9XP]A/J]<,%?!$)N&,62]:.9>C^XM)\&N,GYQ=/B
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M<LA"I;&)R$GE:< *A9\,GI C-(S8OGH$1R9?6>>AAC(\A2:D"O(D5)*L=9U
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MW%DR^H]3,O@<Q.2T<PYQY#ZK6&O),MUR<:UO;\&^6!KC\31;]%Z[-*.Q3\4
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MDVBZ@?I#P\;A_9^;:VN]M;4UL5B2=PE1Q4QU(X"B,GG?9!+,#AE%,Z'^PLD
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M&\7+.P/1[1 4.K9>'MDJ0)P5;P^-!<76VB(,FD<$D6[9W+["7\APQW%+\WL
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M5MC:"*P#? ]RT%O0]2#PT#0XN8(#COPJ%4'(;(ILR_]*B: *KAT?=:!]&K4
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M2C81.%7BOI[;FWGT9<QFY?Z8-KC[R]-G*:$5<.HY*M2KF2(:D#[NO(,NM!7
M4)X19;Q_O#!"&.2@E1#..B=[:Y#B'2QYT3?H*K?&?A6CS=IL:> $@^29MX(/
MS+)+%?QYKC*4$(*Y? NCOK@UH^YN>TXYNV)18,,L7):+)PI7#+FBFT5LUZ=;
M^3;=OMUG^%]R2Y?SR>9&R"BO\ X)O@=<,P.)#,(TI8M$EV7-E3-$HA(PI7EM
M'CB&OA!_3%9ZT[<(BQD!/@%G9$Q.-HJ_0 DQ_X-04R#]ZFN%QBCZIUVR*+-0
M_K'K05:)>=_FAAM!J<&CS9>[KR(35\GBH@H$I(&S">!I.'C J';1T N;=E8L
M2#&1E^X_\)MOV%>PY)[/DJ''OQYS3L&<JXSTP L(M(%]W(3DG(&LTPR</WZJ
M796O$G2WXM^UMJDY.;.H"7'I5=$JADGH8@Y0$K+:Q'&!A7H7814[L1W S]16
MD_\-L7]=ZQ?9UEZJM5P>[T5L#GA036 -Z&-E$GPSC]X>&Q[Y+&H=C/,.='D;
MG)WV\%NYOO@5UOP.G,!0%[G:ABZI%D>I"0$N&-=,84]5-B7DE/W+5$<"4B.,
M@!>G9&2X4BQFDVF;Y A].7 A6K4J[OK[D'3LD_3P_<&'@(QXM9F$[YD8Z(59
MX?DANS)*IA,_3L>I[W\[>; =Q.(1*VK1;#J4\XUN,%L6Q]%L I=M<X-\E8S^
M@7R$@*H&V$Z;>JQ4+M@_&GN*Y1/[FT600%!@,*V?SCJ\938P)"1#EWVQQ&4?
M$"UQJ?1B 1X_RX#EQ+_+=!:=N/$XV4L>Z]7_@%&^E9.5S\E61BR]GFX\UPH7
MQ]!)-S=$CJ'MD>I@N1-:'VN3Z5\UW)L$?25PD40>ILO,K<:B,+)&R_9.R-.*
M6HJEHM)A)P1="\49&]X^;BN3D^4B&6[N0";?OW2:!&=*&1$JU%L,YBMRLMEX
MR$:@FC-815.I:QV/FBC5II(XH!!A']=]P[DO;<I0-ZB_18>V+GV$/R#FH'\C
MM3$EH\$_@3E1J;:59\)O+U4I"1OX0=XO2I);!#_1P^"8.61#B4L% S_ZW:I4
MBUE=J00,-;!>\.OP%S@!>)0JP40$A2CQ='DE\2R""L1(>=&.^J95' 9$O%B6
MHEFDNU[ /\; $$#9!HB-1.L;C@G@AOW *Q@Y'#6IIKB"B:+EXB84,)'@<?I+
MC(G0ES N@N%(RE;!'S "A\ZH^\L1'(XA85&EYD:0?8AL"C;A@LF'?\X<7;&3
M:"Z _;>U.7QC*YH_.SL<1);)I0%C3E&V$D*:%$UKZCG;K.9UJ1,JPE_6?<=B
M@)42AZ35O.CGJ38$K]'5Y!/2$@79IU$E[TC0#,JY&M5(M+9' TOE"M-SZBJW
M$D*6J#]D;PB!A4LP/C&X*JZ:['T2N/V^Q[\'VAXN]I! GD)=%H@O6%BI3M+K
M5 5O&TOT7QB !=DP%X0R.%OCG?B9 XUQ3Z^_-@%M4<-U0P,<P6"ZWWE@B^_8
M?5L/1[P5&Q $OIS7/=ZA1580X[2JZTI>J$\EP03Y^[CK?_7YU-P_C/,"@TYA
M*7#* VOE'D7H='MSPY6AN):%HJ<!;7H@2)@?HLT[,$EA'\V<KF>FM0<%ETEM
ML&M@OT6N(APM"<E"P;D0!><@A\5E<S$$_!V>;B58OF#[*)G@A"I& .EZ(9@]
ML?%;G<-F1'D>! <<C\[&/[P4)7PT?LA+P_^!!<,UZTP$CT.W9*UZ$5?.'0OH
MQW=$&[#P$+UEN$9C0=6=E\=N@16!VN[ME,%M#.X96,0&H6ZW4]^9Y50<INL2
MDWO*L#X9'RB1DG&9%7/"NL/W8.H5K60G^51WN%D3N6" L%'3FF0EJ1K$,&['
M<9%KR%%Y<3I3!]< B8BJ%14\K0)<])90.5!'$] GL& X2: \IJ R1HOQT@Q$
M!JZ0<6N"83 84$W@871]M=O#OHB38B$<$3BC(3,E$B4'4N8*20",>3M!^ #P
MP"P 50UWQ"4"(AHS,+ Z1?#?0NE@FXFJY$(&5&D%:J=F5'0Z'YMC7)R:70*)
M,%V!8BD4F :"UR7G6\P5XE5%._?,"?Q=42&FC@AE#@0N6GKV)28'LFU!AH95
MW1J_'S7L.(I$H4.(  S6!"&O58/_%#:"VU*"Q=@4&)8O!PN@6V.6"A]PK,2U
M'@2G0G6.SU5B;.2;&RLM#),MY]Q=3?G,V'?QK#S*U1RX%>!0I-JW*#@3$-9>
MEY@U02X$B0RTNA9UISB]V7QT(S!9U=5C^K:&)+6=YQ%X=(TG'L7Y)AG=VZR+
MNT(N[-#8K%+_,#& A'HB&X_5@E+-R*\Q&2^IS80&"@$/@F7<$N3,?Y6?.PR!
M),W=/%Z3WDK&GO/R[1"JUY(A^ZPJVKAO13A?(2[2_UU%Q <2%@\4O9MQ)RRP
M-D4BAIV[=<SL:XBO!M3"91J#;1TBL&'JYE.ADS&?HU6@\T4Y9]"^"H.F\CRC
MS^*,,2/"M;,E+O*67F[N9'=WV_?E.ALT<W/CMG F75B5 5W&F,H3Q!_U%BEX
M0M^!FX>&L, "7 E073LF,OQ2S%XDE3'X)Y1S%$/9<&'Y9>8<DW$EQZ#E1DJ?
M?;Y"B7V?:-S3'VC<W9D6Q79R!AYA@Q<>;Z%K9X3@5XCGL#FH3<$00P-+KP1S
MY!5<97E^&[Z O*^5#\5;HKZ,R?C-OBA.PV@QKQQ5KC$] [N>?A6#]%8M9BWL
M[J;%;FYH^">05 /QP[):[JZ/RM-]GS,XD/><G<3@B^A_IVAC="WE,FN]:DBH
M.)U2*I4Q (\XRR,=!6PHR9B@+3F"S0U*KAU+1LFTKD%X98S@T">8Y52A6VIU
M@H$ ,0&L+-2E24X1^V_$9C[;^\:$\E;%U87.LKC 80F@&ZFH8 ]#K]NLTF4,
M%.GU@JL9Q#_#E:$]&"PMSB19RUPGR3>TN8@LOK^DDSVJC-%6"P7Y*9'^,>71
M.P8LE\Q0!I?F3B(A;EW75 4.UGA<-SEA/3;S#141FR[1#)>]I)CX-B3S>NMX
M,<(87#GBQ*<,XB$<H1$#%QCT<B<=ZWPD"1'+?0VVH,:83)5M;FC@"'^"UV.2
M7=;@:I_V3=MG;&]%-I>Z6S,,:-2YY:E)7Y;(\'"R^!*OO,QQI@F/$;P*'V;1
M,@-LI1K6P@NZ'"<#KN?B&Z[3,Y?1@1M#&QA!!C;ER%U3L)U)S%P-'2$QHPBZ
M0)^F[>EQ@NN0FX7XL<\':TJ3E6)$+++(]1T*%B?,E((\B^@4[58Z?H#KQLZR
M'-[FAC;&6<^PC:Q,S&)+0HU_H&7<5W"VP 6ODF&.!_]P*QLF03B@#&RY'I4%
MI](YUO\R0]&!D*X'-7QL-4[<DXL!I;8*@[B6[5WY,@?,>LY*'+,.J>=%:V3!
M55-7T[R6R^@\-.<R$214X.-@+)[ I.1M45_4-9:+?OAP0'MAE>77,A44A-&U
M3%Q;"GJSY:3:S0VP)\#V:I,MO_S,E?_G;R^""C(^#:JXHWM"1F/".<=S!E1#
M7]7GL!%2Q7KMX1X##X03.;%6H:\H.B&J"ZCSE:\1]G:^_"K9&MV*N:(:P#*.
M?Y4OBQJ7W0JXB=[F$6OH!LS/!5WKW[*F 3%Z':O;&A3[6>5UA"E,1(#@D.X_
MF?/I4*\ZNM37-V<1?;-$V\9)?:.RE1K/4"$]_5VU[2V5:O)5.O5I5*=:H^3N
ME"KI@G6>!0](OU'7)@-5.\258AI7[O+WK'(Q7C% .(RM1%U&+(BQN1'RLY>4
MM'+3K@Z=P.-9: JWQF0*P5M:,'*#@ %.ZV2,$E*9Y<C5NK2-DQ<HJ#9?*.*<
M?X%V:_/"!")&BI"@TBA3 \Z!28"0+$57JQ*4M*]M:4/X;],_Y4"_#2LQQZHQ
M"!8OP\#,09 )S0\-OO-V;'"$JLWEKD@L/>LPVZ!=%%(E23LVR)3;TF+4TTLO
M"W6E:R[P!^.B&?=SC N-;>X#0FEI "8#"S:X[^#:4&)HZ2LB_?Y)+6%!8^=(
MTXW51**?Z#P _+NF@Z*N#PN,JGV_F-FS'YC9G:GY9ZZ:]]CNR,GFR1+VIG_C
M)$OX'^ES@!_#?YVS'0I*1=2^H._NU?;OPHV*.*?<2_/<9$L27^:J*3H_L+--
M\12;"A)H\365Q]!2C)HJ<<WJ:$0=8[HKE<@K1-&^(W1=PP#@4(A3)[1,)X1*
MDU-H,?Z-VW'HK_%_USQ">0@JS'XK39:?4AJ<$F:>Z9X!^"12#@QL &G9[9+C
M:NUYM9&%W-W9K6O-N [FRK,C:\9H:0JR6&J56';0<@QT"7=2IM7(B>LM^9[C
M29G8[<TO:NP3=I)H]5:K)+1.C*V^8&1S +PNYRV=FJ&KRE>;-/ID0V +_$)T
MM#$"3J^F&#+'K!>-(FVMTA@>2BE_#@]+'3&;/M:['ZSD_KVMG]<4P[]Q7-N5
MLLE2(9LF7F&+@]2$-1FIEQJ)%HHG06.&8N&EUZ\-#'ZU[_+[^1R.@$5SXE[1
MZ^=T[OMY3H6]61EV,-QYL/9.8=(5AWA-ALB@I'$O39XBV9^Y$/5JR;"&Q.YJ
M[A-R"]?W=T4$MIS4FKM&"K9=SG<S1W\'+'QX5]:"P@-/:RW+ZF$JT$)MYKG9
MSTT9LJZ(U.&X68,I$"XX=VOLQ4?NP#IRPZHIF3H"0>K*CJY^F%Y4-^W+@^ T
MB;#VC'5-UH,.;N!]K72+Z!"31604%(B5:*%+J_OIF0Q4<I?KA@OO.=7,?2F!
MOU@SJO. :C1WX$4V"*#791L:W'N_*')W F(: E$:O<\R[J;:X:Y:C]Q97E-"
MV8T-\3@;6G<%=8T#K<$S+Q]ZGET[<G=Y1\G[-XC^0HK1:@RK".\SCSW;WMR(
M*4++H(, >$RU#4(.T9H$RN'^S&DBA5&:$2F\ANFM1;.KNN0C2N<;>,FZ'=YW
M"0C]_ ,0NEO-8%/U%AF'\CBQ5>P*0H8)R6;!A5*=;0:O$,>6V&"/G Q[@:5A
M_<QUZO"ZN5:I-%'SX(,EWJ=D5:'K,E+7M72%EA(9M(X>J(,@1YM!%8['N!2Q
ME\"7G=;-U*@N+""@6*\3)/(+J)ZC.7-C@Y!((YG:%G'X62L3E4M+:"X%;Y*R
M'H.FYC.J&XH 28;]G*MF(C#13)6Y@?HIMYRR9[5]O+GA;HEDH6.A8G1T*F4D
M#W(^YH#00R[FII Q--L#4YG%YJBN>J>-%>P9,?Q+$!F@=O/-C;J13K'\ 4=+
MJM8DN\IC]-F#G"G)2O!?1KGZW4S%>CX,FJ>TMB>2E\W[5;TY/#='PTD>F5HQ
M 2DK0HH*/%;'R!@P5XRD2UG]Z9-GAM&S9I2!J_/XY$NIKO4Z]YX\V1N&SX??
M#8+GQLK4PLR/3+G74/<%-K2'Q0*MI#J##B+D",R2-)2E\%!=&K0KV-_SY?O;
MOOT52VYWP^ZWR1=V4*-FU;H_J-U:6*"ROI&R[(G&<PZ23>!(-S><]J;:NK7I
MI*UDSGO7V=3"F:!EK#O2JHXMUO(/7.8M8<5&E>HR(PW5F!OB[M24,2!;RK9)
M,T:[Q^CTJ)8=D<#G2C7.T-8E53^!@\"?+[S<!&GLUR:7W(I#\ S]#E'G0:#!
M*9AP2E<L 2Q2Y%0$<Z7%Y>!W1H@-W.I7^),'Z557D'B@ 3"QA=V_;_1"0,-+
M$W'66-&RI!M)FJ/3_(I*[# )E6-+XQGZ^38;S\]QP.J8NJY8,QD(:H&S%)AV
MJ8ZGDP%'#?^J.D'\0,##IT_ S;VFC#?M]L+]4L6BBS5 3*X:]*ZKQ-$[C?U'
MJW/@J4D911DT_5C68QD+7@+\WRVV??V$>$Q7QRQUC._!*B[7(1R]R! <]IOJ
M.T7*F2I ^:FQ7Y=JBE:99,>G8JRX*?_\C:NZ^8SP K8@9*Q!#_+("VJ>R*:Z
M[:#(F9Q^WN-5AA6$+$JP[E!-E>1D2?)L +-ZGJW0*'<+]VE?VSN)X5/#'SUU
MQT;.XW0<J8&=T) %^(26JR,\7"!&W1P':+Y.S.!2[.S:/]B=,)EO)"(,B^):
M^R/"8O0%&8140)A2@3EV:YASMU233I+'(MM($C>E(XB#!!T"DHM!1M@+A[9(
M].M@5>Z=*]I -ND*]\@C E4[*,?JKDT#)8M5Q>O&\>:*9%GR=,.G0P7P%].O
MV^BXS-#49N5\&UF_7S#C^0\PX\XTY2^D*8DM\[[ADE&,;#GM#."N'-JDA ,,
M93Q<T&T01*UPK;ZRP[0W]#8X:N%TE B!D6'(%HZIRCGXK=3G2!FFK] =P^)F
M=>YV=/4UM>\_XX[&XL[4DQTR5K3JKMR3"9RT((Q">9*F-"''IAQ8("_M!!=N
MAV7I(#RPL1,]00QK?$&MDZ@KK_4.W.X_%_2MHL3GC(( 9>R,J,0=)59C2B7L
M'TW#'YM9*'*X(T">VW76H?9B2>P5M).9%)?0NKU8KLJ,.Y_JA>K]R7)T@ I7
MZ\R+R-@@:.( "'>4,)!<))&3-+$F&>)>M [=](181S(WVJ'@ON]@X?$D]<J9
MA54T#W,?:N9;3H9SNB($#A1W,V;F]D,!B*#>W&EH<R/6:@@A'>K#'XLN8#=7
M:CR]Z)Q5=DX%AXO"^&D=;*K!:R2S:DD6OA:?7DMC@EFM4:C;(>U$_ ^Z[6+&
M4X@# ]RTNF9,[/#8;:%F<HG93K6C^Q3/J .C+5V&.:>4-F*#X]?\2$PXE.P?
MW03 [P09VSB?I?Z^W=^]L^@8-0-?L4N^89; *#'"<I;UPDC9#2ET\%37X,K:
MMI\K3L=PTOA"6M*CQ]*CR!V,XIZ1Q")U(WW/E\"R(*-@\&F(@J5V3ICI3>>+
M2*K LFJ$+P%B'F:*"7;) <U7@TM"G&@>I'?!OTOMNN0/R*J\GP!T$OW14":\
M:!Q.*[/?]V#:J([P,N9=_%>P,.H(6/OM]?0+L#0,_5KN815WZ&,Q0^IZ[6JX
M2(\ET\?*F1K0SSW5&B3=KI&7.2CKRYA$INVAN\NAQZ?W[6L<#YUSFWM,DOC)
M%1Y$%YS2YH:%V/3/]32&>#,FIVC"X5ULQ,5>L2YM:"3U.=H"2L^5=5\33 0U
M<TVYSM*ENCX)[N@=N$\5G$<K3E.++1'9CS4=IU3.FXX!B^)Z3< UJUA64\ (
M@0?,,!*V%?1!P,K K.3S-A4H!O:+!\J%C-QEC:-8KH&"LUD4.^_XE=2_<-0)
M"YM"AKP8TTKX)I9GG+'%4XN(M!Y-07L4V @%_8?"Y&P%6.I.<D9(!<'%-L"S
M/$T@SC_>:IB5S>:&Z6C>,9M^/=3$(#.M06-;)R_?$?"IP5N$P5JY/Z[4-DH@
M=O>YDYNNN[DQ'^XAFDY[9<&.[>3Q(1L;R,S601S76#)C$A]OR(K+6JV4'6%
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MT<>1X:(>LAH"-I(;_KM(DMM4_D2/T&PEDF50W/)2RL8'MS+C_$H'!\.,/],
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MSQ3P>Y4Y/?;( 4!Q8.T TDT^XNR ]@?" 2HYQUJ3UA:JRNRGU1LD(E!"8^.
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M,C0S-C(R9&5X,3 Y+FAT;>T]:U/<.+;?NZK_@RZSLP5;S3,ADP"ABE<2=IE
M 9G<N5OW@]I6=VMP6[V6#>G[Z^]Y2+;L=O/(0":323X$\$,Z.CKO<W2\\^[R
MYY/=G7='>X>[W<[.Y?'ER='NT7\OKZ^MO-I9Y3_A^JI[0.SLGQ[^*O;?'IR>
MG)Z_7OCX[OCR:&%7=#OPT(%*<Y7M[AP>_R(N+G\].7J]<*/C?+3U<F53IPM"
M)GJ8OEY(U"!?H+'._&-CF0UUNIR;R=;:)-\6[N^^R7,SYDL#D^;+5O^?VEJO
M_A[(L4ZF6Y=ZK*QXKV[$N1E+F&GOY/CM^]<+F1Z.8*J=_=V=X]VC3R/=U[G
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M<BL:^"9T!)C"//T\['0[C$(.\B>4I9%5M7> I08"R1\N?;BZ=7MG@?*B2TK
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M$,$#8/.!_3JV@7\BK(ZN.$@EO7U-S0%!)KD(.7;B(Y]S@*9QMS-;BNO*MJF
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M4J]-331?<215XK*"#98:6[M+OZC/W3-N=P"XQTI\>$G<@7'#7BV>'='1,W4
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MTHQI35U?1*S,&XRR41$QH*0;D>I3&&4T4 ]"0V75AR09I<1FR5Q=)L2IAKI
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M!E(6BV2I[Q@)@OF1KI>+I\/()I,IHYYPE&D<0:10_^Y!>/&"VF/L9 =R/PV
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M:&U@4&VH"=)(H$)A7K=LKHRJ!K"NQ?&1 5V@('X=X+=]VGHTP)0XWSWF] C
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M:[6EOU\HVT73;]E1>_X'4$L#!!0    ( /V*.%1"*9C"XP0  /@M   5
M9FQD;2TR,#(R,#$R,U]P<F4N>&ULU9I=<^(V%(;O=V;_@^J]:6=J')M-VS!A
M=RA)=IB2CR%LOVYVA'4 366)D>0 _[Z205L,=@K9;<?*!099Y^@]YY%EZ\27
M[U<90T\@%16\&\2MLP !3P6A?-8-<A5BE5(:(*4Q)Y@)#MU@#2IX_^[UJ\MO
MPA!=W0SN4(CF6B]4)XJ6RV6+3"E7@N7:N%2M5&01"D/7OS_^B'[=#-=!(V"
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M7UC>G+$?]O5;T_(W4$L! A0#%     @ _8HX5.^HU^HN0   F8P!  X
M         ( !     &0R-#,V,C)D.&LN:'1M4$L! A0#%     @ _8HX5)_.
MC@Q6T@  MED$ !$              ( !6D   &0R-#,V,C)D97@Q,#$N:'1M
M4$L! A0#%     @ _8HX5!E<XP/."@  0BD  !(              ( !WQ(!
M &0R-#,V,C)D97@Q,#$P+FAT;5!+ 0(4 Q0    ( /V*.%0""*;EHM(  (]U
M!  1              "  =T= 0!D,C0S-C(R9&5X,3 R+FAT;5!+ 0(4 Q0
M   ( /V*.%3G+R(&N,$! .RN"@ 1              "  :[P 0!D,C0S-C(R
M9&5X,3 S+FAT;5!+ 0(4 Q0    ( /V*.%2Z%(KK<,,! (FL"@ 1
M      "  96R P!D,C0S-C(R9&5X,3 T+FAT;5!+ 0(4 Q0    ( /V*.%1N
MKL&\'&L  "JJ @ 1              "  31V!0!D,C0S-C(R9&5X,3 U+FAT
M;5!+ 0(4 Q0    ( /V*.%3L8T0\,H$  )YF @ 1              "  7_A
M!0!D,C0S-C(R9&5X,3 V+FAT;5!+ 0(4 Q0    ( /V*.%1Y^#1<8AP  ">0
M   1              "  >!B!@!D,C0S-C(R9&5X,3 W+FAT;5!+ 0(4 Q0
M   ( /V*.%2T2T)4$$$  #HO 0 1              "  7%_!@!D,C0S-C(R
M9&5X,3 X+FAT;5!+ 0(4 Q0    ( /V*.%3!#)^STAT  'R/   1
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H;2TR,#(R,#$R,U]P<F4N>&UL4$L%!@     /  \ MP,   ,1!P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
